data_2v37_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2v37 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.438 ' CG2' HG22 ' A' ' 91' ' ' VAL . 7.3 mt -66.66 122.19 17.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.436 -0.79 . . . . 0.0 109.317 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.85 133.77 48.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -148.84 167.59 3.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -176.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.482 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.9 OUTLIER -152.04 146.83 18.95 Favored Pre-proline 0 C--N 1.272 -2.776 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 176.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -48.69 131.77 24.79 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.257 1.305 . . . . 0.0 110.157 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 29.0 mt -99.79 121.56 50.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.532 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 5.9 mp -105.98 107.71 18.85 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.18 140.94 24.88 Favored Pre-proline 0 C--N 1.275 -2.651 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 60.4 Cg_endo -75.53 134.65 17.19 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.576 1.517 . . . . 0.0 111.272 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.452 ' C ' ' H ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -67.82 -172.68 0.29 Allowed 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.914 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.523 ' C ' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER 55.83 -9.22 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 175.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.452 ' H ' ' C ' ' A' ' 11' ' ' GLU . 5.7 pt20 -55.66 132.96 50.27 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.4 -179.65 3.98 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.834 -1.166 . . . . 0.0 111.167 -175.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.558 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -54.29 171.76 0.27 Allowed Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.649 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 1.7 Cg_endo -78.71 121.13 7.76 Favored 'Cis proline' 0 N--CA 1.493 1.47 0 C-N-CA 123.793 -1.336 . . . . 0.0 114.012 0.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 20.4 m-85 -110.62 170.49 5.24 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 13.9 Cg_exo -69.7 167.63 70.15 Favored 'Cis proline' 0 N--CA 1.507 2.323 0 CA-C-N 120.172 1.097 . . . . 0.0 112.798 0.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -148.94 142.16 25.04 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 9.3 t0 -67.77 136.03 53.57 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.84 6.06 3.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.11 -175.0 45.48 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.809 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.58 ' HZ1' ' CB ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -145.17 121.72 11.07 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.925 -1.338 . . . . 0.0 110.36 -178.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.2 t -89.88 131.45 37.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -132.0 149.75 32.99 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -105.7 138.79 41.31 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.936 -1.105 . . . . 0.0 108.704 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.373 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.299 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 121.714 0.769 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 48.6 mttm -115.76 146.66 41.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' GLU . 89.6 m-85 -93.84 144.2 25.64 Favored 'General case' 0 C--N 1.282 -2.359 0 O-C-N 121.233 -0.917 . . . . 0.0 112.84 -172.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.34 150.99 22.43 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 21.0 tp -125.86 140.15 52.9 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 172.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.27 171.11 17.48 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 75' ' ' LEU . . . 117.0 169.85 15.2 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.315 -1.422 . . . . 0.0 111.594 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 45' ' ' GLU . 6.5 mtpp -60.05 111.13 1.39 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 120.21 -18.21 9.63 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.7 t -116.68 -97.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.655 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 3.4 t70 -93.52 -8.04 42.53 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -107.02 148.2 29.0 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 1.5 mp0 -55.85 133.55 73.05 Favored Pre-proline 0 C--N 1.264 -3.152 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 24.8 Cg_endo -70.77 127.54 12.0 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 C-N-CA 123.403 -1.499 . . . . 0.0 110.045 -0.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.655 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 15.3 mtpp -82.12 150.41 27.48 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 120.953 -1.092 . . . . 0.0 111.321 -173.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.403 ' O ' ' NH2' ' A' ' 63' ' ' ARG . . . 62.81 38.95 97.35 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.894 -0.504 . . . . 0.0 111.899 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.481 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 5.9 mm -100.27 -48.13 11.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -114.48 143.02 45.63 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.688 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 133.78 26.19 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.437 ' CG2' ' HB2' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -95.85 150.78 4.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.472 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 14.5 t-20 -79.82 105.71 11.31 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 35' ' ' PHE . 2.0 mt-10 -42.81 -36.81 1.59 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.454 -175.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -92.76 -43.73 8.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.206 -0.933 . . . . 0.0 111.562 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.5 p -85.07 -25.35 27.64 Favored 'General case' 0 C--N 1.282 -2.361 0 O-C-N 121.027 -1.045 . . . . 0.0 108.7 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.06 9.51 86.1 Favored Glycine 0 C--N 1.287 -2.154 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.58 ' CB ' ' HZ1' ' A' ' 23' ' ' LYS . 70.0 m -65.8 120.55 13.23 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.395 -1.062 . . . . 0.0 109.472 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.99 121.78 36.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.25 148.95 43.59 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.482 -0.761 . . . . 0.0 110.139 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.442 HG12 ' CE1' ' A' ' 17' ' ' PHE . 11.9 p -98.41 149.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.576 ' OG1' ' NH1' ' A' ' 63' ' ' ARG . 4.3 p -105.02 -15.52 15.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.481 -0.762 . . . . 0.0 112.002 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.576 ' NH1' ' OG1' ' A' ' 62' ' ' THR . 0.1 OUTLIER -157.41 -159.33 0.83 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.871 -1.143 . . . . 0.0 108.506 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.427 ' N ' ' HG3' ' A' ' 63' ' ' ARG . 4.8 t -80.8 179.42 7.82 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.168 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 mt -142.21 167.64 21.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -147.76 139.19 23.72 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.42 ' NE ' ' O ' ' A' ' 97' ' ' VAL . 16.7 ttm105 -76.06 -10.72 59.64 Favored 'General case' 0 C--N 1.282 -2.329 0 O-C-N 122.105 -0.372 . . . . 0.0 111.645 -174.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -90.12 -20.08 23.54 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.703 -1.248 . . . . 0.0 108.964 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.04 -53.26 13.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.408 HG22 ' CD1' ' A' ' 73' ' ' TYR . 1.1 mt -148.36 134.21 11.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.09 -28.29 20.19 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.43 115.08 3.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.47 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 62.3 m-85 -81.78 111.91 18.45 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 174.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.39 95.53 9.72 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.41 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -90.26 170.6 10.14 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 122.25 1.024 . . . . 0.0 108.424 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -134.44 131.96 38.75 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.26 150.14 14.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -142.12 142.13 32.74 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.72 129.35 35.56 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.546 ' HA ' HD23 ' A' ' 87' ' ' LEU . 11.3 p -123.19 150.37 43.44 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -92.59 170.09 10.01 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.22 -0.992 . . . . 0.0 108.564 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -14.98 4.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.19 -5.08 53.41 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.98 -4.91 60.12 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -75.19 150.6 38.64 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.332 -1.099 . . . . 0.0 108.615 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.55 119.64 30.98 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -94.41 -30.62 14.37 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -135.28 170.13 16.4 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 -179.17 51.72 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.56 127.03 7.7 Favored 'Cis proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.158 -1.601 . . . . 0.0 112.609 0.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.438 HG22 ' CG2' ' A' ' 2' ' ' ILE . 2.1 m -105.5 161.92 21.3 Favored Pre-proline 0 C--N 1.28 -2.424 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -94.44 151.17 1.96 Allowed 'Trans proline' 0 C--N 1.288 -2.637 0 C-N-CA 122.238 1.959 . . . . 0.0 112.527 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.2 tp -141.79 129.76 21.93 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -110.88 130.18 55.65 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 120.926 -1.109 . . . . 0.0 110.04 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 46.7 t -111.42 111.66 37.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 174.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.54 142.44 13.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.236 -0.915 . . . . 0.0 109.073 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.42 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 1.5 t -91.91 96.08 5.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 5.7 pt -82.21 172.01 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 O-C-N 120.893 -1.13 . . . . 0.0 110.125 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.417 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 3.1 m-20 . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.4 OUTLIER . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.464 HD13 ' N ' ' A' ' 79' ' ' THR . 11.4 mt -68.77 113.86 4.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.162 -0.961 . . . . 0.0 110.363 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.21 111.2 29.15 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 174.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -127.84 164.21 29.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.479 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -142.63 152.29 59.39 Favored Pre-proline 0 C--N 1.275 -2.652 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 175.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -49.51 136.67 33.05 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.681 1.588 . . . . 0.0 111.108 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 96' ' ' ILE . 21.9 mt -102.55 110.08 28.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.4 mp -98.83 96.87 8.17 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.413 ' CG2' ' NE2' ' A' ' 13' ' ' GLN . 15.6 mt -103.75 133.56 20.2 Favored Pre-proline 0 C--N 1.275 -2.673 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.6 Cg_endo -70.65 120.65 7.26 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.318 1.345 . . . . 0.0 109.683 175.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.42 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -43.1 -71.9 0.07 Allowed 'General case' 0 N--CA 1.522 3.155 0 O-C-N 121.241 -0.912 . . . . 0.0 111.943 -174.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.4 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 34.2 p30 -62.47 42.92 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.519 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 22.3 mt-30 -77.61 140.77 39.7 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.504 ' CD ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -117.77 177.35 4.8 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.416 -0.803 . . . . 0.0 110.038 -176.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -49.02 167.88 0.2 Allowed Pre-proline 0 C--N 1.292 -1.895 0 C-N-CA 123.461 0.704 . . . . 0.0 109.882 178.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 4.8 Cg_exo -77.16 121.64 8.01 Favored 'Cis proline' 0 C--N 1.311 -1.417 0 C-N-CA 123.714 -1.369 . . . . 0.0 113.158 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.416 ' CE2' HG12 ' A' ' 61' ' ' VAL . 26.4 m-85 -102.76 165.88 12.92 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 175.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.22 154.48 85.23 Favored 'Cis proline' 0 N--CA 1.496 1.638 0 C-N-CA 124.184 -1.174 . . . . 0.0 110.516 -1.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -136.56 145.21 44.73 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.205 -0.935 . . . . 0.0 110.136 -178.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.526 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 5.5 t70 -65.87 142.3 57.96 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.44 1.77 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.2 176.35 39.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -146.27 125.74 13.21 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.669 -1.489 . . . . 0.0 110.185 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.4 t -87.6 143.48 11.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.6 t -136.73 160.98 36.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 1' ' ' SER . 10.2 t70 -120.54 137.73 54.23 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.081 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.758 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 121.085 0.469 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -113.86 169.39 9.03 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -115.42 126.3 54.2 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.8 mmt-85 -98.68 119.11 36.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.73 139.71 38.6 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.89 170.29 20.72 Favored 'General case' 0 C--N 1.279 -2.47 0 O-C-N 121.262 -0.899 . . . . 0.0 108.613 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.88 169.99 15.3 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.433 ' NZ ' ' HG3' ' A' ' 45' ' ' GLU . 11.1 mtpp -54.82 115.31 2.11 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 120.8 -21.64 8.36 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.9 t -119.78 -88.07 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.39 -1.065 . . . . 0.0 109.122 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.476 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 15.8 p-10 -93.14 -14.17 27.54 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.419 HE21 ' CG ' ' A' ' 43' ' ' ASP . 11.1 mt-30 -113.9 160.76 18.43 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HG3' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -61.69 133.84 93.67 Favored Pre-proline 0 C--N 1.286 -2.184 0 O-C-N 122.152 -0.343 . . . . 0.0 110.722 -174.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.471 ' HB2' ' CG1' ' A' ' 49' ' ' ILE . 3.2 Cg_exo -76.13 123.76 9.68 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.173 -1.595 . . . . 0.0 109.296 -1.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 27.2 mttp -71.01 154.0 42.16 Favored 'General case' 0 C--N 1.282 -2.346 0 O-C-N 120.923 -1.11 . . . . 0.0 110.894 -174.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.19 21.31 53.11 Favored Glycine 0 N--CA 1.489 2.215 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.201 172.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.471 ' CG1' ' HB2' ' A' ' 46' ' ' PRO . 26.6 mm -73.55 -43.59 54.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -116.7 141.38 48.28 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.428 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.83 129.16 24.0 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.38 149.84 4.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 O-C-N 121.643 -0.661 . . . . 0.0 110.05 -174.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 14.1 t-20 -79.76 112.6 17.18 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -53.28 -31.11 42.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.847 -0.533 . . . . 0.0 111.541 -176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.447 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -97.22 -23.39 16.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 112.601 -174.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 19.5 p -112.29 -27.5 8.29 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.82 5.43 86.38 Favored Glycine 0 C--N 1.283 -2.389 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 t -60.67 125.7 24.69 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 t -86.5 118.76 33.39 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.84 140.65 45.11 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.411 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.416 HG12 ' CE2' ' A' ' 17' ' ' PHE . 7.7 p -99.77 145.17 11.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.4 p -97.51 -14.99 20.77 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.511 -0.743 . . . . 0.0 111.46 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.496 ' NH2' ' OH ' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -153.03 170.6 20.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.847 -1.158 . . . . 0.0 110.938 -177.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 t -66.32 140.25 58.09 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.6 mt -92.44 170.04 10.08 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.63 -1.294 . . . . 0.0 111.106 -173.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.18 102.55 6.99 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 67' ' ' ARG . 4.3 ttm105 -66.35 -18.74 65.54 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 1.2 mp0 -76.94 -26.18 53.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.858 -1.151 . . . . 0.0 108.378 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 t -97.18 -52.99 8.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.97 112.15 29.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.45 -33.66 54.7 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.42 131.89 6.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.496 ' OH ' ' NH2' ' A' ' 63' ' ' ARG . 61.0 m-85 -87.8 120.27 28.95 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -88.48 81.23 7.21 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.19 170.46 16.09 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.128 0.966 . . . . 0.0 109.015 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.9 m-85 -137.13 130.05 30.6 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.56 160.52 13.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.277 0.56 . . . . 0.0 110.143 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -147.4 143.01 27.65 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.464 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -88.72 123.09 32.82 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 173.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -109.0 153.38 23.68 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-O 121.582 0.706 . . . . 0.0 111.677 -172.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 3.0 t70 -96.48 170.1 9.45 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 174.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.501 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -52.79 -27.16 11.96 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -79.69 2.05 24.14 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.484 -0.76 . . . . 0.0 109.511 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.82 19.41 75.1 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -91.3 154.92 18.91 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 m -84.13 124.35 31.05 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.854 0.835 . . . . 0.0 111.012 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.605 ' N ' ' CD2' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -86.11 -45.63 11.2 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 175.289 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -142.41 151.53 41.91 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.44 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 105.39 177.34 24.18 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 107.929 -2.068 . . . . 0.0 107.929 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.32 109.97 0.48 Allowed 'Cis proline' 0 N--CA 1.495 1.605 0 CA-C-N 118.949 1.374 . . . . 0.0 113.065 0.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.44 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 2.5 m -91.47 161.44 34.46 Favored Pre-proline 0 C--N 1.281 -2.374 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.99 155.37 3.92 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 C-N-CA 121.762 1.641 . . . . 0.0 111.726 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 tp -142.85 125.64 16.03 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -109.38 112.09 24.01 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 121.772 -0.58 . . . . 0.0 110.033 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 56.7 t -102.39 97.74 5.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 7' ' ' ILE . 2.8 mp -81.13 132.94 30.39 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 O-C-N 121.653 -0.654 . . . . 0.0 109.456 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 31.8 t -88.22 92.67 3.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 4.9 pt -80.35 171.04 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 O-C-N 121.248 -0.908 . . . . 0.0 109.112 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 C--N 1.284 -2.278 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.159 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.542 ' H3 ' ' CD ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.192 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.444 ' CG2' HG22 ' A' ' 91' ' ' VAL . 4.7 mt -62.57 142.15 17.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 121.449 0.643 . . . . 0.0 109.771 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.38 106.15 15.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -127.8 158.7 39.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.434 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -124.42 151.05 66.16 Favored Pre-proline 0 C--N 1.281 -2.409 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.18 141.72 94.43 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 121.475 1.45 . . . . 0.0 109.155 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 96' ' ' ILE . 24.5 mt -107.96 113.04 42.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 O-C-N 121.412 -0.805 . . . . 0.0 109.865 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.517 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.94 94.2 9.54 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.4 mt -101.25 127.42 31.83 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.8 Cg_endo -70.55 128.11 14.86 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 N-CA-C 109.493 -1.003 . . . . 0.0 109.493 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.497 ' CD ' ' HE ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -59.75 -178.78 0.08 Allowed 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 119.501 -0.879 . . . . 0.0 109.995 -176.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.12 14.86 9.66 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.65 -0.657 . . . . 0.0 111.724 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -67.05 137.06 56.15 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.54 ' CD ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -114.4 -178.58 3.4 Favored 'General case' 0 C--N 1.281 -2.376 0 O-C-N 120.881 -1.137 . . . . 0.0 110.676 -175.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 13.8 mp0 -59.3 169.0 1.39 Allowed Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 30.5 Cg_endo -70.91 114.84 2.48 Favored 'Cis proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.621 -1.408 . . . . 0.0 114.475 0.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -102.92 164.33 15.77 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.3 156.03 88.49 Favored 'Cis proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.864 -1.307 . . . . 0.0 111.092 -0.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' SER . 1.4 tmt_? -134.26 144.7 48.53 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -70.57 137.73 50.3 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.6 m -133.93 2.7 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.57 179.2 48.36 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.506 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 17.3 mttp -146.52 133.69 20.49 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.007 -1.29 . . . . 0.0 110.762 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.454 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 20.0 t -108.23 131.0 59.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -133.96 170.05 20.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.751 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 27' ' ' SER . 0.9 OUTLIER -119.68 154.62 33.79 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.8 -1.188 . . . . 0.0 109.184 177.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.453 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 8.2 m . . . . . 0 C--N 1.267 -3.011 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.026 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -121.4 138.56 54.22 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -93.19 124.34 37.09 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 121.03 -1.044 . . . . 0.0 109.131 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.4 mtm-85 -99.29 148.07 24.53 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.1 tp -131.38 128.82 40.39 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -140.47 170.36 15.94 Favored 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.558 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 120.87 166.18 12.95 Favored Glycine 0 C--N 1.282 -2.465 0 O-C-N 120.815 -1.178 . . . . 0.0 110.259 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 111.48 0.54 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 124.08 -19.14 7.35 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.0 t -120.59 -92.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.289 -1.124 . . . . 0.0 108.976 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.47 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 2.0 t0 -94.13 -10.78 32.15 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.558 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 17.4 mp0 -109.33 159.19 17.18 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -66.59 132.67 94.16 Favored Pre-proline 0 C--N 1.263 -3.172 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.091 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.441 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -74.12 120.12 6.18 Favored 'Cis proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.39 -1.504 . . . . 0.0 110.759 -0.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 43' ' ' ASP . 8.7 mttm -70.86 154.37 41.89 Favored 'General case' 0 C--N 1.289 -2.057 0 O-C-N 121.106 -0.996 . . . . 0.0 111.023 -175.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.78 30.13 74.15 Favored Glycine 0 N--CA 1.495 2.633 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.467 171.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLY . 9.4 mm -90.6 -45.95 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 119.007 1.404 . . . . 0.0 107.647 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -114.34 151.91 32.26 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.271 0.558 . . . . 0.0 110.198 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.7 ptm85 -144.29 137.13 27.02 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.451 HG23 HD11 ' A' ' 52' ' ' ILE . 13.6 tt -105.44 159.73 5.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.407 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 17.6 t-20 -90.45 132.72 35.49 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -31.21 71.92 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.832 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -97.5 -51.88 3.98 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.676 0.75 . . . . 0.0 110.541 -174.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.438 ' HG1' ' CB ' ' A' ' 58' ' ' SER . 7.8 p -80.43 -21.39 42.21 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 24' ' ' VAL . . . 68.75 14.06 66.99 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.506 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 37.0 m -64.07 120.91 12.95 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.173 -1.192 . . . . 0.0 108.849 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.95 122.01 37.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -122.03 154.91 36.65 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.645 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.05 149.8 6.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 63.5 p -98.29 -16.51 19.35 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.613 -0.68 . . . . 0.0 110.226 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.63 178.49 7.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.416 -0.802 . . . . 0.0 109.973 -174.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.7 t -76.62 139.41 40.61 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.0 mt -98.96 156.23 17.01 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.393 -0.817 . . . . 0.0 109.516 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -135.67 128.47 31.09 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.497 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 12.9 mtm180 -64.64 -5.84 6.49 Favored 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.19 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.57 -21.61 52.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.105 -0.997 . . . . 0.0 108.516 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.25 -55.79 5.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.42 HD11 ' CE1' ' A' ' 73' ' ' TYR . 1.2 mt -141.84 136.63 30.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 121.416 -0.803 . . . . 0.0 108.935 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.28 -26.25 25.06 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.3 p -156.35 137.8 5.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.427 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 71.8 m-85 -99.25 116.86 32.41 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.473 HE22 ' CG ' ' A' ' 94' ' ' GLU . 15.1 tp60 -85.86 79.6 9.2 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.65 170.78 16.04 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 34.4 m-85 -137.35 141.15 41.81 Favored 'General case' 0 C--N 1.256 -3.457 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.37 148.51 18.05 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 O-C-N 121.687 -0.633 . . . . 0.0 109.399 -176.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 86' ' ' THR . 0.5 OUTLIER -134.39 135.27 42.51 Favored 'General case' 0 C--N 1.28 -2.455 0 O-C-N 121.195 -0.94 . . . . 0.0 108.859 176.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.51 132.14 34.13 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 174.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 17.7 p -127.0 164.26 21.89 Favored 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.986 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 2.1 t70 -97.54 170.22 9.19 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.497 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 0.9 OUTLIER -46.43 -33.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-O 121.457 0.646 . . . . 0.0 109.874 178.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.53 2.63 21.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.558 -0.714 . . . . 0.0 109.742 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.23 81.39 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 80' ' ' THR . 8.3 mtpp -74.49 150.11 40.0 Favored 'General case' 0 CA--C 1.474 -1.943 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.437 ' CG2' ' HB3' ' A' ' 78' ' ' GLU . 1.2 m -99.6 118.01 35.22 Favored 'General case' 0 C--N 1.272 -2.768 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.132 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.606 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.68 -24.11 17.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.542 ' CD ' ' H3 ' ' A' ' 1' ' ' SER . 0.9 OUTLIER -148.38 158.62 44.21 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.09 -175.19 51.06 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -57.94 108.74 0.2 OUTLIER 'Cis proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.707 -1.372 . . . . 0.0 113.795 0.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -84.85 167.48 26.23 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 172.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -94.47 156.43 2.0 Favored 'Trans proline' 0 C--N 1.286 -2.763 0 C-N-CA 121.959 1.773 . . . . 0.0 112.791 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 tp -142.89 131.28 22.22 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.473 ' CG ' HE22 ' A' ' 74' ' ' GLN . 13.8 mt-10 -106.11 109.76 21.8 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.508 -0.745 . . . . 0.0 109.432 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 89.8 t -98.06 96.67 5.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.402 ' N ' ' O ' ' A' ' 7' ' ' ILE . 4.7 mp -79.79 128.29 38.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.26 105.09 15.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.9 pt -93.3 171.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.282 -2.337 0 O-C-N 120.984 -1.072 . . . . 0.0 108.467 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.483 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.438 HD13 ' N ' ' A' ' 79' ' ' THR . 11.2 mt -65.24 131.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 C-N-CA 119.221 -0.991 . . . . 0.0 109.214 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.95 128.64 73.17 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.45 159.1 22.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -139.59 144.26 38.71 Favored Pre-proline 0 C--N 1.281 -2.37 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -51.08 135.2 44.44 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.446 1.431 . . . . 0.0 109.88 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.7 mt -103.67 115.56 45.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.525 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.42 105.59 17.92 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.1 mt -114.02 123.28 33.0 Favored Pre-proline 0 C--N 1.287 -2.115 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 27.2 Cg_endo -66.83 142.8 64.44 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 120.748 0.965 . . . . 0.0 112.434 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.402 ' HG3' ' HA ' ' A' ' 99' ' ' ASP . 0.6 OUTLIER -67.16 -178.55 0.82 Allowed 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 122.278 1.037 . . . . 0.0 112.307 -176.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.9 m-20 47.25 18.01 0.08 Allowed 'General case' 0 N--CA 1.514 2.762 0 C-N-CA 124.177 0.991 . . . . 0.0 113.341 174.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -76.64 122.84 25.23 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.28 -163.48 1.02 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.354 -0.841 . . . . 0.0 110.428 -175.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.533 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -46.66 165.57 0.19 Allowed Pre-proline 0 N--CA 1.5 2.062 0 CA-C-O 121.377 0.608 . . . . 0.0 111.409 -177.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.533 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 55.3 Cg_endo -86.92 120.9 5.78 Favored 'Cis proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.442 -1.483 . . . . 0.0 113.613 0.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 19' ' ' ARG . 27.4 m-85 -115.27 163.61 19.64 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 19.7 Cg_exo -67.07 162.63 74.65 Favored 'Cis proline' 0 N--CA 1.504 2.136 0 C-N-CA 124.553 -1.019 . . . . 0.0 113.077 -0.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -153.1 149.23 27.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.772 -0.58 . . . . 0.0 109.517 -178.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.476 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -71.39 139.68 49.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.75 -3.48 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.98 170.72 42.63 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.52 ' NZ ' ' O ' ' A' ' 56' ' ' THR . 22.3 tttm -131.24 121.11 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -1.122 . . . . 0.0 109.906 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.85 147.63 5.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 171.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -142.41 170.07 12.24 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 1' ' ' SER . 34.5 t0 -143.27 78.18 1.59 Allowed 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.82 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.035 -172.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.016 0.436 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -127.15 167.37 16.12 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 54' ' ' GLU . 87.9 m-85 -98.41 142.63 29.8 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.944 -1.098 . . . . 0.0 112.123 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.599 ' NH2' ' O ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER -110.05 126.56 54.12 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 172.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 37.5 tp -107.83 142.1 38.41 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 p -151.73 171.58 17.46 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 75' ' ' LEU . . . 121.3 172.73 14.47 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 120.843 -1.161 . . . . 0.0 111.418 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.415 ' CA ' ' HB2' ' A' ' 44' ' ' GLN . 24.9 mtpp -61.19 111.69 1.82 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 121.49 -22.05 7.92 Favored Glycine 0 C--N 1.279 -2.632 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.1 t -118.91 -85.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.14 -14.58 17.69 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.444 ' CD ' ' HA3' ' A' ' 39' ' ' GLY . 27.7 mt-30 -104.16 152.75 21.76 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 173.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.521 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 7.2 mm-40 -66.77 139.5 95.83 Favored Pre-proline 0 C--N 1.285 -2.206 0 O-C-N 121.85 -0.531 . . . . 0.0 110.373 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.462 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 37.7 Cg_endo -68.94 119.62 3.77 Favored 'Cis proline' 0 N--CA 1.509 2.41 0 C-N-CA 123.592 -1.42 . . . . 0.0 111.327 -1.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.521 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 11.2 mtpp -76.96 162.92 27.19 Favored 'General case' 0 C--N 1.288 -2.104 0 O-C-N 120.768 -1.207 . . . . 0.0 110.696 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.04 19.11 50.19 Favored Glycine 0 N--CA 1.496 2.674 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.939 173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.7 mm -83.09 -48.38 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 119.487 1.643 . . . . 0.0 107.591 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.437 ' CZ ' HG12 ' A' ' 95' ' ' VAL . 52.1 m-85 -111.88 145.74 38.97 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.275 0.56 . . . . 0.0 110.646 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -148.35 135.49 20.26 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 tt -102.96 157.01 4.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.43 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 11.6 t-20 -80.91 115.13 20.23 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' PHE . 1.7 mp0 -50.5 -40.84 52.46 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 122.061 -0.399 . . . . 0.0 111.496 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -90.43 -44.58 9.53 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.604 -1.31 . . . . 0.0 111.512 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.52 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 8.8 p -80.78 -28.48 36.36 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 121.226 -0.921 . . . . 0.0 109.417 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.6 10.49 84.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 m -67.38 123.44 20.39 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.388 -1.066 . . . . 0.0 108.224 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.58 124.48 40.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -121.09 150.9 40.51 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 9.8 p -110.49 148.27 14.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.9 p -97.29 -28.12 14.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.495 -0.753 . . . . 0.0 110.926 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.502 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -135.26 167.54 20.83 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.094 -1.004 . . . . 0.0 110.232 -177.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.502 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 13.3 t -57.37 156.5 7.67 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 12' ' ' ASN . 21.6 mt -110.88 140.94 44.91 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.951 -1.093 . . . . 0.0 108.683 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 68' ' ' GLU . 2.7 p-10 -131.4 122.97 27.22 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.536 ' NH1' ' O ' ' A' ' 97' ' ' VAL . 1.4 mtp85 -75.12 10.05 1.7 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.47 ' H ' ' C ' ' A' ' 66' ' ' ASP . 52.1 mt-10 -74.11 -24.19 59.42 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.1 t -126.18 -82.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -91.16 127.67 43.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 121.12 -0.988 . . . . 0.0 108.987 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.59 -25.74 19.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.84 121.03 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.353 -0.842 . . . . 0.0 108.9 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.417 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 79.7 m-85 -80.11 120.66 24.55 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -86.79 94.19 9.47 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.471 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -92.57 170.65 9.57 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.913 0.863 . . . . 0.0 109.198 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.0 m-85 -140.78 131.24 25.3 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.37 146.41 18.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 O-C-N 122.055 -0.403 . . . . 0.0 110.517 -174.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.409 ' CD ' HH11 ' A' ' 36' ' ' ARG . 45.3 mt-10 -132.14 141.65 49.21 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 120.939 -1.101 . . . . 0.0 109.143 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.438 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -86.38 135.43 33.51 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 171.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.526 ' HA ' HD23 ' A' ' 87' ' ' LEU . 1.1 p -127.14 152.36 47.44 Favored 'General case' 0 C--N 1.286 -2.179 0 O-C-N 121.481 -0.762 . . . . 0.0 111.251 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -89.28 171.99 9.37 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.104 0.954 . . . . 0.0 109.614 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -54.02 -9.59 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.101 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -100.57 -34.96 9.69 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.122 . . . . 0.0 108.423 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' NH2' ' A' ' 36' ' ' ARG . . . 118.57 23.44 3.41 Favored Glycine 0 C--N 1.287 -2.156 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -95.6 141.09 29.52 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.0 m -79.96 119.56 22.98 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.442 -0.786 . . . . 0.0 110.611 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -89.02 -25.72 21.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.96 -1.087 . . . . 0.0 108.393 176.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -151.88 160.02 43.66 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.457 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 94.64 -173.85 32.72 Favored Glycine 0 C--N 1.289 -2.046 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.82 105.91 0.43 Allowed 'Cis proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.162 -1.599 . . . . 0.0 111.595 -0.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 5.0 m -73.93 164.47 60.92 Favored Pre-proline 0 C--N 1.286 -2.161 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -92.44 153.71 3.01 Favored 'Trans proline' 0 C--N 1.286 -2.736 0 C-N-CA 121.315 1.343 . . . . 0.0 112.064 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.5 tp -142.12 128.64 20.19 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -108.69 108.45 19.3 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.649 -0.657 . . . . 0.0 109.335 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.437 HG12 ' CZ ' ' A' ' 50' ' ' PHE . 84.7 t -96.72 99.56 9.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 176.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 mp -80.95 132.02 32.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.536 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 19.8 t -89.09 111.47 22.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 13.6 pt -97.08 170.96 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.452 -0.78 . . . . 0.0 109.394 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.504 ' CG ' ' HE ' ' A' ' 67' ' ' ARG . 7.0 m-20 . . . . . 0 C--N 1.297 -1.675 0 O-C-N 121.148 -0.97 . . . . 0.0 108.459 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.519 ' CB ' ' HG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.407 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 79' ' ' THR . 7.2 mt -79.49 122.27 34.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -104.59 142.6 17.62 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.415 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -150.05 160.43 4.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.415 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -132.24 130.77 22.08 Favored Pre-proline 0 C--N 1.276 -2.592 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.42 ' O ' HD23 ' A' ' 8' ' ' LEU . 54.0 Cg_exo -41.15 129.14 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.213 1.942 . . . . 0.0 110.189 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mt -95.79 109.41 22.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.509 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.05 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.535 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -90.41 107.08 18.92 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -107.22 125.19 33.05 Favored Pre-proline 0 C--N 1.286 -2.191 0 O-C-N 121.433 -0.792 . . . . 0.0 109.11 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.3 Cg_endo -64.96 120.11 7.29 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.125 1.216 . . . . 0.0 109.43 175.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.468 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -70.8 -171.97 0.59 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.532 0.682 . . . . 0.0 110.767 -174.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 59.99 -2.9 0.13 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 11' ' ' GLU . 66.0 mt-30 -56.96 137.82 54.95 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.41 175.43 5.51 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 121.272 -0.892 . . . . 0.0 110.707 -174.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -49.68 166.56 0.26 Allowed Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 123.045 0.538 . . . . 0.0 109.935 178.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.583 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 1.9 Cg_endo -78.71 143.22 71.28 Favored 'Cis proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.18 -1.592 . . . . 0.0 112.926 -0.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.487 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 30.0 m-85 -115.41 160.98 32.3 Favored Pre-proline 0 C--N 1.275 -2.663 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 3.9 Cg_endo -70.94 160.64 91.22 Favored 'Cis proline' 0 N--CA 1.487 1.142 0 C-N-CA 124.04 -1.233 . . . . 0.0 112.877 0.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 16' ' ' PRO . 4.9 mtp85 -131.14 136.33 48.25 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -66.84 137.57 56.69 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.03 5.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.53 177.42 37.15 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 117.707 -2.187 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 16.1 tttm -139.2 123.21 17.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.118 -1.225 . . . . 0.0 110.955 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.492 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 14.3 t -82.0 155.99 4.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 172.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 t -144.89 148.4 17.98 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.941 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -112.79 131.69 55.58 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.519 ' HG ' ' CB ' ' A' ' 1' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.286 -2.152 0 O-C-N 121.748 -0.595 . . . . 0.0 110.121 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.407 ' O ' ' NZ ' ' A' ' 34' ' ' LYS . 2.6 p . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 121.46 0.648 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' NZ ' ' O ' ' A' ' 33' ' ' SER . 5.3 mmtm -137.74 170.99 15.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -117.58 121.28 40.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.406 -0.809 . . . . 0.0 109.14 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.406 ' HG3' ' CG2' ' A' ' 80' ' ' THR . 0.0 OUTLIER -100.96 144.28 30.09 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 173.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.9 tp -127.94 142.55 51.22 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.46 171.38 16.17 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.466 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 124.86 166.42 12.38 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.318 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.58 119.05 4.72 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 109.39 -24.81 19.53 Favored Glycine 0 C--N 1.281 -2.491 0 N-CA-C 107.661 -2.175 . . . . 0.0 107.661 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -105.89 -100.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.571 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -90.25 -0.51 57.65 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.393 -0.817 . . . . 0.0 109.351 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -123.36 157.66 32.82 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.997 178.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -47.94 127.21 11.52 Favored Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.847 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.425 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 4.4 Cg_exo -76.38 113.16 2.71 Favored 'Cis proline' 0 C--O 1.203 -1.25 0 C-N-CA 123.694 -1.378 . . . . 0.0 109.188 -1.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 11.4 mtpp -64.9 139.98 58.82 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 121.024 -1.048 . . . . 0.0 111.438 -173.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.67 35.68 35.46 Favored Glycine 0 N--CA 1.502 3.076 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.104 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 41' ' ' GLY . 5.1 mm -104.33 -46.12 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 118.717 1.259 . . . . 0.0 107.944 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.439 ' C ' ' HE ' ' A' ' 51' ' ' ARG . 67.1 m-85 -114.11 137.76 51.31 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.65 0.738 . . . . 0.0 110.318 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.439 ' HE ' ' C ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -143.24 143.33 31.69 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.3 tt -106.58 166.39 3.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.443 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 9.8 t-20 -86.95 120.49 28.27 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.27 -13.98 2.52 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.427 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 52.7 m-80 -119.93 -46.83 2.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.844 -1.16 . . . . 0.0 111.382 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.474 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 22.0 p -79.39 -40.99 28.74 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.742 0.782 . . . . 0.0 108.991 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.42 6.15 56.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 6.6 m -61.77 125.58 24.31 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.4 -1.059 . . . . 0.0 108.169 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.56 129.48 43.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.4 155.78 44.19 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.541 -0.724 . . . . 0.0 109.174 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 8.5 p -106.81 139.87 26.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -94.34 6.28 49.19 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.479 -0.763 . . . . 0.0 112.796 -176.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.669 ' NH1' ' O ' ' A' ' 64' ' ' THR . 15.6 ptt85 -156.18 172.38 18.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.441 -1.412 . . . . 0.0 110.759 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.669 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 5.9 t -65.42 138.17 57.95 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 47.3 mt -96.28 163.89 12.89 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.943 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.545 ' CG ' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -152.07 121.73 6.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -67.1 1.99 1.75 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.411 -0.806 . . . . 0.0 109.352 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 66' ' ' ASP . 4.1 mt-10 -71.73 -22.01 61.68 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -101.34 -70.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.9 mt -130.49 145.86 34.93 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.53 -23.53 15.98 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.4 p -151.38 139.13 13.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.67 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -110.88 143.87 40.81 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.16 95.6 5.69 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.58 170.33 10.94 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 68.6 m-85 -129.93 121.19 26.13 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.38 152.86 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 120.93 0.395 . . . . 0.0 110.106 -176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HA ' ' HA2' ' A' ' 89' ' ' GLY . 48.0 mt-10 -138.88 140.39 38.4 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.701 -0.625 . . . . 0.0 109.401 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.555 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -91.07 124.65 35.46 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 172.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -110.0 158.82 17.86 Favored 'General case' 0 C--N 1.268 -2.936 0 CA-C-O 121.817 0.818 . . . . 0.0 111.523 -171.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.451 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 14.2 t0 -99.58 169.38 9.33 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 175.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 2.4 m -59.33 -19.86 17.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.981 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -80.61 -1.28 41.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.42 24.76 74.39 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 80' ' ' THR . 6.5 pttp -107.5 159.46 16.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.645 -0.915 . . . . 0.0 108.843 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 m -83.23 120.83 26.31 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.358 0.599 . . . . 0.0 112.415 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.576 ' N ' ' CD2' ' A' ' 87' ' ' LEU . 1.2 mm? -79.81 -46.91 16.07 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 1' ' ' SER . 0.5 OUTLIER -142.71 155.05 44.83 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.24 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.527 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 105.08 177.7 24.4 Favored Glycine 0 C--N 1.291 -1.928 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.34 102.59 0.29 Allowed 'Cis proline' 0 N--CA 1.5 1.888 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.403 0.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.527 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 6.8 m -79.17 160.41 70.92 Favored Pre-proline 0 C--N 1.29 -1.989 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -94.03 148.2 2.05 Favored 'Trans proline' 0 C--N 1.284 -2.838 0 C-N-CA 121.673 1.582 . . . . 0.0 111.775 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 tp -131.57 128.4 39.14 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -102.64 119.74 39.35 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 97.7 t -109.18 111.05 34.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mp -94.82 134.41 32.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 21.4 t -91.22 119.57 38.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 12.2 pt -119.17 171.33 7.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 C--N 1.294 -1.841 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.94 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.514 ' H1 ' ' CG ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.0 mt -78.38 139.99 17.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.071 -1.018 . . . . 0.0 111.168 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.83 123.84 69.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 172.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -126.47 162.93 29.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 O-C-N 121.15 -0.969 . . . . 0.0 110.003 -175.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.457 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -142.95 133.76 12.51 Favored Pre-proline 0 C--N 1.289 -2.054 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -47.35 152.72 2.19 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.497 2.131 . . . . 0.0 111.517 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -115.66 114.34 45.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.537 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -89.35 108.39 19.61 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.442 ' C ' HG12 ' A' ' 98' ' ' ILE . 12.7 mt -118.0 130.05 24.97 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 28.1 Cg_endo -67.53 132.06 26.19 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.143 1.228 . . . . 0.0 111.514 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.605 ' CD ' HH21 ' A' ' 67' ' ' ARG . 21.0 pt-20 -54.86 164.75 0.74 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.437 -0.79 . . . . 0.0 109.495 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 60.48 29.64 19.16 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.774 -0.579 . . . . 0.0 111.453 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -60.47 140.48 57.25 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.583 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 48.7 mtm-85 -114.62 169.09 9.32 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.008 -1.057 . . . . 0.0 111.685 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.532 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 22.6 mt-30 -49.71 169.55 0.18 Allowed Pre-proline 0 C--N 1.297 -1.687 0 C-N-CA 123.387 0.675 . . . . 0.0 109.529 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 5.9 Cg_exo -76.32 125.45 11.72 Favored 'Cis proline' 0 N--CA 1.49 1.291 0 C-N-CA 123.978 -1.259 . . . . 0.0 113.268 -0.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.505 ' CE1' ' HD3' ' A' ' 19' ' ' ARG . 35.3 m-85 -100.26 159.3 30.14 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.42 149.27 84.81 Favored 'Cis proline' 0 N--CA 1.505 2.167 0 C-N-CA 124.594 -1.003 . . . . 0.0 112.629 -0.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 13.9 mtp180 -118.89 122.77 43.07 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.458 -0.776 . . . . 0.0 110.081 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -66.22 135.03 53.91 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.1 0.16 2.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.778 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.54 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 172.14 174.32 39.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.5 tttp -134.91 126.66 29.12 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 121.305 -1.115 . . . . 0.0 109.587 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.06 153.12 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.16 170.19 18.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 118.212 -1.395 . . . . 0.0 109.433 -174.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.514 ' CG ' ' H1 ' ' A' ' 1' ' ' SER . 16.3 t0 -143.9 123.37 13.16 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.295 -1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 109.377 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.4 0.619 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -100.07 126.74 46.33 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -86.65 130.12 34.61 Favored 'General case' 0 C--N 1.28 -2.439 0 O-C-N 121.563 -0.711 . . . . 0.0 110.059 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -103.7 135.58 45.0 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 20.2 tp -114.57 145.94 41.35 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -148.01 170.98 16.56 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.14 171.86 16.94 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 120.043 -1.075 . . . . 0.0 111.463 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -60.78 117.44 5.39 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 46' ' ' PRO . . . 117.44 -24.44 9.15 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -175.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.2 t -126.51 -104.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.02 -22.75 66.46 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.223 -0.923 . . . . 0.0 110.22 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -116.73 159.35 22.4 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.585 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 6.6 mm-40 -74.46 150.15 86.86 Favored Pre-proline 0 C--N 1.287 -2.115 0 O-C-N 121.971 -0.456 . . . . 0.0 110.336 -177.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.463 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 31.2 Cg_endo -67.13 115.91 1.8 Allowed 'Cis proline' 0 N--CA 1.511 2.554 0 C-N-CA 123.835 -1.319 . . . . 0.0 110.631 -0.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.585 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 2.1 mtpm? -78.22 165.75 23.53 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.657 -1.277 . . . . 0.0 110.946 -173.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.19 31.47 69.09 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.6 mm -105.69 -45.29 8.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 118.645 1.222 . . . . 0.0 107.936 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CZ ' HG12 ' A' ' 95' ' ' VAL . 97.0 m-85 -124.42 156.25 37.47 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.611 0.72 . . . . 0.0 110.633 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -156.78 150.96 25.11 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.1 tt -108.81 157.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 118.61 -1.236 . . . . 0.0 108.962 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 10.2 t-20 -83.34 119.38 24.53 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -75.56 10.72 1.56 Allowed 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 120.865 0.364 . . . . 0.0 111.496 -175.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 19.5 t-20 -124.14 -43.18 2.1 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.837 -1.165 . . . . 0.0 109.276 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -95.74 -38.6 10.26 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.59 6.06 55.07 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.0 m -66.54 124.56 23.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.568 -0.96 . . . . 0.0 109.512 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.7 t -87.61 124.62 41.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.17 155.66 38.08 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.325 -0.859 . . . . 0.0 109.641 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.17 137.55 29.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.2 -12.99 39.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.454 -0.779 . . . . 0.0 111.548 -174.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.559 ' NE ' ' O ' ' A' ' 64' ' ' THR . 2.0 ptm180 -153.08 -176.4 5.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.841 -1.162 . . . . 0.0 110.208 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.559 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 12.6 t -70.51 156.06 39.9 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.686 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -113.09 123.01 49.28 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 109.407 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -109.07 113.77 26.92 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.605 HH21 ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -58.65 -7.29 0.92 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.518 0.675 . . . . 0.0 109.229 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -70.67 -19.79 62.76 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.7 -58.57 3.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 mt -136.21 134.85 50.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.63 -28.13 24.97 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.3 p -152.79 128.0 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.469 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 29.7 m-85 -91.21 125.44 35.99 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -90.68 85.08 5.97 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 170.45 13.39 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 70.3 m-85 -135.96 133.99 38.16 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.24 155.56 12.61 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 O-C-N 121.826 -0.546 . . . . 0.0 109.595 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -144.76 147.85 33.42 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.21 133.64 37.51 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.516 ' HA ' HD23 ' A' ' 87' ' ' LEU . 17.1 p -128.14 153.93 46.32 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 83' ' ' ASN . 1.2 t70 -109.69 170.7 7.9 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.7 m -56.99 -3.67 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 O-C-N 121.306 -0.871 . . . . 0.0 111.003 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -79.71 -19.68 48.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.34 28.96 31.75 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -116.34 168.21 10.34 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -109.8 118.87 37.66 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.453 -0.78 . . . . 0.0 110.015 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -91.6 -20.31 21.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -157.2 164.08 38.13 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.424 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 114.92 166.5 15.21 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 107.045 -2.422 . . . . 0.0 107.045 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -82.63 107.2 1.02 Allowed 'Cis proline' 0 C--N 1.3 -2.003 0 C-N-CA 123.127 -1.614 . . . . 0.0 110.801 0.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.424 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 18.9 m -78.58 159.46 74.37 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 105.682 -1.969 . . . . 0.0 105.682 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -91.5 148.18 3.47 Favored 'Trans proline' 0 C--N 1.285 -2.77 0 C-N-CA 121.419 1.412 . . . . 0.0 112.675 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.2 tp -138.65 113.28 9.0 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -95.47 113.79 25.48 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 15.8 t -95.28 107.76 19.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 176.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 mp -90.89 127.7 43.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.6 t -84.62 104.86 13.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 7.4 pt -94.67 172.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 O-C-N 121.517 -0.739 . . . . 0.0 109.365 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.508 ' CG ' HH22 ' A' ' 67' ' ' ARG . 1.1 m-20 . . . . . 0 C--N 1.291 -1.939 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.7 mt -59.01 120.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.187 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.0 113.94 45.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -136.74 158.96 37.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.413 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -148.69 139.73 13.79 Favored Pre-proline 0 C--N 1.273 -2.73 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -41.48 132.65 3.58 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.216 1.944 . . . . 0.0 111.451 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.7 mt -98.42 110.91 26.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.542 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -87.71 108.44 19.11 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.5 mt -117.09 136.1 23.25 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 30.0 Cg_endo -70.54 132.37 21.95 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.299 1.333 . . . . 0.0 110.968 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.526 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 13.1 pt-20 -63.78 176.75 0.85 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.018 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.549 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 20.4 t-20 58.56 23.51 10.94 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.587 -0.696 . . . . 0.0 111.757 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -70.22 115.79 9.82 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.549 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -89.57 176.1 7.02 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 120.928 -1.108 . . . . 0.0 109.932 -177.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 11.6 mm-40 -42.92 167.62 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 C-N-CA 124.063 0.945 . . . . 0.0 110.61 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.521 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 2.2 Cg_endo -82.7 146.34 60.09 Favored 'Cis proline' 0 N--CA 1.495 1.567 0 C-N-CA 124.186 -1.172 . . . . 0.0 114.027 -0.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.487 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 42.3 m-85 -133.62 160.35 68.94 Favored Pre-proline 0 C--N 1.282 -2.369 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 18.4 Cg_exo -66.46 163.49 69.81 Favored 'Cis proline' 0 N--CA 1.499 1.807 0 C-N-CA 124.079 -1.217 . . . . 0.0 112.162 -0.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 16' ' ' PRO . 9.9 ttm180 -146.13 143.55 29.4 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.667 -0.646 . . . . 0.0 109.455 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 9.0 t0 -74.73 137.51 42.12 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.64 6.03 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.82 179.47 45.42 Favored Glycine 0 N--CA 1.506 3.322 0 C-N-CA 118.896 -1.621 . . . . 0.0 109.702 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.7 ttpm? -145.37 122.98 11.78 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.787 -1.419 . . . . 0.0 110.118 -177.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.49 143.57 11.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -139.18 170.08 16.45 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 1' ' ' SER . 10.1 t0 -132.67 120.5 21.81 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.265 -3.068 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.823 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -113.66 123.96 51.16 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 79' ' ' THR . 53.0 m-85 -83.33 139.42 33.05 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 120.967 -1.083 . . . . 0.0 109.695 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.533 HH22 ' CD ' ' A' ' 54' ' ' GLU . 41.2 mmt-85 -120.38 155.61 33.06 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.1 tp -133.27 142.07 48.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -147.97 171.52 15.66 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.72 179.4 16.91 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.531 -1.355 . . . . 0.0 111.154 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -63.13 106.98 0.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 46' ' ' PRO . . . 129.64 -18.13 5.45 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -130.46 -90.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.988 -0.713 . . . . 0.0 109.324 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -20.03 32.52 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 120.923 -1.111 . . . . 0.0 108.777 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -112.35 161.26 16.85 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.365 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -69.33 143.41 93.5 Favored Pre-proline 0 C--N 1.281 -2.401 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.573 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.454 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 40.8 Cg_endo -72.87 123.65 8.56 Favored 'Cis proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.179 -1.592 . . . . 0.0 110.271 -2.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -80.35 166.06 21.67 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 120.716 -1.24 . . . . 0.0 109.674 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.4 ' C ' ' HG1' ' A' ' 62' ' ' THR . . . 69.09 34.02 75.27 Favored Glycine 0 C--N 1.284 -2.355 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mm -110.85 -50.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.008 -1.29 . . . . 0.0 108.4 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.432 ' CZ ' HG12 ' A' ' 95' ' ' VAL . 97.3 m-85 -121.59 161.12 22.96 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.405 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.467 ' NE ' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -160.07 134.26 7.4 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 52' ' ' ILE . 19.3 tt -100.13 167.23 2.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 O-C-N 120.793 -1.192 . . . . 0.0 109.04 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -100.59 122.86 43.98 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.533 ' CD ' HH22 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -49.1 -49.75 40.32 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.965 -0.46 . . . . 0.0 112.005 -176.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -90.08 -40.78 12.07 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 111.936 -173.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 p -84.14 -22.79 30.92 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.0 9.19 62.72 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.0 m -64.4 123.72 19.93 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.263 -1.139 . . . . 0.0 108.714 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.15 120.75 35.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.467 ' OG ' ' NE ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -116.88 153.85 31.8 Favored 'General case' 0 C--N 1.282 -2.344 0 O-C-N 121.577 -0.702 . . . . 0.0 109.97 -177.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 7.2 p -105.67 140.83 22.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.456 HG22 ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -93.06 -15.17 26.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.795 . . . . 0.0 111.209 -176.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -154.34 -167.64 2.69 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.747 -1.22 . . . . 0.0 110.004 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -74.78 148.57 40.25 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 mt -106.63 129.95 54.46 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.18 126.77 55.43 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -9.58 44.38 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.19 -28.57 62.27 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.32 -52.9 10.6 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -148.43 136.76 14.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.12 -22.37 27.13 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -155.33 123.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.457 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 65.0 m-85 -88.21 121.65 30.85 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.915 -1.115 . . . . 0.0 108.509 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.2 98.47 11.79 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.63 170.42 9.35 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.2 m-85 -135.46 124.27 23.96 Favored 'General case' 0 C--N 1.262 -3.198 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.88 152.18 6.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.084 0.469 . . . . 0.0 110.293 -174.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.71 140.12 36.73 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.438 HG21 ' CE2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -93.26 130.91 38.81 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 170.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 70.5 p -124.5 164.82 18.95 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.744 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.476 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 25.5 t70 -88.23 167.66 13.39 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.2 m -53.65 -27.07 14.58 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.685 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -79.87 -11.18 59.83 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.582 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.8 56.98 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -76.46 146.97 38.2 Favored 'General case' 0 C--O 1.194 -1.824 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 175.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.2 m -93.4 115.17 27.72 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 118.76 0.709 . . . . 0.0 109.199 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.621 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.05 -31.71 27.22 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -144.84 160.65 40.94 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.0 109.201 175.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.65 178.27 38.16 Favored Glycine 0 C--N 1.287 -2.187 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -67.94 121.36 4.34 Favored 'Cis proline' 0 C--N 1.299 -2.058 0 C-N-CA 123.026 -1.656 . . . . 0.0 111.433 0.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 3.0 m -101.86 163.27 18.12 Favored Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -91.01 150.07 3.84 Favored 'Trans proline' 0 C--N 1.287 -2.673 0 C-N-CA 121.53 1.487 . . . . 0.0 112.372 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.5 tp -137.46 128.3 27.22 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.06 109.94 21.5 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.629 -0.669 . . . . 0.0 109.886 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 61.3 t -91.75 97.08 6.82 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 mt -79.63 132.24 32.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 21.7 t -91.15 116.79 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 11.5 pt -105.85 171.82 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 C--N 1.298 -1.661 0 O-C-N 120.907 -1.12 . . . . 0.0 109.356 -179.78 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.449 ' H ' ' HG2' ' A' ' 88' ' ' GLU . 31.7 mt -65.7 132.13 31.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-O 121.734 0.778 . . . . 0.0 110.74 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.44 122.84 69.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -137.87 169.13 19.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.522 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.5 m -159.81 169.76 9.81 Favored Pre-proline 0 C--N 1.274 -2.695 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.85 134.87 52.5 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.35 1.367 . . . . 0.0 110.745 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.427 HG13 HD13 ' A' ' 93' ' ' LEU . 24.4 mt -106.11 111.83 36.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.536 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.42 98.56 11.85 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.3 mt -101.19 129.0 28.01 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.97 -1.081 . . . . 0.0 109.0 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 5.0 Cg_endo -63.38 124.91 14.61 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 121.091 1.194 . . . . 0.0 110.046 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.04 171.43 5.53 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.717 1.246 . . . . 0.0 113.929 -170.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.512 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 6.4 m-80 47.71 24.15 0.51 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.486 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.458 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 73.0 mt-30 -67.0 146.79 54.0 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 173.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.541 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -104.9 179.26 4.32 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.174 -0.954 . . . . 0.0 110.031 -177.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.564 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -54.2 176.74 0.12 Allowed Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 5.7 Cg_exo -72.79 117.99 4.4 Favored 'Cis proline' 0 N--CA 1.491 1.359 0 C-N-CA 123.942 -1.274 . . . . 0.0 113.986 0.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -100.15 165.08 15.16 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 55.2 Cg_endo -73.12 162.25 92.14 Favored 'Cis proline' 0 N--CA 1.497 1.681 0 C-N-CA 124.242 -1.149 . . . . 0.0 111.84 -0.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 11.3 mtp180 -138.19 145.5 41.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.511 ' CG ' ' HZ2' ' A' ' 23' ' ' LYS . 5.0 t0 -73.75 134.53 43.48 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 59' ' ' VAL . 31.1 m -129.91 3.24 2.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.609 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.83 -171.32 37.48 Favored Glycine 0 N--CA 1.499 2.899 0 C-N-CA 117.347 -2.358 . . . . 0.0 111.146 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HZ2' ' CG ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -150.29 113.68 4.92 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 120.998 -1.295 . . . . 0.0 110.851 -178.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.468 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 11.4 t -100.91 112.06 32.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 169.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.66 154.46 24.0 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.008 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.7 t70 -104.23 135.41 45.74 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.074 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.407 0.622 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -126.61 133.01 51.13 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.9 137.73 36.97 Favored 'General case' 0 C--N 1.273 -2.755 0 O-C-N 121.137 -0.977 . . . . 0.0 108.543 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.97 126.52 54.86 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.5 tp -105.8 148.98 26.9 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.03 170.39 20.02 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.483 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 110.43 172.41 20.05 Favored Glycine 0 N--CA 1.497 2.765 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.954 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.466 ' N ' ' HB2' ' A' ' 44' ' ' GLN . 9.6 mtpp -53.25 114.75 1.59 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 46' ' ' PRO . . . 115.18 -20.66 13.94 Favored Glycine 0 C--N 1.28 -2.564 0 N-CA-C 108.296 -1.921 . . . . 0.0 108.296 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 t -113.06 -89.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -100.17 -13.02 19.11 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.243 -0.91 . . . . 0.0 109.501 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 44' ' ' GLN . 0.4 OUTLIER -100.13 158.42 15.86 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 176.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 137.24 96.17 Favored Pre-proline 0 C--N 1.271 -2.808 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.492 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 5.2 Cg_exo -76.88 119.47 6.39 Favored 'Cis proline' 0 N--CA 1.5 1.874 0 C-N-CA 123.442 -1.483 . . . . 0.0 110.624 -0.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -69.27 144.49 53.6 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.708 -1.245 . . . . 0.0 110.353 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.49 37.83 34.59 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.344 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.418 HG13 ' HA3' ' A' ' 41' ' ' GLY . 5.0 mm -106.11 -43.0 7.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -118.71 149.93 40.61 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.793 0.806 . . . . 0.0 110.264 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.443 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -148.13 142.94 26.75 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 176.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.2 tt -100.09 158.46 3.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 O-C-N 120.505 -1.372 . . . . 0.0 109.845 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 58' ' ' SER . 6.2 m-80 -84.76 84.71 7.6 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.603 ' H ' ' CD ' ' A' ' 54' ' ' GLU . 2.0 pm0 -24.78 -54.52 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 124.18 0.992 . . . . 0.0 113.554 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -80.95 -33.94 33.59 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.168 -0.958 . . . . 0.0 111.939 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -94.94 -25.84 16.38 Favored 'General case' 0 C--N 1.287 -2.126 0 O-C-N 121.161 -0.962 . . . . 0.0 109.073 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 24' ' ' VAL . . . 82.91 10.52 82.89 Favored Glycine 0 C--N 1.285 -2.273 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.478 ' HG ' ' CG ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -66.8 128.73 37.42 Favored 'General case' 0 C--N 1.312 -1.043 0 O-C-N 120.859 -1.377 . . . . 0.0 108.608 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.43 ' O ' HG21 ' A' ' 21' ' ' VAL . 4.6 t -79.91 119.2 28.87 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.443 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -113.29 151.6 30.93 Favored 'General case' 0 C--N 1.282 -2.335 0 O-C-N 121.699 -0.626 . . . . 0.0 109.561 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 12.8 p -112.63 143.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.43 -15.36 21.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.695 -0.628 . . . . 0.0 111.54 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.95 178.54 8.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.464 -1.397 . . . . 0.0 111.783 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.541 ' OG1' ' NH2' ' A' ' 14' ' ' ARG . 4.9 t -70.05 122.51 19.52 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.3 mt -90.81 127.2 36.26 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.161 -0.962 . . . . 0.0 108.926 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.25 139.28 46.77 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.512 ' NE ' ' O ' ' A' ' 97' ' ' VAL . 7.4 mtp180 -81.88 -11.24 59.02 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.803 -0.56 . . . . 0.0 111.29 -176.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.85 -22.76 49.43 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.83 -63.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.422 HD11 ' CE1' ' A' ' 73' ' ' TYR . 0.7 OUTLIER -130.44 127.41 62.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.25 -25.86 31.27 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -156.69 135.97 3.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.422 ' CE1' HD11 ' A' ' 70' ' ' ILE . 67.1 m-85 -98.75 124.7 43.78 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -90.74 90.86 8.13 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.87 170.47 11.15 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 122.132 0.968 . . . . 0.0 109.458 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 53.5 m-85 -134.08 127.6 32.51 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.29 142.89 23.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.24 0.543 . . . . 0.0 110.452 -175.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -133.7 145.19 49.66 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.426 ' HB ' HD21 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -92.24 142.38 27.53 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 171.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.456 ' HA ' HD23 ' A' ' 87' ' ' LEU . 24.1 p -127.6 155.3 44.08 Favored 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.441 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -97.1 170.01 9.42 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.806 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 m -56.42 -16.15 3.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -85.75 -13.08 49.41 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.22 22.65 58.61 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -98.97 150.46 21.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 176.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.7 m -84.49 129.01 34.9 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.559 ' CD2' ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -99.16 -30.24 12.4 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 2' ' ' ILE . 3.9 tp10 -149.47 153.66 37.62 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.447 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 97.96 -176.35 30.64 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.26 104.97 0.36 Allowed 'Cis proline' 0 N--CA 1.496 1.641 0 CA-C-N 118.861 1.33 . . . . 0.0 112.089 -0.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.447 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 16.1 m -79.79 161.94 64.49 Favored Pre-proline 0 C--N 1.284 -2.247 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -93.3 155.76 2.54 Favored 'Trans proline' 0 C--N 1.291 -2.478 0 C-N-CA 121.6 1.533 . . . . 0.0 111.016 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.427 HD13 HG13 ' A' ' 7' ' ' ILE . 12.9 tp -142.18 128.08 19.46 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -108.97 104.14 13.31 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.526 -0.734 . . . . 0.0 109.496 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 70.7 t -94.4 107.95 20.06 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mp -90.64 129.95 40.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.512 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 1.5 t -86.97 109.72 19.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 20.6 pt -109.15 171.54 2.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-O 121.425 0.631 . . . . 0.0 109.407 -176.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.381 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.447 ' HA ' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.422 ' N ' ' OE1' ' A' ' 88' ' ' GLU . 7.9 mt -72.16 139.89 18.96 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-O 121.583 0.706 . . . . 0.0 110.599 -177.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.85 128.04 75.59 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.446 ' CG2' HD11 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -140.68 162.23 23.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.4 -0.813 . . . . 0.0 109.728 -175.158 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.443 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -145.59 156.01 52.87 Favored Pre-proline 0 C--N 1.284 -2.268 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 172.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.431 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 52.8 Cg_exo -49.76 149.42 10.74 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.63 1.553 . . . . 0.0 111.164 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.27 111.88 38.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.551 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -92.64 105.06 17.28 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.6 mt -110.25 128.36 25.5 Favored Pre-proline 0 C--N 1.286 -2.157 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 31.7 Cg_endo -69.91 125.23 11.83 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 120.969 1.113 . . . . 0.0 110.872 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.461 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 11.1 pt-20 -61.37 170.86 1.6 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.822 -175.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.535 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 81.33 -19.17 0.44 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 172.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -52.27 134.31 33.74 Favored 'General case' 0 N--CA 1.518 2.974 0 O-C-N 120.687 -1.258 . . . . 0.0 108.128 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.535 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -111.28 -170.85 1.72 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.773 0.797 . . . . 0.0 111.163 -177.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.48 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 2.5 mp0 -45.88 163.44 0.22 Allowed Pre-proline 0 C--N 1.305 -1.329 0 C-N-CA 124.547 1.139 . . . . 0.0 109.943 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 39.9 Cg_endo -79.33 141.77 62.93 Favored 'Cis proline' 0 C--N 1.314 -1.275 0 C-N-CA 123.146 -1.606 . . . . 0.0 112.103 -0.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 37.3 m-85 -112.83 158.88 36.4 Favored Pre-proline 0 C--N 1.28 -2.454 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.95 153.37 97.65 Favored 'Cis proline' 0 N--CA 1.498 1.747 0 C-N-CA 123.942 -1.274 . . . . 0.0 112.909 0.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.476 ' HG3' ' CD1' ' A' ' 17' ' ' PHE . 7.1 mtp180 -120.33 135.99 54.84 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.92 147.75 52.88 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.9 6.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.873 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.26 -177.19 39.33 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 117.98 -2.057 . . . . 0.0 110.157 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -141.51 117.66 10.65 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.139 -1.212 . . . . 0.0 110.445 -176.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.38 135.84 24.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 103.539 -2.763 . . . . 0.0 103.539 169.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.38 150.64 34.83 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -127.83 112.72 15.06 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.768 0 O-C-N 121.682 -0.636 . . . . 0.0 110.433 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -117.23 147.99 42.03 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -83.89 150.63 25.58 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 121.27 -0.894 . . . . 0.0 109.311 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 6.1 mmp_? -123.73 135.0 53.59 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 173.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.8 tp -112.93 144.27 42.78 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.84 171.02 18.91 Favored 'General case' 0 C--N 1.271 -2.823 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -175.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.472 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 119.22 166.36 13.39 Favored Glycine 0 C--N 1.29 -1.99 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 177.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -59.09 109.92 0.94 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.21 -20.37 7.08 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.4 t -118.19 -86.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.991 -1.299 . . . . 0.0 108.788 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -99.5 -12.63 19.99 Favored 'General case' 0 C--O 1.206 -1.198 0 O-C-N 121.598 -0.689 . . . . 0.0 109.412 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.472 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 13.1 mp0 -109.76 160.34 16.41 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.504 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -60.84 135.81 92.92 Favored Pre-proline 0 C--N 1.273 -2.747 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.303 -174.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -77.21 124.18 10.35 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.824 -1.74 . . . . 0.0 109.97 -1.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -72.4 154.23 41.01 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 121.327 -0.858 . . . . 0.0 109.128 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.41 34.95 63.45 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.148 173.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mm -106.64 -49.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.658 -1.496 . . . . 0.0 107.854 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -118.96 152.73 35.82 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.481 -0.762 . . . . 0.0 110.691 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.639 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 6.9 ptm180 -143.43 169.92 16.76 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 52' ' ' ILE . 8.6 tt -129.2 159.73 40.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 119.231 -0.987 . . . . 0.0 108.758 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 58' ' ' SER . 37.6 t-20 -79.94 96.92 6.53 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 54' ' ' GLU . 2.1 mp0 -33.91 -50.07 0.36 Allowed 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 122.588 0.355 . . . . 0.0 110.942 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -42.78 17.09 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.211 -0.931 . . . . 0.0 112.354 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 p -94.74 -29.76 14.62 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.108 -0.995 . . . . 0.0 111.041 -171.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.33 -1.38 64.44 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -56.05 129.33 39.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.043 -1.269 . . . . 0.0 108.185 176.419 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 t -94.02 134.36 31.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.639 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -131.73 159.67 37.73 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.455 -0.778 . . . . 0.0 109.663 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.79 139.99 23.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -94.74 -2.99 50.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 111.303 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HA ' ' CD2' ' A' ' 17' ' ' PHE . 2.8 ptp85 -157.21 -179.84 8.58 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -69.4 170.42 10.47 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.8 mt -131.41 136.28 47.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.87 122.79 35.68 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.469 HH22 ' CG ' ' A' ' 99' ' ' ASP . 5.3 mtm180 -57.12 -15.61 5.87 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.059 -1.026 . . . . 0.0 111.43 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.28 -19.65 63.91 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.9 -60.02 2.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.481 HD11 ' CE1' ' A' ' 73' ' ' TYR . 1.9 mt -143.68 145.17 22.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.7 -24.92 16.31 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.1 p -154.72 139.01 9.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.784 -0.572 . . . . 0.0 109.647 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.481 ' CE1' HD11 ' A' ' 70' ' ' ILE . 33.5 m-85 -106.39 127.09 53.02 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -91.79 86.88 6.06 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 170.67 13.94 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 78.5 m-85 -135.55 133.37 38.3 Favored 'General case' 0 C--N 1.265 -3.104 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.85 145.42 18.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -135.23 143.88 46.59 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.468 ' C ' HD23 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -90.36 133.02 35.26 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 171.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.475 ' CA ' HD23 ' A' ' 87' ' ' LEU . 39.1 p -129.55 170.5 13.66 Favored 'General case' 0 C--N 1.278 -2.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.262 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 83' ' ' ASN . 6.1 t0 -149.78 171.62 16.45 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.409 -0.807 . . . . 0.0 110.328 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.3 m -13.9 -41.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 126.276 1.83 . . . . 0.0 114.724 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 81' ' ' ASP . 8.0 t-20 -79.43 -7.51 58.45 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 120.722 -1.236 . . . . 0.0 109.732 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 72.18 19.18 78.45 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.5 OUTLIER -99.78 167.61 10.43 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.456 ' CG2' ' O ' ' A' ' 88' ' ' GLU . 91.3 m -94.07 119.68 33.26 Favored 'General case' 0 C--N 1.277 -2.563 0 O-C-N 122.154 -0.341 . . . . 0.0 111.292 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.62 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.71 -34.79 24.84 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.456 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -142.09 163.32 33.19 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.792 -0.568 . . . . 0.0 109.743 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.411 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 89.87 -172.18 38.42 Favored Glycine 0 N--CA 1.481 1.699 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.77 102.95 0.34 Allowed 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.732 -1.362 . . . . 0.0 112.225 -0.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.419 HG23 HD12 ' A' ' 2' ' ' ILE . 5.8 m -74.05 164.19 62.95 Favored Pre-proline 0 C--N 1.285 -2.199 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -94.48 154.61 1.99 Allowed 'Trans proline' 0 C--N 1.291 -2.491 0 C-N-CA 121.694 1.596 . . . . 0.0 111.295 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.446 HD11 ' CG2' ' A' ' 4' ' ' VAL . 16.6 tp -144.36 119.95 10.41 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -99.85 110.48 22.84 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.762 -0.586 . . . . 0.0 110.046 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 50.9 t -94.25 107.3 19.16 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.7 mp -90.82 135.06 27.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 18.7 t -91.33 114.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 22.4 pt -111.42 172.34 2.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 121.58 -0.7 . . . . 0.0 110.498 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.469 ' CG ' HH22 ' A' ' 67' ' ' ARG . 5.6 m-20 . . . . . 0 C--N 1.302 -1.461 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.502 -0.868 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 79' ' ' THR . 3.6 mt -78.08 117.77 23.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.341 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.0 120.41 35.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.427 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -139.75 159.14 27.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -179.238 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.427 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -143.14 145.81 34.21 Favored Pre-proline 0 C--N 1.269 -2.925 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -53.83 134.52 59.4 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.586 1.524 . . . . 0.0 109.928 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.9 mt -106.79 116.66 51.02 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.137 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.541 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -89.61 104.34 16.91 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.3 mt -110.32 127.28 27.28 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -68.83 130.83 21.24 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 120.787 0.991 . . . . 0.0 111.034 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -74.46 -170.53 1.03 Allowed 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.305 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.605 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 0.0 OUTLIER 61.05 -26.97 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 175.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 11' ' ' GLU . 71.9 mt-30 -37.19 139.25 0.24 Allowed 'General case' 0 N--CA 1.521 3.098 0 O-C-N 121.007 -1.058 . . . . 0.0 108.529 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.605 ' NH1' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -91.24 -175.32 4.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.543 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 1.4 mt-30 -67.16 -168.58 0.05 OUTLIER Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.543 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 20.0 Cg_exo -66.96 127.44 8.53 Favored 'Cis proline' 0 N--CA 1.492 1.42 0 CA-C-N 120.499 1.214 . . . . 0.0 112.222 -0.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 15' ' ' GLN . 32.9 m-85 -115.61 163.54 20.38 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 177.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.1 163.35 76.79 Favored 'Cis proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.959 -1.267 . . . . 0.0 111.207 -0.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -136.75 139.81 42.13 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.384 -0.823 . . . . 0.0 109.404 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.49 146.18 55.19 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.83 -1.18 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.456 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 167.04 178.35 39.37 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 118.968 -1.587 . . . . 0.0 109.344 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.1 tttp -135.36 130.63 35.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.306 -1.114 . . . . 0.0 110.625 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.78 145.54 10.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -144.33 170.62 7.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' CB ' HG22 ' A' ' 79' ' ' THR . 7.6 t0 -129.58 148.97 51.53 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.278 -2.538 0 O-C-N 121.96 -0.462 . . . . 0.0 110.163 -178.747 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 33.8 mttm -96.89 156.33 16.39 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.45 ' CE1' HG21 ' A' ' 79' ' ' THR . 70.1 m-85 -105.4 142.24 35.51 Favored 'General case' 0 C--N 1.285 -2.23 0 O-C-N 121.476 -0.765 . . . . 0.0 111.657 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.507 HH12 ' CB ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -103.1 149.0 25.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 174.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.4 tp -125.6 140.26 52.89 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 p -148.29 170.78 17.16 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -174.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.72 174.9 18.96 Favored Glycine 0 N--CA 1.499 2.88 0 O-C-N 121.019 -1.05 . . . . 0.0 111.817 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -59.8 116.34 4.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 115.75 -19.33 14.19 Favored Glycine 0 C--N 1.28 -2.543 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.56 -95.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.588 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 23.0 t70 -83.7 -15.85 47.2 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.046 -1.034 . . . . 0.0 109.765 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -113.26 155.07 25.75 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.226 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.406 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 4.9 mt-10 -54.43 133.31 62.56 Favored Pre-proline 0 C--N 1.29 -2.014 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.523 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.412 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 28.2 Cg_endo -73.62 118.11 4.72 Favored 'Cis proline' 0 N--CA 1.499 1.819 0 C-N-CA 123.526 -1.448 . . . . 0.0 110.305 -1.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.588 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 3.7 mtpp -68.27 145.41 54.27 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 120.902 -1.124 . . . . 0.0 112.242 -172.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.88 28.11 69.69 Favored Glycine 0 N--CA 1.498 2.816 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.389 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 41' ' ' GLY . 17.8 mm -85.26 -46.42 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-N 119.254 1.527 . . . . 0.0 107.053 175.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -107.66 147.39 30.76 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.686 0.755 . . . . 0.0 109.18 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.66 170.09 16.35 Favored 'General case' 0 C--N 1.262 -3.222 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 tt -134.19 150.38 31.02 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.016 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.45 ' CG ' ' HG1' ' A' ' 56' ' ' THR . 19.0 t-20 -84.81 83.2 8.12 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.463 ' CD ' HH21 ' A' ' 36' ' ' ARG . 5.8 mt-10 -37.44 -33.47 0.07 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.557 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -79.72 -15.56 57.28 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.985 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.45 ' HG1' ' CG ' ' A' ' 53' ' ' ASN . 74.8 p -127.27 -36.85 2.09 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.93 6.23 52.4 Favored Glycine 0 C--N 1.277 -2.699 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.4 m -66.16 119.87 12.23 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.41 -1.053 . . . . 0.0 108.745 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.2 t -87.11 134.95 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.27 158.21 44.95 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.358 -0.838 . . . . 0.0 108.756 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -106.81 141.49 21.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 p -89.58 -13.93 36.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.546 -0.722 . . . . 0.0 110.571 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 64' ' ' THR . 1.8 ptm180 -157.18 -173.53 4.48 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.187 -0.945 . . . . 0.0 109.593 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.617 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 14.6 t -70.06 178.65 2.65 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 11' ' ' GLU . 35.2 mt -131.22 162.28 30.33 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 120.541 -1.349 . . . . 0.0 108.504 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -140.0 113.71 8.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -60.45 -11.18 6.14 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.21 -22.8 63.85 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.5 t -105.05 -55.95 5.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.454 HD13 ' CE1' ' A' ' 73' ' ' TYR . 1.4 mt -141.53 142.3 29.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.569 -0.707 . . . . 0.0 110.06 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.22 -23.16 16.3 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.9 135.15 6.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.638 -0.664 . . . . 0.0 109.733 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.454 ' CE1' HD13 ' A' ' 70' ' ' ILE . 84.3 m-85 -100.86 117.28 34.63 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -85.91 87.03 7.35 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.62 170.72 15.48 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 73.1 m-85 -134.08 132.31 39.82 Favored 'General case' 0 C--N 1.264 -3.149 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.2 152.66 13.99 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 O-C-N 121.983 -0.448 . . . . 0.0 109.864 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -138.47 139.51 38.84 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 121.779 -0.575 . . . . 0.0 109.565 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.472 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -88.69 134.21 33.97 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 173.233 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 7.9 p -137.14 163.04 31.77 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.545 -176.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -105.8 171.15 7.49 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.2 m -46.29 -27.72 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.369 0.604 . . . . 0.0 110.5 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.59 0.52 29.69 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.507 -0.745 . . . . 0.0 110.385 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.21 20.46 76.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 80' ' ' THR . 25.5 mttp -85.11 146.89 26.91 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.8 m -99.26 117.04 32.83 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-O 121.145 0.498 . . . . 0.0 110.816 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.58 -28.78 17.31 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -140.81 151.37 44.33 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.507 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 94.73 -177.58 35.84 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.74 102.75 0.16 OUTLIER 'Cis proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.821 -1.325 . . . . 0.0 113.469 -0.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.507 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 3.3 m -74.8 164.19 63.05 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -92.35 151.06 3.03 Favored 'Trans proline' 0 C--N 1.283 -2.912 0 C-N-CA 121.395 1.397 . . . . 0.0 111.905 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.1 tp -135.76 126.74 27.76 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -103.57 105.52 15.79 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 121.831 -0.543 . . . . 0.0 109.715 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.7 104.6 16.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mp -87.57 134.0 28.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 16.1 t -89.67 108.94 19.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 15.3 pt -102.85 171.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.007 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.539 ' H3 ' ' CG ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 5.2 mt -73.73 120.49 22.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.075 -1.016 . . . . 0.0 110.611 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.66 119.98 50.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -142.42 163.76 18.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -149.53 159.44 36.38 Favored Pre-proline 0 C--N 1.278 -2.517 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.34 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 27.3 Cg_exo -44.73 131.03 10.02 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.855 1.703 . . . . 0.0 111.893 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.405 HG13 HD13 ' A' ' 93' ' ' LEU . 19.5 mt -101.4 122.5 53.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.3 mp -106.88 115.8 30.82 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 23.0 mt -122.21 128.04 25.66 Favored Pre-proline 0 C--N 1.26 -3.314 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 21.5 Cg_endo -70.98 141.78 41.06 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 CA-C-N 120.038 1.049 . . . . 0.0 110.064 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.438 ' OE1' ' NH1' ' A' ' 67' ' ' ARG . 3.4 pt-20 -55.69 173.76 0.12 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 121.988 0.899 . . . . 0.0 110.104 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 65' ' ' LEU . 4.1 p30 52.74 19.15 1.18 Allowed 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -57.49 131.35 49.9 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.474 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 3.3 mtt180 -101.84 -174.37 2.57 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 119.546 1.066 . . . . 0.0 110.434 -176.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.535 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 16.8 mt-30 -54.16 168.14 0.47 Allowed Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.535 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 4.1 Cg_exo -77.02 131.71 25.12 Favored 'Cis proline' 0 C--N 1.308 -1.593 0 C-N-CA 123.503 -1.457 . . . . 0.0 112.831 0.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -119.61 159.55 45.71 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 13.0 Cg_exo -69.74 155.29 93.28 Favored 'Cis proline' 0 N--CA 1.493 1.497 0 C-N-CA 123.878 -1.301 . . . . 0.0 110.426 -0.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -129.54 131.34 46.56 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.25 -179.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.21 116.01 9.16 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.5 m -118.42 7.61 6.85 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.592 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.53 163.5 30.91 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -135.58 116.33 14.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.27 -1.135 . . . . 0.0 109.641 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.97 146.9 6.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 t -139.3 166.72 21.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.539 ' CG ' ' H3 ' ' A' ' 1' ' ' SER . 11.9 t70 -112.98 140.14 48.04 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 173.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.301 0.572 . . . . 0.0 109.53 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 121.163 0.506 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.18 138.88 54.36 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -82.43 144.11 30.71 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.747 -0.596 . . . . 0.0 110.598 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.442 HH12 ' CD ' ' A' ' 54' ' ' GLU . 4.2 mmp_? -120.86 145.02 48.06 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 23.4 tp -120.79 153.45 37.05 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -158.13 171.26 20.53 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.51 175.63 18.77 Favored Glycine 0 N--CA 1.502 3.083 0 C-N-CA 119.796 -1.192 . . . . 0.0 111.444 175.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -59.24 119.54 7.56 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 113.07 -19.12 20.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -118.07 -98.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.622 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -85.77 -12.46 50.92 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -113.12 148.89 34.39 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 121.06 -1.025 . . . . 0.0 108.363 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.1 pt-20 -51.85 136.02 36.49 Favored Pre-proline 0 C--N 1.284 -2.282 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.359 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.489 ' HB2' ' CG1' ' A' ' 49' ' ' ILE . 2.9 Cg_exo -72.83 118.07 4.46 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.475 -1.469 . . . . 0.0 109.161 -1.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.622 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 8.9 mtpp -68.56 145.62 53.82 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 120.856 -1.153 . . . . 0.0 111.251 -172.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.76 34.1 87.83 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.806 -0.559 . . . . 0.0 112.383 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.489 ' CG1' ' HB2' ' A' ' 46' ' ' PRO . 8.8 mm -89.47 -45.58 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -111.49 139.22 47.09 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.591 0.71 . . . . 0.0 110.041 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.22 128.96 28.78 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 58' ' ' SER . 7.7 tt -98.9 161.93 2.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.48 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 13.2 t-20 -96.03 106.73 18.94 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' CD ' HH12 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -40.82 -39.15 1.06 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 8.0 t-20 -96.36 -30.95 13.11 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.35 -0.844 . . . . 0.0 112.704 -173.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 18.1 p -98.16 -26.92 14.4 Favored 'General case' 0 C--N 1.283 -2.295 0 O-C-N 120.757 -1.215 . . . . 0.0 108.611 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.01 5.1 88.02 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 4.4 m -63.63 125.22 23.57 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.263 -1.139 . . . . 0.0 109.409 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.66 121.91 41.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.11 146.93 44.71 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.343 -0.848 . . . . 0.0 110.031 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 14.6 p -102.53 142.42 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 p -95.33 -20.05 19.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.524 -0.735 . . . . 0.0 112.908 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.41 ' NH2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -139.89 176.48 8.71 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.483 -1.386 . . . . 0.0 110.253 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.0 t -70.15 127.9 34.42 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 12' ' ' ASN . 97.3 mt -83.22 120.51 25.91 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.292 -0.88 . . . . 0.0 109.131 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -108.61 114.09 27.61 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.45 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.438 ' NH1' ' OE1' ' A' ' 11' ' ' GLU . 14.7 mtp-105 -53.66 -7.96 0.13 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.447 -0.783 . . . . 0.0 110.399 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 66' ' ' ASP . 1.5 mt-10 -68.45 -28.68 67.27 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 t -91.47 -63.55 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -138.68 132.41 40.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.53 -23.7 24.29 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 p -150.22 132.07 5.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -94.7 117.21 29.76 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.35 83.39 7.69 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.06 170.31 11.65 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 64.8 m-85 -138.31 131.14 29.61 Favored 'General case' 0 C--N 1.265 -3.082 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.14 155.73 11.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-O 121.396 0.617 . . . . 0.0 109.75 -175.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.32 147.54 28.47 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.456 ' HB ' HD21 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.83 131.79 47.96 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 175.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.507 ' HA ' HD23 ' A' ' 87' ' ' LEU . 80.8 p -121.22 164.85 16.29 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 83' ' ' ASN . 1.5 t0 -144.75 172.18 13.37 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.837 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 m -38.82 -21.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 123.455 0.702 . . . . 0.0 111.61 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 81' ' ' ASP . 3.9 t-20 -79.14 -4.91 52.7 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.175 -0.953 . . . . 0.0 108.746 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.52 27.55 71.05 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -119.84 162.79 18.52 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.523 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 1.3 m -90.18 124.08 34.54 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -93.95 -13.22 27.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.896 -1.128 . . . . 0.0 107.985 178.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 2' ' ' ILE . 1.0 OUTLIER -156.02 162.36 40.33 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.447 ' N ' ' HG3' ' A' ' 88' ' ' GLU . . . 91.95 -175.64 38.52 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -70.83 104.75 0.49 Allowed 'Cis proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.58 -1.425 . . . . 0.0 111.373 0.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.44 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 18.1 m -76.81 160.62 76.3 Favored Pre-proline 0 C--N 1.284 -2.271 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -93.46 153.79 2.45 Favored 'Trans proline' 0 C--N 1.288 -2.625 0 C-N-CA 121.556 1.504 . . . . 0.0 111.455 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.405 HD13 HG13 ' A' ' 7' ' ' ILE . 8.2 tp -140.3 127.38 20.9 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -112.57 110.21 20.23 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.488 -0.758 . . . . 0.0 109.286 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 t -99.51 101.94 12.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 4.6 mp -80.59 129.37 37.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 O-C-N 121.613 -0.679 . . . . 0.0 109.234 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 16.8 t -86.29 92.14 3.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 13.8 pt -79.71 171.58 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 O-C-N 121.515 -0.741 . . . . 0.0 109.28 -177.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 . . . . . 0 C--N 1.282 -2.349 0 O-C-N 120.983 -1.073 . . . . 0.0 108.674 -178.339 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.421 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.643 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.431 HD13 ' N ' ' A' ' 79' ' ' THR . 7.1 mt -62.58 135.39 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 O-C-N 121.695 -0.628 . . . . 0.0 109.495 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.52 122.34 62.29 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -133.19 160.47 42.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.096 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -131.89 157.34 78.46 Favored Pre-proline 0 C--N 1.275 -2.665 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.35 134.97 67.24 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.285 1.323 . . . . 0.0 109.815 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 mt -109.27 113.97 45.63 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.556 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -92.14 112.58 24.57 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.96 133.99 23.34 Favored Pre-proline 0 C--N 1.287 -2.134 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 31.1 Cg_endo -69.74 140.39 42.63 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.09 1.193 . . . . 0.0 110.692 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.457 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -79.5 174.36 11.65 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.698 178.41 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 58.29 38.22 26.03 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.813 -0.554 . . . . 0.0 110.692 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.47 ' OE1' ' N ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -88.43 166.57 14.14 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 175.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -117.5 167.04 11.65 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.681 -1.262 . . . . 0.0 111.856 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.495 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -64.48 178.71 0.43 Allowed Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 11.8 Cg_exo -66.51 140.34 48.65 Favored 'Cis proline' 0 C--N 1.307 -1.647 0 C-N-CA 123.704 -1.373 . . . . 0.0 112.786 0.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 35.0 m-85 -119.46 167.39 12.23 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 38.5 Cg_endo -66.01 168.53 47.51 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 120.529 1.225 . . . . 0.0 111.899 -0.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -133.35 129.1 37.0 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 120.231 -0.587 . . . . 0.0 109.957 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -66.45 140.44 58.03 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.68 3.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.791 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 172.75 168.39 34.0 Favored Glycine 0 N--CA 1.507 3.371 0 C-N-CA 118.933 -1.603 . . . . 0.0 110.268 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -132.35 122.45 25.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.274 . . . . 0.0 109.936 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.6 135.58 26.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 172.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.8 t -131.61 157.73 43.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 1' ' ' SER . 8.4 t70 -111.29 122.5 48.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 0.0 109.7 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 C--N 1.292 -1.9 0 CA-C-O 121.445 0.64 . . . . 0.0 109.739 179.38 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 80' ' ' THR . 14.0 p . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 121.21 0.529 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -104.83 148.13 26.98 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 54' ' ' GLU . 67.4 m-85 -88.19 126.87 35.36 Favored 'General case' 0 C--N 1.274 -2.706 0 O-C-N 121.359 -0.838 . . . . 0.0 110.35 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -106.24 141.35 37.73 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.2 tp -121.51 145.48 47.9 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -151.64 171.12 18.13 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 117.74 164.86 13.37 Favored Glycine 0 N--CA 1.499 2.839 0 O-C-N 120.951 -1.093 . . . . 0.0 110.561 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -55.46 117.74 3.84 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 117.03 -21.05 11.23 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.3 t -125.06 -92.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.7 -0.882 . . . . 0.0 108.747 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -85.39 -9.14 57.94 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.528 -0.733 . . . . 0.0 109.489 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 4.0 mp0 -125.97 161.71 26.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.447 -0.783 . . . . 0.0 109.35 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.451 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 2.5 mt-10 -60.27 131.63 90.11 Favored Pre-proline 0 C--N 1.289 -2.027 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.361 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.479 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 41.1 Cg_endo -73.03 115.13 2.97 Favored 'Cis proline' 0 N--CA 1.512 2.605 0 C-N-CA 123.521 -1.449 . . . . 0.0 110.992 -1.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 4.5 mttp -66.47 150.32 49.12 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.921 -1.112 . . . . 0.0 112.744 -173.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.18 29.27 36.33 Favored Glycine 0 N--CA 1.493 2.44 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.284 171.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 41' ' ' GLY . 13.9 mm -80.91 -44.29 21.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 174.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -109.16 138.46 45.48 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.656 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.79 138.88 36.2 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.49 152.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 O-C-N 121.825 -0.547 . . . . 0.0 109.546 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 56' ' ' THR . 12.4 t-20 -79.83 119.47 22.75 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 35' ' ' PHE . 3.1 mt-10 -51.11 -45.52 61.59 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 122.207 -0.308 . . . . 0.0 111.658 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.12 -53.02 6.75 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.081 -1.637 . . . . 0.0 111.997 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.449 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 9.9 p -79.74 -27.81 40.52 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.2 0.524 . . . . 0.0 110.575 -172.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.81 12.9 80.73 Favored Glycine 0 C--N 1.285 -2.29 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 14.9 m -67.9 120.14 13.71 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.275 -1.132 . . . . 0.0 108.91 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' GLY . 1.6 t -87.13 132.19 33.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -134.04 150.72 51.23 Favored 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -97.36 142.15 14.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 63.0 p -88.11 -20.76 25.24 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.55 -0.719 . . . . 0.0 110.795 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.59 ' NE ' ' O ' ' A' ' 64' ' ' THR . 1.6 ptm180 -148.27 -172.88 4.18 Favored 'General case' 0 C--N 1.289 -2.062 0 O-C-N 121.208 -0.933 . . . . 0.0 108.834 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.59 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 13.1 t -67.38 168.41 10.75 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.47 ' N ' ' OE1' ' A' ' 13' ' ' GLN . 92.5 mt -122.58 149.34 44.1 Favored 'General case' 0 C--N 1.278 -2.521 0 O-C-N 120.629 -1.294 . . . . 0.0 108.695 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -130.49 117.6 19.87 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -178.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 1.86 1.42 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 66' ' ' ASP . 2.9 mt-10 -78.53 -29.23 46.34 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.79 -55.77 5.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-O 122.209 1.004 . . . . 0.0 108.342 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.85 139.27 43.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.54 -24.21 18.05 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.7 p -154.1 129.6 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -97.21 124.1 41.19 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -98.55 88.39 4.08 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.6 170.74 15.47 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.8 m-85 -124.58 131.57 53.47 Favored 'General case' 0 C--N 1.274 -2.711 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.06 146.92 17.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -137.1 138.53 40.45 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.431 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -86.76 133.54 33.65 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 170.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.511 ' HA ' HD23 ' A' ' 87' ' ' LEU . 4.6 p -129.78 146.13 51.54 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.052 -1.059 . . . . 0.0 112.476 -172.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -80.66 170.14 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.404 HG21 ' N ' ' A' ' 83' ' ' ASN . 35.2 m -61.62 -24.43 33.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.404 ' N ' HG21 ' A' ' 82' ' ' VAL . 15.7 t-20 -79.72 2.5 22.53 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.23 16.93 78.61 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 80' ' ' THR . 14.0 mttp -81.02 142.15 33.68 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 35.5 m -88.76 116.77 27.26 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -91.98 -19.45 22.4 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.77 146.73 23.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.47 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 99.41 -176.72 29.19 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.86 103.99 0.31 Allowed 'Cis proline' 0 N--CA 1.5 1.873 0 C-N-CA 123.669 -1.388 . . . . 0.0 112.519 -0.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.47 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 11.7 m -79.9 162.97 60.41 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -94.52 151.06 1.92 Allowed 'Trans proline' 0 C--N 1.296 -2.19 0 C-N-CA 121.808 1.672 . . . . 0.0 112.101 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 tp -133.88 129.8 36.92 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -107.39 114.13 27.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.477 -0.764 . . . . 0.0 109.907 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 57.8 t -103.81 104.1 16.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.13 139.19 17.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 38.5 t -95.0 124.38 47.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 10.4 pt -112.13 170.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 C--N 1.302 -1.496 0 O-C-N 120.921 -1.112 . . . . 0.0 108.124 178.366 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 2.7 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.485 ' CG2' HG22 ' A' ' 91' ' ' VAL . 24.8 mt -86.46 134.43 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.42 -0.8 . . . . 0.0 110.438 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.89 124.64 72.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 173.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.52 157.05 39.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.74 143.18 47.99 Favored Pre-proline 0 C--N 1.276 -2.596 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.33 133.86 30.92 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.017 1.811 . . . . 0.0 110.359 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.9 mt -105.05 112.29 38.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 O-C-N 121.54 -0.725 . . . . 0.0 109.653 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.531 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -93.49 110.73 22.3 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mt -120.23 134.7 24.11 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.541 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 35.8 Cg_endo -74.13 154.46 47.03 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 CA-C-N 119.68 0.922 . . . . 0.0 112.742 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.0 174.24 10.86 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-O 122.304 1.05 . . . . 0.0 111.12 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.521 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 57.5 t30 52.38 24.69 3.05 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -77.99 137.47 38.31 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 174.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.521 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -101.26 175.21 5.66 Favored 'General case' 0 C--N 1.267 -3.005 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.524 -177.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.58 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -53.49 -179.32 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 6.7 Cg_exo -70.74 128.92 14.45 Favored 'Cis proline' 0 N--CA 1.491 1.338 0 C-N-CA 124.25 -1.146 . . . . 0.0 113.422 -0.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' A' ' 63' ' ' ARG . 22.7 m-85 -113.43 165.74 12.7 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 14.7 Cg_exo -70.66 161.43 88.82 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 C-N-CA 124.412 -1.078 . . . . 0.0 112.254 -1.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.477 ' NH2' ' OE1' ' A' ' 13' ' ' GLN . 1.2 mtp-105 -131.17 128.28 39.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.477 -0.764 . . . . 0.0 109.711 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 5.3 t0 -63.06 133.2 54.14 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.4 m -128.86 5.57 2.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 175.14 168.74 36.11 Favored Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.108 -1.52 . . . . 0.0 109.635 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -131.99 117.09 17.95 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.164 -1.198 . . . . 0.0 109.699 -178.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.5 t -81.81 134.4 27.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.9 t -126.64 133.26 68.99 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 1' ' ' SER . 9.1 t0 -107.4 137.46 45.4 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.692 0 O-C-N 121.104 -0.998 . . . . 0.0 110.752 -175.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 121.545 0.688 . . . . 0.0 109.634 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.466 ' C ' ' HG1' ' A' ' 80' ' ' THR . 11.3 mmtp -105.4 170.61 7.79 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.405 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 23.5 m-85 -120.98 131.9 54.59 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.584 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 4.3 mmp_? -108.28 139.24 43.26 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 15.3 tp -128.54 139.28 52.38 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.07 170.56 15.96 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.418 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 124.31 159.1 10.31 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.93 114.0 1.42 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 124.76 -22.15 6.52 Favored Glycine 0 C--N 1.281 -2.492 0 N-CA-C 107.383 -2.287 . . . . 0.0 107.383 -173.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.52 -97.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.404 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 35.0 t0 -90.87 -5.53 55.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 109.759 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.418 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 7.3 mp0 -114.09 156.88 23.36 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.569 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 14.0 mm-40 -67.21 136.36 93.79 Favored Pre-proline 0 C--N 1.277 -2.563 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.533 -176.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.407 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 29.3 Cg_endo -69.94 115.05 2.3 Favored 'Cis proline' 0 N--CA 1.51 2.449 0 C-N-CA 123.316 -1.535 . . . . 0.0 111.359 -0.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.569 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 6.3 mttm -68.35 152.17 45.82 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.915 -1.116 . . . . 0.0 111.1 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.498 ' O ' ' NH1' ' A' ' 63' ' ' ARG . . . 56.44 49.08 71.32 Favored Glycine 0 N--CA 1.487 2.098 0 O-C-N 121.796 -0.565 . . . . 0.0 112.389 172.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 41' ' ' GLY . 3.7 mm -106.42 -43.0 6.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -116.79 138.73 51.28 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.973 0.892 . . . . 0.0 110.996 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -124.16 170.32 10.84 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -132.91 147.96 31.55 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.473 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 171.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 55' ' ' ASN . 21.1 t-20 -78.68 112.18 15.53 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 118.101 -1.44 . . . . 0.0 108.31 -176.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 mp0 -59.58 10.27 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 C-N-CA 124.455 1.102 . . . . 0.0 112.263 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 53' ' ' ASN . 31.8 m-80 -137.86 -48.39 0.56 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 109.009 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.5 p -87.33 -27.76 22.65 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.543 -0.723 . . . . 0.0 109.478 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.47 5.82 74.77 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 14.6 m -66.84 123.53 20.41 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.394 -1.062 . . . . 0.0 109.379 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.0 t -82.57 122.42 37.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -123.42 140.89 52.54 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.404 -0.81 . . . . 0.0 110.133 -177.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 10.6 p -90.93 144.04 9.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.9 p -96.27 -17.62 20.6 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.773 -0.58 . . . . 0.0 111.146 -176.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.498 ' NH1' ' O ' ' A' ' 48' ' ' GLY . 5.5 ptp85 -153.52 -176.22 5.71 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.783 -1.198 . . . . 0.0 110.464 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.1 t -74.86 142.99 44.07 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 121.446 0.641 . . . . 0.0 110.127 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.2 mt -104.64 158.81 16.25 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.323 -0.861 . . . . 0.0 109.164 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.71 120.71 17.64 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.5 mtm105 -63.91 -12.11 33.97 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.085 . . . . 0.0 108.342 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.03 -22.96 60.55 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.1 t -101.11 -53.23 7.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.447 HD11 ' CE2' ' A' ' 73' ' ' TYR . 1.4 mt -144.9 136.41 20.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.64 -24.24 20.55 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -159.74 140.52 4.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.587 -0.695 . . . . 0.0 109.511 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.447 ' CE2' HD11 ' A' ' 70' ' ' ILE . 58.6 m-85 -104.13 136.99 42.73 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.17 92.28 5.95 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.72 170.56 9.8 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 77.6 m-85 -135.66 140.62 44.63 Favored 'General case' 0 C--N 1.265 -3.08 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.23 155.18 21.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 120.977 0.418 . . . . 0.0 110.079 -177.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 33.1 mt-10 -140.94 141.35 34.5 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 173.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.31 128.37 35.49 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 171.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.466 ' HG1' ' C ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -119.86 161.2 21.22 Favored 'General case' 0 C--N 1.272 -2.766 0 O-C-N 121.543 -0.723 . . . . 0.0 110.847 -172.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 84' ' ' GLY . 5.2 t0 -108.97 170.44 8.04 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -52.98 -22.85 4.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -79.66 2.24 23.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.423 -0.798 . . . . 0.0 109.171 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 62.97 28.14 71.52 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 80' ' ' THR . 17.0 mttm -95.24 137.95 33.61 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.7 m -71.97 117.67 13.86 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.538 ' N ' ' CD2' ' A' ' 87' ' ' LEU . 1.5 mm? -81.45 -46.37 14.67 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.11 157.82 45.03 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.09 -177.48 35.25 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.76 112.92 0.61 Allowed 'Cis proline' 0 N--CA 1.499 1.808 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.652 -0.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.485 HG22 ' CG2' ' A' ' 2' ' ' ILE . 0.9 OUTLIER -93.45 168.27 12.34 Favored Pre-proline 0 C--N 1.284 -2.274 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 175.106 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -96.23 156.67 1.35 Allowed 'Trans proline' 0 C--N 1.295 -2.287 0 C-N-CA 121.564 1.509 . . . . 0.0 112.823 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.6 tp -142.52 124.35 15.14 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -105.43 115.38 30.15 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-O 121.432 0.634 . . . . 0.0 109.652 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 96.0 t -102.55 108.82 24.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mp -90.71 139.34 17.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 O-C-N 121.488 -0.758 . . . . 0.0 108.971 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.17 110.44 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.8 pt -96.7 170.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.411 0 O-C-N 120.883 -1.136 . . . . 0.0 110.481 -175.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 1.1 m . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 24.6 mt -88.98 142.79 12.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.714 0.769 . . . . 0.0 111.329 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.85 135.17 50.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -141.12 162.51 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.134 -0.978 . . . . 0.0 109.177 -176.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -128.0 149.64 71.46 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.71 137.75 50.37 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 110.464 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.435 HG13 HD13 ' A' ' 93' ' ' LEU . 32.1 mt -99.44 110.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.1 mp -100.24 98.39 9.07 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.8 mt -102.18 129.25 26.67 Favored Pre-proline 0 C--N 1.271 -2.837 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 19.4 Cg_endo -66.95 125.16 13.21 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 N-CA-C 109.715 -0.917 . . . . 0.0 109.715 174.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.61 ' CD ' ' HE ' ' A' ' 67' ' ' ARG . 4.5 pt-20 -62.6 -176.74 0.12 Allowed 'General case' 0 C--N 1.284 -2.279 0 CA-C-O 122.266 1.032 . . . . 0.0 111.746 -173.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.74 -4.54 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.447 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 68.0 mt-30 -59.68 113.86 2.46 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.411 ' H ' ' HD3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -79.5 -174.94 4.5 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.924 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 10.3 mm-40 -47.32 166.36 0.19 Allowed Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.488 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 3.4 Cg_endo -82.47 148.4 67.17 Favored 'Cis proline' 0 C--N 1.309 -1.549 0 C-N-CA 123.918 -1.284 . . . . 0.0 114.285 0.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.424 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 37.6 m-85 -134.0 170.46 11.24 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 5.2 Cg_exo -75.07 156.69 99.83 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 120.812 1.326 . . . . 0.0 110.84 0.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.447 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 24.8 mtp180 -133.8 126.51 30.72 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.327 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.69 129.84 43.53 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.2 -5.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.905 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.33 141.27 6.34 Favored Glycine 0 C--N 1.285 -2.275 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 22.9 ttpp -109.9 119.91 40.81 Favored 'General case' 0 C--N 1.286 -2.184 0 O-C-N 121.487 -1.007 . . . . 0.0 109.889 -177.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.84 142.32 14.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 171.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.2 t -126.13 126.2 69.15 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.837 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 14.9 t0 -99.17 128.49 45.31 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 171.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.283 -2.288 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.166 -172.76 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -120.02 170.4 9.32 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.341 -0.849 . . . . 0.0 109.169 178.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.416 ' CD2' ' HA3' ' A' ' 57' ' ' GLY . 47.8 m-85 -105.75 126.38 52.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.234 -0.916 . . . . 0.0 110.3 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.31 121.22 44.7 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.5 tp -99.6 156.77 16.89 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.14 171.44 19.25 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -174.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.34 174.66 19.05 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.356 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 111.17 1.64 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 123.99 -13.51 8.03 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -176.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.7 t -130.46 -99.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.616 -0.932 . . . . 0.0 108.568 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.413 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -84.1 -1.58 55.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.346 -0.846 . . . . 0.0 108.898 178.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -126.12 150.69 48.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 108.685 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.555 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.7 mp0 -60.62 133.06 91.43 Favored Pre-proline 0 C--N 1.279 -2.49 0 C-N-CA 123.579 0.752 . . . . 0.0 110.463 -176.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.435 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 30.6 Cg_endo -66.24 117.46 2.06 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 C-N-CA 123.634 -1.402 . . . . 0.0 110.921 -1.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.555 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 23.3 mttp -69.84 145.56 52.0 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.155 -0.966 . . . . 0.0 111.611 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.24 41.45 79.21 Favored Glycine 0 C--N 1.283 -2.412 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.416 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 41' ' ' GLY . 12.6 mm -88.7 -41.41 14.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -112.25 148.91 33.14 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.069 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -145.47 135.16 23.4 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 172.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 18.6 tt -94.93 161.25 2.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.663 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 11.6 t-20 -79.4 114.4 18.31 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 2.9 mt-10 -65.53 10.55 0.09 Allowed 'General case' 0 C--N 1.286 -2.189 0 O-C-N 121.838 -0.538 . . . . 0.0 112.425 -174.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.445 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.4 t-20 -133.05 -50.19 0.88 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.658 -1.276 . . . . 0.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.0 p -79.4 -54.12 6.24 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.416 ' HA3' ' CD2' ' A' ' 35' ' ' PHE . . . 121.97 2.26 10.3 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -63.48 122.25 15.82 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.671 -0.899 . . . . 0.0 109.466 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 44.5 t -91.35 117.65 35.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -109.17 140.31 42.93 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.918 -176.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.9 p -89.43 141.89 13.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 p -94.32 -19.71 20.42 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.29 -0.881 . . . . 0.0 111.034 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.2 178.21 8.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.006 -1.059 . . . . 0.0 110.393 -176.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 t -68.53 143.8 54.81 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -106.25 142.28 36.2 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.305 -0.872 . . . . 0.0 109.115 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -123.99 122.41 37.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.61 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 6.4 mtm105 -60.48 -9.72 4.05 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -79.15 -27.9 42.76 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.84 -55.56 6.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -144.74 134.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.99 -26.18 22.77 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 p -152.79 139.42 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.683 -0.636 . . . . 0.0 109.641 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -101.17 134.04 44.8 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.444 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 14.5 tp60 -96.96 96.08 8.26 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.61 170.1 9.04 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.193 0.996 . . . . 0.0 108.982 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -137.47 137.28 38.55 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.42 138.21 48.82 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 CA-C-O 121.128 0.489 . . . . 0.0 110.573 -176.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -133.95 139.87 46.4 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.53 141.62 31.48 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 169.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.529 ' HA ' HD23 ' A' ' 87' ' ' LEU . 1.2 p -129.52 162.13 28.89 Favored 'General case' 0 C--N 1.275 -2.668 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.364 -174.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 10.2 t70 -100.67 170.3 8.45 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.502 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.2 m -53.6 -27.01 14.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.426 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 14.0 t-20 -79.89 3.53 19.53 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.408 -0.807 . . . . 0.0 109.538 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.31 17.5 70.39 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.426 ' NZ ' ' OD1' ' A' ' 83' ' ' ASN . 18.1 mttp -82.79 146.91 28.7 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.166 -1.197 . . . . 0.0 108.057 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.7 m -91.51 116.53 28.93 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -92.88 -23.8 18.67 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 89' ' ' GLY . 0.8 OUTLIER -145.41 164.84 30.28 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 88' ' ' GLU . . . 80.72 -166.02 48.53 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -69.65 103.88 0.38 Allowed 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 123.487 -1.464 . . . . 0.0 110.926 -0.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.6 m -72.92 158.21 87.53 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -90.4 141.61 3.4 Favored 'Trans proline' 0 C--N 1.283 -2.901 0 C-N-CA 121.552 1.501 . . . . 0.0 112.424 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.435 HD13 HG13 ' A' ' 7' ' ' ILE . 12.6 tp -131.57 125.73 33.03 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.444 ' HG2' ' NE2' ' A' ' 74' ' ' GLN . 66.3 mt-10 -109.0 123.09 48.58 Favored 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.517 -0.739 . . . . 0.0 109.232 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.3 100.43 10.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.69 135.94 23.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-O 121.457 0.646 . . . . 0.0 109.298 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -92.37 99.25 9.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 16.4 pt -90.76 171.9 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.291 -1.945 0 O-C-N 120.946 -1.096 . . . . 0.0 108.295 179.36 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.523 ' H1 ' ' CG ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 CA--C 1.501 -0.941 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.5 mt -72.34 123.13 26.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.458 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.64 124.43 72.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -131.44 158.78 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 -178.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.417 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -127.37 131.03 23.64 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -41.25 140.89 1.31 Allowed 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.205 1.936 . . . . 0.0 110.85 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 mt -103.93 115.45 45.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.1 mp -107.99 96.8 6.63 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mt -107.79 128.13 26.42 Favored Pre-proline 0 C--N 1.279 -2.471 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 40.5 Cg_endo -72.07 135.4 25.11 Favored 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 120.79 0.993 . . . . 0.0 110.163 175.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.453 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 2.1 pp20? -68.26 -173.32 0.39 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-O 121.996 0.903 . . . . 0.0 111.388 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.65 -5.99 0.1 Allowed 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 174.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.468 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 57.5 mt-30 -61.87 137.0 58.2 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.41 ' CD ' ' N ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -107.14 -159.78 0.71 Allowed 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.681 -0.637 . . . . 0.0 110.158 -174.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.483 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -55.6 166.48 0.97 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.483 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 4.0 Cg_endo -80.29 118.18 5.63 Favored 'Cis proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.273 -1.553 . . . . 0.0 113.525 0.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -107.13 165.58 12.59 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.5 162.77 79.54 Favored 'Cis proline' 0 N--CA 1.504 2.094 0 C-N-CA 124.57 -1.012 . . . . 0.0 111.631 -1.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.468 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 39.4 mtp180 -132.26 144.57 50.7 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 33.7 t70 -77.01 139.34 40.04 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.01 -2.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.859 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 169.77 -178.6 42.64 Favored Glycine 0 N--CA 1.511 3.693 0 C-N-CA 117.355 -2.355 . . . . 0.0 110.401 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 6.8 ttmm -137.01 127.73 27.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.712 -1.464 . . . . 0.0 112.0 -176.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.425 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 15.3 t -94.91 132.57 38.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 168.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.3 156.51 34.47 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.852 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.523 ' CG ' ' H1 ' ' A' ' 1' ' ' SER . 8.3 t70 -132.85 146.05 51.48 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.285 -2.206 0 O-C-N 121.559 -0.713 . . . . 0.0 111.322 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HB3' ' CB ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -131.19 154.74 48.08 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -79.78 144.76 33.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.498 -0.751 . . . . 0.0 110.801 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.439 ' NH1' ' OE1' ' A' ' 78' ' ' GLU . 1.3 mtp180 -116.5 145.08 43.57 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 tp -122.17 143.85 49.31 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 p -144.12 170.86 15.14 Favored 'General case' 0 C--N 1.276 -2.613 0 O-C-N 121.251 -0.905 . . . . 0.0 109.056 -175.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.02 164.88 13.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.56 106.19 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 133.75 -16.23 4.54 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -175.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.2 t -132.73 -88.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.578 -0.954 . . . . 0.0 109.577 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.03 -20.51 34.87 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -118.11 157.31 27.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.844 0.831 . . . . 0.0 109.53 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.8 mp0 -56.33 132.4 76.01 Favored Pre-proline 0 C--N 1.28 -2.414 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.756 -176.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HB2' ' CG1' ' A' ' 49' ' ' ILE . 4.9 Cg_endo -75.85 115.94 3.86 Favored 'Cis proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.091 -1.629 . . . . 0.0 110.126 -0.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.425 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 32.8 mtpt -69.42 153.85 42.92 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 120.721 -1.237 . . . . 0.0 111.425 -174.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.52 9.1 29.69 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-O 119.261 -0.744 . . . . 0.0 113.34 173.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.447 ' CG1' ' HB2' ' A' ' 46' ' ' PRO . 8.1 mm -60.83 -48.76 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.509 0 CA-C-N 120.239 2.019 . . . . 0.0 106.795 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -108.35 166.62 10.62 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-O 121.815 0.817 . . . . 0.0 110.413 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.84 126.6 7.53 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.46 146.84 5.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 57' ' ' GLY . 34.3 t30 -79.46 85.11 5.27 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.483 ' CB ' ' HB3' ' A' ' 34' ' ' LYS . 1.9 mt-10 -30.82 -34.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 124.053 0.941 . . . . 0.0 113.431 -174.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -93.0 -50.42 5.55 Favored 'General case' 0 C--N 1.285 -2.231 0 O-C-N 121.544 -0.723 . . . . 0.0 110.373 -174.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 18.8 p -88.32 -12.32 43.8 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 122.047 0.927 . . . . 0.0 108.831 -175.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . 69.82 9.36 62.47 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.49 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 3.5 m -69.35 124.58 24.22 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.326 -1.103 . . . . 0.0 108.291 177.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' GLY . 1.8 t -90.02 122.52 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.182 -0.949 . . . . 0.0 109.192 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -118.26 154.15 32.75 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.198 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -107.46 149.92 10.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.7 p -104.32 -22.9 13.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.503 -0.748 . . . . 0.0 112.101 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.56 168.52 19.5 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.979 -1.075 . . . . 0.0 111.381 -175.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 t -64.87 123.42 19.36 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.7 mt -82.08 163.54 21.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.063 -1.023 . . . . 0.0 108.497 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -127.92 170.42 12.86 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.546 ' NE ' ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.68 27.39 8.22 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 121.873 0.844 . . . . 0.0 109.158 -177.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -120.32 -42.18 2.58 Favored 'General case' 0 C--N 1.262 -3.213 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.81 -47.78 16.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 mt -129.85 137.25 57.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.44 -24.13 14.23 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 p -156.29 146.43 11.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.423 -0.798 . . . . 0.0 109.345 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.45 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 60.6 m-85 -103.96 114.48 28.76 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 174.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.465 HE22 ' CG ' ' A' ' 94' ' ' GLU . 18.2 tp60 -88.01 83.07 7.07 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.79 170.58 15.54 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 43.8 m-85 -133.69 129.74 37.2 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.77 144.21 15.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 O-C-N 121.894 -0.503 . . . . 0.0 109.859 -175.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.439 ' OE1' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 -131.31 140.95 49.86 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.41 ' C ' HD21 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -86.3 127.63 34.81 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 102.806 -3.035 . . . . 0.0 102.806 167.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.507 ' HA ' HD23 ' A' ' 87' ' ' LEU . 19.5 p -123.04 146.05 48.0 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 118.567 -1.253 . . . . 0.0 111.713 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.416 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 29.0 t70 -88.72 165.76 14.51 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.017 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.416 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -55.76 -27.21 21.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -79.5 -13.19 59.73 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.102 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.04 7.18 50.67 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -76.4 143.77 40.44 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 120.666 -1.49 . . . . 0.0 107.787 178.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.3 m -86.98 116.08 24.8 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -87.24 -20.8 26.37 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -157.94 153.2 25.81 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.452 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 83.91 -169.5 46.53 Favored Glycine 0 C--N 1.28 -2.536 0 N-CA-C 106.698 -2.561 . . . . 0.0 106.698 -174.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.85 103.23 0.14 OUTLIER 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.644 -1.398 . . . . 0.0 112.722 -0.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 3.7 m -78.4 164.35 56.7 Favored Pre-proline 0 C--N 1.289 -2.059 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -93.71 153.14 2.32 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 121.498 1.465 . . . . 0.0 112.622 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 tp -141.0 129.76 22.92 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.465 ' CG ' HE22 ' A' ' 74' ' ' GLN . 31.7 mt-10 -102.92 110.57 22.54 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 60.0 t -103.69 93.08 2.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.76 134.3 27.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 O-C-N 121.507 -0.746 . . . . 0.0 109.24 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 55.2 t -88.38 102.49 12.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 9.5 pt -80.17 170.78 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.244 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 . . . . . 0 C--N 1.28 -2.434 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.989 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.58 ' H1 ' ' CG ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.73 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 79' ' ' THR . 18.9 mt -67.82 148.54 11.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.53 0.681 . . . . 0.0 110.015 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.76 114.31 24.66 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -134.32 169.63 21.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.524 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 2.1 m -159.39 165.94 17.2 Favored Pre-proline 0 C--N 1.276 -2.618 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -55.47 131.32 45.46 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.553 1.502 . . . . 0.0 111.946 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mt -106.13 115.88 48.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.517 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -90.25 108.01 19.49 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.2 mt -109.81 124.23 34.19 Favored Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 6.5 Cg_exo -66.06 124.49 12.69 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.062 1.175 . . . . 0.0 110.777 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -41.86 -72.2 0.07 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.578 0.704 . . . . 0.0 111.797 -176.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.443 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 48.2 p-10 -66.4 40.55 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -174.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.484 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -76.01 56.04 0.96 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 119.608 -1.933 . . . . 0.0 106.145 172.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.564 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -45.59 175.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.331 1.062 . . . . 0.0 113.599 -172.216 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 37.5 mt-30 -48.25 166.34 0.22 Allowed Pre-proline 0 C--N 1.285 -2.201 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.754 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 5.7 Cg_exo -76.1 134.89 37.7 Favored 'Cis proline' 0 N--CA 1.497 1.721 0 C-N-CA 123.725 -1.364 . . . . 0.0 113.898 0.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CZ ' ' O ' ' A' ' 13' ' ' GLN . 24.2 m-85 -102.49 166.24 12.37 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.36 166.7 72.32 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.312 -0.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.564 ' NH2' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -125.1 135.28 52.54 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.98 137.16 51.19 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.25 4.83 3.06 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.011 0 C-N-CA 119.441 -0.903 . . . . 0.0 109.014 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 158.37 -170.32 35.04 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 118.218 -1.944 . . . . 0.0 109.632 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.412 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 19.4 ttmm -148.13 128.56 13.97 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.23 -1.159 . . . . 0.0 109.768 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.25 147.07 5.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.38 163.73 36.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.58 ' CG ' ' H1 ' ' A' ' 1' ' ' SER . 9.8 t70 -125.09 141.11 52.32 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.436 ' H ' ' HG ' ' A' ' 27' ' ' SER . 0.7 OUTLIER . . . . . 0 C--N 1.26 -3.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.362 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.436 ' C ' ' HG2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 121.465 0.65 . . . . 0.0 111.263 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HG2' ' C ' ' A' ' 33' ' ' SER . 6.2 mmtm -147.71 150.51 34.44 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 35.5 m-85 -94.65 124.28 38.59 Favored 'General case' 0 C--N 1.28 -2.446 0 O-C-N 121.408 -0.807 . . . . 0.0 109.485 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.465 HH11 ' CG ' ' A' ' 36' ' ' ARG . 4.4 mmp_? -107.61 125.77 51.73 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.1 tp -106.29 144.45 32.95 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -149.68 170.89 17.64 Favored 'General case' 0 C--N 1.278 -2.5 0 O-C-N 121.163 -0.96 . . . . 0.0 108.732 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.91 176.26 18.71 Favored Glycine 0 N--CA 1.502 3.033 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.056 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -61.11 121.16 11.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 110.16 -20.77 25.62 Favored Glycine 0 C--N 1.28 -2.552 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 -177.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.9 t -116.2 -93.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.47 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 5.5 t70 -92.98 -12.58 30.37 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.59 -0.694 . . . . 0.0 109.647 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -109.7 157.58 18.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -57.81 132.52 82.95 Favored Pre-proline 0 C--N 1.288 -2.1 0 O-C-N 121.982 -0.449 . . . . 0.0 110.084 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.426 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -77.42 118.77 5.95 Favored 'Cis proline' 0 N--CA 1.501 1.959 0 C-N-CA 123.91 -1.287 . . . . 0.0 110.24 -0.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 22.6 mttp -67.14 149.69 50.17 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 120.788 -1.195 . . . . 0.0 111.947 -174.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.22 29.3 72.61 Favored Glycine 0 N--CA 1.49 2.286 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.748 171.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' GLY . 10.6 mm -83.77 -44.75 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 173.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -106.33 147.76 28.82 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.601 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.57 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -141.94 126.25 17.59 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 177.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.61 147.67 8.88 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.464 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 28.5 t-20 -79.68 99.97 7.65 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -42.39 -26.64 0.12 Allowed 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.896 -177.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -106.5 -37.28 6.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.909 -1.12 . . . . 0.0 111.69 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 5.1 p -89.8 -15.23 32.78 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 120.984 -1.072 . . . . 0.0 108.918 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.24 2.62 49.14 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.412 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 19.3 m -64.51 124.37 21.67 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.292 -1.122 . . . . 0.0 108.815 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.1 t -88.96 131.0 37.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.57 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -130.87 160.53 34.17 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.44 149.37 19.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.1 p -94.71 -10.57 31.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.48 -0.763 . . . . 0.0 111.148 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -155.15 162.92 40.85 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.052 -1.03 . . . . 0.0 109.306 -178.196 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.443 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 5.1 t -62.18 138.2 58.37 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 65.2 mt -90.71 131.58 36.31 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -106.06 119.34 38.96 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -57.62 -7.65 0.71 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -77.89 -26.93 49.49 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.9 t -89.87 -53.02 9.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 mt -151.66 144.02 16.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.28 -25.55 16.29 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.1 p -154.92 135.95 5.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.501 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -106.03 138.64 41.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.42 HE22 ' CG ' ' A' ' 94' ' ' GLU . 0.3 OUTLIER -100.7 87.08 3.25 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.11 170.78 15.74 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -132.21 131.37 42.09 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.18 140.64 28.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 O-C-N 122.022 -0.424 . . . . 0.0 110.046 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.28 137.12 49.82 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.462 ' N ' HD12 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -86.2 133.8 33.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 172.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.535 ' HA ' HD23 ' A' ' 87' ' ' LEU . 4.1 p -125.27 159.17 32.31 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.689 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.488 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -101.07 170.55 8.2 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 177.134 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.488 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 0.9 OUTLIER -43.09 -38.0 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 CA-C-O 121.825 0.821 . . . . 0.0 109.613 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.435 ' N ' ' CG2' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -79.95 2.85 21.93 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.697 -0.627 . . . . 0.0 109.975 -177.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 74.67 15.48 80.64 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 80' ' ' THR . 2.0 mtpp -73.51 134.18 43.8 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.0 m -81.27 116.92 21.37 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.803 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -92.33 -22.02 19.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.21 149.37 29.35 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.497 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 105.43 -178.39 23.33 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -71.63 104.43 0.49 Allowed 'Cis proline' 0 N--CA 1.491 1.354 0 C-N-CA 123.304 -1.54 . . . . 0.0 111.568 0.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.497 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 9.5 m -75.23 159.04 83.25 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 176.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -91.78 145.16 3.08 Favored 'Trans proline' 0 C--N 1.279 -3.089 0 C-N-CA 121.529 1.486 . . . . 0.0 111.699 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.2 tp -128.84 126.97 40.94 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.42 ' CG ' HE22 ' A' ' 74' ' ' GLN . 4.2 mt-10 -106.81 110.29 22.42 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 24.8 t -101.8 112.22 34.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.55 136.28 28.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.57 111.76 23.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 9.7 pt -105.45 171.63 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.279 -2.46 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -178.683 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 79' ' ' THR . 17.2 mt -62.01 146.02 12.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-O 121.934 0.874 . . . . 0.0 111.065 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.85 115.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.553 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 174.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -127.14 161.86 33.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.057 -1.027 . . . . 0.0 108.9 -175.498 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.451 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -155.52 138.84 10.89 Favored Pre-proline 0 C--N 1.273 -2.74 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -41.9 138.91 2.55 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 C-N-CA 122.351 2.034 . . . . 0.0 112.724 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.2 mt -104.63 119.44 53.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.8 mp -106.15 79.42 1.4 Allowed 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.7 mt -81.99 140.35 46.47 Favored Pre-proline 0 C--N 1.281 -2.398 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.1 Cg_endo -73.69 137.13 24.44 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 120.748 0.965 . . . . 0.0 111.046 177.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -66.08 170.59 5.48 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.283 -0.886 . . . . 0.0 109.198 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.438 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 5.3 t-20 59.8 13.5 3.58 Favored 'General case' 0 C--N 1.287 -2.114 0 O-C-N 121.752 -0.593 . . . . 0.0 112.093 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -57.58 127.63 32.97 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.534 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -89.67 158.53 17.54 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.153 -0.967 . . . . 0.0 112.781 -170.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 12.3 mp0 -50.07 167.05 0.25 Allowed Pre-proline 0 C--N 1.296 -1.733 0 C-N-CA 124.938 1.295 . . . . 0.0 109.022 176.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 67.8 Cg_endo -79.61 154.67 88.64 Favored 'Cis proline' 0 C--N 1.31 -1.473 0 C-N-CA 123.613 -1.411 . . . . 0.0 113.641 0.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.459 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 33.9 m-85 -135.09 169.86 12.7 Favored Pre-proline 0 C--N 1.276 -2.597 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.6 Cg_exo -68.94 173.34 41.99 Favored 'Cis proline' 0 N--CA 1.493 1.469 0 C-N-CA 124.485 -1.048 . . . . 0.0 112.124 0.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 16' ' ' PRO . 7.1 ttm180 -155.88 145.2 20.81 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -65.65 132.83 49.78 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.01 3.74 5.14 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 163.36 179.11 37.61 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.93 131.88 35.74 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.818 -1.401 . . . . 0.0 110.134 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.2 t -91.69 126.62 44.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 102.179 -3.267 . . . . 0.0 102.179 166.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.0 t -112.07 159.69 11.91 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 C-N-CA 118.472 -1.291 . . . . 0.0 109.068 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -144.99 110.35 5.24 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.283 -2.285 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.079 0.466 . . . . 0.0 111.065 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -107.14 142.35 36.97 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.743 -0.598 . . . . 0.0 110.331 -176.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.418 ' CD1' ' CA ' ' A' ' 57' ' ' GLY . 78.8 m-85 -79.11 139.1 38.14 Favored 'General case' 0 C--N 1.273 -2.74 0 O-C-N 120.972 -1.08 . . . . 0.0 111.255 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.458 ' NH2' ' OG1' ' A' ' 86' ' ' THR . 7.0 mtm-85 -115.57 127.16 55.04 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 172.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.2 tp -108.71 138.97 44.17 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -147.69 170.8 16.75 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.68 163.83 13.0 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -57.21 112.81 1.48 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 125.74 -18.88 6.67 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 107.934 -2.067 . . . . 0.0 107.934 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.3 t -123.77 -97.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.98 -18.32 30.98 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -107.13 156.88 18.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.604 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 15.5 mm-40 -68.54 140.93 92.59 Favored Pre-proline 0 C--N 1.269 -2.893 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.537 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.462 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -70.52 113.39 1.83 Allowed 'Cis proline' 0 N--CA 1.51 2.48 0 C-N-CA 123.605 -1.415 . . . . 0.0 111.438 1.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.604 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 5.3 mtpm? -69.17 152.82 44.64 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.766 -1.209 . . . . 0.0 111.909 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.87 5.1 50.8 Favored Glycine 0 N--CA 1.489 2.198 0 CA-C-O 119.113 -0.826 . . . . 0.0 113.474 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.24 -46.66 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 120.456 2.128 . . . . 0.0 107.338 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' CZ ' HG12 ' A' ' 95' ' ' VAL . 69.6 m-85 -115.75 144.67 43.64 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.296 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.18 136.01 29.52 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.23 157.54 9.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.602 -0.686 . . . . 0.0 109.989 -176.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.456 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 11.4 t-20 -85.32 126.94 34.13 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 175.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 1.8 mt-10 -59.7 -38.54 81.86 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.771 -0.581 . . . . 0.0 111.06 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.443 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 10.6 t30 -88.57 -48.03 7.87 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.014 -1.054 . . . . 0.0 111.673 -176.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.1 p -80.49 -34.43 35.81 Favored 'General case' 0 C--N 1.281 -2.376 0 O-C-N 121.727 -0.608 . . . . 0.0 109.662 -174.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.418 ' CA ' ' CD1' ' A' ' 35' ' ' PHE . . . 84.08 10.38 80.68 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -176.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -64.54 122.09 15.98 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.209 -1.171 . . . . 0.0 108.334 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 22' ' ' GLY . 1.8 t -88.92 127.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.59 146.01 49.29 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.532 -0.73 . . . . 0.0 109.654 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 8.3 p -101.63 149.18 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.8 p -99.86 -17.32 17.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.634 -0.666 . . . . 0.0 112.122 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.562 HH12 ' CG ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -145.93 167.17 23.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.798 -1.189 . . . . 0.0 110.567 -178.63 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.506 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 7.1 t -58.01 122.51 13.19 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt -79.73 140.87 36.81 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.466 -1.396 . . . . 0.0 109.904 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.562 ' CG ' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -124.37 117.3 24.17 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.085 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -14.73 18.86 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 121.765 -0.584 . . . . 0.0 109.88 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.56 -28.3 45.94 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.889 -1.132 . . . . 0.0 108.694 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.86 -52.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 73' ' ' TYR . 1.1 mt -145.33 132.59 15.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.36 -25.46 29.14 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.22 136.59 5.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.444 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 42.7 m-85 -100.05 122.52 43.06 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -92.44 93.91 8.83 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.94 170.75 9.8 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.779 0.799 . . . . 0.0 109.028 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -133.0 131.21 40.46 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.9 150.13 20.1 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -174.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -146.46 146.87 30.71 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 121.302 -0.874 . . . . 0.0 108.652 176.093 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -95.27 135.63 36.62 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 170.419 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.521 ' HA ' HD23 ' A' ' 87' ' ' LEU . 38.0 p -125.76 158.22 35.46 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.411 -0.806 . . . . 0.0 111.553 -171.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.428 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 28.1 t70 -79.64 170.96 15.79 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.428 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 2.1 m -58.41 -27.71 33.9 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -79.61 2.01 23.99 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.736 0.779 . . . . 0.0 108.997 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.36 11.65 85.31 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -77.51 140.05 39.7 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.458 ' OG1' ' NH2' ' A' ' 36' ' ' ARG . 39.0 m -81.51 118.98 23.18 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 120.777 0.322 . . . . 0.0 110.187 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -94.21 -31.29 14.18 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 5.1 tp10 -138.04 153.18 49.37 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.12 -171.5 38.86 Favored Glycine 0 C--N 1.288 -2.119 0 N-CA-C 106.931 -2.467 . . . . 0.0 106.931 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HA ' ' HG2' ' A' ' 78' ' ' GLU . 12.5 Cg_exo -68.37 111.54 1.03 Allowed 'Cis proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.364 -1.515 . . . . 0.0 111.037 -0.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 m -86.9 163.56 40.28 Favored Pre-proline 0 C--N 1.28 -2.432 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -93.85 159.84 2.26 Favored 'Trans proline' 0 C--N 1.289 -2.561 0 C-N-CA 121.933 1.756 . . . . 0.0 110.868 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.4 tp -144.88 124.48 13.24 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.81 113.14 25.12 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 78.1 t -105.16 91.39 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.82 138.04 20.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 O-C-N 121.506 -0.746 . . . . 0.0 109.179 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.1 106.72 18.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.2 pt -97.12 170.92 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.081 -1.012 . . . . 0.0 110.307 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.934 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 7.2 mt -74.96 146.85 8.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.361 0.6 . . . . 0.0 109.621 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.25 137.89 56.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -150.61 167.43 2.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . 0.494 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -140.87 145.73 40.88 Favored Pre-proline 0 C--N 1.289 -2.055 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.28 133.11 35.78 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.093 1.862 . . . . 0.0 110.323 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.2 mt -103.93 112.1 36.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.167 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.536 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.22 105.33 17.74 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.3 mt -111.93 128.4 25.51 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 33.9 Cg_endo -69.27 130.16 19.45 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.172 1.248 . . . . 0.0 110.727 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 66' ' ' ASP . 10.9 pt-20 -64.35 173.88 1.88 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.104 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 57.39 61.75 2.4 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.688 0.756 . . . . 0.0 111.418 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -119.88 131.98 55.42 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -96.97 177.82 5.49 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 121.062 -1.024 . . . . 0.0 111.673 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 18.2 mp0 -54.76 166.94 0.67 Allowed Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 70.5 Cg_endo -78.12 122.13 8.44 Favored 'Cis proline' 0 C--N 1.315 -1.203 0 C-N-CA 123.785 -1.34 . . . . 0.0 114.459 0.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.447 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 29.6 m-85 -97.86 170.2 7.45 Favored Pre-proline 0 C--N 1.279 -2.49 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.7 Cg_exo -68.05 163.27 76.82 Favored 'Cis proline' 0 N--CA 1.493 1.483 0 C-N-CA 124.194 -1.169 . . . . 0.0 111.224 -1.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -124.47 126.93 46.71 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.66 132.64 39.5 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.6 m -127.46 5.67 3.4 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.643 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 166.7 179.55 39.96 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 117.707 -2.187 . . . . 0.0 109.756 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' A' ' 56' ' ' THR . 29.5 tttp -143.03 139.57 30.61 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 120.852 -1.381 . . . . 0.0 109.678 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.6 t -94.34 152.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -144.14 151.4 16.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 9.2 t0 -112.25 135.08 53.37 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.269 -2.9 0 O-C-N 122.141 -0.349 . . . . 0.0 111.501 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 40.8 mttm -113.52 139.17 49.19 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 173.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -89.77 135.5 33.59 Favored 'General case' 0 C--N 1.271 -2.818 0 O-C-N 121.24 -0.912 . . . . 0.0 110.991 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.509 ' NH2' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -100.0 139.27 35.92 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 174.23 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -121.01 135.45 55.21 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -144.91 170.52 15.99 Favored 'General case' 0 C--N 1.274 -2.692 0 O-C-N 121.472 -0.768 . . . . 0.0 109.019 -174.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.494 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 115.15 173.39 17.69 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -58.16 111.5 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 124.52 -15.3 7.62 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.36 -81.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.294 -1.121 . . . . 0.0 109.154 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -96.53 -14.46 22.28 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.494 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 9.3 mp0 -118.85 158.51 25.51 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.521 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -51.9 127.85 36.08 Favored Pre-proline 0 C--N 1.281 -2.389 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.779 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.405 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 4.3 Cg_endo -80.36 120.66 7.32 Favored 'Cis proline' 0 C--O 1.202 -1.311 0 C-N-CA 123.5 -1.458 . . . . 0.0 110.517 -1.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 28.0 mttp -63.47 155.51 29.0 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 120.872 -1.143 . . . . 0.0 111.268 -175.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.75 32.73 48.01 Favored Glycine 0 N--CA 1.49 2.285 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.149 171.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.403 ' CG1' ' HB2' ' A' ' 46' ' ' PRO . 8.7 mm -87.89 -43.44 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -110.39 141.44 43.46 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.813 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.586 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -132.6 120.61 22.02 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 176.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -89.09 141.87 13.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.491 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 46.6 t30 -79.09 84.79 5.04 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 1.3 mp0 -24.22 -53.43 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 125.327 1.451 . . . . 0.0 113.54 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -79.75 -39.49 30.92 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.161 -0.962 . . . . 0.0 111.325 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 29.2 p -94.32 -26.28 16.64 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-O 121.735 0.779 . . . . 0.0 109.313 -174.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.33 2.6 76.67 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -65.07 121.35 14.52 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.313 -1.11 . . . . 0.0 109.482 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.1 t -86.83 120.87 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.586 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -123.73 155.42 37.9 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.418 178.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 7.4 p -102.19 143.54 14.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 59.9 p -90.48 -20.51 22.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.446 -0.784 . . . . 0.0 111.037 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -151.81 175.66 12.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.115 -0.99 . . . . 0.0 110.033 -175.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.411 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 2.7 t -66.62 136.69 55.95 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-O 121.83 0.824 . . . . 0.0 110.793 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.0 mt -98.78 150.61 21.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 11' ' ' GLU . 8.7 m-20 -132.9 122.66 24.67 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.0 mtp-105 -57.26 -13.33 3.11 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -77.79 -22.94 49.37 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.37 -55.87 6.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 73' ' ' TYR . 1.1 mt -144.74 136.39 21.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.11 -25.46 36.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.1 p -160.02 132.83 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 70.6 m-85 -94.42 115.23 27.38 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.21 93.1 6.35 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.41 170.62 10.39 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-O 121.956 0.884 . . . . 0.0 108.994 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 78.4 m-85 -128.15 122.23 31.44 Favored 'General case' 0 C--N 1.266 -3.023 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.37 146.15 11.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -136.5 140.02 42.71 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.49 127.35 33.64 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 170.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.509 ' OG1' ' NH2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -125.46 159.67 31.36 Favored 'General case' 0 C--N 1.267 -3.007 0 C-N-CA 119.265 -0.974 . . . . 0.0 109.895 -178.092 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.532 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 14.8 t70 -97.31 170.3 9.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.532 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.5 m -54.43 -22.6 9.14 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -80.27 -2.86 46.91 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.426 -0.796 . . . . 0.0 109.058 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.12 8.62 86.95 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 80' ' ' THR . 4.2 mttp -81.1 150.21 28.86 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 94.0 m -94.48 118.21 31.3 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-O 121.219 0.533 . . . . 0.0 110.302 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.68 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -89.15 -32.5 17.45 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER -137.83 170.41 16.11 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.593 -0.692 . . . . 0.0 109.758 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.464 ' H ' ' CD ' ' A' ' 88' ' ' GLU . . . 83.5 -165.91 43.1 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -69.63 101.31 0.27 Allowed 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.564 -1.432 . . . . 0.0 110.79 -0.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' A' ' 2' ' ' ILE . 10.6 m -74.15 160.37 81.75 Favored Pre-proline 0 C--N 1.291 -1.954 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -92.49 147.07 2.8 Favored 'Trans proline' 0 C--N 1.285 -2.8 0 C-N-CA 121.868 1.712 . . . . 0.0 112.03 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 tp -130.51 125.85 35.36 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -108.27 106.91 17.28 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.651 -0.656 . . . . 0.0 109.677 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 38.9 t -98.45 100.5 10.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mp -79.93 131.69 33.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -90.05 111.24 22.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 11.3 pt -105.25 171.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 O-C-N 121.688 -0.632 . . . . 0.0 109.537 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--N 1.3 -1.578 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.734 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.553 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 7.0 mt -69.22 138.1 22.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.903 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.56 133.4 69.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.69 157.9 10.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.637 0.732 . . . . 0.0 109.462 -177.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 t -128.36 141.84 42.73 Favored Pre-proline 0 C--N 1.281 -2.384 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.67 132.92 13.41 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.531 1.487 . . . . 0.0 109.811 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.7 mt -98.08 111.89 28.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.521 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.1 mp -100.3 103.12 14.53 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 4.1 mt -108.11 127.8 26.92 Favored Pre-proline 0 C--N 1.27 -2.877 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -74.4 135.98 21.1 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 CA-C-N 119.444 0.837 . . . . 0.0 111.945 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 66' ' ' ASP . 2.9 tt0 -39.38 147.08 0.08 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.502 0.668 . . . . 0.0 111.848 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.479 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 2.3 t-20 59.87 66.54 0.97 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.515 HE22 ' HB2' ' A' ' 65' ' ' LEU . 18.9 mp0 -92.17 54.59 2.39 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 175.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.556 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -26.11 162.34 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -174.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.523 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -46.14 169.18 0.09 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.753 175.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 1.2 Cg_endo -77.47 131.47 24.07 Favored 'Cis proline' 0 N--CA 1.492 1.392 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.37 -0.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.529 ' CZ ' ' N ' ' A' ' 64' ' ' THR . 55.1 m-85 -97.74 163.95 18.5 Favored Pre-proline 0 C--N 1.293 -1.86 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.19 156.27 98.19 Favored 'Cis proline' 0 N--CA 1.502 1.977 0 C-N-CA 124.12 -1.2 . . . . 0.0 110.841 -1.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 38.2 mtp180 -124.77 135.29 52.85 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.435 -0.791 . . . . 0.0 110.101 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.17 140.27 58.44 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.33 -4.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . -176.07 170.44 43.33 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 118.75 -1.69 . . . . 0.0 109.313 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 5.1 tttm -141.62 114.1 8.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.163 -1.198 . . . . 0.0 109.687 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.526 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 22.0 t -79.65 158.92 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.3 t -141.81 170.1 13.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.1 t70 -131.13 143.93 51.01 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 1' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.402 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.079 0.466 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HB2' ' OG1' ' A' ' 80' ' ' THR . 2.4 mmtp -111.02 135.41 51.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.709 -0.619 . . . . 0.0 109.712 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -84.58 116.08 22.96 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.563 HH12 ' CB ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -95.31 133.73 38.89 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.0 tp -106.93 136.91 45.99 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.22 170.45 16.72 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.538 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 117.35 167.3 14.32 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -53.92 116.07 2.35 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 119.33 -22.12 9.03 Favored Glycine 0 C--N 1.28 -2.566 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.82 -83.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.428 -1.043 . . . . 0.0 109.12 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.35 -23.26 16.72 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 20.4 mp0 -103.34 161.22 14.02 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.73 134.69 90.26 Favored Pre-proline 0 C--N 1.27 -2.855 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.457 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 35.1 Cg_endo -68.73 126.42 8.76 Favored 'Cis proline' 0 N--CA 1.514 2.705 0 C-N-CA 123.615 -1.411 . . . . 0.0 110.942 -0.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -87.23 152.51 22.25 Favored 'General case' 0 C--N 1.289 -2.056 0 O-C-N 120.82 -1.175 . . . . 0.0 111.649 -173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.01 15.26 71.67 Favored Glycine 0 N--CA 1.492 2.376 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.314 174.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.0 mm -78.37 -48.86 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 CA-C-N 119.561 1.68 . . . . 0.0 107.653 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -108.42 155.71 20.27 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.708 0.766 . . . . 0.0 109.673 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.553 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -146.75 160.0 42.78 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' NH2' ' A' ' 51' ' ' ARG . 10.9 tt -132.08 164.13 35.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 O-C-N 120.81 -1.181 . . . . 0.0 109.941 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.429 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 21.9 t-20 -91.94 108.71 20.12 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 34' ' ' LYS . 32.1 mt-10 -46.98 -33.45 4.69 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.154 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.405 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 t-20 -95.9 -48.84 5.56 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.415 -0.803 . . . . 0.0 110.961 -176.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.455 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 10.0 p -84.91 -21.58 29.61 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 121.491 -0.756 . . . . 0.0 110.083 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.8 7.82 86.28 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 12.0 m -64.15 123.4 18.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 22' ' ' GLY . 3.3 t -92.78 122.78 44.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.553 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -117.25 149.42 40.46 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.11 143.63 15.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.0 p -91.96 -13.88 30.38 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.547 -0.72 . . . . 0.0 110.852 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.573 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -148.17 160.25 43.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.605 -1.309 . . . . 0.0 109.905 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.573 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -63.21 127.55 31.79 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.515 ' HB2' HE22 ' A' ' 13' ' ' GLN . 34.5 mt -84.68 151.89 24.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.242 -1.536 . . . . 0.0 111.604 -172.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.41 ' HA ' ' CG ' ' A' ' 11' ' ' GLU . 4.8 m-20 -123.91 131.05 53.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.529 ' CB ' HH11 ' A' ' 67' ' ' ARG . 0.0 OUTLIER -72.14 -6.0 39.53 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.017 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -85.44 -19.56 31.12 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -175.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 t -90.25 -62.96 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.463 HG22 ' CD1' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.49 127.98 23.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 175.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.79 -24.63 24.97 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.17 121.79 3.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.463 ' CD1' HG22 ' A' ' 70' ' ' ILE . 65.5 m-85 -92.36 119.7 32.17 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -89.76 81.93 6.33 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.427 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 0.5 OUTLIER -80.46 170.2 16.68 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 122.301 1.048 . . . . 0.0 109.974 -177.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -135.2 136.68 41.98 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.07 147.33 17.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.18 141.8 40.05 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.86 131.78 43.27 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 172.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.563 ' CB ' HH12 ' A' ' 36' ' ' ARG . 18.0 p -122.78 162.32 22.31 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.935 -175.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.97 171.09 7.6 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -47.62 -22.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 O-C-N 121.81 -0.556 . . . . 0.0 111.818 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.48 -17.17 54.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.744 -1.222 . . . . 0.0 109.856 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.91 11.61 57.55 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 80' ' ' THR . 14.2 mttm -90.27 160.54 16.12 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 88' ' ' GLU . 90.3 m -101.2 120.29 40.01 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-O 120.841 0.353 . . . . 0.0 110.085 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.629 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -96.22 -11.23 26.36 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.473 ' O ' ' CG2' ' A' ' 86' ' ' THR . 11.3 tp10 -152.2 167.54 28.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.59 -168.75 52.73 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -67.03 112.56 1.05 Allowed 'Cis proline' 0 N--CA 1.493 1.463 0 C-N-CA 123.25 -1.563 . . . . 0.0 112.356 0.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.421 HG22 ' CG2' ' A' ' 2' ' ' ILE . 5.3 m -83.2 165.28 41.73 Favored Pre-proline 0 C--N 1.284 -2.269 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -94.27 152.54 2.06 Favored 'Trans proline' 0 C--N 1.297 -2.151 0 C-N-CA 121.948 1.766 . . . . 0.0 112.329 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.5 tp -141.49 126.68 18.51 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -108.45 116.64 32.34 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 121.354 -0.841 . . . . 0.0 109.173 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 79.1 t -104.15 104.47 16.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.52 134.52 30.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 15.0 t -89.73 104.0 14.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 15.1 pt -85.46 170.85 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.503 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.284 -2.252 0 O-C-N 120.746 -1.221 . . . . 0.0 109.256 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.217 -0.626 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.426 HD11 HG23 ' A' ' 91' ' ' VAL . 2.7 mt -77.69 123.28 34.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-O 121.873 0.844 . . . . 0.0 110.511 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.64 134.17 44.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -155.0 154.86 6.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.15 141.71 33.5 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -47.63 132.36 20.62 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 121.34 1.36 . . . . 0.0 108.93 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 mt -99.4 112.41 31.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.468 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.537 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -89.5 98.57 11.84 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.5 mt -106.42 121.29 45.79 Favored Pre-proline 0 C--N 1.279 -2.493 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -66.07 137.46 48.45 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 120.629 0.886 . . . . 0.0 111.275 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -72.13 179.5 3.29 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.675 -178.137 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.471 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 2.2 m-20 58.69 17.51 5.16 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 172.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -77.21 129.45 35.95 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.471 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -97.81 -175.39 3.15 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.095 -1.003 . . . . 0.0 110.884 -173.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 4.3 mt-30 -49.2 160.78 0.49 Allowed Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 0.9 OUTLIER -80.53 148.56 76.89 Favored 'Cis proline' 0 C--N 1.301 -1.935 0 C-N-CA 123.195 -1.585 . . . . 0.0 113.901 -0.145 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -129.13 166.49 24.88 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 16.9 Cg_exo -67.26 169.6 49.78 Favored 'Cis proline' 0 N--CA 1.496 1.647 0 C-N-CA 124.354 -1.103 . . . . 0.0 112.157 -0.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.501 ' NE ' ' O ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -137.04 137.67 39.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.622 -0.674 . . . . 0.0 109.583 178.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 12.4 t70 -75.87 140.11 42.03 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.94 5.2 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 162.41 173.89 31.64 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.197 -1.954 . . . . 0.0 109.919 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -136.86 124.88 22.83 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.355 -1.085 . . . . 0.0 109.764 -178.412 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 t -82.94 157.7 3.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 t -144.32 169.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 1' ' ' SER . 10.0 t70 -125.73 141.42 52.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.244 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.507 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 154.94 29.12 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -86.63 137.51 32.42 Favored 'General case' 0 C--N 1.285 -2.227 0 O-C-N 121.973 -0.455 . . . . 0.0 110.003 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' NH2' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -110.08 130.28 55.56 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 173.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.4 tp -111.02 138.01 47.96 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -146.69 171.26 15.41 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.32 173.88 18.8 Favored Glycine 0 N--CA 1.51 3.608 0 C-N-CA 120.0 -1.095 . . . . 0.0 110.78 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -62.32 119.46 9.1 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 46' ' ' PRO . . . 117.32 -22.81 10.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.86 -95.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.619 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -92.55 -6.39 49.72 Favored 'General case' 0 C--O 1.204 -1.327 0 O-C-N 121.22 -0.925 . . . . 0.0 109.171 178.081 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -116.8 148.65 41.01 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.583 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 5.2 mm-40 -58.94 140.08 86.84 Favored Pre-proline 0 C--N 1.271 -2.82 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.204 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 37.2 Cg_endo -68.64 116.02 2.29 Favored 'Cis proline' 0 N--CA 1.511 2.507 0 C-N-CA 123.299 -1.542 . . . . 0.0 110.456 -1.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.619 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 7.8 mtpp -73.4 147.1 44.6 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.657 -1.277 . . . . 0.0 111.305 -172.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.38 21.5 78.6 Favored Glycine 0 N--CA 1.497 2.753 0 O-C-N 121.515 -0.741 . . . . 0.0 112.914 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.2 mm -86.15 -47.27 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' CZ ' HG12 ' A' ' 95' ' ' VAL . 74.8 m-85 -110.04 138.63 46.15 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.163 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -136.59 142.82 43.35 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 tt -111.45 162.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.451 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 19.4 t-20 -97.18 109.89 22.55 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.56 -41.89 0.32 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 122.804 0.442 . . . . 0.0 111.784 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -92.86 -48.04 6.74 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.032 -1.043 . . . . 0.0 111.61 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.1 p -79.98 -27.97 39.58 Favored 'General case' 0 C--N 1.281 -2.401 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 2.85 90.35 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 12.3 m -63.06 122.95 17.33 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.67 -0.9 . . . . 0.0 109.278 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' GLY . 1.6 t -94.88 123.49 47.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -126.7 153.35 45.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.211 -0.931 . . . . 0.0 109.792 177.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 p -104.68 146.12 12.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.0 p -96.25 -7.39 35.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.667 -0.646 . . . . 0.0 112.061 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -154.5 172.06 18.4 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.462 -1.399 . . . . 0.0 110.685 -175.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.443 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 13.9 t -65.16 137.89 57.91 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.1 mt -98.85 149.76 22.58 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -126.3 142.36 51.56 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -91.93 9.24 33.84 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.81 -30.53 20.15 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.5 t -101.18 -47.08 11.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.411 HD11 ' CE2' ' A' ' 73' ' ' TYR . 2.0 mt -134.22 139.96 47.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.293 -0.879 . . . . 0.0 109.121 -178.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.49 -23.98 15.33 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.12 138.1 6.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.26 -0.9 . . . . 0.0 109.084 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.426 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 36.4 m-85 -99.0 128.09 45.06 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -90.79 97.56 11.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.71 170.34 9.65 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 86.2 m-85 -138.88 128.78 25.07 Favored 'General case' 0 C--N 1.268 -2.946 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.4 139.52 33.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 O-C-N 122.043 -0.411 . . . . 0.0 110.045 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -129.33 137.5 51.03 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -85.17 134.37 34.17 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 170.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.507 ' HA ' HD23 ' A' ' 87' ' ' LEU . 15.6 p -128.06 151.21 49.45 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -176.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -116.15 172.2 7.33 Favored 'General case' 0 N--CA 1.508 2.446 0 CA-C-N 118.808 0.731 . . . . 0.0 109.815 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 81' ' ' ASP . 34.8 m -29.3 -40.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.46 -8.6 59.61 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.72 -1.237 . . . . 0.0 110.195 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.61 13.14 78.9 Favored Glycine 0 C--N 1.287 -2.169 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 80' ' ' THR . 5.2 mttp -74.96 160.2 30.87 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 88' ' ' GLU . 16.6 m -96.01 116.53 29.08 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -96.02 -11.07 27.01 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 1.1 tp10 -154.54 154.56 33.3 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.41 -162.24 49.23 Favored Glycine 0 C--N 1.284 -2.316 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.35 105.58 0.24 Allowed 'Cis proline' 0 N--CA 1.495 1.586 0 C-N-CA 123.305 -1.54 . . . . 0.0 111.458 -0.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 20.4 m -73.48 159.09 85.54 Favored Pre-proline 0 C--N 1.286 -2.18 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.37 152.01 3.65 Favored 'Trans proline' 0 C--N 1.283 -2.895 0 C-N-CA 121.359 1.373 . . . . 0.0 111.438 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 tp -139.02 128.51 24.41 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -102.41 111.57 23.92 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.636 -0.665 . . . . 0.0 109.525 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.454 HG12 ' CZ ' ' A' ' 50' ' ' PHE . 4.9 t -93.43 95.34 5.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 174.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 96' ' ' ILE . 1.1 mt -79.96 130.66 35.66 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 t -92.06 122.14 43.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 12.5 pt -112.49 171.52 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.345 -0.847 . . . . 0.0 110.661 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--N 1.296 -1.724 0 O-C-N 121.151 -0.968 . . . . 0.0 108.545 -178.611 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.447 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.438 ' CG2' HG22 ' A' ' 91' ' ' VAL . 7.3 mt -66.66 122.19 17.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.436 -0.79 . . . . 0.0 109.317 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.85 133.77 48.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -148.84 167.59 3.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -176.667 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.482 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.9 OUTLIER -152.04 146.83 18.95 Favored Pre-proline 0 C--N 1.272 -2.776 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 176.516 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -48.69 131.77 24.79 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.257 1.305 . . . . 0.0 110.157 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 29.0 mt -99.79 121.56 50.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.532 ' HB3' ' CG2' ' A' ' 98' ' ' ILE . 5.9 mp -105.98 107.71 18.85 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.1 mt -113.18 140.94 24.88 Favored Pre-proline 0 C--N 1.275 -2.651 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.498 ' HB2' ' NE2' ' A' ' 100' ' ' GLN . 60.4 Cg_endo -75.53 134.65 17.19 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.576 1.517 . . . . 0.0 111.272 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.5 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -67.82 -172.68 0.29 Allowed 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.914 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.523 ' C ' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER 55.83 -9.22 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 175.648 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.452 ' H ' ' C ' ' A' ' 11' ' ' GLU . 5.7 pt20 -55.66 132.96 50.27 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.4 -179.65 3.98 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.834 -1.166 . . . . 0.0 111.167 -175.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.558 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -54.29 171.76 0.27 Allowed Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.649 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 1.7 Cg_endo -78.71 121.13 7.76 Favored 'Cis proline' 0 N--CA 1.493 1.47 0 C-N-CA 123.793 -1.336 . . . . 0.0 114.012 0.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.452 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 20.4 m-85 -110.62 170.49 5.24 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.452 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 13.9 Cg_exo -69.7 167.63 70.15 Favored 'Cis proline' 0 N--CA 1.507 2.323 0 CA-C-N 120.172 1.097 . . . . 0.0 112.798 0.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -148.94 142.16 25.04 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 9.3 t0 -67.77 136.03 53.57 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.84 6.06 3.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.11 -175.0 45.48 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.809 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.58 ' HZ1' ' CB ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -145.17 121.72 11.07 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.925 -1.338 . . . . 0.0 110.36 -178.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.2 t -89.88 131.45 37.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 170.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.5 t -132.0 149.75 32.99 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -105.7 138.79 41.31 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.936 -1.105 . . . . 0.0 108.704 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -26.54 63.4 Favored 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.299 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.454 ' OD1' ' NH1' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -147.71 -13.77 0.38 Allowed 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.662 -1.274 . . . . 0.0 112.264 -172.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -55.27 145.76 44.91 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.665 -1.272 . . . . 0.0 111.307 -175.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -35.38 133.68 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 124.281 3.321 . . . . 0.0 112.732 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -55.14 -19.89 8.77 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.249 -0.907 . . . . 0.0 109.462 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.29 -16.27 46.89 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.0 136.06 57.63 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.857 -174.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 48.6 mttm -115.76 146.66 41.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 54' ' ' GLU . 89.6 m-85 -93.84 144.2 25.64 Favored 'General case' 0 C--N 1.282 -2.359 0 O-C-N 121.233 -0.917 . . . . 0.0 112.84 -172.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.34 150.99 22.43 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.437 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 21.0 tp -125.86 140.15 52.9 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 172.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.27 171.11 17.48 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 75' ' ' LEU . . . 117.0 169.85 15.2 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.315 -1.422 . . . . 0.0 111.594 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 45' ' ' GLU . 6.5 mtpp -60.05 111.13 1.39 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 120.21 -18.21 9.63 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.7 t -116.68 -97.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.655 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 3.4 t70 -93.52 -8.04 42.53 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -107.02 148.2 29.0 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 174.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 1.5 mp0 -55.85 133.55 73.05 Favored Pre-proline 0 C--N 1.264 -3.152 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 24.8 Cg_endo -70.77 127.54 12.0 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 C-N-CA 123.403 -1.499 . . . . 0.0 110.045 -0.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.655 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 15.3 mtpp -82.12 150.41 27.48 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 120.953 -1.092 . . . . 0.0 111.321 -173.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.403 ' O ' ' NH2' ' A' ' 63' ' ' ARG . . . 62.81 38.95 97.35 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.894 -0.504 . . . . 0.0 111.899 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.481 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 5.9 mm -100.27 -48.13 11.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -114.48 143.02 45.63 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.688 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 133.78 26.19 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.437 ' CG2' ' HB2' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -95.85 150.78 4.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.472 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 14.5 t-20 -79.82 105.71 11.31 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.434 ' O ' ' N ' ' A' ' 35' ' ' PHE . 2.0 mt-10 -42.81 -36.81 1.59 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.454 -175.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -92.76 -43.73 8.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.206 -0.933 . . . . 0.0 111.562 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.5 p -85.07 -25.35 27.64 Favored 'General case' 0 C--N 1.282 -2.361 0 O-C-N 121.027 -1.045 . . . . 0.0 108.7 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.06 9.51 86.1 Favored Glycine 0 C--N 1.287 -2.154 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.58 ' CB ' ' HZ1' ' A' ' 23' ' ' LYS . 70.0 m -65.8 120.55 13.23 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.395 -1.062 . . . . 0.0 109.472 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.99 121.78 36.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.25 148.95 43.59 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.482 -0.761 . . . . 0.0 110.139 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.442 HG12 ' CE1' ' A' ' 17' ' ' PHE . 11.9 p -98.41 149.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.576 ' OG1' ' NH1' ' A' ' 63' ' ' ARG . 4.3 p -105.02 -15.52 15.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.481 -0.762 . . . . 0.0 112.002 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.576 ' NH1' ' OG1' ' A' ' 62' ' ' THR . 0.1 OUTLIER -157.41 -159.33 0.83 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.871 -1.143 . . . . 0.0 108.506 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.427 ' N ' ' HG3' ' A' ' 63' ' ' ARG . 4.8 t -80.8 179.42 7.82 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.168 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 mt -142.21 167.64 21.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -147.76 139.19 23.72 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.558 ' NH1' ' O ' ' A' ' 104' ' ' ARG . 16.7 ttm105 -76.06 -10.72 59.64 Favored 'General case' 0 C--N 1.282 -2.329 0 O-C-N 122.105 -0.372 . . . . 0.0 111.645 -174.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -90.12 -20.08 23.54 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.703 -1.248 . . . . 0.0 108.964 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.04 -53.26 13.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.408 HG22 ' CD1' ' A' ' 73' ' ' TYR . 1.1 mt -148.36 134.21 11.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -89.09 -28.29 20.19 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.43 115.08 3.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.47 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 62.3 m-85 -81.78 111.91 18.45 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 174.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.39 95.53 9.72 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 -178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.41 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 0.4 OUTLIER -90.26 170.6 10.14 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 122.25 1.024 . . . . 0.0 108.424 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -134.44 131.96 38.75 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.26 150.14 14.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -176.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -142.12 142.13 32.74 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.72 129.35 35.56 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.546 ' HA ' HD23 ' A' ' 87' ' ' LEU . 11.3 p -123.19 150.37 43.44 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -92.59 170.09 10.01 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.22 -0.992 . . . . 0.0 108.564 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -14.98 4.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.19 -5.08 53.41 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.98 -4.91 60.12 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -75.19 150.6 38.64 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.332 -1.099 . . . . 0.0 108.615 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.55 119.64 30.98 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -94.41 -30.62 14.37 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.467 ' OE1' ' NE ' ' A' ' 29' ' ' ARG . 1.5 tp10 -135.28 170.13 16.4 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 -179.17 51.72 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.56 127.03 7.7 Favored 'Cis proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.158 -1.601 . . . . 0.0 112.609 0.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.438 HG22 ' CG2' ' A' ' 2' ' ' ILE . 2.1 m -105.5 161.92 21.3 Favored Pre-proline 0 C--N 1.28 -2.424 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -94.44 151.17 1.96 Allowed 'Trans proline' 0 C--N 1.288 -2.637 0 C-N-CA 122.238 1.959 . . . . 0.0 112.527 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.2 tp -141.79 129.76 21.93 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -110.88 130.18 55.65 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 120.926 -1.109 . . . . 0.0 110.04 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.47 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 46.7 t -111.42 111.66 37.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 174.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.54 142.44 13.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.236 -0.915 . . . . 0.0 109.073 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.42 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 1.5 t -91.91 96.08 5.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.532 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 5.7 pt -82.21 172.01 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 O-C-N 120.893 -1.13 . . . . 0.0 110.125 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.417 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 3.1 m-20 -97.59 174.97 6.38 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.5 ' NE2' ' O ' ' A' ' 11' ' ' GLU . 0.2 OUTLIER -135.75 105.91 6.33 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.429 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 0.4 OUTLIER 53.63 47.08 24.65 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -173.59 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.27 77.89 0.11 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.79 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.402 ' CG ' HD21 ' A' ' 12' ' ' ASN . 4.4 t30 -68.53 -51.8 38.97 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.558 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 1.2 mtp85 -157.69 82.88 2.92 Favored Pre-proline 0 C--N 1.281 -2.377 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo . . . . . 0 C--O 1.192 -1.798 0 C-N-CA 123.411 2.741 . . . . 0.0 113.239 -178.626 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.4 OUTLIER . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.464 HD13 ' N ' ' A' ' 79' ' ' THR . 11.4 mt -68.77 113.86 4.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.162 -0.961 . . . . 0.0 110.363 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.21 111.2 29.15 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 174.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.479 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -127.84 164.21 29.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.479 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -142.63 152.29 59.39 Favored Pre-proline 0 C--N 1.275 -2.652 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 175.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -49.51 136.67 33.05 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.681 1.588 . . . . 0.0 111.108 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 96' ' ' ILE . 21.9 mt -102.55 110.08 28.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.491 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.4 mp -98.83 96.87 8.17 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.413 ' CG2' ' NE2' ' A' ' 13' ' ' GLN . 15.6 mt -103.75 133.56 20.2 Favored Pre-proline 0 C--N 1.275 -2.673 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.6 Cg_endo -70.65 120.65 7.26 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.318 1.345 . . . . 0.0 109.683 175.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.42 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.0 OUTLIER -43.1 -71.9 0.07 Allowed 'General case' 0 N--CA 1.522 3.155 0 O-C-N 121.241 -0.912 . . . . 0.0 111.943 -174.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.4 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 34.2 p30 -62.47 42.92 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.519 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 22.3 mt-30 -77.61 140.77 39.7 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.504 ' CD ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -117.77 177.35 4.8 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.416 -0.803 . . . . 0.0 110.038 -176.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -49.02 167.88 0.2 Allowed Pre-proline 0 C--N 1.292 -1.895 0 C-N-CA 123.461 0.704 . . . . 0.0 109.882 178.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.531 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 4.8 Cg_exo -77.16 121.64 8.01 Favored 'Cis proline' 0 C--N 1.311 -1.417 0 C-N-CA 123.714 -1.369 . . . . 0.0 113.158 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.416 ' CE2' HG12 ' A' ' 61' ' ' VAL . 26.4 m-85 -102.76 165.88 12.92 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 175.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.22 154.48 85.23 Favored 'Cis proline' 0 N--CA 1.496 1.638 0 C-N-CA 124.184 -1.174 . . . . 0.0 110.516 -1.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.526 ' NH2' ' O ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -136.56 145.21 44.73 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.205 -0.935 . . . . 0.0 110.136 -178.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.526 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 5.5 t70 -65.87 142.3 57.96 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.8 m -137.44 1.77 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.2 176.35 39.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -146.27 125.74 13.21 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.669 -1.489 . . . . 0.0 110.185 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.4 t -87.6 143.48 11.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 172.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.6 t -136.73 160.98 36.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.51 ' O ' ' NH2' ' A' ' 29' ' ' ARG . 10.2 t70 -120.54 137.73 54.23 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.081 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.06 -25.46 4.97 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.431 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 39.5 t0 -148.94 89.95 1.72 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.341 -0.85 . . . . 0.0 108.766 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.51 ' NH2' ' O ' ' A' ' 26' ' ' ASP . 1.0 OUTLIER -77.78 111.44 17.83 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.346 -0.846 . . . . 0.0 108.781 178.019 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HG2' ' HG ' ' A' ' 87' ' ' LEU . 62.3 Cg_exo -44.16 146.26 1.9 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.707 1.604 . . . . 0.0 111.621 178.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.2 mp0 -25.0 -56.6 0.05 Allowed 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 124.243 1.017 . . . . 0.0 112.505 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -118.32 32.74 5.98 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.212 -0.93 . . . . 0.0 108.993 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p -64.35 148.8 49.55 Favored 'General case' 0 C--N 1.286 -2.155 0 O-C-N 121.1 -1.0 . . . . 0.0 110.337 -176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -113.86 169.39 9.03 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -115.42 126.3 54.2 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.8 mmt-85 -98.68 119.11 36.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 42.4 tp -103.73 139.71 38.6 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.89 170.29 20.72 Favored 'General case' 0 C--N 1.279 -2.47 0 O-C-N 121.262 -0.899 . . . . 0.0 108.613 -176.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.88 169.99 15.3 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.433 ' NZ ' ' HG3' ' A' ' 45' ' ' GLU . 11.1 mtpp -54.82 115.31 2.11 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 120.8 -21.64 8.36 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.9 t -119.78 -88.07 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.39 -1.065 . . . . 0.0 109.122 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.476 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 15.8 p-10 -93.14 -14.17 27.54 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.419 HE21 ' CG ' ' A' ' 43' ' ' ASP . 11.1 mt-30 -113.9 160.76 18.43 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HG3' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -61.69 133.84 93.67 Favored Pre-proline 0 C--N 1.286 -2.184 0 O-C-N 122.152 -0.343 . . . . 0.0 110.722 -174.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.471 ' HB2' ' CG1' ' A' ' 49' ' ' ILE . 3.2 Cg_exo -76.13 123.76 9.68 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.173 -1.595 . . . . 0.0 109.296 -1.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 27.2 mttp -71.01 154.0 42.16 Favored 'General case' 0 C--N 1.282 -2.346 0 O-C-N 120.923 -1.11 . . . . 0.0 110.894 -174.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.19 21.31 53.11 Favored Glycine 0 N--CA 1.489 2.215 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.201 172.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.471 ' CG1' ' HB2' ' A' ' 46' ' ' PRO . 26.6 mm -73.55 -43.59 54.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -116.7 141.38 48.28 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.428 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.83 129.16 24.0 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -96.38 149.84 4.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 O-C-N 121.643 -0.661 . . . . 0.0 110.05 -174.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.447 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 14.1 t-20 -79.76 112.6 17.18 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -53.28 -31.11 42.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.847 -0.533 . . . . 0.0 111.541 -176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.447 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -97.22 -23.39 16.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 112.601 -174.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.422 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 19.5 p -112.29 -27.5 8.29 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.82 5.43 86.38 Favored Glycine 0 C--N 1.283 -2.389 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 t -60.67 125.7 24.69 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.6 t -86.5 118.76 33.39 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 176.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.84 140.65 45.11 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.411 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.416 HG12 ' CE2' ' A' ' 17' ' ' PHE . 7.7 p -99.77 145.17 11.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.4 p -97.51 -14.99 20.77 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.511 -0.743 . . . . 0.0 111.46 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.496 ' NH2' ' OH ' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -153.03 170.6 20.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.847 -1.158 . . . . 0.0 110.938 -177.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 t -66.32 140.25 58.09 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.6 mt -92.44 170.04 10.08 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.63 -1.294 . . . . 0.0 111.106 -173.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.18 102.55 6.99 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.554 ' CZ ' ' HB3' ' A' ' 67' ' ' ARG . 4.3 ttm105 -66.35 -18.74 65.54 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 1.2 mp0 -76.94 -26.18 53.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.858 -1.151 . . . . 0.0 108.378 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.8 t -97.18 -52.99 8.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -125.97 112.15 29.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.45 -33.66 54.7 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.4 p -149.42 131.89 6.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.496 ' OH ' ' NH2' ' A' ' 63' ' ' ARG . 61.0 m-85 -87.8 120.27 28.95 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -88.48 81.23 7.21 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.19 170.46 16.09 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.128 0.966 . . . . 0.0 109.015 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.9 m-85 -137.13 130.05 30.6 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.56 160.52 13.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.277 0.56 . . . . 0.0 110.143 -175.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -147.4 143.01 27.65 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.464 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -88.72 123.09 32.82 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 173.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -109.0 153.38 23.68 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-O 121.582 0.706 . . . . 0.0 111.677 -172.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 3.0 t70 -96.48 170.1 9.45 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 174.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.501 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -52.79 -27.16 11.96 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -79.69 2.05 24.14 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.484 -0.76 . . . . 0.0 109.511 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.82 19.41 75.1 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -91.3 154.92 18.91 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.2 m -84.13 124.35 31.05 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.854 0.835 . . . . 0.0 111.012 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.605 ' N ' ' CD2' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -86.11 -45.63 11.2 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 175.289 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -142.41 151.53 41.91 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.44 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 105.39 177.34 24.18 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 107.929 -2.068 . . . . 0.0 107.929 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.32 109.97 0.48 Allowed 'Cis proline' 0 N--CA 1.495 1.605 0 CA-C-N 118.949 1.374 . . . . 0.0 113.065 0.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.44 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 2.5 m -91.47 161.44 34.46 Favored Pre-proline 0 C--N 1.281 -2.374 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.99 155.37 3.92 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 C-N-CA 121.762 1.641 . . . . 0.0 111.726 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 tp -142.85 125.64 16.03 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -109.38 112.09 24.01 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 121.772 -0.58 . . . . 0.0 110.033 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 56.7 t -102.39 97.74 5.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 7' ' ' ILE . 2.8 mp -81.13 132.94 30.39 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 O-C-N 121.653 -0.654 . . . . 0.0 109.456 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 31.8 t -88.22 92.67 3.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 4.9 pt -80.35 171.04 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 O-C-N 121.248 -0.908 . . . . 0.0 109.112 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.79 168.09 9.29 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -148.4 154.16 39.53 Favored 'General case' 0 C--N 1.273 -2.751 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -74.82 63.47 1.18 Allowed 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.585 ' C ' ' H ' ' A' ' 104' ' ' ARG . 57.5 t0 -60.12 165.55 3.34 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 104' ' ' ARG . 1.1 m-80 -68.84 31.55 0.03 OUTLIER 'General case' 0 C--N 1.244 -3.99 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.585 ' H ' ' C ' ' A' ' 102' ' ' ASP . 2.9 mtm105 29.58 58.02 0.77 Allowed Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 122.956 0.502 . . . . 0.0 110.7 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 104' ' ' ARG . 6.2 Cg_exo . . . . . 0 N--CA 1.492 1.428 0 C-N-CA 122.993 2.462 . . . . 0.0 111.397 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.542 ' H3 ' ' CD ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.192 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.444 ' CG2' HG22 ' A' ' 91' ' ' VAL . 4.7 mt -62.57 142.15 17.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 121.449 0.643 . . . . 0.0 109.771 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.38 106.15 15.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -127.8 158.7 39.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.434 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -124.42 151.05 66.16 Favored Pre-proline 0 C--N 1.281 -2.409 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.18 141.72 94.43 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 121.475 1.45 . . . . 0.0 109.155 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 96' ' ' ILE . 24.5 mt -107.96 113.04 42.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 O-C-N 121.412 -0.805 . . . . 0.0 109.865 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.517 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.94 94.2 9.54 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.4 mt -101.25 127.42 31.83 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.8 Cg_endo -70.55 128.11 14.86 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 N-CA-C 109.493 -1.003 . . . . 0.0 109.493 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.497 ' CD ' ' HE ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -59.75 -178.78 0.08 Allowed 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 119.501 -0.879 . . . . 0.0 109.995 -176.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.12 14.86 9.66 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.65 -0.657 . . . . 0.0 111.724 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -67.05 137.06 56.15 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.54 ' CD ' ' N ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -114.4 -178.58 3.4 Favored 'General case' 0 C--N 1.281 -2.376 0 O-C-N 120.881 -1.137 . . . . 0.0 110.676 -175.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 13.8 mp0 -59.3 169.0 1.39 Allowed Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.524 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 30.5 Cg_endo -70.91 114.84 2.48 Favored 'Cis proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.621 -1.408 . . . . 0.0 114.475 0.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -102.92 164.33 15.77 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -68.3 156.03 88.49 Favored 'Cis proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.864 -1.307 . . . . 0.0 111.092 -0.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 60' ' ' SER . 1.4 tmt_? -134.26 144.7 48.53 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -70.57 137.73 50.3 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.6 m -133.93 2.7 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.57 179.2 48.36 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.506 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 17.3 mttp -146.52 133.69 20.49 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.007 -1.29 . . . . 0.0 110.762 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.454 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 20.0 t -108.23 131.0 59.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -133.96 170.05 20.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.751 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 27' ' ' SER . 0.9 OUTLIER -119.68 154.62 33.79 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.8 -1.188 . . . . 0.0 109.184 177.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.453 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 8.2 m -58.33 -48.21 81.28 Favored 'General case' 0 C--N 1.267 -3.011 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.026 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -126.0 56.78 1.4 Allowed 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.265 -0.897 . . . . 0.0 110.591 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.545 ' H ' ' NE ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -44.89 113.77 1.88 Allowed Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.584 -0.698 . . . . 0.0 110.472 -177.541 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.51 ' O ' ' C ' ' A' ' 31' ' ' GLU . 79.0 Cg_exo -43.56 144.82 1.94 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.261 1.974 . . . . 0.0 109.821 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -24.35 -70.84 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.87 0 CA-C-N 118.241 0.473 . . . . 0.0 110.825 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.518 ' NH2' ' O ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -114.58 63.88 0.67 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.938 177.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.518 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -76.86 157.87 31.16 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -121.4 138.56 54.22 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -93.19 124.34 37.09 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 121.03 -1.044 . . . . 0.0 109.131 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.4 mtm-85 -99.29 148.07 24.53 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.1 tp -131.38 128.82 40.39 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -140.47 170.36 15.94 Favored 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.558 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 120.87 166.18 12.95 Favored Glycine 0 C--N 1.282 -2.465 0 O-C-N 120.815 -1.178 . . . . 0.0 110.259 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 111.48 0.54 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 124.08 -19.14 7.35 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 23.0 t -120.59 -92.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.289 -1.124 . . . . 0.0 108.976 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.47 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 2.0 t0 -94.13 -10.78 32.15 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.558 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 17.4 mp0 -109.33 159.19 17.18 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -66.59 132.67 94.16 Favored Pre-proline 0 C--N 1.263 -3.172 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.091 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.441 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -74.12 120.12 6.18 Favored 'Cis proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.39 -1.504 . . . . 0.0 110.759 -0.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 43' ' ' ASP . 8.7 mttm -70.86 154.37 41.89 Favored 'General case' 0 C--N 1.289 -2.057 0 O-C-N 121.106 -0.996 . . . . 0.0 111.023 -175.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.78 30.13 74.15 Favored Glycine 0 N--CA 1.495 2.633 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.467 171.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLY . 9.4 mm -90.6 -45.95 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 119.007 1.404 . . . . 0.0 107.647 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -114.34 151.91 32.26 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.271 0.558 . . . . 0.0 110.198 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.7 ptm85 -144.29 137.13 27.02 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.451 HG23 HD11 ' A' ' 52' ' ' ILE . 13.6 tt -105.44 159.73 5.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.407 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 17.6 t-20 -90.45 132.72 35.49 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -31.21 71.92 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.832 -176.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -97.5 -51.88 3.98 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.676 0.75 . . . . 0.0 110.541 -174.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.438 ' HG1' ' CB ' ' A' ' 58' ' ' SER . 7.8 p -80.43 -21.39 42.21 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 24' ' ' VAL . . . 68.75 14.06 66.99 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.506 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 37.0 m -64.07 120.91 12.95 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.173 -1.192 . . . . 0.0 108.849 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.95 122.01 37.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -122.03 154.91 36.65 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.645 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.05 149.8 6.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 176.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 63.5 p -98.29 -16.51 19.35 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.613 -0.68 . . . . 0.0 110.226 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.63 178.49 7.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.416 -0.802 . . . . 0.0 109.973 -174.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.7 t -76.62 139.41 40.61 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.0 mt -98.96 156.23 17.01 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.393 -0.817 . . . . 0.0 109.516 -178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -135.67 128.47 31.09 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.497 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 12.9 mtm180 -64.64 -5.84 6.49 Favored 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.19 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.57 -21.61 52.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.105 -0.997 . . . . 0.0 108.516 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.25 -55.79 5.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.42 HD11 ' CE1' ' A' ' 73' ' ' TYR . 1.2 mt -141.84 136.63 30.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 121.416 -0.803 . . . . 0.0 108.935 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.28 -26.25 25.06 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.3 p -156.35 137.8 5.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.427 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 71.8 m-85 -99.25 116.86 32.41 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.473 HE22 ' CG ' ' A' ' 94' ' ' GLU . 15.1 tp60 -85.86 79.6 9.2 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.65 170.78 16.04 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.435 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 34.4 m-85 -137.35 141.15 41.81 Favored 'General case' 0 C--N 1.256 -3.457 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.37 148.51 18.05 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 O-C-N 121.687 -0.633 . . . . 0.0 109.399 -176.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 86' ' ' THR . 0.5 OUTLIER -134.39 135.27 42.51 Favored 'General case' 0 C--N 1.28 -2.455 0 O-C-N 121.195 -0.94 . . . . 0.0 108.859 176.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.51 132.14 34.13 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 174.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 17.7 p -127.0 164.26 21.89 Favored 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.986 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 2.1 t70 -97.54 170.22 9.19 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.497 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 0.9 OUTLIER -46.43 -33.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-O 121.457 0.646 . . . . 0.0 109.874 178.848 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.53 2.63 21.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.558 -0.714 . . . . 0.0 109.742 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.23 81.39 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 80' ' ' THR . 8.3 mtpp -74.49 150.11 40.0 Favored 'General case' 0 CA--C 1.474 -1.943 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.437 ' CG2' ' HB3' ' A' ' 78' ' ' GLU . 1.2 m -99.6 118.01 35.22 Favored 'General case' 0 C--N 1.272 -2.768 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.132 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.606 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.68 -24.11 17.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.542 ' CD ' ' H3 ' ' A' ' 1' ' ' SER . 0.9 OUTLIER -148.38 158.62 44.21 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 75.09 -175.19 51.06 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -57.94 108.74 0.2 OUTLIER 'Cis proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.707 -1.372 . . . . 0.0 113.795 0.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.444 HG22 ' CG2' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -84.85 167.48 26.23 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 172.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -94.47 156.43 2.0 Favored 'Trans proline' 0 C--N 1.286 -2.763 0 C-N-CA 121.959 1.773 . . . . 0.0 112.791 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 tp -142.89 131.28 22.22 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.473 ' CG ' HE22 ' A' ' 74' ' ' GLN . 13.8 mt-10 -106.11 109.76 21.8 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.508 -0.745 . . . . 0.0 109.432 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 89.8 t -98.06 96.67 5.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.402 ' N ' ' O ' ' A' ' 7' ' ' ILE . 4.7 mp -79.79 128.29 38.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.26 105.09 15.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.445 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.9 pt -93.3 171.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.51 158.63 15.37 Favored 'General case' 0 C--N 1.282 -2.337 0 O-C-N 120.984 -1.072 . . . . 0.0 108.467 -177.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' OE1' ' NH1' ' A' ' 14' ' ' ARG . 13.8 mt-30 -74.89 68.63 1.79 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 4.9 p30 -72.0 -71.72 0.26 Allowed 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.469 ' CG ' ' H ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -96.65 -46.29 6.36 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.144 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.11 23.95 13.34 Favored 'General case' 0 N--CA 1.508 2.451 0 CA-C-O 121.26 0.552 . . . . 0.0 110.046 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.469 ' H ' ' CG ' ' A' ' 102' ' ' ASP . 13.6 mmm180 39.43 71.29 1.19 Allowed Pre-proline 0 N--CA 1.497 1.92 0 CA-C-O 121.374 0.607 . . . . 0.0 110.993 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 0 C--O 1.187 -2.042 0 C-N-CA 123.474 2.783 . . . . 0.0 110.68 178.077 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.483 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.438 HD13 ' N ' ' A' ' 79' ' ' THR . 11.2 mt -65.24 131.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 C-N-CA 119.221 -0.991 . . . . 0.0 109.214 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.95 128.64 73.17 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.45 159.1 22.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -139.59 144.26 38.71 Favored Pre-proline 0 C--N 1.281 -2.37 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -51.08 135.2 44.44 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.446 1.431 . . . . 0.0 109.88 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 22.7 mt -103.67 115.56 45.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.525 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.42 105.59 17.92 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.1 mt -114.02 123.28 33.0 Favored Pre-proline 0 C--N 1.287 -2.115 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 27.2 Cg_endo -66.83 142.8 64.44 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 120.748 0.965 . . . . 0.0 112.434 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.402 ' HG3' ' HA ' ' A' ' 99' ' ' ASP . 0.6 OUTLIER -67.16 -178.55 0.82 Allowed 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 122.278 1.037 . . . . 0.0 112.307 -176.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.9 m-20 47.25 18.01 0.08 Allowed 'General case' 0 N--CA 1.514 2.762 0 C-N-CA 124.177 0.991 . . . . 0.0 113.341 174.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -76.64 122.84 25.23 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.28 -163.48 1.02 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.354 -0.841 . . . . 0.0 110.428 -175.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.533 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -46.66 165.57 0.19 Allowed Pre-proline 0 N--CA 1.5 2.062 0 CA-C-O 121.377 0.608 . . . . 0.0 111.409 -177.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.533 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 55.3 Cg_endo -86.92 120.9 5.78 Favored 'Cis proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.442 -1.483 . . . . 0.0 113.613 0.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.413 ' CD1' ' HB2' ' A' ' 19' ' ' ARG . 27.4 m-85 -115.27 163.61 19.64 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 19.7 Cg_exo -67.07 162.63 74.65 Favored 'Cis proline' 0 N--CA 1.504 2.136 0 C-N-CA 124.553 -1.019 . . . . 0.0 113.077 -0.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -153.1 149.23 27.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.772 -0.58 . . . . 0.0 109.517 -178.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.476 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -71.39 139.68 49.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.893 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.75 -3.48 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.98 170.72 42.63 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.52 ' NZ ' ' O ' ' A' ' 56' ' ' THR . 22.3 tttm -131.24 121.11 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -1.122 . . . . 0.0 109.906 -178.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.85 147.63 5.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 171.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.6 t -142.41 170.07 12.24 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.602 ' O ' ' NE ' ' A' ' 29' ' ' ARG . 34.5 t0 -143.27 78.18 1.59 Allowed 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -33.31 -46.6 0.18 Allowed 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.035 -172.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.01 66.32 4.97 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.731 0.777 . . . . 0.0 110.152 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.602 ' NE ' ' O ' ' A' ' 26' ' ' ASP . 1.3 mtm180 -77.69 133.15 66.99 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' GLU . 19.1 Cg_exo -59.39 170.46 3.17 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 N-CA-C 108.917 -1.224 . . . . 0.0 108.917 171.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -23.77 -90.54 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.435 ' NE ' HG13 ' A' ' 82' ' ' VAL . 15.1 mtm180 -109.86 27.56 9.46 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.712 -1.242 . . . . 0.0 110.016 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.45 146.38 16.15 Favored 'General case' 0 C--N 1.283 -2.303 0 O-C-N 121.683 -0.636 . . . . 0.0 111.128 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -127.15 167.37 16.12 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 54' ' ' GLU . 87.9 m-85 -98.41 142.63 29.8 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.944 -1.098 . . . . 0.0 112.123 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.599 ' NH2' ' O ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER -110.05 126.56 54.12 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 172.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 37.5 tp -107.83 142.1 38.41 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 p -151.73 171.58 17.46 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 75' ' ' LEU . . . 121.3 172.73 14.47 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 120.843 -1.161 . . . . 0.0 111.418 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.415 ' CA ' ' HB2' ' A' ' 44' ' ' GLN . 24.9 mtpp -61.19 111.69 1.82 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 121.49 -22.05 7.92 Favored Glycine 0 C--N 1.279 -2.632 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.1 t -118.91 -85.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -101.14 -14.58 17.69 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.444 ' CD ' ' HA3' ' A' ' 39' ' ' GLY . 27.7 mt-30 -104.16 152.75 21.76 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 173.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.521 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 7.2 mm-40 -66.77 139.5 95.83 Favored Pre-proline 0 C--N 1.285 -2.206 0 O-C-N 121.85 -0.531 . . . . 0.0 110.373 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.462 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 37.7 Cg_endo -68.94 119.62 3.77 Favored 'Cis proline' 0 N--CA 1.509 2.41 0 C-N-CA 123.592 -1.42 . . . . 0.0 111.327 -1.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.521 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 11.2 mtpp -76.96 162.92 27.19 Favored 'General case' 0 C--N 1.288 -2.104 0 O-C-N 120.768 -1.207 . . . . 0.0 110.696 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.04 19.11 50.19 Favored Glycine 0 N--CA 1.496 2.674 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.939 173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.7 mm -83.09 -48.38 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 119.487 1.643 . . . . 0.0 107.591 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.437 ' CZ ' HG12 ' A' ' 95' ' ' VAL . 52.1 m-85 -111.88 145.74 38.97 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.275 0.56 . . . . 0.0 110.646 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -148.35 135.49 20.26 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 tt -102.96 157.01 4.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -176.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.43 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 11.6 t-20 -80.91 115.13 20.23 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' PHE . 1.7 mp0 -50.5 -40.84 52.46 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 122.061 -0.399 . . . . 0.0 111.496 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -90.43 -44.58 9.53 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.604 -1.31 . . . . 0.0 111.512 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.52 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 8.8 p -80.78 -28.48 36.36 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 121.226 -0.921 . . . . 0.0 109.417 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.6 10.49 84.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 m -67.38 123.44 20.39 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.388 -1.066 . . . . 0.0 108.224 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 t -86.58 124.48 40.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -121.09 150.9 40.51 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 9.8 p -110.49 148.27 14.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.9 p -97.29 -28.12 14.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.495 -0.753 . . . . 0.0 110.926 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.502 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -135.26 167.54 20.83 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.094 -1.004 . . . . 0.0 110.232 -177.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.502 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 13.3 t -57.37 156.5 7.67 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.448 ' O ' ' N ' ' A' ' 12' ' ' ASN . 21.6 mt -110.88 140.94 44.91 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.951 -1.093 . . . . 0.0 108.683 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.47 ' C ' ' H ' ' A' ' 68' ' ' GLU . 2.7 p-10 -131.4 122.97 27.22 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.536 ' NH1' ' O ' ' A' ' 97' ' ' VAL . 1.4 mtp85 -75.12 10.05 1.7 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.47 ' H ' ' C ' ' A' ' 66' ' ' ASP . 52.1 mt-10 -74.11 -24.19 59.42 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.1 t -126.18 -82.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -91.16 127.67 43.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 121.12 -0.988 . . . . 0.0 108.987 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.59 -25.74 19.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.5 p -152.84 121.03 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.353 -0.842 . . . . 0.0 108.9 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.417 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 79.7 m-85 -80.11 120.66 24.55 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -86.79 94.19 9.47 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.471 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -92.57 170.65 9.57 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.913 0.863 . . . . 0.0 109.198 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.484 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.0 m-85 -140.78 131.24 25.3 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.37 146.41 18.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 O-C-N 122.055 -0.403 . . . . 0.0 110.517 -174.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.409 ' CD ' HH11 ' A' ' 36' ' ' ARG . 45.3 mt-10 -132.14 141.65 49.21 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 120.939 -1.101 . . . . 0.0 109.143 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.438 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -86.38 135.43 33.51 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 171.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.526 ' HA ' HD23 ' A' ' 87' ' ' LEU . 1.1 p -127.14 152.36 47.44 Favored 'General case' 0 C--N 1.286 -2.179 0 O-C-N 121.481 -0.762 . . . . 0.0 111.251 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 46.1 p-10 -89.28 171.99 9.37 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.104 0.954 . . . . 0.0 109.614 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.435 HG13 ' NE ' ' A' ' 32' ' ' ARG . 4.1 m -54.02 -9.59 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.101 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -100.57 -34.96 9.69 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.122 . . . . 0.0 108.423 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' NH2' ' A' ' 36' ' ' ARG . . . 118.57 23.44 3.41 Favored Glycine 0 C--N 1.287 -2.156 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -95.6 141.09 29.52 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 89.0 m -79.96 119.56 22.98 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.442 -0.786 . . . . 0.0 110.611 -177.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -89.02 -25.72 21.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.96 -1.087 . . . . 0.0 108.393 176.287 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -151.88 160.02 43.66 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.457 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 94.64 -173.85 32.72 Favored Glycine 0 C--N 1.289 -2.046 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.82 105.91 0.43 Allowed 'Cis proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.162 -1.599 . . . . 0.0 111.595 -0.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 5.0 m -73.93 164.47 60.92 Favored Pre-proline 0 C--N 1.286 -2.161 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -92.44 153.71 3.01 Favored 'Trans proline' 0 C--N 1.286 -2.736 0 C-N-CA 121.315 1.343 . . . . 0.0 112.064 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.5 tp -142.12 128.64 20.19 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -108.69 108.45 19.3 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.649 -0.657 . . . . 0.0 109.335 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.437 HG12 ' CZ ' ' A' ' 50' ' ' PHE . 84.7 t -96.72 99.56 9.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 176.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 mp -80.95 132.02 32.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.536 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 19.8 t -89.09 111.47 22.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 13.6 pt -97.08 170.96 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.452 -0.78 . . . . 0.0 109.394 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 101' ' ' ASN . 7.0 m-20 -84.21 -167.46 1.77 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.148 -0.97 . . . . 0.0 108.459 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.472 ' O ' ' NH1' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -62.85 70.05 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.765 0.793 . . . . 0.0 110.895 -176.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.615 ' O ' ' N ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -52.1 -46.0 65.1 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER 42.02 -6.63 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.876 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 176.856 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 101' ' ' ASN . 54.8 t30 67.74 1.91 2.82 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.686 -1.258 . . . . 0.0 109.896 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.472 ' NH1' ' O ' ' A' ' 100' ' ' GLN . 3.9 mpt_? 61.07 162.27 0.11 Allowed Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo . . . . . 0 C--O 1.19 -1.906 0 C-N-CA 122.186 1.924 . . . . 0.0 111.751 -177.257 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.519 ' CB ' ' HG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.407 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 79' ' ' THR . 7.2 mt -79.49 122.27 34.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -104.59 142.6 17.62 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.415 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -150.05 160.43 4.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.415 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -132.24 130.77 22.08 Favored Pre-proline 0 C--N 1.276 -2.592 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.612 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' O ' HD23 ' A' ' 8' ' ' LEU . 54.0 Cg_exo -41.15 129.14 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.213 1.942 . . . . 0.0 110.189 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 28.8 mt -95.79 109.41 22.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.509 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.05 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.535 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -90.41 107.08 18.92 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 15.9 mt -107.22 125.19 33.05 Favored Pre-proline 0 C--N 1.286 -2.191 0 O-C-N 121.433 -0.792 . . . . 0.0 109.11 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.3 Cg_endo -64.96 120.11 7.29 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.125 1.216 . . . . 0.0 109.43 175.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.468 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -70.8 -171.97 0.59 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.532 0.682 . . . . 0.0 110.767 -174.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 59.99 -2.9 0.13 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 11' ' ' GLU . 66.0 mt-30 -56.96 137.82 54.95 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.41 175.43 5.51 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 121.272 -0.892 . . . . 0.0 110.707 -174.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.475 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -49.68 166.56 0.26 Allowed Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 123.045 0.538 . . . . 0.0 109.935 178.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.583 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 1.9 Cg_endo -78.71 143.22 71.28 Favored 'Cis proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.18 -1.592 . . . . 0.0 112.926 -0.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.487 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 30.0 m-85 -115.41 160.98 32.3 Favored Pre-proline 0 C--N 1.275 -2.663 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 3.9 Cg_endo -70.94 160.64 91.22 Favored 'Cis proline' 0 N--CA 1.487 1.142 0 C-N-CA 124.04 -1.233 . . . . 0.0 112.877 0.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 16' ' ' PRO . 4.9 mtp85 -131.14 136.33 48.25 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -66.84 137.57 56.69 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.03 5.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.53 177.42 37.15 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 117.707 -2.187 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 16.1 tttm -139.2 123.21 17.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.118 -1.225 . . . . 0.0 110.955 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.492 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 14.3 t -82.0 155.99 4.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 172.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.0 t -144.89 148.4 17.98 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.941 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' HB3' ' CG ' ' A' ' 29' ' ' ARG . 11.4 t0 -112.79 131.69 55.58 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.519 ' HG ' ' CB ' ' A' ' 1' ' ' SER . 0.1 OUTLIER -59.25 -18.97 41.84 Favored 'General case' 0 C--N 1.286 -2.152 0 O-C-N 121.748 -0.595 . . . . 0.0 110.121 -178.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -143.99 83.19 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.565 -0.71 . . . . 0.0 109.381 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.44 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 3.4 mtp85 -85.9 115.1 60.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.416 -0.803 . . . . 0.0 109.76 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 31' ' ' GLU . 69.9 Cg_exo -49.04 132.76 28.03 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 121.39 1.394 . . . . 0.0 109.541 174.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -29.52 -45.62 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -176.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mtm180 -113.19 20.84 15.88 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.98 -1.075 . . . . 0.0 110.418 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.407 ' O ' ' NZ ' ' A' ' 34' ' ' LYS . 2.6 p -62.47 173.11 1.31 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.819 -1.176 . . . . 0.0 111.166 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' NZ ' ' O ' ' A' ' 33' ' ' SER . 5.3 mmtm -137.74 170.99 15.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -117.58 121.28 40.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.406 -0.809 . . . . 0.0 109.14 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.406 ' HG3' ' CG2' ' A' ' 80' ' ' THR . 0.0 OUTLIER -100.96 144.28 30.09 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 173.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.9 tp -127.94 142.55 51.22 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.46 171.38 16.17 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 124.86 166.42 12.38 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.318 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.58 119.05 4.72 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 109.39 -24.81 19.53 Favored Glycine 0 C--N 1.281 -2.491 0 N-CA-C 107.661 -2.175 . . . . 0.0 107.661 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -105.89 -100.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.571 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -90.25 -0.51 57.65 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.393 -0.817 . . . . 0.0 109.351 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -123.36 157.66 32.82 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.997 178.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -47.94 127.21 11.52 Favored Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.847 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.425 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 4.4 Cg_exo -76.38 113.16 2.71 Favored 'Cis proline' 0 C--O 1.203 -1.25 0 C-N-CA 123.694 -1.378 . . . . 0.0 109.188 -1.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 11.4 mtpp -64.9 139.98 58.82 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 121.024 -1.048 . . . . 0.0 111.438 -173.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.67 35.68 35.46 Favored Glycine 0 N--CA 1.502 3.076 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.104 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 41' ' ' GLY . 5.1 mm -104.33 -46.12 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 118.717 1.259 . . . . 0.0 107.944 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.439 ' C ' ' HE ' ' A' ' 51' ' ' ARG . 67.1 m-85 -114.11 137.76 51.31 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.65 0.738 . . . . 0.0 110.318 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.439 ' HE ' ' C ' ' A' ' 50' ' ' PHE . 0.0 OUTLIER -143.24 143.33 31.69 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.3 tt -106.58 166.39 3.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.443 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 9.8 t-20 -86.95 120.49 28.27 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.27 -13.98 2.52 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.44 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 52.7 m-80 -119.93 -46.83 2.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.844 -1.16 . . . . 0.0 111.382 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.474 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 22.0 p -79.39 -40.99 28.74 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.742 0.782 . . . . 0.0 108.991 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.42 6.15 56.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 6.6 m -61.77 125.58 24.31 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.4 -1.059 . . . . 0.0 108.169 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.56 129.48 43.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.4 155.78 44.19 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.541 -0.724 . . . . 0.0 109.174 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 8.5 p -106.81 139.87 26.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -94.34 6.28 49.19 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.479 -0.763 . . . . 0.0 112.796 -176.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.669 ' NH1' ' O ' ' A' ' 64' ' ' THR . 15.6 ptt85 -156.18 172.38 18.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.441 -1.412 . . . . 0.0 110.759 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.669 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 5.9 t -65.42 138.17 57.95 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 47.3 mt -96.28 163.89 12.89 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.943 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.545 ' CG ' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -152.07 121.73 6.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 24.0 mtm-85 -67.1 1.99 1.75 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.411 -0.806 . . . . 0.0 109.352 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 66' ' ' ASP . 4.1 mt-10 -71.73 -22.01 61.68 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -101.34 -70.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.9 mt -130.49 145.86 34.93 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.53 -23.53 15.98 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.4 p -151.38 139.13 13.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.67 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -110.88 143.87 40.81 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.16 95.6 5.69 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.58 170.33 10.94 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 68.6 m-85 -129.93 121.19 26.13 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.38 152.86 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 120.93 0.395 . . . . 0.0 110.106 -176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HA ' ' HA2' ' A' ' 89' ' ' GLY . 48.0 mt-10 -138.88 140.39 38.4 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.701 -0.625 . . . . 0.0 109.401 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.555 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -91.07 124.65 35.46 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 172.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -110.0 158.82 17.86 Favored 'General case' 0 C--N 1.268 -2.936 0 CA-C-O 121.817 0.818 . . . . 0.0 111.523 -171.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.451 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 14.2 t0 -99.58 169.38 9.33 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 175.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 2.4 m -59.33 -19.86 17.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.981 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -80.61 -1.28 41.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.42 24.76 74.39 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 80' ' ' THR . 6.5 pttp -107.5 159.46 16.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.645 -0.915 . . . . 0.0 108.843 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 4.2 m -83.23 120.83 26.31 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.358 0.599 . . . . 0.0 112.415 -174.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.576 ' N ' ' CD2' ' A' ' 87' ' ' LEU . 1.2 mm? -79.81 -46.91 16.07 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 1' ' ' SER . 0.5 OUTLIER -142.71 155.05 44.83 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.24 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.527 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 105.08 177.7 24.4 Favored Glycine 0 C--N 1.291 -1.928 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.34 102.59 0.29 Allowed 'Cis proline' 0 N--CA 1.5 1.888 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.403 0.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.527 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 6.8 m -79.17 160.41 70.92 Favored Pre-proline 0 C--N 1.29 -1.989 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -94.03 148.2 2.05 Favored 'Trans proline' 0 C--N 1.284 -2.838 0 C-N-CA 121.673 1.582 . . . . 0.0 111.775 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 tp -131.57 128.4 39.14 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -102.64 119.74 39.35 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 97.7 t -109.18 111.05 34.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 5.2 mp -94.82 134.41 32.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 21.4 t -91.22 119.57 38.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 12.2 pt -119.17 171.33 7.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -90.61 -176.1 4.63 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.54 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 2.0 mp0 -52.85 136.25 34.47 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 103' ' ' ASN . 4.5 p-10 -74.87 -145.72 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 101' ' ' ASN . 1.5 m-20 -63.21 4.05 0.23 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.36 -1.463 . . . . 0.0 109.113 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 101' ' ' ASN . 0.9 OUTLIER 72.68 13.59 5.21 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -173.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.428 ' NE ' ' O ' ' A' ' 103' ' ' ASN . 5.1 mmp_? -124.27 81.85 58.0 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 C--O 1.195 -1.646 0 C-N-CA 122.771 2.314 . . . . 0.0 111.596 -174.013 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.514 ' H1 ' ' CG ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.0 mt -78.38 139.99 17.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.071 -1.018 . . . . 0.0 111.168 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.83 123.84 69.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 172.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.457 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -126.47 162.93 29.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 O-C-N 121.15 -0.969 . . . . 0.0 110.003 -175.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.457 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -142.95 133.76 12.51 Favored Pre-proline 0 C--N 1.289 -2.054 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -47.35 152.72 2.19 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.497 2.131 . . . . 0.0 111.517 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.4 mt -115.66 114.34 45.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.537 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -89.35 108.39 19.61 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.287 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.442 ' C ' HG12 ' A' ' 98' ' ' ILE . 12.7 mt -118.0 130.05 24.97 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 28.1 Cg_endo -67.53 132.06 26.19 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.143 1.228 . . . . 0.0 111.514 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.605 ' CD ' HH21 ' A' ' 67' ' ' ARG . 21.0 pt-20 -54.86 164.75 0.74 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.437 -0.79 . . . . 0.0 109.495 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 60.48 29.64 19.16 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.774 -0.579 . . . . 0.0 111.453 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -60.47 140.48 57.25 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.583 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 48.7 mtm-85 -114.62 169.09 9.32 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.008 -1.057 . . . . 0.0 111.685 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.532 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 22.6 mt-30 -49.71 169.55 0.18 Allowed Pre-proline 0 C--N 1.297 -1.687 0 C-N-CA 123.387 0.675 . . . . 0.0 109.529 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 5.9 Cg_exo -76.32 125.45 11.72 Favored 'Cis proline' 0 N--CA 1.49 1.291 0 C-N-CA 123.978 -1.259 . . . . 0.0 113.268 -0.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.505 ' CE1' ' HD3' ' A' ' 19' ' ' ARG . 35.3 m-85 -100.26 159.3 30.14 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.42 149.27 84.81 Favored 'Cis proline' 0 N--CA 1.505 2.167 0 C-N-CA 124.594 -1.003 . . . . 0.0 112.629 -0.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 13.9 mtp180 -118.89 122.77 43.07 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.458 -0.776 . . . . 0.0 110.081 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -66.22 135.03 53.91 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.1 0.16 2.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.778 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.54 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 172.14 174.32 39.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.5 tttp -134.91 126.66 29.12 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 121.305 -1.115 . . . . 0.0 109.587 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.06 153.12 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.7 t -137.16 170.19 18.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 118.212 -1.395 . . . . 0.0 109.433 -174.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.514 ' CG ' ' H1 ' ' A' ' 1' ' ' SER . 16.3 t0 -143.9 123.37 13.16 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.32 -63.1 1.36 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 109.377 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -75.82 64.81 1.85 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.596 ' NE ' ' OG ' ' A' ' 33' ' ' SER . 9.5 mtp180 -64.94 160.79 52.78 Favored Pre-proline 0 C--N 1.282 -2.358 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.11 -174.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.04 -141.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 123.134 2.556 . . . . 0.0 108.291 165.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.549 ' HB2' ' NH1' ' A' ' 32' ' ' ARG . 33.3 mt-10 -89.08 -84.74 0.21 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.238 -1.538 . . . . 0.0 107.613 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.549 ' NH1' ' HB2' ' A' ' 31' ' ' GLU . 2.6 mtt85 -90.94 79.55 5.87 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.596 ' OG ' ' NE ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -60.32 102.79 0.19 Allowed 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 121.4 0.619 . . . . 0.0 111.579 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -100.07 126.74 46.33 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -86.65 130.12 34.61 Favored 'General case' 0 C--N 1.28 -2.439 0 O-C-N 121.563 -0.711 . . . . 0.0 110.059 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -103.7 135.58 45.0 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.378 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 20.2 tp -114.57 145.94 41.35 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -148.01 170.98 16.56 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -176.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.14 171.86 16.94 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 120.043 -1.075 . . . . 0.0 111.463 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -60.78 117.44 5.39 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 46' ' ' PRO . . . 117.44 -24.44 9.15 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -175.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.2 t -126.51 -104.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.02 -22.75 66.46 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.223 -0.923 . . . . 0.0 110.22 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -116.73 159.35 22.4 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.585 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 6.6 mm-40 -74.46 150.15 86.86 Favored Pre-proline 0 C--N 1.287 -2.115 0 O-C-N 121.971 -0.456 . . . . 0.0 110.336 -177.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.463 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 31.2 Cg_endo -67.13 115.91 1.8 Allowed 'Cis proline' 0 N--CA 1.511 2.554 0 C-N-CA 123.835 -1.319 . . . . 0.0 110.631 -0.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.585 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 2.1 mtpm? -78.22 165.75 23.53 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.657 -1.277 . . . . 0.0 110.946 -173.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.19 31.47 69.09 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.6 mm -105.69 -45.29 8.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 118.645 1.222 . . . . 0.0 107.936 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CZ ' HG12 ' A' ' 95' ' ' VAL . 97.0 m-85 -124.42 156.25 37.47 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.611 0.72 . . . . 0.0 110.633 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -156.78 150.96 25.11 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.1 tt -108.81 157.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 118.61 -1.236 . . . . 0.0 108.962 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 10.2 t-20 -83.34 119.38 24.53 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -75.56 10.72 1.56 Allowed 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 120.865 0.364 . . . . 0.0 111.496 -175.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 19.5 t-20 -124.14 -43.18 2.1 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.837 -1.165 . . . . 0.0 109.276 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.7 p -95.74 -38.6 10.26 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.59 6.06 55.07 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.0 m -66.54 124.56 23.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.568 -0.96 . . . . 0.0 109.512 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.7 t -87.61 124.62 41.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.17 155.66 38.08 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.325 -0.859 . . . . 0.0 109.641 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -102.17 137.55 29.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.2 -12.99 39.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.454 -0.779 . . . . 0.0 111.548 -174.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.559 ' NE ' ' O ' ' A' ' 64' ' ' THR . 2.0 ptm180 -153.08 -176.4 5.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.841 -1.162 . . . . 0.0 110.208 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.559 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 12.6 t -70.51 156.06 39.9 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.686 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -113.09 123.01 49.28 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 109.407 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.442 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -109.07 113.77 26.92 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.605 HH21 ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -58.65 -7.29 0.92 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.518 0.675 . . . . 0.0 109.229 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.442 ' H ' ' C ' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -70.67 -19.79 62.76 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 t -101.7 -58.57 3.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 mt -136.21 134.85 50.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.63 -28.13 24.97 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.3 p -152.79 128.0 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.469 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 29.7 m-85 -91.21 125.44 35.99 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -90.68 85.08 5.97 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 170.45 13.39 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 70.3 m-85 -135.96 133.99 38.16 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.24 155.56 12.61 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 O-C-N 121.826 -0.546 . . . . 0.0 109.595 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -144.76 147.85 33.42 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.21 133.64 37.51 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.516 ' HA ' HD23 ' A' ' 87' ' ' LEU . 17.1 p -128.14 153.93 46.32 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 83' ' ' ASN . 1.2 t70 -109.69 170.7 7.9 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.7 m -56.99 -3.67 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 O-C-N 121.306 -0.871 . . . . 0.0 111.003 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -79.71 -19.68 48.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.34 28.96 31.75 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -116.34 168.21 10.34 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -109.8 118.87 37.66 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.453 -0.78 . . . . 0.0 110.015 -177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.516 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -91.6 -20.31 21.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -157.2 164.08 38.13 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.424 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 114.92 166.5 15.21 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 107.045 -2.422 . . . . 0.0 107.045 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -82.63 107.2 1.02 Allowed 'Cis proline' 0 C--N 1.3 -2.003 0 C-N-CA 123.127 -1.614 . . . . 0.0 110.801 0.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.424 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 18.9 m -78.58 159.46 74.37 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 105.682 -1.969 . . . . 0.0 105.682 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -91.5 148.18 3.47 Favored 'Trans proline' 0 C--N 1.285 -2.77 0 C-N-CA 121.419 1.412 . . . . 0.0 112.675 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.2 tp -138.65 113.28 9.0 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -95.47 113.79 25.48 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 15.8 t -95.28 107.76 19.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 176.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 mp -90.89 127.7 43.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.6 t -84.62 104.86 13.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 7.4 pt -94.67 172.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 O-C-N 121.517 -0.739 . . . . 0.0 109.365 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.519 ' HB3' ' CB ' ' A' ' 103' ' ' ASN . 1.1 m-20 -82.72 179.88 7.64 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -65.02 83.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.439 ' CG ' ' H ' ' A' ' 102' ' ' ASP . 21.2 t-20 64.25 -139.98 0.28 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.439 ' H ' ' CG ' ' A' ' 101' ' ' ASN . 0.4 OUTLIER -64.7 -30.35 71.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.683 -1.261 . . . . 0.0 108.451 179.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.519 ' CB ' ' HB3' ' A' ' 99' ' ' ASP . 60.9 t30 51.42 37.1 18.28 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.824 0.821 . . . . 0.0 109.636 -177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.425 HH12 ' CG ' ' A' ' 102' ' ' ASP . 9.9 mtm-85 -116.89 79.55 10.26 Favored Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo . . . . . 0 C--N 1.312 -1.39 0 C-N-CA 122.498 2.132 . . . . 0.0 112.04 -178.4 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.45 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.7 mt -59.01 120.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.187 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.0 113.94 45.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -136.74 158.96 37.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.413 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -148.69 139.73 13.79 Favored Pre-proline 0 C--N 1.273 -2.73 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -41.48 132.65 3.58 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.216 1.944 . . . . 0.0 111.451 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.7 mt -98.42 110.91 26.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.542 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -87.71 108.44 19.11 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.5 mt -117.09 136.1 23.25 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.508 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 30.0 Cg_endo -70.54 132.37 21.95 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.299 1.333 . . . . 0.0 110.968 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.526 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 13.1 pt-20 -63.78 176.75 0.85 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.018 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.549 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 20.4 t-20 58.56 23.51 10.94 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.587 -0.696 . . . . 0.0 111.757 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -70.22 115.79 9.82 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.549 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -89.57 176.1 7.02 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 120.928 -1.108 . . . . 0.0 109.932 -177.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 11.6 mm-40 -42.92 167.62 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 C-N-CA 124.063 0.945 . . . . 0.0 110.61 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.521 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 2.2 Cg_endo -82.7 146.34 60.09 Favored 'Cis proline' 0 N--CA 1.495 1.567 0 C-N-CA 124.186 -1.172 . . . . 0.0 114.027 -0.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.487 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 42.3 m-85 -133.62 160.35 68.94 Favored Pre-proline 0 C--N 1.282 -2.369 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 18.4 Cg_exo -66.46 163.49 69.81 Favored 'Cis proline' 0 N--CA 1.499 1.807 0 C-N-CA 124.079 -1.217 . . . . 0.0 112.162 -0.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 16' ' ' PRO . 9.9 ttm180 -146.13 143.55 29.4 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.667 -0.646 . . . . 0.0 109.455 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 9.0 t0 -74.73 137.51 42.12 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -132.64 6.03 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.82 179.47 45.42 Favored Glycine 0 N--CA 1.506 3.322 0 C-N-CA 118.896 -1.621 . . . . 0.0 109.702 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.7 ttpm? -145.37 122.98 11.78 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.787 -1.419 . . . . 0.0 110.118 -177.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 45.4 t -93.49 143.57 11.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -139.18 170.08 16.45 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 1' ' ' SER . 10.1 t0 -132.67 120.5 21.81 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -73.79 2.62 7.96 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.823 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -142.46 0.25 1.29 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.507 -1.371 . . . . 0.0 111.758 -174.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.613 ' HD3' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -97.76 150.16 36.48 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 120.554 -1.341 . . . . 0.0 111.729 -171.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -37.63 142.4 0.2 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 123.99 3.127 . . . . 0.0 112.88 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -19.33 28.11 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.39 5.23 42.07 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.909 -0.494 . . . . 0.0 110.0 -177.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.63 147.9 50.33 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.505 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -113.66 123.96 51.16 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 79' ' ' THR . 53.0 m-85 -83.33 139.42 33.05 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 120.967 -1.083 . . . . 0.0 109.695 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.533 HH22 ' CD ' ' A' ' 54' ' ' GLU . 41.2 mmt-85 -120.38 155.61 33.06 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.1 tp -133.27 142.07 48.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -147.97 171.52 15.66 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.72 179.4 16.91 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.531 -1.355 . . . . 0.0 111.154 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -63.13 106.98 0.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 46' ' ' PRO . . . 129.64 -18.13 5.45 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -130.46 -90.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.988 -0.713 . . . . 0.0 109.324 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -20.03 32.52 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 120.923 -1.111 . . . . 0.0 108.777 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -112.35 161.26 16.85 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.365 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -69.33 143.41 93.5 Favored Pre-proline 0 C--N 1.281 -2.401 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.573 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.454 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 40.8 Cg_endo -72.87 123.65 8.56 Favored 'Cis proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.179 -1.592 . . . . 0.0 110.271 -2.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -80.35 166.06 21.67 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 120.716 -1.24 . . . . 0.0 109.674 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.4 ' C ' ' HG1' ' A' ' 62' ' ' THR . . . 69.09 34.02 75.27 Favored Glycine 0 C--N 1.284 -2.355 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.5 mm -110.85 -50.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.008 -1.29 . . . . 0.0 108.4 177.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.432 ' CZ ' HG12 ' A' ' 95' ' ' VAL . 97.3 m-85 -121.59 161.12 22.96 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.405 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.467 ' NE ' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -160.07 134.26 7.4 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 52' ' ' ILE . 19.3 tt -100.13 167.23 2.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 O-C-N 120.793 -1.192 . . . . 0.0 109.04 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -100.59 122.86 43.98 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 176.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.533 ' CD ' HH22 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -49.1 -49.75 40.32 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.965 -0.46 . . . . 0.0 112.005 -176.445 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -90.08 -40.78 12.07 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 111.936 -173.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.3 p -84.14 -22.79 30.92 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.0 9.19 62.72 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.0 m -64.4 123.72 19.93 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.263 -1.139 . . . . 0.0 108.714 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 t -83.15 120.75 35.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.467 ' OG ' ' NE ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -116.88 153.85 31.8 Favored 'General case' 0 C--N 1.282 -2.344 0 O-C-N 121.577 -0.702 . . . . 0.0 109.97 -177.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 7.2 p -105.67 140.83 22.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.456 HG22 ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -93.06 -15.17 26.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.795 . . . . 0.0 111.209 -176.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -154.34 -167.64 2.69 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.747 -1.22 . . . . 0.0 110.004 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 t -74.78 148.57 40.25 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 mt -106.63 129.95 54.46 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.18 126.77 55.43 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.62 -9.58 44.38 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.19 -28.57 62.27 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.32 -52.9 10.6 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -148.43 136.76 14.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.12 -22.37 27.13 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -155.33 123.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.457 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 65.0 m-85 -88.21 121.65 30.85 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.915 -1.115 . . . . 0.0 108.509 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.2 98.47 11.79 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.63 170.42 9.35 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.497 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.2 m-85 -135.46 124.27 23.96 Favored 'General case' 0 C--N 1.262 -3.198 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.88 152.18 6.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.084 0.469 . . . . 0.0 110.293 -174.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -139.71 140.12 36.73 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.438 HG21 ' CE2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -93.26 130.91 38.81 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 170.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 70.5 p -124.5 164.82 18.95 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.744 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.476 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 25.5 t70 -88.23 167.66 13.39 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.2 m -53.65 -27.07 14.58 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.685 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -79.87 -11.18 59.83 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.582 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.8 56.98 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -76.46 146.97 38.2 Favored 'General case' 0 C--O 1.194 -1.824 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 175.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 85.2 m -93.4 115.17 27.72 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 118.76 0.709 . . . . 0.0 109.199 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.621 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.05 -31.71 27.22 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.517 ' HG3' ' NH2' ' A' ' 29' ' ' ARG . 1.6 tt0 -144.84 160.65 40.94 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.0 109.201 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.65 178.27 38.16 Favored Glycine 0 C--N 1.287 -2.187 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -67.94 121.36 4.34 Favored 'Cis proline' 0 C--N 1.299 -2.058 0 C-N-CA 123.026 -1.656 . . . . 0.0 111.433 0.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 3.0 m -101.86 163.27 18.12 Favored Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -91.01 150.07 3.84 Favored 'Trans proline' 0 C--N 1.287 -2.673 0 C-N-CA 121.53 1.487 . . . . 0.0 112.372 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.5 tp -137.46 128.3 27.22 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.06 109.94 21.5 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.629 -0.669 . . . . 0.0 109.886 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 61.3 t -91.75 97.08 6.82 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.1 mt -79.63 132.24 32.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 21.7 t -91.15 116.79 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 11.5 pt -105.85 171.82 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -83.17 172.41 12.66 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.907 -1.12 . . . . 0.0 109.356 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -91.36 158.75 16.36 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.941 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.463 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 0.2 OUTLIER -110.35 30.15 7.04 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 174.089 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 14.9 p-10 -76.14 -26.49 56.37 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 61.21 24.06 14.2 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -174.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -117.49 90.16 34.22 Favored Pre-proline 0 C--N 1.312 -1.027 0 O-C-N 121.671 -0.643 . . . . 0.0 110.293 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 C--N 1.314 -1.276 0 C-N-CA 122.223 1.949 . . . . 0.0 110.194 176.657 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.449 ' H ' ' HG2' ' A' ' 88' ' ' GLU . 31.7 mt -65.7 132.13 31.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-O 121.734 0.778 . . . . 0.0 110.74 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.44 122.84 69.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.522 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -137.87 169.13 19.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.522 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.5 m -159.81 169.76 9.81 Favored Pre-proline 0 C--N 1.274 -2.695 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.85 134.87 52.5 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.35 1.367 . . . . 0.0 110.745 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.427 HG13 HD13 ' A' ' 93' ' ' LEU . 24.4 mt -106.11 111.83 36.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.536 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.42 98.56 11.85 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.3 mt -101.19 129.0 28.01 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.97 -1.081 . . . . 0.0 109.0 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 5.0 Cg_endo -63.38 124.91 14.61 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 121.091 1.194 . . . . 0.0 110.046 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.4 ' CD ' HH11 ' A' ' 104' ' ' ARG . 0.7 OUTLIER -67.04 171.43 5.53 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.717 1.246 . . . . 0.0 113.929 -170.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.512 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 6.4 m-80 47.71 24.15 0.51 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.486 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.458 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 73.0 mt-30 -67.0 146.79 54.0 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 173.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.541 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -104.9 179.26 4.32 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.174 -0.954 . . . . 0.0 110.031 -177.037 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.564 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -54.2 176.74 0.12 Allowed Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.564 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 5.7 Cg_exo -72.79 117.99 4.4 Favored 'Cis proline' 0 N--CA 1.491 1.359 0 C-N-CA 123.942 -1.274 . . . . 0.0 113.986 0.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -100.15 165.08 15.16 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 55.2 Cg_endo -73.12 162.25 92.14 Favored 'Cis proline' 0 N--CA 1.497 1.681 0 C-N-CA 124.242 -1.149 . . . . 0.0 111.84 -0.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 11.3 mtp180 -138.19 145.5 41.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.511 ' CG ' ' HZ2' ' A' ' 23' ' ' LYS . 5.0 t0 -73.75 134.53 43.48 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 59' ' ' VAL . 31.1 m -129.91 3.24 2.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.609 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.83 -171.32 37.48 Favored Glycine 0 N--CA 1.499 2.899 0 C-N-CA 117.347 -2.358 . . . . 0.0 111.146 -178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HZ2' ' CG ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -150.29 113.68 4.92 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 120.998 -1.295 . . . . 0.0 110.851 -178.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.468 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 11.4 t -100.91 112.06 32.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 169.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.5 t -120.66 154.46 24.0 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.008 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.7 t70 -104.23 135.41 45.74 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.58 -32.23 7.79 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -137.02 75.31 1.52 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 37.7 mtm180 -55.61 121.13 36.93 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.181 -0.949 . . . . 0.0 109.641 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 31' ' ' GLU . 54.6 Cg_exo -48.64 141.05 21.14 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.243 1.962 . . . . 0.0 110.328 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -24.88 -59.12 0.06 Allowed 'General case' 0 N--CA 1.51 2.537 0 C-N-CA 123.617 0.767 . . . . 0.0 112.076 -175.376 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.519 ' CZ ' ' HA ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -126.23 52.94 1.66 Allowed 'General case' 0 C--N 1.289 -2.023 0 O-C-N 121.313 -0.867 . . . . 0.0 108.915 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.31 160.56 30.18 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 121.343 -0.848 . . . . 0.0 110.887 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -126.61 133.01 51.13 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -79.9 137.73 36.97 Favored 'General case' 0 C--N 1.273 -2.755 0 O-C-N 121.137 -0.977 . . . . 0.0 108.543 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.97 126.52 54.86 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.5 tp -105.8 148.98 26.9 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.03 170.39 20.02 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -177.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.483 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 110.43 172.41 20.05 Favored Glycine 0 N--CA 1.497 2.765 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.954 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.466 ' N ' ' HB2' ' A' ' 44' ' ' GLN . 9.6 mtpp -53.25 114.75 1.59 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 46' ' ' PRO . . . 115.18 -20.66 13.94 Favored Glycine 0 C--N 1.28 -2.564 0 N-CA-C 108.296 -1.921 . . . . 0.0 108.296 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.2 t -113.06 -89.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -100.17 -13.02 19.11 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.243 -0.91 . . . . 0.0 109.501 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 44' ' ' GLN . 0.4 OUTLIER -100.13 158.42 15.86 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 176.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 137.24 96.17 Favored Pre-proline 0 C--N 1.271 -2.808 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.492 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.432 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 5.2 Cg_exo -76.88 119.47 6.39 Favored 'Cis proline' 0 N--CA 1.5 1.874 0 C-N-CA 123.442 -1.483 . . . . 0.0 110.624 -0.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -69.27 144.49 53.6 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.708 -1.245 . . . . 0.0 110.353 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.49 37.83 34.59 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.344 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.418 HG13 ' HA3' ' A' ' 41' ' ' GLY . 5.0 mm -106.11 -43.0 7.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -118.71 149.93 40.61 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.793 0.806 . . . . 0.0 110.264 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.443 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -148.13 142.94 26.75 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 176.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.2 tt -100.09 158.46 3.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 O-C-N 120.505 -1.372 . . . . 0.0 109.845 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 58' ' ' SER . 6.2 m-80 -84.76 84.71 7.6 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.603 ' H ' ' CD ' ' A' ' 54' ' ' GLU . 2.0 pm0 -24.78 -54.52 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 124.18 0.992 . . . . 0.0 113.554 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.506 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 40.1 t30 -80.95 -33.94 33.59 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.168 -0.958 . . . . 0.0 111.939 -175.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -94.94 -25.84 16.38 Favored 'General case' 0 C--N 1.287 -2.126 0 O-C-N 121.161 -0.962 . . . . 0.0 109.073 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 24' ' ' VAL . . . 82.91 10.52 82.89 Favored Glycine 0 C--N 1.285 -2.273 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.478 ' HG ' ' CG ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -66.8 128.73 37.42 Favored 'General case' 0 C--N 1.312 -1.043 0 O-C-N 120.859 -1.377 . . . . 0.0 108.608 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.43 ' O ' HG21 ' A' ' 21' ' ' VAL . 4.6 t -79.91 119.2 28.87 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.443 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -113.29 151.6 30.93 Favored 'General case' 0 C--N 1.282 -2.335 0 O-C-N 121.699 -0.626 . . . . 0.0 109.561 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 12.8 p -112.63 143.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -96.43 -15.36 21.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.695 -0.628 . . . . 0.0 111.54 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.95 178.54 8.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.464 -1.397 . . . . 0.0 111.783 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.541 ' OG1' ' NH2' ' A' ' 14' ' ' ARG . 4.9 t -70.05 122.51 19.52 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.3 mt -90.81 127.2 36.26 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.161 -0.962 . . . . 0.0 108.926 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.25 139.28 46.77 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.512 ' NE ' ' O ' ' A' ' 97' ' ' VAL . 7.4 mtp180 -81.88 -11.24 59.02 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.803 -0.56 . . . . 0.0 111.29 -176.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.85 -22.76 49.43 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.83 -63.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.422 HD11 ' CE1' ' A' ' 73' ' ' TYR . 0.7 OUTLIER -130.44 127.41 62.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.25 -25.86 31.27 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -156.69 135.97 3.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.422 ' CE1' HD11 ' A' ' 70' ' ' ILE . 67.1 m-85 -98.75 124.7 43.78 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -90.74 90.86 8.13 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.87 170.47 11.15 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 122.132 0.968 . . . . 0.0 109.458 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 53.5 m-85 -134.08 127.6 32.51 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.29 142.89 23.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.24 0.543 . . . . 0.0 110.452 -175.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -133.7 145.19 49.66 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.426 ' HB ' HD21 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -92.24 142.38 27.53 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 171.302 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.456 ' HA ' HD23 ' A' ' 87' ' ' LEU . 24.1 p -127.6 155.3 44.08 Favored 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.441 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -97.1 170.01 9.42 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.806 178.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 m -56.42 -16.15 3.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -85.75 -13.08 49.41 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.22 22.65 58.61 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -98.97 150.46 21.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 176.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 57.7 m -84.49 129.01 34.9 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.559 ' CD2' ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -99.16 -30.24 12.4 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.449 ' HG2' ' H ' ' A' ' 2' ' ' ILE . 3.9 tp10 -149.47 153.66 37.62 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.447 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 97.96 -176.35 30.64 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.26 104.97 0.36 Allowed 'Cis proline' 0 N--CA 1.496 1.641 0 CA-C-N 118.861 1.33 . . . . 0.0 112.089 -0.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.447 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 16.1 m -79.79 161.94 64.49 Favored Pre-proline 0 C--N 1.284 -2.247 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -93.3 155.76 2.54 Favored 'Trans proline' 0 C--N 1.291 -2.478 0 C-N-CA 121.6 1.533 . . . . 0.0 111.016 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.427 HD13 HG13 ' A' ' 7' ' ' ILE . 12.9 tp -142.18 128.08 19.46 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -108.97 104.14 13.31 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.526 -0.734 . . . . 0.0 109.496 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 70.7 t -94.4 107.95 20.06 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.9 mp -90.64 129.95 40.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.512 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 1.5 t -86.97 109.72 19.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 20.6 pt -109.15 171.54 2.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-O 121.425 0.631 . . . . 0.0 109.407 -176.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.33 148.33 30.21 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -133.32 69.01 1.48 Allowed 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 43.3 24.64 0.05 Allowed 'General case' 0 N--CA 1.515 2.792 0 O-C-N 121.713 -0.617 . . . . 0.0 110.12 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.31 -44.04 84.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.049 -1.032 . . . . 0.0 108.695 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 56.86 15.09 2.1 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -176.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.4 HH11 ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER 67.8 110.62 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.498 1.761 0 C-N-CA 122.603 2.202 . . . . 0.0 112.158 -177.882 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.447 ' HA ' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.422 ' N ' ' OE1' ' A' ' 88' ' ' GLU . 7.9 mt -72.16 139.89 18.96 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-O 121.583 0.706 . . . . 0.0 110.599 -177.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.85 128.04 75.59 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.446 ' CG2' HD11 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -140.68 162.23 23.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.4 -0.813 . . . . 0.0 109.728 -175.158 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.443 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -145.59 156.01 52.87 Favored Pre-proline 0 C--N 1.284 -2.268 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 172.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 52.8 Cg_exo -49.76 149.42 10.74 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.63 1.553 . . . . 0.0 111.164 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.1 mt -112.27 111.88 38.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.551 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -92.64 105.06 17.28 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.6 mt -110.25 128.36 25.5 Favored Pre-proline 0 C--N 1.286 -2.157 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 31.7 Cg_endo -69.91 125.23 11.83 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 120.969 1.113 . . . . 0.0 110.872 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.461 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 11.1 pt-20 -61.37 170.86 1.6 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.822 -175.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.535 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 81.33 -19.17 0.44 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 172.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -52.27 134.31 33.74 Favored 'General case' 0 N--CA 1.518 2.974 0 O-C-N 120.687 -1.258 . . . . 0.0 108.128 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.535 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -111.28 -170.85 1.72 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.773 0.797 . . . . 0.0 111.163 -177.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.48 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 2.5 mp0 -45.88 163.44 0.22 Allowed Pre-proline 0 C--N 1.305 -1.329 0 C-N-CA 124.547 1.139 . . . . 0.0 109.943 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 39.9 Cg_endo -79.33 141.77 62.93 Favored 'Cis proline' 0 C--N 1.314 -1.275 0 C-N-CA 123.146 -1.606 . . . . 0.0 112.103 -0.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 37.3 m-85 -112.83 158.88 36.4 Favored Pre-proline 0 C--N 1.28 -2.454 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.95 153.37 97.65 Favored 'Cis proline' 0 N--CA 1.498 1.747 0 C-N-CA 123.942 -1.274 . . . . 0.0 112.909 0.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.476 ' HG3' ' CD1' ' A' ' 17' ' ' PHE . 7.1 mtp180 -120.33 135.99 54.84 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.92 147.75 52.88 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.9 6.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.873 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.26 -177.19 39.33 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 117.98 -2.057 . . . . 0.0 110.157 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -141.51 117.66 10.65 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.139 -1.212 . . . . 0.0 110.445 -176.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.38 135.84 24.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 103.539 -2.763 . . . . 0.0 103.539 169.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.38 150.64 34.83 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -127.83 112.72 15.06 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -8.98 58.93 Favored 'General case' 0 C--N 1.272 -2.768 0 O-C-N 121.682 -0.636 . . . . 0.0 110.433 -173.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -125.67 81.36 1.97 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.4 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 18.9 mtm180 -115.92 142.29 28.9 Favored Pre-proline 0 C--N 1.288 -2.072 0 O-C-N 121.211 -0.93 . . . . 0.0 110.379 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.65 161.37 41.88 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.551 1.501 . . . . 0.0 110.865 173.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.477 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -25.05 -60.77 0.06 Allowed 'General case' 0 N--CA 1.513 2.681 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.63 ' O ' ' NZ ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -129.31 36.53 4.14 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.72 -1.238 . . . . 0.0 110.914 -173.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -57.14 148.7 21.28 Favored 'General case' 0 C--N 1.276 -2.609 0 O-C-N 121.825 -0.547 . . . . 0.0 110.811 -178.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.63 ' NZ ' ' O ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -117.23 147.99 42.03 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -83.89 150.63 25.58 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 121.27 -0.894 . . . . 0.0 109.311 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 6.1 mmp_? -123.73 135.0 53.59 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 173.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 36.8 tp -112.93 144.27 42.78 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.84 171.02 18.91 Favored 'General case' 0 C--N 1.271 -2.823 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -175.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.472 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 119.22 166.36 13.39 Favored Glycine 0 C--N 1.29 -1.99 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 177.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -59.09 109.92 0.94 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 124.21 -20.37 7.08 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -174.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.4 t -118.19 -86.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.991 -1.299 . . . . 0.0 108.788 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -99.5 -12.63 19.99 Favored 'General case' 0 C--O 1.206 -1.198 0 O-C-N 121.598 -0.689 . . . . 0.0 109.412 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.472 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 13.1 mp0 -109.76 160.34 16.41 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.504 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -60.84 135.81 92.92 Favored Pre-proline 0 C--N 1.273 -2.747 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.303 -174.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -77.21 124.18 10.35 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.824 -1.74 . . . . 0.0 109.97 -1.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.0 mttm -72.4 154.23 41.01 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 121.327 -0.858 . . . . 0.0 109.128 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.41 34.95 63.45 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.148 173.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.0 mm -106.64 -49.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.658 -1.496 . . . . 0.0 107.854 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -118.96 152.73 35.82 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.481 -0.762 . . . . 0.0 110.691 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.639 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 6.9 ptm180 -143.43 169.92 16.76 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 52' ' ' ILE . 8.6 tt -129.2 159.73 40.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 119.231 -0.987 . . . . 0.0 108.758 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 58' ' ' SER . 37.6 t-20 -79.94 96.92 6.53 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 54' ' ' GLU . 2.1 mp0 -33.91 -50.07 0.36 Allowed 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 122.588 0.355 . . . . 0.0 110.942 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.49 ' OD1' ' NH2' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -83.03 -42.78 17.09 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.211 -0.931 . . . . 0.0 112.354 -175.68 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 p -94.74 -29.76 14.62 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.108 -0.995 . . . . 0.0 111.041 -171.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 95.33 -1.38 64.44 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -56.05 129.33 39.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.043 -1.269 . . . . 0.0 108.185 176.419 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.9 t -94.02 134.36 31.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.639 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -131.73 159.67 37.73 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.455 -0.778 . . . . 0.0 109.663 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -103.79 139.99 23.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -94.74 -2.99 50.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 111.303 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HA ' ' CD2' ' A' ' 17' ' ' PHE . 2.8 ptp85 -157.21 -179.84 8.58 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 t -69.4 170.42 10.47 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.8 mt -131.41 136.28 47.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.87 122.79 35.68 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.469 HH22 ' CG ' ' A' ' 99' ' ' ASP . 5.3 mtm180 -57.12 -15.61 5.87 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.059 -1.026 . . . . 0.0 111.43 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.28 -19.65 63.91 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.9 -60.02 2.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.481 HD11 ' CE1' ' A' ' 73' ' ' TYR . 1.9 mt -143.68 145.17 22.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.7 -24.92 16.31 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.1 p -154.72 139.01 9.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.784 -0.572 . . . . 0.0 109.647 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.481 ' CE1' HD11 ' A' ' 70' ' ' ILE . 33.5 m-85 -106.39 127.09 53.02 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -91.79 86.88 6.06 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 170.67 13.94 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 78.5 m-85 -135.55 133.37 38.3 Favored 'General case' 0 C--N 1.265 -3.104 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.85 145.42 18.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -175.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -135.23 143.88 46.59 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.468 ' C ' HD23 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -90.36 133.02 35.26 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 171.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.475 ' CA ' HD23 ' A' ' 87' ' ' LEU . 39.1 p -129.55 170.5 13.66 Favored 'General case' 0 C--N 1.278 -2.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.262 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 83' ' ' ASN . 6.1 t0 -149.78 171.62 16.45 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.409 -0.807 . . . . 0.0 110.328 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.3 m -13.9 -41.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 126.276 1.83 . . . . 0.0 114.724 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 81' ' ' ASP . 8.0 t-20 -79.43 -7.51 58.45 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 120.722 -1.236 . . . . 0.0 109.732 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 72.18 19.18 78.45 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.5 OUTLIER -99.78 167.61 10.43 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.456 ' CG2' ' O ' ' A' ' 88' ' ' GLU . 91.3 m -94.07 119.68 33.26 Favored 'General case' 0 C--N 1.277 -2.563 0 O-C-N 122.154 -0.341 . . . . 0.0 111.292 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.62 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.71 -34.79 24.84 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.456 ' O ' ' CG2' ' A' ' 86' ' ' THR . 0.3 OUTLIER -142.09 163.32 33.19 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.792 -0.568 . . . . 0.0 109.743 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.411 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 89.87 -172.18 38.42 Favored Glycine 0 N--CA 1.481 1.699 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.77 102.95 0.34 Allowed 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.732 -1.362 . . . . 0.0 112.225 -0.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.419 HG23 HD12 ' A' ' 2' ' ' ILE . 5.8 m -74.05 164.19 62.95 Favored Pre-proline 0 C--N 1.285 -2.199 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -94.48 154.61 1.99 Allowed 'Trans proline' 0 C--N 1.291 -2.491 0 C-N-CA 121.694 1.596 . . . . 0.0 111.295 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.446 HD11 ' CG2' ' A' ' 4' ' ' VAL . 16.6 tp -144.36 119.95 10.41 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -99.85 110.48 22.84 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.762 -0.586 . . . . 0.0 110.046 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 50.9 t -94.25 107.3 19.16 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.7 mp -90.82 135.06 27.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.461 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 18.7 t -91.33 114.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 22.4 pt -111.42 172.34 2.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 121.58 -0.7 . . . . 0.0 110.498 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.469 ' CG ' HH22 ' A' ' 67' ' ' ARG . 5.6 m-20 -78.51 165.45 23.73 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -69.7 84.35 0.45 Allowed 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -57.77 -46.63 84.28 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.404 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 36.1 t0 47.36 -97.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 0.4 OUTLIER -146.81 30.76 0.97 Allowed 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 173.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.404 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 48.3 mtm180 -84.92 130.22 53.36 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.702 -0.624 . . . . 0.0 111.238 -172.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 C--O 1.202 -1.29 0 C-N-CA 122.859 2.373 . . . . 0.0 110.557 175.398 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.502 -0.868 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.472 HD13 ' N ' ' A' ' 79' ' ' THR . 3.6 mt -78.08 117.77 23.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.341 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.0 120.41 35.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.427 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -139.75 159.14 27.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -179.238 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.427 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -143.14 145.81 34.21 Favored Pre-proline 0 C--N 1.269 -2.925 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -53.83 134.52 59.4 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.586 1.524 . . . . 0.0 109.928 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.9 mt -106.79 116.66 51.02 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.137 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.541 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -89.61 104.34 16.91 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.3 mt -110.32 127.28 27.28 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.483 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -68.83 130.83 21.24 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 120.787 0.991 . . . . 0.0 111.034 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -74.46 -170.53 1.03 Allowed 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.305 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.605 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 0.0 OUTLIER 61.05 -26.97 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 175.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.519 ' H ' ' C ' ' A' ' 11' ' ' GLU . 71.9 mt-30 -37.19 139.25 0.24 Allowed 'General case' 0 N--CA 1.521 3.098 0 O-C-N 121.007 -1.058 . . . . 0.0 108.529 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.605 ' NH1' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -91.24 -175.32 4.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.543 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 1.4 mt-30 -67.16 -168.58 0.05 OUTLIER Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.543 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 20.0 Cg_exo -66.96 127.44 8.53 Favored 'Cis proline' 0 N--CA 1.492 1.42 0 CA-C-N 120.499 1.214 . . . . 0.0 112.222 -0.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.512 ' CD2' ' HA ' ' A' ' 15' ' ' GLN . 32.9 m-85 -115.61 163.54 20.38 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 177.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.1 163.35 76.79 Favored 'Cis proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.959 -1.267 . . . . 0.0 111.207 -0.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.3 mtp85 -136.75 139.81 42.13 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.384 -0.823 . . . . 0.0 109.404 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.49 146.18 55.19 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.6 m -138.83 -1.18 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.456 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 167.04 178.35 39.37 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 118.968 -1.587 . . . . 0.0 109.344 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.1 tttp -135.36 130.63 35.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.306 -1.114 . . . . 0.0 110.625 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.8 t -99.78 145.54 10.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.6 t -144.33 170.62 7.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' CB ' HG22 ' A' ' 79' ' ' THR . 7.6 t0 -129.58 148.97 51.53 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 p -105.17 -7.73 18.85 Favored 'General case' 0 C--N 1.278 -2.538 0 O-C-N 121.96 -0.462 . . . . 0.0 110.163 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.515 ' O ' ' NE ' ' A' ' 29' ' ' ARG . 3.1 m-20 -133.06 25.01 4.25 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.755 -172.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.515 ' NE ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -126.08 158.2 67.01 Favored Pre-proline 0 N--CA 1.506 2.338 0 CA-C-N 119.263 0.938 . . . . 0.0 110.961 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -37.34 129.42 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 123.438 2.759 . . . . 0.0 112.311 178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 8.5 mp0 -42.12 -30.85 0.32 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.985 -0.447 . . . . 0.0 111.097 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.4 mtp180 -103.56 10.45 37.03 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.19 -0.944 . . . . 0.0 110.681 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.48 133.27 49.96 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.485 -1.286 . . . . 0.0 108.358 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 33.8 mttm -96.89 156.33 16.39 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.45 ' CE1' HG21 ' A' ' 79' ' ' THR . 70.1 m-85 -105.4 142.24 35.51 Favored 'General case' 0 C--N 1.285 -2.23 0 O-C-N 121.476 -0.765 . . . . 0.0 111.657 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.507 HH12 ' CB ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -103.1 149.0 25.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 174.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.4 tp -125.6 140.26 52.89 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 174.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 p -148.29 170.78 17.16 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -174.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.72 174.9 18.96 Favored Glycine 0 N--CA 1.499 2.88 0 O-C-N 121.019 -1.05 . . . . 0.0 111.817 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -59.8 116.34 4.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 115.75 -19.33 14.19 Favored Glycine 0 C--N 1.28 -2.543 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.56 -95.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.588 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 23.0 t70 -83.7 -15.85 47.2 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.046 -1.034 . . . . 0.0 109.765 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -113.26 155.07 25.75 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.226 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.406 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 4.9 mt-10 -54.43 133.31 62.56 Favored Pre-proline 0 C--N 1.29 -2.014 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.523 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.412 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 28.2 Cg_endo -73.62 118.11 4.72 Favored 'Cis proline' 0 N--CA 1.499 1.819 0 C-N-CA 123.526 -1.448 . . . . 0.0 110.305 -1.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.588 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 3.7 mtpp -68.27 145.41 54.27 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 120.902 -1.124 . . . . 0.0 112.242 -172.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.88 28.11 69.69 Favored Glycine 0 N--CA 1.498 2.816 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.389 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.401 ' N ' ' O ' ' A' ' 41' ' ' GLY . 17.8 mm -85.26 -46.42 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-N 119.254 1.527 . . . . 0.0 107.053 175.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -107.66 147.39 30.76 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.686 0.755 . . . . 0.0 109.18 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.66 170.09 16.35 Favored 'General case' 0 C--N 1.262 -3.222 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 tt -134.19 150.38 31.02 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.016 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.45 ' CG ' ' HG1' ' A' ' 56' ' ' THR . 19.0 t-20 -84.81 83.2 8.12 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.463 ' CD ' HH21 ' A' ' 36' ' ' ARG . 5.8 mt-10 -37.44 -33.47 0.07 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.557 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -79.72 -15.56 57.28 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.985 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.45 ' HG1' ' CG ' ' A' ' 53' ' ' ASN . 74.8 p -127.27 -36.85 2.09 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 100.93 6.23 52.4 Favored Glycine 0 C--N 1.277 -2.699 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.4 m -66.16 119.87 12.23 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.41 -1.053 . . . . 0.0 108.745 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.421 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.2 t -87.11 134.95 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.27 158.21 44.95 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.358 -0.838 . . . . 0.0 108.756 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -106.81 141.49 21.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 p -89.58 -13.93 36.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.546 -0.722 . . . . 0.0 110.571 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 64' ' ' THR . 1.8 ptm180 -157.18 -173.53 4.48 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.187 -0.945 . . . . 0.0 109.593 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.617 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 14.6 t -70.06 178.65 2.65 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 11' ' ' GLU . 35.2 mt -131.22 162.28 30.33 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 120.541 -1.349 . . . . 0.0 108.504 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -140.0 113.71 8.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -60.45 -11.18 6.14 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.21 -22.8 63.85 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.5 t -105.05 -55.95 5.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.454 HD13 ' CE1' ' A' ' 73' ' ' TYR . 1.4 mt -141.53 142.3 29.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.569 -0.707 . . . . 0.0 110.06 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.22 -23.16 16.3 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.2 p -152.9 135.15 6.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.638 -0.664 . . . . 0.0 109.733 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.454 ' CE1' HD13 ' A' ' 70' ' ' ILE . 84.3 m-85 -100.86 117.28 34.63 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -85.91 87.03 7.35 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.62 170.72 15.48 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 73.1 m-85 -134.08 132.31 39.82 Favored 'General case' 0 C--N 1.264 -3.149 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.2 152.66 13.99 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 O-C-N 121.983 -0.448 . . . . 0.0 109.864 -177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -138.47 139.51 38.84 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 121.779 -0.575 . . . . 0.0 109.565 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.472 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -88.69 134.21 33.97 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 173.233 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 7.9 p -137.14 163.04 31.77 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.545 -176.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -105.8 171.15 7.49 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.2 m -46.29 -27.72 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.369 0.604 . . . . 0.0 110.5 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.59 0.52 29.69 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.507 -0.745 . . . . 0.0 110.385 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.21 20.46 76.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 80' ' ' THR . 25.5 mttp -85.11 146.89 26.91 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 31.8 m -99.26 117.04 32.83 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-O 121.145 0.498 . . . . 0.0 110.816 -177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.596 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.58 -28.78 17.31 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.459 ' CD ' ' NH1' ' A' ' 29' ' ' ARG . 1.1 tp10 -140.81 151.37 44.33 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.507 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 94.73 -177.58 35.84 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.74 102.75 0.16 OUTLIER 'Cis proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.821 -1.325 . . . . 0.0 113.469 -0.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.507 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 3.3 m -74.8 164.19 63.05 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -92.35 151.06 3.03 Favored 'Trans proline' 0 C--N 1.283 -2.912 0 C-N-CA 121.395 1.397 . . . . 0.0 111.905 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.1 tp -135.76 126.74 27.76 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -103.57 105.52 15.79 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 121.831 -0.543 . . . . 0.0 109.715 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.7 104.6 16.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mp -87.57 134.0 28.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.434 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 16.1 t -89.67 108.94 19.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 15.3 pt -102.85 171.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' A' ' 101' ' ' ASN . 4.8 m-20 -80.39 174.47 11.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.424 ' OE1' ' NH2' ' A' ' 14' ' ' ARG . 4.3 mt-30 -66.67 68.76 0.06 Allowed 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 99' ' ' ASP . 1.9 t-20 -75.5 53.53 0.69 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 104' ' ' ARG . 0.8 OUTLIER -57.12 -45.72 83.24 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -178.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.09 -61.12 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 102' ' ' ASP . 77.6 mtp180 -153.97 121.6 2.96 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.187 -2.051 0 C-N-CA 122.753 2.302 . . . . 0.0 111.489 176.884 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.539 ' H3 ' ' CG ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 5.2 mt -73.73 120.49 22.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.075 -1.016 . . . . 0.0 110.611 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.66 119.98 50.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.468 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -142.42 163.76 18.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -149.53 159.44 36.38 Favored Pre-proline 0 C--N 1.278 -2.517 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.34 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.408 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 27.3 Cg_exo -44.73 131.03 10.02 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.855 1.703 . . . . 0.0 111.893 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.405 HG13 HD13 ' A' ' 93' ' ' LEU . 19.5 mt -101.4 122.5 53.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.533 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.3 mp -106.88 115.8 30.82 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 23.0 mt -122.21 128.04 25.66 Favored Pre-proline 0 C--N 1.26 -3.314 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 21.5 Cg_endo -70.98 141.78 41.06 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 CA-C-N 120.038 1.049 . . . . 0.0 110.064 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.438 ' OE1' ' NH1' ' A' ' 67' ' ' ARG . 3.4 pt-20 -55.69 173.76 0.12 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 121.988 0.899 . . . . 0.0 110.104 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.431 ' ND2' ' OE1' ' A' ' 100' ' ' GLN . 4.1 p30 52.74 19.15 1.18 Allowed 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -57.49 131.35 49.9 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.474 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 3.3 mtt180 -101.84 -174.37 2.57 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 119.546 1.066 . . . . 0.0 110.434 -176.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.535 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 16.8 mt-30 -54.16 168.14 0.47 Allowed Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.535 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 4.1 Cg_exo -77.02 131.71 25.12 Favored 'Cis proline' 0 C--N 1.308 -1.593 0 C-N-CA 123.503 -1.457 . . . . 0.0 112.831 0.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -119.61 159.55 45.71 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 13.0 Cg_exo -69.74 155.29 93.28 Favored 'Cis proline' 0 N--CA 1.493 1.497 0 C-N-CA 123.878 -1.301 . . . . 0.0 110.426 -0.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -129.54 131.34 46.56 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.25 -179.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.21 116.01 9.16 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 19.5 m -118.42 7.61 6.85 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.592 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.53 163.5 30.91 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -135.58 116.33 14.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.27 -1.135 . . . . 0.0 109.641 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.8 t -80.97 146.9 6.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 t -139.3 166.72 21.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.539 ' CG ' ' H3 ' ' A' ' 1' ' ' SER . 11.9 t70 -112.98 140.14 48.04 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 173.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -45.15 -35.49 3.21 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.301 0.572 . . . . 0.0 109.53 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -150.93 84.72 1.34 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.624 ' NH2' ' O ' ' A' ' 55' ' ' ASN . 23.3 mtp180 -64.73 121.25 72.3 Favored Pre-proline 0 C--N 1.288 -2.076 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.33 -163.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.601 2.201 . . . . 0.0 113.235 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.82 -78.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 111.882 -174.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -107.77 31.26 5.61 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.322 -0.862 . . . . 0.0 110.239 -173.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.0 143.17 58.13 Favored 'General case' 0 C--N 1.275 -2.654 0 O-C-N 120.927 -1.108 . . . . 0.0 110.876 -178.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.18 138.88 54.36 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -82.43 144.11 30.71 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.747 -0.596 . . . . 0.0 110.598 -178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.442 HH12 ' CD ' ' A' ' 54' ' ' GLU . 4.2 mmp_? -120.86 145.02 48.06 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.402 ' HB2' ' CG2' ' A' ' 52' ' ' ILE . 23.4 tp -120.79 153.45 37.05 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.0 p -158.13 171.26 20.53 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.51 175.63 18.77 Favored Glycine 0 N--CA 1.502 3.083 0 C-N-CA 119.796 -1.192 . . . . 0.0 111.444 175.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -59.24 119.54 7.56 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 113.07 -19.12 20.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -118.07 -98.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.622 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -85.77 -12.46 50.92 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -113.12 148.89 34.39 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 121.06 -1.025 . . . . 0.0 108.363 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.483 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.1 pt-20 -51.85 136.02 36.49 Favored Pre-proline 0 C--N 1.284 -2.282 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.359 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.489 ' HB2' ' CG1' ' A' ' 49' ' ' ILE . 2.9 Cg_exo -72.83 118.07 4.46 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.475 -1.469 . . . . 0.0 109.161 -1.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.622 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 8.9 mtpp -68.56 145.62 53.82 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 120.856 -1.153 . . . . 0.0 111.251 -172.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.76 34.1 87.83 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.806 -0.559 . . . . 0.0 112.383 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.489 ' CG1' ' HB2' ' A' ' 46' ' ' PRO . 8.8 mm -89.47 -45.58 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -111.49 139.22 47.09 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.591 0.71 . . . . 0.0 110.041 -178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -137.22 128.96 28.78 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 58' ' ' SER . 7.7 tt -98.9 161.93 2.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.48 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 13.2 t-20 -96.03 106.73 18.94 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' CD ' HH12 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -40.82 -39.15 1.06 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.108 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.624 ' O ' ' NH2' ' A' ' 29' ' ' ARG . 8.0 t-20 -96.36 -30.95 13.11 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.35 -0.844 . . . . 0.0 112.704 -173.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 18.1 p -98.16 -26.92 14.4 Favored 'General case' 0 C--N 1.283 -2.295 0 O-C-N 120.757 -1.215 . . . . 0.0 108.611 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.01 5.1 88.02 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 4.4 m -63.63 125.22 23.57 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.263 -1.139 . . . . 0.0 109.409 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 t -90.66 121.91 41.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.11 146.93 44.71 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.343 -0.848 . . . . 0.0 110.031 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 14.6 p -102.53 142.42 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.8 p -95.33 -20.05 19.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.524 -0.735 . . . . 0.0 112.908 -173.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.41 ' NH2' ' OD2' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -139.89 176.48 8.71 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.483 -1.386 . . . . 0.0 110.253 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 13.0 t -70.15 127.9 34.42 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.409 ' O ' ' N ' ' A' ' 12' ' ' ASN . 97.3 mt -83.22 120.51 25.91 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.292 -0.88 . . . . 0.0 109.131 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -108.61 114.09 27.61 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.45 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.438 ' NH1' ' OE1' ' A' ' 11' ' ' GLU . 14.7 mtp-105 -53.66 -7.96 0.13 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.447 -0.783 . . . . 0.0 110.399 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 66' ' ' ASP . 1.5 mt-10 -68.45 -28.68 67.27 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 t -91.47 -63.55 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -138.68 132.41 40.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.53 -23.7 24.29 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 p -150.22 132.07 5.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -94.7 117.21 29.76 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.35 83.39 7.69 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.06 170.31 11.65 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 64.8 m-85 -138.31 131.14 29.61 Favored 'General case' 0 C--N 1.265 -3.082 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.14 155.73 11.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-O 121.396 0.617 . . . . 0.0 109.75 -175.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.32 147.54 28.47 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.456 ' HB ' HD21 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.83 131.79 47.96 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 175.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.507 ' HA ' HD23 ' A' ' 87' ' ' LEU . 80.8 p -121.22 164.85 16.29 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 83' ' ' ASN . 1.5 t0 -144.75 172.18 13.37 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.837 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 m -38.82 -21.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 123.455 0.702 . . . . 0.0 111.61 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 81' ' ' ASP . 3.9 t-20 -79.14 -4.91 52.7 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.175 -0.953 . . . . 0.0 108.746 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 63.52 27.55 71.05 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.523 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -119.84 162.79 18.52 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.523 ' N ' ' HG3' ' A' ' 85' ' ' LYS . 1.3 m -90.18 124.08 34.54 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -93.95 -13.22 27.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.896 -1.128 . . . . 0.0 107.985 178.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 2' ' ' ILE . 1.0 OUTLIER -156.02 162.36 40.33 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.447 ' N ' ' HG3' ' A' ' 88' ' ' GLU . . . 91.95 -175.64 38.52 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -70.83 104.75 0.49 Allowed 'Cis proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.58 -1.425 . . . . 0.0 111.373 0.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.44 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 18.1 m -76.81 160.62 76.3 Favored Pre-proline 0 C--N 1.284 -2.271 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -93.46 153.79 2.45 Favored 'Trans proline' 0 C--N 1.288 -2.625 0 C-N-CA 121.556 1.504 . . . . 0.0 111.455 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.405 HD13 HG13 ' A' ' 7' ' ' ILE . 8.2 tp -140.3 127.38 20.9 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -112.57 110.21 20.23 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.488 -0.758 . . . . 0.0 109.286 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.3 t -99.51 101.94 12.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.408 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 4.6 mp -80.59 129.37 37.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 O-C-N 121.613 -0.679 . . . . 0.0 109.234 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 16.8 t -86.29 92.14 3.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 13.8 pt -79.71 171.58 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 O-C-N 121.515 -0.741 . . . . 0.0 109.28 -177.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 101' ' ' ASN . 16.6 m-20 -77.94 166.9 22.29 Favored 'General case' 0 C--N 1.282 -2.349 0 O-C-N 120.983 -1.073 . . . . 0.0 108.674 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.431 ' OE1' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -68.54 68.62 0.15 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 99' ' ' ASP . 4.8 p30 -108.48 24.55 12.87 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.443 ' CG ' ' H ' ' A' ' 103' ' ' ASN . 4.3 p-10 -74.98 -112.78 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 175.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.443 ' H ' ' CG ' ' A' ' 102' ' ' ASP . 2.3 t-20 -128.04 -1.98 5.82 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 173.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.458 ' CZ ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER 60.04 109.67 0.03 OUTLIER Pre-proline 0 C--N 1.307 -1.256 0 C-N-CA 123.113 0.565 . . . . 0.0 111.669 -178.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HD2' ' CZ ' ' A' ' 104' ' ' ARG . 34.8 Cg_endo . . . . . 0 C--O 1.206 -1.083 0 C-N-CA 122.383 2.055 . . . . 0.0 111.08 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.421 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.643 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.431 HD13 ' N ' ' A' ' 79' ' ' THR . 7.1 mt -62.58 135.39 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 O-C-N 121.695 -0.628 . . . . 0.0 109.495 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.52 122.34 62.29 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.412 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -133.19 160.47 42.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.096 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -131.89 157.34 78.46 Favored Pre-proline 0 C--N 1.275 -2.665 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.56 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.35 134.97 67.24 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.285 1.323 . . . . 0.0 109.815 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 mt -109.27 113.97 45.63 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.556 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -92.14 112.58 24.57 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 20.0 mt -117.96 133.99 23.34 Favored Pre-proline 0 C--N 1.287 -2.134 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 31.1 Cg_endo -69.74 140.39 42.63 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.09 1.193 . . . . 0.0 110.692 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.457 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -79.5 174.36 11.65 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.698 178.41 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.527 ' OD1' ' NH2' ' A' ' 104' ' ' ARG . 59.6 m-20 58.29 38.22 26.03 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.813 -0.554 . . . . 0.0 110.692 175.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.47 ' OE1' ' N ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -88.43 166.57 14.14 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 175.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -117.5 167.04 11.65 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.681 -1.262 . . . . 0.0 111.856 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.495 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -64.48 178.71 0.43 Allowed Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 11.8 Cg_exo -66.51 140.34 48.65 Favored 'Cis proline' 0 C--N 1.307 -1.647 0 C-N-CA 123.704 -1.373 . . . . 0.0 112.786 0.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 35.0 m-85 -119.46 167.39 12.23 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 38.5 Cg_endo -66.01 168.53 47.51 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 120.529 1.225 . . . . 0.0 111.899 -0.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -133.35 129.1 37.0 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 120.231 -0.587 . . . . 0.0 109.957 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -66.45 140.44 58.03 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.4 m -137.68 3.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.791 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 172.75 168.39 34.0 Favored Glycine 0 N--CA 1.507 3.371 0 C-N-CA 118.933 -1.603 . . . . 0.0 110.268 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -132.35 122.45 25.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.274 . . . . 0.0 109.936 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.5 t -90.6 135.58 26.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 172.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.8 t -131.61 157.73 43.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 1' ' ' SER . 8.4 t70 -111.29 122.5 48.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 0.0 109.7 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 p -63.51 -6.04 4.58 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.445 0.64 . . . . 0.0 109.739 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 29' ' ' ARG . 23.6 t0 -137.78 29.9 2.58 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 108.943 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.62 ' NH1' ' OG ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -29.57 97.45 0.09 OUTLIER Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.442 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' GLU . 19.7 Cg_exo -62.24 145.1 96.21 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 N-CA-C 108.5 -1.385 . . . . 0.0 108.5 172.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -25.3 -88.04 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -174.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -88.49 26.75 1.39 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.699 -1.251 . . . . 0.0 110.035 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.62 ' OG ' ' NH1' ' A' ' 29' ' ' ARG . 14.0 p -59.67 120.82 10.2 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.918 -1.114 . . . . 0.0 110.372 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -104.83 148.13 26.98 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 54' ' ' GLU . 67.4 m-85 -88.19 126.87 35.36 Favored 'General case' 0 C--N 1.274 -2.706 0 O-C-N 121.359 -0.838 . . . . 0.0 110.35 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -106.24 141.35 37.73 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.2 tp -121.51 145.48 47.9 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -151.64 171.12 18.13 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 117.74 164.86 13.37 Favored Glycine 0 N--CA 1.499 2.839 0 O-C-N 120.951 -1.093 . . . . 0.0 110.561 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -55.46 117.74 3.84 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 117.03 -21.05 11.23 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.3 t -125.06 -92.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.7 -0.882 . . . . 0.0 108.747 -178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -85.39 -9.14 57.94 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.528 -0.733 . . . . 0.0 109.489 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 4.0 mp0 -125.97 161.71 26.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.447 -0.783 . . . . 0.0 109.35 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.451 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 2.5 mt-10 -60.27 131.63 90.11 Favored Pre-proline 0 C--N 1.289 -2.027 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.361 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.479 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 41.1 Cg_endo -73.03 115.13 2.97 Favored 'Cis proline' 0 N--CA 1.512 2.605 0 C-N-CA 123.521 -1.449 . . . . 0.0 110.992 -1.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 4.5 mttp -66.47 150.32 49.12 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.921 -1.112 . . . . 0.0 112.744 -173.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.18 29.27 36.33 Favored Glycine 0 N--CA 1.493 2.44 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.284 171.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 41' ' ' GLY . 13.9 mm -80.91 -44.29 21.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 174.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -109.16 138.46 45.48 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.656 179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.79 138.88 36.2 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -106.49 152.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 O-C-N 121.825 -0.547 . . . . 0.0 109.546 -176.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.449 ' OD1' ' N ' ' A' ' 56' ' ' THR . 12.4 t-20 -79.83 119.47 22.75 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 35' ' ' PHE . 3.1 mt-10 -51.11 -45.52 61.59 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 122.207 -0.308 . . . . 0.0 111.658 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.12 -53.02 6.75 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.081 -1.637 . . . . 0.0 111.997 -176.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.449 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 9.9 p -79.74 -27.81 40.52 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.2 0.524 . . . . 0.0 110.575 -172.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.81 12.9 80.73 Favored Glycine 0 C--N 1.285 -2.29 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 14.9 m -67.9 120.14 13.71 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.275 -1.132 . . . . 0.0 108.91 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.401 ' N ' ' O ' ' A' ' 22' ' ' GLY . 1.6 t -87.13 132.19 33.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -134.04 150.72 51.23 Favored 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -97.36 142.15 14.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 63.0 p -88.11 -20.76 25.24 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.55 -0.719 . . . . 0.0 110.795 -175.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.59 ' NE ' ' O ' ' A' ' 64' ' ' THR . 1.6 ptm180 -148.27 -172.88 4.18 Favored 'General case' 0 C--N 1.289 -2.062 0 O-C-N 121.208 -0.933 . . . . 0.0 108.834 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.59 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 13.1 t -67.38 168.41 10.75 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.47 ' N ' ' OE1' ' A' ' 13' ' ' GLN . 92.5 mt -122.58 149.34 44.1 Favored 'General case' 0 C--N 1.278 -2.521 0 O-C-N 120.629 -1.294 . . . . 0.0 108.695 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.512 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -130.49 117.6 19.87 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -178.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 1.86 1.42 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.512 ' H ' ' C ' ' A' ' 66' ' ' ASP . 2.9 mt-10 -78.53 -29.23 46.34 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.79 -55.77 5.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-O 122.209 1.004 . . . . 0.0 108.342 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.9 mt -137.85 139.27 43.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.54 -24.21 18.05 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.7 p -154.1 129.6 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -97.21 124.1 41.19 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -98.55 88.39 4.08 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.6 170.74 15.47 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.433 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.8 m-85 -124.58 131.57 53.47 Favored 'General case' 0 C--N 1.274 -2.711 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.06 146.92 17.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -137.1 138.53 40.45 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.431 ' N ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -86.76 133.54 33.65 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 170.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.511 ' HA ' HD23 ' A' ' 87' ' ' LEU . 4.6 p -129.78 146.13 51.54 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.052 -1.059 . . . . 0.0 112.476 -172.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -80.66 170.14 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.404 HG21 ' N ' ' A' ' 83' ' ' ASN . 35.2 m -61.62 -24.43 33.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.404 ' N ' HG21 ' A' ' 82' ' ' VAL . 15.7 t-20 -79.72 2.5 22.53 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.23 16.93 78.61 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 80' ' ' THR . 14.0 mttp -81.02 142.15 33.68 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 35.5 m -88.76 116.77 27.26 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.511 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -91.98 -19.45 22.4 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.77 146.73 23.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.47 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 99.41 -176.72 29.19 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.86 103.99 0.31 Allowed 'Cis proline' 0 N--CA 1.5 1.873 0 C-N-CA 123.669 -1.388 . . . . 0.0 112.519 -0.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.47 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 11.7 m -79.9 162.97 60.41 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -94.52 151.06 1.92 Allowed 'Trans proline' 0 C--N 1.296 -2.19 0 C-N-CA 121.808 1.672 . . . . 0.0 112.101 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.3 tp -133.88 129.8 36.92 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -107.39 114.13 27.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.477 -0.764 . . . . 0.0 109.907 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 57.8 t -103.81 104.1 16.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mp -86.13 139.19 17.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 38.5 t -95.0 124.38 47.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 10.4 pt -112.13 170.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -94.54 171.39 8.83 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.921 -1.112 . . . . 0.0 108.124 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -156.93 158.55 36.86 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -71.9 66.76 0.58 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.527 ' CG ' ' N ' ' A' ' 103' ' ' ASN . 4.3 p-10 -56.46 -57.06 13.93 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.406 -171.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.527 ' N ' ' CG ' ' A' ' 102' ' ' ASP . 1.3 m-20 58.92 27.79 16.7 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.527 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 24.9 mtm180 -61.01 135.3 93.17 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--O 1.199 -1.462 0 C-N-CA 122.044 1.829 . . . . 0.0 112.57 -179.311 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 2.7 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.485 ' CG2' HG22 ' A' ' 91' ' ' VAL . 24.8 mt -86.46 134.43 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.42 -0.8 . . . . 0.0 110.438 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.89 124.64 72.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 173.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.52 157.05 39.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.74 143.18 47.99 Favored Pre-proline 0 C--N 1.276 -2.596 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.33 133.86 30.92 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.017 1.811 . . . . 0.0 110.359 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.9 mt -105.05 112.29 38.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 O-C-N 121.54 -0.725 . . . . 0.0 109.653 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.531 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -93.49 110.73 22.3 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.8 mt -120.23 134.7 24.11 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.541 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 35.8 Cg_endo -74.13 154.46 47.03 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 CA-C-N 119.68 0.922 . . . . 0.0 112.742 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.0 174.24 10.86 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-O 122.304 1.05 . . . . 0.0 111.12 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.521 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 57.5 t30 52.38 24.69 3.05 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -77.99 137.47 38.31 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 174.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.521 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -101.26 175.21 5.66 Favored 'General case' 0 C--N 1.267 -3.005 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.524 -177.652 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.58 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -53.49 -179.32 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 6.7 Cg_exo -70.74 128.92 14.45 Favored 'Cis proline' 0 N--CA 1.491 1.338 0 C-N-CA 124.25 -1.146 . . . . 0.0 113.422 -0.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' A' ' 63' ' ' ARG . 22.7 m-85 -113.43 165.74 12.7 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.415 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 14.7 Cg_exo -70.66 161.43 88.82 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 C-N-CA 124.412 -1.078 . . . . 0.0 112.254 -1.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.477 ' NH2' ' OE1' ' A' ' 13' ' ' GLN . 1.2 mtp-105 -131.17 128.28 39.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.477 -0.764 . . . . 0.0 109.711 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 5.3 t0 -63.06 133.2 54.14 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.4 m -128.86 5.57 2.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 175.14 168.74 36.11 Favored Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.108 -1.52 . . . . 0.0 109.635 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -131.99 117.09 17.95 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.164 -1.198 . . . . 0.0 109.699 -178.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.5 t -81.81 134.4 27.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 172.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.9 t -126.64 133.26 68.99 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 1' ' ' SER . 9.1 t0 -107.4 137.46 45.4 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.34 4.0 41.06 Favored 'General case' 0 C--N 1.274 -2.692 0 O-C-N 121.104 -0.998 . . . . 0.0 110.752 -175.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -148.86 72.6 1.19 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.01 126.54 31.47 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.181 -0.95 . . . . 0.0 110.357 -177.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' GLU . 74.9 Cg_exo -49.77 154.3 4.98 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.54 2.16 . . . . 0.0 111.171 174.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -25.12 -63.06 0.06 Allowed 'General case' 0 N--CA 1.512 2.646 0 C-N-CA 123.541 0.736 . . . . 0.0 111.382 -179.125 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' NH2' ' O ' ' A' ' 33' ' ' SER . 1.6 mmm180 -129.99 74.24 1.58 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.964 0.888 . . . . 0.0 109.118 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.538 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -80.49 158.13 25.95 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.545 0.688 . . . . 0.0 109.634 -179.516 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.466 ' C ' ' HG1' ' A' ' 80' ' ' THR . 11.3 mmtp -105.4 170.61 7.79 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.405 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 23.5 m-85 -120.98 131.9 54.59 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.584 ' NE ' ' HA ' ' A' ' 36' ' ' ARG . 4.3 mmp_? -108.28 139.24 43.26 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 76' ' ' PHE . 15.3 tp -128.54 139.28 52.38 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.07 170.56 15.96 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.418 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 124.31 159.1 10.31 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.93 114.0 1.42 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 124.76 -22.15 6.52 Favored Glycine 0 C--N 1.281 -2.492 0 N-CA-C 107.383 -2.287 . . . . 0.0 107.383 -173.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.0 t -116.52 -97.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.404 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 35.0 t0 -90.87 -5.53 55.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 109.759 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.418 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 7.3 mp0 -114.09 156.88 23.36 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.569 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 14.0 mm-40 -67.21 136.36 93.79 Favored Pre-proline 0 C--N 1.277 -2.563 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.533 -176.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 29.3 Cg_endo -69.94 115.05 2.3 Favored 'Cis proline' 0 N--CA 1.51 2.449 0 C-N-CA 123.316 -1.535 . . . . 0.0 111.359 -0.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.569 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 6.3 mttm -68.35 152.17 45.82 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.915 -1.116 . . . . 0.0 111.1 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.498 ' O ' ' NH1' ' A' ' 63' ' ' ARG . . . 56.44 49.08 71.32 Favored Glycine 0 N--CA 1.487 2.098 0 O-C-N 121.796 -0.565 . . . . 0.0 112.389 172.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.439 ' N ' ' O ' ' A' ' 41' ' ' GLY . 3.7 mm -106.42 -43.0 6.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -116.79 138.73 51.28 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.973 0.892 . . . . 0.0 110.996 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -124.16 170.32 10.84 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -132.91 147.96 31.55 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.473 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 171.283 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.498 ' C ' ' H ' ' A' ' 55' ' ' ASN . 21.1 t-20 -78.68 112.18 15.53 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 118.101 -1.44 . . . . 0.0 108.31 -176.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 mp0 -59.58 10.27 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 C-N-CA 124.455 1.102 . . . . 0.0 112.263 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.498 ' H ' ' C ' ' A' ' 53' ' ' ASN . 31.8 m-80 -137.86 -48.39 0.56 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 109.009 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 17.5 p -87.33 -27.76 22.65 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.543 -0.723 . . . . 0.0 109.478 -177.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.47 5.82 74.77 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 14.6 m -66.84 123.53 20.41 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.394 -1.062 . . . . 0.0 109.379 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.493 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.0 t -82.57 122.42 37.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -123.42 140.89 52.54 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.404 -0.81 . . . . 0.0 110.133 -177.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 10.6 p -90.93 144.04 9.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.9 p -96.27 -17.62 20.6 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.773 -0.58 . . . . 0.0 111.146 -176.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.498 ' NH1' ' O ' ' A' ' 48' ' ' GLY . 5.5 ptp85 -153.52 -176.22 5.71 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.783 -1.198 . . . . 0.0 110.464 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.1 t -74.86 142.99 44.07 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 121.446 0.641 . . . . 0.0 110.127 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.2 mt -104.64 158.81 16.25 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.323 -0.861 . . . . 0.0 109.164 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -136.71 120.71 17.64 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 34.5 mtm105 -63.91 -12.11 33.97 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.085 . . . . 0.0 108.342 175.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.03 -22.96 60.55 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.1 t -101.11 -53.23 7.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -176.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.447 HD11 ' CE2' ' A' ' 73' ' ' TYR . 1.4 mt -144.9 136.41 20.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.64 -24.24 20.55 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -159.74 140.52 4.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.587 -0.695 . . . . 0.0 109.511 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.447 ' CE2' HD11 ' A' ' 70' ' ' ILE . 58.6 m-85 -104.13 136.99 42.73 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.17 92.28 5.95 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -91.72 170.56 9.8 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 77.6 m-85 -135.66 140.62 44.63 Favored 'General case' 0 C--N 1.265 -3.08 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.23 155.18 21.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 120.977 0.418 . . . . 0.0 110.079 -177.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 36' ' ' ARG . 33.1 mt-10 -140.94 141.35 34.5 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 173.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.31 128.37 35.49 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 171.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.466 ' HG1' ' C ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -119.86 161.2 21.22 Favored 'General case' 0 C--N 1.272 -2.766 0 O-C-N 121.543 -0.723 . . . . 0.0 110.847 -172.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 84' ' ' GLY . 5.2 t0 -108.97 170.44 8.04 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -52.98 -22.85 4.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -79.66 2.24 23.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.423 -0.798 . . . . 0.0 109.171 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 62.97 28.14 71.52 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 80' ' ' THR . 17.0 mttm -95.24 137.95 33.61 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.7 m -71.97 117.67 13.86 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.538 ' N ' ' CD2' ' A' ' 87' ' ' LEU . 1.5 mm? -81.45 -46.37 14.67 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.11 157.82 45.03 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.09 -177.48 35.25 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.76 112.92 0.61 Allowed 'Cis proline' 0 N--CA 1.499 1.808 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.652 -0.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.485 HG22 ' CG2' ' A' ' 2' ' ' ILE . 0.9 OUTLIER -93.45 168.27 12.34 Favored Pre-proline 0 C--N 1.284 -2.274 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 175.106 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -96.23 156.67 1.35 Allowed 'Trans proline' 0 C--N 1.295 -2.287 0 C-N-CA 121.564 1.509 . . . . 0.0 112.823 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 9.6 tp -142.52 124.35 15.14 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -105.43 115.38 30.15 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-O 121.432 0.634 . . . . 0.0 109.652 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 96.0 t -102.55 108.82 24.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mp -90.71 139.34 17.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 O-C-N 121.488 -0.758 . . . . 0.0 108.971 -178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 17.4 t -95.17 110.44 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.8 pt -96.7 170.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.68 ' CB ' HH12 ' A' ' 104' ' ' ARG . 0.2 OUTLIER -72.98 161.71 30.37 Favored 'General case' 0 C--N 1.281 -2.411 0 O-C-N 120.883 -1.136 . . . . 0.0 110.481 -175.205 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 102' ' ' ASP . 35.7 mt-30 -50.91 87.4 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.547 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 103' ' ' ASN . 5.6 t-20 61.47 -72.4 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.378 -0.826 . . . . 0.0 110.674 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.483 ' O ' ' NH1' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -66.1 77.75 0.09 Allowed 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.277 -0.889 . . . . 0.0 108.855 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 101' ' ' ASN . 0.2 OUTLIER -51.04 -27.8 8.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.769 -178.157 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.68 HH12 ' CB ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER 39.58 65.96 3.29 Favored Pre-proline 0 N--CA 1.505 2.294 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -178.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 C--O 1.195 -1.64 0 C-N-CA 122.335 2.023 . . . . 0.0 111.047 -179.014 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 1.1 m . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.498 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 24.6 mt -88.98 142.79 12.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.714 0.769 . . . . 0.0 111.329 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.85 135.17 50.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.465 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -141.12 162.51 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.134 -0.978 . . . . 0.0 109.177 -176.758 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -128.0 149.64 71.46 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.71 137.75 50.37 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 110.464 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.435 HG13 HD13 ' A' ' 93' ' ' LEU . 32.1 mt -99.44 110.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.1 mp -100.24 98.39 9.07 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 17.8 mt -102.18 129.25 26.67 Favored Pre-proline 0 C--N 1.271 -2.837 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 19.4 Cg_endo -66.95 125.16 13.21 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 N-CA-C 109.715 -0.917 . . . . 0.0 109.715 174.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.61 ' CD ' ' HE ' ' A' ' 67' ' ' ARG . 4.5 pt-20 -62.6 -176.74 0.12 Allowed 'General case' 0 C--N 1.284 -2.279 0 CA-C-O 122.266 1.032 . . . . 0.0 111.746 -173.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.74 -4.54 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 68.0 mt-30 -59.68 113.86 2.46 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.411 ' H ' ' HD3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -79.5 -174.94 4.5 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.924 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.488 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 10.3 mm-40 -47.32 166.36 0.19 Allowed Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.488 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 3.4 Cg_endo -82.47 148.4 67.17 Favored 'Cis proline' 0 C--N 1.309 -1.549 0 C-N-CA 123.918 -1.284 . . . . 0.0 114.285 0.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.424 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 37.6 m-85 -134.0 170.46 11.24 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 5.2 Cg_exo -75.07 156.69 99.83 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 120.812 1.326 . . . . 0.0 110.84 0.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.447 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 24.8 mtp180 -133.8 126.51 30.72 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.327 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.69 129.84 43.53 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.2 -5.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.905 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.33 141.27 6.34 Favored Glycine 0 C--N 1.285 -2.275 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 22.9 ttpp -109.9 119.91 40.81 Favored 'General case' 0 C--N 1.286 -2.184 0 O-C-N 121.487 -1.007 . . . . 0.0 109.889 -177.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.84 142.32 14.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 171.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.2 t -126.13 126.2 69.15 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.837 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 14.9 t0 -99.17 128.49 45.31 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 171.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 p -80.54 -87.55 0.08 Allowed 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.166 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -73.65 53.96 0.45 Allowed 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.534 -0.729 . . . . 0.0 109.463 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 25.7 mtt180 -64.86 155.49 82.87 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.611 -0.681 . . . . 0.0 110.715 -176.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.16 121.76 9.52 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 N-CA-C 107.006 -1.959 . . . . 0.0 107.006 163.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -31.01 -48.89 0.12 Allowed 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -105.03 20.97 17.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.026 -1.046 . . . . 0.0 110.91 -176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 p -64.48 156.26 30.17 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.975 -1.078 . . . . 0.0 108.586 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -120.02 170.4 9.32 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.341 -0.849 . . . . 0.0 109.169 178.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.416 ' CD2' ' HA3' ' A' ' 57' ' ' GLY . 47.8 m-85 -105.75 126.38 52.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.234 -0.916 . . . . 0.0 110.3 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.31 121.22 44.7 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.5 tp -99.6 156.77 16.89 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 175.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.14 171.44 19.25 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -174.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.34 174.66 19.05 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.356 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 111.17 1.64 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 123.99 -13.51 8.03 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -176.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.7 t -130.46 -99.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.616 -0.932 . . . . 0.0 108.568 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.413 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -84.1 -1.58 55.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.346 -0.846 . . . . 0.0 108.898 178.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -126.12 150.69 48.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 108.685 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.555 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.7 mp0 -60.62 133.06 91.43 Favored Pre-proline 0 C--N 1.279 -2.49 0 C-N-CA 123.579 0.752 . . . . 0.0 110.463 -176.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.435 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 30.6 Cg_endo -66.24 117.46 2.06 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 C-N-CA 123.634 -1.402 . . . . 0.0 110.921 -1.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.555 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 23.3 mttp -69.84 145.56 52.0 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.155 -0.966 . . . . 0.0 111.611 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.24 41.45 79.21 Favored Glycine 0 C--N 1.283 -2.412 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.416 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 41' ' ' GLY . 12.6 mm -88.7 -41.41 14.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -112.25 148.91 33.14 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.069 -179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -145.47 135.16 23.4 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 172.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 18.6 tt -94.93 161.25 2.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.663 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.445 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 11.6 t-20 -79.4 114.4 18.31 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 2.9 mt-10 -65.53 10.55 0.09 Allowed 'General case' 0 C--N 1.286 -2.189 0 O-C-N 121.838 -0.538 . . . . 0.0 112.425 -174.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.445 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.4 t-20 -133.05 -50.19 0.88 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.658 -1.276 . . . . 0.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.0 p -79.4 -54.12 6.24 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.416 ' HA3' ' CD2' ' A' ' 35' ' ' PHE . . . 121.97 2.26 10.3 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -63.48 122.25 15.82 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.671 -0.899 . . . . 0.0 109.466 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 52' ' ' ILE . 44.5 t -91.35 117.65 35.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -109.17 140.31 42.93 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.918 -176.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.9 p -89.43 141.89 13.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.3 p -94.32 -19.71 20.42 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.29 -0.881 . . . . 0.0 111.034 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.2 178.21 8.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.006 -1.059 . . . . 0.0 110.393 -176.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 t -68.53 143.8 54.81 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.4 mt -106.25 142.28 36.2 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.305 -0.872 . . . . 0.0 109.115 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -123.99 122.41 37.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.61 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 6.4 mtm105 -60.48 -9.72 4.05 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -79.15 -27.9 42.76 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.84 -55.56 6.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -144.74 134.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.99 -26.18 22.77 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.8 p -152.79 139.42 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.683 -0.636 . . . . 0.0 109.641 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -101.17 134.04 44.8 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.444 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 14.5 tp60 -96.96 96.08 8.26 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.61 170.1 9.04 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.193 0.996 . . . . 0.0 108.982 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -137.47 137.28 38.55 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.42 138.21 48.82 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 CA-C-O 121.128 0.489 . . . . 0.0 110.573 -176.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -133.95 139.87 46.4 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.53 141.62 31.48 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 169.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.529 ' HA ' HD23 ' A' ' 87' ' ' LEU . 1.2 p -129.52 162.13 28.89 Favored 'General case' 0 C--N 1.275 -2.668 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.364 -174.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 10.2 t70 -100.67 170.3 8.45 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.502 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.2 m -53.6 -27.01 14.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.426 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 14.0 t-20 -79.89 3.53 19.53 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.408 -0.807 . . . . 0.0 109.538 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.31 17.5 70.39 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.426 ' NZ ' ' OD1' ' A' ' 83' ' ' ASN . 18.1 mttp -82.79 146.91 28.7 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.166 -1.197 . . . . 0.0 108.057 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 87.7 m -91.51 116.53 28.93 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -92.88 -23.8 18.67 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 89' ' ' GLY . 0.8 OUTLIER -145.41 164.84 30.28 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.407 ' N ' ' HG3' ' A' ' 88' ' ' GLU . . . 80.72 -166.02 48.53 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -69.65 103.88 0.38 Allowed 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 123.487 -1.464 . . . . 0.0 110.926 -0.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.6 m -72.92 158.21 87.53 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -90.4 141.61 3.4 Favored 'Trans proline' 0 C--N 1.283 -2.901 0 C-N-CA 121.552 1.501 . . . . 0.0 112.424 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.435 HD13 HG13 ' A' ' 7' ' ' ILE . 12.6 tp -131.57 125.73 33.03 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.444 ' HG2' ' NE2' ' A' ' 74' ' ' GLN . 66.3 mt-10 -109.0 123.09 48.58 Favored 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.517 -0.739 . . . . 0.0 109.232 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 41.6 t -108.3 100.43 10.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -84.69 135.94 23.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-O 121.457 0.646 . . . . 0.0 109.298 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.1 t -92.37 99.25 9.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 16.4 pt -90.76 171.9 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.09 170.65 15.92 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.946 -1.096 . . . . 0.0 108.295 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.457 ' OE1' ' NH1' ' A' ' 104' ' ' ARG . 4.3 mt-30 -72.2 118.88 15.63 Favored 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 100' ' ' GLN . 4.2 t-20 30.2 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 121.113 0.482 . . . . 0.0 111.541 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.505 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 0.4 OUTLIER 53.05 25.62 4.24 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.645 -0.66 . . . . 0.0 110.013 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 75.71 16.92 2.41 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.734 -0.604 . . . . 0.0 109.385 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.457 ' NH1' ' OE1' ' A' ' 100' ' ' GLN . 3.2 mtm180 49.49 61.7 13.38 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 104' ' ' ARG . 1.1 Cg_endo . . . . . 0 C--O 1.195 -1.671 0 C-N-CA 121.659 1.573 . . . . 0.0 111.411 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.523 ' H1 ' ' CG ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 CA--C 1.501 -0.941 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 40.5 mt -72.34 123.13 26.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.458 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.64 124.43 72.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.417 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.1 OUTLIER -131.44 158.78 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 -178.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.417 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -127.37 131.03 23.64 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.595 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -41.25 140.89 1.31 Allowed 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.205 1.936 . . . . 0.0 110.85 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.6 mt -103.93 115.45 45.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.1 mp -107.99 96.8 6.63 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.3 mt -107.79 128.13 26.42 Favored Pre-proline 0 C--N 1.279 -2.471 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.463 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 40.5 Cg_endo -72.07 135.4 25.11 Favored 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 120.79 0.993 . . . . 0.0 110.163 175.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.453 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 2.1 pp20? -68.26 -173.32 0.39 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-O 121.996 0.903 . . . . 0.0 111.388 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.65 -5.99 0.1 Allowed 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 174.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.468 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 57.5 mt-30 -61.87 137.0 58.2 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.41 ' CD ' ' N ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -107.14 -159.78 0.71 Allowed 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.681 -0.637 . . . . 0.0 110.158 -174.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.483 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -55.6 166.48 0.97 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.483 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 4.0 Cg_endo -80.29 118.18 5.63 Favored 'Cis proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.273 -1.553 . . . . 0.0 113.525 0.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -107.13 165.58 12.59 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.5 162.77 79.54 Favored 'Cis proline' 0 N--CA 1.504 2.094 0 C-N-CA 124.57 -1.012 . . . . 0.0 111.631 -1.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.468 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 39.4 mtp180 -132.26 144.57 50.7 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 33.7 t70 -77.01 139.34 40.04 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.01 -2.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.859 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 169.77 -178.6 42.64 Favored Glycine 0 N--CA 1.511 3.693 0 C-N-CA 117.355 -2.355 . . . . 0.0 110.401 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 6.8 ttmm -137.01 127.73 27.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.712 -1.464 . . . . 0.0 112.0 -176.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.425 ' O ' ' HA2' ' A' ' 57' ' ' GLY . 15.3 t -94.91 132.57 38.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 168.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.3 156.51 34.47 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.852 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.523 ' CG ' ' H1 ' ' A' ' 1' ' ' SER . 8.3 t70 -132.85 146.05 51.48 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.3 -1.71 26.61 Favored 'General case' 0 C--N 1.285 -2.206 0 O-C-N 121.559 -0.713 . . . . 0.0 111.322 -176.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -140.12 86.11 2.06 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.419 ' HD2' ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -125.43 133.0 24.46 Favored Pre-proline 0 C--N 1.295 -1.77 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 -179.381 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' ARG . 69.9 Cg_exo -52.53 131.49 41.12 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.433 1.422 . . . . 0.0 109.146 170.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -31.85 -35.57 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.432 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 8.7 mtp85 -114.39 10.63 17.08 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.253 -0.904 . . . . 0.0 110.794 -173.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 p -71.94 152.62 42.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.132 -0.98 . . . . 0.0 109.512 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HB3' ' CB ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -131.19 154.74 48.08 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.948 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -79.78 144.76 33.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.498 -0.751 . . . . 0.0 110.801 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.439 ' NH1' ' OE1' ' A' ' 78' ' ' GLU . 1.3 mtp180 -116.5 145.08 43.57 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 tp -122.17 143.85 49.31 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 p -144.12 170.86 15.14 Favored 'General case' 0 C--N 1.276 -2.613 0 O-C-N 121.251 -0.905 . . . . 0.0 109.056 -175.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.02 164.88 13.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.56 106.19 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 133.75 -16.23 4.54 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -175.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 38.2 t -132.73 -88.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.578 -0.954 . . . . 0.0 109.577 -178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.03 -20.51 34.87 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -118.11 157.31 27.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.844 0.831 . . . . 0.0 109.53 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.8 mp0 -56.33 132.4 76.01 Favored Pre-proline 0 C--N 1.28 -2.414 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.756 -176.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.447 ' HB2' ' CG1' ' A' ' 49' ' ' ILE . 4.9 Cg_endo -75.85 115.94 3.86 Favored 'Cis proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.091 -1.629 . . . . 0.0 110.126 -0.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.425 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 32.8 mtpt -69.42 153.85 42.92 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 120.721 -1.237 . . . . 0.0 111.425 -174.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.52 9.1 29.69 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-O 119.261 -0.744 . . . . 0.0 113.34 173.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.447 ' CG1' ' HB2' ' A' ' 46' ' ' PRO . 8.1 mm -60.83 -48.76 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.509 0 CA-C-N 120.239 2.019 . . . . 0.0 106.795 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -108.35 166.62 10.62 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-O 121.815 0.817 . . . . 0.0 110.413 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.84 126.6 7.53 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.46 146.84 5.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 57' ' ' GLY . 34.3 t30 -79.46 85.11 5.27 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.483 ' CB ' ' HB3' ' A' ' 34' ' ' LYS . 1.9 mt-10 -30.82 -34.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 124.053 0.941 . . . . 0.0 113.431 -174.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -93.0 -50.42 5.55 Favored 'General case' 0 C--N 1.285 -2.231 0 O-C-N 121.544 -0.723 . . . . 0.0 110.373 -174.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.433 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 18.8 p -88.32 -12.32 43.8 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 122.047 0.927 . . . . 0.0 108.831 -175.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . 69.82 9.36 62.47 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.49 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 3.5 m -69.35 124.58 24.22 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.326 -1.103 . . . . 0.0 108.291 177.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.433 ' N ' ' O ' ' A' ' 22' ' ' GLY . 1.8 t -90.02 122.52 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.182 -0.949 . . . . 0.0 109.192 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -118.26 154.15 32.75 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.198 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -107.46 149.92 10.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.7 p -104.32 -22.9 13.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.503 -0.748 . . . . 0.0 112.101 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.56 168.52 19.5 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.979 -1.075 . . . . 0.0 111.381 -175.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.1 t -64.87 123.42 19.36 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 36.7 mt -82.08 163.54 21.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.063 -1.023 . . . . 0.0 108.497 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -127.92 170.42 12.86 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.546 ' NE ' ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.68 27.39 8.22 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 121.873 0.844 . . . . 0.0 109.158 -177.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -120.32 -42.18 2.58 Favored 'General case' 0 C--N 1.262 -3.213 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.81 -47.78 16.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 mt -129.85 137.25 57.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.44 -24.13 14.23 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 p -156.29 146.43 11.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.423 -0.798 . . . . 0.0 109.345 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.45 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 60.6 m-85 -103.96 114.48 28.76 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 174.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.465 HE22 ' CG ' ' A' ' 94' ' ' GLU . 18.2 tp60 -88.01 83.07 7.07 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.79 170.58 15.54 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 43.8 m-85 -133.69 129.74 37.2 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.77 144.21 15.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 O-C-N 121.894 -0.503 . . . . 0.0 109.859 -175.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.439 ' OE1' ' NH1' ' A' ' 36' ' ' ARG . 56.0 mt-10 -131.31 140.95 49.86 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.41 ' C ' HD21 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -86.3 127.63 34.81 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 102.806 -3.035 . . . . 0.0 102.806 167.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.507 ' HA ' HD23 ' A' ' 87' ' ' LEU . 19.5 p -123.04 146.05 48.0 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 118.567 -1.253 . . . . 0.0 111.713 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.416 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 29.0 t70 -88.72 165.76 14.51 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.017 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.432 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -55.76 -27.21 21.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -79.5 -13.19 59.73 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.102 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.04 7.18 50.67 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -76.4 143.77 40.44 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 120.666 -1.49 . . . . 0.0 107.787 178.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 98.3 m -86.98 116.08 24.8 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -87.24 -20.8 26.37 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -157.94 153.2 25.81 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.452 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 83.91 -169.5 46.53 Favored Glycine 0 C--N 1.28 -2.536 0 N-CA-C 106.698 -2.561 . . . . 0.0 106.698 -174.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.85 103.23 0.14 OUTLIER 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.644 -1.398 . . . . 0.0 112.722 -0.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 3.7 m -78.4 164.35 56.7 Favored Pre-proline 0 C--N 1.289 -2.059 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -93.71 153.14 2.32 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 121.498 1.465 . . . . 0.0 112.622 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.4 tp -141.0 129.76 22.92 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.465 ' CG ' HE22 ' A' ' 74' ' ' GLN . 31.7 mt-10 -102.92 110.57 22.54 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 60.0 t -103.69 93.08 2.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.76 134.3 27.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 O-C-N 121.507 -0.746 . . . . 0.0 109.24 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 55.2 t -88.38 102.49 12.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 8' ' ' LEU . 9.5 pt -80.17 170.78 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.244 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -95.97 178.66 5.35 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 101' ' ' ASN . 34.7 mm-40 -70.94 107.64 4.15 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 100' ' ' GLN . 71.6 m-20 -38.79 -55.75 1.45 Allowed 'General case' 0 N--CA 1.51 2.544 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.58 109.5 16.24 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 171.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -59.25 129.89 44.29 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.6 mmt-85 -104.86 97.34 12.56 Favored Pre-proline 0 C--N 1.282 -2.347 0 O-C-N 121.467 -0.77 . . . . 0.0 109.526 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo . . . . . 0 C--N 1.317 -1.123 0 C-N-CA 122.173 1.915 . . . . 0.0 110.641 178.172 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.58 ' H1 ' ' CG ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.73 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.462 HD12 ' N ' ' A' ' 79' ' ' THR . 18.9 mt -67.82 148.54 11.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.53 0.681 . . . . 0.0 110.015 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.76 114.31 24.66 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -134.32 169.63 21.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.524 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 2.1 m -159.39 165.94 17.2 Favored Pre-proline 0 C--N 1.276 -2.618 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -55.47 131.32 45.46 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.553 1.502 . . . . 0.0 111.946 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 mt -106.13 115.88 48.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.517 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -90.25 108.01 19.49 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 23.2 mt -109.81 124.23 34.19 Favored Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 6.5 Cg_exo -66.06 124.49 12.69 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.062 1.175 . . . . 0.0 110.777 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -41.86 -72.2 0.07 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.578 0.704 . . . . 0.0 111.797 -176.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.443 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 48.2 p-10 -66.4 40.55 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -174.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.484 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -76.01 56.04 0.96 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 119.608 -1.933 . . . . 0.0 106.145 172.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.564 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -45.59 175.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.331 1.062 . . . . 0.0 113.599 -172.216 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 37.5 mt-30 -48.25 166.34 0.22 Allowed Pre-proline 0 C--N 1.285 -2.201 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.754 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 5.7 Cg_exo -76.1 134.89 37.7 Favored 'Cis proline' 0 N--CA 1.497 1.721 0 C-N-CA 123.725 -1.364 . . . . 0.0 113.898 0.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CZ ' ' O ' ' A' ' 13' ' ' GLN . 24.2 m-85 -102.49 166.24 12.37 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -69.36 166.7 72.32 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.312 -0.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.564 ' NH2' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -125.1 135.28 52.54 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.98 137.16 51.19 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.25 4.83 3.06 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.011 0 C-N-CA 119.441 -0.903 . . . . 0.0 109.014 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 158.37 -170.32 35.04 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 118.218 -1.944 . . . . 0.0 109.632 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.412 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 19.4 ttmm -148.13 128.56 13.97 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.23 -1.159 . . . . 0.0 109.768 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.25 147.07 5.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -132.38 163.73 36.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.58 ' CG ' ' H1 ' ' A' ' 1' ' ' SER . 9.8 t70 -125.09 141.11 52.32 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.436 ' H ' ' HG ' ' A' ' 27' ' ' SER . 0.7 OUTLIER -74.25 -21.74 59.63 Favored 'General case' 0 C--N 1.26 -3.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.362 -176.095 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -144.56 82.16 1.68 Allowed 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.459 ' CG ' ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -87.3 115.82 64.03 Favored Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.154 -0.966 . . . . 0.0 109.746 -176.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -42.4 138.09 3.44 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.909 1.739 . . . . 0.0 109.461 175.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -41.49 -35.55 0.72 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.813 -0.554 . . . . 0.0 110.937 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -120.59 40.15 3.58 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.81 -0.556 . . . . 0.0 110.2 -176.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.436 ' C ' ' HG2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -84.62 -179.85 7.22 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.798 -1.189 . . . . 0.0 111.263 -177.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.436 ' HG2' ' C ' ' A' ' 33' ' ' SER . 6.2 mmtm -147.71 150.51 34.44 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 54' ' ' GLU . 35.5 m-85 -94.65 124.28 38.59 Favored 'General case' 0 C--N 1.28 -2.446 0 O-C-N 121.408 -0.807 . . . . 0.0 109.485 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.465 HH11 ' CG ' ' A' ' 36' ' ' ARG . 4.4 mmp_? -107.61 125.77 51.73 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 44.1 tp -106.29 144.45 32.95 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -149.68 170.89 17.64 Favored 'General case' 0 C--N 1.278 -2.5 0 O-C-N 121.163 -0.96 . . . . 0.0 108.732 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.91 176.26 18.71 Favored Glycine 0 N--CA 1.502 3.033 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.056 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -61.11 121.16 11.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 110.16 -20.77 25.62 Favored Glycine 0 C--N 1.28 -2.552 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 -177.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.9 t -116.2 -93.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.47 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 5.5 t70 -92.98 -12.58 30.37 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.59 -0.694 . . . . 0.0 109.647 178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -109.7 157.58 18.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -57.81 132.52 82.95 Favored Pre-proline 0 C--N 1.288 -2.1 0 O-C-N 121.982 -0.449 . . . . 0.0 110.084 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.426 ' O ' ' HA3' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -77.42 118.77 5.95 Favored 'Cis proline' 0 N--CA 1.501 1.959 0 C-N-CA 123.91 -1.287 . . . . 0.0 110.24 -0.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 22.6 mttp -67.14 149.69 50.17 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 120.788 -1.195 . . . . 0.0 111.947 -174.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.22 29.3 72.61 Favored Glycine 0 N--CA 1.49 2.286 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.748 171.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.432 ' N ' ' O ' ' A' ' 41' ' ' GLY . 10.6 mm -83.77 -44.75 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 173.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -106.33 147.76 28.82 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.601 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.57 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -141.94 126.25 17.59 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 177.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.61 147.67 8.88 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.464 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 28.5 t-20 -79.68 99.97 7.65 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -42.39 -26.64 0.12 Allowed 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.896 -177.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -106.5 -37.28 6.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.909 -1.12 . . . . 0.0 111.69 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.464 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 5.1 p -89.8 -15.23 32.78 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 120.984 -1.072 . . . . 0.0 108.918 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.24 2.62 49.14 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.412 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 19.3 m -64.51 124.37 21.67 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.292 -1.122 . . . . 0.0 108.815 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.1 t -88.96 131.0 37.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.57 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -130.87 160.53 34.17 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.44 149.37 19.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.1 p -94.71 -10.57 31.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.48 -0.763 . . . . 0.0 111.148 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -155.15 162.92 40.85 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.052 -1.03 . . . . 0.0 109.306 -178.196 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.443 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 5.1 t -62.18 138.2 58.37 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 65.2 mt -90.71 131.58 36.31 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -106.06 119.34 38.96 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -57.62 -7.65 0.71 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -77.89 -26.93 49.49 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.9 t -89.87 -53.02 9.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 mt -151.66 144.02 16.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.28 -25.55 16.29 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.1 p -154.92 135.95 5.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.501 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -106.03 138.64 41.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.42 HE22 ' CG ' ' A' ' 94' ' ' GLU . 0.3 OUTLIER -100.7 87.08 3.25 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.317 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.11 170.78 15.74 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -132.21 131.37 42.09 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.18 140.64 28.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 O-C-N 122.022 -0.424 . . . . 0.0 110.046 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -130.28 137.12 49.82 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.462 ' N ' HD12 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -86.2 133.8 33.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 172.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.535 ' HA ' HD23 ' A' ' 87' ' ' LEU . 4.1 p -125.27 159.17 32.31 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.689 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.488 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -101.07 170.55 8.2 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 177.134 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.488 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 0.9 OUTLIER -43.09 -38.0 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 CA-C-O 121.825 0.821 . . . . 0.0 109.613 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.435 ' N ' ' CG2' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -79.95 2.85 21.93 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.697 -0.627 . . . . 0.0 109.975 -177.131 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 74.67 15.48 80.64 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 80' ' ' THR . 2.0 mtpp -73.51 134.18 43.8 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 91.0 m -81.27 116.92 21.37 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.803 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -92.33 -22.02 19.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.21 149.37 29.35 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.497 ' HA3' ' N ' ' A' ' 91' ' ' VAL . . . 105.43 -178.39 23.33 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -71.63 104.43 0.49 Allowed 'Cis proline' 0 N--CA 1.491 1.354 0 C-N-CA 123.304 -1.54 . . . . 0.0 111.568 0.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.497 ' N ' ' HA3' ' A' ' 89' ' ' GLY . 9.5 m -75.23 159.04 83.25 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 176.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -91.78 145.16 3.08 Favored 'Trans proline' 0 C--N 1.279 -3.089 0 C-N-CA 121.529 1.486 . . . . 0.0 111.699 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.2 tp -128.84 126.97 40.94 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' CG ' HE22 ' A' ' 74' ' ' GLN . 4.2 mt-10 -106.81 110.29 22.42 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 24.8 t -101.8 112.22 34.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.55 136.28 28.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.57 111.76 23.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 9.7 pt -105.45 171.63 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.58 154.7 27.85 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -91.14 69.02 6.13 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -172.09 155.16 3.62 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.45 -36.85 4.17 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.1 t30 61.21 19.4 10.03 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.3 mtm-85 -57.04 117.67 19.25 Favored Pre-proline 0 N--CA 1.485 1.303 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--N 1.305 -1.711 0 C-N-CA 122.15 1.9 . . . . 0.0 110.603 179.702 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 79' ' ' THR . 17.2 mt -62.01 146.02 12.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-O 121.934 0.874 . . . . 0.0 111.065 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.85 115.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.553 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 174.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.451 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -127.14 161.86 33.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.057 -1.027 . . . . 0.0 108.9 -175.498 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.451 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -155.52 138.84 10.89 Favored Pre-proline 0 C--N 1.273 -2.74 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -41.9 138.91 2.55 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 C-N-CA 122.351 2.034 . . . . 0.0 112.724 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 16.2 mt -104.63 119.44 53.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 175.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.8 mp -106.15 79.42 1.4 Allowed 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 4.7 mt -81.99 140.35 46.47 Favored Pre-proline 0 C--N 1.281 -2.398 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HB3' ' HB2' ' A' ' 100' ' ' GLN . 11.1 Cg_endo -73.69 137.13 24.44 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 120.748 0.965 . . . . 0.0 111.046 177.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -66.08 170.59 5.48 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.283 -0.886 . . . . 0.0 109.198 -178.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.438 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 5.3 t-20 59.8 13.5 3.58 Favored 'General case' 0 C--N 1.287 -2.114 0 O-C-N 121.752 -0.593 . . . . 0.0 112.093 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -57.58 127.63 32.97 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.534 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -89.67 158.53 17.54 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.153 -0.967 . . . . 0.0 112.781 -170.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.53 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 12.3 mp0 -50.07 167.05 0.25 Allowed Pre-proline 0 C--N 1.296 -1.733 0 C-N-CA 124.938 1.295 . . . . 0.0 109.022 176.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.54 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 67.8 Cg_endo -79.61 154.67 88.64 Favored 'Cis proline' 0 C--N 1.31 -1.473 0 C-N-CA 123.613 -1.411 . . . . 0.0 113.641 0.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.459 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 33.9 m-85 -135.09 169.86 12.7 Favored Pre-proline 0 C--N 1.276 -2.597 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.459 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.6 Cg_exo -68.94 173.34 41.99 Favored 'Cis proline' 0 N--CA 1.493 1.469 0 C-N-CA 124.485 -1.048 . . . . 0.0 112.124 0.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.54 ' NH2' ' O ' ' A' ' 16' ' ' PRO . 7.1 ttm180 -155.88 145.2 20.81 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -65.65 132.83 49.78 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.01 3.74 5.14 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 163.36 179.11 37.61 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.93 131.88 35.74 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.818 -1.401 . . . . 0.0 110.134 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.2 t -91.69 126.62 44.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 102.179 -3.267 . . . . 0.0 102.179 166.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.0 t -112.07 159.69 11.91 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 C-N-CA 118.472 -1.291 . . . . 0.0 109.068 -173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -144.99 110.35 5.24 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.33 -56.45 3.31 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -175.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -71.3 62.03 0.33 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 122.634 1.207 . . . . 0.0 107.799 178.196 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 6.9 mtm180 -95.43 126.1 47.15 Favored Pre-proline 0 C--N 1.281 -2.401 0 O-C-N 121.173 -0.954 . . . . 0.0 110.05 -177.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.1 -122.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 122.955 2.437 . . . . 0.0 113.059 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -80.44 -90.39 0.06 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.317 -1.49 . . . . 0.0 110.799 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.6 mtp85 -107.64 36.94 2.56 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.994 -1.066 . . . . 0.0 109.556 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.33 114.16 0.47 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 122.957 0.503 . . . . 0.0 111.065 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -107.14 142.35 36.97 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.743 -0.598 . . . . 0.0 110.331 -176.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.418 ' CD1' ' CA ' ' A' ' 57' ' ' GLY . 78.8 m-85 -79.11 139.1 38.14 Favored 'General case' 0 C--N 1.273 -2.74 0 O-C-N 120.972 -1.08 . . . . 0.0 111.255 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.458 ' NH2' ' OG1' ' A' ' 86' ' ' THR . 7.0 mtm-85 -115.57 127.16 55.04 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 172.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 27.2 tp -108.71 138.97 44.17 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -147.69 170.8 16.75 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.68 163.83 13.0 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -57.21 112.81 1.48 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 125.74 -18.88 6.67 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 107.934 -2.067 . . . . 0.0 107.934 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.3 t -123.77 -97.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -177.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.98 -18.32 30.98 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -107.13 156.88 18.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.604 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 15.5 mm-40 -68.54 140.93 92.59 Favored Pre-proline 0 C--N 1.269 -2.893 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.537 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.462 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -70.52 113.39 1.83 Allowed 'Cis proline' 0 N--CA 1.51 2.48 0 C-N-CA 123.605 -1.415 . . . . 0.0 111.438 1.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.604 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 5.3 mtpm? -69.17 152.82 44.64 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.766 -1.209 . . . . 0.0 111.909 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.87 5.1 50.8 Favored Glycine 0 N--CA 1.489 2.198 0 CA-C-O 119.113 -0.826 . . . . 0.0 113.474 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 11.7 mm -65.24 -46.66 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 120.456 2.128 . . . . 0.0 107.338 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.415 ' CZ ' HG12 ' A' ' 95' ' ' VAL . 69.6 m-85 -115.75 144.67 43.64 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.296 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.18 136.01 29.52 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.23 157.54 9.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.602 -0.686 . . . . 0.0 109.989 -176.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.456 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 11.4 t-20 -85.32 126.94 34.13 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 175.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 1.8 mt-10 -59.7 -38.54 81.86 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.771 -0.581 . . . . 0.0 111.06 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.471 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 10.6 t30 -88.57 -48.03 7.87 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.014 -1.054 . . . . 0.0 111.673 -176.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.1 p -80.49 -34.43 35.81 Favored 'General case' 0 C--N 1.281 -2.376 0 O-C-N 121.727 -0.608 . . . . 0.0 109.662 -174.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' CA ' ' CD1' ' A' ' 35' ' ' PHE . . . 84.08 10.38 80.68 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -176.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -64.54 122.09 15.98 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.209 -1.171 . . . . 0.0 108.334 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.444 ' N ' ' O ' ' A' ' 22' ' ' GLY . 1.8 t -88.92 127.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.59 146.01 49.29 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.532 -0.73 . . . . 0.0 109.654 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 8.3 p -101.63 149.18 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 28.8 p -99.86 -17.32 17.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.634 -0.666 . . . . 0.0 112.122 -175.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.562 HH12 ' CG ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -145.93 167.17 23.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.798 -1.189 . . . . 0.0 110.567 -178.63 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.506 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 7.1 t -58.01 122.51 13.19 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.3 mt -79.73 140.87 36.81 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.466 -1.396 . . . . 0.0 109.904 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.562 ' CG ' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -124.37 117.3 24.17 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.085 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.17 -14.73 18.86 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 121.765 -0.584 . . . . 0.0 109.88 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.56 -28.3 45.94 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.889 -1.132 . . . . 0.0 108.694 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.86 -52.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 73' ' ' TYR . 1.1 mt -145.33 132.59 15.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.36 -25.46 29.14 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.22 136.59 5.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.444 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 42.7 m-85 -100.05 122.52 43.06 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -92.44 93.91 8.83 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.94 170.75 9.8 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.779 0.799 . . . . 0.0 109.028 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -133.0 131.21 40.46 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.9 150.13 20.1 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -174.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 90' ' ' PRO . 0.3 OUTLIER -146.46 146.87 30.71 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 121.302 -0.874 . . . . 0.0 108.652 176.093 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.407 ' OG1' ' HB3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -95.27 135.63 36.62 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 170.419 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.521 ' HA ' HD23 ' A' ' 87' ' ' LEU . 38.0 p -125.76 158.22 35.46 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.411 -0.806 . . . . 0.0 111.553 -171.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.428 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 28.1 t70 -79.64 170.96 15.79 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.428 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 2.1 m -58.41 -27.71 33.9 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -79.61 2.01 23.99 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.736 0.779 . . . . 0.0 108.997 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.36 11.65 85.31 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -77.51 140.05 39.7 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.458 ' OG1' ' NH2' ' A' ' 36' ' ' ARG . 39.0 m -81.51 118.98 23.18 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 120.777 0.322 . . . . 0.0 110.187 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -94.21 -31.29 14.18 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.407 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 5.1 tp10 -138.04 153.18 49.37 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.12 -171.5 38.86 Favored Glycine 0 C--N 1.288 -2.119 0 N-CA-C 106.931 -2.467 . . . . 0.0 106.931 -174.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.41 ' HA ' ' HG2' ' A' ' 78' ' ' GLU . 12.5 Cg_exo -68.37 111.54 1.03 Allowed 'Cis proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.364 -1.515 . . . . 0.0 111.037 -0.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.2 m -86.9 163.56 40.28 Favored Pre-proline 0 C--N 1.28 -2.432 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -93.85 159.84 2.26 Favored 'Trans proline' 0 C--N 1.289 -2.561 0 C-N-CA 121.933 1.756 . . . . 0.0 110.868 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 15.4 tp -144.88 124.48 13.24 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.81 113.14 25.12 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.444 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 78.1 t -105.16 91.39 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.82 138.04 20.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 O-C-N 121.506 -0.746 . . . . 0.0 109.179 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.1 106.72 18.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.2 pt -97.12 170.92 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.081 -1.012 . . . . 0.0 110.307 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -97.77 139.04 34.23 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.726 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.452 ' HB2' ' HB3' ' A' ' 10' ' ' PRO . 34.3 mt-30 -163.99 69.88 0.2 Allowed 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 103' ' ' ASN . 40.0 t-20 -130.19 120.6 24.78 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 103' ' ' ASN . 7.4 m-20 -75.93 18.15 0.28 Allowed 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.512 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER 76.64 23.02 1.11 Allowed 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.799 0.84 . . . . 0.0 109.42 -175.344 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.34 63.3 9.15 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.495 1.61 0 C-N-CA 123.036 2.491 . . . . 0.0 111.968 -177.011 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.934 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 7.2 mt -74.96 146.85 8.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.361 0.6 . . . . 0.0 109.621 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.25 137.89 56.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -150.61 167.43 2.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.494 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -140.87 145.73 40.88 Favored Pre-proline 0 C--N 1.289 -2.055 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.28 133.11 35.78 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.093 1.862 . . . . 0.0 110.323 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.2 mt -103.93 112.1 36.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.167 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.536 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.22 105.33 17.74 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 19.3 mt -111.93 128.4 25.51 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 33.9 Cg_endo -69.27 130.16 19.45 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.172 1.248 . . . . 0.0 110.727 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 66' ' ' ASP . 10.9 pt-20 -64.35 173.88 1.88 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.104 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 57.39 61.75 2.4 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.688 0.756 . . . . 0.0 111.418 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -119.88 131.98 55.42 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -96.97 177.82 5.49 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 121.062 -1.024 . . . . 0.0 111.673 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 18.2 mp0 -54.76 166.94 0.67 Allowed Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 70.5 Cg_endo -78.12 122.13 8.44 Favored 'Cis proline' 0 C--N 1.315 -1.203 0 C-N-CA 123.785 -1.34 . . . . 0.0 114.459 0.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.447 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 29.6 m-85 -97.86 170.2 7.45 Favored Pre-proline 0 C--N 1.279 -2.49 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.7 Cg_exo -68.05 163.27 76.82 Favored 'Cis proline' 0 N--CA 1.493 1.483 0 C-N-CA 124.194 -1.169 . . . . 0.0 111.224 -1.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -124.47 126.93 46.71 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -76.66 132.64 39.5 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 15.6 m -127.46 5.67 3.4 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.643 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.458 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 166.7 179.55 39.96 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 117.707 -2.187 . . . . 0.0 109.756 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' NZ ' ' O ' ' A' ' 56' ' ' THR . 29.5 tttp -143.03 139.57 30.61 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 120.852 -1.381 . . . . 0.0 109.678 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.6 t -94.34 152.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 172.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -144.14 151.4 16.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 9.2 t0 -112.25 135.08 53.37 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -4.64 58.75 Favored 'General case' 0 C--N 1.269 -2.9 0 O-C-N 122.141 -0.349 . . . . 0.0 111.501 -177.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -141.21 -21.37 0.77 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.695 -1.253 . . . . 0.0 111.935 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.608 ' NH1' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -72.51 146.26 88.56 Favored Pre-proline 0 C--N 1.286 -2.191 0 O-C-N 120.66 -1.275 . . . . 0.0 111.398 -171.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -41.86 143.91 1.05 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 123.178 2.586 . . . . 0.0 111.048 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -57.92 -29.1 64.85 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -74.9 52.91 0.56 Allowed 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 p -122.68 134.66 54.47 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 121.241 -0.912 . . . . 0.0 108.766 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 40.8 mttm -113.52 139.17 49.19 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 173.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -89.77 135.5 33.59 Favored 'General case' 0 C--N 1.271 -2.818 0 O-C-N 121.24 -0.912 . . . . 0.0 110.991 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.509 ' NH2' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -100.0 139.27 35.92 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 174.23 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -121.01 135.45 55.21 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -144.91 170.52 15.99 Favored 'General case' 0 C--N 1.274 -2.692 0 O-C-N 121.472 -0.768 . . . . 0.0 109.019 -174.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.494 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 115.15 173.39 17.69 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -58.16 111.5 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 124.52 -15.3 7.62 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.36 -81.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.294 -1.121 . . . . 0.0 109.154 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -96.53 -14.46 22.28 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.494 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 9.3 mp0 -118.85 158.51 25.51 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.521 177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -51.9 127.85 36.08 Favored Pre-proline 0 C--N 1.281 -2.389 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.779 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.405 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 4.3 Cg_endo -80.36 120.66 7.32 Favored 'Cis proline' 0 C--O 1.202 -1.311 0 C-N-CA 123.5 -1.458 . . . . 0.0 110.517 -1.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 28.0 mttp -63.47 155.51 29.0 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 120.872 -1.143 . . . . 0.0 111.268 -175.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.75 32.73 48.01 Favored Glycine 0 N--CA 1.49 2.285 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.149 171.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.403 ' CG1' ' HB2' ' A' ' 46' ' ' PRO . 8.7 mm -87.89 -43.44 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -110.39 141.44 43.46 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.813 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.586 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -132.6 120.61 22.02 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 176.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -89.09 141.87 13.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.491 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 46.6 t30 -79.09 84.79 5.04 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 1.3 mp0 -24.22 -53.43 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 125.327 1.451 . . . . 0.0 113.54 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -79.75 -39.49 30.92 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.161 -0.962 . . . . 0.0 111.325 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 29.2 p -94.32 -26.28 16.64 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-O 121.735 0.779 . . . . 0.0 109.313 -174.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.33 2.6 76.67 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -65.07 121.35 14.52 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.313 -1.11 . . . . 0.0 109.482 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.458 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.1 t -86.83 120.87 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.586 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -123.73 155.42 37.9 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.418 178.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 7.4 p -102.19 143.54 14.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.111 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 59.9 p -90.48 -20.51 22.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.446 -0.784 . . . . 0.0 111.037 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.411 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -151.81 175.66 12.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.115 -0.99 . . . . 0.0 110.033 -175.535 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.411 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 2.7 t -66.62 136.69 55.95 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-O 121.83 0.824 . . . . 0.0 110.793 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.0 mt -98.78 150.61 21.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 11' ' ' GLU . 8.7 m-20 -132.9 122.66 24.67 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.0 mtp-105 -57.26 -13.33 3.11 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -77.79 -22.94 49.37 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.1 t -85.37 -55.87 6.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.405 HG23 ' CD1' ' A' ' 73' ' ' TYR . 1.1 mt -144.74 136.39 21.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.11 -25.46 36.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.1 p -160.02 132.83 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.407 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 70.6 m-85 -94.42 115.23 27.38 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.21 93.1 6.35 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.41 170.62 10.39 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-O 121.956 0.884 . . . . 0.0 108.994 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 78.4 m-85 -128.15 122.23 31.44 Favored 'General case' 0 C--N 1.266 -3.023 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.37 146.15 11.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -177.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -136.5 140.02 42.71 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.49 127.35 33.64 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 170.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.509 ' OG1' ' NH2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -125.46 159.67 31.36 Favored 'General case' 0 C--N 1.267 -3.007 0 C-N-CA 119.265 -0.974 . . . . 0.0 109.895 -178.092 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.532 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 14.8 t70 -97.31 170.3 9.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.532 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.5 m -54.43 -22.6 9.14 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -80.27 -2.86 46.91 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.426 -0.796 . . . . 0.0 109.058 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.12 8.62 86.95 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 80' ' ' THR . 4.2 mttp -81.1 150.21 28.86 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 94.0 m -94.48 118.21 31.3 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-O 121.219 0.533 . . . . 0.0 110.302 -177.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.68 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -89.15 -32.5 17.45 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER -137.83 170.41 16.11 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.593 -0.692 . . . . 0.0 109.758 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.464 ' H ' ' CD ' ' A' ' 88' ' ' GLU . . . 83.5 -165.91 43.1 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -69.63 101.31 0.27 Allowed 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.564 -1.432 . . . . 0.0 110.79 -0.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.419 HG23 ' CD1' ' A' ' 2' ' ' ILE . 10.6 m -74.15 160.37 81.75 Favored Pre-proline 0 C--N 1.291 -1.954 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -92.49 147.07 2.8 Favored 'Trans proline' 0 C--N 1.285 -2.8 0 C-N-CA 121.868 1.712 . . . . 0.0 112.03 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.8 tp -130.51 125.85 35.36 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -108.27 106.91 17.28 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.651 -0.656 . . . . 0.0 109.677 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 38.9 t -98.45 100.5 10.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mp -79.93 131.69 33.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.1 t -90.05 111.24 22.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 11.3 pt -105.25 171.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 O-C-N 121.688 -0.632 . . . . 0.0 109.537 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 101' ' ' ASN . 3.2 m-20 -83.37 176.2 9.28 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.83 68.98 0.44 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 99' ' ' ASP . 48.0 t-20 -83.1 176.97 8.81 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.457 ' C ' ' H ' ' A' ' 104' ' ' ARG . 24.3 t70 -58.67 116.79 3.94 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.441 ' C ' ' ND2' ' A' ' 103' ' ' ASN . 0.4 OUTLIER -69.29 14.72 0.08 Allowed 'General case' 0 C--N 1.283 -2.302 0 O-C-N 121.781 -0.574 . . . . 0.0 110.644 -179.142 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.457 ' H ' ' C ' ' A' ' 102' ' ' ASP . 16.3 mtp180 49.5 64.19 8.98 Favored Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.202 -0.936 . . . . 0.0 109.229 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 104' ' ' ARG . 2.9 Cg_endo . . . . . 0 C--O 1.192 -1.809 0 C-N-CA 122.337 2.025 . . . . 0.0 111.137 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.553 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 7.0 mt -69.22 138.1 22.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.903 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.56 133.4 69.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.69 157.9 10.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.637 0.732 . . . . 0.0 109.462 -177.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 t -128.36 141.84 42.73 Favored Pre-proline 0 C--N 1.281 -2.384 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -45.67 132.92 13.41 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.531 1.487 . . . . 0.0 109.811 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.7 mt -98.08 111.89 28.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.521 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.1 mp -100.3 103.12 14.53 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 97' ' ' VAL . 4.1 mt -108.11 127.8 26.92 Favored Pre-proline 0 C--N 1.27 -2.877 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 18.5 Cg_endo -74.4 135.98 21.1 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 CA-C-N 119.444 0.837 . . . . 0.0 111.945 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 66' ' ' ASP . 2.9 tt0 -39.38 147.08 0.08 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.502 0.668 . . . . 0.0 111.848 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.479 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 2.3 t-20 59.87 66.54 0.97 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.515 HE22 ' HB2' ' A' ' 65' ' ' LEU . 18.9 mp0 -92.17 54.59 2.39 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 175.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.556 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -26.11 162.34 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -174.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.523 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -46.14 169.18 0.09 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.753 175.996 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.523 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 1.2 Cg_endo -77.47 131.47 24.07 Favored 'Cis proline' 0 N--CA 1.492 1.392 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.37 -0.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.529 ' CZ ' ' N ' ' A' ' 64' ' ' THR . 55.1 m-85 -97.74 163.95 18.5 Favored Pre-proline 0 C--N 1.293 -1.86 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.19 156.27 98.19 Favored 'Cis proline' 0 N--CA 1.502 1.977 0 C-N-CA 124.12 -1.2 . . . . 0.0 110.841 -1.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 38.2 mtp180 -124.77 135.29 52.85 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.435 -0.791 . . . . 0.0 110.101 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.17 140.27 58.44 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.33 -4.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.475 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . -176.07 170.44 43.33 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 118.75 -1.69 . . . . 0.0 109.313 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 5.1 tttm -141.62 114.1 8.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.163 -1.198 . . . . 0.0 109.687 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.526 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 22.0 t -79.65 158.92 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.3 t -141.81 170.1 13.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.1 t70 -131.13 143.93 51.01 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 1' ' ' SER . 0.2 OUTLIER -58.84 -39.12 80.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.657 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -163.17 79.95 0.46 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.364 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.487 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 0.8 OUTLIER -64.26 152.03 89.37 Favored Pre-proline 0 C--N 1.289 -2.061 0 O-C-N 120.907 -1.121 . . . . 0.0 108.634 175.907 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' ARG . 73.1 Cg_exo -46.28 -121.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.515 2.741 0 C-N-CA 123.661 2.907 . . . . 0.0 112.1 173.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HB2' ' NH1' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -105.55 -57.91 1.97 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 119.855 -1.778 . . . . 0.0 110.065 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.454 ' NH1' ' HB2' ' A' ' 31' ' ' GLU . 11.9 mtm-85 -125.99 45.61 2.59 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 120.932 -1.105 . . . . 0.0 109.764 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.4 ' OG ' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -68.61 155.58 39.74 Favored 'General case' 0 C--N 1.286 -2.169 0 O-C-N 121.352 -0.843 . . . . 0.0 110.734 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HB2' ' OG1' ' A' ' 80' ' ' THR . 2.4 mmtp -111.02 135.41 51.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.709 -0.619 . . . . 0.0 109.712 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CE1' ' NH1' ' A' ' 29' ' ' ARG . 9.0 m-85 -84.58 116.08 22.96 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.563 HH12 ' CB ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -95.31 133.73 38.89 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 61.0 tp -106.93 136.91 45.99 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 176.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.22 170.45 16.72 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 117.35 167.3 14.32 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -53.92 116.07 2.35 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 119.33 -22.12 9.03 Favored Glycine 0 C--N 1.28 -2.566 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.1 t -117.82 -83.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.428 -1.043 . . . . 0.0 109.12 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.35 -23.26 16.72 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 20.4 mp0 -103.34 161.22 14.02 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.73 134.69 90.26 Favored Pre-proline 0 C--N 1.27 -2.855 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 -176.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.457 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 35.1 Cg_endo -68.73 126.42 8.76 Favored 'Cis proline' 0 N--CA 1.514 2.705 0 C-N-CA 123.615 -1.411 . . . . 0.0 110.942 -0.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -87.23 152.51 22.25 Favored 'General case' 0 C--N 1.289 -2.056 0 O-C-N 120.82 -1.175 . . . . 0.0 111.649 -173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.01 15.26 71.67 Favored Glycine 0 N--CA 1.492 2.376 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.314 174.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.0 mm -78.37 -48.86 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 CA-C-N 119.561 1.68 . . . . 0.0 107.653 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -108.42 155.71 20.27 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.708 0.766 . . . . 0.0 109.673 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.553 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -146.75 160.0 42.78 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.415 ' O ' ' NH2' ' A' ' 51' ' ' ARG . 10.9 tt -132.08 164.13 35.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 O-C-N 120.81 -1.181 . . . . 0.0 109.941 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.429 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 21.9 t-20 -91.94 108.71 20.12 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 34' ' ' LYS . 32.1 mt-10 -46.98 -33.45 4.69 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.154 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 2.3 t-20 -95.9 -48.84 5.56 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.415 -0.803 . . . . 0.0 110.961 -176.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.455 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 10.0 p -84.91 -21.58 29.61 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 121.491 -0.756 . . . . 0.0 110.083 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.8 7.82 86.28 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 12.0 m -64.15 123.4 18.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 22' ' ' GLY . 3.3 t -92.78 122.78 44.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.553 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -117.25 149.42 40.46 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.6 p -104.11 143.63 15.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.0 p -91.96 -13.88 30.38 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.547 -0.72 . . . . 0.0 110.852 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.573 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -148.17 160.25 43.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.605 -1.309 . . . . 0.0 109.905 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.573 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -63.21 127.55 31.79 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.515 ' HB2' HE22 ' A' ' 13' ' ' GLN . 34.5 mt -84.68 151.89 24.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.242 -1.536 . . . . 0.0 111.604 -172.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.41 ' HA ' ' CG ' ' A' ' 11' ' ' GLU . 4.8 m-20 -123.91 131.05 53.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.529 ' CB ' HH11 ' A' ' 67' ' ' ARG . 0.0 OUTLIER -72.14 -6.0 39.53 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.017 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -85.44 -19.56 31.12 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -175.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 t -90.25 -62.96 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.463 HG22 ' CD1' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.49 127.98 23.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 175.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.79 -24.63 24.97 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 p -146.17 121.79 3.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.463 ' CD1' HG22 ' A' ' 70' ' ' ILE . 65.5 m-85 -92.36 119.7 32.17 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -89.76 81.93 6.33 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.427 ' HA ' ' HA2' ' A' ' 39' ' ' GLY . 0.5 OUTLIER -80.46 170.2 16.68 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 122.301 1.048 . . . . 0.0 109.974 -177.5 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -135.2 136.68 41.98 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.07 147.33 17.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -138.18 141.8 40.05 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.86 131.78 43.27 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 172.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.563 ' CB ' HH12 ' A' ' 36' ' ' ARG . 18.0 p -122.78 162.32 22.31 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.935 -175.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.97 171.09 7.6 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -47.62 -22.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 O-C-N 121.81 -0.556 . . . . 0.0 111.818 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.48 -17.17 54.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.744 -1.222 . . . . 0.0 109.856 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.91 11.61 57.55 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 80' ' ' THR . 14.2 mttm -90.27 160.54 16.12 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.473 ' CG2' ' O ' ' A' ' 88' ' ' GLU . 90.3 m -101.2 120.29 40.01 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-O 120.841 0.353 . . . . 0.0 110.085 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.629 ' N ' ' CD1' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -96.22 -11.23 26.36 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.473 ' O ' ' CG2' ' A' ' 86' ' ' THR . 11.3 tp10 -152.2 167.54 28.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.59 -168.75 52.73 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -67.03 112.56 1.05 Allowed 'Cis proline' 0 N--CA 1.493 1.463 0 C-N-CA 123.25 -1.563 . . . . 0.0 112.356 0.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.421 HG22 ' CG2' ' A' ' 2' ' ' ILE . 5.3 m -83.2 165.28 41.73 Favored Pre-proline 0 C--N 1.284 -2.269 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -94.27 152.54 2.06 Favored 'Trans proline' 0 C--N 1.297 -2.151 0 C-N-CA 121.948 1.766 . . . . 0.0 112.329 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.5 tp -141.49 126.68 18.51 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -108.45 116.64 32.34 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 121.354 -0.841 . . . . 0.0 109.173 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 79.1 t -104.15 104.47 16.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.0 mp -92.52 134.52 30.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 15.0 t -89.73 104.0 14.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 15.1 pt -85.46 170.85 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.503 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.87 -177.94 4.88 Favored 'General case' 0 C--N 1.284 -2.252 0 O-C-N 120.746 -1.221 . . . . 0.0 109.256 -176.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 10' ' ' PRO . 4.7 mm-40 -136.17 122.37 20.39 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 1.6 t30 -83.9 50.99 1.93 Allowed 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 171.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.441 ' H ' ' C ' ' A' ' 100' ' ' GLN . 1.3 m-20 36.72 82.48 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.75 -173.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -47.45 -35.69 8.95 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -140.96 94.23 8.0 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.499 1.799 0 C-N-CA 122.659 2.239 . . . . 0.0 111.913 -178.113 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.436 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.217 -0.626 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.426 HD11 HG23 ' A' ' 91' ' ' VAL . 2.7 mt -77.69 123.28 34.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-O 121.873 0.844 . . . . 0.0 110.511 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.64 134.17 44.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -155.0 154.86 6.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.15 141.71 33.5 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -47.63 132.36 20.62 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 121.34 1.36 . . . . 0.0 108.93 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.0 mt -99.4 112.41 31.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.468 -178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.537 ' CD2' ' H ' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -89.5 98.57 11.84 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 12.5 mt -106.42 121.29 45.79 Favored Pre-proline 0 C--N 1.279 -2.493 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -66.07 137.46 48.45 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 120.629 0.886 . . . . 0.0 111.275 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.474 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 0.1 OUTLIER -72.13 179.5 3.29 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.675 -178.137 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.471 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 2.2 m-20 58.69 17.51 5.16 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 172.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -77.21 129.45 35.95 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 174.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.471 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -97.81 -175.39 3.15 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.095 -1.003 . . . . 0.0 110.884 -173.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 4.3 mt-30 -49.2 160.78 0.49 Allowed Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 0.9 OUTLIER -80.53 148.56 76.89 Favored 'Cis proline' 0 C--N 1.301 -1.935 0 C-N-CA 123.195 -1.585 . . . . 0.0 113.901 -0.145 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -129.13 166.49 24.88 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 16.9 Cg_exo -67.26 169.6 49.78 Favored 'Cis proline' 0 N--CA 1.496 1.647 0 C-N-CA 124.354 -1.103 . . . . 0.0 112.157 -0.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.501 ' NE ' ' O ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -137.04 137.67 39.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.622 -0.674 . . . . 0.0 109.583 178.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.407 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 12.4 t70 -75.87 140.11 42.03 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.94 5.2 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 162.41 173.89 31.64 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.197 -1.954 . . . . 0.0 109.919 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -136.86 124.88 22.83 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.355 -1.085 . . . . 0.0 109.764 -178.412 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.1 t -82.94 157.7 3.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 t -144.32 169.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 1' ' ' SER . 10.0 t70 -125.73 141.42 52.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -27.83 65.16 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -162.97 91.7 0.74 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.533 ' NH2' ' O ' ' A' ' 33' ' ' SER . 12.2 mtp-105 -65.67 120.85 71.93 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -39.77 -102.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 123.451 2.767 . . . . 0.0 115.327 -176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -105.21 -67.75 0.9 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.759 -1.213 . . . . 0.0 110.075 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.35 58.88 1.7 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.533 ' O ' ' NH2' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -85.1 138.76 32.21 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.025 -169.571 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 154.94 29.12 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.411 ' CE1' ' HD2' ' A' ' 29' ' ' ARG . 65.9 m-85 -86.63 137.51 32.42 Favored 'General case' 0 C--N 1.285 -2.227 0 O-C-N 121.973 -0.455 . . . . 0.0 110.003 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' NH2' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -110.08 130.28 55.56 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 173.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.4 tp -111.02 138.01 47.96 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -146.69 171.26 15.41 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.32 173.88 18.8 Favored Glycine 0 N--CA 1.51 3.608 0 C-N-CA 120.0 -1.095 . . . . 0.0 110.78 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -62.32 119.46 9.1 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 46' ' ' PRO . . . 117.32 -22.81 10.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -115.86 -95.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.619 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -92.55 -6.39 49.72 Favored 'General case' 0 C--O 1.204 -1.327 0 O-C-N 121.22 -0.925 . . . . 0.0 109.171 178.081 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -116.8 148.65 41.01 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 176.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.583 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 5.2 mm-40 -58.94 140.08 86.84 Favored Pre-proline 0 C--N 1.271 -2.82 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.204 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 37.2 Cg_endo -68.64 116.02 2.29 Favored 'Cis proline' 0 N--CA 1.511 2.507 0 C-N-CA 123.299 -1.542 . . . . 0.0 110.456 -1.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.619 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 7.8 mtpp -73.4 147.1 44.6 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.657 -1.277 . . . . 0.0 111.305 -172.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.38 21.5 78.6 Favored Glycine 0 N--CA 1.497 2.753 0 O-C-N 121.515 -0.741 . . . . 0.0 112.914 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.2 mm -86.15 -47.27 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' CZ ' HG12 ' A' ' 95' ' ' VAL . 74.8 m-85 -110.04 138.63 46.15 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.163 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -136.59 142.82 43.35 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 tt -111.45 162.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.451 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 19.4 t-20 -97.18 109.89 22.55 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -36.56 -41.89 0.32 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 122.804 0.442 . . . . 0.0 111.784 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -92.86 -48.04 6.74 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.032 -1.043 . . . . 0.0 111.61 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.1 p -79.98 -27.97 39.58 Favored 'General case' 0 C--N 1.281 -2.401 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 2.85 90.35 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 12.3 m -63.06 122.95 17.33 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.67 -0.9 . . . . 0.0 109.278 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' N ' ' O ' ' A' ' 22' ' ' GLY . 1.6 t -94.88 123.49 47.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -126.7 153.35 45.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.211 -0.931 . . . . 0.0 109.792 177.814 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 p -104.68 146.12 12.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.0 p -96.25 -7.39 35.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.667 -0.646 . . . . 0.0 112.061 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -154.5 172.06 18.4 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.462 -1.399 . . . . 0.0 110.685 -175.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.443 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 13.9 t -65.16 137.89 57.91 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.1 mt -98.85 149.76 22.58 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 11' ' ' GLU . 0.8 OUTLIER -126.3 142.36 51.56 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.837 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -91.93 9.24 33.84 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.81 -30.53 20.15 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 26.5 t -101.18 -47.08 11.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.411 HD11 ' CE2' ' A' ' 73' ' ' TYR . 2.0 mt -134.22 139.96 47.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.293 -0.879 . . . . 0.0 109.121 -178.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.49 -23.98 15.33 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.8 p -156.12 138.1 6.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.26 -0.9 . . . . 0.0 109.084 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.426 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 36.4 m-85 -99.0 128.09 45.06 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -90.79 97.56 11.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.71 170.34 9.65 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 86.2 m-85 -138.88 128.78 25.07 Favored 'General case' 0 C--N 1.268 -2.946 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -110.4 139.52 33.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 O-C-N 122.043 -0.411 . . . . 0.0 110.045 -176.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -129.33 137.5 51.03 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.428 ' OG1' ' HB3' ' A' ' 88' ' ' GLU . 0.2 OUTLIER -85.17 134.37 34.17 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 170.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.507 ' HA ' HD23 ' A' ' 87' ' ' LEU . 15.6 p -128.06 151.21 49.45 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -176.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' SER . 0.3 OUTLIER -116.15 172.2 7.33 Favored 'General case' 0 N--CA 1.508 2.446 0 CA-C-N 118.808 0.731 . . . . 0.0 109.815 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 81' ' ' ASP . 34.8 m -29.3 -40.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -80.46 -8.6 59.61 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.72 -1.237 . . . . 0.0 110.195 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.61 13.14 78.9 Favored Glycine 0 C--N 1.287 -2.169 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 80' ' ' THR . 5.2 mttp -74.96 160.2 30.87 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.403 ' CG2' ' O ' ' A' ' 88' ' ' GLU . 16.6 m -96.01 116.53 29.08 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -96.02 -11.07 27.01 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.428 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 1.1 tp10 -154.54 154.56 33.3 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.41 -162.24 49.23 Favored Glycine 0 C--N 1.284 -2.316 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.35 105.58 0.24 Allowed 'Cis proline' 0 N--CA 1.495 1.586 0 C-N-CA 123.305 -1.54 . . . . 0.0 111.458 -0.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 20.4 m -73.48 159.09 85.54 Favored Pre-proline 0 C--N 1.286 -2.18 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.37 152.01 3.65 Favored 'Trans proline' 0 C--N 1.283 -2.895 0 C-N-CA 121.359 1.373 . . . . 0.0 111.438 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 tp -139.02 128.51 24.41 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -102.41 111.57 23.92 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.636 -0.665 . . . . 0.0 109.525 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.454 HG12 ' CZ ' ' A' ' 50' ' ' PHE . 4.9 t -93.43 95.34 5.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 174.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 96' ' ' ILE . 1.1 mt -79.96 130.66 35.66 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 t -92.06 122.14 43.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 12.5 pt -112.49 171.52 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.345 -0.847 . . . . 0.0 110.661 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -84.37 158.35 21.15 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.151 -0.968 . . . . 0.0 108.545 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 11' ' ' GLU . 3.9 pt20 -111.09 131.39 55.12 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.459 ' O ' ' C ' ' A' ' 102' ' ' ASP . 48.0 t30 -69.57 -25.26 63.9 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.648 -1.283 . . . . 0.0 107.595 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 101' ' ' ASN . 6.8 t70 -13.19 -84.51 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.745 0 C-N-CA 125.025 1.33 . . . . 0.0 111.403 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 172.35 -35.61 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.538 ' HB3' ' CD ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER 61.8 -177.95 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -177.125 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.538 ' CD ' ' HB3' ' A' ' 104' ' ' ARG . 2.5 Cg_endo . . . . . 0 C--O 1.201 -1.33 0 C-N-CA 121.783 1.655 . . . . 0.0 109.386 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.72 HG21 HG21 ' A' ' 91' ' ' VAL . 7.3 mt -66.66 122.19 17.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.436 -0.79 . . . . 0.0 109.317 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -104.85 133.77 48.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 174.341 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -148.84 167.59 3.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -176.667 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.482 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.9 OUTLIER -152.04 146.83 18.95 Favored Pre-proline 0 C--N 1.272 -2.776 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 176.516 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -48.69 131.77 24.79 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.257 1.305 . . . . 0.0 110.157 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.513 ' C ' HD12 ' A' ' 8' ' ' LEU . 29.0 mt -99.79 121.56 50.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.772 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.9 mp -105.98 107.71 18.85 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.532 HD11 HG21 ' A' ' 21' ' ' VAL . 17.1 mt -113.18 140.94 24.88 Favored Pre-proline 0 C--N 1.275 -2.651 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -175.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 60.4 Cg_endo -75.53 134.65 17.19 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.576 1.517 . . . . 0.0 111.272 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.42 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -67.82 -172.68 0.29 Allowed 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.914 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.523 ' OD1' ' C ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER 55.83 -9.22 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 175.648 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' GLU . 2.1 pt20 -55.66 132.96 50.27 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.4 -179.65 3.98 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.834 -1.166 . . . . 0.0 111.167 -175.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.602 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -54.29 171.76 0.27 Allowed Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.649 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 1.7 Cg_endo -78.71 121.13 7.76 Favored 'Cis proline' 0 N--CA 1.493 1.47 0 C-N-CA 123.793 -1.336 . . . . 0.0 114.012 0.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.518 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 20.4 m-85 -110.62 170.49 5.24 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 13.9 Cg_exo -69.7 167.63 70.15 Favored 'Cis proline' 0 N--CA 1.507 2.323 0 CA-C-N 120.172 1.097 . . . . 0.0 112.798 0.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -148.94 142.16 25.04 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 9.3 t0 -67.77 136.03 53.57 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.532 HG21 HD11 ' A' ' 9' ' ' ILE . 36.0 m -126.84 6.06 3.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.11 -175.0 45.48 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.809 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.579 ' HZ2' ' CB ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -145.17 121.72 11.07 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.925 -1.338 . . . . 0.0 110.36 -178.415 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 59' ' ' VAL . 33.2 t -89.88 131.45 37.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 170.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 3' ' ' VAL . 40.5 t -132.0 149.75 32.99 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -105.7 138.79 41.31 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.936 -1.105 . . . . 0.0 108.704 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.373 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.299 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 121.714 0.769 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 48.6 mttm -115.76 146.66 41.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.902 ' CE1' HG23 ' A' ' 79' ' ' THR . 89.6 m-85 -93.84 144.2 25.64 Favored 'General case' 0 C--N 1.282 -2.359 0 O-C-N 121.233 -0.917 . . . . 0.0 112.84 -172.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.34 150.99 22.43 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.61 ' HG ' HG21 ' A' ' 42' ' ' VAL . 21.0 tp -125.86 140.15 52.9 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 172.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.27 171.11 17.48 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 75' ' ' LEU . . . 117.0 169.85 15.2 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.315 -1.422 . . . . 0.0 111.594 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 45' ' ' GLU . 6.5 mtpp -60.05 111.13 1.39 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 120.21 -18.21 9.63 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.61 HG21 ' HG ' ' A' ' 37' ' ' LEU . 42.7 t -116.68 -97.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.625 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 3.4 t70 -93.52 -8.04 42.53 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 40' ' ' LYS . 35.3 mt-30 -107.02 148.2 29.0 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 174.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 1.5 mp0 -55.85 133.55 73.05 Favored Pre-proline 0 C--N 1.264 -3.152 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 24.8 Cg_endo -70.77 127.54 12.0 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 C-N-CA 123.403 -1.499 . . . . 0.0 110.045 -0.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 15.3 mtpp -82.12 150.41 27.48 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 120.953 -1.092 . . . . 0.0 111.321 -173.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.403 ' O ' ' NH2' ' A' ' 63' ' ' ARG . . . 62.81 38.95 97.35 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.894 -0.504 . . . . 0.0 111.899 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.496 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 5.9 mm -100.27 -48.13 11.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.532 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 88.8 m-85 -114.48 143.02 45.63 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.688 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 133.78 26.19 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.446 ' CG2' ' HB2' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -95.85 150.78 4.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.554 ' OD1' HG23 ' A' ' 56' ' ' THR . 14.5 t-20 -79.82 105.71 11.31 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 35' ' ' PHE . 2.0 mt-10 -42.81 -36.81 1.59 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.454 -175.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -92.76 -43.73 8.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.206 -0.933 . . . . 0.0 111.562 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.554 HG23 ' OD1' ' A' ' 53' ' ' ASN . 4.5 p -85.07 -25.35 27.64 Favored 'General case' 0 C--N 1.282 -2.361 0 O-C-N 121.027 -1.045 . . . . 0.0 108.7 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.06 9.51 86.1 Favored Glycine 0 C--N 1.287 -2.154 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.579 ' CB ' ' HZ2' ' A' ' 23' ' ' LYS . 70.0 m -65.8 120.55 13.23 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.395 -1.062 . . . . 0.0 109.472 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 24' ' ' VAL . 2.0 t -83.99 121.78 36.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.25 148.95 43.59 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.482 -0.761 . . . . 0.0 110.139 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.41 149.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.576 ' OG1' ' NH1' ' A' ' 63' ' ' ARG . 4.3 p -105.02 -15.52 15.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.481 -0.762 . . . . 0.0 112.002 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.686 HH11 ' HG2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -157.41 -159.33 0.83 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.871 -1.143 . . . . 0.0 108.506 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.468 ' N ' ' HG3' ' A' ' 63' ' ' ARG . 4.8 t -80.8 179.42 7.82 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.168 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 mt -142.21 167.64 21.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -147.76 139.19 23.72 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.498 ' NE ' ' O ' ' A' ' 97' ' ' VAL . 16.7 ttm105 -76.06 -10.72 59.64 Favored 'General case' 0 C--N 1.282 -2.329 0 O-C-N 122.105 -0.372 . . . . 0.0 111.645 -174.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -90.12 -20.08 23.54 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.703 -1.248 . . . . 0.0 108.964 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.04 -53.26 13.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 97' ' ' VAL . 1.1 mt -148.36 134.21 11.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -89.09 -28.29 20.19 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.43 115.08 3.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.506 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 62.3 m-85 -81.78 111.91 18.45 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 174.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.439 ' CD ' ' H ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -92.39 95.53 9.72 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -90.26 170.6 10.14 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 122.25 1.024 . . . . 0.0 108.424 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 85.1 m-85 -134.44 131.96 38.75 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.514 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.26 150.14 14.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -176.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.458 ' HB3' ' CG2' ' A' ' 86' ' ' THR . 2.2 mt-10 -142.12 142.13 32.74 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.902 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -88.72 129.35 35.56 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.617 ' C ' HD21 ' A' ' 87' ' ' LEU . 11.3 p -123.19 150.37 43.44 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.642 ' N ' HD21 ' A' ' 87' ' ' LEU . 26.0 t70 -92.59 170.09 10.01 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.22 -0.992 . . . . 0.0 108.564 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -14.98 4.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.19 -5.08 53.41 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.98 -4.91 60.12 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -75.19 150.6 38.64 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.332 -1.099 . . . . 0.0 108.615 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -90.55 119.64 30.98 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.958 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.41 -30.62 14.37 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 86' ' ' THR . 1.5 tp10 -135.28 170.13 16.4 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 -179.17 51.72 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.56 127.03 7.7 Favored 'Cis proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.158 -1.601 . . . . 0.0 112.609 0.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.72 HG21 HG21 ' A' ' 2' ' ' ILE . 2.1 m -105.5 161.92 21.3 Favored Pre-proline 0 C--N 1.28 -2.424 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -94.44 151.17 1.96 Allowed 'Trans proline' 0 C--N 1.288 -2.637 0 C-N-CA 122.238 1.959 . . . . 0.0 112.527 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.46 HD13 HG23 ' A' ' 4' ' ' VAL . 10.2 tp -141.79 129.76 21.93 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -110.88 130.18 55.65 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 120.926 -1.109 . . . . 0.0 110.04 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.532 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 46.7 t -111.42 111.66 37.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 174.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.54 142.44 13.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.236 -0.915 . . . . 0.0 109.073 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.498 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 1.5 t -91.91 96.08 5.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.611 HG21 ' HB3' ' A' ' 8' ' ' LEU . 5.7 pt -82.21 172.01 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 O-C-N 120.893 -1.13 . . . . 0.0 110.125 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.417 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 3.1 m-20 . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.429 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.4 OUTLIER . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.769 HG21 HG21 ' A' ' 91' ' ' VAL . 11.4 mt -68.77 113.86 4.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.162 -0.961 . . . . 0.0 110.363 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.21 111.2 29.15 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 174.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.625 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.84 164.21 29.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.479 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -142.63 152.29 59.39 Favored Pre-proline 0 C--N 1.275 -2.652 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 175.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.686 ' HB3' HD11 ' A' ' 96' ' ' ILE . 48.9 Cg_exo -49.51 136.67 33.05 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.681 1.588 . . . . 0.0 111.108 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.644 HD11 HG21 ' A' ' 59' ' ' VAL . 21.9 mt -102.55 110.08 28.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.723 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.4 mp -98.83 96.87 8.17 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.519 HD11 HG21 ' A' ' 21' ' ' VAL . 15.6 mt -103.75 133.56 20.2 Favored Pre-proline 0 C--N 1.275 -2.673 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.6 Cg_endo -70.65 120.65 7.26 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.318 1.345 . . . . 0.0 109.683 175.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -43.1 -71.9 0.07 Allowed 'General case' 0 N--CA 1.522 3.155 0 O-C-N 121.241 -0.912 . . . . 0.0 111.943 -174.415 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.513 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 34.2 p30 -62.47 42.92 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.519 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 22.3 mt-30 -77.61 140.77 39.7 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -117.77 177.35 4.8 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.416 -0.803 . . . . 0.0 110.038 -176.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.62 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -49.02 167.88 0.2 Allowed Pre-proline 0 C--N 1.292 -1.895 0 C-N-CA 123.461 0.704 . . . . 0.0 109.882 178.324 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 4.8 Cg_exo -77.16 121.64 8.01 Favored 'Cis proline' 0 C--N 1.311 -1.417 0 C-N-CA 123.714 -1.369 . . . . 0.0 113.158 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.404 ' CE2' HG13 ' A' ' 61' ' ' VAL . 26.4 m-85 -102.76 165.88 12.92 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 175.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.22 154.48 85.23 Favored 'Cis proline' 0 N--CA 1.496 1.638 0 C-N-CA 124.184 -1.174 . . . . 0.0 110.516 -1.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.594 ' NH2' ' O ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -136.56 145.21 44.73 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.205 -0.935 . . . . 0.0 110.136 -178.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.594 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 5.5 t70 -65.87 142.3 57.96 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 9' ' ' ILE . 32.8 m -137.44 1.77 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 170.2 176.35 39.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -146.27 125.74 13.21 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.669 -1.489 . . . . 0.0 110.185 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 4' ' ' VAL . 18.4 t -87.6 143.48 11.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 172.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.6 t -136.73 160.98 36.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 1' ' ' SER . 10.2 t70 -120.54 137.73 54.23 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.081 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 1' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.758 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 121.085 0.469 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 54' ' ' GLU . 4.4 mmtp -113.86 169.39 9.03 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 174.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.509 ' CB ' HD13 ' A' ' 52' ' ' ILE . 10.3 m-85 -115.42 126.3 54.2 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HG3' HG21 ' A' ' 80' ' ' THR . 13.8 mmt-85 -98.68 119.11 36.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.725 ' HG ' HG21 ' A' ' 42' ' ' VAL . 42.4 tp -103.73 139.71 38.6 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 176.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.466 HG22 ' CG ' ' A' ' 43' ' ' ASP . 0.2 OUTLIER -152.89 170.29 20.72 Favored 'General case' 0 C--N 1.279 -2.47 0 O-C-N 121.262 -0.899 . . . . 0.0 108.613 -176.43 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' A' ' 43' ' ' ASP . . . 116.88 169.99 15.3 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.43 ' NZ ' ' HG3' ' A' ' 45' ' ' GLU . 11.1 mtpp -54.82 115.31 2.11 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 120.8 -21.64 8.36 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.725 HG21 ' HG ' ' A' ' 37' ' ' LEU . 34.9 t -119.78 -88.07 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.39 -1.065 . . . . 0.0 109.122 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.476 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 15.8 p-10 -93.14 -14.17 27.54 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -113.9 160.76 18.43 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HG3' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -61.69 133.84 93.67 Favored Pre-proline 0 C--N 1.286 -2.184 0 O-C-N 122.152 -0.343 . . . . 0.0 110.722 -174.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HB2' HD11 ' A' ' 49' ' ' ILE . 3.2 Cg_exo -76.13 123.76 9.68 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.173 -1.595 . . . . 0.0 109.296 -1.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 27.2 mttp -71.01 154.0 42.16 Favored 'General case' 0 C--N 1.282 -2.346 0 O-C-N 120.923 -1.11 . . . . 0.0 110.894 -174.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.19 21.31 53.11 Favored Glycine 0 N--CA 1.489 2.215 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.201 172.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.739 HD12 ' NE ' ' A' ' 63' ' ' ARG . 26.6 mm -73.55 -43.59 54.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.542 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 87.9 m-85 -116.7 141.38 48.28 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.428 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.83 129.16 24.0 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.509 HD13 ' CB ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -96.38 149.84 4.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 O-C-N 121.643 -0.661 . . . . 0.0 110.05 -174.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.451 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 14.1 t-20 -79.76 112.6 17.18 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' OE2' ' NH1' ' A' ' 36' ' ' ARG . 1.4 mt-10 -53.28 -31.11 42.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.847 -0.533 . . . . 0.0 111.541 -176.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.402 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -97.22 -23.39 16.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 112.601 -174.004 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 19.5 p -112.29 -27.5 8.29 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 84.82 5.43 86.38 Favored Glycine 0 C--N 1.283 -2.389 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 t -60.67 125.7 24.69 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 7' ' ' ILE . 2.6 t -86.5 118.76 33.39 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 176.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -110.84 140.65 45.11 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.411 -178.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.492 ' CG2' HD21 ' A' ' 65' ' ' LEU . 7.7 p -99.77 145.17 11.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.4 p -97.51 -14.99 20.77 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.511 -0.743 . . . . 0.0 111.46 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.739 ' NE ' HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -153.03 170.6 20.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.847 -1.158 . . . . 0.0 110.938 -177.189 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 t -66.32 140.25 58.09 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.492 HD21 ' CG2' ' A' ' 61' ' ' VAL . 49.6 mt -92.44 170.04 10.08 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.63 -1.294 . . . . 0.0 111.106 -173.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.454 ' HB2' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -127.18 102.55 6.99 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 67' ' ' ARG . 4.3 ttm105 -66.35 -18.74 65.54 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 1.2 mp0 -76.94 -26.18 53.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.858 -1.151 . . . . 0.0 108.378 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' A' ' 66' ' ' ASP . 6.8 t -97.18 -52.99 8.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.408 HG21 ' CG ' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -125.97 112.15 29.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.563 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.45 -33.66 54.7 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.4 p -149.42 131.89 6.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.532 ' OH ' ' NH2' ' A' ' 63' ' ' ARG . 61.0 m-85 -87.8 120.27 28.95 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -88.48 81.23 7.21 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.19 170.46 16.09 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.128 0.966 . . . . 0.0 109.015 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.9 m-85 -137.13 130.05 30.6 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -113.56 160.52 13.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.277 0.56 . . . . 0.0 110.143 -175.345 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.761 ' HB3' HG23 ' A' ' 86' ' ' THR . 47.8 mt-10 -147.4 143.01 27.65 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.646 ' N ' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -88.72 123.09 32.82 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 173.012 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.555 HG21 ' HG3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -109.0 153.38 23.68 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-O 121.582 0.706 . . . . 0.0 111.677 -172.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 3.0 t70 -96.48 170.1 9.45 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 174.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.501 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -52.79 -27.16 11.96 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -79.69 2.05 24.14 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.484 -0.76 . . . . 0.0 109.511 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.82 19.41 75.1 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -91.3 154.92 18.91 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.761 HG23 ' HB3' ' A' ' 78' ' ' GLU . 8.2 m -84.13 124.35 31.05 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.854 0.835 . . . . 0.0 111.012 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -86.11 -45.63 11.2 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 175.289 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -142.41 151.53 41.91 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.51 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 105.39 177.34 24.18 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 107.929 -2.068 . . . . 0.0 107.929 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.32 109.97 0.48 Allowed 'Cis proline' 0 N--CA 1.495 1.605 0 CA-C-N 118.949 1.374 . . . . 0.0 113.065 0.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.769 HG21 HG21 ' A' ' 2' ' ' ILE . 2.5 m -91.47 161.44 34.46 Favored Pre-proline 0 C--N 1.281 -2.374 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.99 155.37 3.92 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 C-N-CA 121.762 1.641 . . . . 0.0 111.726 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.63 HD23 HD11 ' A' ' 37' ' ' LEU . 8.8 tp -142.85 125.64 16.03 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -109.38 112.09 24.01 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 121.772 -0.58 . . . . 0.0 110.033 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.542 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 56.7 t -102.39 97.74 5.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.792 ' H ' HD12 ' A' ' 96' ' ' ILE . 2.8 mp -81.13 132.94 30.39 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 O-C-N 121.653 -0.654 . . . . 0.0 109.456 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 31.8 t -88.22 92.67 3.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.649 HG21 ' HB3' ' A' ' 8' ' ' LEU . 4.9 pt -80.35 171.04 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 O-C-N 121.248 -0.908 . . . . 0.0 109.112 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 C--N 1.284 -2.278 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.159 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.484 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.192 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.721 HG21 HG21 ' A' ' 91' ' ' VAL . 4.7 mt -62.57 142.15 17.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 121.449 0.643 . . . . 0.0 109.771 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.38 106.15 15.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.723 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -127.8 158.7 39.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.434 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -124.42 151.05 66.16 Favored Pre-proline 0 C--N 1.281 -2.409 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.18 141.72 94.43 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 121.475 1.45 . . . . 0.0 109.155 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.422 HD13 ' HA3' ' A' ' 22' ' ' GLY . 24.5 mt -107.96 113.04 42.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 O-C-N 121.412 -0.805 . . . . 0.0 109.865 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.886 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.94 94.2 9.54 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 21' ' ' VAL . 23.4 mt -101.25 127.42 31.83 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.8 Cg_endo -70.55 128.11 14.86 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 N-CA-C 109.493 -1.003 . . . . 0.0 109.493 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.551 ' CD ' ' HE ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -59.75 -178.78 0.08 Allowed 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 119.501 -0.879 . . . . 0.0 109.995 -176.541 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.12 14.86 9.66 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.65 -0.657 . . . . 0.0 111.724 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.441 ' O ' ' OG1' ' A' ' 64' ' ' THR . 26.8 mt-30 -67.05 137.06 56.15 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.54 ' N ' ' CD ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -114.4 -178.58 3.4 Favored 'General case' 0 C--N 1.281 -2.376 0 O-C-N 120.881 -1.137 . . . . 0.0 110.676 -175.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.628 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 13.8 mp0 -59.3 169.0 1.39 Allowed Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.628 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 30.5 Cg_endo -70.91 114.84 2.48 Favored 'Cis proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.621 -1.408 . . . . 0.0 114.475 0.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.439 ' N ' ' HA ' ' A' ' 15' ' ' GLN . 13.7 m-85 -102.92 164.33 15.77 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.431 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 30.9 Cg_endo -68.3 156.03 88.49 Favored 'Cis proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.864 -1.307 . . . . 0.0 111.092 -0.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 60' ' ' SER . 1.4 tmt_? -134.26 144.7 48.53 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -70.57 137.73 50.3 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 9' ' ' ILE . 30.6 m -133.93 2.7 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.422 ' HA3' HD13 ' A' ' 7' ' ' ILE . . . 178.57 179.2 48.36 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.496 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 17.3 mttp -146.52 133.69 20.49 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.007 -1.29 . . . . 0.0 110.762 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.595 HG11 HG11 ' A' ' 77' ' ' VAL . 20.0 t -108.23 131.0 59.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -133.96 170.05 20.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.751 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 1' ' ' SER . 0.9 OUTLIER -119.68 154.62 33.79 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.8 -1.188 . . . . 0.0 109.184 177.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.453 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 8.2 m . . . . . 0 C--N 1.267 -3.011 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.026 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -121.4 138.56 54.22 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.786 ' CE1' HG23 ' A' ' 79' ' ' THR . 36.7 m-85 -93.19 124.34 37.09 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 121.03 -1.044 . . . . 0.0 109.131 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.572 ' NH1' HG21 ' A' ' 80' ' ' THR . 25.4 mtm-85 -99.29 148.07 24.53 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.691 ' O ' HG11 ' A' ' 42' ' ' VAL . 18.1 tp -131.38 128.82 40.39 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -140.47 170.36 15.94 Favored 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.488 ' C ' ' HB2' ' A' ' 44' ' ' GLN . . . 120.87 166.18 12.95 Favored Glycine 0 C--N 1.282 -2.465 0 O-C-N 120.815 -1.178 . . . . 0.0 110.259 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 111.48 0.54 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 124.08 -19.14 7.35 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.691 HG11 ' O ' ' A' ' 37' ' ' LEU . 23.0 t -120.59 -92.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.289 -1.124 . . . . 0.0 108.976 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.489 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 2.0 t0 -94.13 -10.78 32.15 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.516 ' N ' ' OE1' ' A' ' 44' ' ' GLN . 17.4 mp0 -109.33 159.19 17.18 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 45' ' ' GLU . 2.0 pm0 -66.59 132.67 94.16 Favored Pre-proline 0 C--N 1.263 -3.172 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.091 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.441 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -74.12 120.12 6.18 Favored 'Cis proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.39 -1.504 . . . . 0.0 110.759 -0.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 43' ' ' ASP . 8.7 mttm -70.86 154.37 41.89 Favored 'General case' 0 C--N 1.289 -2.057 0 O-C-N 121.106 -0.996 . . . . 0.0 111.023 -175.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.78 30.13 74.15 Favored Glycine 0 N--CA 1.495 2.633 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.467 171.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLY . 9.4 mm -90.6 -45.95 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 119.007 1.404 . . . . 0.0 107.647 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.531 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 69.4 m-85 -114.34 151.91 32.26 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.271 0.558 . . . . 0.0 110.198 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.431 ' HD3' ' CB ' ' A' ' 18' ' ' PRO . 2.7 ptm85 -144.29 137.13 27.02 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 35' ' ' PHE . 13.6 tt -105.44 159.73 5.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.407 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 17.6 t-20 -90.45 132.72 35.49 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HA ' ' H ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -66.15 -31.21 71.92 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.832 -176.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -97.5 -51.88 3.98 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.676 0.75 . . . . 0.0 110.541 -174.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 7.8 p -80.43 -21.39 42.21 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 68.75 14.06 66.99 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.496 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 37.0 m -64.07 120.91 12.95 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.173 -1.192 . . . . 0.0 108.849 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.502 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.3 t -83.95 122.01 37.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -122.03 154.91 36.65 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.645 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.507 ' CG2' HD21 ' A' ' 65' ' ' LEU . 7.4 p -102.05 149.8 6.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 63.5 p -98.29 -16.51 19.35 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.613 -0.68 . . . . 0.0 110.226 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.63 178.49 7.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.416 -0.802 . . . . 0.0 109.973 -174.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 5.7 t -76.62 139.41 40.61 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.507 HD21 ' CG2' ' A' ' 61' ' ' VAL . 53.0 mt -98.96 156.23 17.01 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.393 -0.817 . . . . 0.0 109.516 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -135.67 128.47 31.09 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.551 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 12.9 mtm180 -64.64 -5.84 6.49 Favored 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.19 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.57 -21.61 52.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.105 -0.997 . . . . 0.0 108.516 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.25 -55.79 5.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.403 HD12 ' CE1' ' A' ' 73' ' ' TYR . 1.2 mt -141.84 136.63 30.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 121.416 -0.803 . . . . 0.0 108.935 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.28 -26.25 25.06 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.3 p -156.35 137.8 5.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.463 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 71.8 m-85 -99.25 116.86 32.41 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -85.86 79.6 9.2 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.65 170.78 16.04 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 34.4 m-85 -137.35 141.15 41.81 Favored 'General case' 0 C--N 1.256 -3.457 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.595 HG11 HG11 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -115.37 148.51 18.05 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 O-C-N 121.687 -0.633 . . . . 0.0 109.399 -176.327 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 86' ' ' THR . 0.5 OUTLIER -134.39 135.27 42.51 Favored 'General case' 0 C--N 1.28 -2.455 0 O-C-N 121.195 -0.94 . . . . 0.0 108.859 176.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.786 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -87.51 132.14 34.13 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 174.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.584 ' C ' HD21 ' A' ' 87' ' ' LEU . 17.7 p -127.0 164.26 21.89 Favored 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.986 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 2.1 t70 -97.54 170.22 9.19 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.497 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 0.9 OUTLIER -46.43 -33.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-O 121.457 0.646 . . . . 0.0 109.874 178.848 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -79.53 2.63 21.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.558 -0.714 . . . . 0.0 109.742 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.23 81.39 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 80' ' ' THR . 8.3 mtpp -74.49 150.11 40.0 Favored 'General case' 0 CA--C 1.474 -1.943 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.589 ' C ' HD13 ' A' ' 87' ' ' LEU . 1.2 m -99.6 118.01 35.22 Favored 'General case' 0 C--N 1.272 -2.768 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.132 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.869 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.68 -24.11 17.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.38 158.62 44.21 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.465 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 75.09 -175.19 51.06 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -57.94 108.74 0.2 OUTLIER 'Cis proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.707 -1.372 . . . . 0.0 113.795 0.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.721 HG21 HG21 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -84.85 167.48 26.23 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 172.413 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -94.47 156.43 2.0 Favored 'Trans proline' 0 C--N 1.286 -2.763 0 C-N-CA 121.959 1.773 . . . . 0.0 112.791 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.723 HD13 ' CG2' ' A' ' 4' ' ' VAL . 4.5 tp -142.89 131.28 22.22 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -106.11 109.76 21.8 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.508 -0.745 . . . . 0.0 109.432 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.531 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 89.8 t -98.06 96.67 5.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.58 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.7 mp -79.79 128.29 38.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.26 105.09 15.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.9 pt -93.3 171.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.503 ' OD2' ' NH1' ' A' ' 67' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.282 -2.337 0 O-C-N 120.984 -1.072 . . . . 0.0 108.467 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.459 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 1.023 HG21 HG21 ' A' ' 91' ' ' VAL . 11.2 mt -65.24 131.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 C-N-CA 119.221 -0.991 . . . . 0.0 109.214 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.95 128.64 73.17 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.482 HG23 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -141.45 159.1 22.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -139.59 144.26 38.71 Favored Pre-proline 0 C--N 1.281 -2.37 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.435 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 36.8 Cg_exo -51.08 135.2 44.44 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.446 1.431 . . . . 0.0 109.88 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.421 HD13 ' HA3' ' A' ' 22' ' ' GLY . 22.7 mt -103.67 115.56 45.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.858 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.42 105.59 17.92 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.656 HD11 HG21 ' A' ' 21' ' ' VAL . 34.1 mt -114.02 123.28 33.0 Favored Pre-proline 0 C--N 1.287 -2.115 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 27.2 Cg_endo -66.83 142.8 64.44 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 120.748 0.965 . . . . 0.0 112.434 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -67.16 -178.55 0.82 Allowed 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 122.278 1.037 . . . . 0.0 112.307 -176.284 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.9 m-20 47.25 18.01 0.08 Allowed 'General case' 0 N--CA 1.514 2.762 0 C-N-CA 124.177 0.991 . . . . 0.0 113.341 174.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -76.64 122.84 25.23 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.28 -163.48 1.02 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.354 -0.841 . . . . 0.0 110.428 -175.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.568 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -46.66 165.57 0.19 Allowed Pre-proline 0 N--CA 1.5 2.062 0 CA-C-O 121.377 0.608 . . . . 0.0 111.409 -177.23 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 55.3 Cg_endo -86.92 120.9 5.78 Favored 'Cis proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.442 -1.483 . . . . 0.0 113.613 0.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 19' ' ' ARG . 27.4 m-85 -115.27 163.61 19.64 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 19.7 Cg_exo -67.07 162.63 74.65 Favored 'Cis proline' 0 N--CA 1.504 2.136 0 C-N-CA 124.553 -1.019 . . . . 0.0 113.077 -0.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -153.1 149.23 27.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.772 -0.58 . . . . 0.0 109.517 -178.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.476 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -71.39 139.68 49.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.656 HG21 HD11 ' A' ' 9' ' ' ILE . 33.5 m -132.75 -3.48 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA3' HD13 ' A' ' 7' ' ' ILE . . . -178.98 170.72 42.63 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 tttm -131.24 121.11 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -1.122 . . . . 0.0 109.906 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.577 HG23 ' CG2' ' A' ' 59' ' ' VAL . 41.9 t -91.85 147.63 5.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 171.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 26' ' ' ASP . 17.6 t -142.41 170.07 12.24 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.459 ' OD2' ' N ' ' A' ' 1' ' ' SER . 34.5 t0 -143.27 78.18 1.59 Allowed 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.82 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.035 -172.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.016 0.436 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -127.15 167.37 16.12 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 54' ' ' GLU . 87.9 m-85 -98.41 142.63 29.8 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.944 -1.098 . . . . 0.0 112.123 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.599 ' NH2' ' O ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER -110.05 126.56 54.12 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 172.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.633 ' HG ' HG21 ' A' ' 42' ' ' VAL . 37.5 tp -107.83 142.1 38.41 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 p -151.73 171.58 17.46 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 75' ' ' LEU . . . 121.3 172.73 14.47 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 120.843 -1.161 . . . . 0.0 111.418 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 44' ' ' GLN . 24.9 mtpp -61.19 111.69 1.82 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 121.49 -22.05 7.92 Favored Glycine 0 C--N 1.279 -2.632 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.633 HG21 ' HG ' ' A' ' 37' ' ' LEU . 20.1 t -118.91 -85.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.417 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 6.5 p-10 -101.14 -14.58 17.69 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.458 ' CD ' ' HA2' ' A' ' 39' ' ' GLY . 27.7 mt-30 -104.16 152.75 21.76 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 173.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.542 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 7.2 mm-40 -66.77 139.5 95.83 Favored Pre-proline 0 C--N 1.285 -2.206 0 O-C-N 121.85 -0.531 . . . . 0.0 110.373 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 37.7 Cg_endo -68.94 119.62 3.77 Favored 'Cis proline' 0 N--CA 1.509 2.41 0 C-N-CA 123.592 -1.42 . . . . 0.0 111.327 -1.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.542 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 11.2 mtpp -76.96 162.92 27.19 Favored 'General case' 0 C--N 1.288 -2.104 0 O-C-N 120.768 -1.207 . . . . 0.0 110.696 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.04 19.11 50.19 Favored Glycine 0 N--CA 1.496 2.674 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.939 173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.725 HD12 ' HD2' ' A' ' 63' ' ' ARG . 11.7 mm -83.09 -48.38 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 119.487 1.643 . . . . 0.0 107.591 176.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.74 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 52.1 m-85 -111.88 145.74 38.97 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.275 0.56 . . . . 0.0 110.646 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -148.35 135.49 20.26 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 37' ' ' LEU . 1.9 tt -102.96 157.01 4.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.455 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 11.6 t-20 -80.91 115.13 20.23 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' PHE . 1.7 mp0 -50.5 -40.84 52.46 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 122.061 -0.399 . . . . 0.0 111.496 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -90.43 -44.58 9.53 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.604 -1.31 . . . . 0.0 111.512 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 8.8 p -80.78 -28.48 36.36 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 121.226 -0.921 . . . . 0.0 109.417 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.6 10.49 84.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 m -67.38 123.44 20.39 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.388 -1.066 . . . . 0.0 108.224 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.577 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.1 t -86.58 124.48 40.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -121.09 150.9 40.51 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.622 HG21 HD21 ' A' ' 65' ' ' LEU . 9.8 p -110.49 148.27 14.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.9 p -97.29 -28.12 14.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.495 -0.753 . . . . 0.0 110.926 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.725 ' HD2' HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -135.26 167.54 20.83 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.094 -1.004 . . . . 0.0 110.232 -177.275 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.502 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 13.3 t -57.37 156.5 7.67 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.622 HD21 HG21 ' A' ' 61' ' ' VAL . 21.6 mt -110.88 140.94 44.91 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.951 -1.093 . . . . 0.0 108.683 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 68' ' ' GLU . 2.7 p-10 -131.4 122.97 27.22 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' NH1' ' O ' ' A' ' 97' ' ' VAL . 1.4 mtp85 -75.12 10.05 1.7 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 66' ' ' ASP . 52.1 mt-10 -74.11 -24.19 59.42 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.1 t -126.18 -82.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -91.16 127.67 43.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 121.12 -0.988 . . . . 0.0 108.987 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.59 -25.74 19.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.5 p -152.84 121.03 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.353 -0.842 . . . . 0.0 108.9 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.443 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 79.7 m-85 -80.11 120.66 24.55 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -86.79 94.19 9.47 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.478 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -92.57 170.65 9.57 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.913 0.863 . . . . 0.0 109.198 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.0 m-85 -140.78 131.24 25.3 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.37 146.41 18.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 O-C-N 122.055 -0.403 . . . . 0.0 110.517 -174.294 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.623 ' HB3' HG23 ' A' ' 86' ' ' THR . 45.3 mt-10 -132.14 141.65 49.21 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 120.939 -1.101 . . . . 0.0 109.143 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.609 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -86.38 135.43 33.51 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 171.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.665 ' C ' HD21 ' A' ' 87' ' ' LEU . 1.1 p -127.14 152.36 47.44 Favored 'General case' 0 C--N 1.286 -2.179 0 O-C-N 121.481 -0.762 . . . . 0.0 111.251 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.581 ' N ' HD21 ' A' ' 87' ' ' LEU . 46.1 p-10 -89.28 171.99 9.37 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.104 0.954 . . . . 0.0 109.614 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.421 ' H ' HG13 ' A' ' 82' ' ' VAL . 4.1 m -54.02 -9.59 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.101 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -100.57 -34.96 9.69 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.122 . . . . 0.0 108.423 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' NH2' ' A' ' 36' ' ' ARG . . . 118.57 23.44 3.41 Favored Glycine 0 C--N 1.287 -2.156 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -95.6 141.09 29.52 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.623 HG23 ' HB3' ' A' ' 78' ' ' GLU . 89.0 m -79.96 119.56 22.98 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.442 -0.786 . . . . 0.0 110.611 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.905 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -89.02 -25.72 21.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.96 -1.087 . . . . 0.0 108.393 176.287 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.409 ' OE2' ' N ' ' A' ' 2' ' ' ILE . 26.5 tt0 -151.88 160.02 43.66 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.522 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 94.64 -173.85 32.72 Favored Glycine 0 C--N 1.289 -2.046 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.82 105.91 0.43 Allowed 'Cis proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.162 -1.599 . . . . 0.0 111.595 -0.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.023 HG21 HG21 ' A' ' 2' ' ' ILE . 5.0 m -73.93 164.47 60.92 Favored Pre-proline 0 C--N 1.286 -2.161 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -92.44 153.71 3.01 Favored 'Trans proline' 0 C--N 1.286 -2.736 0 C-N-CA 121.315 1.343 . . . . 0.0 112.064 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.482 HD13 HG23 ' A' ' 4' ' ' VAL . 11.5 tp -142.12 128.64 20.19 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -108.69 108.45 19.3 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.649 -0.657 . . . . 0.0 109.335 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.74 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 84.7 t -96.72 99.56 9.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 176.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 2.4 mp -80.95 132.02 32.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.572 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 19.8 t -89.09 111.47 22.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.576 HG21 ' HB3' ' A' ' 8' ' ' LEU . 13.6 pt -97.08 170.96 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.452 -0.78 . . . . 0.0 109.394 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.535 ' CG ' ' HE ' ' A' ' 67' ' ' ARG . 7.0 m-20 . . . . . 0 C--N 1.297 -1.675 0 O-C-N 121.148 -0.97 . . . . 0.0 108.459 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.463 ' HG ' ' CB ' ' A' ' 27' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.407 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.84 HG21 HG21 ' A' ' 91' ' ' VAL . 7.2 mt -79.49 122.27 34.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -104.59 142.6 17.62 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.664 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.415 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -150.05 160.43 4.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.415 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -132.24 130.77 22.08 Favored Pre-proline 0 C--N 1.276 -2.592 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.612 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HB3' HD11 ' A' ' 96' ' ' ILE . 54.0 Cg_exo -41.15 129.14 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.213 1.942 . . . . 0.0 110.189 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.419 HG22 HG12 ' A' ' 9' ' ' ILE . 28.8 mt -95.79 109.41 22.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.509 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.05 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.933 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -90.41 107.08 18.92 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 7' ' ' ILE . 15.9 mt -107.22 125.19 33.05 Favored Pre-proline 0 C--N 1.286 -2.191 0 O-C-N 121.433 -0.792 . . . . 0.0 109.11 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.3 Cg_endo -64.96 120.11 7.29 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.125 1.216 . . . . 0.0 109.43 175.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.483 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -70.8 -171.97 0.59 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.532 0.682 . . . . 0.0 110.767 -174.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 59.99 -2.9 0.13 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -56.96 137.82 54.95 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.41 175.43 5.51 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 121.272 -0.892 . . . . 0.0 110.707 -174.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -49.68 166.56 0.26 Allowed Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 123.045 0.538 . . . . 0.0 109.935 178.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.583 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 1.9 Cg_endo -78.71 143.22 71.28 Favored 'Cis proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.18 -1.592 . . . . 0.0 112.926 -0.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.501 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 30.0 m-85 -115.41 160.98 32.3 Favored Pre-proline 0 C--N 1.275 -2.663 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 3.9 Cg_endo -70.94 160.64 91.22 Favored 'Cis proline' 0 N--CA 1.487 1.142 0 C-N-CA 124.04 -1.233 . . . . 0.0 112.877 0.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 16' ' ' PRO . 4.9 mtp85 -131.14 136.33 48.25 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -66.84 137.57 56.69 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.03 5.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.53 177.42 37.15 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 117.707 -2.187 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.564 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 16.1 tttm -139.2 123.21 17.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.118 -1.225 . . . . 0.0 110.955 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.564 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 14.3 t -82.0 155.99 4.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 172.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 3' ' ' VAL . 22.0 t -144.89 148.4 17.98 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.941 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.486 ' HB2' HG21 ' A' ' 79' ' ' THR . 11.4 t0 -112.79 131.69 55.58 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.463 ' CB ' ' HG ' ' A' ' 1' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.286 -2.152 0 O-C-N 121.748 -0.595 . . . . 0.0 110.121 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.479 ' O ' ' NZ ' ' A' ' 34' ' ' LYS . 2.6 p . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 121.46 0.648 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 33' ' ' SER . 5.3 mmtm -137.74 170.99 15.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HB3' HD13 ' A' ' 52' ' ' ILE . 14.5 m-85 -117.58 121.28 40.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.406 -0.809 . . . . 0.0 109.14 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.478 ' HG3' ' CG2' ' A' ' 80' ' ' THR . 0.0 OUTLIER -100.96 144.28 30.09 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 173.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.9 tp -127.94 142.55 51.22 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.46 171.38 16.17 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.466 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 124.86 166.42 12.38 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.318 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.58 119.05 4.72 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 109.39 -24.81 19.53 Favored Glycine 0 C--N 1.281 -2.491 0 N-CA-C 107.661 -2.175 . . . . 0.0 107.661 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -105.89 -100.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.553 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -90.25 -0.51 57.65 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.393 -0.817 . . . . 0.0 109.351 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -123.36 157.66 32.82 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.997 178.062 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -47.94 127.21 11.52 Favored Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.847 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.443 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 4.4 Cg_exo -76.38 113.16 2.71 Favored 'Cis proline' 0 C--O 1.203 -1.25 0 C-N-CA 123.694 -1.378 . . . . 0.0 109.188 -1.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.553 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 11.4 mtpp -64.9 139.98 58.82 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 121.024 -1.048 . . . . 0.0 111.438 -173.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.67 35.68 35.46 Favored Glycine 0 N--CA 1.502 3.076 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.104 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 41' ' ' GLY . 5.1 mm -104.33 -46.12 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 118.717 1.259 . . . . 0.0 107.944 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.468 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 67.1 m-85 -114.11 137.76 51.31 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.65 0.738 . . . . 0.0 110.318 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.24 143.33 31.69 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 35' ' ' PHE . 8.3 tt -106.58 166.39 3.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.475 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 9.8 t-20 -86.95 120.49 28.27 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.27 -13.98 2.52 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -119.93 -46.83 2.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.844 -1.16 . . . . 0.0 111.382 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 22.0 p -79.39 -40.99 28.74 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.742 0.782 . . . . 0.0 108.991 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.42 6.15 56.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 6.6 m -61.77 125.58 24.31 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.4 -1.059 . . . . 0.0 108.169 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.484 HG22 HG23 ' A' ' 24' ' ' VAL . 2.1 t -93.56 129.48 43.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.4 155.78 44.19 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.541 -0.724 . . . . 0.0 109.174 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.525 HG22 ' H ' ' A' ' 63' ' ' ARG . 8.5 p -106.81 139.87 26.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -94.34 6.28 49.19 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.479 -0.763 . . . . 0.0 112.796 -176.064 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.669 ' NH1' ' O ' ' A' ' 64' ' ' THR . 15.6 ptt85 -156.18 172.38 18.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.441 -1.412 . . . . 0.0 110.759 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.669 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 5.9 t -65.42 138.17 57.95 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 47.3 mt -96.28 163.89 12.89 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.943 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.567 ' CG ' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -152.07 121.73 6.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.415 ' HG2' ' HB ' ' A' ' 97' ' ' VAL . 24.0 mtm-85 -67.1 1.99 1.75 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.411 -0.806 . . . . 0.0 109.352 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -71.73 -22.01 61.68 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -101.34 -70.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.9 mt -130.49 145.86 34.93 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.53 -23.53 15.98 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.4 p -151.38 139.13 13.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.67 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -110.88 143.87 40.81 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.16 95.6 5.69 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.5 OUTLIER -88.58 170.33 10.94 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.302 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 68.6 m-85 -129.93 121.19 26.13 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.606 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -107.38 152.86 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 120.93 0.395 . . . . 0.0 110.106 -176.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.761 ' HB3' HG23 ' A' ' 86' ' ' THR . 48.0 mt-10 -138.88 140.39 38.4 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.701 -0.625 . . . . 0.0 109.401 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.573 ' N ' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -91.07 124.65 35.46 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 172.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -110.0 158.82 17.86 Favored 'General case' 0 C--N 1.268 -2.936 0 CA-C-O 121.817 0.818 . . . . 0.0 111.523 -171.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.616 ' HB2' HD21 ' A' ' 87' ' ' LEU . 14.2 t0 -99.58 169.38 9.33 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 175.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 2.4 m -59.33 -19.86 17.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.981 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.61 -1.28 41.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.42 24.76 74.39 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 80' ' ' THR . 6.5 pttp -107.5 159.46 16.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.645 -0.915 . . . . 0.0 108.843 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.761 HG23 ' HB3' ' A' ' 78' ' ' GLU . 4.2 m -83.23 120.83 26.31 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.358 0.599 . . . . 0.0 112.415 -174.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.616 HD21 ' HB2' ' A' ' 81' ' ' ASP . 1.2 mm? -79.81 -46.91 16.07 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 1' ' ' SER . 0.5 OUTLIER -142.71 155.05 44.83 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.24 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.596 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 105.08 177.7 24.4 Favored Glycine 0 C--N 1.291 -1.928 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 36.1 Cg_endo -68.34 102.59 0.29 Allowed 'Cis proline' 0 N--CA 1.5 1.888 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.403 0.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.84 HG21 HG21 ' A' ' 2' ' ' ILE . 6.8 m -79.17 160.41 70.92 Favored Pre-proline 0 C--N 1.29 -1.989 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -94.03 148.2 2.05 Favored 'Trans proline' 0 C--N 1.284 -2.838 0 C-N-CA 121.673 1.582 . . . . 0.0 111.775 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 94' ' ' GLU . 3.9 tp -131.57 128.4 39.14 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.467 ' N ' HD12 ' A' ' 93' ' ' LEU . 23.3 mt-10 -102.64 119.74 39.35 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 97.7 t -109.18 111.05 34.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.634 HD13 ' CD1' ' A' ' 8' ' ' LEU . 5.2 mp -94.82 134.41 32.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.483 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 21.4 t -91.22 119.57 38.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.565 HG21 ' HB3' ' A' ' 8' ' ' LEU . 12.2 pt -119.17 171.33 7.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 C--N 1.294 -1.841 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.94 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.492 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.949 HG21 HG21 ' A' ' 91' ' ' VAL . 10.0 mt -78.38 139.99 17.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.071 -1.018 . . . . 0.0 111.168 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -122.83 123.84 69.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 172.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.517 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -126.47 162.93 29.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 O-C-N 121.15 -0.969 . . . . 0.0 110.003 -175.023 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.457 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -142.95 133.76 12.51 Favored Pre-proline 0 C--N 1.289 -2.054 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.131 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -47.35 152.72 2.19 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.497 2.131 . . . . 0.0 111.517 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.433 HG13 HD11 ' A' ' 93' ' ' LEU . 4.4 mt -115.66 114.34 45.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.884 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -89.35 108.39 19.61 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.287 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.463 ' C ' HG12 ' A' ' 98' ' ' ILE . 12.7 mt -118.0 130.05 24.97 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 28.1 Cg_endo -67.53 132.06 26.19 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.143 1.228 . . . . 0.0 111.514 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.63 ' CD ' HH21 ' A' ' 67' ' ' ARG . 21.0 pt-20 -54.86 164.75 0.74 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.437 -0.79 . . . . 0.0 109.495 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 60.48 29.64 19.16 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.774 -0.579 . . . . 0.0 111.453 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.421 ' O ' ' OG1' ' A' ' 64' ' ' THR . 2.8 mt-30 -60.47 140.48 57.25 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.583 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 48.7 mtm-85 -114.62 169.09 9.32 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.008 -1.057 . . . . 0.0 111.685 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.614 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 90.8 mt-30 -49.71 169.55 0.18 Allowed Pre-proline 0 C--N 1.297 -1.687 0 C-N-CA 123.387 0.675 . . . . 0.0 109.529 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 5.9 Cg_exo -76.32 125.45 11.72 Favored 'Cis proline' 0 N--CA 1.49 1.291 0 C-N-CA 123.978 -1.259 . . . . 0.0 113.268 -0.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.533 ' CE1' ' HD3' ' A' ' 19' ' ' ARG . 35.3 m-85 -100.26 159.3 30.14 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 15.4 Cg_exo -68.42 149.27 84.81 Favored 'Cis proline' 0 N--CA 1.505 2.167 0 C-N-CA 124.594 -1.003 . . . . 0.0 112.629 -0.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 13.9 mtp180 -118.89 122.77 43.07 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.458 -0.776 . . . . 0.0 110.081 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 1.7 t70 -66.22 135.03 53.91 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.1 0.16 2.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.778 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.54 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 172.14 174.32 39.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.645 ' CE ' HG22 ' A' ' 25' ' ' VAL . 3.5 tttp -134.91 126.66 29.12 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 121.305 -1.115 . . . . 0.0 109.587 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.585 HG23 ' CG2' ' A' ' 59' ' ' VAL . 62.0 t -89.06 153.12 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.645 HG22 ' CE ' ' A' ' 23' ' ' LYS . 2.7 t -137.16 170.19 18.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 118.212 -1.395 . . . . 0.0 109.433 -174.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 1' ' ' SER . 16.3 t0 -143.9 123.37 13.16 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.295 -1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 109.377 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.4 0.619 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -100.07 126.74 46.33 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.317 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.749 ' HB3' HD13 ' A' ' 52' ' ' ILE . 61.8 m-85 -86.65 130.12 34.61 Favored 'General case' 0 C--N 1.28 -2.439 0 O-C-N 121.563 -0.711 . . . . 0.0 110.059 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HG3' HG21 ' A' ' 80' ' ' THR . 0.3 OUTLIER -103.7 135.58 45.0 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.378 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 20.2 tp -114.57 145.94 41.35 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.515 HG23 ' NH2' ' A' ' 36' ' ' ARG . 1.2 p -148.01 170.98 16.56 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.14 171.86 16.94 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 120.043 -1.075 . . . . 0.0 111.463 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -60.78 117.44 5.39 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 117.44 -24.44 9.15 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -175.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.487 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 15.2 t -126.51 -104.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.02 -22.75 66.46 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.223 -0.923 . . . . 0.0 110.22 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -116.73 159.35 22.4 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.615 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 6.6 mm-40 -74.46 150.15 86.86 Favored Pre-proline 0 C--N 1.287 -2.115 0 O-C-N 121.971 -0.456 . . . . 0.0 110.336 -177.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 31.2 Cg_endo -67.13 115.91 1.8 Allowed 'Cis proline' 0 N--CA 1.511 2.554 0 C-N-CA 123.835 -1.319 . . . . 0.0 110.631 -0.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.615 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 2.1 mtpm? -78.22 165.75 23.53 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.657 -1.277 . . . . 0.0 110.946 -173.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.19 31.47 69.09 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.6 mm -105.69 -45.29 8.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 118.645 1.222 . . . . 0.0 107.936 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.621 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 97.0 m-85 -124.42 156.25 37.47 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.611 0.72 . . . . 0.0 110.633 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -156.78 150.96 25.11 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.749 HD13 ' HB3' ' A' ' 35' ' ' PHE . 15.1 tt -108.81 157.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 118.61 -1.236 . . . . 0.0 108.962 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 10.2 t-20 -83.34 119.38 24.53 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -75.56 10.72 1.56 Allowed 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 120.865 0.364 . . . . 0.0 111.496 -175.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 19.5 t-20 -124.14 -43.18 2.1 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.837 -1.165 . . . . 0.0 109.276 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.417 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 43.7 p -95.74 -38.6 10.26 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.59 6.06 55.07 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.0 m -66.54 124.56 23.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.568 -0.96 . . . . 0.0 109.512 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.585 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.7 t -87.61 124.62 41.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -124.17 155.66 38.08 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.325 -0.859 . . . . 0.0 109.641 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.427 HG13 ' CE1' ' A' ' 17' ' ' PHE . 7.4 p -102.17 137.55 29.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.2 -12.99 39.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.454 -0.779 . . . . 0.0 111.548 -174.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.559 ' NE ' ' O ' ' A' ' 64' ' ' THR . 2.0 ptm180 -153.08 -176.4 5.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.841 -1.162 . . . . 0.0 110.208 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.559 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 12.6 t -70.51 156.06 39.9 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.686 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -113.09 123.01 49.28 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 109.407 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -109.07 113.77 26.92 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.63 HH21 ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -58.65 -7.29 0.92 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.518 0.675 . . . . 0.0 109.229 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -70.67 -19.79 62.76 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 66' ' ' ASP . 2.3 t -101.7 -58.57 3.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 mt -136.21 134.85 50.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.63 -28.13 24.97 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.3 p -152.79 128.0 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.508 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 29.7 m-85 -91.21 125.44 35.99 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -90.68 85.08 5.97 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 170.45 13.39 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 70.3 m-85 -135.96 133.99 38.16 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.744 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -111.24 155.56 12.61 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 O-C-N 121.826 -0.546 . . . . 0.0 109.595 -176.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.41 ' C ' HD11 ' A' ' 2' ' ' ILE . 2.1 mt-10 -144.76 147.85 33.42 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.702 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -94.21 133.64 37.51 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.555 HG21 ' HG3' ' A' ' 36' ' ' ARG . 17.1 p -128.14 153.93 46.32 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 83' ' ' ASN . 1.2 t70 -109.69 170.7 7.9 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.7 m -56.99 -3.67 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 O-C-N 121.306 -0.871 . . . . 0.0 111.003 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -79.71 -19.68 48.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.34 28.96 31.75 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -116.34 168.21 10.34 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 88' ' ' GLU . 1.3 m -109.8 118.87 37.66 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.453 -0.78 . . . . 0.0 110.015 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.91 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.6 -20.31 21.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 86' ' ' THR . 12.7 tt0 -157.2 164.08 38.13 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.46 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 114.92 166.5 15.21 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 107.045 -2.422 . . . . 0.0 107.045 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -82.63 107.2 1.02 Allowed 'Cis proline' 0 C--N 1.3 -2.003 0 C-N-CA 123.127 -1.614 . . . . 0.0 110.801 0.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.949 HG21 HG21 ' A' ' 2' ' ' ILE . 18.9 m -78.58 159.46 74.37 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 105.682 -1.969 . . . . 0.0 105.682 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -91.5 148.18 3.47 Favored 'Trans proline' 0 C--N 1.285 -2.77 0 C-N-CA 121.419 1.412 . . . . 0.0 112.675 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.487 HD21 HG11 ' A' ' 59' ' ' VAL . 11.2 tp -138.65 113.28 9.0 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -95.47 113.79 25.48 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.621 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 15.8 t -95.28 107.76 19.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 176.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.407 HD13 ' CD1' ' A' ' 8' ' ' LEU . 2.4 mp -90.89 127.7 43.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.6 t -84.62 104.86 13.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 7.4 pt -94.67 172.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 O-C-N 121.517 -0.739 . . . . 0.0 109.365 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.506 ' CG ' HH22 ' A' ' 67' ' ' ARG . 1.1 m-20 . . . . . 0 C--N 1.291 -1.939 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 1.02 HG21 HG21 ' A' ' 91' ' ' VAL . 11.7 mt -59.01 120.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.187 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.0 113.94 45.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.496 HG23 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -136.74 158.96 37.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.641 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.413 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -148.69 139.73 13.79 Favored Pre-proline 0 C--N 1.273 -2.73 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -41.48 132.65 3.58 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.216 1.944 . . . . 0.0 111.451 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.52 HG13 HD11 ' A' ' 93' ' ' LEU . 34.7 mt -98.42 110.91 26.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.881 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -87.71 108.44 19.11 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 21' ' ' VAL . 20.5 mt -117.09 136.1 23.25 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 30.0 Cg_endo -70.54 132.37 21.95 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.299 1.333 . . . . 0.0 110.968 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.548 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 13.1 pt-20 -63.78 176.75 0.85 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.018 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.549 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 20.4 t-20 58.56 23.51 10.94 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.587 -0.696 . . . . 0.0 111.757 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 10' ' ' PRO . 2.8 mt-30 -70.22 115.79 9.82 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.549 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -89.57 176.1 7.02 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 120.928 -1.108 . . . . 0.0 109.932 -177.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.573 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 11.6 mm-40 -42.92 167.62 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 C-N-CA 124.063 0.945 . . . . 0.0 110.61 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 2.2 Cg_endo -82.7 146.34 60.09 Favored 'Cis proline' 0 N--CA 1.495 1.567 0 C-N-CA 124.186 -1.172 . . . . 0.0 114.027 -0.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.487 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 42.3 m-85 -133.62 160.35 68.94 Favored Pre-proline 0 C--N 1.282 -2.369 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 18.4 Cg_exo -66.46 163.49 69.81 Favored 'Cis proline' 0 N--CA 1.499 1.807 0 C-N-CA 124.079 -1.217 . . . . 0.0 112.162 -0.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 16' ' ' PRO . 9.9 ttm180 -146.13 143.55 29.4 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.667 -0.646 . . . . 0.0 109.455 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 9.0 t0 -74.73 137.51 42.12 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.638 HG21 HD11 ' A' ' 9' ' ' ILE . 35.0 m -132.64 6.03 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 174.82 179.47 45.42 Favored Glycine 0 N--CA 1.506 3.322 0 C-N-CA 118.896 -1.621 . . . . 0.0 109.702 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.7 ttpm? -145.37 122.98 11.78 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.787 -1.419 . . . . 0.0 110.118 -177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.567 HG11 HG11 ' A' ' 77' ' ' VAL . 45.4 t -93.49 143.57 11.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 171.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' HE2' ' A' ' 23' ' ' LYS . 11.9 t -139.18 170.08 16.45 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 1' ' ' SER . 10.1 t0 -132.67 120.5 21.81 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.419 ' HG ' ' H3 ' ' A' ' 1' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.265 -3.068 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.823 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 82' ' ' VAL . 4.1 mttm -113.66 123.96 51.16 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.911 ' CE2' HG23 ' A' ' 79' ' ' THR . 53.0 m-85 -83.33 139.42 33.05 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 120.967 -1.083 . . . . 0.0 109.695 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.569 HH22 ' CD ' ' A' ' 54' ' ' GLU . 41.2 mmt-85 -120.38 155.61 33.06 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.47 HD11 HD23 ' A' ' 93' ' ' LEU . 16.1 tp -133.27 142.07 48.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -147.97 171.52 15.66 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.72 179.4 16.91 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.531 -1.355 . . . . 0.0 111.154 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -63.13 106.98 0.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 129.64 -18.13 5.45 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -130.46 -90.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.988 -0.713 . . . . 0.0 109.324 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -20.03 32.52 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 120.923 -1.111 . . . . 0.0 108.777 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -112.35 161.26 16.85 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.365 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 6.5 mt-10 -69.33 143.41 93.5 Favored Pre-proline 0 C--N 1.281 -2.401 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.573 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.489 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 40.8 Cg_endo -72.87 123.65 8.56 Favored 'Cis proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.179 -1.592 . . . . 0.0 110.271 -2.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.425 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 2.3 mtpm? -80.35 166.06 21.67 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 120.716 -1.24 . . . . 0.0 109.674 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.09 34.02 75.27 Favored Glycine 0 C--N 1.284 -2.355 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.471 HD13 ' NE ' ' A' ' 63' ' ' ARG . 4.5 mm -110.85 -50.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.008 -1.29 . . . . 0.0 108.4 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.654 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 97.3 m-85 -121.59 161.12 22.96 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.405 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.66 ' HG2' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -160.07 134.26 7.4 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 35' ' ' PHE . 19.3 tt -100.13 167.23 2.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 O-C-N 120.793 -1.192 . . . . 0.0 109.04 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.417 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 7.1 t-20 -100.59 122.86 43.98 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.569 ' CD ' HH22 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -49.1 -49.75 40.32 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.965 -0.46 . . . . 0.0 112.005 -176.445 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -90.08 -40.78 12.07 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 111.936 -173.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 9.3 p -84.14 -22.79 30.92 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.0 9.19 62.72 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.0 m -64.4 123.72 19.93 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.263 -1.139 . . . . 0.0 108.714 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.473 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.3 t -83.15 120.75 35.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -116.88 153.85 31.8 Favored 'General case' 0 C--N 1.282 -2.344 0 O-C-N 121.577 -0.702 . . . . 0.0 109.97 -177.296 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.472 HG23 HD21 ' A' ' 65' ' ' LEU . 7.2 p -105.67 140.83 22.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.66 HG23 ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -93.06 -15.17 26.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.795 . . . . 0.0 111.209 -176.441 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.471 ' NE ' HD13 ' A' ' 49' ' ' ILE . 6.0 ptp180 -154.34 -167.64 2.69 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.747 -1.22 . . . . 0.0 110.004 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 1.7 t -74.78 148.57 40.25 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' ASN . 67.0 mt -106.63 129.95 54.46 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.18 126.77 55.43 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.413 HH12 ' CG ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -67.62 -9.58 44.38 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.19 -28.57 62.27 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.32 -52.9 10.6 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.425 ' O ' HG21 ' A' ' 97' ' ' VAL . 1.1 mt -148.43 136.76 14.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.12 -22.37 27.13 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -155.33 123.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.503 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 65.0 m-85 -88.21 121.65 30.85 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.915 -1.115 . . . . 0.0 108.509 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -90.2 98.47 11.79 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.63 170.42 9.35 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.2 m-85 -135.46 124.27 23.96 Favored 'General case' 0 C--N 1.262 -3.198 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -104.88 152.18 6.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.084 0.469 . . . . 0.0 110.293 -174.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.55 ' HB3' HG23 ' A' ' 86' ' ' THR . 42.7 mt-10 -139.71 140.12 36.73 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.911 HG23 ' CE2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -93.26 130.91 38.81 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 170.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.517 ' C ' HD21 ' A' ' 87' ' ' LEU . 70.5 p -124.5 164.82 18.95 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.744 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.476 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 25.5 t70 -88.23 167.66 13.39 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.2 m -53.65 -27.07 14.58 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.685 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -79.87 -11.18 59.83 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.582 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.8 56.98 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -76.46 146.97 38.2 Favored 'General case' 0 C--O 1.194 -1.824 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 175.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 78' ' ' GLU . 85.2 m -93.4 115.17 27.72 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 118.76 0.709 . . . . 0.0 109.199 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.05 -31.71 27.22 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -144.84 160.65 40.94 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.0 109.201 175.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.422 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 94.65 178.27 38.16 Favored Glycine 0 C--N 1.287 -2.187 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -174.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -67.94 121.36 4.34 Favored 'Cis proline' 0 C--N 1.299 -2.058 0 C-N-CA 123.026 -1.656 . . . . 0.0 111.433 0.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 2' ' ' ILE . 3.0 m -101.86 163.27 18.12 Favored Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -91.01 150.07 3.84 Favored 'Trans proline' 0 C--N 1.287 -2.673 0 C-N-CA 121.53 1.487 . . . . 0.0 112.372 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.52 HD11 HG13 ' A' ' 7' ' ' ILE . 10.5 tp -137.46 128.3 27.22 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.06 109.94 21.5 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.629 -0.669 . . . . 0.0 109.886 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.654 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 61.3 t -91.75 97.08 6.82 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.447 ' HB ' HD12 ' A' ' 8' ' ' LEU . 2.1 mt -79.63 132.24 32.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 21.7 t -91.15 116.79 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 11.5 pt -105.85 171.82 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.413 ' CG ' HH12 ' A' ' 67' ' ' ARG . 11.6 m-20 . . . . . 0 C--N 1.298 -1.661 0 O-C-N 120.907 -1.12 . . . . 0.0 109.356 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 1.09 HG21 HG21 ' A' ' 91' ' ' VAL . 31.7 mt -65.7 132.13 31.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-O 121.734 0.778 . . . . 0.0 110.74 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -119.44 122.84 69.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 175.752 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -137.87 169.13 19.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.522 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.5 m -159.81 169.76 9.81 Favored Pre-proline 0 C--N 1.274 -2.695 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 25.1 Cg_exo -61.85 134.87 52.5 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.35 1.367 . . . . 0.0 110.745 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.613 HD13 ' HA3' ' A' ' 22' ' ' GLY . 24.4 mt -106.11 111.83 36.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.868 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.42 98.56 11.85 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.459 ' CD1' HG21 ' A' ' 21' ' ' VAL . 20.3 mt -101.19 129.0 28.01 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.97 -1.081 . . . . 0.0 109.0 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 5.0 Cg_endo -63.38 124.91 14.61 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 121.091 1.194 . . . . 0.0 110.046 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.52 ' HB3' HG12 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -67.04 171.43 5.53 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.717 1.246 . . . . 0.0 113.929 -170.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.512 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 6.4 m-80 47.71 24.15 0.51 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.486 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.458 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 73.0 mt-30 -67.0 146.79 54.0 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 173.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.541 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -104.9 179.26 4.32 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.174 -0.954 . . . . 0.0 110.031 -177.037 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.639 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -54.2 176.74 0.12 Allowed Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.639 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 5.7 Cg_exo -72.79 117.99 4.4 Favored 'Cis proline' 0 N--CA 1.491 1.359 0 C-N-CA 123.942 -1.274 . . . . 0.0 113.986 0.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 31.8 m-85 -100.15 165.08 15.16 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 55.2 Cg_endo -73.12 162.25 92.14 Favored 'Cis proline' 0 N--CA 1.497 1.681 0 C-N-CA 124.242 -1.149 . . . . 0.0 111.84 -0.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 11.3 mtp180 -138.19 145.5 41.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 5.0 t0 -73.75 134.53 43.48 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.459 HG21 ' CD1' ' A' ' 9' ' ' ILE . 31.1 m -129.91 3.24 2.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.609 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.613 ' HA3' HD13 ' A' ' 7' ' ' ILE . . . -172.83 -171.32 37.48 Favored Glycine 0 N--CA 1.499 2.899 0 C-N-CA 117.347 -2.358 . . . . 0.0 111.146 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -150.29 113.68 4.92 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 120.998 -1.295 . . . . 0.0 110.851 -178.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 4' ' ' VAL . 11.4 t -100.91 112.06 32.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 169.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 3' ' ' VAL . 58.5 t -120.66 154.46 24.0 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.008 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.7 t70 -104.23 135.41 45.74 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.074 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.407 0.622 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -126.61 133.01 51.13 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.614 ' HB3' HD13 ' A' ' 52' ' ' ILE . 12.1 m-85 -79.9 137.73 36.97 Favored 'General case' 0 C--N 1.273 -2.755 0 O-C-N 121.137 -0.977 . . . . 0.0 108.543 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.413 ' NH2' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -114.97 126.52 54.86 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.212 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.584 ' HG ' HG21 ' A' ' 42' ' ' VAL . 19.5 tp -105.8 148.98 26.9 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.413 HG23 ' NH2' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -152.03 170.39 20.02 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -177.154 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.5 ' C ' ' HB2' ' A' ' 44' ' ' GLN . . . 110.43 172.41 20.05 Favored Glycine 0 N--CA 1.497 2.765 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.954 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.48 ' N ' ' HB2' ' A' ' 44' ' ' GLN . 9.6 mtpp -53.25 114.75 1.59 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 115.18 -20.66 13.94 Favored Glycine 0 C--N 1.28 -2.564 0 N-CA-C 108.296 -1.921 . . . . 0.0 108.296 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.584 HG21 ' HG ' ' A' ' 37' ' ' LEU . 9.2 t -113.06 -89.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.45 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 31.7 t70 -100.17 -13.02 19.11 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.243 -0.91 . . . . 0.0 109.501 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 44' ' ' GLN . 0.4 OUTLIER -100.13 158.42 15.86 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 176.743 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 137.24 96.17 Favored Pre-proline 0 C--N 1.271 -2.808 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.492 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.44 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.2 Cg_exo -76.88 119.47 6.39 Favored 'Cis proline' 0 N--CA 1.5 1.874 0 C-N-CA 123.442 -1.483 . . . . 0.0 110.624 -0.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 2.2 mttm -69.27 144.49 53.6 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.708 -1.245 . . . . 0.0 110.353 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.49 37.83 34.59 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.344 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.432 HG13 ' HA2' ' A' ' 41' ' ' GLY . 5.0 mm -106.11 -43.0 7.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.499 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 84.8 m-85 -118.71 149.93 40.61 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.793 0.806 . . . . 0.0 110.264 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.485 ' HG2' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -148.13 142.94 26.75 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 176.499 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' A' ' 35' ' ' PHE . 12.2 tt -100.09 158.46 3.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 O-C-N 120.505 -1.372 . . . . 0.0 109.845 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 58' ' ' SER . 6.2 m-80 -84.76 84.71 7.6 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.732 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 2.0 pm0 -24.78 -54.52 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 124.18 0.992 . . . . 0.0 113.554 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -80.95 -33.94 33.59 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.168 -0.958 . . . . 0.0 111.939 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -94.94 -25.84 16.38 Favored 'General case' 0 C--N 1.287 -2.126 0 O-C-N 121.161 -0.962 . . . . 0.0 109.073 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 82.91 10.52 82.89 Favored Glycine 0 C--N 1.285 -2.273 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -66.8 128.73 37.42 Favored 'General case' 0 C--N 1.312 -1.043 0 O-C-N 120.859 -1.377 . . . . 0.0 108.608 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 7' ' ' ILE . 4.6 t -79.91 119.2 28.87 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.477 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -113.29 151.6 30.93 Favored 'General case' 0 C--N 1.282 -2.335 0 O-C-N 121.699 -0.626 . . . . 0.0 109.561 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.534 HG21 HD11 ' A' ' 65' ' ' LEU . 12.8 p -112.63 143.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.485 HG23 ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -96.43 -15.36 21.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.695 -0.628 . . . . 0.0 111.54 -176.704 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.95 178.54 8.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.464 -1.397 . . . . 0.0 111.783 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.541 ' OG1' ' NH2' ' A' ' 14' ' ' ARG . 4.9 t -70.05 122.51 19.52 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.534 HD11 HG21 ' A' ' 61' ' ' VAL . 28.3 mt -90.81 127.2 36.26 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.161 -0.962 . . . . 0.0 108.926 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.25 139.28 46.77 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.442 ' CG ' ' HB3' ' A' ' 11' ' ' GLU . 7.4 mtp180 -81.88 -11.24 59.02 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.803 -0.56 . . . . 0.0 111.29 -176.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.85 -22.76 49.43 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.83 -63.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.41 ' O ' HG21 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -130.44 127.41 62.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.25 -25.86 31.27 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -156.69 135.97 3.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.419 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 67.1 m-85 -98.75 124.7 43.78 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 -90.74 90.86 8.13 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.87 170.47 11.15 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 122.132 0.968 . . . . 0.0 109.458 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 53.5 m-85 -134.08 127.6 32.51 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.755 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.29 142.89 23.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.24 0.543 . . . . 0.0 110.452 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HB3' HG23 ' A' ' 86' ' ' THR . 45.2 mt-10 -133.7 145.19 49.66 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.698 ' HB ' HD23 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -92.24 142.38 27.53 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 171.302 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.574 ' C ' HD21 ' A' ' 87' ' ' LEU . 24.1 p -127.6 155.3 44.08 Favored 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.441 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.659 ' HB2' HD11 ' A' ' 87' ' ' LEU . 37.3 t0 -97.1 170.01 9.42 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.806 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.441 ' N ' ' OD2' ' A' ' 81' ' ' ASP . 13.5 m -56.42 -16.15 3.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -85.75 -13.08 49.41 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.22 22.65 58.61 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -98.97 150.46 21.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 176.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 78' ' ' GLU . 57.7 m -84.49 129.01 34.9 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.971 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -99.16 -30.24 12.4 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.279 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.502 ' HG2' ' H ' ' A' ' 2' ' ' ILE . 3.9 tp10 -149.47 153.66 37.62 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.602 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 97.96 -176.35 30.64 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.26 104.97 0.36 Allowed 'Cis proline' 0 N--CA 1.496 1.641 0 CA-C-N 118.861 1.33 . . . . 0.0 112.089 -0.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.09 HG21 HG21 ' A' ' 2' ' ' ILE . 16.1 m -79.79 161.94 64.49 Favored Pre-proline 0 C--N 1.284 -2.247 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -93.3 155.76 2.54 Favored 'Trans proline' 0 C--N 1.291 -2.478 0 C-N-CA 121.6 1.533 . . . . 0.0 111.016 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.462 HD13 HG23 ' A' ' 4' ' ' VAL . 12.9 tp -142.18 128.08 19.46 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -108.97 104.14 13.31 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.526 -0.734 . . . . 0.0 109.496 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.499 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 70.7 t -94.4 107.95 20.06 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.9 mp -90.64 129.95 40.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 11' ' ' GLU . 1.5 t -86.97 109.72 19.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.662 HG21 ' HB3' ' A' ' 8' ' ' LEU . 20.6 pt -109.15 171.54 2.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-O 121.425 0.631 . . . . 0.0 109.407 -176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.381 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.476 ' HA ' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 91' ' ' VAL . 7.9 mt -72.16 139.89 18.96 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-O 121.583 0.706 . . . . 0.0 110.599 -177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.85 128.04 75.59 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.522 HG23 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -140.68 162.23 23.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.4 -0.813 . . . . 0.0 109.728 -175.158 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.443 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -145.59 156.01 52.87 Favored Pre-proline 0 C--N 1.284 -2.268 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 172.811 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 52.8 Cg_exo -49.76 149.42 10.74 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.63 1.553 . . . . 0.0 111.164 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.935 HG13 HD11 ' A' ' 93' ' ' LEU . 8.1 mt -112.27 111.88 38.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.914 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -92.64 105.06 17.28 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.6 mt -110.25 128.36 25.5 Favored Pre-proline 0 C--N 1.286 -2.157 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 31.7 Cg_endo -69.91 125.23 11.83 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 120.969 1.113 . . . . 0.0 110.872 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.504 ' HB3' HG12 ' A' ' 97' ' ' VAL . 11.1 pt-20 -61.37 170.86 1.6 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.822 -175.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.535 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 81.33 -19.17 0.44 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 172.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.421 ' O ' ' OG1' ' A' ' 64' ' ' THR . 2.3 mt-30 -52.27 134.31 33.74 Favored 'General case' 0 N--CA 1.518 2.974 0 O-C-N 120.687 -1.258 . . . . 0.0 108.128 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.535 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -111.28 -170.85 1.72 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.773 0.797 . . . . 0.0 111.163 -177.195 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.513 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 2.5 mp0 -45.88 163.44 0.22 Allowed Pre-proline 0 C--N 1.305 -1.329 0 C-N-CA 124.547 1.139 . . . . 0.0 109.943 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 39.9 Cg_endo -79.33 141.77 62.93 Favored 'Cis proline' 0 C--N 1.314 -1.275 0 C-N-CA 123.146 -1.606 . . . . 0.0 112.103 -0.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 37.3 m-85 -112.83 158.88 36.4 Favored Pre-proline 0 C--N 1.28 -2.454 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 59.5 Cg_endo -75.95 153.37 97.65 Favored 'Cis proline' 0 N--CA 1.498 1.747 0 C-N-CA 123.942 -1.274 . . . . 0.0 112.909 0.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 7.1 mtp180 -120.33 135.99 54.84 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.92 147.75 52.88 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.9 6.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.873 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.26 -177.19 39.33 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 117.98 -2.057 . . . . 0.0 110.157 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -141.51 117.66 10.65 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.139 -1.212 . . . . 0.0 110.445 -176.33 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.631 HG23 HG22 ' A' ' 59' ' ' VAL . 21.9 t -87.38 135.84 24.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 103.539 -2.763 . . . . 0.0 103.539 169.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.38 150.64 34.83 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -127.83 112.72 15.06 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.768 0 O-C-N 121.682 -0.636 . . . . 0.0 110.433 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -117.23 147.99 42.03 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.494 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.763 ' HB3' HD13 ' A' ' 52' ' ' ILE . 57.4 m-85 -83.89 150.63 25.58 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 121.27 -0.894 . . . . 0.0 109.311 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.669 ' HG3' HG21 ' A' ' 80' ' ' THR . 6.1 mmp_? -123.73 135.0 53.59 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 173.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.722 ' HG ' HG21 ' A' ' 42' ' ' VAL . 36.8 tp -112.93 144.27 42.78 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.84 171.02 18.91 Favored 'General case' 0 C--N 1.271 -2.823 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -175.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.472 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 119.22 166.36 13.39 Favored Glycine 0 C--N 1.29 -1.99 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 177.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -59.09 109.92 0.94 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.418 ' HA2' HG13 ' A' ' 49' ' ' ILE . . . 124.21 -20.37 7.08 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -174.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.722 HG21 ' HG ' ' A' ' 37' ' ' LEU . 22.4 t -118.19 -86.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.991 -1.299 . . . . 0.0 108.788 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.49 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 27.3 t70 -99.5 -12.63 19.99 Favored 'General case' 0 C--O 1.206 -1.198 0 O-C-N 121.598 -0.689 . . . . 0.0 109.412 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.472 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 13.1 mp0 -109.76 160.34 16.41 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.84 135.81 92.92 Favored Pre-proline 0 C--N 1.273 -2.747 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.303 -174.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.579 ' HB2' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -77.21 124.18 10.35 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.824 -1.74 . . . . 0.0 109.97 -1.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.49 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 6.0 mttm -72.4 154.23 41.01 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 121.327 -0.858 . . . . 0.0 109.128 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.41 34.95 63.45 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.148 173.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.756 HD13 HH11 ' A' ' 63' ' ' ARG . 4.0 mm -106.64 -49.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.658 -1.496 . . . . 0.0 107.854 176.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.49 ' HB2' HG22 ' A' ' 42' ' ' VAL . 94.7 m-85 -118.96 152.73 35.82 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.481 -0.762 . . . . 0.0 110.691 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.639 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 6.9 ptm180 -143.43 169.92 16.76 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.763 HD13 ' HB3' ' A' ' 35' ' ' PHE . 8.6 tt -129.2 159.73 40.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 119.231 -0.987 . . . . 0.0 108.758 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 58' ' ' SER . 37.6 t-20 -79.94 96.92 6.53 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 2.1 mp0 -33.91 -50.07 0.36 Allowed 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 122.588 0.355 . . . . 0.0 110.942 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -42.78 17.09 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.211 -0.931 . . . . 0.0 112.354 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 p -94.74 -29.76 14.62 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.108 -0.995 . . . . 0.0 111.041 -171.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 95.33 -1.38 64.44 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -56.05 129.33 39.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.043 -1.269 . . . . 0.0 108.185 176.419 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 24' ' ' VAL . 1.9 t -94.02 134.36 31.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.639 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -131.73 159.67 37.73 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.455 -0.778 . . . . 0.0 109.663 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 63' ' ' ARG . 12.3 p -103.79 139.99 23.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -94.74 -2.99 50.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 111.303 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.756 HH11 HD13 ' A' ' 49' ' ' ILE . 2.8 ptp85 -157.21 -179.84 8.58 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 3.1 t -69.4 170.42 10.47 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.8 mt -131.41 136.28 47.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.87 122.79 35.68 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.532 HH22 ' CG ' ' A' ' 99' ' ' ASP . 5.3 mtm180 -57.12 -15.61 5.87 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.059 -1.026 . . . . 0.0 111.43 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.28 -19.65 63.91 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.9 -60.02 2.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.482 HD12 ' CE1' ' A' ' 73' ' ' TYR . 1.9 mt -143.68 145.17 22.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.7 -24.92 16.31 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.1 p -154.72 139.01 9.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.784 -0.572 . . . . 0.0 109.647 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.482 ' CE1' HD12 ' A' ' 70' ' ' ILE . 33.5 m-85 -106.39 127.09 53.02 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.4 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 8.6 tp-100 -91.79 86.88 6.06 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 176.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -83.76 170.67 13.94 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.565 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 78.5 m-85 -135.55 133.37 38.3 Favored 'General case' 0 C--N 1.265 -3.104 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.85 145.42 18.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -175.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.612 ' HB3' HG23 ' A' ' 86' ' ' THR . 50.8 mt-10 -135.23 143.88 46.59 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.561 ' C ' HD22 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -90.36 133.02 35.26 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 171.335 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.669 HG21 ' HG3' ' A' ' 36' ' ' ARG . 39.1 p -129.55 170.5 13.66 Favored 'General case' 0 C--N 1.278 -2.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.262 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 83' ' ' ASN . 6.1 t0 -149.78 171.62 16.45 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.409 -0.807 . . . . 0.0 110.328 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 81' ' ' ASP . 8.3 m -13.9 -41.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 126.276 1.83 . . . . 0.0 114.724 -178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 81' ' ' ASP . 8.0 t-20 -79.43 -7.51 58.45 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 120.722 -1.236 . . . . 0.0 109.732 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 72.18 19.18 78.45 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.5 OUTLIER -99.78 167.61 10.43 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 78' ' ' GLU . 91.3 m -94.07 119.68 33.26 Favored 'General case' 0 C--N 1.277 -2.563 0 O-C-N 122.154 -0.341 . . . . 0.0 111.292 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.839 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.71 -34.79 24.84 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 1' ' ' SER . 0.3 OUTLIER -142.09 163.32 33.19 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.792 -0.568 . . . . 0.0 109.743 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.467 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 89.87 -172.18 38.42 Favored Glycine 0 N--CA 1.481 1.699 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.77 102.95 0.34 Allowed 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.732 -1.362 . . . . 0.0 112.225 -0.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 2' ' ' ILE . 5.8 m -74.05 164.19 62.95 Favored Pre-proline 0 C--N 1.285 -2.199 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -94.48 154.61 1.99 Allowed 'Trans proline' 0 C--N 1.291 -2.491 0 C-N-CA 121.694 1.596 . . . . 0.0 111.295 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.935 HD11 HG13 ' A' ' 7' ' ' ILE . 16.6 tp -144.36 119.95 10.41 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.4 ' HG2' ' NE2' ' A' ' 74' ' ' GLN . 59.6 mt-10 -99.85 110.48 22.84 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.762 -0.586 . . . . 0.0 110.046 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 50.9 t -94.25 107.3 19.16 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.7 mp -90.82 135.06 27.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.504 HG12 ' HB3' ' A' ' 11' ' ' GLU . 18.7 t -91.33 114.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.65 HG21 ' HB3' ' A' ' 8' ' ' LEU . 22.4 pt -111.42 172.34 2.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 121.58 -0.7 . . . . 0.0 110.498 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.532 ' CG ' HH22 ' A' ' 67' ' ' ARG . 5.6 m-20 . . . . . 0 C--N 1.302 -1.461 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.406 ' N ' ' OE2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER . . . . . 0 CA--C 1.502 -0.868 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.781 HG21 HG21 ' A' ' 91' ' ' VAL . 3.6 mt -78.08 117.77 23.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.341 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.0 120.41 35.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.47 HG23 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -139.75 159.14 27.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -179.238 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.427 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -143.14 145.81 34.21 Favored Pre-proline 0 C--N 1.269 -2.925 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -53.83 134.52 59.4 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.586 1.524 . . . . 0.0 109.928 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.9 mt -106.79 116.66 51.02 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.137 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.873 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -89.61 104.34 16.91 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.306 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.508 HD12 ' CG1' ' A' ' 95' ' ' VAL . 38.3 mt -110.32 127.28 27.28 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -68.83 130.83 21.24 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 120.787 0.991 . . . . 0.0 111.034 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -74.46 -170.53 1.03 Allowed 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.305 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.605 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 0.0 OUTLIER 61.05 -26.97 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 175.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' GLU . 71.9 mt-30 -37.19 139.25 0.24 Allowed 'General case' 0 N--CA 1.521 3.098 0 O-C-N 121.007 -1.058 . . . . 0.0 108.529 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.605 ' NH1' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -91.24 -175.32 4.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.317 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.623 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 1.4 mt-30 -67.16 -168.58 0.05 OUTLIER Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 20.0 Cg_exo -66.96 127.44 8.53 Favored 'Cis proline' 0 N--CA 1.492 1.42 0 CA-C-N 120.499 1.214 . . . . 0.0 112.222 -0.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 15' ' ' GLN . 32.9 m-85 -115.61 163.54 20.38 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 177.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 17.2 Cg_exo -68.1 163.35 76.79 Favored 'Cis proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.959 -1.267 . . . . 0.0 111.207 -0.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.425 ' NH2' ' OE1' ' A' ' 13' ' ' GLN . 2.3 mtp85 -136.75 139.81 42.13 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.384 -0.823 . . . . 0.0 109.404 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.49 146.18 55.19 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.466 HG21 HD11 ' A' ' 9' ' ' ILE . 33.6 m -138.83 -1.18 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.456 176.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 167.04 178.35 39.37 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 118.968 -1.587 . . . . 0.0 109.344 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.1 tttp -135.36 130.63 35.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.306 -1.114 . . . . 0.0 110.625 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.573 HG11 HG11 ' A' ' 77' ' ' VAL . 41.8 t -99.78 145.54 10.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 26' ' ' ASP . 20.6 t -144.33 170.62 7.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.445 ' N ' HG12 ' A' ' 25' ' ' VAL . 7.6 t0 -129.58 148.97 51.53 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.278 -2.538 0 O-C-N 121.96 -0.462 . . . . 0.0 110.163 -178.747 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.535 ' HB2' HG22 ' A' ' 79' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 33.8 mttm -96.89 156.33 16.39 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.725 ' CE1' HG23 ' A' ' 79' ' ' THR . 70.1 m-85 -105.4 142.24 35.51 Favored 'General case' 0 C--N 1.285 -2.23 0 O-C-N 121.476 -0.765 . . . . 0.0 111.657 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.527 ' NH1' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -103.1 149.0 25.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 174.141 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.529 ' HG ' HG21 ' A' ' 42' ' ' VAL . 26.4 tp -125.6 140.26 52.89 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 p -148.29 170.78 17.16 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -174.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.72 174.9 18.96 Favored Glycine 0 N--CA 1.499 2.88 0 O-C-N 121.019 -1.05 . . . . 0.0 111.817 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -59.8 116.34 4.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 115.75 -19.33 14.19 Favored Glycine 0 C--N 1.28 -2.543 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.529 HG21 ' HG ' ' A' ' 37' ' ' LEU . 27.1 t -122.56 -95.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.588 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 23.0 t70 -83.7 -15.85 47.2 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.046 -1.034 . . . . 0.0 109.765 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -113.26 155.07 25.75 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.226 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 4.9 mt-10 -54.43 133.31 62.56 Favored Pre-proline 0 C--N 1.29 -2.014 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.523 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HG2' HG13 ' A' ' 49' ' ' ILE . 28.2 Cg_endo -73.62 118.11 4.72 Favored 'Cis proline' 0 N--CA 1.499 1.819 0 C-N-CA 123.526 -1.448 . . . . 0.0 110.305 -1.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.588 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 3.7 mtpp -68.27 145.41 54.27 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 120.902 -1.124 . . . . 0.0 112.242 -172.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.88 28.11 69.69 Favored Glycine 0 N--CA 1.498 2.816 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.389 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.436 HG13 ' HG2' ' A' ' 46' ' ' PRO . 17.8 mm -85.26 -46.42 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-N 119.254 1.527 . . . . 0.0 107.053 175.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -107.66 147.39 30.76 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.686 0.755 . . . . 0.0 109.18 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.66 170.09 16.35 Favored 'General case' 0 C--N 1.262 -3.222 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.411 HD11 ' HA2' ' A' ' 57' ' ' GLY . 1.2 tt -134.19 150.38 31.02 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.016 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.413 ' OD1' HG23 ' A' ' 56' ' ' THR . 19.0 t-20 -84.81 83.2 8.12 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 36' ' ' ARG . 5.8 mt-10 -37.44 -33.47 0.07 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.557 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -79.72 -15.56 57.28 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.985 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.413 HG23 ' OD1' ' A' ' 53' ' ' ASN . 74.8 p -127.27 -36.85 2.09 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 52' ' ' ILE . . . 100.93 6.23 52.4 Favored Glycine 0 C--N 1.277 -2.699 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.4 m -66.16 119.87 12.23 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.41 -1.053 . . . . 0.0 108.745 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.542 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.2 t -87.11 134.95 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.27 158.21 44.95 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.358 -0.838 . . . . 0.0 108.756 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 13.6 p -106.81 141.49 21.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 p -89.58 -13.93 36.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.546 -0.722 . . . . 0.0 110.571 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 64' ' ' THR . 1.8 ptm180 -157.18 -173.53 4.48 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.187 -0.945 . . . . 0.0 109.593 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.617 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 14.6 t -70.06 178.65 2.65 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 11' ' ' GLU . 35.2 mt -131.22 162.28 30.33 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 120.541 -1.349 . . . . 0.0 108.504 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.401 ' OD1' ' NH2' ' A' ' 63' ' ' ARG . 14.1 m-20 -140.0 113.71 8.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -60.45 -11.18 6.14 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.21 -22.8 63.85 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.5 t -105.05 -55.95 5.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.469 HD12 ' CE1' ' A' ' 73' ' ' TYR . 1.4 mt -141.53 142.3 29.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.569 -0.707 . . . . 0.0 110.06 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.22 -23.16 16.3 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 7.2 p -152.9 135.15 6.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.638 -0.664 . . . . 0.0 109.733 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.469 ' CE1' HD12 ' A' ' 70' ' ' ILE . 84.3 m-85 -100.86 117.28 34.63 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -85.91 87.03 7.35 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.431 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -81.62 170.72 15.48 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 73.1 m-85 -134.08 132.31 39.82 Favored 'General case' 0 C--N 1.264 -3.149 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.671 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.2 152.66 13.99 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 O-C-N 121.983 -0.448 . . . . 0.0 109.864 -177.066 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.716 ' HB3' HG23 ' A' ' 86' ' ' THR . 50.4 mt-10 -138.47 139.51 38.84 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 121.779 -0.575 . . . . 0.0 109.565 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.725 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -88.69 134.21 33.97 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 173.233 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 7.9 p -137.14 163.04 31.77 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.545 -176.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -105.8 171.15 7.49 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.2 m -46.29 -27.72 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.369 0.604 . . . . 0.0 110.5 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.59 0.52 29.69 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.507 -0.745 . . . . 0.0 110.385 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.21 20.46 76.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 80' ' ' THR . 25.5 mttp -85.11 146.89 26.91 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.716 HG23 ' HB3' ' A' ' 78' ' ' GLU . 31.8 m -99.26 117.04 32.83 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-O 121.145 0.498 . . . . 0.0 110.816 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.842 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.58 -28.78 17.31 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.332 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.406 ' OE2' ' N ' ' A' ' 1' ' ' SER . 1.1 tp10 -140.81 151.37 44.33 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 94.73 -177.58 35.84 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.74 102.75 0.16 OUTLIER 'Cis proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.821 -1.325 . . . . 0.0 113.469 -0.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.781 HG21 HG21 ' A' ' 2' ' ' ILE . 3.3 m -74.8 164.19 63.05 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -92.35 151.06 3.03 Favored 'Trans proline' 0 C--N 1.283 -2.912 0 C-N-CA 121.395 1.397 . . . . 0.0 111.905 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 4' ' ' VAL . 12.1 tp -135.76 126.74 27.76 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 175.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -103.57 105.52 15.79 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 121.831 -0.543 . . . . 0.0 109.715 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.508 ' CG1' HD12 ' A' ' 9' ' ' ILE . 24.7 t -95.7 104.6 16.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 175.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mp -87.57 134.0 28.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 16.1 t -89.67 108.94 19.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.604 HG21 ' HB3' ' A' ' 8' ' ' LEU . 15.3 pt -102.85 171.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 4.8 m-20 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.581 ' H2 ' ' CG ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.884 HG21 HG21 ' A' ' 91' ' ' VAL . 5.2 mt -73.73 120.49 22.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.075 -1.016 . . . . 0.0 110.611 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.66 119.98 50.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.54 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -142.42 163.76 18.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -149.53 159.44 36.38 Favored Pre-proline 0 C--N 1.278 -2.517 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.34 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.752 ' HB3' HD11 ' A' ' 96' ' ' ILE . 27.3 Cg_exo -44.73 131.03 10.02 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.855 1.703 . . . . 0.0 111.893 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.57 HG13 HD11 ' A' ' 93' ' ' LEU . 19.5 mt -101.4 122.5 53.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.3 mp -106.88 115.8 30.82 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.919 HD11 HG21 ' A' ' 21' ' ' VAL . 23.0 mt -122.21 128.04 25.66 Favored Pre-proline 0 C--N 1.26 -3.314 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 21.5 Cg_endo -70.98 141.78 41.06 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 CA-C-N 120.038 1.049 . . . . 0.0 110.064 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.438 ' OE1' ' NH1' ' A' ' 67' ' ' ARG . 3.4 pt-20 -55.69 173.76 0.12 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 121.988 0.899 . . . . 0.0 110.104 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 65' ' ' LEU . 4.1 p30 52.74 19.15 1.18 Allowed 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.513 ' HG3' HG22 ' A' ' 9' ' ' ILE . 1.6 mm-40 -57.49 131.35 49.9 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 173.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.474 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 3.3 mtt180 -101.84 -174.37 2.57 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 119.546 1.066 . . . . 0.0 110.434 -176.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.636 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 16.8 mt-30 -54.16 168.14 0.47 Allowed Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.636 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 4.1 Cg_exo -77.02 131.71 25.12 Favored 'Cis proline' 0 C--N 1.308 -1.593 0 C-N-CA 123.503 -1.457 . . . . 0.0 112.831 0.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -119.61 159.55 45.71 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 13.0 Cg_exo -69.74 155.29 93.28 Favored 'Cis proline' 0 N--CA 1.493 1.497 0 C-N-CA 123.878 -1.301 . . . . 0.0 110.426 -0.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -129.54 131.34 46.56 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.25 -179.303 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.21 116.01 9.16 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.919 HG21 HD11 ' A' ' 9' ' ' ILE . 19.5 m -118.42 7.61 6.85 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.592 -178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . -179.53 163.5 30.91 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -135.58 116.33 14.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.27 -1.135 . . . . 0.0 109.641 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.577 HG23 ' CG2' ' A' ' 59' ' ' VAL . 21.8 t -80.97 146.9 6.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 t -139.3 166.72 21.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.581 ' CG ' ' H2 ' ' A' ' 1' ' ' SER . 11.9 t70 -112.98 140.14 48.04 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 173.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 1' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.301 0.572 . . . . 0.0 109.53 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 121.163 0.506 . . . . 0.0 110.876 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.18 138.88 54.36 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.487 ' CE2' HG23 ' A' ' 79' ' ' THR . 71.6 m-85 -82.43 144.11 30.71 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.747 -0.596 . . . . 0.0 110.598 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.454 HH12 ' CD ' ' A' ' 54' ' ' GLU . 4.2 mmp_? -120.86 145.02 48.06 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 38' ' ' THR . 23.4 tp -120.79 153.45 37.05 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 37' ' ' LEU . 3.0 p -158.13 171.26 20.53 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.51 175.63 18.77 Favored Glycine 0 N--CA 1.502 3.083 0 C-N-CA 119.796 -1.192 . . . . 0.0 111.444 175.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -59.24 119.54 7.56 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 113.07 -19.12 20.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.462 HG21 ' HG ' ' A' ' 37' ' ' LEU . 47.5 t -118.07 -98.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.619 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -85.77 -12.46 50.92 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -113.12 148.89 34.39 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 121.06 -1.025 . . . . 0.0 108.363 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.509 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.1 pt-20 -51.85 136.02 36.49 Favored Pre-proline 0 C--N 1.284 -2.282 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.359 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.503 ' HB2' ' CG1' ' A' ' 49' ' ' ILE . 2.9 Cg_exo -72.83 118.07 4.46 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.475 -1.469 . . . . 0.0 109.161 -1.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.619 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 8.9 mtpp -68.56 145.62 53.82 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 120.856 -1.153 . . . . 0.0 111.251 -172.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.76 34.1 87.83 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.806 -0.559 . . . . 0.0 112.383 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.586 HG23 ' HD2' ' A' ' 63' ' ' ARG . 8.8 mm -89.47 -45.58 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.743 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 26.3 m-85 -111.49 139.22 47.09 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.591 0.71 . . . . 0.0 110.041 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HE ' ' HG ' ' A' ' 60' ' ' SER . 0.6 OUTLIER -137.22 128.96 28.78 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.578 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 58' ' ' SER . 7.7 tt -98.9 161.93 2.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.523 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 13.2 t-20 -96.03 106.73 18.94 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' CD ' HH12 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -40.82 -39.15 1.06 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.108 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 8.0 t-20 -96.36 -30.95 13.11 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.35 -0.844 . . . . 0.0 112.704 -173.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 18.1 p -98.16 -26.92 14.4 Favored 'General case' 0 C--N 1.283 -2.295 0 O-C-N 120.757 -1.215 . . . . 0.0 108.611 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.01 5.1 88.02 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 4.4 m -63.63 125.22 23.57 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.263 -1.139 . . . . 0.0 109.409 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.577 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.0 t -90.66 121.91 41.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.419 ' HG ' ' HE ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -119.11 146.93 44.71 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.343 -0.848 . . . . 0.0 110.031 -178.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 14.6 p -102.53 142.42 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 49' ' ' ILE . 43.8 p -95.33 -20.05 19.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.524 -0.735 . . . . 0.0 112.908 -173.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.586 ' HD2' HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -139.89 176.48 8.71 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.483 -1.386 . . . . 0.0 110.253 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.47 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 13.0 t -70.15 127.9 34.42 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.546 HD22 ' CE2' ' A' ' 73' ' ' TYR . 97.3 mt -83.22 120.51 25.91 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.292 -0.88 . . . . 0.0 109.131 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.436 ' OD2' ' NH2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -108.61 114.09 27.61 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.45 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.449 ' HG3' ' CG1' ' A' ' 97' ' ' VAL . 14.7 mtp-105 -53.66 -7.96 0.13 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.447 -0.783 . . . . 0.0 110.399 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.45 -28.68 67.27 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 t -91.47 -63.55 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -138.68 132.41 40.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.53 -23.7 24.29 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.8 p -150.22 132.07 5.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.546 ' CE2' HD22 ' A' ' 65' ' ' LEU . 82.8 m-85 -94.7 117.21 29.76 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.35 83.39 7.69 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.462 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -87.06 170.31 11.65 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 64.8 m-85 -138.31 131.14 29.61 Favored 'General case' 0 C--N 1.265 -3.082 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.7 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -110.14 155.73 11.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-O 121.396 0.617 . . . . 0.0 109.75 -175.902 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.32 147.54 28.47 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.79 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.83 131.79 47.96 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 175.237 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.625 ' C ' HD21 ' A' ' 87' ' ' LEU . 80.8 p -121.22 164.85 16.29 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 83' ' ' ASN . 1.5 t0 -144.75 172.18 13.37 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.837 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 m -38.82 -21.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 123.455 0.702 . . . . 0.0 111.61 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 81' ' ' ASP . 3.9 t-20 -79.14 -4.91 52.7 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.175 -0.953 . . . . 0.0 108.746 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 63.52 27.55 71.05 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -119.84 162.79 18.52 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 88' ' ' GLU . 1.3 m -90.18 124.08 34.54 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.843 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -93.95 -13.22 27.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.896 -1.128 . . . . 0.0 107.985 178.412 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.647 ' O ' HG22 ' A' ' 86' ' ' THR . 1.0 OUTLIER -156.02 162.36 40.33 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.526 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 91.95 -175.64 38.52 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -70.83 104.75 0.49 Allowed 'Cis proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.58 -1.425 . . . . 0.0 111.373 0.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.884 HG21 HG21 ' A' ' 2' ' ' ILE . 18.1 m -76.81 160.62 76.3 Favored Pre-proline 0 C--N 1.284 -2.271 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -93.46 153.79 2.45 Favored 'Trans proline' 0 C--N 1.288 -2.625 0 C-N-CA 121.556 1.504 . . . . 0.0 111.455 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.57 HD11 HG13 ' A' ' 7' ' ' ILE . 8.2 tp -140.3 127.38 20.9 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -112.57 110.21 20.23 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.488 -0.758 . . . . 0.0 109.286 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.743 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 5.3 t -99.51 101.94 12.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.752 HD11 ' HB3' ' A' ' 6' ' ' PRO . 4.6 mp -80.59 129.37 37.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 O-C-N 121.613 -0.679 . . . . 0.0 109.234 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.449 ' CG1' ' HG3' ' A' ' 67' ' ' ARG . 16.8 t -86.29 92.14 3.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 13.8 pt -79.71 171.58 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 O-C-N 121.515 -0.741 . . . . 0.0 109.28 -177.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 . . . . . 0 C--N 1.282 -2.349 0 O-C-N 120.983 -1.073 . . . . 0.0 108.674 -178.339 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.421 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.643 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.887 HG21 HG21 ' A' ' 91' ' ' VAL . 7.1 mt -62.58 135.39 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 O-C-N 121.695 -0.628 . . . . 0.0 109.495 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.52 122.34 62.29 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.475 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -133.19 160.47 42.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.096 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -131.89 157.34 78.46 Favored Pre-proline 0 C--N 1.275 -2.665 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.56 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.35 134.97 67.24 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.285 1.323 . . . . 0.0 109.815 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 mt -109.27 113.97 45.63 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.934 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -92.14 112.58 24.57 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.389 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.613 HD11 HG21 ' A' ' 21' ' ' VAL . 20.0 mt -117.96 133.99 23.34 Favored Pre-proline 0 C--N 1.287 -2.134 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 31.1 Cg_endo -69.74 140.39 42.63 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.09 1.193 . . . . 0.0 110.692 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.481 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -79.5 174.36 11.65 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.698 178.41 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 58.29 38.22 26.03 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.813 -0.554 . . . . 0.0 110.692 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.47 ' OE1' ' N ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -88.43 166.57 14.14 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 175.762 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -117.5 167.04 11.65 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.681 -1.262 . . . . 0.0 111.856 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.567 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -64.48 178.71 0.43 Allowed Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.428 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 11.8 Cg_exo -66.51 140.34 48.65 Favored 'Cis proline' 0 C--N 1.307 -1.647 0 C-N-CA 123.704 -1.373 . . . . 0.0 112.786 0.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 62' ' ' THR . 35.0 m-85 -119.46 167.39 12.23 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 38.5 Cg_endo -66.01 168.53 47.51 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 120.529 1.225 . . . . 0.0 111.899 -0.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -133.35 129.1 37.0 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 120.231 -0.587 . . . . 0.0 109.957 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -66.45 140.44 58.03 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.613 HG21 HD11 ' A' ' 9' ' ' ILE . 35.4 m -137.68 3.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.791 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 172.75 168.39 34.0 Favored Glycine 0 N--CA 1.507 3.371 0 C-N-CA 118.933 -1.603 . . . . 0.0 110.268 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -132.35 122.45 25.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.274 . . . . 0.0 109.936 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.546 ' CG1' HG23 ' A' ' 2' ' ' ILE . 16.5 t -90.6 135.58 26.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 172.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.8 t -131.61 157.73 43.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 1' ' ' SER . 8.4 t70 -111.29 122.5 48.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 0.0 109.7 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.408 ' H ' ' HG ' ' A' ' 27' ' ' SER . 2.2 p . . . . . 0 C--N 1.292 -1.9 0 CA-C-O 121.445 0.64 . . . . 0.0 109.739 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.62 ' HB2' HG22 ' A' ' 79' ' ' THR . 14.0 p . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 121.21 0.529 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -104.83 148.13 26.98 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.589 ' CE2' HG23 ' A' ' 79' ' ' THR . 67.4 m-85 -88.19 126.87 35.36 Favored 'General case' 0 C--N 1.274 -2.706 0 O-C-N 121.359 -0.838 . . . . 0.0 110.35 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.449 ' HG3' HG21 ' A' ' 80' ' ' THR . 4.7 mtp180 -106.24 141.35 37.73 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.2 tp -121.51 145.48 47.9 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -151.64 171.12 18.13 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 117.74 164.86 13.37 Favored Glycine 0 N--CA 1.499 2.839 0 O-C-N 120.951 -1.093 . . . . 0.0 110.561 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -55.46 117.74 3.84 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 117.03 -21.05 11.23 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 50' ' ' PHE . 43.3 t -125.06 -92.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.7 -0.882 . . . . 0.0 108.747 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -85.39 -9.14 57.94 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.528 -0.733 . . . . 0.0 109.489 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 4.0 mp0 -125.97 161.71 26.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.447 -0.783 . . . . 0.0 109.35 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.468 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 2.5 mt-10 -60.27 131.63 90.11 Favored Pre-proline 0 C--N 1.289 -2.027 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.361 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.479 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 41.1 Cg_endo -73.03 115.13 2.97 Favored 'Cis proline' 0 N--CA 1.512 2.605 0 C-N-CA 123.521 -1.449 . . . . 0.0 110.992 -1.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 4.5 mttp -66.47 150.32 49.12 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.921 -1.112 . . . . 0.0 112.744 -173.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.18 29.27 36.33 Favored Glycine 0 N--CA 1.493 2.44 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.284 171.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 41' ' ' GLY . 13.9 mm -80.91 -44.29 21.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 174.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.499 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 62.1 m-85 -109.16 138.46 45.48 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.656 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -139.79 138.88 36.2 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.454 HG13 HG22 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -106.49 152.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 O-C-N 121.825 -0.547 . . . . 0.0 109.546 -176.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -79.83 119.47 22.75 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 35' ' ' PHE . 3.1 mt-10 -51.11 -45.52 61.59 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 122.207 -0.308 . . . . 0.0 111.658 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -81.12 -53.02 6.75 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.081 -1.637 . . . . 0.0 111.997 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 p -79.74 -27.81 40.52 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.2 0.524 . . . . 0.0 110.575 -172.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.81 12.9 80.73 Favored Glycine 0 C--N 1.285 -2.29 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 14.9 m -67.9 120.14 13.71 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.275 -1.132 . . . . 0.0 108.91 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.456 ' CG2' HG23 ' A' ' 24' ' ' VAL . 1.6 t -87.13 132.19 33.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -134.04 150.72 51.23 Favored 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -97.36 142.15 14.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' PHE . 63.0 p -88.11 -20.76 25.24 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.55 -0.719 . . . . 0.0 110.795 -175.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.59 ' NE ' ' O ' ' A' ' 64' ' ' THR . 1.6 ptm180 -148.27 -172.88 4.18 Favored 'General case' 0 C--N 1.289 -2.062 0 O-C-N 121.208 -0.933 . . . . 0.0 108.834 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.59 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 13.1 t -67.38 168.41 10.75 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.47 ' N ' ' OE1' ' A' ' 13' ' ' GLN . 92.5 mt -122.58 149.34 44.1 Favored 'General case' 0 C--N 1.278 -2.521 0 O-C-N 120.629 -1.294 . . . . 0.0 108.695 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -130.49 117.6 19.87 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -178.569 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 1.86 1.42 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 66' ' ' ASP . 2.9 mt-10 -78.53 -29.23 46.34 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.79 -55.77 5.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-O 122.209 1.004 . . . . 0.0 108.342 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.4 HG21 ' CG ' ' A' ' 73' ' ' TYR . 1.9 mt -137.85 139.27 43.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.54 -24.21 18.05 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.7 p -154.1 129.6 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 58.1 m-85 -97.21 124.1 41.19 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -98.55 88.39 4.08 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.6 170.74 15.47 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.8 m-85 -124.58 131.57 53.47 Favored 'General case' 0 C--N 1.274 -2.711 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.614 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.06 146.92 17.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -177.285 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.65 ' HB3' HG23 ' A' ' 86' ' ' THR . 40.8 mt-10 -137.1 138.53 40.45 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.638 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -86.76 133.54 33.65 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 170.322 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.605 ' C ' HD21 ' A' ' 87' ' ' LEU . 4.6 p -129.78 146.13 51.54 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.052 -1.059 . . . . 0.0 112.476 -172.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.519 ' HB2' HD11 ' A' ' 87' ' ' LEU . 1.4 t70 -80.66 170.14 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.446 HG22 ' OD2' ' A' ' 81' ' ' ASP . 35.2 m -61.62 -24.43 33.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -79.72 2.5 22.53 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.23 16.93 78.61 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 80' ' ' THR . 14.0 mttp -81.02 142.15 33.68 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.65 HG23 ' HB3' ' A' ' 78' ' ' GLU . 35.5 m -88.76 116.77 27.26 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.904 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.98 -19.45 22.4 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.77 146.73 23.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.537 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 99.41 -176.72 29.19 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.86 103.99 0.31 Allowed 'Cis proline' 0 N--CA 1.5 1.873 0 C-N-CA 123.669 -1.388 . . . . 0.0 112.519 -0.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.887 HG21 HG21 ' A' ' 2' ' ' ILE . 11.7 m -79.9 162.97 60.41 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -94.52 151.06 1.92 Allowed 'Trans proline' 0 C--N 1.296 -2.19 0 C-N-CA 121.808 1.672 . . . . 0.0 112.101 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.44 HD13 ' CG2' ' A' ' 4' ' ' VAL . 5.3 tp -133.88 129.8 36.92 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -107.39 114.13 27.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.477 -0.764 . . . . 0.0 109.907 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.499 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 57.8 t -103.81 104.1 16.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.552 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.8 mp -86.13 139.19 17.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 38.5 t -95.0 124.38 47.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 10.4 pt -112.13 170.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 C--N 1.302 -1.496 0 O-C-N 120.921 -1.112 . . . . 0.0 108.124 178.366 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 2.7 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.746 HG21 HG21 ' A' ' 91' ' ' VAL . 24.8 mt -86.46 134.43 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.42 -0.8 . . . . 0.0 110.438 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -120.89 124.64 72.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 173.886 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.463 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -135.52 157.05 39.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.74 143.18 47.99 Favored Pre-proline 0 C--N 1.276 -2.596 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.33 133.86 30.92 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.017 1.811 . . . . 0.0 110.359 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.42 HG21 HG23 ' A' ' 21' ' ' VAL . 42.9 mt -105.05 112.29 38.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 O-C-N 121.54 -0.725 . . . . 0.0 109.653 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.873 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -93.49 110.73 22.3 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.536 HG22 ' NE2' ' A' ' 13' ' ' GLN . 1.8 mt -120.23 134.7 24.11 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.541 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 35.8 Cg_endo -74.13 154.46 47.03 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 CA-C-N 119.68 0.922 . . . . 0.0 112.742 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.0 174.24 10.86 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-O 122.304 1.05 . . . . 0.0 111.12 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.583 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 57.5 t30 52.38 24.69 3.05 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -77.99 137.47 38.31 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 174.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.583 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -101.26 175.21 5.66 Favored 'General case' 0 C--N 1.267 -3.005 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.524 -177.652 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.651 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -53.49 -179.32 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.651 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 6.7 Cg_exo -70.74 128.92 14.45 Favored 'Cis proline' 0 N--CA 1.491 1.338 0 C-N-CA 124.25 -1.146 . . . . 0.0 113.422 -0.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 63' ' ' ARG . 22.7 m-85 -113.43 165.74 12.7 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 14.7 Cg_exo -70.66 161.43 88.82 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 C-N-CA 124.412 -1.078 . . . . 0.0 112.254 -1.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.477 ' NH2' ' OE1' ' A' ' 13' ' ' GLN . 1.2 mtp-105 -131.17 128.28 39.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.477 -0.764 . . . . 0.0 109.711 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 5.3 t0 -63.06 133.2 54.14 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.42 HG23 HG21 ' A' ' 7' ' ' ILE . 29.4 m -128.86 5.57 2.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 175.14 168.74 36.11 Favored Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.108 -1.52 . . . . 0.0 109.635 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -131.99 117.09 17.95 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.164 -1.198 . . . . 0.0 109.699 -178.399 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.516 HG23 HG22 ' A' ' 59' ' ' VAL . 16.5 t -81.81 134.4 27.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 172.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 3' ' ' VAL . 24.9 t -126.64 133.26 68.99 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.613 ' CB ' HG21 ' A' ' 79' ' ' THR . 9.1 t0 -107.4 137.46 45.4 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.692 0 O-C-N 121.104 -0.998 . . . . 0.0 110.752 -175.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 121.545 0.688 . . . . 0.0 109.634 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 11.3 mmtp -105.4 170.61 7.79 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.613 ' HB3' HD13 ' A' ' 52' ' ' ILE . 23.5 m-85 -120.98 131.9 54.59 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.685 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 4.3 mmp_? -108.28 139.24 43.26 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.687 ' O ' HG11 ' A' ' 42' ' ' VAL . 15.3 tp -128.54 139.28 52.38 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.07 170.56 15.96 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.31 159.1 10.31 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.93 114.0 1.42 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 124.76 -22.15 6.52 Favored Glycine 0 C--N 1.281 -2.492 0 N-CA-C 107.383 -2.287 . . . . 0.0 107.383 -173.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.687 HG11 ' O ' ' A' ' 37' ' ' LEU . 47.0 t -116.52 -97.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' OD2' ' NZ ' ' A' ' 47' ' ' LYS . 35.0 t0 -90.87 -5.53 55.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 109.759 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -114.09 156.88 23.36 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.583 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 14.0 mm-40 -67.21 136.36 93.79 Favored Pre-proline 0 C--N 1.277 -2.563 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.533 -176.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.541 ' HB2' HD11 ' A' ' 49' ' ' ILE . 29.3 Cg_endo -69.94 115.05 2.3 Favored 'Cis proline' 0 N--CA 1.51 2.449 0 C-N-CA 123.316 -1.535 . . . . 0.0 111.359 -0.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.583 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 6.3 mttm -68.35 152.17 45.82 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.915 -1.116 . . . . 0.0 111.1 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.574 ' O ' ' NH1' ' A' ' 63' ' ' ARG . . . 56.44 49.08 71.32 Favored Glycine 0 N--CA 1.487 2.098 0 O-C-N 121.796 -0.565 . . . . 0.0 112.389 172.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.855 HD13 HH11 ' A' ' 63' ' ' ARG . 3.7 mm -106.42 -43.0 6.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -116.79 138.73 51.28 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.973 0.892 . . . . 0.0 110.996 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -124.16 170.32 10.84 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.613 HD13 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -132.91 147.96 31.55 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.473 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 171.283 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 55' ' ' ASN . 21.1 t-20 -78.68 112.18 15.53 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 118.101 -1.44 . . . . 0.0 108.31 -176.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 mp0 -59.58 10.27 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 C-N-CA 124.455 1.102 . . . . 0.0 112.263 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 53' ' ' ASN . 31.8 m-80 -137.86 -48.39 0.56 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 109.009 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 17.5 p -87.33 -27.76 22.65 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.543 -0.723 . . . . 0.0 109.478 -177.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.47 5.82 74.77 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 14.6 m -66.84 123.53 20.41 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.394 -1.062 . . . . 0.0 109.379 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.552 HG11 HD21 ' A' ' 93' ' ' LEU . 2.0 t -82.57 122.42 37.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -123.42 140.89 52.54 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.404 -0.81 . . . . 0.0 110.133 -177.547 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 10.6 p -90.93 144.04 9.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.9 p -96.27 -17.62 20.6 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.773 -0.58 . . . . 0.0 111.146 -176.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.855 HH11 HD13 ' A' ' 49' ' ' ILE . 5.5 ptp85 -153.52 -176.22 5.71 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.783 -1.198 . . . . 0.0 110.464 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 4.1 t -74.86 142.99 44.07 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 121.446 0.641 . . . . 0.0 110.127 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.2 mt -104.64 158.81 16.25 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.323 -0.861 . . . . 0.0 109.164 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.406 ' HB3' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -136.71 120.71 17.64 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HG3' HG12 ' A' ' 97' ' ' VAL . 34.5 mtm105 -63.91 -12.11 33.97 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.085 . . . . 0.0 108.342 175.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.03 -22.96 60.55 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 66' ' ' ASP . 24.1 t -101.11 -53.23 7.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.459 HD12 ' CE2' ' A' ' 73' ' ' TYR . 1.4 mt -144.9 136.41 20.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.64 -24.24 20.55 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -159.74 140.52 4.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.587 -0.695 . . . . 0.0 109.511 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.459 ' CE2' HD12 ' A' ' 70' ' ' ILE . 58.6 m-85 -104.13 136.99 42.73 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -97.17 92.28 5.95 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -91.72 170.56 9.8 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.643 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 77.6 m-85 -135.66 140.62 44.63 Favored 'General case' 0 C--N 1.265 -3.08 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -119.23 155.18 21.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 120.977 0.418 . . . . 0.0 110.079 -177.186 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.809 ' HB3' HG23 ' A' ' 86' ' ' THR . 33.1 mt-10 -140.94 141.35 34.5 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 173.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -88.31 128.37 35.49 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 171.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.502 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.1 OUTLIER -119.86 161.2 21.22 Favored 'General case' 0 C--N 1.272 -2.766 0 O-C-N 121.543 -0.723 . . . . 0.0 110.847 -172.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.608 ' HB2' HD21 ' A' ' 87' ' ' LEU . 5.2 t0 -108.97 170.44 8.04 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -52.98 -22.85 4.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -79.66 2.24 23.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.423 -0.798 . . . . 0.0 109.171 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 62.97 28.14 71.52 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 80' ' ' THR . 17.0 mttm -95.24 137.95 33.61 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.809 HG23 ' HB3' ' A' ' 78' ' ' GLU . 10.7 m -71.97 117.67 13.86 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.608 HD21 ' HB2' ' A' ' 81' ' ' ASP . 1.5 mm? -81.45 -46.37 14.67 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.448 ' OE2' ' N ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -140.11 157.82 45.03 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 95.09 -177.48 35.25 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.76 112.92 0.61 Allowed 'Cis proline' 0 N--CA 1.499 1.808 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.652 -0.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.746 HG21 HG21 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -93.45 168.27 12.34 Favored Pre-proline 0 C--N 1.284 -2.274 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 175.106 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -96.23 156.67 1.35 Allowed 'Trans proline' 0 C--N 1.295 -2.287 0 C-N-CA 121.564 1.509 . . . . 0.0 112.823 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.552 HD21 HG11 ' A' ' 59' ' ' VAL . 9.6 tp -142.52 124.35 15.14 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -105.43 115.38 30.15 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-O 121.432 0.634 . . . . 0.0 109.652 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 96.0 t -102.55 108.82 24.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.624 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.8 mp -90.71 139.34 17.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 O-C-N 121.488 -0.758 . . . . 0.0 108.971 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.433 HG12 ' HG3' ' A' ' 67' ' ' ARG . 17.4 t -95.17 110.44 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.8 pt -96.7 170.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.411 0 O-C-N 120.883 -1.136 . . . . 0.0 110.481 -175.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.482 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 1.1 m . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.913 HG21 HG21 ' A' ' 91' ' ' VAL . 24.6 mt -88.98 142.79 12.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.714 0.769 . . . . 0.0 111.329 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.85 135.17 50.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.584 HG21 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -141.12 162.51 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.134 -0.978 . . . . 0.0 109.177 -176.758 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -128.0 149.64 71.46 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.648 ' HB3' HD11 ' A' ' 96' ' ' ILE . 50.4 Cg_exo -51.71 137.75 50.37 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 110.464 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.604 HG13 HD11 ' A' ' 93' ' ' LEU . 32.1 mt -99.44 110.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -100.24 98.39 9.07 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.4 ' CG1' HG22 ' A' ' 7' ' ' ILE . 17.8 mt -102.18 129.25 26.67 Favored Pre-proline 0 C--N 1.271 -2.837 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 19.4 Cg_endo -66.95 125.16 13.21 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 N-CA-C 109.715 -0.917 . . . . 0.0 109.715 174.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.746 ' HB3' HG12 ' A' ' 97' ' ' VAL . 4.5 pt-20 -62.6 -176.74 0.12 Allowed 'General case' 0 C--N 1.284 -2.279 0 CA-C-O 122.266 1.032 . . . . 0.0 111.746 -173.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.74 -4.54 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.447 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 68.0 mt-30 -59.68 113.86 2.46 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.43 ' HD3' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -79.5 -174.94 4.5 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.924 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.57 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 10.3 mm-40 -47.32 166.36 0.19 Allowed Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 3.4 Cg_endo -82.47 148.4 67.17 Favored 'Cis proline' 0 C--N 1.309 -1.549 0 C-N-CA 123.918 -1.284 . . . . 0.0 114.285 0.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 37.6 m-85 -134.0 170.46 11.24 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 5.2 Cg_exo -75.07 156.69 99.83 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 120.812 1.326 . . . . 0.0 110.84 0.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.447 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 24.8 mtp180 -133.8 126.51 30.72 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.327 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.69 129.84 43.53 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -126.2 -5.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.905 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.33 141.27 6.34 Favored Glycine 0 C--N 1.285 -2.275 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 22.9 ttpp -109.9 119.91 40.81 Favored 'General case' 0 C--N 1.286 -2.184 0 O-C-N 121.487 -1.007 . . . . 0.0 109.889 -177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.592 HG23 ' CG2' ' A' ' 59' ' ' VAL . 44.0 t -80.84 142.32 14.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 171.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.2 t -126.13 126.2 69.15 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.837 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 14.9 t0 -99.17 128.49 45.31 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 171.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.283 -2.288 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.166 -172.76 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -120.02 170.4 9.32 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.341 -0.849 . . . . 0.0 109.169 178.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.69 ' HB3' HD13 ' A' ' 52' ' ' ILE . 47.8 m-85 -105.75 126.38 52.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.234 -0.916 . . . . 0.0 110.3 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' HG3' HG21 ' A' ' 80' ' ' THR . 0.0 OUTLIER -109.31 121.22 44.7 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.111 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.677 HD11 HD23 ' A' ' 93' ' ' LEU . 19.5 tp -99.6 156.77 16.89 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -160.14 171.44 19.25 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -174.679 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.34 174.66 19.05 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.356 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 111.17 1.64 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 123.99 -13.51 8.03 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -176.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.7 t -130.46 -99.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.616 -0.932 . . . . 0.0 108.568 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.418 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -84.1 -1.58 55.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.346 -0.846 . . . . 0.0 108.898 178.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -126.12 150.69 48.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 108.685 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.583 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.7 mp0 -60.62 133.06 91.43 Favored Pre-proline 0 C--N 1.279 -2.49 0 C-N-CA 123.579 0.752 . . . . 0.0 110.463 -176.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 30.6 Cg_endo -66.24 117.46 2.06 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 C-N-CA 123.634 -1.402 . . . . 0.0 110.921 -1.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.583 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 23.3 mttp -69.84 145.56 52.0 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.155 -0.966 . . . . 0.0 111.611 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.24 41.45 79.21 Favored Glycine 0 C--N 1.283 -2.412 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.416 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 41' ' ' GLY . 12.6 mm -88.7 -41.41 14.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 74.2 m-85 -112.25 148.91 33.14 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.069 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -145.47 135.16 23.4 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 172.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.69 HD13 ' HB3' ' A' ' 35' ' ' PHE . 18.6 tt -94.93 161.25 2.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.663 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -79.4 114.4 18.31 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.486 ' HA ' ' H ' ' A' ' 35' ' ' PHE . 2.9 mt-10 -65.53 10.55 0.09 Allowed 'General case' 0 C--N 1.286 -2.189 0 O-C-N 121.838 -0.538 . . . . 0.0 112.425 -174.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -133.05 -50.19 0.88 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.658 -1.276 . . . . 0.0 110.175 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.0 p -79.4 -54.12 6.24 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 35' ' ' PHE . . . 121.97 2.26 10.3 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -63.48 122.25 15.82 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.671 -0.899 . . . . 0.0 109.466 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.592 ' CG2' HG23 ' A' ' 24' ' ' VAL . 44.5 t -91.35 117.65 35.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -109.17 140.31 42.93 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.918 -176.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.409 ' CG2' HD21 ' A' ' 65' ' ' LEU . 8.9 p -89.43 141.89 13.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' A' ' 49' ' ' ILE . 24.3 p -94.32 -19.71 20.42 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.29 -0.881 . . . . 0.0 111.034 -175.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.2 178.21 8.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.006 -1.059 . . . . 0.0 110.393 -176.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 2.0 t -68.53 143.8 54.81 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 61' ' ' VAL . 63.4 mt -106.25 142.28 36.2 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.305 -0.872 . . . . 0.0 109.115 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.484 ' HB2' HG23 ' A' ' 69' ' ' VAL . 19.4 m-20 -123.99 122.41 37.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.647 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 6.4 mtm105 -60.48 -9.72 4.05 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -79.15 -27.9 42.76 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.484 HG23 ' HB2' ' A' ' 66' ' ' ASP . 20.9 t -88.84 -55.56 6.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -144.74 134.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.99 -26.18 22.77 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.8 p -152.79 139.42 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.683 -0.636 . . . . 0.0 109.641 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -101.17 134.04 44.8 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.479 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 14.5 tp60 -96.96 96.08 8.26 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -98.61 170.1 9.04 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.193 0.996 . . . . 0.0 108.982 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.9 m-85 -137.47 137.28 38.55 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.709 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -117.42 138.21 48.82 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 CA-C-O 121.128 0.489 . . . . 0.0 110.573 -176.423 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.673 ' HB3' HG23 ' A' ' 86' ' ' THR . 32.7 mt-10 -133.95 139.87 46.4 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.643 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.53 141.62 31.48 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 169.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.478 ' C ' HD21 ' A' ' 87' ' ' LEU . 1.2 p -129.52 162.13 28.89 Favored 'General case' 0 C--N 1.275 -2.668 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.364 -174.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 10.2 t70 -100.67 170.3 8.45 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.502 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.2 m -53.6 -27.01 14.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.457 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 14.0 t-20 -79.89 3.53 19.53 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.408 -0.807 . . . . 0.0 109.538 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.31 17.5 70.39 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.457 ' NZ ' ' OD1' ' A' ' 83' ' ' ASN . 18.1 mttp -82.79 146.91 28.7 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.166 -1.197 . . . . 0.0 108.057 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.673 HG23 ' HB3' ' A' ' 78' ' ' GLU . 87.7 m -91.51 116.53 28.93 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.925 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.88 -23.8 18.67 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.779 ' HG3' HD12 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -145.41 164.84 30.28 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.526 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 80.72 -166.02 48.53 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -69.65 103.88 0.38 Allowed 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 123.487 -1.464 . . . . 0.0 110.926 -0.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.913 HG21 HG21 ' A' ' 2' ' ' ILE . 14.6 m -72.92 158.21 87.53 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -90.4 141.61 3.4 Favored 'Trans proline' 0 C--N 1.283 -2.901 0 C-N-CA 121.552 1.501 . . . . 0.0 112.424 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.677 HD23 HD11 ' A' ' 37' ' ' LEU . 12.6 tp -131.57 125.73 33.03 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.479 ' HG2' ' NE2' ' A' ' 74' ' ' GLN . 66.3 mt-10 -109.0 123.09 48.58 Favored 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.517 -0.739 . . . . 0.0 109.232 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 41.6 t -108.3 100.43 10.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.769 ' H ' HD12 ' A' ' 96' ' ' ILE . 3.4 mp -84.69 135.94 23.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-O 121.457 0.646 . . . . 0.0 109.298 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.746 HG12 ' HB3' ' A' ' 11' ' ' GLU . 5.1 t -92.37 99.25 9.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.588 HG21 ' HB3' ' A' ' 8' ' ' LEU . 16.4 pt -90.76 171.9 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.291 -1.945 0 O-C-N 120.946 -1.096 . . . . 0.0 108.295 179.36 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.505 ' N ' ' OE1' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.501 -0.941 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.95 HG21 HG21 ' A' ' 91' ' ' VAL . 40.5 mt -72.34 123.13 26.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.458 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.64 124.43 72.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -131.44 158.78 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 -178.268 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.417 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -127.37 131.03 23.64 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.595 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.459 ' HB2' HD11 ' A' ' 8' ' ' LEU . 53.6 Cg_exo -41.25 140.89 1.31 Allowed 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.205 1.936 . . . . 0.0 110.85 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.52 HG13 HD11 ' A' ' 93' ' ' LEU . 12.6 mt -103.93 115.45 45.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.724 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -107.99 96.8 6.63 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.44 ' CG1' HG22 ' A' ' 7' ' ' ILE . 1.3 mt -107.79 128.13 26.42 Favored Pre-proline 0 C--N 1.279 -2.471 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -176.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 40.5 Cg_endo -72.07 135.4 25.11 Favored 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 120.79 0.993 . . . . 0.0 110.163 175.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.46 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 2.1 pp20? -68.26 -173.32 0.39 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-O 121.996 0.903 . . . . 0.0 111.388 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.472 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 0.8 OUTLIER 60.65 -5.99 0.1 Allowed 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 174.639 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.536 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 57.5 mt-30 -61.87 137.0 58.2 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.472 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -107.14 -159.78 0.71 Allowed 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.681 -0.637 . . . . 0.0 110.158 -174.729 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.521 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -55.6 166.48 0.97 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.616 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.521 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 4.0 Cg_endo -80.29 118.18 5.63 Favored 'Cis proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.273 -1.553 . . . . 0.0 113.525 0.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -107.13 165.58 12.59 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.5 162.77 79.54 Favored 'Cis proline' 0 N--CA 1.504 2.094 0 C-N-CA 124.57 -1.012 . . . . 0.0 111.631 -1.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.536 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 39.4 mtp180 -132.26 144.57 50.7 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 33.7 t70 -77.01 139.34 40.04 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.484 HG23 HG21 ' A' ' 7' ' ' ILE . 31.0 m -127.01 -2.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.859 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 169.77 -178.6 42.64 Favored Glycine 0 N--CA 1.511 3.693 0 C-N-CA 117.355 -2.355 . . . . 0.0 110.401 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.494 ' NZ ' ' O ' ' A' ' 56' ' ' THR . 6.8 ttmm -137.01 127.73 27.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.712 -1.464 . . . . 0.0 112.0 -176.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.667 HG11 HG11 ' A' ' 77' ' ' VAL . 15.3 t -94.91 132.57 38.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 168.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.3 156.51 34.47 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.852 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 1' ' ' SER . 8.3 t70 -132.85 146.05 51.48 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.285 -2.206 0 O-C-N 121.559 -0.713 . . . . 0.0 111.322 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.539 ' HB3' ' CB ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -131.19 154.74 48.08 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.948 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -79.78 144.76 33.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.498 -0.751 . . . . 0.0 110.801 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.468 ' NH1' ' OE1' ' A' ' 78' ' ' GLU . 1.3 mtp180 -116.5 145.08 43.57 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 tp -122.17 143.85 49.31 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 p -144.12 170.86 15.14 Favored 'General case' 0 C--N 1.276 -2.613 0 O-C-N 121.251 -0.905 . . . . 0.0 109.056 -175.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.02 164.88 13.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.56 106.19 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 133.75 -16.23 4.54 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -175.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 50' ' ' PHE . 38.2 t -132.73 -88.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.578 -0.954 . . . . 0.0 109.577 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.03 -20.51 34.87 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -118.11 157.31 27.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.844 0.831 . . . . 0.0 109.53 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 45' ' ' GLU . 1.8 mp0 -56.33 132.4 76.01 Favored Pre-proline 0 C--N 1.28 -2.414 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.756 -176.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.632 ' HB2' HD11 ' A' ' 49' ' ' ILE . 4.9 Cg_endo -75.85 115.94 3.86 Favored 'Cis proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.091 -1.629 . . . . 0.0 110.126 -0.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 32.8 mtpt -69.42 153.85 42.92 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 120.721 -1.237 . . . . 0.0 111.425 -174.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.52 9.1 29.69 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-O 119.261 -0.744 . . . . 0.0 113.34 173.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 46' ' ' PRO . 8.1 mm -60.83 -48.76 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.509 0 CA-C-N 120.239 2.019 . . . . 0.0 106.795 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.418 ' HB2' HG22 ' A' ' 42' ' ' VAL . 86.4 m-85 -108.35 166.62 10.62 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-O 121.815 0.817 . . . . 0.0 110.413 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.84 126.6 7.53 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.432 HG13 HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -93.46 146.84 5.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.298 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 57' ' ' GLY . 1.9 t-20 -79.46 85.11 5.27 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.539 ' CB ' ' HB3' ' A' ' 34' ' ' LYS . 1.9 mt-10 -30.82 -34.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 124.053 0.941 . . . . 0.0 113.431 -174.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -93.0 -50.42 5.55 Favored 'General case' 0 C--N 1.285 -2.231 0 O-C-N 121.544 -0.723 . . . . 0.0 110.373 -174.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.494 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 18.8 p -88.32 -12.32 43.8 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 122.047 0.927 . . . . 0.0 108.831 -175.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . 69.82 9.36 62.47 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.49 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 3.5 m -69.35 124.58 24.22 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.326 -1.103 . . . . 0.0 108.291 177.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.499 ' CG2' HG23 ' A' ' 24' ' ' VAL . 1.8 t -90.02 122.52 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.182 -0.949 . . . . 0.0 109.192 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -118.26 154.15 32.75 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.198 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.602 ' CG2' HD21 ' A' ' 65' ' ' LEU . 12.1 p -107.46 149.92 10.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.7 p -104.32 -22.9 13.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.503 -0.748 . . . . 0.0 112.101 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HD2' HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -137.56 168.52 19.5 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.979 -1.075 . . . . 0.0 111.381 -175.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 12.1 t -64.87 123.42 19.36 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.602 HD21 ' CG2' ' A' ' 61' ' ' VAL . 36.7 mt -82.08 163.54 21.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.063 -1.023 . . . . 0.0 108.497 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -127.92 170.42 12.86 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.546 ' NE ' ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.68 27.39 8.22 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 121.873 0.844 . . . . 0.0 109.158 -177.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -120.32 -42.18 2.58 Favored 'General case' 0 C--N 1.262 -3.213 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.81 -47.78 16.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 70' ' ' ILE . 2.0 mt -129.85 137.25 57.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.44 -24.13 14.23 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 p -156.29 146.43 11.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.423 -0.798 . . . . 0.0 109.345 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.492 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 60.6 m-85 -103.96 114.48 28.76 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 174.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.499 HE22 ' HG2' ' A' ' 94' ' ' GLU . 5.6 tp-100 -88.01 83.07 7.07 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.79 170.58 15.54 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 43.8 m-85 -133.69 129.74 37.2 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.698 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -105.77 144.21 15.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 O-C-N 121.894 -0.503 . . . . 0.0 109.859 -175.711 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.708 ' HB3' HG23 ' A' ' 86' ' ' THR . 56.0 mt-10 -131.31 140.95 49.86 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.648 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -86.3 127.63 34.81 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 102.806 -3.035 . . . . 0.0 102.806 167.735 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.584 ' C ' HD21 ' A' ' 87' ' ' LEU . 19.5 p -123.04 146.05 48.0 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 118.567 -1.253 . . . . 0.0 111.713 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.736 ' N ' HD21 ' A' ' 87' ' ' LEU . 29.0 t70 -88.72 165.76 14.51 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.017 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG13 ' H ' ' A' ' 82' ' ' VAL . 1.0 OUTLIER -55.76 -27.21 21.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -79.5 -13.19 59.73 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.102 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.04 7.18 50.67 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -76.4 143.77 40.44 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 120.666 -1.49 . . . . 0.0 107.787 178.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.708 HG23 ' HB3' ' A' ' 78' ' ' GLU . 98.3 m -86.98 116.08 24.8 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.884 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -87.24 -20.8 26.37 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.505 ' OE1' ' N ' ' A' ' 1' ' ' SER . 4.7 tt0 -157.94 153.2 25.81 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.521 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 83.91 -169.5 46.53 Favored Glycine 0 C--N 1.28 -2.536 0 N-CA-C 106.698 -2.561 . . . . 0.0 106.698 -174.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.85 103.23 0.14 OUTLIER 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.644 -1.398 . . . . 0.0 112.722 -0.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.95 HG21 HG21 ' A' ' 2' ' ' ILE . 3.7 m -78.4 164.35 56.7 Favored Pre-proline 0 C--N 1.289 -2.059 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -93.71 153.14 2.32 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 121.498 1.465 . . . . 0.0 112.622 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 4' ' ' VAL . 5.4 tp -141.0 129.76 22.92 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.499 ' HG2' HE22 ' A' ' 74' ' ' GLN . 31.7 mt-10 -102.92 110.57 22.54 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 60.0 t -103.69 93.08 2.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 96' ' ' ILE . 3.4 mp -79.76 134.3 27.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 O-C-N 121.507 -0.746 . . . . 0.0 109.24 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 55.2 t -88.38 102.49 12.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.518 HG21 ' HB3' ' A' ' 8' ' ' LEU . 9.5 pt -80.17 170.78 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.244 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 . . . . . 0 C--N 1.28 -2.434 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.989 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.467 ' N ' ' OE2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.73 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.777 HG21 HG21 ' A' ' 91' ' ' VAL . 18.9 mt -67.82 148.54 11.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.53 0.681 . . . . 0.0 110.015 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.76 114.31 24.66 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -134.32 169.63 21.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.635 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.524 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 2.1 m -159.39 165.94 17.2 Favored Pre-proline 0 C--N 1.276 -2.618 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 33.1 Cg_exo -55.47 131.32 45.46 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.553 1.502 . . . . 0.0 111.946 -175.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.4 HG13 HD11 ' A' ' 93' ' ' LEU . 11.1 mt -106.13 115.88 48.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.841 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -90.25 108.01 19.49 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' CD1' HG13 ' A' ' 95' ' ' VAL . 23.2 mt -109.81 124.23 34.19 Favored Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 6.5 Cg_exo -66.06 124.49 12.69 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.062 1.175 . . . . 0.0 110.777 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -41.86 -72.2 0.07 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.578 0.704 . . . . 0.0 111.797 -176.466 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.492 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 48.2 p-10 -66.4 40.55 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -174.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.484 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -76.01 56.04 0.96 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 119.608 -1.933 . . . . 0.0 106.145 172.074 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.564 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -45.59 175.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.331 1.062 . . . . 0.0 113.599 -172.216 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 37.5 mt-30 -48.25 166.34 0.22 Allowed Pre-proline 0 C--N 1.285 -2.201 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.754 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 5.7 Cg_exo -76.1 134.89 37.7 Favored 'Cis proline' 0 N--CA 1.497 1.721 0 C-N-CA 123.725 -1.364 . . . . 0.0 113.898 0.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CZ ' ' O ' ' A' ' 13' ' ' GLN . 24.2 m-85 -102.49 166.24 12.37 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 12.2 Cg_exo -69.36 166.7 72.32 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.312 -0.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.564 ' NH2' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -125.1 135.28 52.54 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.98 137.16 51.19 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.25 4.83 3.06 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.011 0 C-N-CA 119.441 -0.903 . . . . 0.0 109.014 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 158.37 -170.32 35.04 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 118.218 -1.944 . . . . 0.0 109.632 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 19.4 ttmm -148.13 128.56 13.97 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.23 -1.159 . . . . 0.0 109.768 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.672 HG11 HG11 ' A' ' 77' ' ' VAL . 21.7 t -89.25 147.07 5.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 26' ' ' ASP . 61.0 t -132.38 163.73 36.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 9.8 t70 -125.09 141.11 52.32 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.459 ' HG ' ' HB2' ' A' ' 1' ' ' SER . 0.7 OUTLIER . . . . . 0 C--N 1.26 -3.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.362 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.477 ' C ' ' HG2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 121.465 0.65 . . . . 0.0 111.263 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HG2' ' C ' ' A' ' 33' ' ' SER . 6.2 mmtm -147.71 150.51 34.44 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.491 ' N ' ' O ' ' A' ' 54' ' ' GLU . 35.5 m-85 -94.65 124.28 38.59 Favored 'General case' 0 C--N 1.28 -2.446 0 O-C-N 121.408 -0.807 . . . . 0.0 109.485 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.698 ' HG3' HG21 ' A' ' 80' ' ' THR . 4.4 mmp_? -107.61 125.77 51.73 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.669 ' HG ' HG21 ' A' ' 42' ' ' VAL . 44.1 tp -106.29 144.45 32.95 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -149.68 170.89 17.64 Favored 'General case' 0 C--N 1.278 -2.5 0 O-C-N 121.163 -0.96 . . . . 0.0 108.732 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.91 176.26 18.71 Favored Glycine 0 N--CA 1.502 3.033 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.056 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 44' ' ' GLN . 36.5 mtpt -61.11 121.16 11.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 110.16 -20.77 25.62 Favored Glycine 0 C--N 1.28 -2.552 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 -177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.669 HG21 ' HG ' ' A' ' 37' ' ' LEU . 40.9 t -116.2 -93.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -92.98 -12.58 30.37 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.59 -0.694 . . . . 0.0 109.647 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 40' ' ' LYS . 6.0 mm-40 -109.7 157.58 18.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -57.81 132.52 82.95 Favored Pre-proline 0 C--N 1.288 -2.1 0 O-C-N 121.982 -0.449 . . . . 0.0 110.084 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.444 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -77.42 118.77 5.95 Favored 'Cis proline' 0 N--CA 1.501 1.959 0 C-N-CA 123.91 -1.287 . . . . 0.0 110.24 -0.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 mttp -67.14 149.69 50.17 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 120.788 -1.195 . . . . 0.0 111.947 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.22 29.3 72.61 Favored Glycine 0 N--CA 1.49 2.286 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.748 171.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.498 HG23 ' HD2' ' A' ' 63' ' ' ARG . 10.6 mm -83.77 -44.75 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 173.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.663 ' HB2' HG22 ' A' ' 42' ' ' VAL . 84.3 m-85 -106.33 147.76 28.82 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.601 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.57 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -141.94 126.25 17.59 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 177.076 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.61 147.67 8.88 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.542 ' CG ' HG23 ' A' ' 56' ' ' THR . 28.5 t-20 -79.68 99.97 7.65 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -42.39 -26.64 0.12 Allowed 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.896 -177.014 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -106.5 -37.28 6.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.909 -1.12 . . . . 0.0 111.69 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.542 HG23 ' CG ' ' A' ' 53' ' ' ASN . 5.1 p -89.8 -15.23 32.78 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 120.984 -1.072 . . . . 0.0 108.918 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.24 2.62 49.14 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.518 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 19.3 m -64.51 124.37 21.67 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.292 -1.122 . . . . 0.0 108.815 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 24' ' ' VAL . 2.1 t -88.96 131.0 37.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.57 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -130.87 160.53 34.17 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.44 149.37 19.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.1 p -94.71 -10.57 31.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.48 -0.763 . . . . 0.0 111.148 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -155.15 162.92 40.85 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.052 -1.03 . . . . 0.0 109.306 -178.196 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.528 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 5.1 t -62.18 138.2 58.37 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 65.2 mt -90.71 131.58 36.31 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -106.06 119.34 38.96 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -57.62 -7.65 0.71 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -77.89 -26.93 49.49 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.9 t -89.87 -53.02 9.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.416 HD12 ' CE1' ' A' ' 73' ' ' TYR . 2.8 mt -151.66 144.02 16.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.28 -25.55 16.29 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.1 p -154.92 135.95 5.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.501 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.416 ' CE1' HD12 ' A' ' 70' ' ' ILE . 37.4 m-85 -106.03 138.64 41.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -100.7 87.08 3.25 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.405 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -81.11 170.78 15.74 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 57.0 m-85 -132.21 131.37 42.09 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.716 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -110.18 140.64 28.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 O-C-N 122.022 -0.424 . . . . 0.0 110.046 -177.059 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.619 ' HB3' HG23 ' A' ' 86' ' ' THR . 43.8 mt-10 -130.28 137.12 49.82 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.681 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -86.2 133.8 33.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 172.466 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.698 HG21 ' HG3' ' A' ' 36' ' ' ARG . 4.1 p -125.27 159.17 32.31 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.689 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.488 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -101.07 170.55 8.2 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 177.134 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.488 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 0.9 OUTLIER -43.09 -38.0 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 CA-C-O 121.825 0.821 . . . . 0.0 109.613 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.435 ' N ' ' CG2' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -79.95 2.85 21.93 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.697 -0.627 . . . . 0.0 109.975 -177.131 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.67 15.48 80.64 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 80' ' ' THR . 2.0 mtpp -73.51 134.18 43.8 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.619 HG23 ' HB3' ' A' ' 78' ' ' GLU . 91.0 m -81.27 116.92 21.37 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.803 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.914 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.33 -22.02 19.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.592 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.467 ' OE2' ' N ' ' A' ' 1' ' ' SER . 1.0 OUTLIER -151.21 149.37 29.35 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.265 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.556 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 105.43 -178.39 23.33 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -71.63 104.43 0.49 Allowed 'Cis proline' 0 N--CA 1.491 1.354 0 C-N-CA 123.304 -1.54 . . . . 0.0 111.568 0.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 2' ' ' ILE . 9.5 m -75.23 159.04 83.25 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 176.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -91.78 145.16 3.08 Favored 'Trans proline' 0 C--N 1.279 -3.089 0 C-N-CA 121.529 1.486 . . . . 0.0 111.699 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.544 HD23 HD11 ' A' ' 37' ' ' LEU . 11.2 tp -128.84 126.97 40.94 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 4.2 mt-10 -106.81 110.29 22.42 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.63 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 24.8 t -101.8 112.22 34.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.7 mp -97.55 136.28 28.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.57 111.76 23.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.674 HG21 ' HB3' ' A' ' 8' ' ' LEU . 9.7 pt -105.45 171.63 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.279 -2.46 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -178.683 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.516 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.85 HG21 HG21 ' A' ' 91' ' ' VAL . 17.2 mt -62.01 146.02 12.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-O 121.934 0.874 . . . . 0.0 111.065 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -134.85 115.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.553 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 174.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.528 HG23 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -127.14 161.86 33.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.057 -1.027 . . . . 0.0 108.9 -175.498 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.451 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -155.52 138.84 10.89 Favored Pre-proline 0 C--N 1.273 -2.74 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.815 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -41.9 138.91 2.55 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 C-N-CA 122.351 2.034 . . . . 0.0 112.724 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.508 HG13 HD11 ' A' ' 93' ' ' LEU . 16.2 mt -104.63 119.44 53.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 175.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.8 mp -106.15 79.42 1.4 Allowed 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.486 HG13 HG22 ' A' ' 7' ' ' ILE . 4.7 mt -81.99 140.35 46.47 Favored Pre-proline 0 C--N 1.281 -2.398 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.1 Cg_endo -73.69 137.13 24.44 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 120.748 0.965 . . . . 0.0 111.046 177.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.696 ' HB3' HG12 ' A' ' 97' ' ' VAL . 1.5 pt-20 -66.08 170.59 5.48 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.283 -0.886 . . . . 0.0 109.198 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.438 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 5.3 t-20 59.8 13.5 3.58 Favored 'General case' 0 C--N 1.287 -2.114 0 O-C-N 121.752 -0.593 . . . . 0.0 112.093 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -57.58 127.63 32.97 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.571 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -89.67 158.53 17.54 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.153 -0.967 . . . . 0.0 112.781 -170.73 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.59 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 12.3 mp0 -50.07 167.05 0.25 Allowed Pre-proline 0 C--N 1.296 -1.733 0 C-N-CA 124.938 1.295 . . . . 0.0 109.022 176.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 67.8 Cg_endo -79.61 154.67 88.64 Favored 'Cis proline' 0 C--N 1.31 -1.473 0 C-N-CA 123.613 -1.411 . . . . 0.0 113.641 0.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 33.9 m-85 -135.09 169.86 12.7 Favored Pre-proline 0 C--N 1.276 -2.597 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.6 Cg_exo -68.94 173.34 41.99 Favored 'Cis proline' 0 N--CA 1.493 1.469 0 C-N-CA 124.485 -1.048 . . . . 0.0 112.124 0.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.571 ' NH2' ' O ' ' A' ' 14' ' ' ARG . 7.1 ttm180 -155.88 145.2 20.81 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -65.65 132.83 49.78 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.01 3.74 5.14 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 163.36 179.11 37.61 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.93 131.88 35.74 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.818 -1.401 . . . . 0.0 110.134 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 77' ' ' VAL . 24.2 t -91.69 126.62 44.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 102.179 -3.267 . . . . 0.0 102.179 166.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.437 ' HB ' HG13 ' A' ' 3' ' ' VAL . 33.0 t -112.07 159.69 11.91 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 C-N-CA 118.472 -1.291 . . . . 0.0 109.068 -173.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 1' ' ' SER . 29.3 t0 -144.99 110.35 5.24 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 174.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.283 -2.285 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.079 0.466 . . . . 0.0 111.065 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' NZ ' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -107.14 142.35 36.97 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.743 -0.598 . . . . 0.0 110.331 -176.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.418 ' CD1' ' CA ' ' A' ' 57' ' ' GLY . 78.8 m-85 -79.11 139.1 38.14 Favored 'General case' 0 C--N 1.273 -2.74 0 O-C-N 120.972 -1.08 . . . . 0.0 111.255 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.458 ' NH2' ' OG1' ' A' ' 86' ' ' THR . 7.0 mtm-85 -115.57 127.16 55.04 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 172.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.546 ' HG ' HG21 ' A' ' 42' ' ' VAL . 27.2 tp -108.71 138.97 44.17 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -147.69 170.8 16.75 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.68 163.83 13.0 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -57.21 112.81 1.48 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 125.74 -18.88 6.67 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 107.934 -2.067 . . . . 0.0 107.934 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.546 HG21 ' HG ' ' A' ' 37' ' ' LEU . 39.3 t -123.77 -97.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.98 -18.32 30.98 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -107.13 156.88 18.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.625 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 15.5 mm-40 -68.54 140.93 92.59 Favored Pre-proline 0 C--N 1.269 -2.893 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.537 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.48 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -70.52 113.39 1.83 Allowed 'Cis proline' 0 N--CA 1.51 2.48 0 C-N-CA 123.605 -1.415 . . . . 0.0 111.438 1.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.625 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 5.3 mtpm? -69.17 152.82 44.64 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.766 -1.209 . . . . 0.0 111.909 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.441 ' O ' ' OG1' ' A' ' 62' ' ' THR . . . 69.87 5.1 50.8 Favored Glycine 0 N--CA 1.489 2.198 0 CA-C-O 119.113 -0.826 . . . . 0.0 113.474 171.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.402 ' CG1' ' HB2' ' A' ' 46' ' ' PRO . 11.7 mm -65.24 -46.66 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 120.456 2.128 . . . . 0.0 107.338 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.641 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 69.6 m-85 -115.75 144.67 43.64 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.296 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.18 136.01 29.52 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.0 OUTLIER -109.23 157.54 9.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.602 -0.686 . . . . 0.0 109.989 -176.122 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.49 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 11.4 t-20 -85.32 126.94 34.13 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 175.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 34' ' ' LYS . 1.8 mt-10 -59.7 -38.54 81.86 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.771 -0.581 . . . . 0.0 111.06 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 10.6 t30 -88.57 -48.03 7.87 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.014 -1.054 . . . . 0.0 111.673 -176.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.1 p -80.49 -34.43 35.81 Favored 'General case' 0 C--N 1.281 -2.376 0 O-C-N 121.727 -0.608 . . . . 0.0 109.662 -174.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.418 ' CA ' ' CD1' ' A' ' 35' ' ' PHE . . . 84.08 10.38 80.68 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -176.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 16.8 m -64.54 122.09 15.98 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.209 -1.171 . . . . 0.0 108.334 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.555 HG22 HG23 ' A' ' 24' ' ' VAL . 1.8 t -88.92 127.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.59 146.01 49.29 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.532 -0.73 . . . . 0.0 109.654 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.455 HG21 ' CG ' ' A' ' 65' ' ' LEU . 8.3 p -101.63 149.18 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 48' ' ' GLY . 28.8 p -99.86 -17.32 17.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.634 -0.666 . . . . 0.0 112.122 -175.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -145.93 167.17 23.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.798 -1.189 . . . . 0.0 110.567 -178.63 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.506 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 7.1 t -58.01 122.51 13.19 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.455 ' CG ' HG21 ' A' ' 61' ' ' VAL . 86.3 mt -79.73 140.87 36.81 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.466 -1.396 . . . . 0.0 109.904 -175.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.499 ' CG ' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -124.37 117.3 24.17 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.085 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -60.17 -14.73 18.86 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 121.765 -0.584 . . . . 0.0 109.88 178.7 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 1.5 mp0 -78.56 -28.3 45.94 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.889 -1.132 . . . . 0.0 108.694 -176.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.86 -52.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -145.33 132.59 15.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.36 -25.46 29.14 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.22 136.59 5.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 42.7 m-85 -100.05 122.52 43.06 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -92.44 93.91 8.83 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.94 170.75 9.8 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.779 0.799 . . . . 0.0 109.028 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 93.5 m-85 -133.0 131.21 40.46 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -117.9 150.13 20.1 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -174.191 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.635 ' HB3' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -146.46 146.87 30.71 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 121.302 -0.874 . . . . 0.0 108.652 176.093 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.712 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -95.27 135.63 36.62 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 170.419 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.712 ' C ' HD21 ' A' ' 87' ' ' LEU . 38.0 p -125.76 158.22 35.46 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.411 -0.806 . . . . 0.0 111.553 -171.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.429 ' HB2' HD11 ' A' ' 87' ' ' LEU . 28.1 t70 -79.64 170.96 15.79 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.428 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 2.1 m -58.41 -27.71 33.9 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -79.61 2.01 23.99 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.736 0.779 . . . . 0.0 108.997 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.434 ' HA2' ' HZ1' ' A' ' 34' ' ' LYS . . . 77.36 11.65 85.31 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -77.51 140.05 39.7 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.489 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.635 HG23 ' HB3' ' A' ' 78' ' ' GLU . 39.0 m -81.51 118.98 23.18 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 120.777 0.322 . . . . 0.0 110.187 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.927 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.21 -31.29 14.18 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.322 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.468 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 5.1 tp10 -138.04 153.18 49.37 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.56 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 89.12 -171.5 38.86 Favored Glycine 0 C--N 1.288 -2.119 0 N-CA-C 106.931 -2.467 . . . . 0.0 106.931 -174.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.37 111.54 1.03 Allowed 'Cis proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.364 -1.515 . . . . 0.0 111.037 -0.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.85 HG21 HG21 ' A' ' 2' ' ' ILE . 4.2 m -86.9 163.56 40.28 Favored Pre-proline 0 C--N 1.28 -2.432 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -93.85 159.84 2.26 Favored 'Trans proline' 0 C--N 1.289 -2.561 0 C-N-CA 121.933 1.756 . . . . 0.0 110.868 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.528 HD13 HG23 ' A' ' 4' ' ' VAL . 15.4 tp -144.88 124.48 13.24 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.81 113.14 25.12 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.641 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 78.1 t -105.16 91.39 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.82 138.04 20.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 O-C-N 121.506 -0.746 . . . . 0.0 109.179 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.696 HG12 ' HB3' ' A' ' 11' ' ' GLU . 4.0 t -97.1 106.72 18.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.2 pt -97.12 170.92 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.081 -1.012 . . . . 0.0 110.307 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.934 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.856 HG21 HG21 ' A' ' 91' ' ' VAL . 7.2 mt -74.96 146.85 8.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.361 0.6 . . . . 0.0 109.621 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -125.25 137.89 56.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.379 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -150.61 167.43 2.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . 0.494 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -140.87 145.73 40.88 Favored Pre-proline 0 C--N 1.289 -2.055 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.358 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.28 133.11 35.78 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.093 1.862 . . . . 0.0 110.323 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.2 mt -103.93 112.1 36.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.167 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.898 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.22 105.33 17.74 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.634 HD11 HG21 ' A' ' 21' ' ' VAL . 19.3 mt -111.93 128.4 25.51 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 33.9 Cg_endo -69.27 130.16 19.45 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.172 1.248 . . . . 0.0 110.727 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 66' ' ' ASP . 10.9 pt-20 -64.35 173.88 1.88 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.104 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 57.39 61.75 2.4 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.688 0.756 . . . . 0.0 111.418 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.423 ' O ' ' OG1' ' A' ' 64' ' ' THR . 35.1 mt-30 -119.88 131.98 55.42 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 174.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -96.97 177.82 5.49 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 121.062 -1.024 . . . . 0.0 111.673 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.567 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 18.2 mp0 -54.76 166.94 0.67 Allowed Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 70.5 Cg_endo -78.12 122.13 8.44 Favored 'Cis proline' 0 C--N 1.315 -1.203 0 C-N-CA 123.785 -1.34 . . . . 0.0 114.459 0.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.506 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 29.6 m-85 -97.86 170.2 7.45 Favored Pre-proline 0 C--N 1.279 -2.49 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.506 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.7 Cg_exo -68.05 163.27 76.82 Favored 'Cis proline' 0 N--CA 1.493 1.483 0 C-N-CA 124.194 -1.169 . . . . 0.0 111.224 -1.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 19' ' ' ARG . 1.1 mtp180 -124.47 126.93 46.71 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 24.6 t70 -76.66 132.64 39.5 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.634 HG21 HD11 ' A' ' 9' ' ' ILE . 15.6 m -127.46 5.67 3.4 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.643 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 166.7 179.55 39.96 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 117.707 -2.187 . . . . 0.0 109.756 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.471 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 29.5 tttp -143.03 139.57 30.61 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 120.852 -1.381 . . . . 0.0 109.678 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 77' ' ' VAL . 6.6 t -94.34 152.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 172.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.465 ' HB ' HG13 ' A' ' 3' ' ' VAL . 3.5 t -144.14 151.4 16.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 9.2 t0 -112.25 135.08 53.37 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.269 -2.9 0 O-C-N 122.141 -0.349 . . . . 0.0 111.501 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.656 ' HB2' HG22 ' A' ' 79' ' ' THR . 1.4 p . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 40.8 mttm -113.52 139.17 49.19 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 173.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.846 ' CE1' HG23 ' A' ' 79' ' ' THR . 61.9 m-85 -89.77 135.5 33.59 Favored 'General case' 0 C--N 1.271 -2.818 0 O-C-N 121.24 -0.912 . . . . 0.0 110.991 -174.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.509 ' NH2' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -100.0 139.27 35.92 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 174.23 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.463 HD11 HD23 ' A' ' 93' ' ' LEU . 19.2 tp -121.01 135.45 55.21 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -144.91 170.52 15.99 Favored 'General case' 0 C--N 1.274 -2.692 0 O-C-N 121.472 -0.768 . . . . 0.0 109.019 -174.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.15 173.39 17.69 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -58.16 111.5 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 124.52 -15.3 7.62 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 50' ' ' PHE . 21.2 t -129.36 -81.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.294 -1.121 . . . . 0.0 109.154 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -96.53 -14.46 22.28 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -118.85 158.51 25.51 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.521 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -51.9 127.85 36.08 Favored Pre-proline 0 C--N 1.281 -2.389 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.779 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.445 ' HB2' HD11 ' A' ' 49' ' ' ILE . 4.3 Cg_endo -80.36 120.66 7.32 Favored 'Cis proline' 0 C--O 1.202 -1.311 0 C-N-CA 123.5 -1.458 . . . . 0.0 110.517 -1.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 28.0 mttp -63.47 155.51 29.0 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 120.872 -1.143 . . . . 0.0 111.268 -175.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.75 32.73 48.01 Favored Glycine 0 N--CA 1.49 2.285 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.149 171.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.488 HD12 ' HD2' ' A' ' 63' ' ' ARG . 8.7 mm -87.89 -43.44 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.521 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 67.1 m-85 -110.39 141.44 43.46 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.813 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.586 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -132.6 120.61 22.02 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 176.802 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -89.09 141.87 13.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.513 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 46.6 t30 -79.09 84.79 5.04 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 1.3 mp0 -24.22 -53.43 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 125.327 1.451 . . . . 0.0 113.54 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -79.75 -39.49 30.92 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.161 -0.962 . . . . 0.0 111.325 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 29.2 p -94.32 -26.28 16.64 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-O 121.735 0.779 . . . . 0.0 109.313 -174.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.33 2.6 76.67 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -65.07 121.35 14.52 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.313 -1.11 . . . . 0.0 109.482 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.1 t -86.83 120.87 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.586 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -123.73 155.42 37.9 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.418 178.193 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.568 ' CG2' HD21 ' A' ' 65' ' ' LEU . 7.4 p -102.19 143.54 14.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.111 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 59.9 p -90.48 -20.51 22.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.446 -0.784 . . . . 0.0 111.037 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.49 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -151.81 175.66 12.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.115 -0.99 . . . . 0.0 110.033 -175.535 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.49 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 2.7 t -66.62 136.69 55.95 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-O 121.83 0.824 . . . . 0.0 110.793 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.568 HD21 ' CG2' ' A' ' 61' ' ' VAL . 22.0 mt -98.78 150.61 21.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.65 ' HB2' HG23 ' A' ' 69' ' ' VAL . 8.7 m-20 -132.9 122.66 24.67 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.0 mtp-105 -57.26 -13.33 3.11 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -77.79 -22.94 49.37 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 66' ' ' ASP . 25.1 t -85.37 -55.87 6.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' HG21 ' A' ' 97' ' ' VAL . 1.1 mt -144.74 136.39 21.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.11 -25.46 36.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 4.1 p -160.02 132.83 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.456 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 70.6 m-85 -94.42 115.23 27.38 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.21 93.1 6.35 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.41 170.62 10.39 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-O 121.956 0.884 . . . . 0.0 108.994 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 78.4 m-85 -128.15 122.23 31.44 Favored 'General case' 0 C--N 1.266 -3.023 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.565 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -103.37 146.15 11.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -177.389 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.75 ' HB3' HG23 ' A' ' 86' ' ' THR . 91.3 mt-10 -136.5 140.02 42.71 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.846 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -83.49 127.35 33.64 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 170.039 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.509 ' OG1' ' NH2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -125.46 159.67 31.36 Favored 'General case' 0 C--N 1.267 -3.007 0 C-N-CA 119.265 -0.974 . . . . 0.0 109.895 -178.092 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.532 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 14.8 t70 -97.31 170.3 9.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.532 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.5 m -54.43 -22.6 9.14 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -80.27 -2.86 46.91 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.426 -0.796 . . . . 0.0 109.058 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.12 8.62 86.95 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 80' ' ' THR . 4.2 mttp -81.1 150.21 28.86 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.75 HG23 ' HB3' ' A' ' 78' ' ' GLU . 94.0 m -94.48 118.21 31.3 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-O 121.219 0.533 . . . . 0.0 110.302 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.908 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -89.15 -32.5 17.45 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER -137.83 170.41 16.11 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.593 -0.692 . . . . 0.0 109.758 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.511 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 83.5 -165.91 43.1 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -69.63 101.31 0.27 Allowed 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.564 -1.432 . . . . 0.0 110.79 -0.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.856 HG21 HG21 ' A' ' 2' ' ' ILE . 10.6 m -74.15 160.37 81.75 Favored Pre-proline 0 C--N 1.291 -1.954 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -92.49 147.07 2.8 Favored 'Trans proline' 0 C--N 1.285 -2.8 0 C-N-CA 121.868 1.712 . . . . 0.0 112.03 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.463 HD23 HD11 ' A' ' 37' ' ' LEU . 8.8 tp -130.51 125.85 35.36 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -108.27 106.91 17.28 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.651 -0.656 . . . . 0.0 109.677 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.521 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 38.9 t -98.45 100.5 10.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.64 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.8 mp -79.93 131.69 33.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 70' ' ' ILE . 3.1 t -90.05 111.24 22.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 11.3 pt -105.25 171.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 O-C-N 121.688 -0.632 . . . . 0.0 109.537 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--N 1.3 -1.578 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.734 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.492 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 91' ' ' VAL . 7.0 mt -69.22 138.1 22.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.903 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.56 133.4 69.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -146.69 157.9 10.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.637 0.732 . . . . 0.0 109.462 -177.36 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 t -128.36 141.84 42.73 Favored Pre-proline 0 C--N 1.281 -2.384 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.502 ' HB3' HD11 ' A' ' 96' ' ' ILE . 53.4 Cg_exo -45.67 132.92 13.41 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.531 1.487 . . . . 0.0 109.811 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' A' ' 95' ' ' VAL . 40.7 mt -98.08 111.89 28.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.764 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -100.3 103.12 14.53 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.623 HG22 HE21 ' A' ' 13' ' ' GLN . 4.1 mt -108.11 127.8 26.92 Favored Pre-proline 0 C--N 1.27 -2.877 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -74.4 135.98 21.1 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 CA-C-N 119.444 0.837 . . . . 0.0 111.945 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.401 ' CG ' ' HA ' ' A' ' 66' ' ' ASP . 2.9 tt0 -39.38 147.08 0.08 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.502 0.668 . . . . 0.0 111.848 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.522 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 2.3 t-20 59.87 66.54 0.97 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.623 HE21 HG22 ' A' ' 9' ' ' ILE . 18.9 mp0 -92.17 54.59 2.39 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 175.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.54 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -26.11 162.34 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -174.619 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.558 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -46.14 169.18 0.09 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.753 175.996 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 1.2 Cg_endo -77.47 131.47 24.07 Favored 'Cis proline' 0 N--CA 1.492 1.392 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.37 -0.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.529 ' CZ ' ' N ' ' A' ' 64' ' ' THR . 55.1 m-85 -97.74 163.95 18.5 Favored Pre-proline 0 C--N 1.293 -1.86 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.19 156.27 98.19 Favored 'Cis proline' 0 N--CA 1.502 1.977 0 C-N-CA 124.12 -1.2 . . . . 0.0 110.841 -1.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 38.2 mtp180 -124.77 135.29 52.85 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.435 -0.791 . . . . 0.0 110.101 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -62.17 140.27 58.44 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.756 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.33 -4.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . -176.07 170.44 43.33 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 118.75 -1.69 . . . . 0.0 109.313 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 5.1 tttm -141.62 114.1 8.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.163 -1.198 . . . . 0.0 109.687 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.694 HG11 HG11 ' A' ' 77' ' ' VAL . 22.0 t -79.65 158.92 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' CE ' ' A' ' 23' ' ' LYS . 6.3 t -141.81 170.1 13.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.1 t70 -131.13 143.93 51.01 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 1' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.402 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.079 0.466 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HB2' HH22 ' A' ' 36' ' ' ARG . 2.4 mmtp -111.02 135.41 51.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.709 -0.619 . . . . 0.0 109.712 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -84.58 116.08 22.96 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.597 ' NH1' HG21 ' A' ' 80' ' ' THR . 0.0 OUTLIER -95.31 133.73 38.89 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.633 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.706 ' HG ' HG21 ' A' ' 42' ' ' VAL . 61.0 tp -106.93 136.91 45.99 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 176.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.22 170.45 16.72 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.538 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 117.35 167.3 14.32 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -53.92 116.07 2.35 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 119.33 -22.12 9.03 Favored Glycine 0 C--N 1.28 -2.566 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.872 HG22 ' HB2' ' A' ' 50' ' ' PHE . 11.1 t -117.82 -83.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.428 -1.043 . . . . 0.0 109.12 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.35 -23.26 16.72 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 20.4 mp0 -103.34 161.22 14.02 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.447 ' HA ' ' C ' ' A' ' 46' ' ' PRO . 2.5 mp0 -68.73 134.69 90.26 Favored Pre-proline 0 C--N 1.27 -2.855 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.457 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 35.1 Cg_endo -68.73 126.42 8.76 Favored 'Cis proline' 0 N--CA 1.514 2.705 0 C-N-CA 123.615 -1.411 . . . . 0.0 110.942 -0.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -87.23 152.51 22.25 Favored 'General case' 0 C--N 1.289 -2.056 0 O-C-N 120.82 -1.175 . . . . 0.0 111.649 -173.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.01 15.26 71.67 Favored Glycine 0 N--CA 1.492 2.376 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.314 174.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.0 mm -78.37 -48.86 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 CA-C-N 119.561 1.68 . . . . 0.0 107.653 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.872 ' HB2' HG22 ' A' ' 42' ' ' VAL . 91.8 m-85 -108.42 155.71 20.27 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.708 0.766 . . . . 0.0 109.673 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.553 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -146.75 160.0 42.78 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.715 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.426 HG12 ' N ' ' A' ' 53' ' ' ASN . 10.9 tt -132.08 164.13 35.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 O-C-N 120.81 -1.181 . . . . 0.0 109.941 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 21.9 t-20 -91.94 108.71 20.12 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' OE2' ' NZ ' ' A' ' 34' ' ' LYS . 32.1 mt-10 -46.98 -33.45 4.69 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.154 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.405 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 t-20 -95.9 -48.84 5.56 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.415 -0.803 . . . . 0.0 110.961 -176.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 10.0 p -84.91 -21.58 29.61 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 121.491 -0.756 . . . . 0.0 110.083 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.8 7.82 86.28 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 12.0 m -64.15 123.4 18.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.547 HG13 HD22 ' A' ' 37' ' ' LEU . 3.3 t -92.78 122.78 44.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.553 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -117.25 149.42 40.46 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.516 ' CG2' HD21 ' A' ' 65' ' ' LEU . 8.6 p -104.11 143.63 15.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.0 p -91.96 -13.88 30.38 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.547 -0.72 . . . . 0.0 110.852 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.573 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -148.17 160.25 43.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.605 -1.309 . . . . 0.0 109.905 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.573 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -63.21 127.55 31.79 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.596 ' HB2' HE22 ' A' ' 13' ' ' GLN . 34.5 mt -84.68 151.89 24.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.242 -1.536 . . . . 0.0 111.604 -172.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.717 ' HB2' HG23 ' A' ' 69' ' ' VAL . 4.8 m-20 -123.91 131.05 53.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.558 HH11 ' CB ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -72.14 -6.0 39.53 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.017 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -85.44 -19.56 31.12 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -175.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.717 HG23 ' HB2' ' A' ' 66' ' ' ASP . 34.1 t -90.25 -62.96 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.516 HG21 ' CD1' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.49 127.98 23.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 175.669 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.79 -24.63 24.97 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -146.17 121.79 3.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.516 ' CD1' HG21 ' A' ' 70' ' ' ILE . 65.5 m-85 -92.36 119.7 32.17 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -89.76 81.93 6.33 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.468 HD23 HG23 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -80.46 170.2 16.68 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 122.301 1.048 . . . . 0.0 109.974 -177.5 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 90.4 m-85 -135.2 136.68 41.98 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.694 HG11 HG11 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -114.07 147.33 17.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -178.51 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.566 ' HB3' HG23 ' A' ' 86' ' ' THR . 49.0 mt-10 -138.18 141.8 40.05 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.508 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -96.86 131.78 43.27 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 172.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.597 HG21 ' NH1' ' A' ' 36' ' ' ARG . 18.0 p -122.78 162.32 22.31 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.935 -175.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.439 ' HB2' HD11 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -107.97 171.09 7.6 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -47.62 -22.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 O-C-N 121.81 -0.556 . . . . 0.0 111.818 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.48 -17.17 54.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.744 -1.222 . . . . 0.0 109.856 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.91 11.61 57.55 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' THR . 14.2 mttm -90.27 160.54 16.12 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.628 ' C ' HD13 ' A' ' 87' ' ' LEU . 90.3 m -101.2 120.29 40.01 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-O 120.841 0.353 . . . . 0.0 110.085 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.901 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -96.22 -11.23 26.36 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.578 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.473 ' O ' ' CG2' ' A' ' 86' ' ' THR . 11.3 tp10 -152.2 167.54 28.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.59 -168.75 52.73 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -67.03 112.56 1.05 Allowed 'Cis proline' 0 N--CA 1.493 1.463 0 C-N-CA 123.25 -1.563 . . . . 0.0 112.356 0.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 2' ' ' ILE . 5.3 m -83.2 165.28 41.73 Favored Pre-proline 0 C--N 1.284 -2.269 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -94.27 152.54 2.06 Favored 'Trans proline' 0 C--N 1.297 -2.151 0 C-N-CA 121.948 1.766 . . . . 0.0 112.329 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.525 HD13 ' CG2' ' A' ' 4' ' ' VAL . 6.5 tp -141.49 126.68 18.51 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -108.45 116.64 32.34 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 121.354 -0.841 . . . . 0.0 109.173 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.519 HG22 ' HB ' ' A' ' 7' ' ' ILE . 79.1 t -104.15 104.47 16.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 96' ' ' ILE . 3.0 mp -92.52 134.52 30.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 15.0 t -89.73 104.0 14.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 8' ' ' LEU . 15.1 pt -85.46 170.85 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.503 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.422 ' OD2' ' NH2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.284 -2.252 0 O-C-N 120.746 -1.221 . . . . 0.0 109.256 -176.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.217 -0.626 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.765 ' CG2' HG21 ' A' ' 91' ' ' VAL . 2.7 mt -77.69 123.28 34.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-O 121.873 0.844 . . . . 0.0 110.511 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.64 134.17 44.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.821 HG21 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -155.0 154.86 6.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.15 141.71 33.5 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -47.63 132.36 20.62 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 121.34 1.36 . . . . 0.0 108.93 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.568 HG13 HD11 ' A' ' 93' ' ' LEU . 3.0 mt -99.4 112.41 31.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.468 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.896 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -89.5 98.57 11.84 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.49 ' CD1' HG13 ' A' ' 95' ' ' VAL . 12.5 mt -106.42 121.29 45.79 Favored Pre-proline 0 C--N 1.279 -2.493 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -66.07 137.46 48.45 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 120.629 0.886 . . . . 0.0 111.275 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -72.13 179.5 3.29 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.675 -178.137 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.543 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 2.2 m-20 58.69 17.51 5.16 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 172.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.41 ' O ' ' OG1' ' A' ' 64' ' ' THR . 58.3 mt-30 -77.21 129.45 35.95 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 174.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.543 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -97.81 -175.39 3.15 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.095 -1.003 . . . . 0.0 110.884 -173.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 4.3 mt-30 -49.2 160.78 0.49 Allowed Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 0.9 OUTLIER -80.53 148.56 76.89 Favored 'Cis proline' 0 C--N 1.301 -1.935 0 C-N-CA 123.195 -1.585 . . . . 0.0 113.901 -0.145 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -129.13 166.49 24.88 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 16.9 Cg_exo -67.26 169.6 49.78 Favored 'Cis proline' 0 N--CA 1.496 1.647 0 C-N-CA 124.354 -1.103 . . . . 0.0 112.157 -0.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.501 ' NE ' ' O ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -137.04 137.67 39.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.622 -0.674 . . . . 0.0 109.583 178.646 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 12.4 t70 -75.87 140.11 42.03 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.94 5.2 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 162.41 173.89 31.64 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.197 -1.954 . . . . 0.0 109.919 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -136.86 124.88 22.83 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.355 -1.085 . . . . 0.0 109.764 -178.412 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.812 HG11 HG11 ' A' ' 77' ' ' VAL . 8.1 t -82.94 157.7 3.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 t -144.32 169.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.0 t70 -125.73 141.42 52.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.244 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.507 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 154.94 29.12 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' GLU . 65.9 m-85 -86.63 137.51 32.42 Favored 'General case' 0 C--N 1.285 -2.227 0 O-C-N 121.973 -0.455 . . . . 0.0 110.003 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' NH2' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -110.08 130.28 55.56 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 173.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.666 ' HG ' HG21 ' A' ' 42' ' ' VAL . 46.4 tp -111.02 138.01 47.96 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -146.69 171.26 15.41 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.478 ' H ' ' HG3' ' A' ' 44' ' ' GLN . . . 113.32 173.88 18.8 Favored Glycine 0 N--CA 1.51 3.608 0 C-N-CA 120.0 -1.095 . . . . 0.0 110.78 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -62.32 119.46 9.1 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 117.32 -22.81 10.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.666 HG21 ' HG ' ' A' ' 37' ' ' LEU . 21.3 t -115.86 -95.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.602 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -92.55 -6.39 49.72 Favored 'General case' 0 C--O 1.204 -1.327 0 O-C-N 121.22 -0.925 . . . . 0.0 109.171 178.081 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.478 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 20.0 mt-30 -116.8 148.65 41.01 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.627 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 5.2 mm-40 -58.94 140.08 86.84 Favored Pre-proline 0 C--N 1.271 -2.82 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.204 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 37.2 Cg_endo -68.64 116.02 2.29 Favored 'Cis proline' 0 N--CA 1.511 2.507 0 C-N-CA 123.299 -1.542 . . . . 0.0 110.456 -1.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.627 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 7.8 mtpp -73.4 147.1 44.6 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.657 -1.277 . . . . 0.0 111.305 -172.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.38 21.5 78.6 Favored Glycine 0 N--CA 1.497 2.753 0 O-C-N 121.515 -0.741 . . . . 0.0 112.914 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.553 HD12 ' HD2' ' A' ' 63' ' ' ARG . 17.2 mm -86.15 -47.27 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 74.8 m-85 -110.04 138.63 46.15 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.163 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -136.59 142.82 43.35 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 tt -111.45 162.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 19.4 t-20 -97.18 109.89 22.55 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -36.56 -41.89 0.32 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 122.804 0.442 . . . . 0.0 111.784 -177.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -92.86 -48.04 6.74 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.032 -1.043 . . . . 0.0 111.61 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.1 p -79.98 -27.97 39.58 Favored 'General case' 0 C--N 1.281 -2.401 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 2.85 90.35 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 12.3 m -63.06 122.95 17.33 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.67 -0.9 . . . . 0.0 109.278 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 24' ' ' VAL . 1.6 t -94.88 123.49 47.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -126.7 153.35 45.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.211 -0.931 . . . . 0.0 109.792 177.814 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.612 HG22 ' H ' ' A' ' 63' ' ' ARG . 2.5 p -104.68 146.12 12.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.0 p -96.25 -7.39 35.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.667 -0.646 . . . . 0.0 112.061 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.612 ' H ' HG22 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -154.5 172.06 18.4 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.462 -1.399 . . . . 0.0 110.685 -175.601 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.462 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 13.9 t -65.16 137.89 57.91 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.1 mt -98.85 149.76 22.58 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD1' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -126.3 142.36 51.56 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -91.93 9.24 33.84 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.81 -30.53 20.15 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.559 HG23 ' OD1' ' A' ' 66' ' ' ASP . 26.5 t -101.18 -47.08 11.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.22 139.96 47.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.293 -0.879 . . . . 0.0 109.121 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.49 -23.98 15.33 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.8 p -156.12 138.1 6.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.26 -0.9 . . . . 0.0 109.084 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 36.4 m-85 -99.0 128.09 45.06 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -90.79 97.56 11.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.71 170.34 9.65 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 86.2 m-85 -138.88 128.78 25.07 Favored 'General case' 0 C--N 1.268 -2.946 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.812 HG11 HG11 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -110.4 139.52 33.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 O-C-N 122.043 -0.411 . . . . 0.0 110.045 -176.063 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.697 ' HB3' HG23 ' A' ' 86' ' ' THR . 41.2 mt-10 -129.33 137.5 51.03 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.616 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -85.17 134.37 34.17 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 170.229 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 33' ' ' SER . 15.6 p -128.06 151.21 49.45 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -176.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.545 ' N ' HD21 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -116.15 172.2 7.33 Favored 'General case' 0 N--CA 1.508 2.446 0 CA-C-N 118.808 0.731 . . . . 0.0 109.815 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 81' ' ' ASP . 34.8 m -29.3 -40.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.446 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 28.7 t-20 -80.46 -8.6 59.61 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.72 -1.237 . . . . 0.0 110.195 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.61 13.14 78.9 Favored Glycine 0 C--N 1.287 -2.169 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' THR . 5.2 mttp -74.96 160.2 30.87 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 78' ' ' GLU . 16.6 m -96.01 116.53 29.08 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.926 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -96.02 -11.07 27.01 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.205 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.539 ' HG3' HD12 ' A' ' 2' ' ' ILE . 1.1 tp10 -154.54 154.56 33.3 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 78.41 -162.24 49.23 Favored Glycine 0 C--N 1.284 -2.316 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.35 105.58 0.24 Allowed 'Cis proline' 0 N--CA 1.495 1.586 0 C-N-CA 123.305 -1.54 . . . . 0.0 111.458 -0.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 77' ' ' VAL . 20.4 m -73.48 159.09 85.54 Favored Pre-proline 0 C--N 1.286 -2.18 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.37 152.01 3.65 Favored 'Trans proline' 0 C--N 1.283 -2.895 0 C-N-CA 121.359 1.373 . . . . 0.0 111.438 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.821 HD13 HG21 ' A' ' 4' ' ' VAL . 4.2 tp -139.02 128.51 24.41 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.42 ' N ' HD12 ' A' ' 93' ' ' LEU . 9.3 mt-10 -102.41 111.57 23.92 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.636 -0.665 . . . . 0.0 109.525 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 4.9 t -93.43 95.34 5.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 174.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.1 mt -79.96 130.66 35.66 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 t -92.06 122.14 43.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.68 HG21 ' HB3' ' A' ' 8' ' ' LEU . 12.5 pt -112.49 171.52 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.345 -0.847 . . . . 0.0 110.661 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--N 1.296 -1.724 0 O-C-N 121.151 -0.968 . . . . 0.0 108.545 -178.611 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.447 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.72 HG21 HG21 ' A' ' 91' ' ' VAL . 7.3 mt -66.66 122.19 17.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.436 -0.79 . . . . 0.0 109.317 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -104.85 133.77 48.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 174.341 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -148.84 167.59 3.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -176.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.482 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.9 OUTLIER -152.04 146.83 18.95 Favored Pre-proline 0 C--N 1.272 -2.776 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 176.516 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -48.69 131.77 24.79 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.257 1.305 . . . . 0.0 110.157 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.513 ' C ' HD12 ' A' ' 8' ' ' LEU . 29.0 mt -99.79 121.56 50.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.772 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.9 mp -105.98 107.71 18.85 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.532 HD11 HG21 ' A' ' 21' ' ' VAL . 17.1 mt -113.18 140.94 24.88 Favored Pre-proline 0 C--N 1.275 -2.651 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -175.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HB2' ' NE2' ' A' ' 100' ' ' GLN . 60.4 Cg_endo -75.53 134.65 17.19 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.576 1.517 . . . . 0.0 111.272 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.5 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -67.82 -172.68 0.29 Allowed 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.914 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.523 ' OD1' ' C ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER 55.83 -9.22 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 175.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 11' ' ' GLU . 2.1 pt20 -55.66 132.96 50.27 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.4 -179.65 3.98 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.834 -1.166 . . . . 0.0 111.167 -175.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.602 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -54.29 171.76 0.27 Allowed Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.649 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 1.7 Cg_endo -78.71 121.13 7.76 Favored 'Cis proline' 0 N--CA 1.493 1.47 0 C-N-CA 123.793 -1.336 . . . . 0.0 114.012 0.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.518 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 20.4 m-85 -110.62 170.49 5.24 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 13.9 Cg_exo -69.7 167.63 70.15 Favored 'Cis proline' 0 N--CA 1.507 2.323 0 CA-C-N 120.172 1.097 . . . . 0.0 112.798 0.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -148.94 142.16 25.04 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 9.3 t0 -67.77 136.03 53.57 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.532 HG21 HD11 ' A' ' 9' ' ' ILE . 36.0 m -126.84 6.06 3.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.11 -175.0 45.48 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.809 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.579 ' HZ2' ' CB ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -145.17 121.72 11.07 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.925 -1.338 . . . . 0.0 110.36 -178.415 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 59' ' ' VAL . 33.2 t -89.88 131.45 37.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 170.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 3' ' ' VAL . 40.5 t -132.0 149.75 32.99 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -177.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -105.7 138.79 41.31 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.936 -1.105 . . . . 0.0 108.704 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -26.54 63.4 Favored 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.299 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.454 ' OD1' ' NH1' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -147.71 -13.77 0.38 Allowed 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.662 -1.274 . . . . 0.0 112.264 -172.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -55.27 145.76 44.91 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.665 -1.272 . . . . 0.0 111.307 -175.152 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -35.38 133.68 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 124.281 3.321 . . . . 0.0 112.732 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -55.14 -19.89 8.77 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.249 -0.907 . . . . 0.0 109.462 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.592 ' NH2' HG22 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -83.29 -16.27 46.89 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.322 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.0 136.06 57.63 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.857 -174.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 48.6 mttm -115.76 146.66 41.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.902 ' CE1' HG23 ' A' ' 79' ' ' THR . 89.6 m-85 -93.84 144.2 25.64 Favored 'General case' 0 C--N 1.282 -2.359 0 O-C-N 121.233 -0.917 . . . . 0.0 112.84 -172.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.34 150.99 22.43 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.61 ' HG ' HG21 ' A' ' 42' ' ' VAL . 21.0 tp -125.86 140.15 52.9 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 172.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.27 171.11 17.48 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 75' ' ' LEU . . . 117.0 169.85 15.2 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.315 -1.422 . . . . 0.0 111.594 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 45' ' ' GLU . 6.5 mtpp -60.05 111.13 1.39 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 120.21 -18.21 9.63 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.61 HG21 ' HG ' ' A' ' 37' ' ' LEU . 42.7 t -116.68 -97.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.625 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 3.4 t70 -93.52 -8.04 42.53 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 40' ' ' LYS . 35.3 mt-30 -107.02 148.2 29.0 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 174.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 1.5 mp0 -55.85 133.55 73.05 Favored Pre-proline 0 C--N 1.264 -3.152 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 24.8 Cg_endo -70.77 127.54 12.0 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 C-N-CA 123.403 -1.499 . . . . 0.0 110.045 -0.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 15.3 mtpp -82.12 150.41 27.48 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 120.953 -1.092 . . . . 0.0 111.321 -173.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.403 ' O ' ' NH2' ' A' ' 63' ' ' ARG . . . 62.81 38.95 97.35 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.894 -0.504 . . . . 0.0 111.899 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.496 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 5.9 mm -100.27 -48.13 11.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.532 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 88.8 m-85 -114.48 143.02 45.63 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.688 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 133.78 26.19 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.446 ' CG2' ' HB2' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -95.85 150.78 4.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.554 ' OD1' HG23 ' A' ' 56' ' ' THR . 14.5 t-20 -79.82 105.71 11.31 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 35' ' ' PHE . 2.0 mt-10 -42.81 -36.81 1.59 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.454 -175.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -92.76 -43.73 8.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.206 -0.933 . . . . 0.0 111.562 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.554 HG23 ' OD1' ' A' ' 53' ' ' ASN . 4.5 p -85.07 -25.35 27.64 Favored 'General case' 0 C--N 1.282 -2.361 0 O-C-N 121.027 -1.045 . . . . 0.0 108.7 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.06 9.51 86.1 Favored Glycine 0 C--N 1.287 -2.154 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.579 ' CB ' ' HZ2' ' A' ' 23' ' ' LYS . 70.0 m -65.8 120.55 13.23 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.395 -1.062 . . . . 0.0 109.472 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 24' ' ' VAL . 2.0 t -83.99 121.78 36.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.25 148.95 43.59 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.482 -0.761 . . . . 0.0 110.139 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 p -98.41 149.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.576 ' OG1' ' NH1' ' A' ' 63' ' ' ARG . 4.3 p -105.02 -15.52 15.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.481 -0.762 . . . . 0.0 112.002 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.686 HH11 ' HG2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -157.41 -159.33 0.83 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.871 -1.143 . . . . 0.0 108.506 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.468 ' N ' ' HG3' ' A' ' 63' ' ' ARG . 4.8 t -80.8 179.42 7.82 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.168 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 mt -142.21 167.64 21.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -147.76 139.19 23.72 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.558 ' NH1' ' O ' ' A' ' 104' ' ' ARG . 16.7 ttm105 -76.06 -10.72 59.64 Favored 'General case' 0 C--N 1.282 -2.329 0 O-C-N 122.105 -0.372 . . . . 0.0 111.645 -174.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -90.12 -20.08 23.54 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.703 -1.248 . . . . 0.0 108.964 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.04 -53.26 13.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 97' ' ' VAL . 1.1 mt -148.36 134.21 11.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -89.09 -28.29 20.19 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.43 115.08 3.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.506 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 62.3 m-85 -81.78 111.91 18.45 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 174.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.439 ' CD ' ' H ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -92.39 95.53 9.72 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -90.26 170.6 10.14 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 122.25 1.024 . . . . 0.0 108.424 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 85.1 m-85 -134.44 131.96 38.75 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.514 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.26 150.14 14.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -176.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.458 ' HB3' ' CG2' ' A' ' 86' ' ' THR . 2.2 mt-10 -142.12 142.13 32.74 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.902 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -88.72 129.35 35.56 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.617 ' C ' HD21 ' A' ' 87' ' ' LEU . 11.3 p -123.19 150.37 43.44 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.642 ' N ' HD21 ' A' ' 87' ' ' LEU . 26.0 t70 -92.59 170.09 10.01 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.22 -0.992 . . . . 0.0 108.564 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.592 HG22 ' NH2' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -58.54 -14.98 4.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.19 -5.08 53.41 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.98 -4.91 60.12 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -75.19 150.6 38.64 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.332 -1.099 . . . . 0.0 108.615 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -90.55 119.64 30.98 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.958 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.41 -30.62 14.37 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 86' ' ' THR . 1.5 tp10 -135.28 170.13 16.4 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 -179.17 51.72 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.56 127.03 7.7 Favored 'Cis proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.158 -1.601 . . . . 0.0 112.609 0.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.72 HG21 HG21 ' A' ' 2' ' ' ILE . 2.1 m -105.5 161.92 21.3 Favored Pre-proline 0 C--N 1.28 -2.424 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -94.44 151.17 1.96 Allowed 'Trans proline' 0 C--N 1.288 -2.637 0 C-N-CA 122.238 1.959 . . . . 0.0 112.527 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.46 HD13 HG23 ' A' ' 4' ' ' VAL . 10.2 tp -141.79 129.76 21.93 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -110.88 130.18 55.65 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 120.926 -1.109 . . . . 0.0 110.04 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.532 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 46.7 t -111.42 111.66 37.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 174.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.54 142.44 13.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.236 -0.915 . . . . 0.0 109.073 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.498 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 1.5 t -91.91 96.08 5.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.611 HG21 ' HB3' ' A' ' 8' ' ' LEU . 5.7 pt -82.21 172.01 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 O-C-N 120.893 -1.13 . . . . 0.0 110.125 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.417 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 3.1 m-20 -97.59 174.97 6.38 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.512 ' NE2' ' HB2' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -135.75 105.91 6.33 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.438 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 0.4 OUTLIER 53.63 47.08 24.65 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -173.59 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.27 77.89 0.11 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.79 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.454 ' CG ' HD22 ' A' ' 12' ' ' ASN . 4.4 t30 -68.53 -51.8 38.97 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.558 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 1.2 mtp85 -157.69 82.88 2.92 Favored Pre-proline 0 C--N 1.281 -2.377 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo . . . . . 0 C--O 1.192 -1.798 0 C-N-CA 123.411 2.741 . . . . 0.0 113.239 -178.626 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.429 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.4 OUTLIER . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.769 HG21 HG21 ' A' ' 91' ' ' VAL . 11.4 mt -68.77 113.86 4.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.162 -0.961 . . . . 0.0 110.363 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.21 111.2 29.15 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 174.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.625 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.84 164.21 29.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.479 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -142.63 152.29 59.39 Favored Pre-proline 0 C--N 1.275 -2.652 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 175.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.686 ' HB3' HD11 ' A' ' 96' ' ' ILE . 48.9 Cg_exo -49.51 136.67 33.05 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.681 1.588 . . . . 0.0 111.108 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.644 HD11 HG21 ' A' ' 59' ' ' VAL . 21.9 mt -102.55 110.08 28.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.723 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.4 mp -98.83 96.87 8.17 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.519 HD11 HG21 ' A' ' 21' ' ' VAL . 15.6 mt -103.75 133.56 20.2 Favored Pre-proline 0 C--N 1.275 -2.673 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.6 Cg_endo -70.65 120.65 7.26 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.318 1.345 . . . . 0.0 109.683 175.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -43.1 -71.9 0.07 Allowed 'General case' 0 N--CA 1.522 3.155 0 O-C-N 121.241 -0.912 . . . . 0.0 111.943 -174.415 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.513 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 34.2 p30 -62.47 42.92 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.519 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 22.3 mt-30 -77.61 140.77 39.7 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -117.77 177.35 4.8 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.416 -0.803 . . . . 0.0 110.038 -176.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.62 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -49.02 167.88 0.2 Allowed Pre-proline 0 C--N 1.292 -1.895 0 C-N-CA 123.461 0.704 . . . . 0.0 109.882 178.324 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 4.8 Cg_exo -77.16 121.64 8.01 Favored 'Cis proline' 0 C--N 1.311 -1.417 0 C-N-CA 123.714 -1.369 . . . . 0.0 113.158 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.404 ' CE2' HG13 ' A' ' 61' ' ' VAL . 26.4 m-85 -102.76 165.88 12.92 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 175.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.22 154.48 85.23 Favored 'Cis proline' 0 N--CA 1.496 1.638 0 C-N-CA 124.184 -1.174 . . . . 0.0 110.516 -1.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.594 ' NH2' ' O ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -136.56 145.21 44.73 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.205 -0.935 . . . . 0.0 110.136 -178.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.594 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 5.5 t70 -65.87 142.3 57.96 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 9' ' ' ILE . 32.8 m -137.44 1.77 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 170.2 176.35 39.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -146.27 125.74 13.21 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.669 -1.489 . . . . 0.0 110.185 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 4' ' ' VAL . 18.4 t -87.6 143.48 11.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 172.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.6 t -136.73 160.98 36.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.587 ' HB3' ' HG3' ' A' ' 29' ' ' ARG . 10.2 t70 -120.54 137.73 54.23 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.081 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -51.06 -25.46 4.97 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.451 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 39.5 t0 -148.94 89.95 1.72 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.341 -0.85 . . . . 0.0 108.766 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 26' ' ' ASP . 1.0 OUTLIER -77.78 111.44 17.83 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.346 -0.846 . . . . 0.0 108.781 178.019 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.499 ' HG2' ' HG ' ' A' ' 87' ' ' LEU . 62.3 Cg_exo -44.16 146.26 1.9 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.707 1.604 . . . . 0.0 111.621 178.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.2 mp0 -25.0 -56.6 0.05 Allowed 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 124.243 1.017 . . . . 0.0 112.505 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.447 ' HB2' HG12 ' A' ' 82' ' ' VAL . 5.3 mtm180 -118.32 32.74 5.98 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.212 -0.93 . . . . 0.0 108.993 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p -64.35 148.8 49.55 Favored 'General case' 0 C--N 1.286 -2.155 0 O-C-N 121.1 -1.0 . . . . 0.0 110.337 -176.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 54' ' ' GLU . 4.4 mmtp -113.86 169.39 9.03 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 174.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.509 ' CB ' HD13 ' A' ' 52' ' ' ILE . 10.3 m-85 -115.42 126.3 54.2 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HG3' HG21 ' A' ' 80' ' ' THR . 13.8 mmt-85 -98.68 119.11 36.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.725 ' HG ' HG21 ' A' ' 42' ' ' VAL . 42.4 tp -103.73 139.71 38.6 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 176.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.466 HG22 ' CG ' ' A' ' 43' ' ' ASP . 0.2 OUTLIER -152.89 170.29 20.72 Favored 'General case' 0 C--N 1.279 -2.47 0 O-C-N 121.262 -0.899 . . . . 0.0 108.613 -176.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' A' ' 43' ' ' ASP . . . 116.88 169.99 15.3 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.43 ' NZ ' ' HG3' ' A' ' 45' ' ' GLU . 11.1 mtpp -54.82 115.31 2.11 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 120.8 -21.64 8.36 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.725 HG21 ' HG ' ' A' ' 37' ' ' LEU . 34.9 t -119.78 -88.07 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.39 -1.065 . . . . 0.0 109.122 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.476 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 15.8 p-10 -93.14 -14.17 27.54 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -113.9 160.76 18.43 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HG3' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -61.69 133.84 93.67 Favored Pre-proline 0 C--N 1.286 -2.184 0 O-C-N 122.152 -0.343 . . . . 0.0 110.722 -174.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HB2' HD11 ' A' ' 49' ' ' ILE . 3.2 Cg_exo -76.13 123.76 9.68 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.173 -1.595 . . . . 0.0 109.296 -1.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 27.2 mttp -71.01 154.0 42.16 Favored 'General case' 0 C--N 1.282 -2.346 0 O-C-N 120.923 -1.11 . . . . 0.0 110.894 -174.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.19 21.31 53.11 Favored Glycine 0 N--CA 1.489 2.215 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.201 172.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.739 HD12 ' NE ' ' A' ' 63' ' ' ARG . 26.6 mm -73.55 -43.59 54.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.542 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 87.9 m-85 -116.7 141.38 48.28 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.428 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.83 129.16 24.0 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.509 HD13 ' CB ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -96.38 149.84 4.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 O-C-N 121.643 -0.661 . . . . 0.0 110.05 -174.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.451 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 14.1 t-20 -79.76 112.6 17.18 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' OE2' ' NH1' ' A' ' 36' ' ' ARG . 1.4 mt-10 -53.28 -31.11 42.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.847 -0.533 . . . . 0.0 111.541 -176.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.402 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -97.22 -23.39 16.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 112.601 -174.004 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 19.5 p -112.29 -27.5 8.29 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 84.82 5.43 86.38 Favored Glycine 0 C--N 1.283 -2.389 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 t -60.67 125.7 24.69 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 7' ' ' ILE . 2.6 t -86.5 118.76 33.39 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 176.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -110.84 140.65 45.11 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.411 -178.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.492 ' CG2' HD21 ' A' ' 65' ' ' LEU . 7.7 p -99.77 145.17 11.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.4 p -97.51 -14.99 20.77 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.511 -0.743 . . . . 0.0 111.46 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.739 ' NE ' HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -153.03 170.6 20.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.847 -1.158 . . . . 0.0 110.938 -177.189 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 t -66.32 140.25 58.09 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.492 HD21 ' CG2' ' A' ' 61' ' ' VAL . 49.6 mt -92.44 170.04 10.08 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.63 -1.294 . . . . 0.0 111.106 -173.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.454 ' HB2' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -127.18 102.55 6.99 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 67' ' ' ARG . 4.3 ttm105 -66.35 -18.74 65.54 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 1.2 mp0 -76.94 -26.18 53.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.858 -1.151 . . . . 0.0 108.378 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' A' ' 66' ' ' ASP . 6.8 t -97.18 -52.99 8.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.408 HG21 ' CG ' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -125.97 112.15 29.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.563 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.45 -33.66 54.7 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.4 p -149.42 131.89 6.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.532 ' OH ' ' NH2' ' A' ' 63' ' ' ARG . 61.0 m-85 -87.8 120.27 28.95 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -88.48 81.23 7.21 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.19 170.46 16.09 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.128 0.966 . . . . 0.0 109.015 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.9 m-85 -137.13 130.05 30.6 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -113.56 160.52 13.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.277 0.56 . . . . 0.0 110.143 -175.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.761 ' HB3' HG23 ' A' ' 86' ' ' THR . 47.8 mt-10 -147.4 143.01 27.65 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.646 ' N ' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -88.72 123.09 32.82 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 173.012 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.555 HG21 ' HG3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -109.0 153.38 23.68 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-O 121.582 0.706 . . . . 0.0 111.677 -172.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 3.0 t70 -96.48 170.1 9.45 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 174.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.501 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -52.79 -27.16 11.96 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -79.69 2.05 24.14 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.484 -0.76 . . . . 0.0 109.511 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.82 19.41 75.1 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -91.3 154.92 18.91 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.761 HG23 ' HB3' ' A' ' 78' ' ' GLU . 8.2 m -84.13 124.35 31.05 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.854 0.835 . . . . 0.0 111.012 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -86.11 -45.63 11.2 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 175.289 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -142.41 151.53 41.91 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.51 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 105.39 177.34 24.18 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 107.929 -2.068 . . . . 0.0 107.929 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.32 109.97 0.48 Allowed 'Cis proline' 0 N--CA 1.495 1.605 0 CA-C-N 118.949 1.374 . . . . 0.0 113.065 0.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.769 HG21 HG21 ' A' ' 2' ' ' ILE . 2.5 m -91.47 161.44 34.46 Favored Pre-proline 0 C--N 1.281 -2.374 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.99 155.37 3.92 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 C-N-CA 121.762 1.641 . . . . 0.0 111.726 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.63 HD23 HD11 ' A' ' 37' ' ' LEU . 8.8 tp -142.85 125.64 16.03 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -109.38 112.09 24.01 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 121.772 -0.58 . . . . 0.0 110.033 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.542 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 56.7 t -102.39 97.74 5.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.792 ' H ' HD12 ' A' ' 96' ' ' ILE . 2.8 mp -81.13 132.94 30.39 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 O-C-N 121.653 -0.654 . . . . 0.0 109.456 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 31.8 t -88.22 92.67 3.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.649 HG21 ' HB3' ' A' ' 8' ' ' LEU . 4.9 pt -80.35 171.04 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 O-C-N 121.248 -0.908 . . . . 0.0 109.112 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.79 168.09 9.29 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 10' ' ' PRO . 15.9 pt20 -148.4 154.16 39.53 Favored 'General case' 0 C--N 1.273 -2.751 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -74.82 63.47 1.18 Allowed 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 104' ' ' ARG . 57.5 t0 -60.12 165.55 3.34 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 104' ' ' ARG . 3.7 m-20 -68.84 31.55 0.03 OUTLIER 'General case' 0 C--N 1.244 -3.99 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 102' ' ' ASP . 2.9 mtm105 29.58 58.02 0.77 Allowed Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 122.956 0.502 . . . . 0.0 110.7 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 104' ' ' ARG . 6.2 Cg_exo . . . . . 0 N--CA 1.492 1.428 0 C-N-CA 122.993 2.462 . . . . 0.0 111.397 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.484 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.192 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.721 HG21 HG21 ' A' ' 91' ' ' VAL . 4.7 mt -62.57 142.15 17.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 121.449 0.643 . . . . 0.0 109.771 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.38 106.15 15.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.723 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -127.8 158.7 39.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.434 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -124.42 151.05 66.16 Favored Pre-proline 0 C--N 1.281 -2.409 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.18 141.72 94.43 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 121.475 1.45 . . . . 0.0 109.155 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.422 HD13 ' HA3' ' A' ' 22' ' ' GLY . 24.5 mt -107.96 113.04 42.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 O-C-N 121.412 -0.805 . . . . 0.0 109.865 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.886 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.94 94.2 9.54 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 21' ' ' VAL . 23.4 mt -101.25 127.42 31.83 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.8 Cg_endo -70.55 128.11 14.86 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 N-CA-C 109.493 -1.003 . . . . 0.0 109.493 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.551 ' CD ' ' HE ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -59.75 -178.78 0.08 Allowed 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 119.501 -0.879 . . . . 0.0 109.995 -176.541 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.12 14.86 9.66 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.65 -0.657 . . . . 0.0 111.724 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.441 ' O ' ' OG1' ' A' ' 64' ' ' THR . 26.8 mt-30 -67.05 137.06 56.15 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.54 ' N ' ' CD ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -114.4 -178.58 3.4 Favored 'General case' 0 C--N 1.281 -2.376 0 O-C-N 120.881 -1.137 . . . . 0.0 110.676 -175.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.628 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 13.8 mp0 -59.3 169.0 1.39 Allowed Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.628 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 30.5 Cg_endo -70.91 114.84 2.48 Favored 'Cis proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.621 -1.408 . . . . 0.0 114.475 0.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.439 ' N ' ' HA ' ' A' ' 15' ' ' GLN . 13.7 m-85 -102.92 164.33 15.77 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.431 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 30.9 Cg_endo -68.3 156.03 88.49 Favored 'Cis proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.864 -1.307 . . . . 0.0 111.092 -0.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 60' ' ' SER . 1.4 tmt_? -134.26 144.7 48.53 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -70.57 137.73 50.3 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 9' ' ' ILE . 30.6 m -133.93 2.7 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.422 ' HA3' HD13 ' A' ' 7' ' ' ILE . . . 178.57 179.2 48.36 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 17.3 mttp -146.52 133.69 20.49 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.007 -1.29 . . . . 0.0 110.762 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.595 HG11 HG11 ' A' ' 77' ' ' VAL . 20.0 t -108.23 131.0 59.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -133.96 170.05 20.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.751 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 1' ' ' SER . 0.9 OUTLIER -119.68 154.62 33.79 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.8 -1.188 . . . . 0.0 109.184 177.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.453 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 8.2 m -58.33 -48.21 81.28 Favored 'General case' 0 C--N 1.267 -3.011 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.026 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -126.0 56.78 1.4 Allowed 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.265 -0.897 . . . . 0.0 110.591 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.624 ' H ' ' NE ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -44.89 113.77 1.88 Allowed Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.584 -0.698 . . . . 0.0 110.472 -177.541 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.51 ' O ' ' C ' ' A' ' 31' ' ' GLU . 79.0 Cg_exo -43.56 144.82 1.94 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.261 1.974 . . . . 0.0 109.821 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -24.35 -70.84 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.87 0 CA-C-N 118.241 0.473 . . . . 0.0 110.825 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -114.58 63.88 0.67 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.938 177.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.559 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -76.86 157.87 31.16 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.547 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -121.4 138.56 54.22 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.786 ' CE1' HG23 ' A' ' 79' ' ' THR . 36.7 m-85 -93.19 124.34 37.09 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 121.03 -1.044 . . . . 0.0 109.131 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.572 ' NH1' HG21 ' A' ' 80' ' ' THR . 25.4 mtm-85 -99.29 148.07 24.53 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.691 ' O ' HG11 ' A' ' 42' ' ' VAL . 18.1 tp -131.38 128.82 40.39 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -140.47 170.36 15.94 Favored 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.488 ' C ' ' HB2' ' A' ' 44' ' ' GLN . . . 120.87 166.18 12.95 Favored Glycine 0 C--N 1.282 -2.465 0 O-C-N 120.815 -1.178 . . . . 0.0 110.259 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 111.48 0.54 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 124.08 -19.14 7.35 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.691 HG11 ' O ' ' A' ' 37' ' ' LEU . 23.0 t -120.59 -92.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.289 -1.124 . . . . 0.0 108.976 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.489 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 2.0 t0 -94.13 -10.78 32.15 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.516 ' N ' ' OE1' ' A' ' 44' ' ' GLN . 17.4 mp0 -109.33 159.19 17.18 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 45' ' ' GLU . 2.0 pm0 -66.59 132.67 94.16 Favored Pre-proline 0 C--N 1.263 -3.172 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.091 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.441 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -74.12 120.12 6.18 Favored 'Cis proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.39 -1.504 . . . . 0.0 110.759 -0.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 43' ' ' ASP . 8.7 mttm -70.86 154.37 41.89 Favored 'General case' 0 C--N 1.289 -2.057 0 O-C-N 121.106 -0.996 . . . . 0.0 111.023 -175.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.78 30.13 74.15 Favored Glycine 0 N--CA 1.495 2.633 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.467 171.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLY . 9.4 mm -90.6 -45.95 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 119.007 1.404 . . . . 0.0 107.647 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.531 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 69.4 m-85 -114.34 151.91 32.26 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.271 0.558 . . . . 0.0 110.198 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.431 ' HD3' ' CB ' ' A' ' 18' ' ' PRO . 2.7 ptm85 -144.29 137.13 27.02 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 35' ' ' PHE . 13.6 tt -105.44 159.73 5.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.407 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 17.6 t-20 -90.45 132.72 35.49 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HA ' ' H ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -66.15 -31.21 71.92 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.832 -176.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -97.5 -51.88 3.98 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.676 0.75 . . . . 0.0 110.541 -174.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 7.8 p -80.43 -21.39 42.21 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 68.75 14.06 66.99 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.496 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 37.0 m -64.07 120.91 12.95 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.173 -1.192 . . . . 0.0 108.849 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.502 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.3 t -83.95 122.01 37.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -122.03 154.91 36.65 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.645 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.507 ' CG2' HD21 ' A' ' 65' ' ' LEU . 7.4 p -102.05 149.8 6.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 63.5 p -98.29 -16.51 19.35 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.613 -0.68 . . . . 0.0 110.226 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.63 178.49 7.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.416 -0.802 . . . . 0.0 109.973 -174.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 5.7 t -76.62 139.41 40.61 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.507 HD21 ' CG2' ' A' ' 61' ' ' VAL . 53.0 mt -98.96 156.23 17.01 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.393 -0.817 . . . . 0.0 109.516 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -135.67 128.47 31.09 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.551 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 12.9 mtm180 -64.64 -5.84 6.49 Favored 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.19 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.57 -21.61 52.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.105 -0.997 . . . . 0.0 108.516 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.25 -55.79 5.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.403 HD12 ' CE1' ' A' ' 73' ' ' TYR . 1.2 mt -141.84 136.63 30.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 121.416 -0.803 . . . . 0.0 108.935 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.28 -26.25 25.06 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.3 p -156.35 137.8 5.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.463 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 71.8 m-85 -99.25 116.86 32.41 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -85.86 79.6 9.2 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.65 170.78 16.04 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 34.4 m-85 -137.35 141.15 41.81 Favored 'General case' 0 C--N 1.256 -3.457 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.595 HG11 HG11 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -115.37 148.51 18.05 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 O-C-N 121.687 -0.633 . . . . 0.0 109.399 -176.327 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 86' ' ' THR . 0.5 OUTLIER -134.39 135.27 42.51 Favored 'General case' 0 C--N 1.28 -2.455 0 O-C-N 121.195 -0.94 . . . . 0.0 108.859 176.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.786 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -87.51 132.14 34.13 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 174.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.584 ' C ' HD21 ' A' ' 87' ' ' LEU . 17.7 p -127.0 164.26 21.89 Favored 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.986 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 2.1 t70 -97.54 170.22 9.19 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.497 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 0.9 OUTLIER -46.43 -33.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-O 121.457 0.646 . . . . 0.0 109.874 178.848 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -79.53 2.63 21.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.558 -0.714 . . . . 0.0 109.742 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.23 81.39 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 80' ' ' THR . 8.3 mtpp -74.49 150.11 40.0 Favored 'General case' 0 CA--C 1.474 -1.943 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.589 ' C ' HD13 ' A' ' 87' ' ' LEU . 1.2 m -99.6 118.01 35.22 Favored 'General case' 0 C--N 1.272 -2.768 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.132 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.869 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.68 -24.11 17.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.38 158.62 44.21 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.465 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 75.09 -175.19 51.06 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -57.94 108.74 0.2 OUTLIER 'Cis proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.707 -1.372 . . . . 0.0 113.795 0.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.721 HG21 HG21 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -84.85 167.48 26.23 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 172.413 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -94.47 156.43 2.0 Favored 'Trans proline' 0 C--N 1.286 -2.763 0 C-N-CA 121.959 1.773 . . . . 0.0 112.791 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.723 HD13 ' CG2' ' A' ' 4' ' ' VAL . 4.5 tp -142.89 131.28 22.22 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -106.11 109.76 21.8 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.508 -0.745 . . . . 0.0 109.432 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.531 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 89.8 t -98.06 96.67 5.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.58 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.7 mp -79.79 128.29 38.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.26 105.09 15.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.9 pt -93.3 171.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.503 ' OD2' ' NH1' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -95.51 158.63 15.37 Favored 'General case' 0 C--N 1.282 -2.337 0 O-C-N 120.984 -1.072 . . . . 0.0 108.467 -177.508 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' OE1' ' NH1' ' A' ' 14' ' ' ARG . 13.8 mt-30 -74.89 68.63 1.79 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 4.9 p30 -72.0 -71.72 0.26 Allowed 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -96.65 -46.29 6.36 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.144 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.11 23.95 13.34 Favored 'General case' 0 N--CA 1.508 2.451 0 CA-C-O 121.26 0.552 . . . . 0.0 110.046 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.528 ' H ' ' CG ' ' A' ' 102' ' ' ASP . 13.6 mmm180 39.43 71.29 1.19 Allowed Pre-proline 0 N--CA 1.497 1.92 0 CA-C-O 121.374 0.607 . . . . 0.0 110.993 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 0 C--O 1.187 -2.042 0 C-N-CA 123.474 2.783 . . . . 0.0 110.68 178.077 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.459 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 1.023 HG21 HG21 ' A' ' 91' ' ' VAL . 11.2 mt -65.24 131.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 C-N-CA 119.221 -0.991 . . . . 0.0 109.214 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.95 128.64 73.17 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.482 HG23 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -141.45 159.1 22.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -139.59 144.26 38.71 Favored Pre-proline 0 C--N 1.281 -2.37 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.435 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 36.8 Cg_exo -51.08 135.2 44.44 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.446 1.431 . . . . 0.0 109.88 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.421 HD13 ' HA3' ' A' ' 22' ' ' GLY . 22.7 mt -103.67 115.56 45.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.858 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.42 105.59 17.92 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.656 HD11 HG21 ' A' ' 21' ' ' VAL . 34.1 mt -114.02 123.28 33.0 Favored Pre-proline 0 C--N 1.287 -2.115 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 27.2 Cg_endo -66.83 142.8 64.44 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 120.748 0.965 . . . . 0.0 112.434 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -67.16 -178.55 0.82 Allowed 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 122.278 1.037 . . . . 0.0 112.307 -176.284 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.9 m-20 47.25 18.01 0.08 Allowed 'General case' 0 N--CA 1.514 2.762 0 C-N-CA 124.177 0.991 . . . . 0.0 113.341 174.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -76.64 122.84 25.23 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.28 -163.48 1.02 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.354 -0.841 . . . . 0.0 110.428 -175.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.568 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -46.66 165.57 0.19 Allowed Pre-proline 0 N--CA 1.5 2.062 0 CA-C-O 121.377 0.608 . . . . 0.0 111.409 -177.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 55.3 Cg_endo -86.92 120.9 5.78 Favored 'Cis proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.442 -1.483 . . . . 0.0 113.613 0.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 19' ' ' ARG . 27.4 m-85 -115.27 163.61 19.64 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 19.7 Cg_exo -67.07 162.63 74.65 Favored 'Cis proline' 0 N--CA 1.504 2.136 0 C-N-CA 124.553 -1.019 . . . . 0.0 113.077 -0.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -153.1 149.23 27.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.772 -0.58 . . . . 0.0 109.517 -178.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.476 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -71.39 139.68 49.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.656 HG21 HD11 ' A' ' 9' ' ' ILE . 33.5 m -132.75 -3.48 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA3' HD13 ' A' ' 7' ' ' ILE . . . -178.98 170.72 42.63 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 tttm -131.24 121.11 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -1.122 . . . . 0.0 109.906 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.577 HG23 ' CG2' ' A' ' 59' ' ' VAL . 41.9 t -91.85 147.63 5.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 171.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 26' ' ' ASP . 17.6 t -142.41 170.07 12.24 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.602 ' O ' ' NE ' ' A' ' 29' ' ' ARG . 34.5 t0 -143.27 78.18 1.59 Allowed 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -33.31 -46.6 0.18 Allowed 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.035 -172.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.01 66.32 4.97 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.731 0.777 . . . . 0.0 110.152 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.602 ' NE ' ' O ' ' A' ' 26' ' ' ASP . 1.3 mtm180 -77.69 133.15 66.99 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' GLU . 19.1 Cg_exo -59.39 170.46 3.17 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 N-CA-C 108.917 -1.224 . . . . 0.0 108.917 171.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -23.77 -90.54 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.566 ' CZ ' HG11 ' A' ' 82' ' ' VAL . 15.1 mtm180 -109.86 27.56 9.46 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.712 -1.242 . . . . 0.0 110.016 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.45 146.38 16.15 Favored 'General case' 0 C--N 1.283 -2.303 0 O-C-N 121.683 -0.636 . . . . 0.0 111.128 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -127.15 167.37 16.12 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 54' ' ' GLU . 87.9 m-85 -98.41 142.63 29.8 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.944 -1.098 . . . . 0.0 112.123 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.599 ' NH2' ' O ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER -110.05 126.56 54.12 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 172.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.633 ' HG ' HG21 ' A' ' 42' ' ' VAL . 37.5 tp -107.83 142.1 38.41 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 p -151.73 171.58 17.46 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 75' ' ' LEU . . . 121.3 172.73 14.47 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 120.843 -1.161 . . . . 0.0 111.418 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 44' ' ' GLN . 24.9 mtpp -61.19 111.69 1.82 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 121.49 -22.05 7.92 Favored Glycine 0 C--N 1.279 -2.632 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.633 HG21 ' HG ' ' A' ' 37' ' ' LEU . 20.1 t -118.91 -85.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.417 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 6.5 p-10 -101.14 -14.58 17.69 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.458 ' CD ' ' HA2' ' A' ' 39' ' ' GLY . 27.7 mt-30 -104.16 152.75 21.76 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 173.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.542 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 7.2 mm-40 -66.77 139.5 95.83 Favored Pre-proline 0 C--N 1.285 -2.206 0 O-C-N 121.85 -0.531 . . . . 0.0 110.373 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 37.7 Cg_endo -68.94 119.62 3.77 Favored 'Cis proline' 0 N--CA 1.509 2.41 0 C-N-CA 123.592 -1.42 . . . . 0.0 111.327 -1.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.542 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 11.2 mtpp -76.96 162.92 27.19 Favored 'General case' 0 C--N 1.288 -2.104 0 O-C-N 120.768 -1.207 . . . . 0.0 110.696 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.04 19.11 50.19 Favored Glycine 0 N--CA 1.496 2.674 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.939 173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.725 HD12 ' HD2' ' A' ' 63' ' ' ARG . 11.7 mm -83.09 -48.38 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 119.487 1.643 . . . . 0.0 107.591 176.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.74 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 52.1 m-85 -111.88 145.74 38.97 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.275 0.56 . . . . 0.0 110.646 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -148.35 135.49 20.26 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 37' ' ' LEU . 1.9 tt -102.96 157.01 4.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.455 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 11.6 t-20 -80.91 115.13 20.23 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' PHE . 1.7 mp0 -50.5 -40.84 52.46 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 122.061 -0.399 . . . . 0.0 111.496 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -90.43 -44.58 9.53 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.604 -1.31 . . . . 0.0 111.512 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 8.8 p -80.78 -28.48 36.36 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 121.226 -0.921 . . . . 0.0 109.417 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.6 10.49 84.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 m -67.38 123.44 20.39 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.388 -1.066 . . . . 0.0 108.224 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.577 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.1 t -86.58 124.48 40.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -121.09 150.9 40.51 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.622 HG21 HD21 ' A' ' 65' ' ' LEU . 9.8 p -110.49 148.27 14.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.9 p -97.29 -28.12 14.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.495 -0.753 . . . . 0.0 110.926 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.725 ' HD2' HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -135.26 167.54 20.83 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.094 -1.004 . . . . 0.0 110.232 -177.275 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.502 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 13.3 t -57.37 156.5 7.67 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.622 HD21 HG21 ' A' ' 61' ' ' VAL . 21.6 mt -110.88 140.94 44.91 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.951 -1.093 . . . . 0.0 108.683 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 68' ' ' GLU . 2.7 p-10 -131.4 122.97 27.22 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' NH1' ' O ' ' A' ' 97' ' ' VAL . 1.4 mtp85 -75.12 10.05 1.7 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 66' ' ' ASP . 52.1 mt-10 -74.11 -24.19 59.42 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.1 t -126.18 -82.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -91.16 127.67 43.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 121.12 -0.988 . . . . 0.0 108.987 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.59 -25.74 19.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.5 p -152.84 121.03 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.353 -0.842 . . . . 0.0 108.9 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.443 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 79.7 m-85 -80.11 120.66 24.55 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -86.79 94.19 9.47 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.478 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -92.57 170.65 9.57 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.913 0.863 . . . . 0.0 109.198 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.0 m-85 -140.78 131.24 25.3 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.37 146.41 18.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 O-C-N 122.055 -0.403 . . . . 0.0 110.517 -174.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.623 ' HB3' HG23 ' A' ' 86' ' ' THR . 45.3 mt-10 -132.14 141.65 49.21 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 120.939 -1.101 . . . . 0.0 109.143 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.609 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -86.38 135.43 33.51 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 171.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.665 ' C ' HD21 ' A' ' 87' ' ' LEU . 1.1 p -127.14 152.36 47.44 Favored 'General case' 0 C--N 1.286 -2.179 0 O-C-N 121.481 -0.762 . . . . 0.0 111.251 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.581 ' N ' HD21 ' A' ' 87' ' ' LEU . 46.1 p-10 -89.28 171.99 9.37 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.104 0.954 . . . . 0.0 109.614 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.566 HG11 ' CZ ' ' A' ' 32' ' ' ARG . 4.1 m -54.02 -9.59 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.101 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -100.57 -34.96 9.69 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.122 . . . . 0.0 108.423 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' NH2' ' A' ' 36' ' ' ARG . . . 118.57 23.44 3.41 Favored Glycine 0 C--N 1.287 -2.156 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -95.6 141.09 29.52 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.623 HG23 ' HB3' ' A' ' 78' ' ' GLU . 89.0 m -79.96 119.56 22.98 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.442 -0.786 . . . . 0.0 110.611 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.905 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -89.02 -25.72 21.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.96 -1.087 . . . . 0.0 108.393 176.287 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.409 ' OE2' ' N ' ' A' ' 2' ' ' ILE . 26.5 tt0 -151.88 160.02 43.66 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.522 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 94.64 -173.85 32.72 Favored Glycine 0 C--N 1.289 -2.046 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.82 105.91 0.43 Allowed 'Cis proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.162 -1.599 . . . . 0.0 111.595 -0.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.023 HG21 HG21 ' A' ' 2' ' ' ILE . 5.0 m -73.93 164.47 60.92 Favored Pre-proline 0 C--N 1.286 -2.161 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -92.44 153.71 3.01 Favored 'Trans proline' 0 C--N 1.286 -2.736 0 C-N-CA 121.315 1.343 . . . . 0.0 112.064 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.482 HD13 HG23 ' A' ' 4' ' ' VAL . 11.5 tp -142.12 128.64 20.19 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -108.69 108.45 19.3 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.649 -0.657 . . . . 0.0 109.335 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.74 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 84.7 t -96.72 99.56 9.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 176.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 2.4 mp -80.95 132.02 32.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.572 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 19.8 t -89.09 111.47 22.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.576 HG21 ' HB3' ' A' ' 8' ' ' LEU . 13.6 pt -97.08 170.96 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.452 -0.78 . . . . 0.0 109.394 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 101' ' ' ASN . 7.0 m-20 -84.21 -167.46 1.77 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.148 -0.97 . . . . 0.0 108.459 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.473 ' O ' ' NH1' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -62.85 70.05 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.765 0.793 . . . . 0.0 110.895 -176.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.615 ' O ' ' N ' ' A' ' 103' ' ' ASN . 0.5 OUTLIER -52.1 -46.0 65.1 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER 42.02 -6.63 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.876 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 176.856 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 101' ' ' ASN . 54.8 t30 67.74 1.91 2.82 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.686 -1.258 . . . . 0.0 109.896 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.473 ' NH1' ' O ' ' A' ' 100' ' ' GLN . 3.9 mpt_? 61.07 162.27 0.11 Allowed Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo . . . . . 0 C--O 1.19 -1.906 0 C-N-CA 122.186 1.924 . . . . 0.0 111.751 -177.257 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.463 ' HG ' ' CB ' ' A' ' 27' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.407 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.84 HG21 HG21 ' A' ' 91' ' ' VAL . 7.2 mt -79.49 122.27 34.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -104.59 142.6 17.62 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.664 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.415 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -150.05 160.43 4.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.415 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -132.24 130.77 22.08 Favored Pre-proline 0 C--N 1.276 -2.592 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.612 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HB3' HD11 ' A' ' 96' ' ' ILE . 54.0 Cg_exo -41.15 129.14 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.213 1.942 . . . . 0.0 110.189 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.419 HG22 HG12 ' A' ' 9' ' ' ILE . 28.8 mt -95.79 109.41 22.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.509 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.05 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.933 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -90.41 107.08 18.92 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 7' ' ' ILE . 15.9 mt -107.22 125.19 33.05 Favored Pre-proline 0 C--N 1.286 -2.191 0 O-C-N 121.433 -0.792 . . . . 0.0 109.11 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.3 Cg_endo -64.96 120.11 7.29 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.125 1.216 . . . . 0.0 109.43 175.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.483 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -70.8 -171.97 0.59 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.532 0.682 . . . . 0.0 110.767 -174.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 59.99 -2.9 0.13 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -56.96 137.82 54.95 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.41 175.43 5.51 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 121.272 -0.892 . . . . 0.0 110.707 -174.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -49.68 166.56 0.26 Allowed Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 123.045 0.538 . . . . 0.0 109.935 178.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.583 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 1.9 Cg_endo -78.71 143.22 71.28 Favored 'Cis proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.18 -1.592 . . . . 0.0 112.926 -0.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.501 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 30.0 m-85 -115.41 160.98 32.3 Favored Pre-proline 0 C--N 1.275 -2.663 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 3.9 Cg_endo -70.94 160.64 91.22 Favored 'Cis proline' 0 N--CA 1.487 1.142 0 C-N-CA 124.04 -1.233 . . . . 0.0 112.877 0.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 16' ' ' PRO . 4.9 mtp85 -131.14 136.33 48.25 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -66.84 137.57 56.69 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.03 5.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.53 177.42 37.15 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 117.707 -2.187 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.564 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 16.1 tttm -139.2 123.21 17.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.118 -1.225 . . . . 0.0 110.955 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.564 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 14.3 t -82.0 155.99 4.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 172.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 3' ' ' VAL . 22.0 t -144.89 148.4 17.98 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.941 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.486 ' HB2' HG21 ' A' ' 79' ' ' THR . 11.4 t0 -112.79 131.69 55.58 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.463 ' CB ' ' HG ' ' A' ' 1' ' ' SER . 0.1 OUTLIER -59.25 -18.97 41.84 Favored 'General case' 0 C--N 1.286 -2.152 0 O-C-N 121.748 -0.595 . . . . 0.0 110.121 -178.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -143.99 83.19 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.565 -0.71 . . . . 0.0 109.381 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 3.4 mtp85 -85.9 115.1 60.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.416 -0.803 . . . . 0.0 109.76 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.479 ' HG2' ' HG ' ' A' ' 87' ' ' LEU . 69.9 Cg_exo -49.04 132.76 28.03 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 121.39 1.394 . . . . 0.0 109.541 174.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -29.52 -45.62 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -176.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mtm180 -113.19 20.84 15.88 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.98 -1.075 . . . . 0.0 110.418 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.479 ' O ' ' NZ ' ' A' ' 34' ' ' LYS . 2.6 p -62.47 173.11 1.31 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.819 -1.176 . . . . 0.0 111.166 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 33' ' ' SER . 5.3 mmtm -137.74 170.99 15.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HB3' HD13 ' A' ' 52' ' ' ILE . 14.5 m-85 -117.58 121.28 40.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.406 -0.809 . . . . 0.0 109.14 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.478 ' HG3' ' CG2' ' A' ' 80' ' ' THR . 0.0 OUTLIER -100.96 144.28 30.09 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 173.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.9 tp -127.94 142.55 51.22 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.46 171.38 16.17 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 124.86 166.42 12.38 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.318 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.58 119.05 4.72 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 109.39 -24.81 19.53 Favored Glycine 0 C--N 1.281 -2.491 0 N-CA-C 107.661 -2.175 . . . . 0.0 107.661 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -105.89 -100.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.553 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -90.25 -0.51 57.65 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.393 -0.817 . . . . 0.0 109.351 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -123.36 157.66 32.82 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.997 178.062 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -47.94 127.21 11.52 Favored Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.847 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.443 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 4.4 Cg_exo -76.38 113.16 2.71 Favored 'Cis proline' 0 C--O 1.203 -1.25 0 C-N-CA 123.694 -1.378 . . . . 0.0 109.188 -1.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.553 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 11.4 mtpp -64.9 139.98 58.82 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 121.024 -1.048 . . . . 0.0 111.438 -173.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.67 35.68 35.46 Favored Glycine 0 N--CA 1.502 3.076 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.104 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 41' ' ' GLY . 5.1 mm -104.33 -46.12 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 118.717 1.259 . . . . 0.0 107.944 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.468 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 67.1 m-85 -114.11 137.76 51.31 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.65 0.738 . . . . 0.0 110.318 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.24 143.33 31.69 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 35' ' ' PHE . 8.3 tt -106.58 166.39 3.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.475 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 9.8 t-20 -86.95 120.49 28.27 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.27 -13.98 2.52 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.543 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 52.7 m-80 -119.93 -46.83 2.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.844 -1.16 . . . . 0.0 111.382 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 22.0 p -79.39 -40.99 28.74 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.742 0.782 . . . . 0.0 108.991 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.42 6.15 56.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 6.6 m -61.77 125.58 24.31 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.4 -1.059 . . . . 0.0 108.169 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.484 HG22 HG23 ' A' ' 24' ' ' VAL . 2.1 t -93.56 129.48 43.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.4 155.78 44.19 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.541 -0.724 . . . . 0.0 109.174 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.525 HG22 ' H ' ' A' ' 63' ' ' ARG . 8.5 p -106.81 139.87 26.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -94.34 6.28 49.19 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.479 -0.763 . . . . 0.0 112.796 -176.064 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.669 ' NH1' ' O ' ' A' ' 64' ' ' THR . 15.6 ptt85 -156.18 172.38 18.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.441 -1.412 . . . . 0.0 110.759 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.669 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 5.9 t -65.42 138.17 57.95 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 47.3 mt -96.28 163.89 12.89 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.943 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.567 ' CG ' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -152.07 121.73 6.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.415 ' HG2' ' HB ' ' A' ' 97' ' ' VAL . 24.0 mtm-85 -67.1 1.99 1.75 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.411 -0.806 . . . . 0.0 109.352 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -71.73 -22.01 61.68 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -101.34 -70.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.9 mt -130.49 145.86 34.93 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.53 -23.53 15.98 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.4 p -151.38 139.13 13.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.67 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -110.88 143.87 40.81 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.16 95.6 5.69 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.5 OUTLIER -88.58 170.33 10.94 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.302 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 68.6 m-85 -129.93 121.19 26.13 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.606 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -107.38 152.86 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 120.93 0.395 . . . . 0.0 110.106 -176.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.761 ' HB3' HG23 ' A' ' 86' ' ' THR . 48.0 mt-10 -138.88 140.39 38.4 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.701 -0.625 . . . . 0.0 109.401 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.573 ' N ' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -91.07 124.65 35.46 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 172.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -110.0 158.82 17.86 Favored 'General case' 0 C--N 1.268 -2.936 0 CA-C-O 121.817 0.818 . . . . 0.0 111.523 -171.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.616 ' HB2' HD21 ' A' ' 87' ' ' LEU . 14.2 t0 -99.58 169.38 9.33 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 175.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 2.4 m -59.33 -19.86 17.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.981 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.61 -1.28 41.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.42 24.76 74.39 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 80' ' ' THR . 6.5 pttp -107.5 159.46 16.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.645 -0.915 . . . . 0.0 108.843 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.761 HG23 ' HB3' ' A' ' 78' ' ' GLU . 4.2 m -83.23 120.83 26.31 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.358 0.599 . . . . 0.0 112.415 -174.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.616 HD21 ' HB2' ' A' ' 81' ' ' ASP . 1.2 mm? -79.81 -46.91 16.07 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 1' ' ' SER . 0.5 OUTLIER -142.71 155.05 44.83 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.24 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.596 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 105.08 177.7 24.4 Favored Glycine 0 C--N 1.291 -1.928 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 36.1 Cg_endo -68.34 102.59 0.29 Allowed 'Cis proline' 0 N--CA 1.5 1.888 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.403 0.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.84 HG21 HG21 ' A' ' 2' ' ' ILE . 6.8 m -79.17 160.41 70.92 Favored Pre-proline 0 C--N 1.29 -1.989 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -94.03 148.2 2.05 Favored 'Trans proline' 0 C--N 1.284 -2.838 0 C-N-CA 121.673 1.582 . . . . 0.0 111.775 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 94' ' ' GLU . 3.9 tp -131.57 128.4 39.14 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.467 ' N ' HD12 ' A' ' 93' ' ' LEU . 23.3 mt-10 -102.64 119.74 39.35 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 97.7 t -109.18 111.05 34.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.634 HD13 ' CD1' ' A' ' 8' ' ' LEU . 5.2 mp -94.82 134.41 32.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.483 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 21.4 t -91.22 119.57 38.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.565 HG21 ' HB3' ' A' ' 8' ' ' LEU . 12.2 pt -119.17 171.33 7.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -90.61 -176.1 4.63 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -52.85 136.25 34.47 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 103' ' ' ASN . 4.5 p-10 -74.87 -145.72 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 101' ' ' ASN . 1.5 m-20 -63.21 4.05 0.23 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.36 -1.463 . . . . 0.0 109.113 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 101' ' ' ASN . 0.9 OUTLIER 72.68 13.59 5.21 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -173.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.486 ' NE ' ' O ' ' A' ' 103' ' ' ASN . 5.1 mmp_? -124.27 81.85 58.0 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 C--O 1.195 -1.646 0 C-N-CA 122.771 2.314 . . . . 0.0 111.596 -174.013 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.492 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.949 HG21 HG21 ' A' ' 91' ' ' VAL . 10.0 mt -78.38 139.99 17.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.071 -1.018 . . . . 0.0 111.168 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -122.83 123.84 69.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 172.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.517 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -126.47 162.93 29.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 O-C-N 121.15 -0.969 . . . . 0.0 110.003 -175.023 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.457 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -142.95 133.76 12.51 Favored Pre-proline 0 C--N 1.289 -2.054 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.131 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -47.35 152.72 2.19 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.497 2.131 . . . . 0.0 111.517 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.433 HG13 HD11 ' A' ' 93' ' ' LEU . 4.4 mt -115.66 114.34 45.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.884 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -89.35 108.39 19.61 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.287 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.463 ' C ' HG12 ' A' ' 98' ' ' ILE . 12.7 mt -118.0 130.05 24.97 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 28.1 Cg_endo -67.53 132.06 26.19 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.143 1.228 . . . . 0.0 111.514 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.63 ' CD ' HH21 ' A' ' 67' ' ' ARG . 21.0 pt-20 -54.86 164.75 0.74 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.437 -0.79 . . . . 0.0 109.495 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 60.48 29.64 19.16 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.774 -0.579 . . . . 0.0 111.453 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.421 ' O ' ' OG1' ' A' ' 64' ' ' THR . 2.8 mt-30 -60.47 140.48 57.25 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.583 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 48.7 mtm-85 -114.62 169.09 9.32 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.008 -1.057 . . . . 0.0 111.685 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.614 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 90.8 mt-30 -49.71 169.55 0.18 Allowed Pre-proline 0 C--N 1.297 -1.687 0 C-N-CA 123.387 0.675 . . . . 0.0 109.529 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 5.9 Cg_exo -76.32 125.45 11.72 Favored 'Cis proline' 0 N--CA 1.49 1.291 0 C-N-CA 123.978 -1.259 . . . . 0.0 113.268 -0.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.533 ' CE1' ' HD3' ' A' ' 19' ' ' ARG . 35.3 m-85 -100.26 159.3 30.14 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 15.4 Cg_exo -68.42 149.27 84.81 Favored 'Cis proline' 0 N--CA 1.505 2.167 0 C-N-CA 124.594 -1.003 . . . . 0.0 112.629 -0.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 13.9 mtp180 -118.89 122.77 43.07 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.458 -0.776 . . . . 0.0 110.081 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 1.7 t70 -66.22 135.03 53.91 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.1 0.16 2.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.778 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.54 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 172.14 174.32 39.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.645 ' CE ' HG22 ' A' ' 25' ' ' VAL . 3.5 tttp -134.91 126.66 29.12 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 121.305 -1.115 . . . . 0.0 109.587 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.585 HG23 ' CG2' ' A' ' 59' ' ' VAL . 62.0 t -89.06 153.12 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.645 HG22 ' CE ' ' A' ' 23' ' ' LYS . 2.7 t -137.16 170.19 18.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 118.212 -1.395 . . . . 0.0 109.433 -174.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 1' ' ' SER . 16.3 t0 -143.9 123.37 13.16 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.32 -63.1 1.36 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 109.377 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -75.82 64.81 1.85 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.596 ' NE ' ' OG ' ' A' ' 33' ' ' SER . 9.5 mtp180 -64.94 160.79 52.78 Favored Pre-proline 0 C--N 1.282 -2.358 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.11 -174.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.629 ' HG2' HD23 ' A' ' 87' ' ' LEU . 31.2 Cg_exo -65.04 -141.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 123.134 2.556 . . . . 0.0 108.291 165.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.599 ' HB2' ' NH1' ' A' ' 32' ' ' ARG . 33.3 mt-10 -89.08 -84.74 0.21 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.238 -1.538 . . . . 0.0 107.613 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.599 ' NH1' ' HB2' ' A' ' 31' ' ' GLU . 2.6 mtt85 -90.94 79.55 5.87 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.596 ' OG ' ' NE ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -60.32 102.79 0.19 Allowed 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 121.4 0.619 . . . . 0.0 111.579 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -100.07 126.74 46.33 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.749 ' HB3' HD13 ' A' ' 52' ' ' ILE . 61.8 m-85 -86.65 130.12 34.61 Favored 'General case' 0 C--N 1.28 -2.439 0 O-C-N 121.563 -0.711 . . . . 0.0 110.059 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HG3' HG21 ' A' ' 80' ' ' THR . 0.3 OUTLIER -103.7 135.58 45.0 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.378 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 20.2 tp -114.57 145.94 41.35 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.515 HG23 ' NH2' ' A' ' 36' ' ' ARG . 1.2 p -148.01 170.98 16.56 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.14 171.86 16.94 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 120.043 -1.075 . . . . 0.0 111.463 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -60.78 117.44 5.39 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 117.44 -24.44 9.15 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -175.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.487 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 15.2 t -126.51 -104.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.02 -22.75 66.46 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.223 -0.923 . . . . 0.0 110.22 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -116.73 159.35 22.4 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.615 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 6.6 mm-40 -74.46 150.15 86.86 Favored Pre-proline 0 C--N 1.287 -2.115 0 O-C-N 121.971 -0.456 . . . . 0.0 110.336 -177.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 31.2 Cg_endo -67.13 115.91 1.8 Allowed 'Cis proline' 0 N--CA 1.511 2.554 0 C-N-CA 123.835 -1.319 . . . . 0.0 110.631 -0.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.615 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 2.1 mtpm? -78.22 165.75 23.53 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.657 -1.277 . . . . 0.0 110.946 -173.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.19 31.47 69.09 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.6 mm -105.69 -45.29 8.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 118.645 1.222 . . . . 0.0 107.936 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.621 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 97.0 m-85 -124.42 156.25 37.47 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.611 0.72 . . . . 0.0 110.633 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -156.78 150.96 25.11 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.749 HD13 ' HB3' ' A' ' 35' ' ' PHE . 15.1 tt -108.81 157.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 118.61 -1.236 . . . . 0.0 108.962 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 10.2 t-20 -83.34 119.38 24.53 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -75.56 10.72 1.56 Allowed 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 120.865 0.364 . . . . 0.0 111.496 -175.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 19.5 t-20 -124.14 -43.18 2.1 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.837 -1.165 . . . . 0.0 109.276 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.417 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 43.7 p -95.74 -38.6 10.26 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.59 6.06 55.07 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.0 m -66.54 124.56 23.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.568 -0.96 . . . . 0.0 109.512 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.585 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.7 t -87.61 124.62 41.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -124.17 155.66 38.08 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.325 -0.859 . . . . 0.0 109.641 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.427 HG13 ' CE1' ' A' ' 17' ' ' PHE . 7.4 p -102.17 137.55 29.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.2 -12.99 39.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.454 -0.779 . . . . 0.0 111.548 -174.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.559 ' NE ' ' O ' ' A' ' 64' ' ' THR . 2.0 ptm180 -153.08 -176.4 5.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.841 -1.162 . . . . 0.0 110.208 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.559 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 12.6 t -70.51 156.06 39.9 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.686 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -113.09 123.01 49.28 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 109.407 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -109.07 113.77 26.92 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.63 HH21 ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -58.65 -7.29 0.92 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.518 0.675 . . . . 0.0 109.229 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -70.67 -19.79 62.76 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 66' ' ' ASP . 2.3 t -101.7 -58.57 3.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 mt -136.21 134.85 50.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.63 -28.13 24.97 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.3 p -152.79 128.0 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.508 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 29.7 m-85 -91.21 125.44 35.99 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -90.68 85.08 5.97 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 170.45 13.39 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 70.3 m-85 -135.96 133.99 38.16 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.744 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -111.24 155.56 12.61 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 O-C-N 121.826 -0.546 . . . . 0.0 109.595 -176.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.41 ' C ' HD11 ' A' ' 2' ' ' ILE . 2.1 mt-10 -144.76 147.85 33.42 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.702 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -94.21 133.64 37.51 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.555 HG21 ' HG3' ' A' ' 36' ' ' ARG . 17.1 p -128.14 153.93 46.32 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' OD1' ' NH1' ' A' ' 32' ' ' ARG . 1.2 t70 -109.69 170.7 7.9 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 32' ' ' ARG . 29.7 m -56.99 -3.67 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 O-C-N 121.306 -0.871 . . . . 0.0 111.003 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -79.71 -19.68 48.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.34 28.96 31.75 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -116.34 168.21 10.34 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 88' ' ' GLU . 1.3 m -109.8 118.87 37.66 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.453 -0.78 . . . . 0.0 110.015 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.91 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.6 -20.31 21.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 86' ' ' THR . 12.7 tt0 -157.2 164.08 38.13 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.46 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 114.92 166.5 15.21 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 107.045 -2.422 . . . . 0.0 107.045 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -82.63 107.2 1.02 Allowed 'Cis proline' 0 C--N 1.3 -2.003 0 C-N-CA 123.127 -1.614 . . . . 0.0 110.801 0.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.949 HG21 HG21 ' A' ' 2' ' ' ILE . 18.9 m -78.58 159.46 74.37 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 105.682 -1.969 . . . . 0.0 105.682 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -91.5 148.18 3.47 Favored 'Trans proline' 0 C--N 1.285 -2.77 0 C-N-CA 121.419 1.412 . . . . 0.0 112.675 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.487 HD21 HG11 ' A' ' 59' ' ' VAL . 11.2 tp -138.65 113.28 9.0 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -95.47 113.79 25.48 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.621 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 15.8 t -95.28 107.76 19.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 176.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.407 HD13 ' CD1' ' A' ' 8' ' ' LEU . 2.4 mp -90.89 127.7 43.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.6 t -84.62 104.86 13.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 7.4 pt -94.67 172.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 O-C-N 121.517 -0.739 . . . . 0.0 109.365 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.582 ' HB3' ' CB ' ' A' ' 103' ' ' ASN . 1.1 m-20 -82.72 179.88 7.64 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -65.02 83.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 21.2 t-20 64.25 -139.98 0.28 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 101' ' ' ASN . 0.4 OUTLIER -64.7 -30.35 71.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.683 -1.261 . . . . 0.0 108.451 179.521 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.582 ' CB ' ' HB3' ' A' ' 99' ' ' ASP . 60.9 t30 51.42 37.1 18.28 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.824 0.821 . . . . 0.0 109.636 -177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.418 HH12 ' CG ' ' A' ' 102' ' ' ASP . 9.9 mtm-85 -116.89 79.55 10.26 Favored Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo . . . . . 0 C--N 1.312 -1.39 0 C-N-CA 122.498 2.132 . . . . 0.0 112.04 -178.4 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 1.02 HG21 HG21 ' A' ' 91' ' ' VAL . 11.7 mt -59.01 120.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.187 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.0 113.94 45.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.496 HG23 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -136.74 158.96 37.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.641 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.413 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -148.69 139.73 13.79 Favored Pre-proline 0 C--N 1.273 -2.73 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -41.48 132.65 3.58 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.216 1.944 . . . . 0.0 111.451 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.52 HG13 HD11 ' A' ' 93' ' ' LEU . 34.7 mt -98.42 110.91 26.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.881 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -87.71 108.44 19.11 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 21' ' ' VAL . 20.5 mt -117.09 136.1 23.25 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 30.0 Cg_endo -70.54 132.37 21.95 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.299 1.333 . . . . 0.0 110.968 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.548 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 13.1 pt-20 -63.78 176.75 0.85 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.018 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.549 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 20.4 t-20 58.56 23.51 10.94 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.587 -0.696 . . . . 0.0 111.757 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 10' ' ' PRO . 2.8 mt-30 -70.22 115.79 9.82 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.549 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -89.57 176.1 7.02 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 120.928 -1.108 . . . . 0.0 109.932 -177.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.573 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 11.6 mm-40 -42.92 167.62 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 C-N-CA 124.063 0.945 . . . . 0.0 110.61 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 2.2 Cg_endo -82.7 146.34 60.09 Favored 'Cis proline' 0 N--CA 1.495 1.567 0 C-N-CA 124.186 -1.172 . . . . 0.0 114.027 -0.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.487 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 42.3 m-85 -133.62 160.35 68.94 Favored Pre-proline 0 C--N 1.282 -2.369 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 18.4 Cg_exo -66.46 163.49 69.81 Favored 'Cis proline' 0 N--CA 1.499 1.807 0 C-N-CA 124.079 -1.217 . . . . 0.0 112.162 -0.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 16' ' ' PRO . 9.9 ttm180 -146.13 143.55 29.4 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.667 -0.646 . . . . 0.0 109.455 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 9.0 t0 -74.73 137.51 42.12 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.638 HG21 HD11 ' A' ' 9' ' ' ILE . 35.0 m -132.64 6.03 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 174.82 179.47 45.42 Favored Glycine 0 N--CA 1.506 3.322 0 C-N-CA 118.896 -1.621 . . . . 0.0 109.702 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.7 ttpm? -145.37 122.98 11.78 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.787 -1.419 . . . . 0.0 110.118 -177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.567 HG11 HG11 ' A' ' 77' ' ' VAL . 45.4 t -93.49 143.57 11.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 171.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' HE2' ' A' ' 23' ' ' LYS . 11.9 t -139.18 170.08 16.45 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 1' ' ' SER . 10.1 t0 -132.67 120.5 21.81 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.419 ' HG ' ' H3 ' ' A' ' 1' ' ' SER . 0.2 OUTLIER -73.79 2.62 7.96 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.823 -176.277 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.45 ' C ' ' HD3' ' A' ' 29' ' ' ARG . 11.6 m-20 -142.46 0.25 1.29 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.507 -1.371 . . . . 0.0 111.758 -174.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.658 ' N ' ' HD3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -97.76 150.16 36.48 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 120.554 -1.341 . . . . 0.0 111.729 -171.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -37.63 142.4 0.2 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 123.99 3.127 . . . . 0.0 112.88 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -19.33 28.11 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.448 ' O ' ' NZ ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -101.39 5.23 42.07 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.909 -0.494 . . . . 0.0 110.0 -177.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.63 147.9 50.33 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.505 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 32' ' ' ARG . 4.1 mttm -113.66 123.96 51.16 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.911 ' CE2' HG23 ' A' ' 79' ' ' THR . 53.0 m-85 -83.33 139.42 33.05 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 120.967 -1.083 . . . . 0.0 109.695 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.569 HH22 ' CD ' ' A' ' 54' ' ' GLU . 41.2 mmt-85 -120.38 155.61 33.06 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.47 HD11 HD23 ' A' ' 93' ' ' LEU . 16.1 tp -133.27 142.07 48.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -147.97 171.52 15.66 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.72 179.4 16.91 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.531 -1.355 . . . . 0.0 111.154 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -63.13 106.98 0.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 129.64 -18.13 5.45 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -130.46 -90.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.988 -0.713 . . . . 0.0 109.324 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -20.03 32.52 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 120.923 -1.111 . . . . 0.0 108.777 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -112.35 161.26 16.85 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.365 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 6.5 mt-10 -69.33 143.41 93.5 Favored Pre-proline 0 C--N 1.281 -2.401 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.573 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.489 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 40.8 Cg_endo -72.87 123.65 8.56 Favored 'Cis proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.179 -1.592 . . . . 0.0 110.271 -2.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.425 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 2.3 mtpm? -80.35 166.06 21.67 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 120.716 -1.24 . . . . 0.0 109.674 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.09 34.02 75.27 Favored Glycine 0 C--N 1.284 -2.355 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.471 HD13 ' NE ' ' A' ' 63' ' ' ARG . 4.5 mm -110.85 -50.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.008 -1.29 . . . . 0.0 108.4 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.654 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 97.3 m-85 -121.59 161.12 22.96 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.405 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.66 ' HG2' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -160.07 134.26 7.4 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 35' ' ' PHE . 19.3 tt -100.13 167.23 2.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 O-C-N 120.793 -1.192 . . . . 0.0 109.04 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.417 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 7.1 t-20 -100.59 122.86 43.98 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.569 ' CD ' HH22 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -49.1 -49.75 40.32 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.965 -0.46 . . . . 0.0 112.005 -176.445 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -90.08 -40.78 12.07 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 111.936 -173.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 9.3 p -84.14 -22.79 30.92 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.0 9.19 62.72 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.0 m -64.4 123.72 19.93 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.263 -1.139 . . . . 0.0 108.714 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.473 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.3 t -83.15 120.75 35.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -116.88 153.85 31.8 Favored 'General case' 0 C--N 1.282 -2.344 0 O-C-N 121.577 -0.702 . . . . 0.0 109.97 -177.296 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.472 HG23 HD21 ' A' ' 65' ' ' LEU . 7.2 p -105.67 140.83 22.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.66 HG23 ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -93.06 -15.17 26.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.795 . . . . 0.0 111.209 -176.441 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.471 ' NE ' HD13 ' A' ' 49' ' ' ILE . 6.0 ptp180 -154.34 -167.64 2.69 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.747 -1.22 . . . . 0.0 110.004 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 1.7 t -74.78 148.57 40.25 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' ASN . 67.0 mt -106.63 129.95 54.46 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.18 126.77 55.43 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.413 HH12 ' CG ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -67.62 -9.58 44.38 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.19 -28.57 62.27 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.32 -52.9 10.6 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.425 ' O ' HG21 ' A' ' 97' ' ' VAL . 1.1 mt -148.43 136.76 14.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.12 -22.37 27.13 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -155.33 123.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.503 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 65.0 m-85 -88.21 121.65 30.85 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.915 -1.115 . . . . 0.0 108.509 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -90.2 98.47 11.79 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.63 170.42 9.35 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.2 m-85 -135.46 124.27 23.96 Favored 'General case' 0 C--N 1.262 -3.198 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -104.88 152.18 6.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.084 0.469 . . . . 0.0 110.293 -174.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' HB3' HG23 ' A' ' 86' ' ' THR . 42.7 mt-10 -139.71 140.12 36.73 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.911 HG23 ' CE2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -93.26 130.91 38.81 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 170.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.517 ' C ' HD21 ' A' ' 87' ' ' LEU . 70.5 p -124.5 164.82 18.95 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.744 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.476 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 25.5 t70 -88.23 167.66 13.39 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.2 m -53.65 -27.07 14.58 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.685 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -79.87 -11.18 59.83 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.582 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.8 56.98 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -76.46 146.97 38.2 Favored 'General case' 0 C--O 1.194 -1.824 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 175.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 78' ' ' GLU . 85.2 m -93.4 115.17 27.72 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 118.76 0.709 . . . . 0.0 109.199 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.05 -31.71 27.22 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.54 ' HG3' ' NH2' ' A' ' 29' ' ' ARG . 1.6 tt0 -144.84 160.65 40.94 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.0 109.201 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.422 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 94.65 178.27 38.16 Favored Glycine 0 C--N 1.287 -2.187 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -174.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -67.94 121.36 4.34 Favored 'Cis proline' 0 C--N 1.299 -2.058 0 C-N-CA 123.026 -1.656 . . . . 0.0 111.433 0.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 2' ' ' ILE . 3.0 m -101.86 163.27 18.12 Favored Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -91.01 150.07 3.84 Favored 'Trans proline' 0 C--N 1.287 -2.673 0 C-N-CA 121.53 1.487 . . . . 0.0 112.372 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.52 HD11 HG13 ' A' ' 7' ' ' ILE . 10.5 tp -137.46 128.3 27.22 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.06 109.94 21.5 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.629 -0.669 . . . . 0.0 109.886 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.654 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 61.3 t -91.75 97.08 6.82 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.447 ' HB ' HD12 ' A' ' 8' ' ' LEU . 2.1 mt -79.63 132.24 32.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 21.7 t -91.15 116.79 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 11.5 pt -105.85 171.82 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.413 ' CG ' HH12 ' A' ' 67' ' ' ARG . 11.6 m-20 -83.17 172.41 12.66 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.907 -1.12 . . . . 0.0 109.356 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -91.36 158.75 16.36 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.941 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.463 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 0.2 OUTLIER -110.35 30.15 7.04 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 174.089 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 14.9 p-10 -76.14 -26.49 56.37 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 61.21 24.06 14.2 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -174.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -117.49 90.16 34.22 Favored Pre-proline 0 C--N 1.312 -1.027 0 O-C-N 121.671 -0.643 . . . . 0.0 110.293 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 C--N 1.314 -1.276 0 C-N-CA 122.223 1.949 . . . . 0.0 110.194 176.657 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 1.09 HG21 HG21 ' A' ' 91' ' ' VAL . 31.7 mt -65.7 132.13 31.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-O 121.734 0.778 . . . . 0.0 110.74 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -119.44 122.84 69.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 175.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -137.87 169.13 19.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.522 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.5 m -159.81 169.76 9.81 Favored Pre-proline 0 C--N 1.274 -2.695 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 25.1 Cg_exo -61.85 134.87 52.5 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.35 1.367 . . . . 0.0 110.745 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.613 HD13 ' HA3' ' A' ' 22' ' ' GLY . 24.4 mt -106.11 111.83 36.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.868 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.42 98.56 11.85 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.459 ' CD1' HG21 ' A' ' 21' ' ' VAL . 20.3 mt -101.19 129.0 28.01 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.97 -1.081 . . . . 0.0 109.0 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 5.0 Cg_endo -63.38 124.91 14.61 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 121.091 1.194 . . . . 0.0 110.046 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.52 ' HB3' HG12 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -67.04 171.43 5.53 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.717 1.246 . . . . 0.0 113.929 -170.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.512 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 6.4 m-80 47.71 24.15 0.51 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.486 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.458 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 73.0 mt-30 -67.0 146.79 54.0 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 173.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.541 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -104.9 179.26 4.32 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.174 -0.954 . . . . 0.0 110.031 -177.037 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.639 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -54.2 176.74 0.12 Allowed Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.639 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 5.7 Cg_exo -72.79 117.99 4.4 Favored 'Cis proline' 0 N--CA 1.491 1.359 0 C-N-CA 123.942 -1.274 . . . . 0.0 113.986 0.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 31.8 m-85 -100.15 165.08 15.16 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 55.2 Cg_endo -73.12 162.25 92.14 Favored 'Cis proline' 0 N--CA 1.497 1.681 0 C-N-CA 124.242 -1.149 . . . . 0.0 111.84 -0.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 11.3 mtp180 -138.19 145.5 41.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 5.0 t0 -73.75 134.53 43.48 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.459 HG21 ' CD1' ' A' ' 9' ' ' ILE . 31.1 m -129.91 3.24 2.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.609 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.613 ' HA3' HD13 ' A' ' 7' ' ' ILE . . . -172.83 -171.32 37.48 Favored Glycine 0 N--CA 1.499 2.899 0 C-N-CA 117.347 -2.358 . . . . 0.0 111.146 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -150.29 113.68 4.92 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 120.998 -1.295 . . . . 0.0 110.851 -178.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 4' ' ' VAL . 11.4 t -100.91 112.06 32.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 169.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 3' ' ' VAL . 58.5 t -120.66 154.46 24.0 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.008 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.7 t70 -104.23 135.41 45.74 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.58 -32.23 7.79 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -137.02 75.31 1.52 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 37.7 mtm180 -55.61 121.13 36.93 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.181 -0.949 . . . . 0.0 109.641 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 31' ' ' GLU . 54.6 Cg_exo -48.64 141.05 21.14 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.243 1.962 . . . . 0.0 110.328 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -24.88 -59.12 0.06 Allowed 'General case' 0 N--CA 1.51 2.537 0 C-N-CA 123.617 0.767 . . . . 0.0 112.076 -175.376 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -126.23 52.94 1.66 Allowed 'General case' 0 C--N 1.289 -2.023 0 O-C-N 121.313 -0.867 . . . . 0.0 108.915 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.31 160.56 30.18 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 121.343 -0.848 . . . . 0.0 110.887 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -126.61 133.01 51.13 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.614 ' HB3' HD13 ' A' ' 52' ' ' ILE . 12.1 m-85 -79.9 137.73 36.97 Favored 'General case' 0 C--N 1.273 -2.755 0 O-C-N 121.137 -0.977 . . . . 0.0 108.543 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.413 ' NH2' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -114.97 126.52 54.86 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.212 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.584 ' HG ' HG21 ' A' ' 42' ' ' VAL . 19.5 tp -105.8 148.98 26.9 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.413 HG23 ' NH2' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -152.03 170.39 20.02 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -177.154 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.5 ' C ' ' HB2' ' A' ' 44' ' ' GLN . . . 110.43 172.41 20.05 Favored Glycine 0 N--CA 1.497 2.765 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.954 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.48 ' N ' ' HB2' ' A' ' 44' ' ' GLN . 9.6 mtpp -53.25 114.75 1.59 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 115.18 -20.66 13.94 Favored Glycine 0 C--N 1.28 -2.564 0 N-CA-C 108.296 -1.921 . . . . 0.0 108.296 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.584 HG21 ' HG ' ' A' ' 37' ' ' LEU . 9.2 t -113.06 -89.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.45 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 31.7 t70 -100.17 -13.02 19.11 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.243 -0.91 . . . . 0.0 109.501 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 44' ' ' GLN . 0.4 OUTLIER -100.13 158.42 15.86 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 176.743 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 137.24 96.17 Favored Pre-proline 0 C--N 1.271 -2.808 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.492 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.44 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.2 Cg_exo -76.88 119.47 6.39 Favored 'Cis proline' 0 N--CA 1.5 1.874 0 C-N-CA 123.442 -1.483 . . . . 0.0 110.624 -0.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 2.2 mttm -69.27 144.49 53.6 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.708 -1.245 . . . . 0.0 110.353 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.49 37.83 34.59 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.344 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.432 HG13 ' HA2' ' A' ' 41' ' ' GLY . 5.0 mm -106.11 -43.0 7.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.499 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 84.8 m-85 -118.71 149.93 40.61 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.793 0.806 . . . . 0.0 110.264 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.485 ' HG2' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -148.13 142.94 26.75 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 176.499 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' A' ' 35' ' ' PHE . 12.2 tt -100.09 158.46 3.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 O-C-N 120.505 -1.372 . . . . 0.0 109.845 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 58' ' ' SER . 6.2 m-80 -84.76 84.71 7.6 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.732 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 2.0 pm0 -24.78 -54.52 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 124.18 0.992 . . . . 0.0 113.554 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.506 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 40.1 t30 -80.95 -33.94 33.59 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.168 -0.958 . . . . 0.0 111.939 -175.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -94.94 -25.84 16.38 Favored 'General case' 0 C--N 1.287 -2.126 0 O-C-N 121.161 -0.962 . . . . 0.0 109.073 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 82.91 10.52 82.89 Favored Glycine 0 C--N 1.285 -2.273 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -66.8 128.73 37.42 Favored 'General case' 0 C--N 1.312 -1.043 0 O-C-N 120.859 -1.377 . . . . 0.0 108.608 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 7' ' ' ILE . 4.6 t -79.91 119.2 28.87 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.477 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -113.29 151.6 30.93 Favored 'General case' 0 C--N 1.282 -2.335 0 O-C-N 121.699 -0.626 . . . . 0.0 109.561 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.534 HG21 HD11 ' A' ' 65' ' ' LEU . 12.8 p -112.63 143.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.485 HG23 ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -96.43 -15.36 21.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.695 -0.628 . . . . 0.0 111.54 -176.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.95 178.54 8.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.464 -1.397 . . . . 0.0 111.783 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.541 ' OG1' ' NH2' ' A' ' 14' ' ' ARG . 4.9 t -70.05 122.51 19.52 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.534 HD11 HG21 ' A' ' 61' ' ' VAL . 28.3 mt -90.81 127.2 36.26 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.161 -0.962 . . . . 0.0 108.926 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.25 139.28 46.77 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.442 ' CG ' ' HB3' ' A' ' 11' ' ' GLU . 7.4 mtp180 -81.88 -11.24 59.02 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.803 -0.56 . . . . 0.0 111.29 -176.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.85 -22.76 49.43 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.83 -63.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.41 ' O ' HG21 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -130.44 127.41 62.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.25 -25.86 31.27 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -156.69 135.97 3.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.419 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 67.1 m-85 -98.75 124.7 43.78 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.7 tp60 -90.74 90.86 8.13 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.87 170.47 11.15 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 122.132 0.968 . . . . 0.0 109.458 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 53.5 m-85 -134.08 127.6 32.51 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.755 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.29 142.89 23.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.24 0.543 . . . . 0.0 110.452 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HB3' HG23 ' A' ' 86' ' ' THR . 45.2 mt-10 -133.7 145.19 49.66 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.698 ' HB ' HD23 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -92.24 142.38 27.53 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 171.302 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.574 ' C ' HD21 ' A' ' 87' ' ' LEU . 24.1 p -127.6 155.3 44.08 Favored 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.441 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.659 ' HB2' HD11 ' A' ' 87' ' ' LEU . 37.3 t0 -97.1 170.01 9.42 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.806 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.441 ' N ' ' OD2' ' A' ' 81' ' ' ASP . 13.5 m -56.42 -16.15 3.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -85.75 -13.08 49.41 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.22 22.65 58.61 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -98.97 150.46 21.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 176.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 78' ' ' GLU . 57.7 m -84.49 129.01 34.9 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.971 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -99.16 -30.24 12.4 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.279 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.502 ' HG2' ' H ' ' A' ' 2' ' ' ILE . 3.9 tp10 -149.47 153.66 37.62 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.602 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 97.96 -176.35 30.64 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.26 104.97 0.36 Allowed 'Cis proline' 0 N--CA 1.496 1.641 0 CA-C-N 118.861 1.33 . . . . 0.0 112.089 -0.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.09 HG21 HG21 ' A' ' 2' ' ' ILE . 16.1 m -79.79 161.94 64.49 Favored Pre-proline 0 C--N 1.284 -2.247 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -93.3 155.76 2.54 Favored 'Trans proline' 0 C--N 1.291 -2.478 0 C-N-CA 121.6 1.533 . . . . 0.0 111.016 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.462 HD13 HG23 ' A' ' 4' ' ' VAL . 12.9 tp -142.18 128.08 19.46 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -108.97 104.14 13.31 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.526 -0.734 . . . . 0.0 109.496 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.499 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 70.7 t -94.4 107.95 20.06 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.9 mp -90.64 129.95 40.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 11' ' ' GLU . 1.5 t -86.97 109.72 19.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.662 HG21 ' HB3' ' A' ' 8' ' ' LEU . 20.6 pt -109.15 171.54 2.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-O 121.425 0.631 . . . . 0.0 109.407 -176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.33 148.33 30.21 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -133.32 69.01 1.48 Allowed 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 43.3 24.64 0.05 Allowed 'General case' 0 N--CA 1.515 2.792 0 O-C-N 121.713 -0.617 . . . . 0.0 110.12 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.31 -44.04 84.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.049 -1.032 . . . . 0.0 108.695 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER 56.86 15.09 2.1 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -176.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.409 ' NH1' ' OE1' ' A' ' 11' ' ' GLU . 0.0 OUTLIER 67.8 110.62 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.498 1.761 0 C-N-CA 122.603 2.202 . . . . 0.0 112.158 -177.882 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.476 ' HA ' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 91' ' ' VAL . 7.9 mt -72.16 139.89 18.96 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-O 121.583 0.706 . . . . 0.0 110.599 -177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.85 128.04 75.59 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.522 HG23 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -140.68 162.23 23.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.4 -0.813 . . . . 0.0 109.728 -175.158 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.443 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -145.59 156.01 52.87 Favored Pre-proline 0 C--N 1.284 -2.268 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 172.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 52.8 Cg_exo -49.76 149.42 10.74 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.63 1.553 . . . . 0.0 111.164 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.935 HG13 HD11 ' A' ' 93' ' ' LEU . 8.1 mt -112.27 111.88 38.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.914 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -92.64 105.06 17.28 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.6 mt -110.25 128.36 25.5 Favored Pre-proline 0 C--N 1.286 -2.157 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 31.7 Cg_endo -69.91 125.23 11.83 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 120.969 1.113 . . . . 0.0 110.872 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.504 ' HB3' HG12 ' A' ' 97' ' ' VAL . 11.1 pt-20 -61.37 170.86 1.6 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.822 -175.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.535 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 81.33 -19.17 0.44 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 172.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.421 ' O ' ' OG1' ' A' ' 64' ' ' THR . 2.3 mt-30 -52.27 134.31 33.74 Favored 'General case' 0 N--CA 1.518 2.974 0 O-C-N 120.687 -1.258 . . . . 0.0 108.128 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.535 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -111.28 -170.85 1.72 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.773 0.797 . . . . 0.0 111.163 -177.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.513 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 2.5 mp0 -45.88 163.44 0.22 Allowed Pre-proline 0 C--N 1.305 -1.329 0 C-N-CA 124.547 1.139 . . . . 0.0 109.943 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 39.9 Cg_endo -79.33 141.77 62.93 Favored 'Cis proline' 0 C--N 1.314 -1.275 0 C-N-CA 123.146 -1.606 . . . . 0.0 112.103 -0.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 37.3 m-85 -112.83 158.88 36.4 Favored Pre-proline 0 C--N 1.28 -2.454 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 59.5 Cg_endo -75.95 153.37 97.65 Favored 'Cis proline' 0 N--CA 1.498 1.747 0 C-N-CA 123.942 -1.274 . . . . 0.0 112.909 0.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 7.1 mtp180 -120.33 135.99 54.84 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.92 147.75 52.88 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.9 6.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.873 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.26 -177.19 39.33 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 117.98 -2.057 . . . . 0.0 110.157 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -141.51 117.66 10.65 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.139 -1.212 . . . . 0.0 110.445 -176.33 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.631 HG23 HG22 ' A' ' 59' ' ' VAL . 21.9 t -87.38 135.84 24.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 103.539 -2.763 . . . . 0.0 103.539 169.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.38 150.64 34.83 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 1' ' ' SER . 24.0 t0 -127.83 112.72 15.06 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -8.98 58.93 Favored 'General case' 0 C--N 1.272 -2.768 0 O-C-N 121.682 -0.636 . . . . 0.0 110.433 -173.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -125.67 81.36 1.97 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.492 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.461 HH11 ' HD2' ' A' ' 29' ' ' ARG . 18.9 mtm180 -115.92 142.29 28.9 Favored Pre-proline 0 C--N 1.288 -2.072 0 O-C-N 121.211 -0.93 . . . . 0.0 110.379 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.65 161.37 41.88 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.551 1.501 . . . . 0.0 110.865 173.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -25.05 -60.77 0.06 Allowed 'General case' 0 N--CA 1.513 2.681 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.63 ' O ' ' NZ ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -129.31 36.53 4.14 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.72 -1.238 . . . . 0.0 110.914 -173.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -57.14 148.7 21.28 Favored 'General case' 0 C--N 1.276 -2.609 0 O-C-N 121.825 -0.547 . . . . 0.0 110.811 -178.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.63 ' NZ ' ' O ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -117.23 147.99 42.03 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.763 ' HB3' HD13 ' A' ' 52' ' ' ILE . 57.4 m-85 -83.89 150.63 25.58 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 121.27 -0.894 . . . . 0.0 109.311 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.669 ' HG3' HG21 ' A' ' 80' ' ' THR . 6.1 mmp_? -123.73 135.0 53.59 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 173.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.722 ' HG ' HG21 ' A' ' 42' ' ' VAL . 36.8 tp -112.93 144.27 42.78 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.84 171.02 18.91 Favored 'General case' 0 C--N 1.271 -2.823 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -175.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.472 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 119.22 166.36 13.39 Favored Glycine 0 C--N 1.29 -1.99 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 177.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -59.09 109.92 0.94 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.418 ' HA2' HG13 ' A' ' 49' ' ' ILE . . . 124.21 -20.37 7.08 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -174.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.722 HG21 ' HG ' ' A' ' 37' ' ' LEU . 22.4 t -118.19 -86.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.991 -1.299 . . . . 0.0 108.788 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.49 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 27.3 t70 -99.5 -12.63 19.99 Favored 'General case' 0 C--O 1.206 -1.198 0 O-C-N 121.598 -0.689 . . . . 0.0 109.412 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.472 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 13.1 mp0 -109.76 160.34 16.41 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.84 135.81 92.92 Favored Pre-proline 0 C--N 1.273 -2.747 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.303 -174.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.579 ' HB2' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -77.21 124.18 10.35 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.824 -1.74 . . . . 0.0 109.97 -1.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.49 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 6.0 mttm -72.4 154.23 41.01 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 121.327 -0.858 . . . . 0.0 109.128 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.41 34.95 63.45 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.148 173.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.756 HD13 HH11 ' A' ' 63' ' ' ARG . 4.0 mm -106.64 -49.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.658 -1.496 . . . . 0.0 107.854 176.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.49 ' HB2' HG22 ' A' ' 42' ' ' VAL . 94.7 m-85 -118.96 152.73 35.82 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.481 -0.762 . . . . 0.0 110.691 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.639 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 6.9 ptm180 -143.43 169.92 16.76 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.763 HD13 ' HB3' ' A' ' 35' ' ' PHE . 8.6 tt -129.2 159.73 40.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 119.231 -0.987 . . . . 0.0 108.758 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 58' ' ' SER . 37.6 t-20 -79.94 96.92 6.53 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 2.1 mp0 -33.91 -50.07 0.36 Allowed 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 122.588 0.355 . . . . 0.0 110.942 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.49 ' OD1' ' NH2' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -83.03 -42.78 17.09 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.211 -0.931 . . . . 0.0 112.354 -175.68 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 p -94.74 -29.76 14.62 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.108 -0.995 . . . . 0.0 111.041 -171.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 95.33 -1.38 64.44 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -56.05 129.33 39.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.043 -1.269 . . . . 0.0 108.185 176.419 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 24' ' ' VAL . 1.9 t -94.02 134.36 31.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.639 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -131.73 159.67 37.73 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.455 -0.778 . . . . 0.0 109.663 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 63' ' ' ARG . 12.3 p -103.79 139.99 23.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -94.74 -2.99 50.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 111.303 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.756 HH11 HD13 ' A' ' 49' ' ' ILE . 2.8 ptp85 -157.21 -179.84 8.58 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 3.1 t -69.4 170.42 10.47 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.8 mt -131.41 136.28 47.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.87 122.79 35.68 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.532 HH22 ' CG ' ' A' ' 99' ' ' ASP . 5.3 mtm180 -57.12 -15.61 5.87 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.059 -1.026 . . . . 0.0 111.43 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.28 -19.65 63.91 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.9 -60.02 2.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.482 HD12 ' CE1' ' A' ' 73' ' ' TYR . 1.9 mt -143.68 145.17 22.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.7 -24.92 16.31 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.1 p -154.72 139.01 9.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.784 -0.572 . . . . 0.0 109.647 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.482 ' CE1' HD12 ' A' ' 70' ' ' ILE . 33.5 m-85 -106.39 127.09 53.02 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.4 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 8.6 tp-100 -91.79 86.88 6.06 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 176.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -83.76 170.67 13.94 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.565 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 78.5 m-85 -135.55 133.37 38.3 Favored 'General case' 0 C--N 1.265 -3.104 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.85 145.42 18.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -175.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.612 ' HB3' HG23 ' A' ' 86' ' ' THR . 50.8 mt-10 -135.23 143.88 46.59 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.561 ' C ' HD22 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -90.36 133.02 35.26 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 171.335 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.669 HG21 ' HG3' ' A' ' 36' ' ' ARG . 39.1 p -129.55 170.5 13.66 Favored 'General case' 0 C--N 1.278 -2.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.262 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 83' ' ' ASN . 6.1 t0 -149.78 171.62 16.45 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.409 -0.807 . . . . 0.0 110.328 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 81' ' ' ASP . 8.3 m -13.9 -41.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 126.276 1.83 . . . . 0.0 114.724 -178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 81' ' ' ASP . 8.0 t-20 -79.43 -7.51 58.45 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 120.722 -1.236 . . . . 0.0 109.732 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 72.18 19.18 78.45 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.5 OUTLIER -99.78 167.61 10.43 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 78' ' ' GLU . 91.3 m -94.07 119.68 33.26 Favored 'General case' 0 C--N 1.277 -2.563 0 O-C-N 122.154 -0.341 . . . . 0.0 111.292 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.839 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.71 -34.79 24.84 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 1' ' ' SER . 0.3 OUTLIER -142.09 163.32 33.19 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.792 -0.568 . . . . 0.0 109.743 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.467 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 89.87 -172.18 38.42 Favored Glycine 0 N--CA 1.481 1.699 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.77 102.95 0.34 Allowed 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.732 -1.362 . . . . 0.0 112.225 -0.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 2' ' ' ILE . 5.8 m -74.05 164.19 62.95 Favored Pre-proline 0 C--N 1.285 -2.199 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -94.48 154.61 1.99 Allowed 'Trans proline' 0 C--N 1.291 -2.491 0 C-N-CA 121.694 1.596 . . . . 0.0 111.295 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.935 HD11 HG13 ' A' ' 7' ' ' ILE . 16.6 tp -144.36 119.95 10.41 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.4 ' HG2' ' NE2' ' A' ' 74' ' ' GLN . 59.6 mt-10 -99.85 110.48 22.84 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.762 -0.586 . . . . 0.0 110.046 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 50.9 t -94.25 107.3 19.16 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.7 mp -90.82 135.06 27.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.504 HG12 ' HB3' ' A' ' 11' ' ' GLU . 18.7 t -91.33 114.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.65 HG21 ' HB3' ' A' ' 8' ' ' LEU . 22.4 pt -111.42 172.34 2.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 121.58 -0.7 . . . . 0.0 110.498 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.532 ' CG ' HH22 ' A' ' 67' ' ' ARG . 5.6 m-20 -78.51 165.45 23.73 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -69.7 84.35 0.45 Allowed 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -57.77 -46.63 84.28 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.438 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 36.1 t0 47.36 -97.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 0.4 OUTLIER -146.81 30.76 0.97 Allowed 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 173.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.438 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 48.3 mtm180 -84.92 130.22 53.36 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.702 -0.624 . . . . 0.0 111.238 -172.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 C--O 1.202 -1.29 0 C-N-CA 122.859 2.373 . . . . 0.0 110.557 175.398 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.406 ' N ' ' OE2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER . . . . . 0 CA--C 1.502 -0.868 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.781 HG21 HG21 ' A' ' 91' ' ' VAL . 3.6 mt -78.08 117.77 23.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.341 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.0 120.41 35.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.47 HG23 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -139.75 159.14 27.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -179.238 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.427 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -143.14 145.81 34.21 Favored Pre-proline 0 C--N 1.269 -2.925 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -53.83 134.52 59.4 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.586 1.524 . . . . 0.0 109.928 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.9 mt -106.79 116.66 51.02 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.137 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.873 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -89.61 104.34 16.91 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.306 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.508 HD12 ' CG1' ' A' ' 95' ' ' VAL . 38.3 mt -110.32 127.28 27.28 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -68.83 130.83 21.24 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 120.787 0.991 . . . . 0.0 111.034 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -74.46 -170.53 1.03 Allowed 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.305 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.605 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 0.0 OUTLIER 61.05 -26.97 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 175.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' GLU . 71.9 mt-30 -37.19 139.25 0.24 Allowed 'General case' 0 N--CA 1.521 3.098 0 O-C-N 121.007 -1.058 . . . . 0.0 108.529 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.605 ' NH1' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -91.24 -175.32 4.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.317 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.623 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 1.4 mt-30 -67.16 -168.58 0.05 OUTLIER Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 20.0 Cg_exo -66.96 127.44 8.53 Favored 'Cis proline' 0 N--CA 1.492 1.42 0 CA-C-N 120.499 1.214 . . . . 0.0 112.222 -0.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 15' ' ' GLN . 32.9 m-85 -115.61 163.54 20.38 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 177.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 17.2 Cg_exo -68.1 163.35 76.79 Favored 'Cis proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.959 -1.267 . . . . 0.0 111.207 -0.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.425 ' NH2' ' OE1' ' A' ' 13' ' ' GLN . 2.3 mtp85 -136.75 139.81 42.13 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.384 -0.823 . . . . 0.0 109.404 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.49 146.18 55.19 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.466 HG21 HD11 ' A' ' 9' ' ' ILE . 33.6 m -138.83 -1.18 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.456 176.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 167.04 178.35 39.37 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 118.968 -1.587 . . . . 0.0 109.344 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.1 tttp -135.36 130.63 35.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.306 -1.114 . . . . 0.0 110.625 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.573 HG11 HG11 ' A' ' 77' ' ' VAL . 41.8 t -99.78 145.54 10.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 26' ' ' ASP . 20.6 t -144.33 170.62 7.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.445 ' N ' HG12 ' A' ' 25' ' ' VAL . 7.6 t0 -129.58 148.97 51.53 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 p -105.17 -7.73 18.85 Favored 'General case' 0 C--N 1.278 -2.538 0 O-C-N 121.96 -0.462 . . . . 0.0 110.163 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.515 ' O ' ' NE ' ' A' ' 29' ' ' ARG . 3.1 m-20 -133.06 25.01 4.25 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.755 -172.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.515 ' NE ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -126.08 158.2 67.01 Favored Pre-proline 0 N--CA 1.506 2.338 0 CA-C-N 119.263 0.938 . . . . 0.0 110.961 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' A' ' 33' ' ' SER . 82.4 Cg_exo -37.34 129.42 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 123.438 2.759 . . . . 0.0 112.311 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 8.5 mp0 -42.12 -30.85 0.32 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.985 -0.447 . . . . 0.0 111.097 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 32' ' ' ARG . 17.4 mtp180 -103.56 10.45 37.03 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.19 -0.944 . . . . 0.0 110.681 -175.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.535 ' HB2' HG22 ' A' ' 79' ' ' THR . 0.3 OUTLIER -55.48 133.27 49.96 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.485 -1.286 . . . . 0.0 108.358 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 33.8 mttm -96.89 156.33 16.39 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.725 ' CE1' HG23 ' A' ' 79' ' ' THR . 70.1 m-85 -105.4 142.24 35.51 Favored 'General case' 0 C--N 1.285 -2.23 0 O-C-N 121.476 -0.765 . . . . 0.0 111.657 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.527 ' NH1' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -103.1 149.0 25.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 174.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.529 ' HG ' HG21 ' A' ' 42' ' ' VAL . 26.4 tp -125.6 140.26 52.89 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 p -148.29 170.78 17.16 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -174.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.72 174.9 18.96 Favored Glycine 0 N--CA 1.499 2.88 0 O-C-N 121.019 -1.05 . . . . 0.0 111.817 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -59.8 116.34 4.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 115.75 -19.33 14.19 Favored Glycine 0 C--N 1.28 -2.543 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.529 HG21 ' HG ' ' A' ' 37' ' ' LEU . 27.1 t -122.56 -95.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.588 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 23.0 t70 -83.7 -15.85 47.2 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.046 -1.034 . . . . 0.0 109.765 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -113.26 155.07 25.75 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.226 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 4.9 mt-10 -54.43 133.31 62.56 Favored Pre-proline 0 C--N 1.29 -2.014 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.523 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HG2' HG13 ' A' ' 49' ' ' ILE . 28.2 Cg_endo -73.62 118.11 4.72 Favored 'Cis proline' 0 N--CA 1.499 1.819 0 C-N-CA 123.526 -1.448 . . . . 0.0 110.305 -1.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.588 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 3.7 mtpp -68.27 145.41 54.27 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 120.902 -1.124 . . . . 0.0 112.242 -172.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.88 28.11 69.69 Favored Glycine 0 N--CA 1.498 2.816 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.389 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.436 HG13 ' HG2' ' A' ' 46' ' ' PRO . 17.8 mm -85.26 -46.42 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-N 119.254 1.527 . . . . 0.0 107.053 175.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -107.66 147.39 30.76 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.686 0.755 . . . . 0.0 109.18 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.66 170.09 16.35 Favored 'General case' 0 C--N 1.262 -3.222 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.411 HD11 ' HA2' ' A' ' 57' ' ' GLY . 1.2 tt -134.19 150.38 31.02 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.016 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.413 ' OD1' HG23 ' A' ' 56' ' ' THR . 19.0 t-20 -84.81 83.2 8.12 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 36' ' ' ARG . 5.8 mt-10 -37.44 -33.47 0.07 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.557 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -79.72 -15.56 57.28 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.985 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.413 HG23 ' OD1' ' A' ' 53' ' ' ASN . 74.8 p -127.27 -36.85 2.09 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 52' ' ' ILE . . . 100.93 6.23 52.4 Favored Glycine 0 C--N 1.277 -2.699 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.4 m -66.16 119.87 12.23 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.41 -1.053 . . . . 0.0 108.745 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.542 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.2 t -87.11 134.95 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.27 158.21 44.95 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.358 -0.838 . . . . 0.0 108.756 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 13.6 p -106.81 141.49 21.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 p -89.58 -13.93 36.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.546 -0.722 . . . . 0.0 110.571 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 64' ' ' THR . 1.8 ptm180 -157.18 -173.53 4.48 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.187 -0.945 . . . . 0.0 109.593 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.617 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 14.6 t -70.06 178.65 2.65 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 11' ' ' GLU . 35.2 mt -131.22 162.28 30.33 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 120.541 -1.349 . . . . 0.0 108.504 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.401 ' OD1' ' NH2' ' A' ' 63' ' ' ARG . 14.1 m-20 -140.0 113.71 8.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -60.45 -11.18 6.14 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.21 -22.8 63.85 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.5 t -105.05 -55.95 5.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.469 HD12 ' CE1' ' A' ' 73' ' ' TYR . 1.4 mt -141.53 142.3 29.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.569 -0.707 . . . . 0.0 110.06 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.22 -23.16 16.3 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 7.2 p -152.9 135.15 6.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.638 -0.664 . . . . 0.0 109.733 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.469 ' CE1' HD12 ' A' ' 70' ' ' ILE . 84.3 m-85 -100.86 117.28 34.63 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -85.91 87.03 7.35 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.431 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -81.62 170.72 15.48 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 73.1 m-85 -134.08 132.31 39.82 Favored 'General case' 0 C--N 1.264 -3.149 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.671 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.2 152.66 13.99 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 O-C-N 121.983 -0.448 . . . . 0.0 109.864 -177.066 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.716 ' HB3' HG23 ' A' ' 86' ' ' THR . 50.4 mt-10 -138.47 139.51 38.84 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 121.779 -0.575 . . . . 0.0 109.565 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.725 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -88.69 134.21 33.97 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 173.233 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 7.9 p -137.14 163.04 31.77 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.545 -176.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -105.8 171.15 7.49 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.2 m -46.29 -27.72 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.369 0.604 . . . . 0.0 110.5 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.59 0.52 29.69 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.507 -0.745 . . . . 0.0 110.385 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.21 20.46 76.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 80' ' ' THR . 25.5 mttp -85.11 146.89 26.91 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.716 HG23 ' HB3' ' A' ' 78' ' ' GLU . 31.8 m -99.26 117.04 32.83 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-O 121.145 0.498 . . . . 0.0 110.816 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.842 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.58 -28.78 17.31 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.332 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.459 ' CD ' ' NH1' ' A' ' 29' ' ' ARG . 1.1 tp10 -140.81 151.37 44.33 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 94.73 -177.58 35.84 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.74 102.75 0.16 OUTLIER 'Cis proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.821 -1.325 . . . . 0.0 113.469 -0.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.781 HG21 HG21 ' A' ' 2' ' ' ILE . 3.3 m -74.8 164.19 63.05 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -92.35 151.06 3.03 Favored 'Trans proline' 0 C--N 1.283 -2.912 0 C-N-CA 121.395 1.397 . . . . 0.0 111.905 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 4' ' ' VAL . 12.1 tp -135.76 126.74 27.76 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 175.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -103.57 105.52 15.79 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 121.831 -0.543 . . . . 0.0 109.715 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.508 ' CG1' HD12 ' A' ' 9' ' ' ILE . 24.7 t -95.7 104.6 16.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 175.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mp -87.57 134.0 28.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 16.1 t -89.67 108.94 19.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.604 HG21 ' HB3' ' A' ' 8' ' ' LEU . 15.3 pt -102.85 171.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 101' ' ' ASN . 4.8 m-20 -80.39 174.47 11.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.424 ' OE1' ' NH2' ' A' ' 14' ' ' ARG . 4.3 mt-30 -66.67 68.76 0.06 Allowed 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 99' ' ' ASP . 1.9 t-20 -75.5 53.53 0.69 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 104' ' ' ARG . 0.8 OUTLIER -57.12 -45.72 83.24 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -178.189 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.09 -61.12 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 102' ' ' ASP . 77.6 mtp180 -153.97 121.6 2.96 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.187 -2.051 0 C-N-CA 122.753 2.302 . . . . 0.0 111.489 176.884 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.581 ' H2 ' ' CG ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.884 HG21 HG21 ' A' ' 91' ' ' VAL . 5.2 mt -73.73 120.49 22.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.075 -1.016 . . . . 0.0 110.611 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.66 119.98 50.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.54 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -142.42 163.76 18.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -149.53 159.44 36.38 Favored Pre-proline 0 C--N 1.278 -2.517 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.34 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.752 ' HB3' HD11 ' A' ' 96' ' ' ILE . 27.3 Cg_exo -44.73 131.03 10.02 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.855 1.703 . . . . 0.0 111.893 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.57 HG13 HD11 ' A' ' 93' ' ' LEU . 19.5 mt -101.4 122.5 53.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.3 mp -106.88 115.8 30.82 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.919 HD11 HG21 ' A' ' 21' ' ' VAL . 23.0 mt -122.21 128.04 25.66 Favored Pre-proline 0 C--N 1.26 -3.314 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 21.5 Cg_endo -70.98 141.78 41.06 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 CA-C-N 120.038 1.049 . . . . 0.0 110.064 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.438 ' OE1' ' NH1' ' A' ' 67' ' ' ARG . 3.4 pt-20 -55.69 173.76 0.12 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 121.988 0.899 . . . . 0.0 110.104 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.431 ' ND2' ' OE1' ' A' ' 100' ' ' GLN . 4.1 p30 52.74 19.15 1.18 Allowed 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.513 ' HG3' HG22 ' A' ' 9' ' ' ILE . 1.6 mm-40 -57.49 131.35 49.9 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 173.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.474 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 3.3 mtt180 -101.84 -174.37 2.57 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 119.546 1.066 . . . . 0.0 110.434 -176.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.636 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 16.8 mt-30 -54.16 168.14 0.47 Allowed Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.636 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 4.1 Cg_exo -77.02 131.71 25.12 Favored 'Cis proline' 0 C--N 1.308 -1.593 0 C-N-CA 123.503 -1.457 . . . . 0.0 112.831 0.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -119.61 159.55 45.71 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 13.0 Cg_exo -69.74 155.29 93.28 Favored 'Cis proline' 0 N--CA 1.493 1.497 0 C-N-CA 123.878 -1.301 . . . . 0.0 110.426 -0.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -129.54 131.34 46.56 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.25 -179.303 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.21 116.01 9.16 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.919 HG21 HD11 ' A' ' 9' ' ' ILE . 19.5 m -118.42 7.61 6.85 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.592 -178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . -179.53 163.5 30.91 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -135.58 116.33 14.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.27 -1.135 . . . . 0.0 109.641 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.577 HG23 ' CG2' ' A' ' 59' ' ' VAL . 21.8 t -80.97 146.9 6.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 t -139.3 166.72 21.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.581 ' CG ' ' H2 ' ' A' ' 1' ' ' SER . 11.9 t70 -112.98 140.14 48.04 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 173.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -45.15 -35.49 3.21 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.301 0.572 . . . . 0.0 109.53 -177.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -150.93 84.72 1.34 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.624 ' NH2' ' O ' ' A' ' 55' ' ' ASN . 23.3 mtp180 -64.73 121.25 72.3 Favored Pre-proline 0 C--N 1.288 -2.076 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.33 -163.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.601 2.201 . . . . 0.0 113.235 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.82 -78.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 111.882 -174.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.624 ' HB2' HG13 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -107.77 31.26 5.61 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.322 -0.862 . . . . 0.0 110.239 -173.675 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.8 OUTLIER -65.0 143.17 58.13 Favored 'General case' 0 C--N 1.275 -2.654 0 O-C-N 120.927 -1.108 . . . . 0.0 110.876 -178.068 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.454 ' NZ ' ' O ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -124.18 138.88 54.36 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.487 ' CE2' HG23 ' A' ' 79' ' ' THR . 71.6 m-85 -82.43 144.11 30.71 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.747 -0.596 . . . . 0.0 110.598 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.454 HH12 ' CD ' ' A' ' 54' ' ' GLU . 4.2 mmp_? -120.86 145.02 48.06 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 38' ' ' THR . 23.4 tp -120.79 153.45 37.05 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 37' ' ' LEU . 3.0 p -158.13 171.26 20.53 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.51 175.63 18.77 Favored Glycine 0 N--CA 1.502 3.083 0 C-N-CA 119.796 -1.192 . . . . 0.0 111.444 175.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -59.24 119.54 7.56 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 113.07 -19.12 20.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.462 HG21 ' HG ' ' A' ' 37' ' ' LEU . 47.5 t -118.07 -98.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.619 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -85.77 -12.46 50.92 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -113.12 148.89 34.39 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 121.06 -1.025 . . . . 0.0 108.363 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.509 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.1 pt-20 -51.85 136.02 36.49 Favored Pre-proline 0 C--N 1.284 -2.282 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.359 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.503 ' HB2' ' CG1' ' A' ' 49' ' ' ILE . 2.9 Cg_exo -72.83 118.07 4.46 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.475 -1.469 . . . . 0.0 109.161 -1.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.619 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 8.9 mtpp -68.56 145.62 53.82 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 120.856 -1.153 . . . . 0.0 111.251 -172.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.76 34.1 87.83 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.806 -0.559 . . . . 0.0 112.383 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.586 HG23 ' HD2' ' A' ' 63' ' ' ARG . 8.8 mm -89.47 -45.58 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.743 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 26.3 m-85 -111.49 139.22 47.09 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.591 0.71 . . . . 0.0 110.041 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HE ' ' HG ' ' A' ' 60' ' ' SER . 0.6 OUTLIER -137.22 128.96 28.78 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.578 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 58' ' ' SER . 7.7 tt -98.9 161.93 2.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.523 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 13.2 t-20 -96.03 106.73 18.94 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' CD ' HH12 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -40.82 -39.15 1.06 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.108 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.624 ' O ' ' NH2' ' A' ' 29' ' ' ARG . 8.0 t-20 -96.36 -30.95 13.11 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.35 -0.844 . . . . 0.0 112.704 -173.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 18.1 p -98.16 -26.92 14.4 Favored 'General case' 0 C--N 1.283 -2.295 0 O-C-N 120.757 -1.215 . . . . 0.0 108.611 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.01 5.1 88.02 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 4.4 m -63.63 125.22 23.57 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.263 -1.139 . . . . 0.0 109.409 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.577 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.0 t -90.66 121.91 41.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.419 ' HG ' ' HE ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -119.11 146.93 44.71 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.343 -0.848 . . . . 0.0 110.031 -178.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 14.6 p -102.53 142.42 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 49' ' ' ILE . 43.8 p -95.33 -20.05 19.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.524 -0.735 . . . . 0.0 112.908 -173.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.586 ' HD2' HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -139.89 176.48 8.71 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.483 -1.386 . . . . 0.0 110.253 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.47 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 13.0 t -70.15 127.9 34.42 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.546 HD22 ' CE2' ' A' ' 73' ' ' TYR . 97.3 mt -83.22 120.51 25.91 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.292 -0.88 . . . . 0.0 109.131 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.436 ' OD2' ' NH2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -108.61 114.09 27.61 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.45 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.449 ' HG3' ' CG1' ' A' ' 97' ' ' VAL . 14.7 mtp-105 -53.66 -7.96 0.13 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.447 -0.783 . . . . 0.0 110.399 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.45 -28.68 67.27 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 t -91.47 -63.55 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -138.68 132.41 40.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.53 -23.7 24.29 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.8 p -150.22 132.07 5.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.546 ' CE2' HD22 ' A' ' 65' ' ' LEU . 82.8 m-85 -94.7 117.21 29.76 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.35 83.39 7.69 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.462 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -87.06 170.31 11.65 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 64.8 m-85 -138.31 131.14 29.61 Favored 'General case' 0 C--N 1.265 -3.082 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.7 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -110.14 155.73 11.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-O 121.396 0.617 . . . . 0.0 109.75 -175.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.32 147.54 28.47 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.79 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.83 131.79 47.96 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 175.237 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.625 ' C ' HD21 ' A' ' 87' ' ' LEU . 80.8 p -121.22 164.85 16.29 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 83' ' ' ASN . 1.5 t0 -144.75 172.18 13.37 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.837 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.624 HG13 ' HB2' ' A' ' 32' ' ' ARG . 24.4 m -38.82 -21.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 123.455 0.702 . . . . 0.0 111.61 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 81' ' ' ASP . 3.9 t-20 -79.14 -4.91 52.7 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.175 -0.953 . . . . 0.0 108.746 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 63.52 27.55 71.05 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -119.84 162.79 18.52 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 88' ' ' GLU . 1.3 m -90.18 124.08 34.54 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.843 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -93.95 -13.22 27.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.896 -1.128 . . . . 0.0 107.985 178.412 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.647 ' O ' HG22 ' A' ' 86' ' ' THR . 1.0 OUTLIER -156.02 162.36 40.33 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.526 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 91.95 -175.64 38.52 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -70.83 104.75 0.49 Allowed 'Cis proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.58 -1.425 . . . . 0.0 111.373 0.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.884 HG21 HG21 ' A' ' 2' ' ' ILE . 18.1 m -76.81 160.62 76.3 Favored Pre-proline 0 C--N 1.284 -2.271 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -93.46 153.79 2.45 Favored 'Trans proline' 0 C--N 1.288 -2.625 0 C-N-CA 121.556 1.504 . . . . 0.0 111.455 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.57 HD11 HG13 ' A' ' 7' ' ' ILE . 8.2 tp -140.3 127.38 20.9 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -112.57 110.21 20.23 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.488 -0.758 . . . . 0.0 109.286 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.743 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 5.3 t -99.51 101.94 12.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.752 HD11 ' HB3' ' A' ' 6' ' ' PRO . 4.6 mp -80.59 129.37 37.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 O-C-N 121.613 -0.679 . . . . 0.0 109.234 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.449 ' CG1' ' HG3' ' A' ' 67' ' ' ARG . 16.8 t -86.29 92.14 3.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 13.8 pt -79.71 171.58 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 O-C-N 121.515 -0.741 . . . . 0.0 109.28 -177.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 101' ' ' ASN . 16.6 m-20 -77.94 166.9 22.29 Favored 'General case' 0 C--N 1.282 -2.349 0 O-C-N 120.983 -1.073 . . . . 0.0 108.674 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.431 ' OE1' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -68.54 68.62 0.15 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 99' ' ' ASP . 5.8 p-10 -108.48 24.55 12.87 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 104' ' ' ARG . 4.3 p-10 -74.98 -112.78 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 175.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -128.04 -1.98 5.82 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.458 ' CZ ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER 60.04 109.67 0.03 OUTLIER Pre-proline 0 C--N 1.307 -1.256 0 C-N-CA 123.113 0.565 . . . . 0.0 111.669 -178.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HD2' ' CZ ' ' A' ' 104' ' ' ARG . 34.8 Cg_endo . . . . . 0 C--O 1.206 -1.083 0 C-N-CA 122.383 2.055 . . . . 0.0 111.08 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.49 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.643 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.887 HG21 HG21 ' A' ' 91' ' ' VAL . 7.1 mt -62.58 135.39 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 O-C-N 121.695 -0.628 . . . . 0.0 109.495 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.52 122.34 62.29 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.475 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -133.19 160.47 42.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.096 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -131.89 157.34 78.46 Favored Pre-proline 0 C--N 1.275 -2.665 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.56 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.35 134.97 67.24 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.285 1.323 . . . . 0.0 109.815 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 mt -109.27 113.97 45.63 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.934 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -92.14 112.58 24.57 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.389 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.613 HD11 HG21 ' A' ' 21' ' ' VAL . 20.0 mt -117.96 133.99 23.34 Favored Pre-proline 0 C--N 1.287 -2.134 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 31.1 Cg_endo -69.74 140.39 42.63 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.09 1.193 . . . . 0.0 110.692 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.481 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -79.5 174.36 11.65 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.698 178.41 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.527 ' OD1' ' NH2' ' A' ' 104' ' ' ARG . 59.6 m-20 58.29 38.22 26.03 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.813 -0.554 . . . . 0.0 110.692 175.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.47 ' OE1' ' N ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -88.43 166.57 14.14 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 175.762 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -117.5 167.04 11.65 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.681 -1.262 . . . . 0.0 111.856 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.567 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -64.48 178.71 0.43 Allowed Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.428 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 11.8 Cg_exo -66.51 140.34 48.65 Favored 'Cis proline' 0 C--N 1.307 -1.647 0 C-N-CA 123.704 -1.373 . . . . 0.0 112.786 0.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 62' ' ' THR . 35.0 m-85 -119.46 167.39 12.23 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 38.5 Cg_endo -66.01 168.53 47.51 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 120.529 1.225 . . . . 0.0 111.899 -0.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -133.35 129.1 37.0 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 120.231 -0.587 . . . . 0.0 109.957 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -66.45 140.44 58.03 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.613 HG21 HD11 ' A' ' 9' ' ' ILE . 35.4 m -137.68 3.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.791 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 172.75 168.39 34.0 Favored Glycine 0 N--CA 1.507 3.371 0 C-N-CA 118.933 -1.603 . . . . 0.0 110.268 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -132.35 122.45 25.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.274 . . . . 0.0 109.936 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.546 ' CG1' HG23 ' A' ' 2' ' ' ILE . 16.5 t -90.6 135.58 26.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 172.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.8 t -131.61 157.73 43.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 1' ' ' SER . 8.4 t70 -111.29 122.5 48.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 0.0 109.7 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.408 ' H ' ' HG ' ' A' ' 27' ' ' SER . 2.2 p -63.51 -6.04 4.58 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.445 0.64 . . . . 0.0 109.739 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 29' ' ' ARG . 23.6 t0 -137.78 29.9 2.58 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 108.943 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.656 ' NH1' ' OG ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -29.57 97.45 0.09 OUTLIER Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.442 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' GLU . 19.7 Cg_exo -62.24 145.1 96.21 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 N-CA-C 108.5 -1.385 . . . . 0.0 108.5 172.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -25.3 -88.04 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -174.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.559 ' HB2' HG13 ' A' ' 82' ' ' VAL . 2.5 mmp_? -88.49 26.75 1.39 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.699 -1.251 . . . . 0.0 110.035 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.656 ' OG ' ' NH1' ' A' ' 29' ' ' ARG . 14.0 p -59.67 120.82 10.2 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.918 -1.114 . . . . 0.0 110.372 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -104.83 148.13 26.98 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.589 ' CE2' HG23 ' A' ' 79' ' ' THR . 67.4 m-85 -88.19 126.87 35.36 Favored 'General case' 0 C--N 1.274 -2.706 0 O-C-N 121.359 -0.838 . . . . 0.0 110.35 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.449 ' HG3' HG21 ' A' ' 80' ' ' THR . 4.7 mtp180 -106.24 141.35 37.73 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.2 tp -121.51 145.48 47.9 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -151.64 171.12 18.13 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 117.74 164.86 13.37 Favored Glycine 0 N--CA 1.499 2.839 0 O-C-N 120.951 -1.093 . . . . 0.0 110.561 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -55.46 117.74 3.84 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 117.03 -21.05 11.23 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 50' ' ' PHE . 43.3 t -125.06 -92.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.7 -0.882 . . . . 0.0 108.747 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -85.39 -9.14 57.94 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.528 -0.733 . . . . 0.0 109.489 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 4.0 mp0 -125.97 161.71 26.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.447 -0.783 . . . . 0.0 109.35 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.468 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 2.5 mt-10 -60.27 131.63 90.11 Favored Pre-proline 0 C--N 1.289 -2.027 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.361 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.479 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 41.1 Cg_endo -73.03 115.13 2.97 Favored 'Cis proline' 0 N--CA 1.512 2.605 0 C-N-CA 123.521 -1.449 . . . . 0.0 110.992 -1.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 4.5 mttp -66.47 150.32 49.12 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.921 -1.112 . . . . 0.0 112.744 -173.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.18 29.27 36.33 Favored Glycine 0 N--CA 1.493 2.44 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.284 171.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 41' ' ' GLY . 13.9 mm -80.91 -44.29 21.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 174.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.499 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 62.1 m-85 -109.16 138.46 45.48 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.656 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -139.79 138.88 36.2 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.454 HG13 HG22 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -106.49 152.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 O-C-N 121.825 -0.547 . . . . 0.0 109.546 -176.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -79.83 119.47 22.75 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 35' ' ' PHE . 3.1 mt-10 -51.11 -45.52 61.59 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 122.207 -0.308 . . . . 0.0 111.658 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.437 HD22 ' C ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -81.12 -53.02 6.75 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.081 -1.637 . . . . 0.0 111.997 -176.438 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 p -79.74 -27.81 40.52 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.2 0.524 . . . . 0.0 110.575 -172.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.81 12.9 80.73 Favored Glycine 0 C--N 1.285 -2.29 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 14.9 m -67.9 120.14 13.71 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.275 -1.132 . . . . 0.0 108.91 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.456 ' CG2' HG23 ' A' ' 24' ' ' VAL . 1.6 t -87.13 132.19 33.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -134.04 150.72 51.23 Favored 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -97.36 142.15 14.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' PHE . 63.0 p -88.11 -20.76 25.24 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.55 -0.719 . . . . 0.0 110.795 -175.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.59 ' NE ' ' O ' ' A' ' 64' ' ' THR . 1.6 ptm180 -148.27 -172.88 4.18 Favored 'General case' 0 C--N 1.289 -2.062 0 O-C-N 121.208 -0.933 . . . . 0.0 108.834 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.59 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 13.1 t -67.38 168.41 10.75 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.47 ' N ' ' OE1' ' A' ' 13' ' ' GLN . 92.5 mt -122.58 149.34 44.1 Favored 'General case' 0 C--N 1.278 -2.521 0 O-C-N 120.629 -1.294 . . . . 0.0 108.695 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -130.49 117.6 19.87 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -178.569 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 1.86 1.42 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 66' ' ' ASP . 2.9 mt-10 -78.53 -29.23 46.34 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.79 -55.77 5.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-O 122.209 1.004 . . . . 0.0 108.342 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.4 HG21 ' CG ' ' A' ' 73' ' ' TYR . 1.9 mt -137.85 139.27 43.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.54 -24.21 18.05 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.7 p -154.1 129.6 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 58.1 m-85 -97.21 124.1 41.19 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -98.55 88.39 4.08 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.6 170.74 15.47 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.8 m-85 -124.58 131.57 53.47 Favored 'General case' 0 C--N 1.274 -2.711 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.614 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.06 146.92 17.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -177.285 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.65 ' HB3' HG23 ' A' ' 86' ' ' THR . 40.8 mt-10 -137.1 138.53 40.45 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.638 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -86.76 133.54 33.65 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 170.322 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.605 ' C ' HD21 ' A' ' 87' ' ' LEU . 4.6 p -129.78 146.13 51.54 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.052 -1.059 . . . . 0.0 112.476 -172.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.519 ' HB2' HD11 ' A' ' 87' ' ' LEU . 1.4 t70 -80.66 170.14 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 32' ' ' ARG . 35.2 m -61.62 -24.43 33.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -79.72 2.5 22.53 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.23 16.93 78.61 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 80' ' ' THR . 14.0 mttp -81.02 142.15 33.68 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.65 HG23 ' HB3' ' A' ' 78' ' ' GLU . 35.5 m -88.76 116.77 27.26 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.904 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.98 -19.45 22.4 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.77 146.73 23.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.537 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 99.41 -176.72 29.19 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.86 103.99 0.31 Allowed 'Cis proline' 0 N--CA 1.5 1.873 0 C-N-CA 123.669 -1.388 . . . . 0.0 112.519 -0.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.887 HG21 HG21 ' A' ' 2' ' ' ILE . 11.7 m -79.9 162.97 60.41 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -94.52 151.06 1.92 Allowed 'Trans proline' 0 C--N 1.296 -2.19 0 C-N-CA 121.808 1.672 . . . . 0.0 112.101 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.44 HD13 ' CG2' ' A' ' 4' ' ' VAL . 5.3 tp -133.88 129.8 36.92 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -107.39 114.13 27.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.477 -0.764 . . . . 0.0 109.907 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.499 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 57.8 t -103.81 104.1 16.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.552 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.8 mp -86.13 139.19 17.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 38.5 t -95.0 124.38 47.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 10.4 pt -112.13 170.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -94.54 171.39 8.83 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.921 -1.112 . . . . 0.0 108.124 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 102' ' ' ASP . 23.2 pt20 -156.93 158.55 36.86 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -71.9 66.76 0.58 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.527 ' CG ' ' N ' ' A' ' 103' ' ' ASN . 4.3 p-10 -56.46 -57.06 13.93 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.406 -171.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.527 ' N ' ' CG ' ' A' ' 102' ' ' ASP . 1.3 m-20 58.92 27.79 16.7 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.527 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 24.9 mtm180 -61.01 135.3 93.17 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--O 1.199 -1.462 0 C-N-CA 122.044 1.829 . . . . 0.0 112.57 -179.311 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 2.7 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.746 HG21 HG21 ' A' ' 91' ' ' VAL . 24.8 mt -86.46 134.43 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.42 -0.8 . . . . 0.0 110.438 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -120.89 124.64 72.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 173.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.463 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -135.52 157.05 39.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.74 143.18 47.99 Favored Pre-proline 0 C--N 1.276 -2.596 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.33 133.86 30.92 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.017 1.811 . . . . 0.0 110.359 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.42 HG21 HG23 ' A' ' 21' ' ' VAL . 42.9 mt -105.05 112.29 38.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 O-C-N 121.54 -0.725 . . . . 0.0 109.653 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.873 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -93.49 110.73 22.3 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.536 HG22 ' NE2' ' A' ' 13' ' ' GLN . 1.8 mt -120.23 134.7 24.11 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.541 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 35.8 Cg_endo -74.13 154.46 47.03 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 CA-C-N 119.68 0.922 . . . . 0.0 112.742 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.0 174.24 10.86 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-O 122.304 1.05 . . . . 0.0 111.12 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.583 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 57.5 t30 52.38 24.69 3.05 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -77.99 137.47 38.31 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 174.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.583 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -101.26 175.21 5.66 Favored 'General case' 0 C--N 1.267 -3.005 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.524 -177.652 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.651 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -53.49 -179.32 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.651 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 6.7 Cg_exo -70.74 128.92 14.45 Favored 'Cis proline' 0 N--CA 1.491 1.338 0 C-N-CA 124.25 -1.146 . . . . 0.0 113.422 -0.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 63' ' ' ARG . 22.7 m-85 -113.43 165.74 12.7 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 14.7 Cg_exo -70.66 161.43 88.82 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 C-N-CA 124.412 -1.078 . . . . 0.0 112.254 -1.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.477 ' NH2' ' OE1' ' A' ' 13' ' ' GLN . 1.2 mtp-105 -131.17 128.28 39.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.477 -0.764 . . . . 0.0 109.711 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 5.3 t0 -63.06 133.2 54.14 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.42 HG23 HG21 ' A' ' 7' ' ' ILE . 29.4 m -128.86 5.57 2.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 175.14 168.74 36.11 Favored Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.108 -1.52 . . . . 0.0 109.635 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -131.99 117.09 17.95 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.164 -1.198 . . . . 0.0 109.699 -178.399 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.516 HG23 HG22 ' A' ' 59' ' ' VAL . 16.5 t -81.81 134.4 27.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 172.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 3' ' ' VAL . 24.9 t -126.64 133.26 68.99 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.613 ' CB ' HG21 ' A' ' 79' ' ' THR . 9.1 t0 -107.4 137.46 45.4 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.34 4.0 41.06 Favored 'General case' 0 C--N 1.274 -2.692 0 O-C-N 121.104 -0.998 . . . . 0.0 110.752 -175.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -148.86 72.6 1.19 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.452 ' HG3' ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -104.01 126.54 31.47 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.181 -0.95 . . . . 0.0 110.357 -177.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' GLU . 74.9 Cg_exo -49.77 154.3 4.98 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.54 2.16 . . . . 0.0 111.171 174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -25.12 -63.06 0.06 Allowed 'General case' 0 N--CA 1.512 2.646 0 C-N-CA 123.541 0.736 . . . . 0.0 111.382 -179.125 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' NH2' ' O ' ' A' ' 33' ' ' SER . 1.6 mmm180 -129.99 74.24 1.58 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.964 0.888 . . . . 0.0 109.118 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.538 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -80.49 158.13 25.95 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.545 0.688 . . . . 0.0 109.634 -179.516 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 11.3 mmtp -105.4 170.61 7.79 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.613 ' HB3' HD13 ' A' ' 52' ' ' ILE . 23.5 m-85 -120.98 131.9 54.59 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.685 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 4.3 mmp_? -108.28 139.24 43.26 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.687 ' O ' HG11 ' A' ' 42' ' ' VAL . 15.3 tp -128.54 139.28 52.38 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.07 170.56 15.96 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.31 159.1 10.31 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.93 114.0 1.42 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 124.76 -22.15 6.52 Favored Glycine 0 C--N 1.281 -2.492 0 N-CA-C 107.383 -2.287 . . . . 0.0 107.383 -173.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.687 HG11 ' O ' ' A' ' 37' ' ' LEU . 47.0 t -116.52 -97.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' OD2' ' NZ ' ' A' ' 47' ' ' LYS . 35.0 t0 -90.87 -5.53 55.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 109.759 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -114.09 156.88 23.36 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.583 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 14.0 mm-40 -67.21 136.36 93.79 Favored Pre-proline 0 C--N 1.277 -2.563 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.533 -176.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.541 ' HB2' HD11 ' A' ' 49' ' ' ILE . 29.3 Cg_endo -69.94 115.05 2.3 Favored 'Cis proline' 0 N--CA 1.51 2.449 0 C-N-CA 123.316 -1.535 . . . . 0.0 111.359 -0.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.583 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 6.3 mttm -68.35 152.17 45.82 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.915 -1.116 . . . . 0.0 111.1 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.574 ' O ' ' NH1' ' A' ' 63' ' ' ARG . . . 56.44 49.08 71.32 Favored Glycine 0 N--CA 1.487 2.098 0 O-C-N 121.796 -0.565 . . . . 0.0 112.389 172.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.855 HD13 HH11 ' A' ' 63' ' ' ARG . 3.7 mm -106.42 -43.0 6.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -116.79 138.73 51.28 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.973 0.892 . . . . 0.0 110.996 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -124.16 170.32 10.84 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.613 HD13 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -132.91 147.96 31.55 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.473 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 171.283 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 55' ' ' ASN . 21.1 t-20 -78.68 112.18 15.53 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 118.101 -1.44 . . . . 0.0 108.31 -176.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 mp0 -59.58 10.27 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 C-N-CA 124.455 1.102 . . . . 0.0 112.263 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 53' ' ' ASN . 31.8 m-80 -137.86 -48.39 0.56 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 109.009 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 17.5 p -87.33 -27.76 22.65 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.543 -0.723 . . . . 0.0 109.478 -177.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.47 5.82 74.77 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 14.6 m -66.84 123.53 20.41 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.394 -1.062 . . . . 0.0 109.379 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.552 HG11 HD21 ' A' ' 93' ' ' LEU . 2.0 t -82.57 122.42 37.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -123.42 140.89 52.54 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.404 -0.81 . . . . 0.0 110.133 -177.547 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 10.6 p -90.93 144.04 9.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.9 p -96.27 -17.62 20.6 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.773 -0.58 . . . . 0.0 111.146 -176.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.855 HH11 HD13 ' A' ' 49' ' ' ILE . 5.5 ptp85 -153.52 -176.22 5.71 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.783 -1.198 . . . . 0.0 110.464 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 4.1 t -74.86 142.99 44.07 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 121.446 0.641 . . . . 0.0 110.127 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.2 mt -104.64 158.81 16.25 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.323 -0.861 . . . . 0.0 109.164 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.406 ' HB3' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -136.71 120.71 17.64 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HG3' HG12 ' A' ' 97' ' ' VAL . 34.5 mtm105 -63.91 -12.11 33.97 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.085 . . . . 0.0 108.342 175.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.03 -22.96 60.55 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 66' ' ' ASP . 24.1 t -101.11 -53.23 7.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.459 HD12 ' CE2' ' A' ' 73' ' ' TYR . 1.4 mt -144.9 136.41 20.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.64 -24.24 20.55 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -159.74 140.52 4.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.587 -0.695 . . . . 0.0 109.511 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.459 ' CE2' HD12 ' A' ' 70' ' ' ILE . 58.6 m-85 -104.13 136.99 42.73 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -97.17 92.28 5.95 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -91.72 170.56 9.8 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.643 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 77.6 m-85 -135.66 140.62 44.63 Favored 'General case' 0 C--N 1.265 -3.08 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -119.23 155.18 21.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 120.977 0.418 . . . . 0.0 110.079 -177.186 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.809 ' HB3' HG23 ' A' ' 86' ' ' THR . 33.1 mt-10 -140.94 141.35 34.5 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 173.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -88.31 128.37 35.49 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 171.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.502 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.1 OUTLIER -119.86 161.2 21.22 Favored 'General case' 0 C--N 1.272 -2.766 0 O-C-N 121.543 -0.723 . . . . 0.0 110.847 -172.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.608 ' HB2' HD21 ' A' ' 87' ' ' LEU . 5.2 t0 -108.97 170.44 8.04 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -52.98 -22.85 4.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -79.66 2.24 23.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.423 -0.798 . . . . 0.0 109.171 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 62.97 28.14 71.52 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 80' ' ' THR . 17.0 mttm -95.24 137.95 33.61 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.809 HG23 ' HB3' ' A' ' 78' ' ' GLU . 10.7 m -71.97 117.67 13.86 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.608 HD21 ' HB2' ' A' ' 81' ' ' ASP . 1.5 mm? -81.45 -46.37 14.67 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.448 ' OE2' ' N ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -140.11 157.82 45.03 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 95.09 -177.48 35.25 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.76 112.92 0.61 Allowed 'Cis proline' 0 N--CA 1.499 1.808 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.652 -0.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.746 HG21 HG21 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -93.45 168.27 12.34 Favored Pre-proline 0 C--N 1.284 -2.274 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 175.106 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -96.23 156.67 1.35 Allowed 'Trans proline' 0 C--N 1.295 -2.287 0 C-N-CA 121.564 1.509 . . . . 0.0 112.823 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.552 HD21 HG11 ' A' ' 59' ' ' VAL . 9.6 tp -142.52 124.35 15.14 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -105.43 115.38 30.15 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-O 121.432 0.634 . . . . 0.0 109.652 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 96.0 t -102.55 108.82 24.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.624 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.8 mp -90.71 139.34 17.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 O-C-N 121.488 -0.758 . . . . 0.0 108.971 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.433 HG12 ' HG3' ' A' ' 67' ' ' ARG . 17.4 t -95.17 110.44 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.8 pt -96.7 170.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.711 ' CB ' HH12 ' A' ' 104' ' ' ARG . 0.2 OUTLIER -72.98 161.71 30.37 Favored 'General case' 0 C--N 1.281 -2.411 0 O-C-N 120.883 -1.136 . . . . 0.0 110.481 -175.205 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 102' ' ' ASP . 35.7 mt-30 -50.91 87.4 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.547 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 103' ' ' ASN . 5.6 t-20 61.47 -72.4 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.378 -0.826 . . . . 0.0 110.674 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.483 ' O ' ' NH1' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -66.1 77.75 0.09 Allowed 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.277 -0.889 . . . . 0.0 108.855 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 101' ' ' ASN . 0.2 OUTLIER -51.04 -27.8 8.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.769 -178.157 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.711 HH12 ' CB ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER 39.58 65.96 3.29 Favored Pre-proline 0 N--CA 1.505 2.294 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -178.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 C--O 1.195 -1.64 0 C-N-CA 122.335 2.023 . . . . 0.0 111.047 -179.014 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 1.1 m . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.913 HG21 HG21 ' A' ' 91' ' ' VAL . 24.6 mt -88.98 142.79 12.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.714 0.769 . . . . 0.0 111.329 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.85 135.17 50.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.584 HG21 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -141.12 162.51 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.134 -0.978 . . . . 0.0 109.177 -176.758 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -128.0 149.64 71.46 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.648 ' HB3' HD11 ' A' ' 96' ' ' ILE . 50.4 Cg_exo -51.71 137.75 50.37 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 110.464 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.604 HG13 HD11 ' A' ' 93' ' ' LEU . 32.1 mt -99.44 110.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -100.24 98.39 9.07 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.4 ' CG1' HG22 ' A' ' 7' ' ' ILE . 17.8 mt -102.18 129.25 26.67 Favored Pre-proline 0 C--N 1.271 -2.837 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 19.4 Cg_endo -66.95 125.16 13.21 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 N-CA-C 109.715 -0.917 . . . . 0.0 109.715 174.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.746 ' HB3' HG12 ' A' ' 97' ' ' VAL . 4.5 pt-20 -62.6 -176.74 0.12 Allowed 'General case' 0 C--N 1.284 -2.279 0 CA-C-O 122.266 1.032 . . . . 0.0 111.746 -173.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.74 -4.54 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 68.0 mt-30 -59.68 113.86 2.46 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.43 ' HD3' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -79.5 -174.94 4.5 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.924 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.57 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 10.3 mm-40 -47.32 166.36 0.19 Allowed Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 3.4 Cg_endo -82.47 148.4 67.17 Favored 'Cis proline' 0 C--N 1.309 -1.549 0 C-N-CA 123.918 -1.284 . . . . 0.0 114.285 0.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 37.6 m-85 -134.0 170.46 11.24 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 5.2 Cg_exo -75.07 156.69 99.83 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 120.812 1.326 . . . . 0.0 110.84 0.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.447 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 24.8 mtp180 -133.8 126.51 30.72 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.327 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.69 129.84 43.53 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -126.2 -5.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.905 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.33 141.27 6.34 Favored Glycine 0 C--N 1.285 -2.275 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 22.9 ttpp -109.9 119.91 40.81 Favored 'General case' 0 C--N 1.286 -2.184 0 O-C-N 121.487 -1.007 . . . . 0.0 109.889 -177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.592 HG23 ' CG2' ' A' ' 59' ' ' VAL . 44.0 t -80.84 142.32 14.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 171.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.2 t -126.13 126.2 69.15 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.837 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 14.9 t0 -99.17 128.49 45.31 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 171.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 p -80.54 -87.55 0.08 Allowed 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.166 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -73.65 53.96 0.45 Allowed 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.534 -0.729 . . . . 0.0 109.463 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' NH2' ' O ' ' A' ' 56' ' ' THR . 25.7 mtt180 -64.86 155.49 82.87 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.611 -0.681 . . . . 0.0 110.715 -176.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.16 121.76 9.52 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 N-CA-C 107.006 -1.959 . . . . 0.0 107.006 163.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -31.01 -48.89 0.12 Allowed 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 32' ' ' ARG . 3.5 mtp180 -105.03 20.97 17.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.026 -1.046 . . . . 0.0 110.91 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 p -64.48 156.26 30.17 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.975 -1.078 . . . . 0.0 108.586 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -120.02 170.4 9.32 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.341 -0.849 . . . . 0.0 109.169 178.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.69 ' HB3' HD13 ' A' ' 52' ' ' ILE . 47.8 m-85 -105.75 126.38 52.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.234 -0.916 . . . . 0.0 110.3 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' HG3' HG21 ' A' ' 80' ' ' THR . 0.0 OUTLIER -109.31 121.22 44.7 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.111 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.677 HD11 HD23 ' A' ' 93' ' ' LEU . 19.5 tp -99.6 156.77 16.89 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -160.14 171.44 19.25 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -174.679 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.34 174.66 19.05 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.356 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 111.17 1.64 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 123.99 -13.51 8.03 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -176.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.7 t -130.46 -99.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.616 -0.932 . . . . 0.0 108.568 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.418 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -84.1 -1.58 55.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.346 -0.846 . . . . 0.0 108.898 178.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -126.12 150.69 48.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 108.685 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.583 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.7 mp0 -60.62 133.06 91.43 Favored Pre-proline 0 C--N 1.279 -2.49 0 C-N-CA 123.579 0.752 . . . . 0.0 110.463 -176.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 30.6 Cg_endo -66.24 117.46 2.06 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 C-N-CA 123.634 -1.402 . . . . 0.0 110.921 -1.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.583 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 23.3 mttp -69.84 145.56 52.0 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.155 -0.966 . . . . 0.0 111.611 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.24 41.45 79.21 Favored Glycine 0 C--N 1.283 -2.412 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.416 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 41' ' ' GLY . 12.6 mm -88.7 -41.41 14.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 74.2 m-85 -112.25 148.91 33.14 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.069 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -145.47 135.16 23.4 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 172.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.69 HD13 ' HB3' ' A' ' 35' ' ' PHE . 18.6 tt -94.93 161.25 2.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.663 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -79.4 114.4 18.31 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.486 ' HA ' ' H ' ' A' ' 35' ' ' PHE . 2.9 mt-10 -65.53 10.55 0.09 Allowed 'General case' 0 C--N 1.286 -2.189 0 O-C-N 121.838 -0.538 . . . . 0.0 112.425 -174.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.411 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 1.4 t-20 -133.05 -50.19 0.88 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.658 -1.276 . . . . 0.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.471 ' O ' ' NH2' ' A' ' 29' ' ' ARG . 55.0 p -79.4 -54.12 6.24 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -177.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 35' ' ' PHE . . . 121.97 2.26 10.3 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -63.48 122.25 15.82 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.671 -0.899 . . . . 0.0 109.466 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.592 ' CG2' HG23 ' A' ' 24' ' ' VAL . 44.5 t -91.35 117.65 35.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -109.17 140.31 42.93 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.918 -176.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.409 ' CG2' HD21 ' A' ' 65' ' ' LEU . 8.9 p -89.43 141.89 13.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' A' ' 49' ' ' ILE . 24.3 p -94.32 -19.71 20.42 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.29 -0.881 . . . . 0.0 111.034 -175.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.2 178.21 8.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.006 -1.059 . . . . 0.0 110.393 -176.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 2.0 t -68.53 143.8 54.81 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 61' ' ' VAL . 63.4 mt -106.25 142.28 36.2 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.305 -0.872 . . . . 0.0 109.115 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.484 ' HB2' HG23 ' A' ' 69' ' ' VAL . 19.4 m-20 -123.99 122.41 37.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.647 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 6.4 mtm105 -60.48 -9.72 4.05 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -79.15 -27.9 42.76 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.484 HG23 ' HB2' ' A' ' 66' ' ' ASP . 20.9 t -88.84 -55.56 6.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -144.74 134.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.99 -26.18 22.77 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.8 p -152.79 139.42 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.683 -0.636 . . . . 0.0 109.641 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -101.17 134.04 44.8 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.479 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 14.5 tp60 -96.96 96.08 8.26 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -98.61 170.1 9.04 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.193 0.996 . . . . 0.0 108.982 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.9 m-85 -137.47 137.28 38.55 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.709 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -117.42 138.21 48.82 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 CA-C-O 121.128 0.489 . . . . 0.0 110.573 -176.423 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.673 ' HB3' HG23 ' A' ' 86' ' ' THR . 32.7 mt-10 -133.95 139.87 46.4 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.643 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.53 141.62 31.48 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 169.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.478 ' C ' HD21 ' A' ' 87' ' ' LEU . 1.2 p -129.52 162.13 28.89 Favored 'General case' 0 C--N 1.275 -2.668 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.364 -174.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 10.2 t70 -100.67 170.3 8.45 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.502 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.2 m -53.6 -27.01 14.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.457 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 14.0 t-20 -79.89 3.53 19.53 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.408 -0.807 . . . . 0.0 109.538 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.31 17.5 70.39 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.457 ' NZ ' ' OD1' ' A' ' 83' ' ' ASN . 18.1 mttp -82.79 146.91 28.7 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.166 -1.197 . . . . 0.0 108.057 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.673 HG23 ' HB3' ' A' ' 78' ' ' GLU . 87.7 m -91.51 116.53 28.93 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.925 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.88 -23.8 18.67 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.779 ' HG3' HD12 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -145.41 164.84 30.28 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.526 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 80.72 -166.02 48.53 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -69.65 103.88 0.38 Allowed 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 123.487 -1.464 . . . . 0.0 110.926 -0.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.913 HG21 HG21 ' A' ' 2' ' ' ILE . 14.6 m -72.92 158.21 87.53 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -90.4 141.61 3.4 Favored 'Trans proline' 0 C--N 1.283 -2.901 0 C-N-CA 121.552 1.501 . . . . 0.0 112.424 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.677 HD23 HD11 ' A' ' 37' ' ' LEU . 12.6 tp -131.57 125.73 33.03 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.479 ' HG2' ' NE2' ' A' ' 74' ' ' GLN . 66.3 mt-10 -109.0 123.09 48.58 Favored 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.517 -0.739 . . . . 0.0 109.232 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 41.6 t -108.3 100.43 10.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.769 ' H ' HD12 ' A' ' 96' ' ' ILE . 3.4 mp -84.69 135.94 23.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-O 121.457 0.646 . . . . 0.0 109.298 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.746 HG12 ' HB3' ' A' ' 11' ' ' GLU . 5.1 t -92.37 99.25 9.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.588 HG21 ' HB3' ' A' ' 8' ' ' LEU . 16.4 pt -90.76 171.9 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.09 170.65 15.92 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.946 -1.096 . . . . 0.0 108.295 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.457 ' OE1' ' NH1' ' A' ' 104' ' ' ARG . 4.3 mt-30 -72.2 118.88 15.63 Favored 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 100' ' ' GLN . 46.1 t30 30.2 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 121.113 0.482 . . . . 0.0 111.541 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.505 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 0.4 OUTLIER 53.05 25.62 4.24 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.645 -0.66 . . . . 0.0 110.013 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 75.71 16.92 2.41 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.734 -0.604 . . . . 0.0 109.385 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.457 ' NH1' ' OE1' ' A' ' 100' ' ' GLN . 3.2 mtm180 49.49 61.7 13.38 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 104' ' ' ARG . 1.1 Cg_endo . . . . . 0 C--O 1.195 -1.671 0 C-N-CA 121.659 1.573 . . . . 0.0 111.411 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.505 ' N ' ' OE1' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.501 -0.941 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.95 HG21 HG21 ' A' ' 91' ' ' VAL . 40.5 mt -72.34 123.13 26.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.458 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.64 124.43 72.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -131.44 158.78 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 -178.268 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.417 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -127.37 131.03 23.64 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.595 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.459 ' HB2' HD11 ' A' ' 8' ' ' LEU . 53.6 Cg_exo -41.25 140.89 1.31 Allowed 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.205 1.936 . . . . 0.0 110.85 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.52 HG13 HD11 ' A' ' 93' ' ' LEU . 12.6 mt -103.93 115.45 45.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.724 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -107.99 96.8 6.63 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.44 ' CG1' HG22 ' A' ' 7' ' ' ILE . 1.3 mt -107.79 128.13 26.42 Favored Pre-proline 0 C--N 1.279 -2.471 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -176.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 40.5 Cg_endo -72.07 135.4 25.11 Favored 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 120.79 0.993 . . . . 0.0 110.163 175.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.46 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 2.1 pp20? -68.26 -173.32 0.39 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-O 121.996 0.903 . . . . 0.0 111.388 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.472 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 0.8 OUTLIER 60.65 -5.99 0.1 Allowed 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 174.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.536 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 57.5 mt-30 -61.87 137.0 58.2 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.472 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -107.14 -159.78 0.71 Allowed 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.681 -0.637 . . . . 0.0 110.158 -174.729 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.521 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -55.6 166.48 0.97 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.521 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 4.0 Cg_endo -80.29 118.18 5.63 Favored 'Cis proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.273 -1.553 . . . . 0.0 113.525 0.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -107.13 165.58 12.59 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.5 162.77 79.54 Favored 'Cis proline' 0 N--CA 1.504 2.094 0 C-N-CA 124.57 -1.012 . . . . 0.0 111.631 -1.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.536 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 39.4 mtp180 -132.26 144.57 50.7 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 33.7 t70 -77.01 139.34 40.04 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.484 HG23 HG21 ' A' ' 7' ' ' ILE . 31.0 m -127.01 -2.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.859 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 169.77 -178.6 42.64 Favored Glycine 0 N--CA 1.511 3.693 0 C-N-CA 117.355 -2.355 . . . . 0.0 110.401 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.494 ' NZ ' ' O ' ' A' ' 56' ' ' THR . 6.8 ttmm -137.01 127.73 27.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.712 -1.464 . . . . 0.0 112.0 -176.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.667 HG11 HG11 ' A' ' 77' ' ' VAL . 15.3 t -94.91 132.57 38.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 168.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.3 156.51 34.47 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.852 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' A' ' 29' ' ' ARG . 8.3 t70 -132.85 146.05 51.48 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.3 -1.71 26.61 Favored 'General case' 0 C--N 1.285 -2.206 0 O-C-N 121.559 -0.713 . . . . 0.0 111.322 -176.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -140.12 86.11 2.06 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.499 ' HD2' ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -125.43 133.0 24.46 Favored Pre-proline 0 C--N 1.295 -1.77 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 -179.381 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' ARG . 69.9 Cg_exo -52.53 131.49 41.12 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.433 1.422 . . . . 0.0 109.146 170.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -31.85 -35.57 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.463 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 8.7 mtp85 -114.39 10.63 17.08 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.253 -0.904 . . . . 0.0 110.794 -173.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 p -71.94 152.62 42.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.132 -0.98 . . . . 0.0 109.512 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.539 ' HB3' ' CB ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -131.19 154.74 48.08 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.948 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -79.78 144.76 33.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.498 -0.751 . . . . 0.0 110.801 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.468 ' NH1' ' OE1' ' A' ' 78' ' ' GLU . 1.3 mtp180 -116.5 145.08 43.57 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 tp -122.17 143.85 49.31 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 p -144.12 170.86 15.14 Favored 'General case' 0 C--N 1.276 -2.613 0 O-C-N 121.251 -0.905 . . . . 0.0 109.056 -175.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.02 164.88 13.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.56 106.19 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 133.75 -16.23 4.54 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -175.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 50' ' ' PHE . 38.2 t -132.73 -88.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.578 -0.954 . . . . 0.0 109.577 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.03 -20.51 34.87 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -118.11 157.31 27.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.844 0.831 . . . . 0.0 109.53 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 45' ' ' GLU . 1.8 mp0 -56.33 132.4 76.01 Favored Pre-proline 0 C--N 1.28 -2.414 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.756 -176.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.632 ' HB2' HD11 ' A' ' 49' ' ' ILE . 4.9 Cg_endo -75.85 115.94 3.86 Favored 'Cis proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.091 -1.629 . . . . 0.0 110.126 -0.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 32.8 mtpt -69.42 153.85 42.92 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 120.721 -1.237 . . . . 0.0 111.425 -174.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.52 9.1 29.69 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-O 119.261 -0.744 . . . . 0.0 113.34 173.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 46' ' ' PRO . 8.1 mm -60.83 -48.76 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.509 0 CA-C-N 120.239 2.019 . . . . 0.0 106.795 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.418 ' HB2' HG22 ' A' ' 42' ' ' VAL . 86.4 m-85 -108.35 166.62 10.62 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-O 121.815 0.817 . . . . 0.0 110.413 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.84 126.6 7.53 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.432 HG13 HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -93.46 146.84 5.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.298 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.475 ' O ' ' N ' ' A' ' 57' ' ' GLY . 1.9 t-20 -79.46 85.11 5.27 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.539 ' CB ' ' HB3' ' A' ' 34' ' ' LYS . 1.9 mt-10 -30.82 -34.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 124.053 0.941 . . . . 0.0 113.431 -174.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -93.0 -50.42 5.55 Favored 'General case' 0 C--N 1.285 -2.231 0 O-C-N 121.544 -0.723 . . . . 0.0 110.373 -174.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.494 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 18.8 p -88.32 -12.32 43.8 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 122.047 0.927 . . . . 0.0 108.831 -175.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . 69.82 9.36 62.47 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.49 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 3.5 m -69.35 124.58 24.22 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.326 -1.103 . . . . 0.0 108.291 177.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.499 ' CG2' HG23 ' A' ' 24' ' ' VAL . 1.8 t -90.02 122.52 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.182 -0.949 . . . . 0.0 109.192 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -118.26 154.15 32.75 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.198 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.602 ' CG2' HD21 ' A' ' 65' ' ' LEU . 12.1 p -107.46 149.92 10.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.7 p -104.32 -22.9 13.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.503 -0.748 . . . . 0.0 112.101 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HD2' HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -137.56 168.52 19.5 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.979 -1.075 . . . . 0.0 111.381 -175.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 12.1 t -64.87 123.42 19.36 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.602 HD21 ' CG2' ' A' ' 61' ' ' VAL . 36.7 mt -82.08 163.54 21.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.063 -1.023 . . . . 0.0 108.497 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -127.92 170.42 12.86 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.546 ' NE ' ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.68 27.39 8.22 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 121.873 0.844 . . . . 0.0 109.158 -177.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -120.32 -42.18 2.58 Favored 'General case' 0 C--N 1.262 -3.213 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.81 -47.78 16.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 70' ' ' ILE . 2.0 mt -129.85 137.25 57.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.44 -24.13 14.23 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 p -156.29 146.43 11.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.423 -0.798 . . . . 0.0 109.345 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.492 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 60.6 m-85 -103.96 114.48 28.76 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 174.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.499 HE22 ' HG2' ' A' ' 94' ' ' GLU . 5.6 tp-100 -88.01 83.07 7.07 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.79 170.58 15.54 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 43.8 m-85 -133.69 129.74 37.2 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.698 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -105.77 144.21 15.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 O-C-N 121.894 -0.503 . . . . 0.0 109.859 -175.711 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.708 ' HB3' HG23 ' A' ' 86' ' ' THR . 56.0 mt-10 -131.31 140.95 49.86 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.648 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -86.3 127.63 34.81 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 102.806 -3.035 . . . . 0.0 102.806 167.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.584 ' C ' HD21 ' A' ' 87' ' ' LEU . 19.5 p -123.04 146.05 48.0 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 118.567 -1.253 . . . . 0.0 111.713 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.736 ' N ' HD21 ' A' ' 87' ' ' LEU . 29.0 t70 -88.72 165.76 14.51 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.017 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -55.76 -27.21 21.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -79.5 -13.19 59.73 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.102 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.04 7.18 50.67 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -76.4 143.77 40.44 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 120.666 -1.49 . . . . 0.0 107.787 178.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.708 HG23 ' HB3' ' A' ' 78' ' ' GLU . 98.3 m -86.98 116.08 24.8 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.884 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -87.24 -20.8 26.37 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' OE1' ' N ' ' A' ' 1' ' ' SER . 4.7 tt0 -157.94 153.2 25.81 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.521 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 83.91 -169.5 46.53 Favored Glycine 0 C--N 1.28 -2.536 0 N-CA-C 106.698 -2.561 . . . . 0.0 106.698 -174.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.85 103.23 0.14 OUTLIER 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.644 -1.398 . . . . 0.0 112.722 -0.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.95 HG21 HG21 ' A' ' 2' ' ' ILE . 3.7 m -78.4 164.35 56.7 Favored Pre-proline 0 C--N 1.289 -2.059 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -93.71 153.14 2.32 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 121.498 1.465 . . . . 0.0 112.622 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 4' ' ' VAL . 5.4 tp -141.0 129.76 22.92 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.499 ' HG2' HE22 ' A' ' 74' ' ' GLN . 31.7 mt-10 -102.92 110.57 22.54 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 60.0 t -103.69 93.08 2.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 96' ' ' ILE . 3.4 mp -79.76 134.3 27.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 O-C-N 121.507 -0.746 . . . . 0.0 109.24 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 55.2 t -88.38 102.49 12.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.518 HG21 ' HB3' ' A' ' 8' ' ' LEU . 9.5 pt -80.17 170.78 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.244 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -95.97 178.66 5.35 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 101' ' ' ASN . 34.7 mm-40 -70.94 107.64 4.15 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 100' ' ' GLN . 71.6 m-20 -38.79 -55.75 1.45 Allowed 'General case' 0 N--CA 1.51 2.544 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.503 ' O ' ' NH1' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -118.58 109.5 16.24 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 171.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.422 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 8.5 t30 -59.25 129.89 44.29 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 102' ' ' ASP . 6.6 mmt-85 -104.86 97.34 12.56 Favored Pre-proline 0 C--N 1.282 -2.347 0 O-C-N 121.467 -0.77 . . . . 0.0 109.526 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 103' ' ' ASN . 38.1 Cg_endo . . . . . 0 C--N 1.317 -1.123 0 C-N-CA 122.173 1.915 . . . . 0.0 110.641 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.467 ' N ' ' OE2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.73 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.777 HG21 HG21 ' A' ' 91' ' ' VAL . 18.9 mt -67.82 148.54 11.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.53 0.681 . . . . 0.0 110.015 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.76 114.31 24.66 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -134.32 169.63 21.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.524 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 2.1 m -159.39 165.94 17.2 Favored Pre-proline 0 C--N 1.276 -2.618 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 33.1 Cg_exo -55.47 131.32 45.46 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.553 1.502 . . . . 0.0 111.946 -175.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.4 HG13 HD11 ' A' ' 93' ' ' LEU . 11.1 mt -106.13 115.88 48.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.841 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -90.25 108.01 19.49 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.421 ' CD1' HG13 ' A' ' 95' ' ' VAL . 23.2 mt -109.81 124.23 34.19 Favored Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 6.5 Cg_exo -66.06 124.49 12.69 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.062 1.175 . . . . 0.0 110.777 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -41.86 -72.2 0.07 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.578 0.704 . . . . 0.0 111.797 -176.466 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.492 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 48.2 p-10 -66.4 40.55 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -174.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.484 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -76.01 56.04 0.96 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 119.608 -1.933 . . . . 0.0 106.145 172.074 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.564 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -45.59 175.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.331 1.062 . . . . 0.0 113.599 -172.216 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 37.5 mt-30 -48.25 166.34 0.22 Allowed Pre-proline 0 C--N 1.285 -2.201 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.754 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 5.7 Cg_exo -76.1 134.89 37.7 Favored 'Cis proline' 0 N--CA 1.497 1.721 0 C-N-CA 123.725 -1.364 . . . . 0.0 113.898 0.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CZ ' ' O ' ' A' ' 13' ' ' GLN . 24.2 m-85 -102.49 166.24 12.37 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 12.2 Cg_exo -69.36 166.7 72.32 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.312 -0.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.564 ' NH2' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -125.1 135.28 52.54 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.98 137.16 51.19 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.25 4.83 3.06 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.011 0 C-N-CA 119.441 -0.903 . . . . 0.0 109.014 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 158.37 -170.32 35.04 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 118.218 -1.944 . . . . 0.0 109.632 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 19.4 ttmm -148.13 128.56 13.97 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.23 -1.159 . . . . 0.0 109.768 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.672 HG11 HG11 ' A' ' 77' ' ' VAL . 21.7 t -89.25 147.07 5.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 26' ' ' ASP . 61.0 t -132.38 163.73 36.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 9.8 t70 -125.09 141.11 52.32 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.459 ' HG ' ' HB2' ' A' ' 1' ' ' SER . 0.7 OUTLIER -74.25 -21.74 59.63 Favored 'General case' 0 C--N 1.26 -3.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.362 -176.095 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -144.56 82.16 1.68 Allowed 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' CG ' ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -87.3 115.82 64.03 Favored Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.154 -0.966 . . . . 0.0 109.746 -176.29 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -42.4 138.09 3.44 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.909 1.739 . . . . 0.0 109.461 175.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -41.49 -35.55 0.72 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.813 -0.554 . . . . 0.0 110.937 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -120.59 40.15 3.58 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.81 -0.556 . . . . 0.0 110.2 -176.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.477 ' C ' ' HG2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -84.62 -179.85 7.22 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.798 -1.189 . . . . 0.0 111.263 -177.336 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HG2' ' C ' ' A' ' 33' ' ' SER . 6.2 mmtm -147.71 150.51 34.44 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.491 ' N ' ' O ' ' A' ' 54' ' ' GLU . 35.5 m-85 -94.65 124.28 38.59 Favored 'General case' 0 C--N 1.28 -2.446 0 O-C-N 121.408 -0.807 . . . . 0.0 109.485 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.698 ' HG3' HG21 ' A' ' 80' ' ' THR . 4.4 mmp_? -107.61 125.77 51.73 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.669 ' HG ' HG21 ' A' ' 42' ' ' VAL . 44.1 tp -106.29 144.45 32.95 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -149.68 170.89 17.64 Favored 'General case' 0 C--N 1.278 -2.5 0 O-C-N 121.163 -0.96 . . . . 0.0 108.732 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.91 176.26 18.71 Favored Glycine 0 N--CA 1.502 3.033 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.056 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 44' ' ' GLN . 36.5 mtpt -61.11 121.16 11.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 110.16 -20.77 25.62 Favored Glycine 0 C--N 1.28 -2.552 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 -177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.669 HG21 ' HG ' ' A' ' 37' ' ' LEU . 40.9 t -116.2 -93.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -92.98 -12.58 30.37 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.59 -0.694 . . . . 0.0 109.647 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 40' ' ' LYS . 6.0 mm-40 -109.7 157.58 18.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -57.81 132.52 82.95 Favored Pre-proline 0 C--N 1.288 -2.1 0 O-C-N 121.982 -0.449 . . . . 0.0 110.084 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.444 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -77.42 118.77 5.95 Favored 'Cis proline' 0 N--CA 1.501 1.959 0 C-N-CA 123.91 -1.287 . . . . 0.0 110.24 -0.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 mttp -67.14 149.69 50.17 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 120.788 -1.195 . . . . 0.0 111.947 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.22 29.3 72.61 Favored Glycine 0 N--CA 1.49 2.286 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.748 171.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.498 HG23 ' HD2' ' A' ' 63' ' ' ARG . 10.6 mm -83.77 -44.75 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 173.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.663 ' HB2' HG22 ' A' ' 42' ' ' VAL . 84.3 m-85 -106.33 147.76 28.82 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.601 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.57 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -141.94 126.25 17.59 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 177.076 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.61 147.67 8.88 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.542 ' CG ' HG23 ' A' ' 56' ' ' THR . 28.5 t-20 -79.68 99.97 7.65 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -42.39 -26.64 0.12 Allowed 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.896 -177.014 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -106.5 -37.28 6.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.909 -1.12 . . . . 0.0 111.69 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.542 HG23 ' CG ' ' A' ' 53' ' ' ASN . 5.1 p -89.8 -15.23 32.78 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 120.984 -1.072 . . . . 0.0 108.918 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.24 2.62 49.14 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.518 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 19.3 m -64.51 124.37 21.67 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.292 -1.122 . . . . 0.0 108.815 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 24' ' ' VAL . 2.1 t -88.96 131.0 37.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.57 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -130.87 160.53 34.17 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.44 149.37 19.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.1 p -94.71 -10.57 31.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.48 -0.763 . . . . 0.0 111.148 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -155.15 162.92 40.85 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.052 -1.03 . . . . 0.0 109.306 -178.196 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.528 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 5.1 t -62.18 138.2 58.37 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 65.2 mt -90.71 131.58 36.31 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -106.06 119.34 38.96 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -57.62 -7.65 0.71 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -77.89 -26.93 49.49 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.9 t -89.87 -53.02 9.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.416 HD12 ' CE1' ' A' ' 73' ' ' TYR . 2.8 mt -151.66 144.02 16.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.28 -25.55 16.29 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.1 p -154.92 135.95 5.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.501 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.416 ' CE1' HD12 ' A' ' 70' ' ' ILE . 37.4 m-85 -106.03 138.64 41.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -100.7 87.08 3.25 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.405 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -81.11 170.78 15.74 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 57.0 m-85 -132.21 131.37 42.09 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.716 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -110.18 140.64 28.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 O-C-N 122.022 -0.424 . . . . 0.0 110.046 -177.059 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.619 ' HB3' HG23 ' A' ' 86' ' ' THR . 43.8 mt-10 -130.28 137.12 49.82 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.681 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -86.2 133.8 33.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 172.466 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.698 HG21 ' HG3' ' A' ' 36' ' ' ARG . 4.1 p -125.27 159.17 32.31 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.689 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.488 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -101.07 170.55 8.2 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 177.134 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.488 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 0.9 OUTLIER -43.09 -38.0 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 CA-C-O 121.825 0.821 . . . . 0.0 109.613 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.435 ' N ' ' CG2' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -79.95 2.85 21.93 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.697 -0.627 . . . . 0.0 109.975 -177.131 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.67 15.48 80.64 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 80' ' ' THR . 2.0 mtpp -73.51 134.18 43.8 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.619 HG23 ' HB3' ' A' ' 78' ' ' GLU . 91.0 m -81.27 116.92 21.37 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.803 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.914 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.33 -22.02 19.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.592 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.467 ' OE2' ' N ' ' A' ' 1' ' ' SER . 1.0 OUTLIER -151.21 149.37 29.35 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.265 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.556 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 105.43 -178.39 23.33 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -71.63 104.43 0.49 Allowed 'Cis proline' 0 N--CA 1.491 1.354 0 C-N-CA 123.304 -1.54 . . . . 0.0 111.568 0.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 2' ' ' ILE . 9.5 m -75.23 159.04 83.25 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 176.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -91.78 145.16 3.08 Favored 'Trans proline' 0 C--N 1.279 -3.089 0 C-N-CA 121.529 1.486 . . . . 0.0 111.699 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.544 HD23 HD11 ' A' ' 37' ' ' LEU . 11.2 tp -128.84 126.97 40.94 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 4.2 mt-10 -106.81 110.29 22.42 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.63 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 24.8 t -101.8 112.22 34.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.7 mp -97.55 136.28 28.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.57 111.76 23.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.674 HG21 ' HB3' ' A' ' 8' ' ' LEU . 9.7 pt -105.45 171.63 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.58 154.7 27.85 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -91.14 69.02 6.13 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -172.09 155.16 3.62 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.439 ' OD1' ' NH1' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -115.45 -36.85 4.17 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.068 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.1 t30 61.21 19.4 10.03 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.439 ' NH1' ' OD1' ' A' ' 102' ' ' ASP . 4.3 mtm-85 -57.04 117.67 19.25 Favored Pre-proline 0 N--CA 1.485 1.303 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--N 1.305 -1.711 0 C-N-CA 122.15 1.9 . . . . 0.0 110.603 179.702 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.411 ' H3 ' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.85 HG21 HG21 ' A' ' 91' ' ' VAL . 17.2 mt -62.01 146.02 12.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-O 121.934 0.874 . . . . 0.0 111.065 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -134.85 115.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.553 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 174.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.528 HG23 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -127.14 161.86 33.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.057 -1.027 . . . . 0.0 108.9 -175.498 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.451 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -155.52 138.84 10.89 Favored Pre-proline 0 C--N 1.273 -2.74 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -41.9 138.91 2.55 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 C-N-CA 122.351 2.034 . . . . 0.0 112.724 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.508 HG13 HD11 ' A' ' 93' ' ' LEU . 16.2 mt -104.63 119.44 53.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 175.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.8 mp -106.15 79.42 1.4 Allowed 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.486 HG13 HG22 ' A' ' 7' ' ' ILE . 4.7 mt -81.99 140.35 46.47 Favored Pre-proline 0 C--N 1.281 -2.398 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 100' ' ' GLN . 11.1 Cg_endo -73.69 137.13 24.44 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 120.748 0.965 . . . . 0.0 111.046 177.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.696 ' HB3' HG12 ' A' ' 97' ' ' VAL . 1.5 pt-20 -66.08 170.59 5.48 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.283 -0.886 . . . . 0.0 109.198 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.438 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 5.3 t-20 59.8 13.5 3.58 Favored 'General case' 0 C--N 1.287 -2.114 0 O-C-N 121.752 -0.593 . . . . 0.0 112.093 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -57.58 127.63 32.97 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.571 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -89.67 158.53 17.54 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.153 -0.967 . . . . 0.0 112.781 -170.73 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.59 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 12.3 mp0 -50.07 167.05 0.25 Allowed Pre-proline 0 C--N 1.296 -1.733 0 C-N-CA 124.938 1.295 . . . . 0.0 109.022 176.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 67.8 Cg_endo -79.61 154.67 88.64 Favored 'Cis proline' 0 C--N 1.31 -1.473 0 C-N-CA 123.613 -1.411 . . . . 0.0 113.641 0.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 33.9 m-85 -135.09 169.86 12.7 Favored Pre-proline 0 C--N 1.276 -2.597 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.6 Cg_exo -68.94 173.34 41.99 Favored 'Cis proline' 0 N--CA 1.493 1.469 0 C-N-CA 124.485 -1.048 . . . . 0.0 112.124 0.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.571 ' NH2' ' O ' ' A' ' 14' ' ' ARG . 7.1 ttm180 -155.88 145.2 20.81 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -65.65 132.83 49.78 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.01 3.74 5.14 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 163.36 179.11 37.61 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.93 131.88 35.74 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.818 -1.401 . . . . 0.0 110.134 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 77' ' ' VAL . 24.2 t -91.69 126.62 44.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 102.179 -3.267 . . . . 0.0 102.179 166.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.437 ' HB ' HG13 ' A' ' 3' ' ' VAL . 33.0 t -112.07 159.69 11.91 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 C-N-CA 118.472 -1.291 . . . . 0.0 109.068 -173.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -144.99 110.35 5.24 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -88.33 -56.45 3.31 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -175.138 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -71.3 62.03 0.33 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 122.634 1.207 . . . . 0.0 107.799 178.196 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 6.9 mtm180 -95.43 126.1 47.15 Favored Pre-proline 0 C--N 1.281 -2.401 0 O-C-N 121.173 -0.954 . . . . 0.0 110.05 -177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.1 -122.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 122.955 2.437 . . . . 0.0 113.059 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -80.44 -90.39 0.06 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.317 -1.49 . . . . 0.0 110.799 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 6.6 mtp85 -107.64 36.94 2.56 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.994 -1.066 . . . . 0.0 109.556 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -41.33 114.16 0.47 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 122.957 0.503 . . . . 0.0 111.065 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' NZ ' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -107.14 142.35 36.97 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.743 -0.598 . . . . 0.0 110.331 -176.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.418 ' CD1' ' CA ' ' A' ' 57' ' ' GLY . 78.8 m-85 -79.11 139.1 38.14 Favored 'General case' 0 C--N 1.273 -2.74 0 O-C-N 120.972 -1.08 . . . . 0.0 111.255 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.458 ' NH2' ' OG1' ' A' ' 86' ' ' THR . 7.0 mtm-85 -115.57 127.16 55.04 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 172.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.546 ' HG ' HG21 ' A' ' 42' ' ' VAL . 27.2 tp -108.71 138.97 44.17 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -147.69 170.8 16.75 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.68 163.83 13.0 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -57.21 112.81 1.48 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 125.74 -18.88 6.67 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 107.934 -2.067 . . . . 0.0 107.934 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.546 HG21 ' HG ' ' A' ' 37' ' ' LEU . 39.3 t -123.77 -97.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.98 -18.32 30.98 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -107.13 156.88 18.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.625 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 15.5 mm-40 -68.54 140.93 92.59 Favored Pre-proline 0 C--N 1.269 -2.893 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.537 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.48 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -70.52 113.39 1.83 Allowed 'Cis proline' 0 N--CA 1.51 2.48 0 C-N-CA 123.605 -1.415 . . . . 0.0 111.438 1.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.625 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 5.3 mtpm? -69.17 152.82 44.64 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.766 -1.209 . . . . 0.0 111.909 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.441 ' O ' ' OG1' ' A' ' 62' ' ' THR . . . 69.87 5.1 50.8 Favored Glycine 0 N--CA 1.489 2.198 0 CA-C-O 119.113 -0.826 . . . . 0.0 113.474 171.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.402 ' CG1' ' HB2' ' A' ' 46' ' ' PRO . 11.7 mm -65.24 -46.66 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 120.456 2.128 . . . . 0.0 107.338 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.641 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 69.6 m-85 -115.75 144.67 43.64 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.296 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.18 136.01 29.52 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.0 OUTLIER -109.23 157.54 9.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.602 -0.686 . . . . 0.0 109.989 -176.122 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.49 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 11.4 t-20 -85.32 126.94 34.13 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 175.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 34' ' ' LYS . 1.8 mt-10 -59.7 -38.54 81.86 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.771 -0.581 . . . . 0.0 111.06 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.471 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 10.6 t30 -88.57 -48.03 7.87 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.014 -1.054 . . . . 0.0 111.673 -176.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.1 p -80.49 -34.43 35.81 Favored 'General case' 0 C--N 1.281 -2.376 0 O-C-N 121.727 -0.608 . . . . 0.0 109.662 -174.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' CA ' ' CD1' ' A' ' 35' ' ' PHE . . . 84.08 10.38 80.68 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -176.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 16.8 m -64.54 122.09 15.98 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.209 -1.171 . . . . 0.0 108.334 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.555 HG22 HG23 ' A' ' 24' ' ' VAL . 1.8 t -88.92 127.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.59 146.01 49.29 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.532 -0.73 . . . . 0.0 109.654 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.455 HG21 ' CG ' ' A' ' 65' ' ' LEU . 8.3 p -101.63 149.18 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 48' ' ' GLY . 28.8 p -99.86 -17.32 17.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.634 -0.666 . . . . 0.0 112.122 -175.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -145.93 167.17 23.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.798 -1.189 . . . . 0.0 110.567 -178.63 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.506 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 7.1 t -58.01 122.51 13.19 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.455 ' CG ' HG21 ' A' ' 61' ' ' VAL . 86.3 mt -79.73 140.87 36.81 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.466 -1.396 . . . . 0.0 109.904 -175.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.499 ' CG ' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -124.37 117.3 24.17 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.085 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -60.17 -14.73 18.86 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 121.765 -0.584 . . . . 0.0 109.88 178.7 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 1.5 mp0 -78.56 -28.3 45.94 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.889 -1.132 . . . . 0.0 108.694 -176.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.86 -52.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -145.33 132.59 15.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.36 -25.46 29.14 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.22 136.59 5.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 42.7 m-85 -100.05 122.52 43.06 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -92.44 93.91 8.83 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.94 170.75 9.8 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.779 0.799 . . . . 0.0 109.028 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 93.5 m-85 -133.0 131.21 40.46 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -117.9 150.13 20.1 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -174.191 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.635 ' HB3' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -146.46 146.87 30.71 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 121.302 -0.874 . . . . 0.0 108.652 176.093 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.712 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -95.27 135.63 36.62 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 170.419 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.712 ' C ' HD21 ' A' ' 87' ' ' LEU . 38.0 p -125.76 158.22 35.46 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.411 -0.806 . . . . 0.0 111.553 -171.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.429 ' HB2' HD11 ' A' ' 87' ' ' LEU . 28.1 t70 -79.64 170.96 15.79 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.428 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 2.1 m -58.41 -27.71 33.9 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -79.61 2.01 23.99 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.736 0.779 . . . . 0.0 108.997 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' HA2' ' HZ1' ' A' ' 34' ' ' LYS . . . 77.36 11.65 85.31 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -77.51 140.05 39.7 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.489 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.635 HG23 ' HB3' ' A' ' 78' ' ' GLU . 39.0 m -81.51 118.98 23.18 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 120.777 0.322 . . . . 0.0 110.187 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.927 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.21 -31.29 14.18 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.322 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.468 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 5.1 tp10 -138.04 153.18 49.37 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.56 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 89.12 -171.5 38.86 Favored Glycine 0 C--N 1.288 -2.119 0 N-CA-C 106.931 -2.467 . . . . 0.0 106.931 -174.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.37 111.54 1.03 Allowed 'Cis proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.364 -1.515 . . . . 0.0 111.037 -0.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.85 HG21 HG21 ' A' ' 2' ' ' ILE . 4.2 m -86.9 163.56 40.28 Favored Pre-proline 0 C--N 1.28 -2.432 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -93.85 159.84 2.26 Favored 'Trans proline' 0 C--N 1.289 -2.561 0 C-N-CA 121.933 1.756 . . . . 0.0 110.868 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.528 HD13 HG23 ' A' ' 4' ' ' VAL . 15.4 tp -144.88 124.48 13.24 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.81 113.14 25.12 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.641 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 78.1 t -105.16 91.39 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.82 138.04 20.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 O-C-N 121.506 -0.746 . . . . 0.0 109.179 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.696 HG12 ' HB3' ' A' ' 11' ' ' GLU . 4.0 t -97.1 106.72 18.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.2 pt -97.12 170.92 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.081 -1.012 . . . . 0.0 110.307 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -97.77 139.04 34.23 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.726 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.559 ' HB2' ' HB3' ' A' ' 10' ' ' PRO . 34.3 mt-30 -163.99 69.88 0.2 Allowed 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 103' ' ' ASN . 40.0 t-20 -130.19 120.6 24.78 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 103' ' ' ASN . 7.4 m-20 -75.93 18.15 0.28 Allowed 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.507 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER 76.64 23.02 1.11 Allowed 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.799 0.84 . . . . 0.0 109.42 -175.344 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.34 63.3 9.15 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.495 1.61 0 C-N-CA 123.036 2.491 . . . . 0.0 111.968 -177.011 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.934 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.856 HG21 HG21 ' A' ' 91' ' ' VAL . 7.2 mt -74.96 146.85 8.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.361 0.6 . . . . 0.0 109.621 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -125.25 137.89 56.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.379 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -150.61 167.43 2.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.494 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -140.87 145.73 40.88 Favored Pre-proline 0 C--N 1.289 -2.055 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.358 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.28 133.11 35.78 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.093 1.862 . . . . 0.0 110.323 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.2 mt -103.93 112.1 36.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.167 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.898 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.22 105.33 17.74 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.634 HD11 HG21 ' A' ' 21' ' ' VAL . 19.3 mt -111.93 128.4 25.51 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 33.9 Cg_endo -69.27 130.16 19.45 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.172 1.248 . . . . 0.0 110.727 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 66' ' ' ASP . 10.9 pt-20 -64.35 173.88 1.88 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.104 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 57.39 61.75 2.4 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.688 0.756 . . . . 0.0 111.418 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.423 ' O ' ' OG1' ' A' ' 64' ' ' THR . 35.1 mt-30 -119.88 131.98 55.42 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 174.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -96.97 177.82 5.49 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 121.062 -1.024 . . . . 0.0 111.673 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.567 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 18.2 mp0 -54.76 166.94 0.67 Allowed Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 70.5 Cg_endo -78.12 122.13 8.44 Favored 'Cis proline' 0 C--N 1.315 -1.203 0 C-N-CA 123.785 -1.34 . . . . 0.0 114.459 0.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.506 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 29.6 m-85 -97.86 170.2 7.45 Favored Pre-proline 0 C--N 1.279 -2.49 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.506 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.7 Cg_exo -68.05 163.27 76.82 Favored 'Cis proline' 0 N--CA 1.493 1.483 0 C-N-CA 124.194 -1.169 . . . . 0.0 111.224 -1.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 19' ' ' ARG . 1.1 mtp180 -124.47 126.93 46.71 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 24.6 t70 -76.66 132.64 39.5 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.634 HG21 HD11 ' A' ' 9' ' ' ILE . 15.6 m -127.46 5.67 3.4 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.643 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 166.7 179.55 39.96 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 117.707 -2.187 . . . . 0.0 109.756 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 29.5 tttp -143.03 139.57 30.61 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 120.852 -1.381 . . . . 0.0 109.678 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 77' ' ' VAL . 6.6 t -94.34 152.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 172.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.465 ' HB ' HG13 ' A' ' 3' ' ' VAL . 3.5 t -144.14 151.4 16.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 9.2 t0 -112.25 135.08 53.37 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -4.64 58.75 Favored 'General case' 0 C--N 1.269 -2.9 0 O-C-N 122.141 -0.349 . . . . 0.0 111.501 -177.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -141.21 -21.37 0.77 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.695 -1.253 . . . . 0.0 111.935 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.608 ' NH1' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -72.51 146.26 88.56 Favored Pre-proline 0 C--N 1.286 -2.191 0 O-C-N 120.66 -1.275 . . . . 0.0 111.398 -171.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -41.86 143.91 1.05 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 123.178 2.586 . . . . 0.0 111.048 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -57.92 -29.1 64.85 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -74.9 52.91 0.56 Allowed 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.656 ' HB2' HG22 ' A' ' 79' ' ' THR . 1.4 p -122.68 134.66 54.47 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 121.241 -0.912 . . . . 0.0 108.766 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 40.8 mttm -113.52 139.17 49.19 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 173.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.846 ' CE1' HG23 ' A' ' 79' ' ' THR . 61.9 m-85 -89.77 135.5 33.59 Favored 'General case' 0 C--N 1.271 -2.818 0 O-C-N 121.24 -0.912 . . . . 0.0 110.991 -174.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.509 ' NH2' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -100.0 139.27 35.92 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 174.23 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.463 HD11 HD23 ' A' ' 93' ' ' LEU . 19.2 tp -121.01 135.45 55.21 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -144.91 170.52 15.99 Favored 'General case' 0 C--N 1.274 -2.692 0 O-C-N 121.472 -0.768 . . . . 0.0 109.019 -174.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.15 173.39 17.69 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -58.16 111.5 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 124.52 -15.3 7.62 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 50' ' ' PHE . 21.2 t -129.36 -81.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.294 -1.121 . . . . 0.0 109.154 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -96.53 -14.46 22.28 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -118.85 158.51 25.51 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.521 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -51.9 127.85 36.08 Favored Pre-proline 0 C--N 1.281 -2.389 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.779 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.445 ' HB2' HD11 ' A' ' 49' ' ' ILE . 4.3 Cg_endo -80.36 120.66 7.32 Favored 'Cis proline' 0 C--O 1.202 -1.311 0 C-N-CA 123.5 -1.458 . . . . 0.0 110.517 -1.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 28.0 mttp -63.47 155.51 29.0 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 120.872 -1.143 . . . . 0.0 111.268 -175.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.75 32.73 48.01 Favored Glycine 0 N--CA 1.49 2.285 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.149 171.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.488 HD12 ' HD2' ' A' ' 63' ' ' ARG . 8.7 mm -87.89 -43.44 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.521 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 67.1 m-85 -110.39 141.44 43.46 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.813 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.586 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -132.6 120.61 22.02 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 176.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -89.09 141.87 13.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.513 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 46.6 t30 -79.09 84.79 5.04 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 1.3 mp0 -24.22 -53.43 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 125.327 1.451 . . . . 0.0 113.54 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -79.75 -39.49 30.92 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.161 -0.962 . . . . 0.0 111.325 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 29.2 p -94.32 -26.28 16.64 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-O 121.735 0.779 . . . . 0.0 109.313 -174.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.33 2.6 76.67 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -65.07 121.35 14.52 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.313 -1.11 . . . . 0.0 109.482 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.1 t -86.83 120.87 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.586 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -123.73 155.42 37.9 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.418 178.193 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.568 ' CG2' HD21 ' A' ' 65' ' ' LEU . 7.4 p -102.19 143.54 14.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.111 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 59.9 p -90.48 -20.51 22.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.446 -0.784 . . . . 0.0 111.037 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.49 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -151.81 175.66 12.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.115 -0.99 . . . . 0.0 110.033 -175.535 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.49 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 2.7 t -66.62 136.69 55.95 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-O 121.83 0.824 . . . . 0.0 110.793 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.568 HD21 ' CG2' ' A' ' 61' ' ' VAL . 22.0 mt -98.78 150.61 21.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.65 ' HB2' HG23 ' A' ' 69' ' ' VAL . 8.7 m-20 -132.9 122.66 24.67 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.0 mtp-105 -57.26 -13.33 3.11 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -77.79 -22.94 49.37 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 66' ' ' ASP . 25.1 t -85.37 -55.87 6.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' HG21 ' A' ' 97' ' ' VAL . 1.1 mt -144.74 136.39 21.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.11 -25.46 36.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 4.1 p -160.02 132.83 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.456 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 70.6 m-85 -94.42 115.23 27.38 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.21 93.1 6.35 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.41 170.62 10.39 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-O 121.956 0.884 . . . . 0.0 108.994 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 78.4 m-85 -128.15 122.23 31.44 Favored 'General case' 0 C--N 1.266 -3.023 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.565 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -103.37 146.15 11.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -177.389 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.75 ' HB3' HG23 ' A' ' 86' ' ' THR . 91.3 mt-10 -136.5 140.02 42.71 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.846 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -83.49 127.35 33.64 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 170.039 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.509 ' OG1' ' NH2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -125.46 159.67 31.36 Favored 'General case' 0 C--N 1.267 -3.007 0 C-N-CA 119.265 -0.974 . . . . 0.0 109.895 -178.092 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.532 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 14.8 t70 -97.31 170.3 9.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.532 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.5 m -54.43 -22.6 9.14 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -80.27 -2.86 46.91 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.426 -0.796 . . . . 0.0 109.058 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.12 8.62 86.95 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 80' ' ' THR . 4.2 mttp -81.1 150.21 28.86 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.75 HG23 ' HB3' ' A' ' 78' ' ' GLU . 94.0 m -94.48 118.21 31.3 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-O 121.219 0.533 . . . . 0.0 110.302 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.908 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -89.15 -32.5 17.45 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER -137.83 170.41 16.11 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.593 -0.692 . . . . 0.0 109.758 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.511 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 83.5 -165.91 43.1 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -69.63 101.31 0.27 Allowed 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.564 -1.432 . . . . 0.0 110.79 -0.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.856 HG21 HG21 ' A' ' 2' ' ' ILE . 10.6 m -74.15 160.37 81.75 Favored Pre-proline 0 C--N 1.291 -1.954 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -92.49 147.07 2.8 Favored 'Trans proline' 0 C--N 1.285 -2.8 0 C-N-CA 121.868 1.712 . . . . 0.0 112.03 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.463 HD23 HD11 ' A' ' 37' ' ' LEU . 8.8 tp -130.51 125.85 35.36 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -108.27 106.91 17.28 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.651 -0.656 . . . . 0.0 109.677 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.521 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 38.9 t -98.45 100.5 10.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.64 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.8 mp -79.93 131.69 33.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 70' ' ' ILE . 3.1 t -90.05 111.24 22.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 11.3 pt -105.25 171.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 O-C-N 121.688 -0.632 . . . . 0.0 109.537 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 101' ' ' ASN . 3.2 m-20 -83.37 176.2 9.28 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.83 68.98 0.44 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 99' ' ' ASP . 48.0 t-20 -83.1 176.97 8.81 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 104' ' ' ARG . 24.3 t70 -58.67 116.79 3.94 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -69.29 14.72 0.08 Allowed 'General case' 0 C--N 1.283 -2.302 0 O-C-N 121.781 -0.574 . . . . 0.0 110.644 -179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.445 ' H ' ' C ' ' A' ' 102' ' ' ASP . 16.3 mtp180 49.5 64.19 8.98 Favored Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.202 -0.936 . . . . 0.0 109.229 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 104' ' ' ARG . 2.9 Cg_endo . . . . . 0 C--O 1.192 -1.809 0 C-N-CA 122.337 2.025 . . . . 0.0 111.137 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.492 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 91' ' ' VAL . 7.0 mt -69.22 138.1 22.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.903 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.56 133.4 69.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -146.69 157.9 10.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.637 0.732 . . . . 0.0 109.462 -177.36 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 t -128.36 141.84 42.73 Favored Pre-proline 0 C--N 1.281 -2.384 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.502 ' HB3' HD11 ' A' ' 96' ' ' ILE . 53.4 Cg_exo -45.67 132.92 13.41 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.531 1.487 . . . . 0.0 109.811 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' A' ' 95' ' ' VAL . 40.7 mt -98.08 111.89 28.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.764 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -100.3 103.12 14.53 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.623 HG22 HE21 ' A' ' 13' ' ' GLN . 4.1 mt -108.11 127.8 26.92 Favored Pre-proline 0 C--N 1.27 -2.877 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.609 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 18.5 Cg_endo -74.4 135.98 21.1 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 CA-C-N 119.444 0.837 . . . . 0.0 111.945 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.401 ' CG ' ' HA ' ' A' ' 66' ' ' ASP . 2.9 tt0 -39.38 147.08 0.08 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.502 0.668 . . . . 0.0 111.848 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.522 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 2.3 t-20 59.87 66.54 0.97 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.623 HE21 HG22 ' A' ' 9' ' ' ILE . 18.9 mp0 -92.17 54.59 2.39 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 175.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.54 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -26.11 162.34 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -174.619 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.558 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -46.14 169.18 0.09 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.753 175.996 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 1.2 Cg_endo -77.47 131.47 24.07 Favored 'Cis proline' 0 N--CA 1.492 1.392 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.37 -0.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.529 ' CZ ' ' N ' ' A' ' 64' ' ' THR . 55.1 m-85 -97.74 163.95 18.5 Favored Pre-proline 0 C--N 1.293 -1.86 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.19 156.27 98.19 Favored 'Cis proline' 0 N--CA 1.502 1.977 0 C-N-CA 124.12 -1.2 . . . . 0.0 110.841 -1.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 38.2 mtp180 -124.77 135.29 52.85 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.435 -0.791 . . . . 0.0 110.101 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -62.17 140.27 58.44 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.756 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.33 -4.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . -176.07 170.44 43.33 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 118.75 -1.69 . . . . 0.0 109.313 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 5.1 tttm -141.62 114.1 8.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.163 -1.198 . . . . 0.0 109.687 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.694 HG11 HG11 ' A' ' 77' ' ' VAL . 22.0 t -79.65 158.92 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' CE ' ' A' ' 23' ' ' LYS . 6.3 t -141.81 170.1 13.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.1 t70 -131.13 143.93 51.01 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 1' ' ' SER . 0.2 OUTLIER -58.84 -39.12 80.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.657 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -163.17 79.95 0.46 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.364 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.564 ' HG2' HG21 ' A' ' 79' ' ' THR . 0.8 OUTLIER -64.26 152.03 89.37 Favored Pre-proline 0 C--N 1.289 -2.061 0 O-C-N 120.907 -1.121 . . . . 0.0 108.634 175.907 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' ARG . 73.1 Cg_exo -46.28 -121.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.515 2.741 0 C-N-CA 123.661 2.907 . . . . 0.0 112.1 173.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HB2' ' NH1' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -105.55 -57.91 1.97 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 119.855 -1.778 . . . . 0.0 110.065 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.471 ' NH1' ' HB2' ' A' ' 31' ' ' GLU . 11.9 mtm-85 -125.99 45.61 2.59 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 120.932 -1.105 . . . . 0.0 109.764 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.425 ' OG ' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -68.61 155.58 39.74 Favored 'General case' 0 C--N 1.286 -2.169 0 O-C-N 121.352 -0.843 . . . . 0.0 110.734 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HB2' HH22 ' A' ' 36' ' ' ARG . 2.4 mmtp -111.02 135.41 51.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.709 -0.619 . . . . 0.0 109.712 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CE1' ' NH1' ' A' ' 29' ' ' ARG . 9.0 m-85 -84.58 116.08 22.96 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.597 ' NH1' HG21 ' A' ' 80' ' ' THR . 0.0 OUTLIER -95.31 133.73 38.89 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.633 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.706 ' HG ' HG21 ' A' ' 42' ' ' VAL . 61.0 tp -106.93 136.91 45.99 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 176.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.22 170.45 16.72 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 117.35 167.3 14.32 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -53.92 116.07 2.35 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 119.33 -22.12 9.03 Favored Glycine 0 C--N 1.28 -2.566 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.872 HG22 ' HB2' ' A' ' 50' ' ' PHE . 11.1 t -117.82 -83.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.428 -1.043 . . . . 0.0 109.12 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.35 -23.26 16.72 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 20.4 mp0 -103.34 161.22 14.02 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.447 ' HA ' ' C ' ' A' ' 46' ' ' PRO . 2.5 mp0 -68.73 134.69 90.26 Favored Pre-proline 0 C--N 1.27 -2.855 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.457 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 35.1 Cg_endo -68.73 126.42 8.76 Favored 'Cis proline' 0 N--CA 1.514 2.705 0 C-N-CA 123.615 -1.411 . . . . 0.0 110.942 -0.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -87.23 152.51 22.25 Favored 'General case' 0 C--N 1.289 -2.056 0 O-C-N 120.82 -1.175 . . . . 0.0 111.649 -173.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.01 15.26 71.67 Favored Glycine 0 N--CA 1.492 2.376 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.314 174.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.0 mm -78.37 -48.86 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 CA-C-N 119.561 1.68 . . . . 0.0 107.653 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.872 ' HB2' HG22 ' A' ' 42' ' ' VAL . 91.8 m-85 -108.42 155.71 20.27 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.708 0.766 . . . . 0.0 109.673 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.553 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -146.75 160.0 42.78 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.426 HG12 ' N ' ' A' ' 53' ' ' ASN . 10.9 tt -132.08 164.13 35.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 O-C-N 120.81 -1.181 . . . . 0.0 109.941 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 21.9 t-20 -91.94 108.71 20.12 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' OE2' ' NZ ' ' A' ' 34' ' ' LYS . 32.1 mt-10 -46.98 -33.45 4.69 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.154 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 2.3 t-20 -95.9 -48.84 5.56 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.415 -0.803 . . . . 0.0 110.961 -176.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 10.0 p -84.91 -21.58 29.61 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 121.491 -0.756 . . . . 0.0 110.083 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.8 7.82 86.28 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 12.0 m -64.15 123.4 18.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.547 HG13 HD22 ' A' ' 37' ' ' LEU . 3.3 t -92.78 122.78 44.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.553 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -117.25 149.42 40.46 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.516 ' CG2' HD21 ' A' ' 65' ' ' LEU . 8.6 p -104.11 143.63 15.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.0 p -91.96 -13.88 30.38 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.547 -0.72 . . . . 0.0 110.852 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.573 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -148.17 160.25 43.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.605 -1.309 . . . . 0.0 109.905 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.573 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -63.21 127.55 31.79 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.596 ' HB2' HE22 ' A' ' 13' ' ' GLN . 34.5 mt -84.68 151.89 24.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.242 -1.536 . . . . 0.0 111.604 -172.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.717 ' HB2' HG23 ' A' ' 69' ' ' VAL . 4.8 m-20 -123.91 131.05 53.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.558 HH11 ' CB ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -72.14 -6.0 39.53 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.017 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -85.44 -19.56 31.12 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -175.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.717 HG23 ' HB2' ' A' ' 66' ' ' ASP . 34.1 t -90.25 -62.96 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.516 HG21 ' CD1' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.49 127.98 23.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 175.669 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.79 -24.63 24.97 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -146.17 121.79 3.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.516 ' CD1' HG21 ' A' ' 70' ' ' ILE . 65.5 m-85 -92.36 119.7 32.17 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -89.76 81.93 6.33 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.468 HD23 HG23 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -80.46 170.2 16.68 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 122.301 1.048 . . . . 0.0 109.974 -177.5 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 90.4 m-85 -135.2 136.68 41.98 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.694 HG11 HG11 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -114.07 147.33 17.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -178.51 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.566 ' HB3' HG23 ' A' ' 86' ' ' THR . 49.0 mt-10 -138.18 141.8 40.05 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.564 HG21 ' HG2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -96.86 131.78 43.27 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 172.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.597 HG21 ' NH1' ' A' ' 36' ' ' ARG . 18.0 p -122.78 162.32 22.31 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.935 -175.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.439 ' HB2' HD11 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -107.97 171.09 7.6 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -47.62 -22.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 O-C-N 121.81 -0.556 . . . . 0.0 111.818 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.48 -17.17 54.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.744 -1.222 . . . . 0.0 109.856 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.91 11.61 57.55 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' THR . 14.2 mttm -90.27 160.54 16.12 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.628 ' C ' HD13 ' A' ' 87' ' ' LEU . 90.3 m -101.2 120.29 40.01 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-O 120.841 0.353 . . . . 0.0 110.085 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.901 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -96.22 -11.23 26.36 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.578 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.473 ' O ' ' CG2' ' A' ' 86' ' ' THR . 11.3 tp10 -152.2 167.54 28.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.59 -168.75 52.73 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -67.03 112.56 1.05 Allowed 'Cis proline' 0 N--CA 1.493 1.463 0 C-N-CA 123.25 -1.563 . . . . 0.0 112.356 0.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 2' ' ' ILE . 5.3 m -83.2 165.28 41.73 Favored Pre-proline 0 C--N 1.284 -2.269 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -94.27 152.54 2.06 Favored 'Trans proline' 0 C--N 1.297 -2.151 0 C-N-CA 121.948 1.766 . . . . 0.0 112.329 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.525 HD13 ' CG2' ' A' ' 4' ' ' VAL . 6.5 tp -141.49 126.68 18.51 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -108.45 116.64 32.34 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 121.354 -0.841 . . . . 0.0 109.173 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG22 ' HB ' ' A' ' 7' ' ' ILE . 79.1 t -104.15 104.47 16.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 96' ' ' ILE . 3.0 mp -92.52 134.52 30.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 15.0 t -89.73 104.0 14.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 8' ' ' LEU . 15.1 pt -85.46 170.85 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.503 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.422 ' OD2' ' NH2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -91.87 -177.94 4.88 Favored 'General case' 0 C--N 1.284 -2.252 0 O-C-N 120.746 -1.221 . . . . 0.0 109.256 -176.667 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.609 ' HG2' ' HB2' ' A' ' 10' ' ' PRO . 4.7 mm-40 -136.17 122.37 20.39 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 1.6 t30 -83.9 50.99 1.93 Allowed 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 171.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 36.72 82.48 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.75 -173.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -47.45 -35.69 8.95 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -140.96 94.23 8.0 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.499 1.799 0 C-N-CA 122.659 2.239 . . . . 0.0 111.913 -178.113 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.217 -0.626 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.765 ' CG2' HG21 ' A' ' 91' ' ' VAL . 2.7 mt -77.69 123.28 34.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-O 121.873 0.844 . . . . 0.0 110.511 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.64 134.17 44.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.821 HG21 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -155.0 154.86 6.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.15 141.71 33.5 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -47.63 132.36 20.62 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 121.34 1.36 . . . . 0.0 108.93 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.568 HG13 HD11 ' A' ' 93' ' ' LEU . 3.0 mt -99.4 112.41 31.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.468 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.896 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -89.5 98.57 11.84 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.49 ' CD1' HG13 ' A' ' 95' ' ' VAL . 12.5 mt -106.42 121.29 45.79 Favored Pre-proline 0 C--N 1.279 -2.493 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -66.07 137.46 48.45 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 120.629 0.886 . . . . 0.0 111.275 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -72.13 179.5 3.29 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.675 -178.137 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.543 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 2.2 m-20 58.69 17.51 5.16 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 172.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.41 ' O ' ' OG1' ' A' ' 64' ' ' THR . 58.3 mt-30 -77.21 129.45 35.95 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 174.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.543 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -97.81 -175.39 3.15 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.095 -1.003 . . . . 0.0 110.884 -173.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 4.3 mt-30 -49.2 160.78 0.49 Allowed Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 0.9 OUTLIER -80.53 148.56 76.89 Favored 'Cis proline' 0 C--N 1.301 -1.935 0 C-N-CA 123.195 -1.585 . . . . 0.0 113.901 -0.145 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -129.13 166.49 24.88 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 16.9 Cg_exo -67.26 169.6 49.78 Favored 'Cis proline' 0 N--CA 1.496 1.647 0 C-N-CA 124.354 -1.103 . . . . 0.0 112.157 -0.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.501 ' NE ' ' O ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -137.04 137.67 39.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.622 -0.674 . . . . 0.0 109.583 178.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 12.4 t70 -75.87 140.11 42.03 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.94 5.2 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 162.41 173.89 31.64 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.197 -1.954 . . . . 0.0 109.919 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -136.86 124.88 22.83 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.355 -1.085 . . . . 0.0 109.764 -178.412 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.812 HG11 HG11 ' A' ' 77' ' ' VAL . 8.1 t -82.94 157.7 3.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 t -144.32 169.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.0 t70 -125.73 141.42 52.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -27.83 65.16 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -162.97 91.7 0.74 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.533 ' NH2' ' O ' ' A' ' 33' ' ' SER . 12.2 mtp-105 -65.67 120.85 71.93 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HB2' ' H ' ' A' ' 31' ' ' GLU . 5.0 Cg_exo -39.77 -102.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 123.451 2.767 . . . . 0.0 115.327 -176.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.431 ' H ' ' HB2' ' A' ' 30' ' ' PRO . 6.2 mt-10 -105.21 -67.75 0.9 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.759 -1.213 . . . . 0.0 110.075 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.35 58.88 1.7 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.3 OUTLIER -85.1 138.76 32.21 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.025 -169.571 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 154.94 29.12 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' GLU . 65.9 m-85 -86.63 137.51 32.42 Favored 'General case' 0 C--N 1.285 -2.227 0 O-C-N 121.973 -0.455 . . . . 0.0 110.003 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' NH2' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -110.08 130.28 55.56 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 173.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.666 ' HG ' HG21 ' A' ' 42' ' ' VAL . 46.4 tp -111.02 138.01 47.96 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -146.69 171.26 15.41 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' H ' ' HG3' ' A' ' 44' ' ' GLN . . . 113.32 173.88 18.8 Favored Glycine 0 N--CA 1.51 3.608 0 C-N-CA 120.0 -1.095 . . . . 0.0 110.78 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -62.32 119.46 9.1 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 117.32 -22.81 10.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.666 HG21 ' HG ' ' A' ' 37' ' ' LEU . 21.3 t -115.86 -95.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.602 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -92.55 -6.39 49.72 Favored 'General case' 0 C--O 1.204 -1.327 0 O-C-N 121.22 -0.925 . . . . 0.0 109.171 178.081 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.478 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 20.0 mt-30 -116.8 148.65 41.01 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.627 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 5.2 mm-40 -58.94 140.08 86.84 Favored Pre-proline 0 C--N 1.271 -2.82 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.204 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 37.2 Cg_endo -68.64 116.02 2.29 Favored 'Cis proline' 0 N--CA 1.511 2.507 0 C-N-CA 123.299 -1.542 . . . . 0.0 110.456 -1.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.627 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 7.8 mtpp -73.4 147.1 44.6 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.657 -1.277 . . . . 0.0 111.305 -172.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.38 21.5 78.6 Favored Glycine 0 N--CA 1.497 2.753 0 O-C-N 121.515 -0.741 . . . . 0.0 112.914 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.553 HD12 ' HD2' ' A' ' 63' ' ' ARG . 17.2 mm -86.15 -47.27 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 74.8 m-85 -110.04 138.63 46.15 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.163 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -136.59 142.82 43.35 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 tt -111.45 162.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 19.4 t-20 -97.18 109.89 22.55 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -36.56 -41.89 0.32 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 122.804 0.442 . . . . 0.0 111.784 -177.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -92.86 -48.04 6.74 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.032 -1.043 . . . . 0.0 111.61 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.1 p -79.98 -27.97 39.58 Favored 'General case' 0 C--N 1.281 -2.401 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 2.85 90.35 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 12.3 m -63.06 122.95 17.33 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.67 -0.9 . . . . 0.0 109.278 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 24' ' ' VAL . 1.6 t -94.88 123.49 47.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -126.7 153.35 45.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.211 -0.931 . . . . 0.0 109.792 177.814 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.612 HG22 ' H ' ' A' ' 63' ' ' ARG . 2.5 p -104.68 146.12 12.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.0 p -96.25 -7.39 35.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.667 -0.646 . . . . 0.0 112.061 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.612 ' H ' HG22 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -154.5 172.06 18.4 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.462 -1.399 . . . . 0.0 110.685 -175.601 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.462 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 13.9 t -65.16 137.89 57.91 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.1 mt -98.85 149.76 22.58 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD1' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -126.3 142.36 51.56 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -91.93 9.24 33.84 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.81 -30.53 20.15 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.559 HG23 ' OD1' ' A' ' 66' ' ' ASP . 26.5 t -101.18 -47.08 11.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.22 139.96 47.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.293 -0.879 . . . . 0.0 109.121 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.49 -23.98 15.33 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.8 p -156.12 138.1 6.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.26 -0.9 . . . . 0.0 109.084 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 36.4 m-85 -99.0 128.09 45.06 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -90.79 97.56 11.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.71 170.34 9.65 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 86.2 m-85 -138.88 128.78 25.07 Favored 'General case' 0 C--N 1.268 -2.946 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.812 HG11 HG11 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -110.4 139.52 33.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 O-C-N 122.043 -0.411 . . . . 0.0 110.045 -176.063 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.697 ' HB3' HG23 ' A' ' 86' ' ' THR . 41.2 mt-10 -129.33 137.5 51.03 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.616 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -85.17 134.37 34.17 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 170.229 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 33' ' ' SER . 15.6 p -128.06 151.21 49.45 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -176.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.545 ' N ' HD21 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -116.15 172.2 7.33 Favored 'General case' 0 N--CA 1.508 2.446 0 CA-C-N 118.808 0.731 . . . . 0.0 109.815 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 81' ' ' ASP . 34.8 m -29.3 -40.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.446 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 28.7 t-20 -80.46 -8.6 59.61 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.72 -1.237 . . . . 0.0 110.195 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.61 13.14 78.9 Favored Glycine 0 C--N 1.287 -2.169 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' THR . 5.2 mttp -74.96 160.2 30.87 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 78' ' ' GLU . 16.6 m -96.01 116.53 29.08 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.926 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -96.02 -11.07 27.01 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.205 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.539 ' HG3' HD12 ' A' ' 2' ' ' ILE . 1.1 tp10 -154.54 154.56 33.3 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 78.41 -162.24 49.23 Favored Glycine 0 C--N 1.284 -2.316 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.35 105.58 0.24 Allowed 'Cis proline' 0 N--CA 1.495 1.586 0 C-N-CA 123.305 -1.54 . . . . 0.0 111.458 -0.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 77' ' ' VAL . 20.4 m -73.48 159.09 85.54 Favored Pre-proline 0 C--N 1.286 -2.18 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.37 152.01 3.65 Favored 'Trans proline' 0 C--N 1.283 -2.895 0 C-N-CA 121.359 1.373 . . . . 0.0 111.438 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.821 HD13 HG21 ' A' ' 4' ' ' VAL . 4.2 tp -139.02 128.51 24.41 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' N ' HD12 ' A' ' 93' ' ' LEU . 9.3 mt-10 -102.41 111.57 23.92 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.636 -0.665 . . . . 0.0 109.525 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 4.9 t -93.43 95.34 5.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 174.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.1 mt -79.96 130.66 35.66 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 t -92.06 122.14 43.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.68 HG21 ' HB3' ' A' ' 8' ' ' LEU . 12.5 pt -112.49 171.52 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.345 -0.847 . . . . 0.0 110.661 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -84.37 158.35 21.15 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.151 -0.968 . . . . 0.0 108.545 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 11' ' ' GLU . 3.9 pt20 -111.09 131.39 55.12 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.459 ' O ' ' C ' ' A' ' 102' ' ' ASP . 48.0 t30 -69.57 -25.26 63.9 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.648 -1.283 . . . . 0.0 107.595 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 101' ' ' ASN . 6.8 t70 -13.19 -84.51 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.745 0 C-N-CA 125.025 1.33 . . . . 0.0 111.403 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 172.35 -35.61 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.558 ' HB3' ' CD ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER 61.8 -177.95 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -177.125 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 104' ' ' ARG . 2.5 Cg_endo . . . . . 0 C--O 1.201 -1.33 0 C-N-CA 121.783 1.655 . . . . 0.0 109.386 177.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.72 HG21 HG21 ' A' ' 91' ' ' VAL . 7.3 mt -66.66 122.19 17.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.436 -0.79 . . . . 0.0 109.317 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -104.85 133.77 48.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 174.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -148.84 167.59 3.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -176.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.482 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.9 OUTLIER -152.04 146.83 18.95 Favored Pre-proline 0 C--N 1.272 -2.776 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 176.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -48.69 131.77 24.79 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.257 1.305 . . . . 0.0 110.157 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.513 ' C ' HD12 ' A' ' 8' ' ' LEU . 29.0 mt -99.79 121.56 50.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.772 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.9 mp -105.98 107.71 18.85 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.532 HD11 HG21 ' A' ' 21' ' ' VAL . 17.1 mt -113.18 140.94 24.88 Favored Pre-proline 0 C--N 1.275 -2.651 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -175.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 60.4 Cg_endo -75.53 134.65 17.19 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.576 1.517 . . . . 0.0 111.272 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.42 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -67.82 -172.68 0.29 Allowed 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.914 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.523 ' OD1' ' C ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER 55.83 -9.22 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 175.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.786 HE22 HG11 ' A' ' 61' ' ' VAL . 5.7 pt20 -55.66 132.96 50.27 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.4 -179.65 3.98 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.834 -1.166 . . . . 0.0 111.167 -175.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.602 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -54.29 171.76 0.27 Allowed Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.649 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 1.7 Cg_endo -78.71 121.13 7.76 Favored 'Cis proline' 0 N--CA 1.493 1.47 0 C-N-CA 123.793 -1.336 . . . . 0.0 114.012 0.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.518 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 20.4 m-85 -110.62 170.49 5.24 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 13.9 Cg_exo -69.7 167.63 70.15 Favored 'Cis proline' 0 N--CA 1.507 2.323 0 CA-C-N 120.172 1.097 . . . . 0.0 112.798 0.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -148.94 142.16 25.04 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 9.3 t0 -67.77 136.03 53.57 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.532 HG21 HD11 ' A' ' 9' ' ' ILE . 36.0 m -126.84 6.06 3.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.11 -175.0 45.48 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.809 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.579 ' HZ2' ' CB ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -145.17 121.72 11.07 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.925 -1.338 . . . . 0.0 110.36 -178.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 59' ' ' VAL . 33.2 t -89.88 131.45 37.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 170.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 3' ' ' VAL . 40.5 t -132.0 149.75 32.99 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -105.7 138.79 41.31 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.936 -1.105 . . . . 0.0 108.704 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.373 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.299 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 121.714 0.769 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 48.6 mttm -115.76 146.66 41.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.902 ' CE1' HG23 ' A' ' 79' ' ' THR . 89.6 m-85 -93.84 144.2 25.64 Favored 'General case' 0 C--N 1.282 -2.359 0 O-C-N 121.233 -0.917 . . . . 0.0 112.84 -172.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.34 150.99 22.43 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.61 ' HG ' HG21 ' A' ' 42' ' ' VAL . 21.0 tp -125.86 140.15 52.9 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 172.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.27 171.11 17.48 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 75' ' ' LEU . . . 117.0 169.85 15.2 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.315 -1.422 . . . . 0.0 111.594 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 45' ' ' GLU . 6.5 mtpp -60.05 111.13 1.39 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 120.21 -18.21 9.63 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.61 HG21 ' HG ' ' A' ' 37' ' ' LEU . 42.7 t -116.68 -97.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.625 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 3.4 t70 -93.52 -8.04 42.53 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 40' ' ' LYS . 35.3 mt-30 -107.02 148.2 29.0 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 174.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.508 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 1.5 mp0 -55.85 133.55 73.05 Favored Pre-proline 0 C--N 1.264 -3.152 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 24.8 Cg_endo -70.77 127.54 12.0 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 C-N-CA 123.403 -1.499 . . . . 0.0 110.045 -0.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 15.3 mtpp -82.12 150.41 27.48 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 120.953 -1.092 . . . . 0.0 111.321 -173.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.403 ' O ' ' NH2' ' A' ' 63' ' ' ARG . . . 62.81 38.95 97.35 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.894 -0.504 . . . . 0.0 111.899 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.496 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 5.9 mm -100.27 -48.13 11.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.532 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 88.8 m-85 -114.48 143.02 45.63 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.688 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 133.78 26.19 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.446 ' CG2' ' HB2' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -95.85 150.78 4.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.554 ' OD1' HG23 ' A' ' 56' ' ' THR . 14.5 t-20 -79.82 105.71 11.31 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 35' ' ' PHE . 2.0 mt-10 -42.81 -36.81 1.59 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.454 -175.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -92.76 -43.73 8.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.206 -0.933 . . . . 0.0 111.562 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.554 HG23 ' OD1' ' A' ' 53' ' ' ASN . 4.5 p -85.07 -25.35 27.64 Favored 'General case' 0 C--N 1.282 -2.361 0 O-C-N 121.027 -1.045 . . . . 0.0 108.7 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.06 9.51 86.1 Favored Glycine 0 C--N 1.287 -2.154 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.579 ' CB ' ' HZ2' ' A' ' 23' ' ' LYS . 70.0 m -65.8 120.55 13.23 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.395 -1.062 . . . . 0.0 109.472 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 24' ' ' VAL . 2.0 t -83.99 121.78 36.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.25 148.95 43.59 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.482 -0.761 . . . . 0.0 110.139 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.786 HG11 HE22 ' A' ' 13' ' ' GLN . 11.9 p -98.41 149.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.576 ' OG1' ' NH1' ' A' ' 63' ' ' ARG . 4.3 p -105.02 -15.52 15.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.481 -0.762 . . . . 0.0 112.002 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.686 HH11 ' HG2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -157.41 -159.33 0.83 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.871 -1.143 . . . . 0.0 108.506 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.468 ' N ' ' HG3' ' A' ' 63' ' ' ARG . 4.8 t -80.8 179.42 7.82 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.168 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 mt -142.21 167.64 21.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -147.76 139.19 23.72 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.498 ' NE ' ' O ' ' A' ' 97' ' ' VAL . 16.7 ttm105 -76.06 -10.72 59.64 Favored 'General case' 0 C--N 1.282 -2.329 0 O-C-N 122.105 -0.372 . . . . 0.0 111.645 -174.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -90.12 -20.08 23.54 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.703 -1.248 . . . . 0.0 108.964 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.04 -53.26 13.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 97' ' ' VAL . 1.1 mt -148.36 134.21 11.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -89.09 -28.29 20.19 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.43 115.08 3.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.506 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 62.3 m-85 -81.78 111.91 18.45 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 174.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.439 ' CD ' ' H ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -92.39 95.53 9.72 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -90.26 170.6 10.14 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 122.25 1.024 . . . . 0.0 108.424 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 85.1 m-85 -134.44 131.96 38.75 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.514 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.26 150.14 14.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -176.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.458 ' HB3' ' CG2' ' A' ' 86' ' ' THR . 2.2 mt-10 -142.12 142.13 32.74 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.902 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -88.72 129.35 35.56 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.617 ' C ' HD21 ' A' ' 87' ' ' LEU . 11.3 p -123.19 150.37 43.44 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.642 ' N ' HD21 ' A' ' 87' ' ' LEU . 26.0 t70 -92.59 170.09 10.01 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.22 -0.992 . . . . 0.0 108.564 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.54 -14.98 4.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.19 -5.08 53.41 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.98 -4.91 60.12 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -75.19 150.6 38.64 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.332 -1.099 . . . . 0.0 108.615 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -90.55 119.64 30.98 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.958 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.41 -30.62 14.37 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 86' ' ' THR . 1.5 tp10 -135.28 170.13 16.4 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 -179.17 51.72 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.56 127.03 7.7 Favored 'Cis proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.158 -1.601 . . . . 0.0 112.609 0.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.72 HG21 HG21 ' A' ' 2' ' ' ILE . 2.1 m -105.5 161.92 21.3 Favored Pre-proline 0 C--N 1.28 -2.424 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -94.44 151.17 1.96 Allowed 'Trans proline' 0 C--N 1.288 -2.637 0 C-N-CA 122.238 1.959 . . . . 0.0 112.527 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.46 HD13 HG23 ' A' ' 4' ' ' VAL . 10.2 tp -141.79 129.76 21.93 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -110.88 130.18 55.65 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 120.926 -1.109 . . . . 0.0 110.04 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.532 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 46.7 t -111.42 111.66 37.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 174.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.54 142.44 13.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.236 -0.915 . . . . 0.0 109.073 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.498 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 1.5 t -91.91 96.08 5.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.611 HG21 ' HB3' ' A' ' 8' ' ' LEU . 5.7 pt -82.21 172.01 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 O-C-N 120.893 -1.13 . . . . 0.0 110.125 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.417 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 3.1 m-20 . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.429 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.4 OUTLIER . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.769 HG21 HG21 ' A' ' 91' ' ' VAL . 11.4 mt -68.77 113.86 4.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.162 -0.961 . . . . 0.0 110.363 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.21 111.2 29.15 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 174.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.625 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.84 164.21 29.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.479 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -142.63 152.29 59.39 Favored Pre-proline 0 C--N 1.275 -2.652 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 175.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.686 ' HB3' HD11 ' A' ' 96' ' ' ILE . 48.9 Cg_exo -49.51 136.67 33.05 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.681 1.588 . . . . 0.0 111.108 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.644 HD11 HG21 ' A' ' 59' ' ' VAL . 21.9 mt -102.55 110.08 28.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.723 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.4 mp -98.83 96.87 8.17 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.519 HD11 HG21 ' A' ' 21' ' ' VAL . 15.6 mt -103.75 133.56 20.2 Favored Pre-proline 0 C--N 1.275 -2.673 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.6 Cg_endo -70.65 120.65 7.26 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.318 1.345 . . . . 0.0 109.683 175.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -43.1 -71.9 0.07 Allowed 'General case' 0 N--CA 1.522 3.155 0 O-C-N 121.241 -0.912 . . . . 0.0 111.943 -174.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.513 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 34.2 p30 -62.47 42.92 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.519 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 22.3 mt-30 -77.61 140.77 39.7 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -117.77 177.35 4.8 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.416 -0.803 . . . . 0.0 110.038 -176.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.62 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -49.02 167.88 0.2 Allowed Pre-proline 0 C--N 1.292 -1.895 0 C-N-CA 123.461 0.704 . . . . 0.0 109.882 178.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 4.8 Cg_exo -77.16 121.64 8.01 Favored 'Cis proline' 0 C--N 1.311 -1.417 0 C-N-CA 123.714 -1.369 . . . . 0.0 113.158 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.404 ' CE2' HG13 ' A' ' 61' ' ' VAL . 26.4 m-85 -102.76 165.88 12.92 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 175.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.22 154.48 85.23 Favored 'Cis proline' 0 N--CA 1.496 1.638 0 C-N-CA 124.184 -1.174 . . . . 0.0 110.516 -1.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.594 ' NH2' ' O ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -136.56 145.21 44.73 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.205 -0.935 . . . . 0.0 110.136 -178.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.594 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 5.5 t70 -65.87 142.3 57.96 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 9' ' ' ILE . 32.8 m -137.44 1.77 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 170.2 176.35 39.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -146.27 125.74 13.21 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.669 -1.489 . . . . 0.0 110.185 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 4' ' ' VAL . 18.4 t -87.6 143.48 11.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 172.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.6 t -136.73 160.98 36.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 1' ' ' SER . 10.2 t70 -120.54 137.73 54.23 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.081 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 1' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.758 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 121.085 0.469 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 54' ' ' GLU . 4.4 mmtp -113.86 169.39 9.03 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 174.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.509 ' CB ' HD13 ' A' ' 52' ' ' ILE . 10.3 m-85 -115.42 126.3 54.2 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HG3' HG21 ' A' ' 80' ' ' THR . 13.8 mmt-85 -98.68 119.11 36.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.725 ' HG ' HG21 ' A' ' 42' ' ' VAL . 42.4 tp -103.73 139.71 38.6 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 176.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.466 HG22 ' CG ' ' A' ' 43' ' ' ASP . 0.2 OUTLIER -152.89 170.29 20.72 Favored 'General case' 0 C--N 1.279 -2.47 0 O-C-N 121.262 -0.899 . . . . 0.0 108.613 -176.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' A' ' 43' ' ' ASP . . . 116.88 169.99 15.3 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.43 ' NZ ' ' HG3' ' A' ' 45' ' ' GLU . 11.1 mtpp -54.82 115.31 2.11 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 120.8 -21.64 8.36 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.725 HG21 ' HG ' ' A' ' 37' ' ' LEU . 34.9 t -119.78 -88.07 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.39 -1.065 . . . . 0.0 109.122 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.476 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 15.8 p-10 -93.14 -14.17 27.54 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.451 HE21 ' CG ' ' A' ' 43' ' ' ASP . 11.1 mt-30 -113.9 160.76 18.43 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HG3' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -61.69 133.84 93.67 Favored Pre-proline 0 C--N 1.286 -2.184 0 O-C-N 122.152 -0.343 . . . . 0.0 110.722 -174.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HB2' HD11 ' A' ' 49' ' ' ILE . 3.2 Cg_exo -76.13 123.76 9.68 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.173 -1.595 . . . . 0.0 109.296 -1.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 27.2 mttp -71.01 154.0 42.16 Favored 'General case' 0 C--N 1.282 -2.346 0 O-C-N 120.923 -1.11 . . . . 0.0 110.894 -174.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.19 21.31 53.11 Favored Glycine 0 N--CA 1.489 2.215 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.201 172.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.739 HD12 ' NE ' ' A' ' 63' ' ' ARG . 26.6 mm -73.55 -43.59 54.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.542 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 87.9 m-85 -116.7 141.38 48.28 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.428 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.83 129.16 24.0 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.509 HD13 ' CB ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -96.38 149.84 4.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 O-C-N 121.643 -0.661 . . . . 0.0 110.05 -174.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.451 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 14.1 t-20 -79.76 112.6 17.18 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' OE2' ' NH1' ' A' ' 36' ' ' ARG . 1.4 mt-10 -53.28 -31.11 42.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.847 -0.533 . . . . 0.0 111.541 -176.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.402 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -97.22 -23.39 16.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 112.601 -174.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 19.5 p -112.29 -27.5 8.29 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 84.82 5.43 86.38 Favored Glycine 0 C--N 1.283 -2.389 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 t -60.67 125.7 24.69 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 7' ' ' ILE . 2.6 t -86.5 118.76 33.39 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 176.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -110.84 140.65 45.11 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.411 -178.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.492 ' CG2' HD21 ' A' ' 65' ' ' LEU . 7.7 p -99.77 145.17 11.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.4 p -97.51 -14.99 20.77 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.511 -0.743 . . . . 0.0 111.46 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.739 ' NE ' HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -153.03 170.6 20.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.847 -1.158 . . . . 0.0 110.938 -177.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 t -66.32 140.25 58.09 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.492 HD21 ' CG2' ' A' ' 61' ' ' VAL . 49.6 mt -92.44 170.04 10.08 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.63 -1.294 . . . . 0.0 111.106 -173.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.454 ' HB2' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -127.18 102.55 6.99 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 67' ' ' ARG . 4.3 ttm105 -66.35 -18.74 65.54 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 1.2 mp0 -76.94 -26.18 53.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.858 -1.151 . . . . 0.0 108.378 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' A' ' 66' ' ' ASP . 6.8 t -97.18 -52.99 8.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.408 HG21 ' CG ' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -125.97 112.15 29.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.45 -33.66 54.7 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.4 p -149.42 131.89 6.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.532 ' OH ' ' NH2' ' A' ' 63' ' ' ARG . 61.0 m-85 -87.8 120.27 28.95 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -88.48 81.23 7.21 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.19 170.46 16.09 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.128 0.966 . . . . 0.0 109.015 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.9 m-85 -137.13 130.05 30.6 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -113.56 160.52 13.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.277 0.56 . . . . 0.0 110.143 -175.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.761 ' HB3' HG23 ' A' ' 86' ' ' THR . 47.8 mt-10 -147.4 143.01 27.65 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.646 ' N ' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -88.72 123.09 32.82 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 173.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.555 HG21 ' HG3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -109.0 153.38 23.68 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-O 121.582 0.706 . . . . 0.0 111.677 -172.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.501 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 3.0 t70 -96.48 170.1 9.45 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 174.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.501 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -52.79 -27.16 11.96 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -79.69 2.05 24.14 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.484 -0.76 . . . . 0.0 109.511 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.82 19.41 75.1 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -91.3 154.92 18.91 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.761 HG23 ' HB3' ' A' ' 78' ' ' GLU . 8.2 m -84.13 124.35 31.05 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.854 0.835 . . . . 0.0 111.012 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -86.11 -45.63 11.2 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 175.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -142.41 151.53 41.91 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.51 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 105.39 177.34 24.18 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 107.929 -2.068 . . . . 0.0 107.929 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.32 109.97 0.48 Allowed 'Cis proline' 0 N--CA 1.495 1.605 0 CA-C-N 118.949 1.374 . . . . 0.0 113.065 0.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.769 HG21 HG21 ' A' ' 2' ' ' ILE . 2.5 m -91.47 161.44 34.46 Favored Pre-proline 0 C--N 1.281 -2.374 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.99 155.37 3.92 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 C-N-CA 121.762 1.641 . . . . 0.0 111.726 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.63 HD23 HD11 ' A' ' 37' ' ' LEU . 8.8 tp -142.85 125.64 16.03 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -109.38 112.09 24.01 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 121.772 -0.58 . . . . 0.0 110.033 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.542 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 56.7 t -102.39 97.74 5.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.792 ' H ' HD12 ' A' ' 96' ' ' ILE . 2.8 mp -81.13 132.94 30.39 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 O-C-N 121.653 -0.654 . . . . 0.0 109.456 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 31.8 t -88.22 92.67 3.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.649 HG21 ' HB3' ' A' ' 8' ' ' LEU . 4.9 pt -80.35 171.04 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 O-C-N 121.248 -0.908 . . . . 0.0 109.112 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 C--N 1.284 -2.278 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.159 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.484 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.192 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.721 HG21 HG21 ' A' ' 91' ' ' VAL . 4.7 mt -62.57 142.15 17.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 121.449 0.643 . . . . 0.0 109.771 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.38 106.15 15.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.723 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -127.8 158.7 39.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.434 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -124.42 151.05 66.16 Favored Pre-proline 0 C--N 1.281 -2.409 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.18 141.72 94.43 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 121.475 1.45 . . . . 0.0 109.155 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.422 HD13 ' HA3' ' A' ' 22' ' ' GLY . 24.5 mt -107.96 113.04 42.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 O-C-N 121.412 -0.805 . . . . 0.0 109.865 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.886 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.94 94.2 9.54 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 21' ' ' VAL . 23.4 mt -101.25 127.42 31.83 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.8 Cg_endo -70.55 128.11 14.86 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 N-CA-C 109.493 -1.003 . . . . 0.0 109.493 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.551 ' CD ' ' HE ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -59.75 -178.78 0.08 Allowed 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 119.501 -0.879 . . . . 0.0 109.995 -176.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.12 14.86 9.66 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.65 -0.657 . . . . 0.0 111.724 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.441 ' O ' ' OG1' ' A' ' 64' ' ' THR . 26.8 mt-30 -67.05 137.06 56.15 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.54 ' N ' ' CD ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -114.4 -178.58 3.4 Favored 'General case' 0 C--N 1.281 -2.376 0 O-C-N 120.881 -1.137 . . . . 0.0 110.676 -175.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.628 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 13.8 mp0 -59.3 169.0 1.39 Allowed Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.628 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 30.5 Cg_endo -70.91 114.84 2.48 Favored 'Cis proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.621 -1.408 . . . . 0.0 114.475 0.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.439 ' N ' ' HA ' ' A' ' 15' ' ' GLN . 13.7 m-85 -102.92 164.33 15.77 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.431 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 30.9 Cg_endo -68.3 156.03 88.49 Favored 'Cis proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.864 -1.307 . . . . 0.0 111.092 -0.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 60' ' ' SER . 1.4 tmt_? -134.26 144.7 48.53 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -70.57 137.73 50.3 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 9' ' ' ILE . 30.6 m -133.93 2.7 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.422 ' HA3' HD13 ' A' ' 7' ' ' ILE . . . 178.57 179.2 48.36 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.496 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 17.3 mttp -146.52 133.69 20.49 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.007 -1.29 . . . . 0.0 110.762 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.595 HG11 HG11 ' A' ' 77' ' ' VAL . 20.0 t -108.23 131.0 59.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -133.96 170.05 20.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.751 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 1' ' ' SER . 0.9 OUTLIER -119.68 154.62 33.79 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.8 -1.188 . . . . 0.0 109.184 177.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.453 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 8.2 m . . . . . 0 C--N 1.267 -3.011 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.026 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.69 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -121.4 138.56 54.22 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.786 ' CE1' HG23 ' A' ' 79' ' ' THR . 36.7 m-85 -93.19 124.34 37.09 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 121.03 -1.044 . . . . 0.0 109.131 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.572 ' NH1' HG21 ' A' ' 80' ' ' THR . 25.4 mtm-85 -99.29 148.07 24.53 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.691 ' O ' HG11 ' A' ' 42' ' ' VAL . 18.1 tp -131.38 128.82 40.39 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -140.47 170.36 15.94 Favored 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.488 ' C ' ' HB2' ' A' ' 44' ' ' GLN . . . 120.87 166.18 12.95 Favored Glycine 0 C--N 1.282 -2.465 0 O-C-N 120.815 -1.178 . . . . 0.0 110.259 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 111.48 0.54 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 124.08 -19.14 7.35 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.691 HG11 ' O ' ' A' ' 37' ' ' LEU . 23.0 t -120.59 -92.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.289 -1.124 . . . . 0.0 108.976 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.489 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 2.0 t0 -94.13 -10.78 32.15 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.516 ' N ' ' OE1' ' A' ' 44' ' ' GLN . 17.4 mp0 -109.33 159.19 17.18 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 45' ' ' GLU . 2.0 pm0 -66.59 132.67 94.16 Favored Pre-proline 0 C--N 1.263 -3.172 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.091 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.441 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -74.12 120.12 6.18 Favored 'Cis proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.39 -1.504 . . . . 0.0 110.759 -0.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 43' ' ' ASP . 8.7 mttm -70.86 154.37 41.89 Favored 'General case' 0 C--N 1.289 -2.057 0 O-C-N 121.106 -0.996 . . . . 0.0 111.023 -175.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.78 30.13 74.15 Favored Glycine 0 N--CA 1.495 2.633 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.467 171.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLY . 9.4 mm -90.6 -45.95 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 119.007 1.404 . . . . 0.0 107.647 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.531 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 69.4 m-85 -114.34 151.91 32.26 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.271 0.558 . . . . 0.0 110.198 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.431 ' HD3' ' CB ' ' A' ' 18' ' ' PRO . 2.7 ptm85 -144.29 137.13 27.02 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 35' ' ' PHE . 13.6 tt -105.44 159.73 5.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.407 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 17.6 t-20 -90.45 132.72 35.49 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HA ' ' H ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -66.15 -31.21 71.92 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.832 -176.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -97.5 -51.88 3.98 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.676 0.75 . . . . 0.0 110.541 -174.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 7.8 p -80.43 -21.39 42.21 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 68.75 14.06 66.99 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.496 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 37.0 m -64.07 120.91 12.95 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.173 -1.192 . . . . 0.0 108.849 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.502 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.3 t -83.95 122.01 37.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -122.03 154.91 36.65 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.645 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.507 ' CG2' HD21 ' A' ' 65' ' ' LEU . 7.4 p -102.05 149.8 6.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 63.5 p -98.29 -16.51 19.35 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.613 -0.68 . . . . 0.0 110.226 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.63 178.49 7.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.416 -0.802 . . . . 0.0 109.973 -174.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 5.7 t -76.62 139.41 40.61 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.507 HD21 ' CG2' ' A' ' 61' ' ' VAL . 53.0 mt -98.96 156.23 17.01 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.393 -0.817 . . . . 0.0 109.516 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -135.67 128.47 31.09 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.551 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 12.9 mtm180 -64.64 -5.84 6.49 Favored 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.19 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.57 -21.61 52.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.105 -0.997 . . . . 0.0 108.516 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.25 -55.79 5.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.403 HD12 ' CE1' ' A' ' 73' ' ' TYR . 1.2 mt -141.84 136.63 30.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 121.416 -0.803 . . . . 0.0 108.935 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.28 -26.25 25.06 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.3 p -156.35 137.8 5.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.463 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 71.8 m-85 -99.25 116.86 32.41 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.511 HE22 ' CG ' ' A' ' 94' ' ' GLU . 15.1 tp60 -85.86 79.6 9.2 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.65 170.78 16.04 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 34.4 m-85 -137.35 141.15 41.81 Favored 'General case' 0 C--N 1.256 -3.457 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.595 HG11 HG11 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -115.37 148.51 18.05 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 O-C-N 121.687 -0.633 . . . . 0.0 109.399 -176.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 86' ' ' THR . 0.5 OUTLIER -134.39 135.27 42.51 Favored 'General case' 0 C--N 1.28 -2.455 0 O-C-N 121.195 -0.94 . . . . 0.0 108.859 176.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.786 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -87.51 132.14 34.13 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 174.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.584 ' C ' HD21 ' A' ' 87' ' ' LEU . 17.7 p -127.0 164.26 21.89 Favored 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.986 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 2.1 t70 -97.54 170.22 9.19 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.497 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 0.9 OUTLIER -46.43 -33.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-O 121.457 0.646 . . . . 0.0 109.874 178.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.53 2.63 21.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.558 -0.714 . . . . 0.0 109.742 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.23 81.39 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 80' ' ' THR . 8.3 mtpp -74.49 150.11 40.0 Favored 'General case' 0 CA--C 1.474 -1.943 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.589 ' C ' HD13 ' A' ' 87' ' ' LEU . 1.2 m -99.6 118.01 35.22 Favored 'General case' 0 C--N 1.272 -2.768 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.132 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.869 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.68 -24.11 17.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.38 158.62 44.21 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.465 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 75.09 -175.19 51.06 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -57.94 108.74 0.2 OUTLIER 'Cis proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.707 -1.372 . . . . 0.0 113.795 0.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.721 HG21 HG21 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -84.85 167.48 26.23 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 172.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -94.47 156.43 2.0 Favored 'Trans proline' 0 C--N 1.286 -2.763 0 C-N-CA 121.959 1.773 . . . . 0.0 112.791 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.723 HD13 ' CG2' ' A' ' 4' ' ' VAL . 4.5 tp -142.89 131.28 22.22 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.511 ' CG ' HE22 ' A' ' 74' ' ' GLN . 13.8 mt-10 -106.11 109.76 21.8 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.508 -0.745 . . . . 0.0 109.432 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.531 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 89.8 t -98.06 96.67 5.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.58 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.7 mp -79.79 128.29 38.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.26 105.09 15.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.9 pt -93.3 171.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.503 ' OD2' ' NH1' ' A' ' 67' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.282 -2.337 0 O-C-N 120.984 -1.072 . . . . 0.0 108.467 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.459 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 1.023 HG21 HG21 ' A' ' 91' ' ' VAL . 11.2 mt -65.24 131.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 C-N-CA 119.221 -0.991 . . . . 0.0 109.214 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.95 128.64 73.17 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.482 HG23 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -141.45 159.1 22.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -139.59 144.26 38.71 Favored Pre-proline 0 C--N 1.281 -2.37 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.435 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 36.8 Cg_exo -51.08 135.2 44.44 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.446 1.431 . . . . 0.0 109.88 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.421 HD13 ' HA3' ' A' ' 22' ' ' GLY . 22.7 mt -103.67 115.56 45.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.858 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.42 105.59 17.92 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.656 HD11 HG21 ' A' ' 21' ' ' VAL . 34.1 mt -114.02 123.28 33.0 Favored Pre-proline 0 C--N 1.287 -2.115 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 27.2 Cg_endo -66.83 142.8 64.44 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 120.748 0.965 . . . . 0.0 112.434 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -67.16 -178.55 0.82 Allowed 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 122.278 1.037 . . . . 0.0 112.307 -176.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.9 m-20 47.25 18.01 0.08 Allowed 'General case' 0 N--CA 1.514 2.762 0 C-N-CA 124.177 0.991 . . . . 0.0 113.341 174.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -76.64 122.84 25.23 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.28 -163.48 1.02 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.354 -0.841 . . . . 0.0 110.428 -175.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.568 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -46.66 165.57 0.19 Allowed Pre-proline 0 N--CA 1.5 2.062 0 CA-C-O 121.377 0.608 . . . . 0.0 111.409 -177.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 55.3 Cg_endo -86.92 120.9 5.78 Favored 'Cis proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.442 -1.483 . . . . 0.0 113.613 0.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 19' ' ' ARG . 27.4 m-85 -115.27 163.61 19.64 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 19.7 Cg_exo -67.07 162.63 74.65 Favored 'Cis proline' 0 N--CA 1.504 2.136 0 C-N-CA 124.553 -1.019 . . . . 0.0 113.077 -0.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -153.1 149.23 27.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.772 -0.58 . . . . 0.0 109.517 -178.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.476 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -71.39 139.68 49.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.656 HG21 HD11 ' A' ' 9' ' ' ILE . 33.5 m -132.75 -3.48 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA3' HD13 ' A' ' 7' ' ' ILE . . . -178.98 170.72 42.63 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 tttm -131.24 121.11 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -1.122 . . . . 0.0 109.906 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.577 HG23 ' CG2' ' A' ' 59' ' ' VAL . 41.9 t -91.85 147.63 5.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 171.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 26' ' ' ASP . 17.6 t -142.41 170.07 12.24 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.459 ' OD2' ' N ' ' A' ' 1' ' ' SER . 34.5 t0 -143.27 78.18 1.59 Allowed 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.82 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.035 -172.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.016 0.436 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -127.15 167.37 16.12 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 54' ' ' GLU . 87.9 m-85 -98.41 142.63 29.8 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.944 -1.098 . . . . 0.0 112.123 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.599 ' NH2' ' O ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER -110.05 126.56 54.12 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 172.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.633 ' HG ' HG21 ' A' ' 42' ' ' VAL . 37.5 tp -107.83 142.1 38.41 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 p -151.73 171.58 17.46 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 75' ' ' LEU . . . 121.3 172.73 14.47 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 120.843 -1.161 . . . . 0.0 111.418 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 44' ' ' GLN . 24.9 mtpp -61.19 111.69 1.82 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 121.49 -22.05 7.92 Favored Glycine 0 C--N 1.279 -2.632 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.633 HG21 ' HG ' ' A' ' 37' ' ' LEU . 20.1 t -118.91 -85.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.417 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 6.5 p-10 -101.14 -14.58 17.69 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.458 ' CD ' ' HA2' ' A' ' 39' ' ' GLY . 27.7 mt-30 -104.16 152.75 21.76 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 173.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.542 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 7.2 mm-40 -66.77 139.5 95.83 Favored Pre-proline 0 C--N 1.285 -2.206 0 O-C-N 121.85 -0.531 . . . . 0.0 110.373 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 37.7 Cg_endo -68.94 119.62 3.77 Favored 'Cis proline' 0 N--CA 1.509 2.41 0 C-N-CA 123.592 -1.42 . . . . 0.0 111.327 -1.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.542 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 11.2 mtpp -76.96 162.92 27.19 Favored 'General case' 0 C--N 1.288 -2.104 0 O-C-N 120.768 -1.207 . . . . 0.0 110.696 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.04 19.11 50.19 Favored Glycine 0 N--CA 1.496 2.674 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.939 173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.725 HD12 ' HD2' ' A' ' 63' ' ' ARG . 11.7 mm -83.09 -48.38 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 119.487 1.643 . . . . 0.0 107.591 176.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.74 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 52.1 m-85 -111.88 145.74 38.97 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.275 0.56 . . . . 0.0 110.646 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -148.35 135.49 20.26 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 37' ' ' LEU . 1.9 tt -102.96 157.01 4.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.455 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 11.6 t-20 -80.91 115.13 20.23 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' PHE . 1.7 mp0 -50.5 -40.84 52.46 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 122.061 -0.399 . . . . 0.0 111.496 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -90.43 -44.58 9.53 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.604 -1.31 . . . . 0.0 111.512 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 8.8 p -80.78 -28.48 36.36 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 121.226 -0.921 . . . . 0.0 109.417 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.6 10.49 84.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 m -67.38 123.44 20.39 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.388 -1.066 . . . . 0.0 108.224 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.577 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.1 t -86.58 124.48 40.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -121.09 150.9 40.51 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.622 HG21 HD21 ' A' ' 65' ' ' LEU . 9.8 p -110.49 148.27 14.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.9 p -97.29 -28.12 14.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.495 -0.753 . . . . 0.0 110.926 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.725 ' HD2' HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -135.26 167.54 20.83 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.094 -1.004 . . . . 0.0 110.232 -177.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.502 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 13.3 t -57.37 156.5 7.67 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.622 HD21 HG21 ' A' ' 61' ' ' VAL . 21.6 mt -110.88 140.94 44.91 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.951 -1.093 . . . . 0.0 108.683 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 68' ' ' GLU . 2.7 p-10 -131.4 122.97 27.22 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.572 ' NH1' ' O ' ' A' ' 97' ' ' VAL . 1.4 mtp85 -75.12 10.05 1.7 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 66' ' ' ASP . 52.1 mt-10 -74.11 -24.19 59.42 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.1 t -126.18 -82.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -91.16 127.67 43.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 121.12 -0.988 . . . . 0.0 108.987 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.59 -25.74 19.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.5 p -152.84 121.03 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.353 -0.842 . . . . 0.0 108.9 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.443 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 79.7 m-85 -80.11 120.66 24.55 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.463 HE22 ' HG3' ' A' ' 94' ' ' GLU . 26.2 tp60 -86.79 94.19 9.47 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.478 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -92.57 170.65 9.57 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.913 0.863 . . . . 0.0 109.198 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.0 m-85 -140.78 131.24 25.3 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.37 146.41 18.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 O-C-N 122.055 -0.403 . . . . 0.0 110.517 -174.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.623 ' HB3' HG23 ' A' ' 86' ' ' THR . 45.3 mt-10 -132.14 141.65 49.21 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 120.939 -1.101 . . . . 0.0 109.143 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.609 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -86.38 135.43 33.51 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 171.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.665 ' C ' HD21 ' A' ' 87' ' ' LEU . 1.1 p -127.14 152.36 47.44 Favored 'General case' 0 C--N 1.286 -2.179 0 O-C-N 121.481 -0.762 . . . . 0.0 111.251 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.581 ' N ' HD21 ' A' ' 87' ' ' LEU . 46.1 p-10 -89.28 171.99 9.37 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.104 0.954 . . . . 0.0 109.614 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.421 ' H ' HG13 ' A' ' 82' ' ' VAL . 4.1 m -54.02 -9.59 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.101 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -100.57 -34.96 9.69 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.122 . . . . 0.0 108.423 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' NH2' ' A' ' 36' ' ' ARG . . . 118.57 23.44 3.41 Favored Glycine 0 C--N 1.287 -2.156 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -95.6 141.09 29.52 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.623 HG23 ' HB3' ' A' ' 78' ' ' GLU . 89.0 m -79.96 119.56 22.98 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.442 -0.786 . . . . 0.0 110.611 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.905 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -89.02 -25.72 21.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.96 -1.087 . . . . 0.0 108.393 176.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.409 ' OE2' ' N ' ' A' ' 2' ' ' ILE . 26.5 tt0 -151.88 160.02 43.66 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.522 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 94.64 -173.85 32.72 Favored Glycine 0 C--N 1.289 -2.046 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.82 105.91 0.43 Allowed 'Cis proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.162 -1.599 . . . . 0.0 111.595 -0.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.023 HG21 HG21 ' A' ' 2' ' ' ILE . 5.0 m -73.93 164.47 60.92 Favored Pre-proline 0 C--N 1.286 -2.161 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -92.44 153.71 3.01 Favored 'Trans proline' 0 C--N 1.286 -2.736 0 C-N-CA 121.315 1.343 . . . . 0.0 112.064 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.482 HD13 HG23 ' A' ' 4' ' ' VAL . 11.5 tp -142.12 128.64 20.19 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.463 ' HG3' HE22 ' A' ' 74' ' ' GLN . 17.2 mt-10 -108.69 108.45 19.3 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.649 -0.657 . . . . 0.0 109.335 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.74 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 84.7 t -96.72 99.56 9.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 176.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 2.4 mp -80.95 132.02 32.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.572 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 19.8 t -89.09 111.47 22.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.576 HG21 ' HB3' ' A' ' 8' ' ' LEU . 13.6 pt -97.08 170.96 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.452 -0.78 . . . . 0.0 109.394 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.535 ' CG ' ' HE ' ' A' ' 67' ' ' ARG . 7.0 m-20 . . . . . 0 C--N 1.297 -1.675 0 O-C-N 121.148 -0.97 . . . . 0.0 108.459 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.463 ' HG ' ' CB ' ' A' ' 27' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.407 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.84 HG21 HG21 ' A' ' 91' ' ' VAL . 7.2 mt -79.49 122.27 34.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -104.59 142.6 17.62 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.415 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -150.05 160.43 4.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.415 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -132.24 130.77 22.08 Favored Pre-proline 0 C--N 1.276 -2.592 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HB3' HD11 ' A' ' 96' ' ' ILE . 54.0 Cg_exo -41.15 129.14 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.213 1.942 . . . . 0.0 110.189 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.419 HG22 HG12 ' A' ' 9' ' ' ILE . 28.8 mt -95.79 109.41 22.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.509 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.05 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.933 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -90.41 107.08 18.92 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 7' ' ' ILE . 15.9 mt -107.22 125.19 33.05 Favored Pre-proline 0 C--N 1.286 -2.191 0 O-C-N 121.433 -0.792 . . . . 0.0 109.11 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.3 Cg_endo -64.96 120.11 7.29 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.125 1.216 . . . . 0.0 109.43 175.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.483 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -70.8 -171.97 0.59 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.532 0.682 . . . . 0.0 110.767 -174.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 59.99 -2.9 0.13 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -56.96 137.82 54.95 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.41 175.43 5.51 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 121.272 -0.892 . . . . 0.0 110.707 -174.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -49.68 166.56 0.26 Allowed Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 123.045 0.538 . . . . 0.0 109.935 178.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.583 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 1.9 Cg_endo -78.71 143.22 71.28 Favored 'Cis proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.18 -1.592 . . . . 0.0 112.926 -0.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.501 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 30.0 m-85 -115.41 160.98 32.3 Favored Pre-proline 0 C--N 1.275 -2.663 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 3.9 Cg_endo -70.94 160.64 91.22 Favored 'Cis proline' 0 N--CA 1.487 1.142 0 C-N-CA 124.04 -1.233 . . . . 0.0 112.877 0.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 16' ' ' PRO . 4.9 mtp85 -131.14 136.33 48.25 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -66.84 137.57 56.69 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.03 5.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.53 177.42 37.15 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 117.707 -2.187 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.564 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 16.1 tttm -139.2 123.21 17.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.118 -1.225 . . . . 0.0 110.955 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.564 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 14.3 t -82.0 155.99 4.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 172.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 3' ' ' VAL . 22.0 t -144.89 148.4 17.98 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.941 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.486 ' HB2' HG21 ' A' ' 79' ' ' THR . 11.4 t0 -112.79 131.69 55.58 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.463 ' CB ' ' HG ' ' A' ' 1' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.286 -2.152 0 O-C-N 121.748 -0.595 . . . . 0.0 110.121 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.479 ' O ' ' NZ ' ' A' ' 34' ' ' LYS . 2.6 p . . . . . 0 N--CA 1.499 1.994 0 CA-C-O 121.46 0.648 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 33' ' ' SER . 5.3 mmtm -137.74 170.99 15.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HB3' HD13 ' A' ' 52' ' ' ILE . 14.5 m-85 -117.58 121.28 40.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.406 -0.809 . . . . 0.0 109.14 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.478 ' HG3' ' CG2' ' A' ' 80' ' ' THR . 0.0 OUTLIER -100.96 144.28 30.09 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 173.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.9 tp -127.94 142.55 51.22 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.46 171.38 16.17 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.466 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 124.86 166.42 12.38 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.318 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.58 119.05 4.72 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 109.39 -24.81 19.53 Favored Glycine 0 C--N 1.281 -2.491 0 N-CA-C 107.661 -2.175 . . . . 0.0 107.661 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -105.89 -100.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.553 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -90.25 -0.51 57.65 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.393 -0.817 . . . . 0.0 109.351 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -123.36 157.66 32.82 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.997 178.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -47.94 127.21 11.52 Favored Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.847 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.443 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 4.4 Cg_exo -76.38 113.16 2.71 Favored 'Cis proline' 0 C--O 1.203 -1.25 0 C-N-CA 123.694 -1.378 . . . . 0.0 109.188 -1.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.553 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 11.4 mtpp -64.9 139.98 58.82 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 121.024 -1.048 . . . . 0.0 111.438 -173.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.67 35.68 35.46 Favored Glycine 0 N--CA 1.502 3.076 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.104 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 41' ' ' GLY . 5.1 mm -104.33 -46.12 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 118.717 1.259 . . . . 0.0 107.944 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.468 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 67.1 m-85 -114.11 137.76 51.31 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.65 0.738 . . . . 0.0 110.318 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.24 143.33 31.69 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 35' ' ' PHE . 8.3 tt -106.58 166.39 3.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.475 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 9.8 t-20 -86.95 120.49 28.27 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.27 -13.98 2.52 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -119.93 -46.83 2.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.844 -1.16 . . . . 0.0 111.382 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 22.0 p -79.39 -40.99 28.74 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.742 0.782 . . . . 0.0 108.991 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.42 6.15 56.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 6.6 m -61.77 125.58 24.31 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.4 -1.059 . . . . 0.0 108.169 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.484 HG22 HG23 ' A' ' 24' ' ' VAL . 2.1 t -93.56 129.48 43.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.4 155.78 44.19 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.541 -0.724 . . . . 0.0 109.174 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.525 HG22 ' H ' ' A' ' 63' ' ' ARG . 8.5 p -106.81 139.87 26.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -94.34 6.28 49.19 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.479 -0.763 . . . . 0.0 112.796 -176.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.669 ' NH1' ' O ' ' A' ' 64' ' ' THR . 15.6 ptt85 -156.18 172.38 18.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.441 -1.412 . . . . 0.0 110.759 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.669 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 5.9 t -65.42 138.17 57.95 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 47.3 mt -96.28 163.89 12.89 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.943 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.567 ' CG ' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -152.07 121.73 6.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.415 ' HG2' ' HB ' ' A' ' 97' ' ' VAL . 24.0 mtm-85 -67.1 1.99 1.75 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.411 -0.806 . . . . 0.0 109.352 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -71.73 -22.01 61.68 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -101.34 -70.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.9 mt -130.49 145.86 34.93 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.53 -23.53 15.98 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.4 p -151.38 139.13 13.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.67 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -110.88 143.87 40.81 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.16 95.6 5.69 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.5 OUTLIER -88.58 170.33 10.94 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.302 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 68.6 m-85 -129.93 121.19 26.13 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.606 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -107.38 152.86 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 120.93 0.395 . . . . 0.0 110.106 -176.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.761 ' HB3' HG23 ' A' ' 86' ' ' THR . 48.0 mt-10 -138.88 140.39 38.4 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.701 -0.625 . . . . 0.0 109.401 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.573 ' N ' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -91.07 124.65 35.46 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 172.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -110.0 158.82 17.86 Favored 'General case' 0 C--N 1.268 -2.936 0 CA-C-O 121.817 0.818 . . . . 0.0 111.523 -171.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.616 ' HB2' HD21 ' A' ' 87' ' ' LEU . 14.2 t0 -99.58 169.38 9.33 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 175.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 2.4 m -59.33 -19.86 17.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.981 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -80.61 -1.28 41.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.42 24.76 74.39 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 80' ' ' THR . 6.5 pttp -107.5 159.46 16.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.645 -0.915 . . . . 0.0 108.843 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.761 HG23 ' HB3' ' A' ' 78' ' ' GLU . 4.2 m -83.23 120.83 26.31 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.358 0.599 . . . . 0.0 112.415 -174.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.616 HD21 ' HB2' ' A' ' 81' ' ' ASP . 1.2 mm? -79.81 -46.91 16.07 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 1' ' ' SER . 0.5 OUTLIER -142.71 155.05 44.83 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.24 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.596 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 105.08 177.7 24.4 Favored Glycine 0 C--N 1.291 -1.928 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 36.1 Cg_endo -68.34 102.59 0.29 Allowed 'Cis proline' 0 N--CA 1.5 1.888 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.403 0.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.84 HG21 HG21 ' A' ' 2' ' ' ILE . 6.8 m -79.17 160.41 70.92 Favored Pre-proline 0 C--N 1.29 -1.989 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -94.03 148.2 2.05 Favored 'Trans proline' 0 C--N 1.284 -2.838 0 C-N-CA 121.673 1.582 . . . . 0.0 111.775 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 94' ' ' GLU . 3.9 tp -131.57 128.4 39.14 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.467 ' N ' HD12 ' A' ' 93' ' ' LEU . 23.3 mt-10 -102.64 119.74 39.35 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 97.7 t -109.18 111.05 34.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.634 HD13 ' CD1' ' A' ' 8' ' ' LEU . 5.2 mp -94.82 134.41 32.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.483 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 21.4 t -91.22 119.57 38.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.565 HG21 ' HB3' ' A' ' 8' ' ' LEU . 12.2 pt -119.17 171.33 7.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 . . . . . 0 C--N 1.294 -1.841 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.94 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.492 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.949 HG21 HG21 ' A' ' 91' ' ' VAL . 10.0 mt -78.38 139.99 17.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.071 -1.018 . . . . 0.0 111.168 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -122.83 123.84 69.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 172.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.517 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -126.47 162.93 29.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 O-C-N 121.15 -0.969 . . . . 0.0 110.003 -175.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.457 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -142.95 133.76 12.51 Favored Pre-proline 0 C--N 1.289 -2.054 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -47.35 152.72 2.19 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.497 2.131 . . . . 0.0 111.517 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.433 HG13 HD11 ' A' ' 93' ' ' LEU . 4.4 mt -115.66 114.34 45.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.884 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -89.35 108.39 19.61 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.463 ' C ' HG12 ' A' ' 98' ' ' ILE . 12.7 mt -118.0 130.05 24.97 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 28.1 Cg_endo -67.53 132.06 26.19 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.143 1.228 . . . . 0.0 111.514 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.63 ' CD ' HH21 ' A' ' 67' ' ' ARG . 21.0 pt-20 -54.86 164.75 0.74 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.437 -0.79 . . . . 0.0 109.495 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 60.48 29.64 19.16 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.774 -0.579 . . . . 0.0 111.453 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.421 ' O ' ' OG1' ' A' ' 64' ' ' THR . 2.8 mt-30 -60.47 140.48 57.25 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.583 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 48.7 mtm-85 -114.62 169.09 9.32 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.008 -1.057 . . . . 0.0 111.685 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.614 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 22.6 mt-30 -49.71 169.55 0.18 Allowed Pre-proline 0 C--N 1.297 -1.687 0 C-N-CA 123.387 0.675 . . . . 0.0 109.529 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 5.9 Cg_exo -76.32 125.45 11.72 Favored 'Cis proline' 0 N--CA 1.49 1.291 0 C-N-CA 123.978 -1.259 . . . . 0.0 113.268 -0.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.533 ' CE1' ' HD3' ' A' ' 19' ' ' ARG . 35.3 m-85 -100.26 159.3 30.14 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 15.4 Cg_exo -68.42 149.27 84.81 Favored 'Cis proline' 0 N--CA 1.505 2.167 0 C-N-CA 124.594 -1.003 . . . . 0.0 112.629 -0.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 13.9 mtp180 -118.89 122.77 43.07 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.458 -0.776 . . . . 0.0 110.081 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 1.7 t70 -66.22 135.03 53.91 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.1 0.16 2.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.778 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.54 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 172.14 174.32 39.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.645 ' CE ' HG22 ' A' ' 25' ' ' VAL . 3.5 tttp -134.91 126.66 29.12 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 121.305 -1.115 . . . . 0.0 109.587 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.585 HG23 ' CG2' ' A' ' 59' ' ' VAL . 62.0 t -89.06 153.12 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.645 HG22 ' CE ' ' A' ' 23' ' ' LYS . 2.7 t -137.16 170.19 18.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 118.212 -1.395 . . . . 0.0 109.433 -174.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 1' ' ' SER . 16.3 t0 -143.9 123.37 13.16 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.295 -1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 109.377 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 121.4 0.619 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -100.07 126.74 46.33 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.749 ' HB3' HD13 ' A' ' 52' ' ' ILE . 61.8 m-85 -86.65 130.12 34.61 Favored 'General case' 0 C--N 1.28 -2.439 0 O-C-N 121.563 -0.711 . . . . 0.0 110.059 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HG3' HG21 ' A' ' 80' ' ' THR . 0.3 OUTLIER -103.7 135.58 45.0 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 20.2 tp -114.57 145.94 41.35 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.515 HG23 ' NH2' ' A' ' 36' ' ' ARG . 1.2 p -148.01 170.98 16.56 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.14 171.86 16.94 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 120.043 -1.075 . . . . 0.0 111.463 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -60.78 117.44 5.39 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 117.44 -24.44 9.15 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -175.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.487 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 15.2 t -126.51 -104.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.02 -22.75 66.46 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.223 -0.923 . . . . 0.0 110.22 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -116.73 159.35 22.4 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.615 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 6.6 mm-40 -74.46 150.15 86.86 Favored Pre-proline 0 C--N 1.287 -2.115 0 O-C-N 121.971 -0.456 . . . . 0.0 110.336 -177.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 31.2 Cg_endo -67.13 115.91 1.8 Allowed 'Cis proline' 0 N--CA 1.511 2.554 0 C-N-CA 123.835 -1.319 . . . . 0.0 110.631 -0.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.615 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 2.1 mtpm? -78.22 165.75 23.53 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.657 -1.277 . . . . 0.0 110.946 -173.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.19 31.47 69.09 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.6 mm -105.69 -45.29 8.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 118.645 1.222 . . . . 0.0 107.936 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.621 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 97.0 m-85 -124.42 156.25 37.47 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.611 0.72 . . . . 0.0 110.633 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -156.78 150.96 25.11 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.749 HD13 ' HB3' ' A' ' 35' ' ' PHE . 15.1 tt -108.81 157.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 118.61 -1.236 . . . . 0.0 108.962 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 10.2 t-20 -83.34 119.38 24.53 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -75.56 10.72 1.56 Allowed 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 120.865 0.364 . . . . 0.0 111.496 -175.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 19.5 t-20 -124.14 -43.18 2.1 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.837 -1.165 . . . . 0.0 109.276 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.417 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 43.7 p -95.74 -38.6 10.26 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.59 6.06 55.07 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.0 m -66.54 124.56 23.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.568 -0.96 . . . . 0.0 109.512 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.585 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.7 t -87.61 124.62 41.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -124.17 155.66 38.08 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.325 -0.859 . . . . 0.0 109.641 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.427 HG13 ' CE1' ' A' ' 17' ' ' PHE . 7.4 p -102.17 137.55 29.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.2 -12.99 39.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.454 -0.779 . . . . 0.0 111.548 -174.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.559 ' NE ' ' O ' ' A' ' 64' ' ' THR . 2.0 ptm180 -153.08 -176.4 5.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.841 -1.162 . . . . 0.0 110.208 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.559 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 12.6 t -70.51 156.06 39.9 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.686 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -113.09 123.01 49.28 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 109.407 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -109.07 113.77 26.92 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.63 HH21 ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -58.65 -7.29 0.92 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.518 0.675 . . . . 0.0 109.229 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -70.67 -19.79 62.76 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 66' ' ' ASP . 2.3 t -101.7 -58.57 3.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 mt -136.21 134.85 50.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.63 -28.13 24.97 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.3 p -152.79 128.0 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.508 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 29.7 m-85 -91.21 125.44 35.99 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -90.68 85.08 5.97 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 170.45 13.39 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 70.3 m-85 -135.96 133.99 38.16 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.744 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -111.24 155.56 12.61 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 O-C-N 121.826 -0.546 . . . . 0.0 109.595 -176.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.41 ' C ' HD11 ' A' ' 2' ' ' ILE . 2.1 mt-10 -144.76 147.85 33.42 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.702 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -94.21 133.64 37.51 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.555 HG21 ' HG3' ' A' ' 36' ' ' ARG . 17.1 p -128.14 153.93 46.32 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.412 ' C ' ' H ' ' A' ' 83' ' ' ASN . 1.2 t70 -109.69 170.7 7.9 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.7 m -56.99 -3.67 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 O-C-N 121.306 -0.871 . . . . 0.0 111.003 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -79.71 -19.68 48.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.34 28.96 31.75 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -116.34 168.21 10.34 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 88' ' ' GLU . 1.3 m -109.8 118.87 37.66 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.453 -0.78 . . . . 0.0 110.015 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.91 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.6 -20.31 21.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 86' ' ' THR . 12.7 tt0 -157.2 164.08 38.13 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.46 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 114.92 166.5 15.21 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 107.045 -2.422 . . . . 0.0 107.045 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -82.63 107.2 1.02 Allowed 'Cis proline' 0 C--N 1.3 -2.003 0 C-N-CA 123.127 -1.614 . . . . 0.0 110.801 0.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.949 HG21 HG21 ' A' ' 2' ' ' ILE . 18.9 m -78.58 159.46 74.37 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 105.682 -1.969 . . . . 0.0 105.682 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -91.5 148.18 3.47 Favored 'Trans proline' 0 C--N 1.285 -2.77 0 C-N-CA 121.419 1.412 . . . . 0.0 112.675 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.487 HD21 HG11 ' A' ' 59' ' ' VAL . 11.2 tp -138.65 113.28 9.0 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -95.47 113.79 25.48 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.621 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 15.8 t -95.28 107.76 19.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 176.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.407 HD13 ' CD1' ' A' ' 8' ' ' LEU . 2.4 mp -90.89 127.7 43.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.6 t -84.62 104.86 13.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 7.4 pt -94.67 172.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 O-C-N 121.517 -0.739 . . . . 0.0 109.365 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.506 ' CG ' HH22 ' A' ' 67' ' ' ARG . 1.1 m-20 . . . . . 0 C--N 1.291 -1.939 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 1.02 HG21 HG21 ' A' ' 91' ' ' VAL . 11.7 mt -59.01 120.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.187 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.0 113.94 45.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.496 HG23 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -136.74 158.96 37.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.413 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -148.69 139.73 13.79 Favored Pre-proline 0 C--N 1.273 -2.73 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -41.48 132.65 3.58 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.216 1.944 . . . . 0.0 111.451 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.52 HG13 HD11 ' A' ' 93' ' ' LEU . 34.7 mt -98.42 110.91 26.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.881 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -87.71 108.44 19.11 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 21' ' ' VAL . 20.5 mt -117.09 136.1 23.25 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 30.0 Cg_endo -70.54 132.37 21.95 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.299 1.333 . . . . 0.0 110.968 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.548 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 13.1 pt-20 -63.78 176.75 0.85 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.018 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.549 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 20.4 t-20 58.56 23.51 10.94 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.587 -0.696 . . . . 0.0 111.757 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 10' ' ' PRO . 2.8 mt-30 -70.22 115.79 9.82 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.549 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -89.57 176.1 7.02 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 120.928 -1.108 . . . . 0.0 109.932 -177.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.573 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 11.6 mm-40 -42.92 167.62 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 C-N-CA 124.063 0.945 . . . . 0.0 110.61 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 2.2 Cg_endo -82.7 146.34 60.09 Favored 'Cis proline' 0 N--CA 1.495 1.567 0 C-N-CA 124.186 -1.172 . . . . 0.0 114.027 -0.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.487 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 42.3 m-85 -133.62 160.35 68.94 Favored Pre-proline 0 C--N 1.282 -2.369 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 18.4 Cg_exo -66.46 163.49 69.81 Favored 'Cis proline' 0 N--CA 1.499 1.807 0 C-N-CA 124.079 -1.217 . . . . 0.0 112.162 -0.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 16' ' ' PRO . 9.9 ttm180 -146.13 143.55 29.4 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.667 -0.646 . . . . 0.0 109.455 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 9.0 t0 -74.73 137.51 42.12 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.638 HG21 HD11 ' A' ' 9' ' ' ILE . 35.0 m -132.64 6.03 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 174.82 179.47 45.42 Favored Glycine 0 N--CA 1.506 3.322 0 C-N-CA 118.896 -1.621 . . . . 0.0 109.702 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.7 ttpm? -145.37 122.98 11.78 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.787 -1.419 . . . . 0.0 110.118 -177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.567 HG11 HG11 ' A' ' 77' ' ' VAL . 45.4 t -93.49 143.57 11.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 171.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' HE2' ' A' ' 23' ' ' LYS . 11.9 t -139.18 170.08 16.45 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 1' ' ' SER . 10.1 t0 -132.67 120.5 21.81 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.419 ' HG ' ' H3 ' ' A' ' 1' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.265 -3.068 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.823 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.482 1.14 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' A' ' 82' ' ' VAL . 4.1 mttm -113.66 123.96 51.16 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.911 ' CE2' HG23 ' A' ' 79' ' ' THR . 53.0 m-85 -83.33 139.42 33.05 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 120.967 -1.083 . . . . 0.0 109.695 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.569 HH22 ' CD ' ' A' ' 54' ' ' GLU . 41.2 mmt-85 -120.38 155.61 33.06 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.47 HD11 HD23 ' A' ' 93' ' ' LEU . 16.1 tp -133.27 142.07 48.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -147.97 171.52 15.66 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.72 179.4 16.91 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.531 -1.355 . . . . 0.0 111.154 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -63.13 106.98 0.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 129.64 -18.13 5.45 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -130.46 -90.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.988 -0.713 . . . . 0.0 109.324 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -20.03 32.52 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 120.923 -1.111 . . . . 0.0 108.777 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -112.35 161.26 16.85 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.365 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 6.5 mt-10 -69.33 143.41 93.5 Favored Pre-proline 0 C--N 1.281 -2.401 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.573 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.489 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 40.8 Cg_endo -72.87 123.65 8.56 Favored 'Cis proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.179 -1.592 . . . . 0.0 110.271 -2.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.425 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 2.3 mtpm? -80.35 166.06 21.67 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 120.716 -1.24 . . . . 0.0 109.674 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.09 34.02 75.27 Favored Glycine 0 C--N 1.284 -2.355 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.471 HD13 ' NE ' ' A' ' 63' ' ' ARG . 4.5 mm -110.85 -50.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.008 -1.29 . . . . 0.0 108.4 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.654 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 97.3 m-85 -121.59 161.12 22.96 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.405 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.66 ' HG2' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -160.07 134.26 7.4 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 35' ' ' PHE . 19.3 tt -100.13 167.23 2.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 O-C-N 120.793 -1.192 . . . . 0.0 109.04 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.417 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 7.1 t-20 -100.59 122.86 43.98 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.569 ' CD ' HH22 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -49.1 -49.75 40.32 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.965 -0.46 . . . . 0.0 112.005 -176.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -90.08 -40.78 12.07 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 111.936 -173.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 9.3 p -84.14 -22.79 30.92 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.0 9.19 62.72 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.0 m -64.4 123.72 19.93 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.263 -1.139 . . . . 0.0 108.714 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.473 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.3 t -83.15 120.75 35.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -116.88 153.85 31.8 Favored 'General case' 0 C--N 1.282 -2.344 0 O-C-N 121.577 -0.702 . . . . 0.0 109.97 -177.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.472 HG23 HD21 ' A' ' 65' ' ' LEU . 7.2 p -105.67 140.83 22.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.66 HG23 ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -93.06 -15.17 26.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.795 . . . . 0.0 111.209 -176.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.471 ' NE ' HD13 ' A' ' 49' ' ' ILE . 6.0 ptp180 -154.34 -167.64 2.69 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.747 -1.22 . . . . 0.0 110.004 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 1.7 t -74.78 148.57 40.25 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' ASN . 67.0 mt -106.63 129.95 54.46 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.18 126.77 55.43 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.413 HH12 ' CG ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -67.62 -9.58 44.38 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.19 -28.57 62.27 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.32 -52.9 10.6 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.425 ' O ' HG21 ' A' ' 97' ' ' VAL . 1.1 mt -148.43 136.76 14.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.12 -22.37 27.13 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -155.33 123.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.503 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 65.0 m-85 -88.21 121.65 30.85 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.915 -1.115 . . . . 0.0 108.509 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.2 98.47 11.79 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.63 170.42 9.35 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.2 m-85 -135.46 124.27 23.96 Favored 'General case' 0 C--N 1.262 -3.198 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -104.88 152.18 6.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.084 0.469 . . . . 0.0 110.293 -174.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.55 ' HB3' HG23 ' A' ' 86' ' ' THR . 42.7 mt-10 -139.71 140.12 36.73 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.911 HG23 ' CE2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -93.26 130.91 38.81 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 170.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.517 ' C ' HD21 ' A' ' 87' ' ' LEU . 70.5 p -124.5 164.82 18.95 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.744 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.476 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 25.5 t70 -88.23 167.66 13.39 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.2 m -53.65 -27.07 14.58 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.685 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -79.87 -11.18 59.83 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.582 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.8 56.98 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -76.46 146.97 38.2 Favored 'General case' 0 C--O 1.194 -1.824 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 175.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 78' ' ' GLU . 85.2 m -93.4 115.17 27.72 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 118.76 0.709 . . . . 0.0 109.199 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.05 -31.71 27.22 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -144.84 160.65 40.94 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.0 109.201 175.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.422 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 94.65 178.27 38.16 Favored Glycine 0 C--N 1.287 -2.187 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -174.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -67.94 121.36 4.34 Favored 'Cis proline' 0 C--N 1.299 -2.058 0 C-N-CA 123.026 -1.656 . . . . 0.0 111.433 0.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 2' ' ' ILE . 3.0 m -101.86 163.27 18.12 Favored Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -91.01 150.07 3.84 Favored 'Trans proline' 0 C--N 1.287 -2.673 0 C-N-CA 121.53 1.487 . . . . 0.0 112.372 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.52 HD11 HG13 ' A' ' 7' ' ' ILE . 10.5 tp -137.46 128.3 27.22 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.06 109.94 21.5 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.629 -0.669 . . . . 0.0 109.886 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.654 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 61.3 t -91.75 97.08 6.82 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.447 ' HB ' HD12 ' A' ' 8' ' ' LEU . 2.1 mt -79.63 132.24 32.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 21.7 t -91.15 116.79 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 11.5 pt -105.85 171.82 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.413 ' CG ' HH12 ' A' ' 67' ' ' ARG . 11.6 m-20 . . . . . 0 C--N 1.298 -1.661 0 O-C-N 120.907 -1.12 . . . . 0.0 109.356 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 1.09 HG21 HG21 ' A' ' 91' ' ' VAL . 31.7 mt -65.7 132.13 31.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-O 121.734 0.778 . . . . 0.0 110.74 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -119.44 122.84 69.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 175.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -137.87 169.13 19.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.522 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.5 m -159.81 169.76 9.81 Favored Pre-proline 0 C--N 1.274 -2.695 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 25.1 Cg_exo -61.85 134.87 52.5 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.35 1.367 . . . . 0.0 110.745 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.613 HD13 ' HA3' ' A' ' 22' ' ' GLY . 24.4 mt -106.11 111.83 36.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.868 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.42 98.56 11.85 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.459 ' CD1' HG21 ' A' ' 21' ' ' VAL . 20.3 mt -101.19 129.0 28.01 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.97 -1.081 . . . . 0.0 109.0 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 5.0 Cg_endo -63.38 124.91 14.61 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 121.091 1.194 . . . . 0.0 110.046 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.52 ' HB3' HG12 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -67.04 171.43 5.53 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.717 1.246 . . . . 0.0 113.929 -170.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.512 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 6.4 m-80 47.71 24.15 0.51 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.486 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.458 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 73.0 mt-30 -67.0 146.79 54.0 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 173.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.541 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -104.9 179.26 4.32 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.174 -0.954 . . . . 0.0 110.031 -177.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.639 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -54.2 176.74 0.12 Allowed Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.639 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 5.7 Cg_exo -72.79 117.99 4.4 Favored 'Cis proline' 0 N--CA 1.491 1.359 0 C-N-CA 123.942 -1.274 . . . . 0.0 113.986 0.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 31.8 m-85 -100.15 165.08 15.16 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 55.2 Cg_endo -73.12 162.25 92.14 Favored 'Cis proline' 0 N--CA 1.497 1.681 0 C-N-CA 124.242 -1.149 . . . . 0.0 111.84 -0.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 11.3 mtp180 -138.19 145.5 41.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 5.0 t0 -73.75 134.53 43.48 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.459 HG21 ' CD1' ' A' ' 9' ' ' ILE . 31.1 m -129.91 3.24 2.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.609 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.613 ' HA3' HD13 ' A' ' 7' ' ' ILE . . . -172.83 -171.32 37.48 Favored Glycine 0 N--CA 1.499 2.899 0 C-N-CA 117.347 -2.358 . . . . 0.0 111.146 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -150.29 113.68 4.92 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 120.998 -1.295 . . . . 0.0 110.851 -178.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 4' ' ' VAL . 11.4 t -100.91 112.06 32.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 169.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 3' ' ' VAL . 58.5 t -120.66 154.46 24.0 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.008 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.7 t70 -104.23 135.41 45.74 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.074 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.483 1.224 0 CA-C-O 121.407 0.622 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -126.61 133.01 51.13 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.614 ' HB3' HD13 ' A' ' 52' ' ' ILE . 12.1 m-85 -79.9 137.73 36.97 Favored 'General case' 0 C--N 1.273 -2.755 0 O-C-N 121.137 -0.977 . . . . 0.0 108.543 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.413 ' NH2' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -114.97 126.52 54.86 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.584 ' HG ' HG21 ' A' ' 42' ' ' VAL . 19.5 tp -105.8 148.98 26.9 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.413 HG23 ' NH2' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -152.03 170.39 20.02 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -177.154 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.5 ' C ' ' HB2' ' A' ' 44' ' ' GLN . . . 110.43 172.41 20.05 Favored Glycine 0 N--CA 1.497 2.765 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.954 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.48 ' N ' ' HB2' ' A' ' 44' ' ' GLN . 9.6 mtpp -53.25 114.75 1.59 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 115.18 -20.66 13.94 Favored Glycine 0 C--N 1.28 -2.564 0 N-CA-C 108.296 -1.921 . . . . 0.0 108.296 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.584 HG21 ' HG ' ' A' ' 37' ' ' LEU . 9.2 t -113.06 -89.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.45 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 31.7 t70 -100.17 -13.02 19.11 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.243 -0.91 . . . . 0.0 109.501 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 44' ' ' GLN . 0.4 OUTLIER -100.13 158.42 15.86 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 176.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 137.24 96.17 Favored Pre-proline 0 C--N 1.271 -2.808 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.492 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.44 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.2 Cg_exo -76.88 119.47 6.39 Favored 'Cis proline' 0 N--CA 1.5 1.874 0 C-N-CA 123.442 -1.483 . . . . 0.0 110.624 -0.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 2.2 mttm -69.27 144.49 53.6 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.708 -1.245 . . . . 0.0 110.353 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.49 37.83 34.59 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.344 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.432 HG13 ' HA2' ' A' ' 41' ' ' GLY . 5.0 mm -106.11 -43.0 7.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.499 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 84.8 m-85 -118.71 149.93 40.61 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.793 0.806 . . . . 0.0 110.264 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.485 ' HG2' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -148.13 142.94 26.75 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 176.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' A' ' 35' ' ' PHE . 12.2 tt -100.09 158.46 3.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 O-C-N 120.505 -1.372 . . . . 0.0 109.845 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 58' ' ' SER . 6.2 m-80 -84.76 84.71 7.6 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.732 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 2.0 pm0 -24.78 -54.52 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 124.18 0.992 . . . . 0.0 113.554 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -80.95 -33.94 33.59 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.168 -0.958 . . . . 0.0 111.939 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -94.94 -25.84 16.38 Favored 'General case' 0 C--N 1.287 -2.126 0 O-C-N 121.161 -0.962 . . . . 0.0 109.073 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 82.91 10.52 82.89 Favored Glycine 0 C--N 1.285 -2.273 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -66.8 128.73 37.42 Favored 'General case' 0 C--N 1.312 -1.043 0 O-C-N 120.859 -1.377 . . . . 0.0 108.608 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 7' ' ' ILE . 4.6 t -79.91 119.2 28.87 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.477 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -113.29 151.6 30.93 Favored 'General case' 0 C--N 1.282 -2.335 0 O-C-N 121.699 -0.626 . . . . 0.0 109.561 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.534 HG21 HD11 ' A' ' 65' ' ' LEU . 12.8 p -112.63 143.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.485 HG23 ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -96.43 -15.36 21.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.695 -0.628 . . . . 0.0 111.54 -176.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.95 178.54 8.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.464 -1.397 . . . . 0.0 111.783 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.541 ' OG1' ' NH2' ' A' ' 14' ' ' ARG . 4.9 t -70.05 122.51 19.52 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.534 HD11 HG21 ' A' ' 61' ' ' VAL . 28.3 mt -90.81 127.2 36.26 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.161 -0.962 . . . . 0.0 108.926 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.25 139.28 46.77 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.442 ' CG ' ' HB3' ' A' ' 11' ' ' GLU . 7.4 mtp180 -81.88 -11.24 59.02 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.803 -0.56 . . . . 0.0 111.29 -176.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.85 -22.76 49.43 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.83 -63.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.41 ' O ' HG21 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -130.44 127.41 62.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.25 -25.86 31.27 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -156.69 135.97 3.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.419 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 67.1 m-85 -98.75 124.7 43.78 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -90.74 90.86 8.13 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.87 170.47 11.15 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 122.132 0.968 . . . . 0.0 109.458 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 53.5 m-85 -134.08 127.6 32.51 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.755 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.29 142.89 23.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.24 0.543 . . . . 0.0 110.452 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HB3' HG23 ' A' ' 86' ' ' THR . 45.2 mt-10 -133.7 145.19 49.66 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.698 ' HB ' HD23 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -92.24 142.38 27.53 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 171.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.574 ' C ' HD21 ' A' ' 87' ' ' LEU . 24.1 p -127.6 155.3 44.08 Favored 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.441 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.659 ' HB2' HD11 ' A' ' 87' ' ' LEU . 37.3 t0 -97.1 170.01 9.42 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.806 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.441 ' N ' ' OD2' ' A' ' 81' ' ' ASP . 13.5 m -56.42 -16.15 3.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -85.75 -13.08 49.41 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.22 22.65 58.61 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -98.97 150.46 21.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 176.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 78' ' ' GLU . 57.7 m -84.49 129.01 34.9 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.971 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -99.16 -30.24 12.4 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.502 ' HG2' ' H ' ' A' ' 2' ' ' ILE . 3.9 tp10 -149.47 153.66 37.62 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.602 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 97.96 -176.35 30.64 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.26 104.97 0.36 Allowed 'Cis proline' 0 N--CA 1.496 1.641 0 CA-C-N 118.861 1.33 . . . . 0.0 112.089 -0.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.09 HG21 HG21 ' A' ' 2' ' ' ILE . 16.1 m -79.79 161.94 64.49 Favored Pre-proline 0 C--N 1.284 -2.247 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -93.3 155.76 2.54 Favored 'Trans proline' 0 C--N 1.291 -2.478 0 C-N-CA 121.6 1.533 . . . . 0.0 111.016 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.462 HD13 HG23 ' A' ' 4' ' ' VAL . 12.9 tp -142.18 128.08 19.46 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -108.97 104.14 13.31 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.526 -0.734 . . . . 0.0 109.496 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.499 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 70.7 t -94.4 107.95 20.06 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.9 mp -90.64 129.95 40.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 11' ' ' GLU . 1.5 t -86.97 109.72 19.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.662 HG21 ' HB3' ' A' ' 8' ' ' LEU . 20.6 pt -109.15 171.54 2.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-O 121.425 0.631 . . . . 0.0 109.407 -176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.381 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.476 ' HA ' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 91' ' ' VAL . 7.9 mt -72.16 139.89 18.96 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-O 121.583 0.706 . . . . 0.0 110.599 -177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.85 128.04 75.59 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.522 HG23 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -140.68 162.23 23.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.4 -0.813 . . . . 0.0 109.728 -175.158 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.443 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -145.59 156.01 52.87 Favored Pre-proline 0 C--N 1.284 -2.268 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 172.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 52.8 Cg_exo -49.76 149.42 10.74 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.63 1.553 . . . . 0.0 111.164 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.935 HG13 HD11 ' A' ' 93' ' ' LEU . 8.1 mt -112.27 111.88 38.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.914 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -92.64 105.06 17.28 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.6 mt -110.25 128.36 25.5 Favored Pre-proline 0 C--N 1.286 -2.157 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 31.7 Cg_endo -69.91 125.23 11.83 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 120.969 1.113 . . . . 0.0 110.872 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.504 ' HB3' HG12 ' A' ' 97' ' ' VAL . 11.1 pt-20 -61.37 170.86 1.6 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.822 -175.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.535 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 81.33 -19.17 0.44 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 172.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.421 ' O ' ' OG1' ' A' ' 64' ' ' THR . 2.3 mt-30 -52.27 134.31 33.74 Favored 'General case' 0 N--CA 1.518 2.974 0 O-C-N 120.687 -1.258 . . . . 0.0 108.128 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.535 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -111.28 -170.85 1.72 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.773 0.797 . . . . 0.0 111.163 -177.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.513 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 2.5 mp0 -45.88 163.44 0.22 Allowed Pre-proline 0 C--N 1.305 -1.329 0 C-N-CA 124.547 1.139 . . . . 0.0 109.943 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 39.9 Cg_endo -79.33 141.77 62.93 Favored 'Cis proline' 0 C--N 1.314 -1.275 0 C-N-CA 123.146 -1.606 . . . . 0.0 112.103 -0.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 37.3 m-85 -112.83 158.88 36.4 Favored Pre-proline 0 C--N 1.28 -2.454 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 59.5 Cg_endo -75.95 153.37 97.65 Favored 'Cis proline' 0 N--CA 1.498 1.747 0 C-N-CA 123.942 -1.274 . . . . 0.0 112.909 0.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 7.1 mtp180 -120.33 135.99 54.84 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.92 147.75 52.88 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.9 6.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.873 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.26 -177.19 39.33 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 117.98 -2.057 . . . . 0.0 110.157 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -141.51 117.66 10.65 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.139 -1.212 . . . . 0.0 110.445 -176.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.631 HG23 HG22 ' A' ' 59' ' ' VAL . 21.9 t -87.38 135.84 24.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 103.539 -2.763 . . . . 0.0 103.539 169.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.38 150.64 34.83 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -127.83 112.72 15.06 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 176.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.272 -2.768 0 O-C-N 121.682 -0.636 . . . . 0.0 110.433 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -117.23 147.99 42.03 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.763 ' HB3' HD13 ' A' ' 52' ' ' ILE . 57.4 m-85 -83.89 150.63 25.58 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 121.27 -0.894 . . . . 0.0 109.311 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.669 ' HG3' HG21 ' A' ' 80' ' ' THR . 6.1 mmp_? -123.73 135.0 53.59 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 173.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.722 ' HG ' HG21 ' A' ' 42' ' ' VAL . 36.8 tp -112.93 144.27 42.78 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.84 171.02 18.91 Favored 'General case' 0 C--N 1.271 -2.823 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -175.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.472 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 119.22 166.36 13.39 Favored Glycine 0 C--N 1.29 -1.99 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 177.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -59.09 109.92 0.94 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.418 ' HA2' HG13 ' A' ' 49' ' ' ILE . . . 124.21 -20.37 7.08 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -174.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.722 HG21 ' HG ' ' A' ' 37' ' ' LEU . 22.4 t -118.19 -86.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.991 -1.299 . . . . 0.0 108.788 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.49 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 27.3 t70 -99.5 -12.63 19.99 Favored 'General case' 0 C--O 1.206 -1.198 0 O-C-N 121.598 -0.689 . . . . 0.0 109.412 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.472 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 13.1 mp0 -109.76 160.34 16.41 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.84 135.81 92.92 Favored Pre-proline 0 C--N 1.273 -2.747 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.303 -174.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.579 ' HB2' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -77.21 124.18 10.35 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.824 -1.74 . . . . 0.0 109.97 -1.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.49 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 6.0 mttm -72.4 154.23 41.01 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 121.327 -0.858 . . . . 0.0 109.128 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.41 34.95 63.45 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.148 173.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.756 HD13 HH11 ' A' ' 63' ' ' ARG . 4.0 mm -106.64 -49.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.658 -1.496 . . . . 0.0 107.854 176.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.49 ' HB2' HG22 ' A' ' 42' ' ' VAL . 94.7 m-85 -118.96 152.73 35.82 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.481 -0.762 . . . . 0.0 110.691 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.639 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 6.9 ptm180 -143.43 169.92 16.76 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.763 HD13 ' HB3' ' A' ' 35' ' ' PHE . 8.6 tt -129.2 159.73 40.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 119.231 -0.987 . . . . 0.0 108.758 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 58' ' ' SER . 37.6 t-20 -79.94 96.92 6.53 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 2.1 mp0 -33.91 -50.07 0.36 Allowed 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 122.588 0.355 . . . . 0.0 110.942 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -42.78 17.09 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.211 -0.931 . . . . 0.0 112.354 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 p -94.74 -29.76 14.62 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.108 -0.995 . . . . 0.0 111.041 -171.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 95.33 -1.38 64.44 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -56.05 129.33 39.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.043 -1.269 . . . . 0.0 108.185 176.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 24' ' ' VAL . 1.9 t -94.02 134.36 31.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.639 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -131.73 159.67 37.73 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.455 -0.778 . . . . 0.0 109.663 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 63' ' ' ARG . 12.3 p -103.79 139.99 23.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -94.74 -2.99 50.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 111.303 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.756 HH11 HD13 ' A' ' 49' ' ' ILE . 2.8 ptp85 -157.21 -179.84 8.58 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 3.1 t -69.4 170.42 10.47 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.8 mt -131.41 136.28 47.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.87 122.79 35.68 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.532 HH22 ' CG ' ' A' ' 99' ' ' ASP . 5.3 mtm180 -57.12 -15.61 5.87 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.059 -1.026 . . . . 0.0 111.43 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.28 -19.65 63.91 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.9 -60.02 2.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.482 HD12 ' CE1' ' A' ' 73' ' ' TYR . 1.9 mt -143.68 145.17 22.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.7 -24.92 16.31 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.1 p -154.72 139.01 9.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.784 -0.572 . . . . 0.0 109.647 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.482 ' CE1' HD12 ' A' ' 70' ' ' ILE . 33.5 m-85 -106.39 127.09 53.02 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.4 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 8.6 tp-100 -91.79 86.88 6.06 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 176.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -83.76 170.67 13.94 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 78.5 m-85 -135.55 133.37 38.3 Favored 'General case' 0 C--N 1.265 -3.104 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.85 145.42 18.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -175.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.612 ' HB3' HG23 ' A' ' 86' ' ' THR . 50.8 mt-10 -135.23 143.88 46.59 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.561 ' C ' HD22 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -90.36 133.02 35.26 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 171.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.669 HG21 ' HG3' ' A' ' 36' ' ' ARG . 39.1 p -129.55 170.5 13.66 Favored 'General case' 0 C--N 1.278 -2.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.262 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 83' ' ' ASN . 6.1 t0 -149.78 171.62 16.45 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.409 -0.807 . . . . 0.0 110.328 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 81' ' ' ASP . 8.3 m -13.9 -41.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 126.276 1.83 . . . . 0.0 114.724 -178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 81' ' ' ASP . 8.0 t-20 -79.43 -7.51 58.45 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 120.722 -1.236 . . . . 0.0 109.732 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 72.18 19.18 78.45 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.5 OUTLIER -99.78 167.61 10.43 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 78' ' ' GLU . 91.3 m -94.07 119.68 33.26 Favored 'General case' 0 C--N 1.277 -2.563 0 O-C-N 122.154 -0.341 . . . . 0.0 111.292 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.839 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.71 -34.79 24.84 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 1' ' ' SER . 0.3 OUTLIER -142.09 163.32 33.19 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.792 -0.568 . . . . 0.0 109.743 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.467 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 89.87 -172.18 38.42 Favored Glycine 0 N--CA 1.481 1.699 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.77 102.95 0.34 Allowed 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.732 -1.362 . . . . 0.0 112.225 -0.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 2' ' ' ILE . 5.8 m -74.05 164.19 62.95 Favored Pre-proline 0 C--N 1.285 -2.199 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -94.48 154.61 1.99 Allowed 'Trans proline' 0 C--N 1.291 -2.491 0 C-N-CA 121.694 1.596 . . . . 0.0 111.295 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.935 HD11 HG13 ' A' ' 7' ' ' ILE . 16.6 tp -144.36 119.95 10.41 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.4 ' HG2' ' NE2' ' A' ' 74' ' ' GLN . 59.6 mt-10 -99.85 110.48 22.84 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.762 -0.586 . . . . 0.0 110.046 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 50.9 t -94.25 107.3 19.16 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.7 mp -90.82 135.06 27.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.504 HG12 ' HB3' ' A' ' 11' ' ' GLU . 18.7 t -91.33 114.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.65 HG21 ' HB3' ' A' ' 8' ' ' LEU . 22.4 pt -111.42 172.34 2.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 121.58 -0.7 . . . . 0.0 110.498 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.532 ' CG ' HH22 ' A' ' 67' ' ' ARG . 5.6 m-20 . . . . . 0 C--N 1.302 -1.461 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.406 ' N ' ' OE2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER . . . . . 0 CA--C 1.502 -0.868 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.781 HG21 HG21 ' A' ' 91' ' ' VAL . 3.6 mt -78.08 117.77 23.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.341 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.0 120.41 35.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.47 HG23 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -139.75 159.14 27.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -179.238 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.427 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -143.14 145.81 34.21 Favored Pre-proline 0 C--N 1.269 -2.925 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -53.83 134.52 59.4 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.586 1.524 . . . . 0.0 109.928 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.9 mt -106.79 116.66 51.02 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.137 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.873 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -89.61 104.34 16.91 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.508 HD12 ' CG1' ' A' ' 95' ' ' VAL . 38.3 mt -110.32 127.28 27.28 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -68.83 130.83 21.24 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 120.787 0.991 . . . . 0.0 111.034 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -74.46 -170.53 1.03 Allowed 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.305 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.605 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 0.0 OUTLIER 61.05 -26.97 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 175.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' GLU . 71.9 mt-30 -37.19 139.25 0.24 Allowed 'General case' 0 N--CA 1.521 3.098 0 O-C-N 121.007 -1.058 . . . . 0.0 108.529 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.605 ' NH1' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -91.24 -175.32 4.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.623 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 1.4 mt-30 -67.16 -168.58 0.05 OUTLIER Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 20.0 Cg_exo -66.96 127.44 8.53 Favored 'Cis proline' 0 N--CA 1.492 1.42 0 CA-C-N 120.499 1.214 . . . . 0.0 112.222 -0.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 15' ' ' GLN . 32.9 m-85 -115.61 163.54 20.38 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 177.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 17.2 Cg_exo -68.1 163.35 76.79 Favored 'Cis proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.959 -1.267 . . . . 0.0 111.207 -0.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.425 ' NH2' ' OE1' ' A' ' 13' ' ' GLN . 2.3 mtp85 -136.75 139.81 42.13 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.384 -0.823 . . . . 0.0 109.404 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.49 146.18 55.19 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.466 HG21 HD11 ' A' ' 9' ' ' ILE . 33.6 m -138.83 -1.18 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.456 176.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 167.04 178.35 39.37 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 118.968 -1.587 . . . . 0.0 109.344 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.1 tttp -135.36 130.63 35.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.306 -1.114 . . . . 0.0 110.625 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.573 HG11 HG11 ' A' ' 77' ' ' VAL . 41.8 t -99.78 145.54 10.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 26' ' ' ASP . 20.6 t -144.33 170.62 7.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.445 ' N ' HG12 ' A' ' 25' ' ' VAL . 7.6 t0 -129.58 148.97 51.53 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.278 -2.538 0 O-C-N 121.96 -0.462 . . . . 0.0 110.163 -178.747 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.535 ' HB2' HG22 ' A' ' 79' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 33.8 mttm -96.89 156.33 16.39 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.725 ' CE1' HG23 ' A' ' 79' ' ' THR . 70.1 m-85 -105.4 142.24 35.51 Favored 'General case' 0 C--N 1.285 -2.23 0 O-C-N 121.476 -0.765 . . . . 0.0 111.657 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.527 ' NH1' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -103.1 149.0 25.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 174.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.529 ' HG ' HG21 ' A' ' 42' ' ' VAL . 26.4 tp -125.6 140.26 52.89 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 p -148.29 170.78 17.16 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -174.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.72 174.9 18.96 Favored Glycine 0 N--CA 1.499 2.88 0 O-C-N 121.019 -1.05 . . . . 0.0 111.817 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -59.8 116.34 4.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 115.75 -19.33 14.19 Favored Glycine 0 C--N 1.28 -2.543 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.529 HG21 ' HG ' ' A' ' 37' ' ' LEU . 27.1 t -122.56 -95.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.588 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 23.0 t70 -83.7 -15.85 47.2 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.046 -1.034 . . . . 0.0 109.765 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -113.26 155.07 25.75 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.226 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 4.9 mt-10 -54.43 133.31 62.56 Favored Pre-proline 0 C--N 1.29 -2.014 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.523 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HG2' HG13 ' A' ' 49' ' ' ILE . 28.2 Cg_endo -73.62 118.11 4.72 Favored 'Cis proline' 0 N--CA 1.499 1.819 0 C-N-CA 123.526 -1.448 . . . . 0.0 110.305 -1.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.588 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 3.7 mtpp -68.27 145.41 54.27 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 120.902 -1.124 . . . . 0.0 112.242 -172.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.88 28.11 69.69 Favored Glycine 0 N--CA 1.498 2.816 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.389 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.436 HG13 ' HG2' ' A' ' 46' ' ' PRO . 17.8 mm -85.26 -46.42 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-N 119.254 1.527 . . . . 0.0 107.053 175.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -107.66 147.39 30.76 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.686 0.755 . . . . 0.0 109.18 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.66 170.09 16.35 Favored 'General case' 0 C--N 1.262 -3.222 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.411 HD11 ' HA2' ' A' ' 57' ' ' GLY . 1.2 tt -134.19 150.38 31.02 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.016 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.413 ' OD1' HG23 ' A' ' 56' ' ' THR . 19.0 t-20 -84.81 83.2 8.12 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 36' ' ' ARG . 5.8 mt-10 -37.44 -33.47 0.07 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.557 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -79.72 -15.56 57.28 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.985 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.413 HG23 ' OD1' ' A' ' 53' ' ' ASN . 74.8 p -127.27 -36.85 2.09 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 52' ' ' ILE . . . 100.93 6.23 52.4 Favored Glycine 0 C--N 1.277 -2.699 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.4 m -66.16 119.87 12.23 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.41 -1.053 . . . . 0.0 108.745 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.542 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.2 t -87.11 134.95 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.27 158.21 44.95 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.358 -0.838 . . . . 0.0 108.756 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 13.6 p -106.81 141.49 21.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 p -89.58 -13.93 36.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.546 -0.722 . . . . 0.0 110.571 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 64' ' ' THR . 1.8 ptm180 -157.18 -173.53 4.48 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.187 -0.945 . . . . 0.0 109.593 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.617 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 14.6 t -70.06 178.65 2.65 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 11' ' ' GLU . 35.2 mt -131.22 162.28 30.33 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 120.541 -1.349 . . . . 0.0 108.504 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.401 ' OD1' ' NH2' ' A' ' 63' ' ' ARG . 14.1 m-20 -140.0 113.71 8.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -60.45 -11.18 6.14 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.21 -22.8 63.85 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.5 t -105.05 -55.95 5.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.469 HD12 ' CE1' ' A' ' 73' ' ' TYR . 1.4 mt -141.53 142.3 29.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.569 -0.707 . . . . 0.0 110.06 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.22 -23.16 16.3 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 7.2 p -152.9 135.15 6.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.638 -0.664 . . . . 0.0 109.733 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.469 ' CE1' HD12 ' A' ' 70' ' ' ILE . 84.3 m-85 -100.86 117.28 34.63 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -85.91 87.03 7.35 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.431 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -81.62 170.72 15.48 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 73.1 m-85 -134.08 132.31 39.82 Favored 'General case' 0 C--N 1.264 -3.149 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.671 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.2 152.66 13.99 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 O-C-N 121.983 -0.448 . . . . 0.0 109.864 -177.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.716 ' HB3' HG23 ' A' ' 86' ' ' THR . 50.4 mt-10 -138.47 139.51 38.84 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 121.779 -0.575 . . . . 0.0 109.565 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.725 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -88.69 134.21 33.97 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 173.233 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 7.9 p -137.14 163.04 31.77 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.545 -176.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -105.8 171.15 7.49 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.2 m -46.29 -27.72 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.369 0.604 . . . . 0.0 110.5 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.59 0.52 29.69 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.507 -0.745 . . . . 0.0 110.385 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.21 20.46 76.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 80' ' ' THR . 25.5 mttp -85.11 146.89 26.91 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.716 HG23 ' HB3' ' A' ' 78' ' ' GLU . 31.8 m -99.26 117.04 32.83 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-O 121.145 0.498 . . . . 0.0 110.816 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.842 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.58 -28.78 17.31 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.406 ' OE2' ' N ' ' A' ' 1' ' ' SER . 1.1 tp10 -140.81 151.37 44.33 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 94.73 -177.58 35.84 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.74 102.75 0.16 OUTLIER 'Cis proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.821 -1.325 . . . . 0.0 113.469 -0.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.781 HG21 HG21 ' A' ' 2' ' ' ILE . 3.3 m -74.8 164.19 63.05 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -92.35 151.06 3.03 Favored 'Trans proline' 0 C--N 1.283 -2.912 0 C-N-CA 121.395 1.397 . . . . 0.0 111.905 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 4' ' ' VAL . 12.1 tp -135.76 126.74 27.76 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 175.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -103.57 105.52 15.79 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 121.831 -0.543 . . . . 0.0 109.715 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.508 ' CG1' HD12 ' A' ' 9' ' ' ILE . 24.7 t -95.7 104.6 16.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 175.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mp -87.57 134.0 28.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 16.1 t -89.67 108.94 19.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.604 HG21 ' HB3' ' A' ' 8' ' ' LEU . 15.3 pt -102.85 171.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.407 ' O ' ' HB3' ' A' ' 10' ' ' PRO . 4.8 m-20 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.581 ' H2 ' ' CG ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.884 HG21 HG21 ' A' ' 91' ' ' VAL . 5.2 mt -73.73 120.49 22.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.075 -1.016 . . . . 0.0 110.611 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.66 119.98 50.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.54 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -142.42 163.76 18.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -149.53 159.44 36.38 Favored Pre-proline 0 C--N 1.278 -2.517 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.34 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.752 ' HB3' HD11 ' A' ' 96' ' ' ILE . 27.3 Cg_exo -44.73 131.03 10.02 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.855 1.703 . . . . 0.0 111.893 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.57 HG13 HD11 ' A' ' 93' ' ' LEU . 19.5 mt -101.4 122.5 53.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.3 mp -106.88 115.8 30.82 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.919 HD11 HG21 ' A' ' 21' ' ' VAL . 23.0 mt -122.21 128.04 25.66 Favored Pre-proline 0 C--N 1.26 -3.314 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 21.5 Cg_endo -70.98 141.78 41.06 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 CA-C-N 120.038 1.049 . . . . 0.0 110.064 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.438 ' OE1' ' NH1' ' A' ' 67' ' ' ARG . 3.4 pt-20 -55.69 173.76 0.12 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 121.988 0.899 . . . . 0.0 110.104 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 65' ' ' LEU . 4.1 p30 52.74 19.15 1.18 Allowed 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.513 ' HG3' HG22 ' A' ' 9' ' ' ILE . 1.6 mm-40 -57.49 131.35 49.9 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 173.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.474 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 3.3 mtt180 -101.84 -174.37 2.57 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 119.546 1.066 . . . . 0.0 110.434 -176.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.636 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 16.8 mt-30 -54.16 168.14 0.47 Allowed Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.636 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 4.1 Cg_exo -77.02 131.71 25.12 Favored 'Cis proline' 0 C--N 1.308 -1.593 0 C-N-CA 123.503 -1.457 . . . . 0.0 112.831 0.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -119.61 159.55 45.71 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 13.0 Cg_exo -69.74 155.29 93.28 Favored 'Cis proline' 0 N--CA 1.493 1.497 0 C-N-CA 123.878 -1.301 . . . . 0.0 110.426 -0.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -129.54 131.34 46.56 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.25 -179.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.21 116.01 9.16 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.919 HG21 HD11 ' A' ' 9' ' ' ILE . 19.5 m -118.42 7.61 6.85 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.592 -178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . -179.53 163.5 30.91 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -135.58 116.33 14.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.27 -1.135 . . . . 0.0 109.641 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.577 HG23 ' CG2' ' A' ' 59' ' ' VAL . 21.8 t -80.97 146.9 6.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 t -139.3 166.72 21.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.581 ' CG ' ' H2 ' ' A' ' 1' ' ' SER . 11.9 t70 -112.98 140.14 48.04 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 173.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 1' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.301 0.572 . . . . 0.0 109.53 -177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.704 0 CA-C-O 121.163 0.506 . . . . 0.0 110.876 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.18 138.88 54.36 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.487 ' CE2' HG23 ' A' ' 79' ' ' THR . 71.6 m-85 -82.43 144.11 30.71 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.747 -0.596 . . . . 0.0 110.598 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.454 HH12 ' CD ' ' A' ' 54' ' ' GLU . 4.2 mmp_? -120.86 145.02 48.06 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 38' ' ' THR . 23.4 tp -120.79 153.45 37.05 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 37' ' ' LEU . 3.0 p -158.13 171.26 20.53 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.51 175.63 18.77 Favored Glycine 0 N--CA 1.502 3.083 0 C-N-CA 119.796 -1.192 . . . . 0.0 111.444 175.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -59.24 119.54 7.56 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 113.07 -19.12 20.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.462 HG21 ' HG ' ' A' ' 37' ' ' LEU . 47.5 t -118.07 -98.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.619 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -85.77 -12.46 50.92 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -113.12 148.89 34.39 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 121.06 -1.025 . . . . 0.0 108.363 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.509 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.1 pt-20 -51.85 136.02 36.49 Favored Pre-proline 0 C--N 1.284 -2.282 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.359 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.503 ' HB2' ' CG1' ' A' ' 49' ' ' ILE . 2.9 Cg_exo -72.83 118.07 4.46 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.475 -1.469 . . . . 0.0 109.161 -1.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.619 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 8.9 mtpp -68.56 145.62 53.82 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 120.856 -1.153 . . . . 0.0 111.251 -172.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.76 34.1 87.83 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.806 -0.559 . . . . 0.0 112.383 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.586 HG23 ' HD2' ' A' ' 63' ' ' ARG . 8.8 mm -89.47 -45.58 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.743 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 26.3 m-85 -111.49 139.22 47.09 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.591 0.71 . . . . 0.0 110.041 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HE ' ' HG ' ' A' ' 60' ' ' SER . 0.6 OUTLIER -137.22 128.96 28.78 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 58' ' ' SER . 7.7 tt -98.9 161.93 2.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.523 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 13.2 t-20 -96.03 106.73 18.94 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' CD ' HH12 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -40.82 -39.15 1.06 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.404 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 8.0 t-20 -96.36 -30.95 13.11 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.35 -0.844 . . . . 0.0 112.704 -173.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 18.1 p -98.16 -26.92 14.4 Favored 'General case' 0 C--N 1.283 -2.295 0 O-C-N 120.757 -1.215 . . . . 0.0 108.611 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.01 5.1 88.02 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 4.4 m -63.63 125.22 23.57 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.263 -1.139 . . . . 0.0 109.409 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.577 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.0 t -90.66 121.91 41.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.419 ' HG ' ' HE ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -119.11 146.93 44.71 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.343 -0.848 . . . . 0.0 110.031 -178.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 14.6 p -102.53 142.42 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 49' ' ' ILE . 43.8 p -95.33 -20.05 19.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.524 -0.735 . . . . 0.0 112.908 -173.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.586 ' HD2' HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -139.89 176.48 8.71 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.483 -1.386 . . . . 0.0 110.253 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.47 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 13.0 t -70.15 127.9 34.42 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.546 HD22 ' CE2' ' A' ' 73' ' ' TYR . 97.3 mt -83.22 120.51 25.91 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.292 -0.88 . . . . 0.0 109.131 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.436 ' OD2' ' NH2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -108.61 114.09 27.61 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.45 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.449 ' HG3' ' CG1' ' A' ' 97' ' ' VAL . 14.7 mtp-105 -53.66 -7.96 0.13 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.447 -0.783 . . . . 0.0 110.399 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.45 -28.68 67.27 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 t -91.47 -63.55 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -138.68 132.41 40.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.53 -23.7 24.29 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.8 p -150.22 132.07 5.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.546 ' CE2' HD22 ' A' ' 65' ' ' LEU . 82.8 m-85 -94.7 117.21 29.76 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.35 83.39 7.69 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.462 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -87.06 170.31 11.65 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 64.8 m-85 -138.31 131.14 29.61 Favored 'General case' 0 C--N 1.265 -3.082 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.7 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -110.14 155.73 11.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-O 121.396 0.617 . . . . 0.0 109.75 -175.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.32 147.54 28.47 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.79 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.83 131.79 47.96 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 175.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.625 ' C ' HD21 ' A' ' 87' ' ' LEU . 80.8 p -121.22 164.85 16.29 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 83' ' ' ASN . 1.5 t0 -144.75 172.18 13.37 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.837 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 m -38.82 -21.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 123.455 0.702 . . . . 0.0 111.61 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 81' ' ' ASP . 3.9 t-20 -79.14 -4.91 52.7 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.175 -0.953 . . . . 0.0 108.746 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 63.52 27.55 71.05 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -119.84 162.79 18.52 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 88' ' ' GLU . 1.3 m -90.18 124.08 34.54 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.843 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -93.95 -13.22 27.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.896 -1.128 . . . . 0.0 107.985 178.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.647 ' O ' HG22 ' A' ' 86' ' ' THR . 1.0 OUTLIER -156.02 162.36 40.33 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.526 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 91.95 -175.64 38.52 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -70.83 104.75 0.49 Allowed 'Cis proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.58 -1.425 . . . . 0.0 111.373 0.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.884 HG21 HG21 ' A' ' 2' ' ' ILE . 18.1 m -76.81 160.62 76.3 Favored Pre-proline 0 C--N 1.284 -2.271 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -93.46 153.79 2.45 Favored 'Trans proline' 0 C--N 1.288 -2.625 0 C-N-CA 121.556 1.504 . . . . 0.0 111.455 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.57 HD11 HG13 ' A' ' 7' ' ' ILE . 8.2 tp -140.3 127.38 20.9 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -112.57 110.21 20.23 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.488 -0.758 . . . . 0.0 109.286 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.743 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 5.3 t -99.51 101.94 12.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.752 HD11 ' HB3' ' A' ' 6' ' ' PRO . 4.6 mp -80.59 129.37 37.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 O-C-N 121.613 -0.679 . . . . 0.0 109.234 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.449 ' CG1' ' HG3' ' A' ' 67' ' ' ARG . 16.8 t -86.29 92.14 3.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 13.8 pt -79.71 171.58 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 O-C-N 121.515 -0.741 . . . . 0.0 109.28 -177.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 . . . . . 0 C--N 1.282 -2.349 0 O-C-N 120.983 -1.073 . . . . 0.0 108.674 -178.339 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.421 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.643 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.887 HG21 HG21 ' A' ' 91' ' ' VAL . 7.1 mt -62.58 135.39 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 O-C-N 121.695 -0.628 . . . . 0.0 109.495 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.52 122.34 62.29 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.475 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -133.19 160.47 42.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -131.89 157.34 78.46 Favored Pre-proline 0 C--N 1.275 -2.665 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.35 134.97 67.24 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.285 1.323 . . . . 0.0 109.815 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 mt -109.27 113.97 45.63 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.934 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -92.14 112.58 24.57 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.613 HD11 HG21 ' A' ' 21' ' ' VAL . 20.0 mt -117.96 133.99 23.34 Favored Pre-proline 0 C--N 1.287 -2.134 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 31.1 Cg_endo -69.74 140.39 42.63 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.09 1.193 . . . . 0.0 110.692 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.481 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -79.5 174.36 11.65 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.698 178.41 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 58.29 38.22 26.03 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.813 -0.554 . . . . 0.0 110.692 175.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.47 ' OE1' ' N ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -88.43 166.57 14.14 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 175.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -117.5 167.04 11.65 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.681 -1.262 . . . . 0.0 111.856 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.567 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -64.48 178.71 0.43 Allowed Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 11.8 Cg_exo -66.51 140.34 48.65 Favored 'Cis proline' 0 C--N 1.307 -1.647 0 C-N-CA 123.704 -1.373 . . . . 0.0 112.786 0.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 62' ' ' THR . 35.0 m-85 -119.46 167.39 12.23 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 38.5 Cg_endo -66.01 168.53 47.51 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 120.529 1.225 . . . . 0.0 111.899 -0.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -133.35 129.1 37.0 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 120.231 -0.587 . . . . 0.0 109.957 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -66.45 140.44 58.03 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.613 HG21 HD11 ' A' ' 9' ' ' ILE . 35.4 m -137.68 3.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.791 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 172.75 168.39 34.0 Favored Glycine 0 N--CA 1.507 3.371 0 C-N-CA 118.933 -1.603 . . . . 0.0 110.268 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -132.35 122.45 25.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.274 . . . . 0.0 109.936 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.546 ' CG1' HG23 ' A' ' 2' ' ' ILE . 16.5 t -90.6 135.58 26.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 172.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.8 t -131.61 157.73 43.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 1' ' ' SER . 8.4 t70 -111.29 122.5 48.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 0.0 109.7 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.408 ' H ' ' HG ' ' A' ' 27' ' ' SER . 2.2 p . . . . . 0 C--N 1.292 -1.9 0 CA-C-O 121.445 0.64 . . . . 0.0 109.739 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.62 ' HB2' HG22 ' A' ' 79' ' ' THR . 14.0 p . . . . . 0 N--CA 1.484 1.246 0 CA-C-O 121.21 0.529 . . . . 0.0 110.372 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -104.83 148.13 26.98 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.589 ' CE2' HG23 ' A' ' 79' ' ' THR . 67.4 m-85 -88.19 126.87 35.36 Favored 'General case' 0 C--N 1.274 -2.706 0 O-C-N 121.359 -0.838 . . . . 0.0 110.35 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.449 ' HG3' HG21 ' A' ' 80' ' ' THR . 4.7 mtp180 -106.24 141.35 37.73 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.2 tp -121.51 145.48 47.9 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -151.64 171.12 18.13 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 117.74 164.86 13.37 Favored Glycine 0 N--CA 1.499 2.839 0 O-C-N 120.951 -1.093 . . . . 0.0 110.561 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -55.46 117.74 3.84 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 117.03 -21.05 11.23 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 50' ' ' PHE . 43.3 t -125.06 -92.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.7 -0.882 . . . . 0.0 108.747 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -85.39 -9.14 57.94 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.528 -0.733 . . . . 0.0 109.489 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 4.0 mp0 -125.97 161.71 26.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.447 -0.783 . . . . 0.0 109.35 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.468 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 2.5 mt-10 -60.27 131.63 90.11 Favored Pre-proline 0 C--N 1.289 -2.027 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.361 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.479 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 41.1 Cg_endo -73.03 115.13 2.97 Favored 'Cis proline' 0 N--CA 1.512 2.605 0 C-N-CA 123.521 -1.449 . . . . 0.0 110.992 -1.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 4.5 mttp -66.47 150.32 49.12 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.921 -1.112 . . . . 0.0 112.744 -173.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.18 29.27 36.33 Favored Glycine 0 N--CA 1.493 2.44 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.284 171.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 41' ' ' GLY . 13.9 mm -80.91 -44.29 21.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 174.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.499 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 62.1 m-85 -109.16 138.46 45.48 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.656 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -139.79 138.88 36.2 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.454 HG13 HG22 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -106.49 152.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 O-C-N 121.825 -0.547 . . . . 0.0 109.546 -176.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -79.83 119.47 22.75 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 35' ' ' PHE . 3.1 mt-10 -51.11 -45.52 61.59 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 122.207 -0.308 . . . . 0.0 111.658 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.437 HD22 ' C ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -81.12 -53.02 6.75 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.081 -1.637 . . . . 0.0 111.997 -176.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 p -79.74 -27.81 40.52 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.2 0.524 . . . . 0.0 110.575 -172.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.81 12.9 80.73 Favored Glycine 0 C--N 1.285 -2.29 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 14.9 m -67.9 120.14 13.71 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.275 -1.132 . . . . 0.0 108.91 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.456 ' CG2' HG23 ' A' ' 24' ' ' VAL . 1.6 t -87.13 132.19 33.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -134.04 150.72 51.23 Favored 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -97.36 142.15 14.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' PHE . 63.0 p -88.11 -20.76 25.24 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.55 -0.719 . . . . 0.0 110.795 -175.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.59 ' NE ' ' O ' ' A' ' 64' ' ' THR . 1.6 ptm180 -148.27 -172.88 4.18 Favored 'General case' 0 C--N 1.289 -2.062 0 O-C-N 121.208 -0.933 . . . . 0.0 108.834 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.59 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 13.1 t -67.38 168.41 10.75 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.47 ' N ' ' OE1' ' A' ' 13' ' ' GLN . 92.5 mt -122.58 149.34 44.1 Favored 'General case' 0 C--N 1.278 -2.521 0 O-C-N 120.629 -1.294 . . . . 0.0 108.695 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -130.49 117.6 19.87 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -178.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 1.86 1.42 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 66' ' ' ASP . 2.9 mt-10 -78.53 -29.23 46.34 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.79 -55.77 5.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-O 122.209 1.004 . . . . 0.0 108.342 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.4 HG21 ' CG ' ' A' ' 73' ' ' TYR . 1.9 mt -137.85 139.27 43.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.54 -24.21 18.05 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.7 p -154.1 129.6 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 58.1 m-85 -97.21 124.1 41.19 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -98.55 88.39 4.08 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.6 170.74 15.47 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.8 m-85 -124.58 131.57 53.47 Favored 'General case' 0 C--N 1.274 -2.711 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.614 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.06 146.92 17.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -177.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.65 ' HB3' HG23 ' A' ' 86' ' ' THR . 40.8 mt-10 -137.1 138.53 40.45 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.638 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -86.76 133.54 33.65 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 170.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.605 ' C ' HD21 ' A' ' 87' ' ' LEU . 4.6 p -129.78 146.13 51.54 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.052 -1.059 . . . . 0.0 112.476 -172.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.519 ' HB2' HD11 ' A' ' 87' ' ' LEU . 1.4 t70 -80.66 170.14 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.446 HG22 ' OD2' ' A' ' 81' ' ' ASP . 35.2 m -61.62 -24.43 33.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -79.72 2.5 22.53 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.23 16.93 78.61 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 80' ' ' THR . 14.0 mttp -81.02 142.15 33.68 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.65 HG23 ' HB3' ' A' ' 78' ' ' GLU . 35.5 m -88.76 116.77 27.26 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.904 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.98 -19.45 22.4 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.77 146.73 23.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.537 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 99.41 -176.72 29.19 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.86 103.99 0.31 Allowed 'Cis proline' 0 N--CA 1.5 1.873 0 C-N-CA 123.669 -1.388 . . . . 0.0 112.519 -0.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.887 HG21 HG21 ' A' ' 2' ' ' ILE . 11.7 m -79.9 162.97 60.41 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -94.52 151.06 1.92 Allowed 'Trans proline' 0 C--N 1.296 -2.19 0 C-N-CA 121.808 1.672 . . . . 0.0 112.101 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.44 HD13 ' CG2' ' A' ' 4' ' ' VAL . 5.3 tp -133.88 129.8 36.92 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -107.39 114.13 27.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.477 -0.764 . . . . 0.0 109.907 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.499 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 57.8 t -103.81 104.1 16.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.552 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.8 mp -86.13 139.19 17.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 38.5 t -95.0 124.38 47.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 10.4 pt -112.13 170.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 . . . . . 0 C--N 1.302 -1.496 0 O-C-N 120.921 -1.112 . . . . 0.0 108.124 178.366 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 2.7 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.746 HG21 HG21 ' A' ' 91' ' ' VAL . 24.8 mt -86.46 134.43 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.42 -0.8 . . . . 0.0 110.438 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -120.89 124.64 72.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 173.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.463 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -135.52 157.05 39.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.74 143.18 47.99 Favored Pre-proline 0 C--N 1.276 -2.596 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.33 133.86 30.92 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.017 1.811 . . . . 0.0 110.359 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.42 HG21 HG23 ' A' ' 21' ' ' VAL . 42.9 mt -105.05 112.29 38.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 O-C-N 121.54 -0.725 . . . . 0.0 109.653 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.873 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -93.49 110.73 22.3 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.536 HG22 ' NE2' ' A' ' 13' ' ' GLN . 1.8 mt -120.23 134.7 24.11 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.541 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 35.8 Cg_endo -74.13 154.46 47.03 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 CA-C-N 119.68 0.922 . . . . 0.0 112.742 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.0 174.24 10.86 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-O 122.304 1.05 . . . . 0.0 111.12 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.583 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 57.5 t30 52.38 24.69 3.05 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -77.99 137.47 38.31 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 174.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.583 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -101.26 175.21 5.66 Favored 'General case' 0 C--N 1.267 -3.005 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.524 -177.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.651 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -53.49 -179.32 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.651 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 6.7 Cg_exo -70.74 128.92 14.45 Favored 'Cis proline' 0 N--CA 1.491 1.338 0 C-N-CA 124.25 -1.146 . . . . 0.0 113.422 -0.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 63' ' ' ARG . 22.7 m-85 -113.43 165.74 12.7 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 14.7 Cg_exo -70.66 161.43 88.82 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 C-N-CA 124.412 -1.078 . . . . 0.0 112.254 -1.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.477 ' NH2' ' OE1' ' A' ' 13' ' ' GLN . 1.2 mtp-105 -131.17 128.28 39.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.477 -0.764 . . . . 0.0 109.711 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 5.3 t0 -63.06 133.2 54.14 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.42 HG23 HG21 ' A' ' 7' ' ' ILE . 29.4 m -128.86 5.57 2.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 175.14 168.74 36.11 Favored Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.108 -1.52 . . . . 0.0 109.635 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -131.99 117.09 17.95 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.164 -1.198 . . . . 0.0 109.699 -178.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.516 HG23 HG22 ' A' ' 59' ' ' VAL . 16.5 t -81.81 134.4 27.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 172.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 3' ' ' VAL . 24.9 t -126.64 133.26 68.99 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.613 ' CB ' HG21 ' A' ' 79' ' ' THR . 9.1 t0 -107.4 137.46 45.4 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.274 -2.692 0 O-C-N 121.104 -0.998 . . . . 0.0 110.752 -175.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.524 0 CA-C-O 121.545 0.688 . . . . 0.0 109.634 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 11.3 mmtp -105.4 170.61 7.79 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.613 ' HB3' HD13 ' A' ' 52' ' ' ILE . 23.5 m-85 -120.98 131.9 54.59 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.685 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 4.3 mmp_? -108.28 139.24 43.26 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.687 ' O ' HG11 ' A' ' 42' ' ' VAL . 15.3 tp -128.54 139.28 52.38 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.07 170.56 15.96 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.31 159.1 10.31 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.93 114.0 1.42 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 124.76 -22.15 6.52 Favored Glycine 0 C--N 1.281 -2.492 0 N-CA-C 107.383 -2.287 . . . . 0.0 107.383 -173.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.687 HG11 ' O ' ' A' ' 37' ' ' LEU . 47.0 t -116.52 -97.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.451 ' OD2' ' NZ ' ' A' ' 47' ' ' LYS . 35.0 t0 -90.87 -5.53 55.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 109.759 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -114.09 156.88 23.36 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.583 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 14.0 mm-40 -67.21 136.36 93.79 Favored Pre-proline 0 C--N 1.277 -2.563 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.533 -176.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.541 ' HB2' HD11 ' A' ' 49' ' ' ILE . 29.3 Cg_endo -69.94 115.05 2.3 Favored 'Cis proline' 0 N--CA 1.51 2.449 0 C-N-CA 123.316 -1.535 . . . . 0.0 111.359 -0.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.583 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 6.3 mttm -68.35 152.17 45.82 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.915 -1.116 . . . . 0.0 111.1 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.574 ' O ' ' NH1' ' A' ' 63' ' ' ARG . . . 56.44 49.08 71.32 Favored Glycine 0 N--CA 1.487 2.098 0 O-C-N 121.796 -0.565 . . . . 0.0 112.389 172.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.855 HD13 HH11 ' A' ' 63' ' ' ARG . 3.7 mm -106.42 -43.0 6.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -116.79 138.73 51.28 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.973 0.892 . . . . 0.0 110.996 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -124.16 170.32 10.84 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.613 HD13 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -132.91 147.96 31.55 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.473 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 171.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 55' ' ' ASN . 21.1 t-20 -78.68 112.18 15.53 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 118.101 -1.44 . . . . 0.0 108.31 -176.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 mp0 -59.58 10.27 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 C-N-CA 124.455 1.102 . . . . 0.0 112.263 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 53' ' ' ASN . 31.8 m-80 -137.86 -48.39 0.56 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 109.009 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 17.5 p -87.33 -27.76 22.65 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.543 -0.723 . . . . 0.0 109.478 -177.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.47 5.82 74.77 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 14.6 m -66.84 123.53 20.41 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.394 -1.062 . . . . 0.0 109.379 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.552 HG11 HD21 ' A' ' 93' ' ' LEU . 2.0 t -82.57 122.42 37.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -123.42 140.89 52.54 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.404 -0.81 . . . . 0.0 110.133 -177.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 10.6 p -90.93 144.04 9.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.9 p -96.27 -17.62 20.6 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.773 -0.58 . . . . 0.0 111.146 -176.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.855 HH11 HD13 ' A' ' 49' ' ' ILE . 5.5 ptp85 -153.52 -176.22 5.71 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.783 -1.198 . . . . 0.0 110.464 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 4.1 t -74.86 142.99 44.07 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 121.446 0.641 . . . . 0.0 110.127 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.2 mt -104.64 158.81 16.25 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.323 -0.861 . . . . 0.0 109.164 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.406 ' HB3' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -136.71 120.71 17.64 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HG3' HG12 ' A' ' 97' ' ' VAL . 34.5 mtm105 -63.91 -12.11 33.97 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.085 . . . . 0.0 108.342 175.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.03 -22.96 60.55 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 66' ' ' ASP . 24.1 t -101.11 -53.23 7.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.459 HD12 ' CE2' ' A' ' 73' ' ' TYR . 1.4 mt -144.9 136.41 20.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.64 -24.24 20.55 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -159.74 140.52 4.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.587 -0.695 . . . . 0.0 109.511 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.459 ' CE2' HD12 ' A' ' 70' ' ' ILE . 58.6 m-85 -104.13 136.99 42.73 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.17 92.28 5.95 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -91.72 170.56 9.8 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 77.6 m-85 -135.66 140.62 44.63 Favored 'General case' 0 C--N 1.265 -3.08 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -119.23 155.18 21.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 120.977 0.418 . . . . 0.0 110.079 -177.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.809 ' HB3' HG23 ' A' ' 86' ' ' THR . 33.1 mt-10 -140.94 141.35 34.5 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 173.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -88.31 128.37 35.49 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 171.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.502 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.1 OUTLIER -119.86 161.2 21.22 Favored 'General case' 0 C--N 1.272 -2.766 0 O-C-N 121.543 -0.723 . . . . 0.0 110.847 -172.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.608 ' HB2' HD21 ' A' ' 87' ' ' LEU . 5.2 t0 -108.97 170.44 8.04 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -52.98 -22.85 4.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -79.66 2.24 23.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.423 -0.798 . . . . 0.0 109.171 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 62.97 28.14 71.52 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 80' ' ' THR . 17.0 mttm -95.24 137.95 33.61 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.809 HG23 ' HB3' ' A' ' 78' ' ' GLU . 10.7 m -71.97 117.67 13.86 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.608 HD21 ' HB2' ' A' ' 81' ' ' ASP . 1.5 mm? -81.45 -46.37 14.67 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.448 ' OE2' ' N ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -140.11 157.82 45.03 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 95.09 -177.48 35.25 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.76 112.92 0.61 Allowed 'Cis proline' 0 N--CA 1.499 1.808 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.652 -0.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.746 HG21 HG21 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -93.45 168.27 12.34 Favored Pre-proline 0 C--N 1.284 -2.274 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 175.106 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -96.23 156.67 1.35 Allowed 'Trans proline' 0 C--N 1.295 -2.287 0 C-N-CA 121.564 1.509 . . . . 0.0 112.823 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.552 HD21 HG11 ' A' ' 59' ' ' VAL . 9.6 tp -142.52 124.35 15.14 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -105.43 115.38 30.15 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-O 121.432 0.634 . . . . 0.0 109.652 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 96.0 t -102.55 108.82 24.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.624 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.8 mp -90.71 139.34 17.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 O-C-N 121.488 -0.758 . . . . 0.0 108.971 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.433 HG12 ' HG3' ' A' ' 67' ' ' ARG . 17.4 t -95.17 110.44 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.8 pt -96.7 170.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 99' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.411 0 O-C-N 120.883 -1.136 . . . . 0.0 110.481 -175.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.482 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 1.1 m . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.913 HG21 HG21 ' A' ' 91' ' ' VAL . 24.6 mt -88.98 142.79 12.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.714 0.769 . . . . 0.0 111.329 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.85 135.17 50.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.584 HG21 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -141.12 162.51 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.134 -0.978 . . . . 0.0 109.177 -176.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -128.0 149.64 71.46 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.648 ' HB3' HD11 ' A' ' 96' ' ' ILE . 50.4 Cg_exo -51.71 137.75 50.37 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 110.464 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.604 HG13 HD11 ' A' ' 93' ' ' LEU . 32.1 mt -99.44 110.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -100.24 98.39 9.07 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.4 ' CG1' HG22 ' A' ' 7' ' ' ILE . 17.8 mt -102.18 129.25 26.67 Favored Pre-proline 0 C--N 1.271 -2.837 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 19.4 Cg_endo -66.95 125.16 13.21 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 N-CA-C 109.715 -0.917 . . . . 0.0 109.715 174.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.746 ' HB3' HG12 ' A' ' 97' ' ' VAL . 4.5 pt-20 -62.6 -176.74 0.12 Allowed 'General case' 0 C--N 1.284 -2.279 0 CA-C-O 122.266 1.032 . . . . 0.0 111.746 -173.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.74 -4.54 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.447 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 68.0 mt-30 -59.68 113.86 2.46 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.43 ' HD3' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -79.5 -174.94 4.5 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.924 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.57 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 10.3 mm-40 -47.32 166.36 0.19 Allowed Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 3.4 Cg_endo -82.47 148.4 67.17 Favored 'Cis proline' 0 C--N 1.309 -1.549 0 C-N-CA 123.918 -1.284 . . . . 0.0 114.285 0.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 37.6 m-85 -134.0 170.46 11.24 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 5.2 Cg_exo -75.07 156.69 99.83 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 120.812 1.326 . . . . 0.0 110.84 0.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.447 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 24.8 mtp180 -133.8 126.51 30.72 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.327 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.69 129.84 43.53 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -126.2 -5.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.905 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.33 141.27 6.34 Favored Glycine 0 C--N 1.285 -2.275 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 22.9 ttpp -109.9 119.91 40.81 Favored 'General case' 0 C--N 1.286 -2.184 0 O-C-N 121.487 -1.007 . . . . 0.0 109.889 -177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.592 HG23 ' CG2' ' A' ' 59' ' ' VAL . 44.0 t -80.84 142.32 14.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 171.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.2 t -126.13 126.2 69.15 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.837 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 14.9 t0 -99.17 128.49 45.31 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 171.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 C--N 1.283 -2.288 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.166 -172.76 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -120.02 170.4 9.32 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.341 -0.849 . . . . 0.0 109.169 178.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.69 ' HB3' HD13 ' A' ' 52' ' ' ILE . 47.8 m-85 -105.75 126.38 52.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.234 -0.916 . . . . 0.0 110.3 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.474 ' HG3' HG21 ' A' ' 80' ' ' THR . 0.0 OUTLIER -109.31 121.22 44.7 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.677 HD11 HD23 ' A' ' 93' ' ' LEU . 19.5 tp -99.6 156.77 16.89 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -160.14 171.44 19.25 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -174.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.34 174.66 19.05 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.356 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 111.17 1.64 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 123.99 -13.51 8.03 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -176.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.7 t -130.46 -99.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.616 -0.932 . . . . 0.0 108.568 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.418 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -84.1 -1.58 55.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.346 -0.846 . . . . 0.0 108.898 178.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -126.12 150.69 48.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 108.685 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.583 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.7 mp0 -60.62 133.06 91.43 Favored Pre-proline 0 C--N 1.279 -2.49 0 C-N-CA 123.579 0.752 . . . . 0.0 110.463 -176.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 30.6 Cg_endo -66.24 117.46 2.06 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 C-N-CA 123.634 -1.402 . . . . 0.0 110.921 -1.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.583 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 23.3 mttp -69.84 145.56 52.0 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.155 -0.966 . . . . 0.0 111.611 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.24 41.45 79.21 Favored Glycine 0 C--N 1.283 -2.412 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.416 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 41' ' ' GLY . 12.6 mm -88.7 -41.41 14.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 74.2 m-85 -112.25 148.91 33.14 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.069 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -145.47 135.16 23.4 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 172.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.69 HD13 ' HB3' ' A' ' 35' ' ' PHE . 18.6 tt -94.93 161.25 2.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.663 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -79.4 114.4 18.31 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.486 ' HA ' ' H ' ' A' ' 35' ' ' PHE . 2.9 mt-10 -65.53 10.55 0.09 Allowed 'General case' 0 C--N 1.286 -2.189 0 O-C-N 121.838 -0.538 . . . . 0.0 112.425 -174.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -133.05 -50.19 0.88 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.658 -1.276 . . . . 0.0 110.175 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 55.0 p -79.4 -54.12 6.24 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -177.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 35' ' ' PHE . . . 121.97 2.26 10.3 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -63.48 122.25 15.82 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.671 -0.899 . . . . 0.0 109.466 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.592 ' CG2' HG23 ' A' ' 24' ' ' VAL . 44.5 t -91.35 117.65 35.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -109.17 140.31 42.93 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.918 -176.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.409 ' CG2' HD21 ' A' ' 65' ' ' LEU . 8.9 p -89.43 141.89 13.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' A' ' 49' ' ' ILE . 24.3 p -94.32 -19.71 20.42 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.29 -0.881 . . . . 0.0 111.034 -175.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.2 178.21 8.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.006 -1.059 . . . . 0.0 110.393 -176.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 2.0 t -68.53 143.8 54.81 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 61' ' ' VAL . 63.4 mt -106.25 142.28 36.2 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.305 -0.872 . . . . 0.0 109.115 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.484 ' HB2' HG23 ' A' ' 69' ' ' VAL . 19.4 m-20 -123.99 122.41 37.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.647 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 6.4 mtm105 -60.48 -9.72 4.05 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -79.15 -27.9 42.76 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.484 HG23 ' HB2' ' A' ' 66' ' ' ASP . 20.9 t -88.84 -55.56 6.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -144.74 134.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.99 -26.18 22.77 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.8 p -152.79 139.42 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.683 -0.636 . . . . 0.0 109.641 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -101.17 134.04 44.8 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.479 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 14.5 tp60 -96.96 96.08 8.26 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -98.61 170.1 9.04 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.193 0.996 . . . . 0.0 108.982 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.9 m-85 -137.47 137.28 38.55 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.709 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -117.42 138.21 48.82 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 CA-C-O 121.128 0.489 . . . . 0.0 110.573 -176.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.673 ' HB3' HG23 ' A' ' 86' ' ' THR . 32.7 mt-10 -133.95 139.87 46.4 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.643 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.53 141.62 31.48 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 169.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.478 ' C ' HD21 ' A' ' 87' ' ' LEU . 1.2 p -129.52 162.13 28.89 Favored 'General case' 0 C--N 1.275 -2.668 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.364 -174.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 10.2 t70 -100.67 170.3 8.45 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.502 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.2 m -53.6 -27.01 14.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.457 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 14.0 t-20 -79.89 3.53 19.53 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.408 -0.807 . . . . 0.0 109.538 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.31 17.5 70.39 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.457 ' NZ ' ' OD1' ' A' ' 83' ' ' ASN . 18.1 mttp -82.79 146.91 28.7 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.166 -1.197 . . . . 0.0 108.057 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.673 HG23 ' HB3' ' A' ' 78' ' ' GLU . 87.7 m -91.51 116.53 28.93 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.925 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.88 -23.8 18.67 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.779 ' HG3' HD12 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -145.41 164.84 30.28 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.526 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 80.72 -166.02 48.53 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -69.65 103.88 0.38 Allowed 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 123.487 -1.464 . . . . 0.0 110.926 -0.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.913 HG21 HG21 ' A' ' 2' ' ' ILE . 14.6 m -72.92 158.21 87.53 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -90.4 141.61 3.4 Favored 'Trans proline' 0 C--N 1.283 -2.901 0 C-N-CA 121.552 1.501 . . . . 0.0 112.424 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.677 HD23 HD11 ' A' ' 37' ' ' LEU . 12.6 tp -131.57 125.73 33.03 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.479 ' HG2' ' NE2' ' A' ' 74' ' ' GLN . 66.3 mt-10 -109.0 123.09 48.58 Favored 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.517 -0.739 . . . . 0.0 109.232 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 41.6 t -108.3 100.43 10.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.769 ' H ' HD12 ' A' ' 96' ' ' ILE . 3.4 mp -84.69 135.94 23.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-O 121.457 0.646 . . . . 0.0 109.298 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.746 HG12 ' HB3' ' A' ' 11' ' ' GLU . 5.1 t -92.37 99.25 9.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.588 HG21 ' HB3' ' A' ' 8' ' ' LEU . 16.4 pt -90.76 171.9 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.291 -1.945 0 O-C-N 120.946 -1.096 . . . . 0.0 108.295 179.36 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.505 ' N ' ' OE1' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.501 -0.941 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.95 HG21 HG21 ' A' ' 91' ' ' VAL . 40.5 mt -72.34 123.13 26.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.458 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.64 124.43 72.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -131.44 158.78 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 -178.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.417 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -127.37 131.03 23.64 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.459 ' HB2' HD11 ' A' ' 8' ' ' LEU . 53.6 Cg_exo -41.25 140.89 1.31 Allowed 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.205 1.936 . . . . 0.0 110.85 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.52 HG13 HD11 ' A' ' 93' ' ' LEU . 12.6 mt -103.93 115.45 45.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.724 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -107.99 96.8 6.63 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.44 ' CG1' HG22 ' A' ' 7' ' ' ILE . 1.3 mt -107.79 128.13 26.42 Favored Pre-proline 0 C--N 1.279 -2.471 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -176.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 40.5 Cg_endo -72.07 135.4 25.11 Favored 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 120.79 0.993 . . . . 0.0 110.163 175.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.46 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 2.1 pp20? -68.26 -173.32 0.39 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-O 121.996 0.903 . . . . 0.0 111.388 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.472 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 0.8 OUTLIER 60.65 -5.99 0.1 Allowed 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 174.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.536 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 57.5 mt-30 -61.87 137.0 58.2 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.472 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -107.14 -159.78 0.71 Allowed 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.681 -0.637 . . . . 0.0 110.158 -174.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.521 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -55.6 166.48 0.97 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.521 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 4.0 Cg_endo -80.29 118.18 5.63 Favored 'Cis proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.273 -1.553 . . . . 0.0 113.525 0.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -107.13 165.58 12.59 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.5 162.77 79.54 Favored 'Cis proline' 0 N--CA 1.504 2.094 0 C-N-CA 124.57 -1.012 . . . . 0.0 111.631 -1.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.536 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 39.4 mtp180 -132.26 144.57 50.7 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 33.7 t70 -77.01 139.34 40.04 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.484 HG23 HG21 ' A' ' 7' ' ' ILE . 31.0 m -127.01 -2.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.859 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 169.77 -178.6 42.64 Favored Glycine 0 N--CA 1.511 3.693 0 C-N-CA 117.355 -2.355 . . . . 0.0 110.401 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.494 ' NZ ' ' O ' ' A' ' 56' ' ' THR . 6.8 ttmm -137.01 127.73 27.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.712 -1.464 . . . . 0.0 112.0 -176.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.667 HG11 HG11 ' A' ' 77' ' ' VAL . 15.3 t -94.91 132.57 38.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 168.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.3 156.51 34.47 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.852 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.493 ' HA ' ' O ' ' A' ' 1' ' ' SER . 8.3 t70 -132.85 146.05 51.48 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.285 -2.206 0 O-C-N 121.559 -0.713 . . . . 0.0 111.322 -176.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.499 2.008 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.539 ' HB3' ' CB ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -131.19 154.74 48.08 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -79.78 144.76 33.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.498 -0.751 . . . . 0.0 110.801 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.468 ' NH1' ' OE1' ' A' ' 78' ' ' GLU . 1.3 mtp180 -116.5 145.08 43.57 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 tp -122.17 143.85 49.31 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 p -144.12 170.86 15.14 Favored 'General case' 0 C--N 1.276 -2.613 0 O-C-N 121.251 -0.905 . . . . 0.0 109.056 -175.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.02 164.88 13.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.56 106.19 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 133.75 -16.23 4.54 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -175.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 50' ' ' PHE . 38.2 t -132.73 -88.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.578 -0.954 . . . . 0.0 109.577 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.03 -20.51 34.87 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -118.11 157.31 27.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.844 0.831 . . . . 0.0 109.53 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 45' ' ' GLU . 1.8 mp0 -56.33 132.4 76.01 Favored Pre-proline 0 C--N 1.28 -2.414 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.756 -176.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.632 ' HB2' HD11 ' A' ' 49' ' ' ILE . 4.9 Cg_endo -75.85 115.94 3.86 Favored 'Cis proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.091 -1.629 . . . . 0.0 110.126 -0.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 32.8 mtpt -69.42 153.85 42.92 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 120.721 -1.237 . . . . 0.0 111.425 -174.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.52 9.1 29.69 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-O 119.261 -0.744 . . . . 0.0 113.34 173.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 46' ' ' PRO . 8.1 mm -60.83 -48.76 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.509 0 CA-C-N 120.239 2.019 . . . . 0.0 106.795 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.418 ' HB2' HG22 ' A' ' 42' ' ' VAL . 86.4 m-85 -108.35 166.62 10.62 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-O 121.815 0.817 . . . . 0.0 110.413 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.84 126.6 7.53 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.432 HG13 HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -93.46 146.84 5.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.477 HD22 ' CG2' ' A' ' 56' ' ' THR . 34.3 t30 -79.46 85.11 5.27 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.539 ' CB ' ' HB3' ' A' ' 34' ' ' LYS . 1.9 mt-10 -30.82 -34.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 124.053 0.941 . . . . 0.0 113.431 -174.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -93.0 -50.42 5.55 Favored 'General case' 0 C--N 1.285 -2.231 0 O-C-N 121.544 -0.723 . . . . 0.0 110.373 -174.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.494 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 18.8 p -88.32 -12.32 43.8 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 122.047 0.927 . . . . 0.0 108.831 -175.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . 69.82 9.36 62.47 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.49 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 3.5 m -69.35 124.58 24.22 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.326 -1.103 . . . . 0.0 108.291 177.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.499 ' CG2' HG23 ' A' ' 24' ' ' VAL . 1.8 t -90.02 122.52 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.182 -0.949 . . . . 0.0 109.192 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -118.26 154.15 32.75 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.198 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.602 ' CG2' HD21 ' A' ' 65' ' ' LEU . 12.1 p -107.46 149.92 10.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.7 p -104.32 -22.9 13.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.503 -0.748 . . . . 0.0 112.101 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HD2' HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -137.56 168.52 19.5 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.979 -1.075 . . . . 0.0 111.381 -175.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 12.1 t -64.87 123.42 19.36 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.602 HD21 ' CG2' ' A' ' 61' ' ' VAL . 36.7 mt -82.08 163.54 21.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.063 -1.023 . . . . 0.0 108.497 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -127.92 170.42 12.86 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.546 ' NE ' ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.68 27.39 8.22 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 121.873 0.844 . . . . 0.0 109.158 -177.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -120.32 -42.18 2.58 Favored 'General case' 0 C--N 1.262 -3.213 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.81 -47.78 16.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 70' ' ' ILE . 2.0 mt -129.85 137.25 57.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.44 -24.13 14.23 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 p -156.29 146.43 11.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.423 -0.798 . . . . 0.0 109.345 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.492 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 60.6 m-85 -103.96 114.48 28.76 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 174.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.503 HE22 ' CG ' ' A' ' 94' ' ' GLU . 18.2 tp60 -88.01 83.07 7.07 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.79 170.58 15.54 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 43.8 m-85 -133.69 129.74 37.2 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.698 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -105.77 144.21 15.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 O-C-N 121.894 -0.503 . . . . 0.0 109.859 -175.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.708 ' HB3' HG23 ' A' ' 86' ' ' THR . 56.0 mt-10 -131.31 140.95 49.86 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.648 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -86.3 127.63 34.81 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 102.806 -3.035 . . . . 0.0 102.806 167.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.584 ' C ' HD21 ' A' ' 87' ' ' LEU . 19.5 p -123.04 146.05 48.0 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 118.567 -1.253 . . . . 0.0 111.713 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.736 ' N ' HD21 ' A' ' 87' ' ' LEU . 29.0 t70 -88.72 165.76 14.51 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.017 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG13 ' H ' ' A' ' 82' ' ' VAL . 1.0 OUTLIER -55.76 -27.21 21.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -79.5 -13.19 59.73 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.102 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.04 7.18 50.67 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -76.4 143.77 40.44 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 120.666 -1.49 . . . . 0.0 107.787 178.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.708 HG23 ' HB3' ' A' ' 78' ' ' GLU . 98.3 m -86.98 116.08 24.8 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.884 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -87.24 -20.8 26.37 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.505 ' OE1' ' N ' ' A' ' 1' ' ' SER . 4.7 tt0 -157.94 153.2 25.81 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.521 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 83.91 -169.5 46.53 Favored Glycine 0 C--N 1.28 -2.536 0 N-CA-C 106.698 -2.561 . . . . 0.0 106.698 -174.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.85 103.23 0.14 OUTLIER 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.644 -1.398 . . . . 0.0 112.722 -0.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.95 HG21 HG21 ' A' ' 2' ' ' ILE . 3.7 m -78.4 164.35 56.7 Favored Pre-proline 0 C--N 1.289 -2.059 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -93.71 153.14 2.32 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 121.498 1.465 . . . . 0.0 112.622 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 4' ' ' VAL . 5.4 tp -141.0 129.76 22.92 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.503 ' CG ' HE22 ' A' ' 74' ' ' GLN . 31.7 mt-10 -102.92 110.57 22.54 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 60.0 t -103.69 93.08 2.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 96' ' ' ILE . 3.4 mp -79.76 134.3 27.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 O-C-N 121.507 -0.746 . . . . 0.0 109.24 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.546 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 55.2 t -88.38 102.49 12.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.518 HG21 ' HB3' ' A' ' 8' ' ' LEU . 9.5 pt -80.17 170.78 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.244 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 . . . . . 0 C--N 1.28 -2.434 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.989 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.467 ' N ' ' OE2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.73 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.777 HG21 HG21 ' A' ' 91' ' ' VAL . 18.9 mt -67.82 148.54 11.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.53 0.681 . . . . 0.0 110.015 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.76 114.31 24.66 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -134.32 169.63 21.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.524 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 2.1 m -159.39 165.94 17.2 Favored Pre-proline 0 C--N 1.276 -2.618 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 33.1 Cg_exo -55.47 131.32 45.46 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.553 1.502 . . . . 0.0 111.946 -175.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.4 HG13 HD11 ' A' ' 93' ' ' LEU . 11.1 mt -106.13 115.88 48.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.841 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -90.25 108.01 19.49 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' CD1' HG13 ' A' ' 95' ' ' VAL . 23.2 mt -109.81 124.23 34.19 Favored Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 6.5 Cg_exo -66.06 124.49 12.69 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.062 1.175 . . . . 0.0 110.777 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -41.86 -72.2 0.07 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.578 0.704 . . . . 0.0 111.797 -176.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.492 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 48.2 p-10 -66.4 40.55 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -174.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.484 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -76.01 56.04 0.96 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 119.608 -1.933 . . . . 0.0 106.145 172.074 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.564 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -45.59 175.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.331 1.062 . . . . 0.0 113.599 -172.216 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 37.5 mt-30 -48.25 166.34 0.22 Allowed Pre-proline 0 C--N 1.285 -2.201 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.754 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 5.7 Cg_exo -76.1 134.89 37.7 Favored 'Cis proline' 0 N--CA 1.497 1.721 0 C-N-CA 123.725 -1.364 . . . . 0.0 113.898 0.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CZ ' ' O ' ' A' ' 13' ' ' GLN . 24.2 m-85 -102.49 166.24 12.37 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 12.2 Cg_exo -69.36 166.7 72.32 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.312 -0.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.564 ' NH2' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -125.1 135.28 52.54 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.98 137.16 51.19 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.25 4.83 3.06 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.011 0 C-N-CA 119.441 -0.903 . . . . 0.0 109.014 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 158.37 -170.32 35.04 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 118.218 -1.944 . . . . 0.0 109.632 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 19.4 ttmm -148.13 128.56 13.97 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.23 -1.159 . . . . 0.0 109.768 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.672 HG11 HG11 ' A' ' 77' ' ' VAL . 21.7 t -89.25 147.07 5.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 26' ' ' ASP . 61.0 t -132.38 163.73 36.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 9.8 t70 -125.09 141.11 52.32 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.459 ' HG ' ' HB2' ' A' ' 1' ' ' SER . 0.7 OUTLIER . . . . . 0 C--N 1.26 -3.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.362 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.477 ' C ' ' HG2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.063 0 CA-C-O 121.465 0.65 . . . . 0.0 111.263 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HG2' ' C ' ' A' ' 33' ' ' SER . 6.2 mmtm -147.71 150.51 34.44 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.491 ' N ' ' O ' ' A' ' 54' ' ' GLU . 35.5 m-85 -94.65 124.28 38.59 Favored 'General case' 0 C--N 1.28 -2.446 0 O-C-N 121.408 -0.807 . . . . 0.0 109.485 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.698 ' HG3' HG21 ' A' ' 80' ' ' THR . 4.4 mmp_? -107.61 125.77 51.73 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.669 ' HG ' HG21 ' A' ' 42' ' ' VAL . 44.1 tp -106.29 144.45 32.95 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -149.68 170.89 17.64 Favored 'General case' 0 C--N 1.278 -2.5 0 O-C-N 121.163 -0.96 . . . . 0.0 108.732 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.91 176.26 18.71 Favored Glycine 0 N--CA 1.502 3.033 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.056 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 44' ' ' GLN . 36.5 mtpt -61.11 121.16 11.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 110.16 -20.77 25.62 Favored Glycine 0 C--N 1.28 -2.552 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 -177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.669 HG21 ' HG ' ' A' ' 37' ' ' LEU . 40.9 t -116.2 -93.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -92.98 -12.58 30.37 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.59 -0.694 . . . . 0.0 109.647 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 40' ' ' LYS . 6.0 mm-40 -109.7 157.58 18.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -57.81 132.52 82.95 Favored Pre-proline 0 C--N 1.288 -2.1 0 O-C-N 121.982 -0.449 . . . . 0.0 110.084 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.444 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -77.42 118.77 5.95 Favored 'Cis proline' 0 N--CA 1.501 1.959 0 C-N-CA 123.91 -1.287 . . . . 0.0 110.24 -0.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 mttp -67.14 149.69 50.17 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 120.788 -1.195 . . . . 0.0 111.947 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.22 29.3 72.61 Favored Glycine 0 N--CA 1.49 2.286 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.748 171.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.498 HG23 ' HD2' ' A' ' 63' ' ' ARG . 10.6 mm -83.77 -44.75 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 173.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.663 ' HB2' HG22 ' A' ' 42' ' ' VAL . 84.3 m-85 -106.33 147.76 28.82 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.601 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.57 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -141.94 126.25 17.59 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 177.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.61 147.67 8.88 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.542 ' CG ' HG23 ' A' ' 56' ' ' THR . 28.5 t-20 -79.68 99.97 7.65 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -42.39 -26.64 0.12 Allowed 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.896 -177.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -106.5 -37.28 6.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.909 -1.12 . . . . 0.0 111.69 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.542 HG23 ' CG ' ' A' ' 53' ' ' ASN . 5.1 p -89.8 -15.23 32.78 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 120.984 -1.072 . . . . 0.0 108.918 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.24 2.62 49.14 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.518 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 19.3 m -64.51 124.37 21.67 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.292 -1.122 . . . . 0.0 108.815 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 24' ' ' VAL . 2.1 t -88.96 131.0 37.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.57 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -130.87 160.53 34.17 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.44 149.37 19.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.1 p -94.71 -10.57 31.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.48 -0.763 . . . . 0.0 111.148 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -155.15 162.92 40.85 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.052 -1.03 . . . . 0.0 109.306 -178.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.528 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 5.1 t -62.18 138.2 58.37 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 65.2 mt -90.71 131.58 36.31 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -106.06 119.34 38.96 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -57.62 -7.65 0.71 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -77.89 -26.93 49.49 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.9 t -89.87 -53.02 9.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.416 HD12 ' CE1' ' A' ' 73' ' ' TYR . 2.8 mt -151.66 144.02 16.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.28 -25.55 16.29 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.1 p -154.92 135.95 5.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.501 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.416 ' CE1' HD12 ' A' ' 70' ' ' ILE . 37.4 m-85 -106.03 138.64 41.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.443 HE22 ' CG ' ' A' ' 94' ' ' GLU . 0.3 OUTLIER -100.7 87.08 3.25 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.317 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.405 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -81.11 170.78 15.74 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 57.0 m-85 -132.21 131.37 42.09 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.716 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -110.18 140.64 28.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 O-C-N 122.022 -0.424 . . . . 0.0 110.046 -177.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.619 ' HB3' HG23 ' A' ' 86' ' ' THR . 43.8 mt-10 -130.28 137.12 49.82 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.681 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -86.2 133.8 33.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 172.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.698 HG21 ' HG3' ' A' ' 36' ' ' ARG . 4.1 p -125.27 159.17 32.31 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.689 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.488 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -101.07 170.55 8.2 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 177.134 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.488 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 0.9 OUTLIER -43.09 -38.0 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 CA-C-O 121.825 0.821 . . . . 0.0 109.613 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.435 ' N ' ' CG2' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -79.95 2.85 21.93 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.697 -0.627 . . . . 0.0 109.975 -177.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.67 15.48 80.64 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 80' ' ' THR . 2.0 mtpp -73.51 134.18 43.8 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.619 HG23 ' HB3' ' A' ' 78' ' ' GLU . 91.0 m -81.27 116.92 21.37 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.803 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.914 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.33 -22.02 19.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.467 ' OE2' ' N ' ' A' ' 1' ' ' SER . 1.0 OUTLIER -151.21 149.37 29.35 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.265 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.556 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 105.43 -178.39 23.33 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -71.63 104.43 0.49 Allowed 'Cis proline' 0 N--CA 1.491 1.354 0 C-N-CA 123.304 -1.54 . . . . 0.0 111.568 0.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 2' ' ' ILE . 9.5 m -75.23 159.04 83.25 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 176.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -91.78 145.16 3.08 Favored 'Trans proline' 0 C--N 1.279 -3.089 0 C-N-CA 121.529 1.486 . . . . 0.0 111.699 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.544 HD23 HD11 ' A' ' 37' ' ' LEU . 11.2 tp -128.84 126.97 40.94 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.443 ' CG ' HE22 ' A' ' 74' ' ' GLN . 4.2 mt-10 -106.81 110.29 22.42 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.63 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 24.8 t -101.8 112.22 34.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.7 mp -97.55 136.28 28.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.57 111.76 23.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.674 HG21 ' HB3' ' A' ' 8' ' ' LEU . 9.7 pt -105.45 171.63 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 . . . . . 0 C--N 1.279 -2.46 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -178.683 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.516 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.85 HG21 HG21 ' A' ' 91' ' ' VAL . 17.2 mt -62.01 146.02 12.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-O 121.934 0.874 . . . . 0.0 111.065 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -134.85 115.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.553 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 174.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.528 HG23 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -127.14 161.86 33.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.057 -1.027 . . . . 0.0 108.9 -175.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.451 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -155.52 138.84 10.89 Favored Pre-proline 0 C--N 1.273 -2.74 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -41.9 138.91 2.55 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 C-N-CA 122.351 2.034 . . . . 0.0 112.724 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.508 HG13 HD11 ' A' ' 93' ' ' LEU . 16.2 mt -104.63 119.44 53.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 175.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.8 mp -106.15 79.42 1.4 Allowed 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.486 HG13 HG22 ' A' ' 7' ' ' ILE . 4.7 mt -81.99 140.35 46.47 Favored Pre-proline 0 C--N 1.281 -2.398 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.503 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.1 Cg_endo -73.69 137.13 24.44 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 120.748 0.965 . . . . 0.0 111.046 177.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.696 ' HB3' HG12 ' A' ' 97' ' ' VAL . 1.5 pt-20 -66.08 170.59 5.48 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.283 -0.886 . . . . 0.0 109.198 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.438 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 5.3 t-20 59.8 13.5 3.58 Favored 'General case' 0 C--N 1.287 -2.114 0 O-C-N 121.752 -0.593 . . . . 0.0 112.093 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -57.58 127.63 32.97 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.571 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -89.67 158.53 17.54 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.153 -0.967 . . . . 0.0 112.781 -170.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.59 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 12.3 mp0 -50.07 167.05 0.25 Allowed Pre-proline 0 C--N 1.296 -1.733 0 C-N-CA 124.938 1.295 . . . . 0.0 109.022 176.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 67.8 Cg_endo -79.61 154.67 88.64 Favored 'Cis proline' 0 C--N 1.31 -1.473 0 C-N-CA 123.613 -1.411 . . . . 0.0 113.641 0.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 33.9 m-85 -135.09 169.86 12.7 Favored Pre-proline 0 C--N 1.276 -2.597 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.6 Cg_exo -68.94 173.34 41.99 Favored 'Cis proline' 0 N--CA 1.493 1.469 0 C-N-CA 124.485 -1.048 . . . . 0.0 112.124 0.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.571 ' NH2' ' O ' ' A' ' 14' ' ' ARG . 7.1 ttm180 -155.88 145.2 20.81 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -65.65 132.83 49.78 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.01 3.74 5.14 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 163.36 179.11 37.61 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.93 131.88 35.74 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.818 -1.401 . . . . 0.0 110.134 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 77' ' ' VAL . 24.2 t -91.69 126.62 44.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 102.179 -3.267 . . . . 0.0 102.179 166.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.437 ' HB ' HG13 ' A' ' 3' ' ' VAL . 33.0 t -112.07 159.69 11.91 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 C-N-CA 118.472 -1.291 . . . . 0.0 109.068 -173.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 1' ' ' SER . 29.3 t0 -144.99 110.35 5.24 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 174.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.283 -2.285 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -175.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.079 0.466 . . . . 0.0 111.065 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' NZ ' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -107.14 142.35 36.97 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.743 -0.598 . . . . 0.0 110.331 -176.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.418 ' CD1' ' CA ' ' A' ' 57' ' ' GLY . 78.8 m-85 -79.11 139.1 38.14 Favored 'General case' 0 C--N 1.273 -2.74 0 O-C-N 120.972 -1.08 . . . . 0.0 111.255 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.458 ' NH2' ' OG1' ' A' ' 86' ' ' THR . 7.0 mtm-85 -115.57 127.16 55.04 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 172.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.546 ' HG ' HG21 ' A' ' 42' ' ' VAL . 27.2 tp -108.71 138.97 44.17 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -147.69 170.8 16.75 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.68 163.83 13.0 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -57.21 112.81 1.48 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 125.74 -18.88 6.67 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 107.934 -2.067 . . . . 0.0 107.934 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.546 HG21 ' HG ' ' A' ' 37' ' ' LEU . 39.3 t -123.77 -97.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.98 -18.32 30.98 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -107.13 156.88 18.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.625 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 15.5 mm-40 -68.54 140.93 92.59 Favored Pre-proline 0 C--N 1.269 -2.893 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.537 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.48 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -70.52 113.39 1.83 Allowed 'Cis proline' 0 N--CA 1.51 2.48 0 C-N-CA 123.605 -1.415 . . . . 0.0 111.438 1.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.625 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 5.3 mtpm? -69.17 152.82 44.64 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.766 -1.209 . . . . 0.0 111.909 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.441 ' O ' ' OG1' ' A' ' 62' ' ' THR . . . 69.87 5.1 50.8 Favored Glycine 0 N--CA 1.489 2.198 0 CA-C-O 119.113 -0.826 . . . . 0.0 113.474 171.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.402 ' CG1' ' HB2' ' A' ' 46' ' ' PRO . 11.7 mm -65.24 -46.66 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 120.456 2.128 . . . . 0.0 107.338 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.641 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 69.6 m-85 -115.75 144.67 43.64 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.296 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.18 136.01 29.52 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.0 OUTLIER -109.23 157.54 9.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.602 -0.686 . . . . 0.0 109.989 -176.122 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.49 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 11.4 t-20 -85.32 126.94 34.13 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 175.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 34' ' ' LYS . 1.8 mt-10 -59.7 -38.54 81.86 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.771 -0.581 . . . . 0.0 111.06 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.441 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 10.6 t30 -88.57 -48.03 7.87 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.014 -1.054 . . . . 0.0 111.673 -176.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.1 p -80.49 -34.43 35.81 Favored 'General case' 0 C--N 1.281 -2.376 0 O-C-N 121.727 -0.608 . . . . 0.0 109.662 -174.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.418 ' CA ' ' CD1' ' A' ' 35' ' ' PHE . . . 84.08 10.38 80.68 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -176.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 16.8 m -64.54 122.09 15.98 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.209 -1.171 . . . . 0.0 108.334 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.555 HG22 HG23 ' A' ' 24' ' ' VAL . 1.8 t -88.92 127.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.59 146.01 49.29 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.532 -0.73 . . . . 0.0 109.654 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.455 HG21 ' CG ' ' A' ' 65' ' ' LEU . 8.3 p -101.63 149.18 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 48' ' ' GLY . 28.8 p -99.86 -17.32 17.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.634 -0.666 . . . . 0.0 112.122 -175.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -145.93 167.17 23.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.798 -1.189 . . . . 0.0 110.567 -178.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.506 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 7.1 t -58.01 122.51 13.19 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.455 ' CG ' HG21 ' A' ' 61' ' ' VAL . 86.3 mt -79.73 140.87 36.81 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.466 -1.396 . . . . 0.0 109.904 -175.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.499 ' CG ' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -124.37 117.3 24.17 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -60.17 -14.73 18.86 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 121.765 -0.584 . . . . 0.0 109.88 178.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 1.5 mp0 -78.56 -28.3 45.94 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.889 -1.132 . . . . 0.0 108.694 -176.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.86 -52.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -145.33 132.59 15.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.36 -25.46 29.14 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.22 136.59 5.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 42.7 m-85 -100.05 122.52 43.06 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -92.44 93.91 8.83 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.94 170.75 9.8 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.779 0.799 . . . . 0.0 109.028 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 93.5 m-85 -133.0 131.21 40.46 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -117.9 150.13 20.1 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -174.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.635 ' HB3' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -146.46 146.87 30.71 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 121.302 -0.874 . . . . 0.0 108.652 176.093 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.712 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -95.27 135.63 36.62 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 170.419 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.712 ' C ' HD21 ' A' ' 87' ' ' LEU . 38.0 p -125.76 158.22 35.46 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.411 -0.806 . . . . 0.0 111.553 -171.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.429 ' HB2' HD11 ' A' ' 87' ' ' LEU . 28.1 t70 -79.64 170.96 15.79 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.428 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 2.1 m -58.41 -27.71 33.9 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -79.61 2.01 23.99 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.736 0.779 . . . . 0.0 108.997 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.434 ' HA2' ' HZ1' ' A' ' 34' ' ' LYS . . . 77.36 11.65 85.31 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -77.51 140.05 39.7 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.635 HG23 ' HB3' ' A' ' 78' ' ' GLU . 39.0 m -81.51 118.98 23.18 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 120.777 0.322 . . . . 0.0 110.187 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.927 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.21 -31.29 14.18 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.468 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 5.1 tp10 -138.04 153.18 49.37 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.56 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 89.12 -171.5 38.86 Favored Glycine 0 C--N 1.288 -2.119 0 N-CA-C 106.931 -2.467 . . . . 0.0 106.931 -174.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.37 111.54 1.03 Allowed 'Cis proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.364 -1.515 . . . . 0.0 111.037 -0.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.85 HG21 HG21 ' A' ' 2' ' ' ILE . 4.2 m -86.9 163.56 40.28 Favored Pre-proline 0 C--N 1.28 -2.432 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -93.85 159.84 2.26 Favored 'Trans proline' 0 C--N 1.289 -2.561 0 C-N-CA 121.933 1.756 . . . . 0.0 110.868 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.528 HD13 HG23 ' A' ' 4' ' ' VAL . 15.4 tp -144.88 124.48 13.24 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.81 113.14 25.12 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.641 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 78.1 t -105.16 91.39 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.82 138.04 20.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 O-C-N 121.506 -0.746 . . . . 0.0 109.179 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.696 HG12 ' HB3' ' A' ' 11' ' ' GLU . 4.0 t -97.1 106.72 18.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.2 pt -97.12 170.92 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.081 -1.012 . . . . 0.0 110.307 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.304 -1.395 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.934 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.856 HG21 HG21 ' A' ' 91' ' ' VAL . 7.2 mt -74.96 146.85 8.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.361 0.6 . . . . 0.0 109.621 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -125.25 137.89 56.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.379 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -150.61 167.43 2.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . 0.494 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -140.87 145.73 40.88 Favored Pre-proline 0 C--N 1.289 -2.055 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.28 133.11 35.78 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.093 1.862 . . . . 0.0 110.323 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.2 mt -103.93 112.1 36.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.167 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.898 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.22 105.33 17.74 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.634 HD11 HG21 ' A' ' 21' ' ' VAL . 19.3 mt -111.93 128.4 25.51 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 33.9 Cg_endo -69.27 130.16 19.45 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.172 1.248 . . . . 0.0 110.727 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 66' ' ' ASP . 10.9 pt-20 -64.35 173.88 1.88 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.104 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 57.39 61.75 2.4 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.688 0.756 . . . . 0.0 111.418 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.423 ' O ' ' OG1' ' A' ' 64' ' ' THR . 73.8 mt-30 -119.88 131.98 55.42 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 174.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -96.97 177.82 5.49 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 121.062 -1.024 . . . . 0.0 111.673 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.567 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 18.2 mp0 -54.76 166.94 0.67 Allowed Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 70.5 Cg_endo -78.12 122.13 8.44 Favored 'Cis proline' 0 C--N 1.315 -1.203 0 C-N-CA 123.785 -1.34 . . . . 0.0 114.459 0.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.506 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 29.6 m-85 -97.86 170.2 7.45 Favored Pre-proline 0 C--N 1.279 -2.49 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.506 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.7 Cg_exo -68.05 163.27 76.82 Favored 'Cis proline' 0 N--CA 1.493 1.483 0 C-N-CA 124.194 -1.169 . . . . 0.0 111.224 -1.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 19' ' ' ARG . 1.1 mtp180 -124.47 126.93 46.71 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 24.6 t70 -76.66 132.64 39.5 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.634 HG21 HD11 ' A' ' 9' ' ' ILE . 15.6 m -127.46 5.67 3.4 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.643 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 166.7 179.55 39.96 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 117.707 -2.187 . . . . 0.0 109.756 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.471 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 29.5 tttp -143.03 139.57 30.61 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 120.852 -1.381 . . . . 0.0 109.678 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 77' ' ' VAL . 6.6 t -94.34 152.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 172.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.465 ' HB ' HG13 ' A' ' 3' ' ' VAL . 3.5 t -144.14 151.4 16.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 9.2 t0 -112.25 135.08 53.37 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.269 -2.9 0 O-C-N 122.141 -0.349 . . . . 0.0 111.501 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.656 ' HB2' HG22 ' A' ' 79' ' ' THR . 1.4 p . . . . . 0 CA--C 1.506 -0.73 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 40.8 mttm -113.52 139.17 49.19 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 173.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.846 ' CE1' HG23 ' A' ' 79' ' ' THR . 61.9 m-85 -89.77 135.5 33.59 Favored 'General case' 0 C--N 1.271 -2.818 0 O-C-N 121.24 -0.912 . . . . 0.0 110.991 -174.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.509 ' NH2' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -100.0 139.27 35.92 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 174.23 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.463 HD11 HD23 ' A' ' 93' ' ' LEU . 19.2 tp -121.01 135.45 55.21 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -144.91 170.52 15.99 Favored 'General case' 0 C--N 1.274 -2.692 0 O-C-N 121.472 -0.768 . . . . 0.0 109.019 -174.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.15 173.39 17.69 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -58.16 111.5 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 124.52 -15.3 7.62 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 50' ' ' PHE . 21.2 t -129.36 -81.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.294 -1.121 . . . . 0.0 109.154 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -96.53 -14.46 22.28 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -118.85 158.51 25.51 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.521 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -51.9 127.85 36.08 Favored Pre-proline 0 C--N 1.281 -2.389 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.779 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.445 ' HB2' HD11 ' A' ' 49' ' ' ILE . 4.3 Cg_endo -80.36 120.66 7.32 Favored 'Cis proline' 0 C--O 1.202 -1.311 0 C-N-CA 123.5 -1.458 . . . . 0.0 110.517 -1.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 28.0 mttp -63.47 155.51 29.0 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 120.872 -1.143 . . . . 0.0 111.268 -175.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.75 32.73 48.01 Favored Glycine 0 N--CA 1.49 2.285 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.149 171.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.488 HD12 ' HD2' ' A' ' 63' ' ' ARG . 8.7 mm -87.89 -43.44 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.521 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 67.1 m-85 -110.39 141.44 43.46 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.813 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.586 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -132.6 120.61 22.02 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 176.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -89.09 141.87 13.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.513 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 46.6 t30 -79.09 84.79 5.04 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 1.3 mp0 -24.22 -53.43 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 125.327 1.451 . . . . 0.0 113.54 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -79.75 -39.49 30.92 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.161 -0.962 . . . . 0.0 111.325 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 29.2 p -94.32 -26.28 16.64 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-O 121.735 0.779 . . . . 0.0 109.313 -174.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.33 2.6 76.67 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -65.07 121.35 14.52 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.313 -1.11 . . . . 0.0 109.482 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.1 t -86.83 120.87 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.586 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -123.73 155.42 37.9 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.418 178.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.568 ' CG2' HD21 ' A' ' 65' ' ' LEU . 7.4 p -102.19 143.54 14.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 59.9 p -90.48 -20.51 22.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.446 -0.784 . . . . 0.0 111.037 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.49 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -151.81 175.66 12.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.115 -0.99 . . . . 0.0 110.033 -175.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.49 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 2.7 t -66.62 136.69 55.95 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-O 121.83 0.824 . . . . 0.0 110.793 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.568 HD21 ' CG2' ' A' ' 61' ' ' VAL . 22.0 mt -98.78 150.61 21.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.65 ' HB2' HG23 ' A' ' 69' ' ' VAL . 8.7 m-20 -132.9 122.66 24.67 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.0 mtp-105 -57.26 -13.33 3.11 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -77.79 -22.94 49.37 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 66' ' ' ASP . 25.1 t -85.37 -55.87 6.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' HG21 ' A' ' 97' ' ' VAL . 1.1 mt -144.74 136.39 21.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.11 -25.46 36.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 4.1 p -160.02 132.83 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.456 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 70.6 m-85 -94.42 115.23 27.38 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.447 ' HA ' HE21 ' A' ' 74' ' ' GLN . 0.0 OUTLIER -97.21 93.1 6.35 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.008 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.41 170.62 10.39 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-O 121.956 0.884 . . . . 0.0 108.994 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 78.4 m-85 -128.15 122.23 31.44 Favored 'General case' 0 C--N 1.266 -3.023 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.565 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -103.37 146.15 11.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -177.389 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.75 ' HB3' HG23 ' A' ' 86' ' ' THR . 91.3 mt-10 -136.5 140.02 42.71 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.846 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -83.49 127.35 33.64 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 170.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.509 ' OG1' ' NH2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -125.46 159.67 31.36 Favored 'General case' 0 C--N 1.267 -3.007 0 C-N-CA 119.265 -0.974 . . . . 0.0 109.895 -178.092 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.532 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 14.8 t70 -97.31 170.3 9.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.532 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.5 m -54.43 -22.6 9.14 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -80.27 -2.86 46.91 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.426 -0.796 . . . . 0.0 109.058 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.12 8.62 86.95 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 80' ' ' THR . 4.2 mttp -81.1 150.21 28.86 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.75 HG23 ' HB3' ' A' ' 78' ' ' GLU . 94.0 m -94.48 118.21 31.3 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-O 121.219 0.533 . . . . 0.0 110.302 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.908 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -89.15 -32.5 17.45 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER -137.83 170.41 16.11 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.593 -0.692 . . . . 0.0 109.758 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.511 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 83.5 -165.91 43.1 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -69.63 101.31 0.27 Allowed 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.564 -1.432 . . . . 0.0 110.79 -0.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.856 HG21 HG21 ' A' ' 2' ' ' ILE . 10.6 m -74.15 160.37 81.75 Favored Pre-proline 0 C--N 1.291 -1.954 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -92.49 147.07 2.8 Favored 'Trans proline' 0 C--N 1.285 -2.8 0 C-N-CA 121.868 1.712 . . . . 0.0 112.03 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.463 HD23 HD11 ' A' ' 37' ' ' LEU . 8.8 tp -130.51 125.85 35.36 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -108.27 106.91 17.28 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.651 -0.656 . . . . 0.0 109.677 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.521 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 38.9 t -98.45 100.5 10.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.64 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.8 mp -79.93 131.69 33.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 70' ' ' ILE . 3.1 t -90.05 111.24 22.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 11.3 pt -105.25 171.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 O-C-N 121.688 -0.632 . . . . 0.0 109.537 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--N 1.3 -1.578 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.734 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.492 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 91' ' ' VAL . 7.0 mt -69.22 138.1 22.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.903 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.56 133.4 69.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -146.69 157.9 10.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.637 0.732 . . . . 0.0 109.462 -177.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 t -128.36 141.84 42.73 Favored Pre-proline 0 C--N 1.281 -2.384 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.502 ' HB3' HD11 ' A' ' 96' ' ' ILE . 53.4 Cg_exo -45.67 132.92 13.41 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.531 1.487 . . . . 0.0 109.811 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' A' ' 95' ' ' VAL . 40.7 mt -98.08 111.89 28.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.764 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -100.3 103.12 14.53 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.623 HG22 HE21 ' A' ' 13' ' ' GLN . 4.1 mt -108.11 127.8 26.92 Favored Pre-proline 0 C--N 1.27 -2.877 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -74.4 135.98 21.1 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 CA-C-N 119.444 0.837 . . . . 0.0 111.945 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.401 ' CG ' ' HA ' ' A' ' 66' ' ' ASP . 2.9 tt0 -39.38 147.08 0.08 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.502 0.668 . . . . 0.0 111.848 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.522 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 2.3 t-20 59.87 66.54 0.97 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.623 HE21 HG22 ' A' ' 9' ' ' ILE . 18.9 mp0 -92.17 54.59 2.39 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 175.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.54 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -26.11 162.34 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -174.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.558 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -46.14 169.18 0.09 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.753 175.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 1.2 Cg_endo -77.47 131.47 24.07 Favored 'Cis proline' 0 N--CA 1.492 1.392 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.37 -0.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.529 ' CZ ' ' N ' ' A' ' 64' ' ' THR . 55.1 m-85 -97.74 163.95 18.5 Favored Pre-proline 0 C--N 1.293 -1.86 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.19 156.27 98.19 Favored 'Cis proline' 0 N--CA 1.502 1.977 0 C-N-CA 124.12 -1.2 . . . . 0.0 110.841 -1.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 38.2 mtp180 -124.77 135.29 52.85 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.435 -0.791 . . . . 0.0 110.101 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -62.17 140.27 58.44 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.33 -4.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . -176.07 170.44 43.33 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 118.75 -1.69 . . . . 0.0 109.313 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 5.1 tttm -141.62 114.1 8.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.163 -1.198 . . . . 0.0 109.687 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.694 HG11 HG11 ' A' ' 77' ' ' VAL . 22.0 t -79.65 158.92 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' CE ' ' A' ' 23' ' ' LYS . 6.3 t -141.81 170.1 13.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.1 t70 -131.13 143.93 51.01 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 1' ' ' SER . 0.2 OUTLIER . . . . . 0 C--N 1.281 -2.402 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.079 0.466 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HB2' HH22 ' A' ' 36' ' ' ARG . 2.4 mmtp -111.02 135.41 51.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.709 -0.619 . . . . 0.0 109.712 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -84.58 116.08 22.96 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.597 ' NH1' HG21 ' A' ' 80' ' ' THR . 0.0 OUTLIER -95.31 133.73 38.89 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.706 ' HG ' HG21 ' A' ' 42' ' ' VAL . 61.0 tp -106.93 136.91 45.99 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 176.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.22 170.45 16.72 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.538 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 117.35 167.3 14.32 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -53.92 116.07 2.35 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 119.33 -22.12 9.03 Favored Glycine 0 C--N 1.28 -2.566 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.872 HG22 ' HB2' ' A' ' 50' ' ' PHE . 11.1 t -117.82 -83.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.428 -1.043 . . . . 0.0 109.12 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.35 -23.26 16.72 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 20.4 mp0 -103.34 161.22 14.02 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.447 ' HA ' ' C ' ' A' ' 46' ' ' PRO . 2.5 mp0 -68.73 134.69 90.26 Favored Pre-proline 0 C--N 1.27 -2.855 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.457 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 35.1 Cg_endo -68.73 126.42 8.76 Favored 'Cis proline' 0 N--CA 1.514 2.705 0 C-N-CA 123.615 -1.411 . . . . 0.0 110.942 -0.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -87.23 152.51 22.25 Favored 'General case' 0 C--N 1.289 -2.056 0 O-C-N 120.82 -1.175 . . . . 0.0 111.649 -173.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.01 15.26 71.67 Favored Glycine 0 N--CA 1.492 2.376 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.314 174.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.0 mm -78.37 -48.86 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 CA-C-N 119.561 1.68 . . . . 0.0 107.653 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.872 ' HB2' HG22 ' A' ' 42' ' ' VAL . 91.8 m-85 -108.42 155.71 20.27 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.708 0.766 . . . . 0.0 109.673 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.553 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -146.75 160.0 42.78 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.426 HG12 ' N ' ' A' ' 53' ' ' ASN . 10.9 tt -132.08 164.13 35.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 O-C-N 120.81 -1.181 . . . . 0.0 109.941 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 21.9 t-20 -91.94 108.71 20.12 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.464 ' OE2' ' NZ ' ' A' ' 34' ' ' LYS . 32.1 mt-10 -46.98 -33.45 4.69 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.154 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.405 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 t-20 -95.9 -48.84 5.56 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.415 -0.803 . . . . 0.0 110.961 -176.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 10.0 p -84.91 -21.58 29.61 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 121.491 -0.756 . . . . 0.0 110.083 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.8 7.82 86.28 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 12.0 m -64.15 123.4 18.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.547 HG13 HD22 ' A' ' 37' ' ' LEU . 3.3 t -92.78 122.78 44.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.553 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -117.25 149.42 40.46 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.516 ' CG2' HD21 ' A' ' 65' ' ' LEU . 8.6 p -104.11 143.63 15.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.0 p -91.96 -13.88 30.38 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.547 -0.72 . . . . 0.0 110.852 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.573 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -148.17 160.25 43.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.605 -1.309 . . . . 0.0 109.905 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.573 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -63.21 127.55 31.79 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.596 ' HB2' HE22 ' A' ' 13' ' ' GLN . 34.5 mt -84.68 151.89 24.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.242 -1.536 . . . . 0.0 111.604 -172.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.717 ' HB2' HG23 ' A' ' 69' ' ' VAL . 4.8 m-20 -123.91 131.05 53.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.558 HH11 ' CB ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -72.14 -6.0 39.53 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.017 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -85.44 -19.56 31.12 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -175.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.717 HG23 ' HB2' ' A' ' 66' ' ' ASP . 34.1 t -90.25 -62.96 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.516 HG21 ' CD1' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.49 127.98 23.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 175.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.79 -24.63 24.97 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -146.17 121.79 3.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.516 ' CD1' HG21 ' A' ' 70' ' ' ILE . 65.5 m-85 -92.36 119.7 32.17 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -89.76 81.93 6.33 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.468 HD23 HG23 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -80.46 170.2 16.68 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 122.301 1.048 . . . . 0.0 109.974 -177.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 90.4 m-85 -135.2 136.68 41.98 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.694 HG11 HG11 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -114.07 147.33 17.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -178.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.566 ' HB3' HG23 ' A' ' 86' ' ' THR . 49.0 mt-10 -138.18 141.8 40.05 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.508 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -96.86 131.78 43.27 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 172.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.597 HG21 ' NH1' ' A' ' 36' ' ' ARG . 18.0 p -122.78 162.32 22.31 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.935 -175.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.439 ' HB2' HD11 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -107.97 171.09 7.6 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -47.62 -22.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 O-C-N 121.81 -0.556 . . . . 0.0 111.818 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.48 -17.17 54.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.744 -1.222 . . . . 0.0 109.856 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.91 11.61 57.55 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' THR . 14.2 mttm -90.27 160.54 16.12 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.628 ' C ' HD13 ' A' ' 87' ' ' LEU . 90.3 m -101.2 120.29 40.01 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-O 120.841 0.353 . . . . 0.0 110.085 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.901 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -96.22 -11.23 26.36 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.473 ' O ' ' CG2' ' A' ' 86' ' ' THR . 11.3 tp10 -152.2 167.54 28.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.59 -168.75 52.73 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -67.03 112.56 1.05 Allowed 'Cis proline' 0 N--CA 1.493 1.463 0 C-N-CA 123.25 -1.563 . . . . 0.0 112.356 0.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 2' ' ' ILE . 5.3 m -83.2 165.28 41.73 Favored Pre-proline 0 C--N 1.284 -2.269 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -94.27 152.54 2.06 Favored 'Trans proline' 0 C--N 1.297 -2.151 0 C-N-CA 121.948 1.766 . . . . 0.0 112.329 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.525 HD13 ' CG2' ' A' ' 4' ' ' VAL . 6.5 tp -141.49 126.68 18.51 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -108.45 116.64 32.34 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 121.354 -0.841 . . . . 0.0 109.173 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.519 HG22 ' HB ' ' A' ' 7' ' ' ILE . 79.1 t -104.15 104.47 16.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 96' ' ' ILE . 3.0 mp -92.52 134.52 30.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 15.0 t -89.73 104.0 14.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 8' ' ' LEU . 15.1 pt -85.46 170.85 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.503 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.422 ' OD2' ' NH2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.284 -2.252 0 O-C-N 120.746 -1.221 . . . . 0.0 109.256 -176.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.217 -0.626 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.765 ' CG2' HG21 ' A' ' 91' ' ' VAL . 2.7 mt -77.69 123.28 34.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-O 121.873 0.844 . . . . 0.0 110.511 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.64 134.17 44.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.821 HG21 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -155.0 154.86 6.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.15 141.71 33.5 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -47.63 132.36 20.62 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 121.34 1.36 . . . . 0.0 108.93 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.568 HG13 HD11 ' A' ' 93' ' ' LEU . 3.0 mt -99.4 112.41 31.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.468 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.896 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -89.5 98.57 11.84 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.49 ' CD1' HG13 ' A' ' 95' ' ' VAL . 12.5 mt -106.42 121.29 45.79 Favored Pre-proline 0 C--N 1.279 -2.493 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -66.07 137.46 48.45 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 120.629 0.886 . . . . 0.0 111.275 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -72.13 179.5 3.29 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.675 -178.137 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.543 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 2.2 m-20 58.69 17.51 5.16 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 172.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.41 ' O ' ' OG1' ' A' ' 64' ' ' THR . 58.3 mt-30 -77.21 129.45 35.95 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 174.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.543 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -97.81 -175.39 3.15 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.095 -1.003 . . . . 0.0 110.884 -173.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 4.3 mt-30 -49.2 160.78 0.49 Allowed Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 0.9 OUTLIER -80.53 148.56 76.89 Favored 'Cis proline' 0 C--N 1.301 -1.935 0 C-N-CA 123.195 -1.585 . . . . 0.0 113.901 -0.145 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -129.13 166.49 24.88 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.501 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 16.9 Cg_exo -67.26 169.6 49.78 Favored 'Cis proline' 0 N--CA 1.496 1.647 0 C-N-CA 124.354 -1.103 . . . . 0.0 112.157 -0.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.501 ' NE ' ' O ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -137.04 137.67 39.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.622 -0.674 . . . . 0.0 109.583 178.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 12.4 t70 -75.87 140.11 42.03 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.94 5.2 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 162.41 173.89 31.64 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.197 -1.954 . . . . 0.0 109.919 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -136.86 124.88 22.83 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.355 -1.085 . . . . 0.0 109.764 -178.412 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.812 HG11 HG11 ' A' ' 77' ' ' VAL . 8.1 t -82.94 157.7 3.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 t -144.32 169.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.0 t70 -125.73 141.42 52.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.284 -2.244 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.507 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 154.94 29.12 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' GLU . 65.9 m-85 -86.63 137.51 32.42 Favored 'General case' 0 C--N 1.285 -2.227 0 O-C-N 121.973 -0.455 . . . . 0.0 110.003 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' NH2' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -110.08 130.28 55.56 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 173.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.666 ' HG ' HG21 ' A' ' 42' ' ' VAL . 46.4 tp -111.02 138.01 47.96 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -146.69 171.26 15.41 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.478 ' H ' ' HG3' ' A' ' 44' ' ' GLN . . . 113.32 173.88 18.8 Favored Glycine 0 N--CA 1.51 3.608 0 C-N-CA 120.0 -1.095 . . . . 0.0 110.78 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -62.32 119.46 9.1 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 117.32 -22.81 10.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.666 HG21 ' HG ' ' A' ' 37' ' ' LEU . 21.3 t -115.86 -95.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.602 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -92.55 -6.39 49.72 Favored 'General case' 0 C--O 1.204 -1.327 0 O-C-N 121.22 -0.925 . . . . 0.0 109.171 178.081 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.478 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 20.0 mt-30 -116.8 148.65 41.01 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.627 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 5.2 mm-40 -58.94 140.08 86.84 Favored Pre-proline 0 C--N 1.271 -2.82 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.204 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 37.2 Cg_endo -68.64 116.02 2.29 Favored 'Cis proline' 0 N--CA 1.511 2.507 0 C-N-CA 123.299 -1.542 . . . . 0.0 110.456 -1.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.627 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 7.8 mtpp -73.4 147.1 44.6 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.657 -1.277 . . . . 0.0 111.305 -172.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.38 21.5 78.6 Favored Glycine 0 N--CA 1.497 2.753 0 O-C-N 121.515 -0.741 . . . . 0.0 112.914 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.553 HD12 ' HD2' ' A' ' 63' ' ' ARG . 17.2 mm -86.15 -47.27 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 74.8 m-85 -110.04 138.63 46.15 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.163 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -136.59 142.82 43.35 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 tt -111.45 162.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 19.4 t-20 -97.18 109.89 22.55 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -36.56 -41.89 0.32 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 122.804 0.442 . . . . 0.0 111.784 -177.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -92.86 -48.04 6.74 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.032 -1.043 . . . . 0.0 111.61 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.1 p -79.98 -27.97 39.58 Favored 'General case' 0 C--N 1.281 -2.401 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 2.85 90.35 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 12.3 m -63.06 122.95 17.33 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.67 -0.9 . . . . 0.0 109.278 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 24' ' ' VAL . 1.6 t -94.88 123.49 47.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -126.7 153.35 45.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.211 -0.931 . . . . 0.0 109.792 177.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.612 HG22 ' H ' ' A' ' 63' ' ' ARG . 2.5 p -104.68 146.12 12.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.0 p -96.25 -7.39 35.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.667 -0.646 . . . . 0.0 112.061 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.612 ' H ' HG22 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -154.5 172.06 18.4 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.462 -1.399 . . . . 0.0 110.685 -175.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.462 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 13.9 t -65.16 137.89 57.91 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.1 mt -98.85 149.76 22.58 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD1' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -126.3 142.36 51.56 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -91.93 9.24 33.84 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.81 -30.53 20.15 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.559 HG23 ' OD1' ' A' ' 66' ' ' ASP . 26.5 t -101.18 -47.08 11.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.22 139.96 47.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.293 -0.879 . . . . 0.0 109.121 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.49 -23.98 15.33 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.8 p -156.12 138.1 6.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.26 -0.9 . . . . 0.0 109.084 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 36.4 m-85 -99.0 128.09 45.06 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -90.79 97.56 11.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.71 170.34 9.65 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 86.2 m-85 -138.88 128.78 25.07 Favored 'General case' 0 C--N 1.268 -2.946 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.812 HG11 HG11 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -110.4 139.52 33.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 O-C-N 122.043 -0.411 . . . . 0.0 110.045 -176.063 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.697 ' HB3' HG23 ' A' ' 86' ' ' THR . 41.2 mt-10 -129.33 137.5 51.03 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.616 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -85.17 134.37 34.17 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 170.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 33' ' ' SER . 15.6 p -128.06 151.21 49.45 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -176.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.545 ' N ' HD21 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -116.15 172.2 7.33 Favored 'General case' 0 N--CA 1.508 2.446 0 CA-C-N 118.808 0.731 . . . . 0.0 109.815 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 81' ' ' ASP . 34.8 m -29.3 -40.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.446 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 28.7 t-20 -80.46 -8.6 59.61 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.72 -1.237 . . . . 0.0 110.195 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.61 13.14 78.9 Favored Glycine 0 C--N 1.287 -2.169 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' THR . 5.2 mttp -74.96 160.2 30.87 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 78' ' ' GLU . 16.6 m -96.01 116.53 29.08 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.926 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -96.02 -11.07 27.01 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.539 ' HG3' HD12 ' A' ' 2' ' ' ILE . 1.1 tp10 -154.54 154.56 33.3 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 78.41 -162.24 49.23 Favored Glycine 0 C--N 1.284 -2.316 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.35 105.58 0.24 Allowed 'Cis proline' 0 N--CA 1.495 1.586 0 C-N-CA 123.305 -1.54 . . . . 0.0 111.458 -0.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 77' ' ' VAL . 20.4 m -73.48 159.09 85.54 Favored Pre-proline 0 C--N 1.286 -2.18 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.37 152.01 3.65 Favored 'Trans proline' 0 C--N 1.283 -2.895 0 C-N-CA 121.359 1.373 . . . . 0.0 111.438 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.821 HD13 HG21 ' A' ' 4' ' ' VAL . 4.2 tp -139.02 128.51 24.41 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.42 ' N ' HD12 ' A' ' 93' ' ' LEU . 9.3 mt-10 -102.41 111.57 23.92 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.636 -0.665 . . . . 0.0 109.525 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 4.9 t -93.43 95.34 5.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 174.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.1 mt -79.96 130.66 35.66 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 t -92.06 122.14 43.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.68 HG21 ' HB3' ' A' ' 8' ' ' LEU . 12.5 pt -112.49 171.52 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.345 -0.847 . . . . 0.0 110.661 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 . . . . . 0 C--N 1.296 -1.724 0 O-C-N 121.151 -0.968 . . . . 0.0 108.545 -178.611 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.447 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.72 HG21 HG21 ' A' ' 91' ' ' VAL . 7.3 mt -66.66 122.19 17.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 121.436 -0.79 . . . . 0.0 109.317 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -104.85 133.77 48.12 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 174.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.482 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -148.84 167.59 3.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -176.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.482 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.9 OUTLIER -152.04 146.83 18.95 Favored Pre-proline 0 C--N 1.272 -2.776 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 176.516 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -48.69 131.77 24.79 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 121.257 1.305 . . . . 0.0 110.157 -178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.513 ' C ' HD12 ' A' ' 8' ' ' LEU . 29.0 mt -99.79 121.56 50.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.772 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.9 mp -105.98 107.71 18.85 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -176.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.532 HD11 HG21 ' A' ' 21' ' ' VAL . 17.1 mt -113.18 140.94 24.88 Favored Pre-proline 0 C--N 1.275 -2.651 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 -175.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HB2' ' NE2' ' A' ' 100' ' ' GLN . 60.4 Cg_endo -75.53 134.65 17.19 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.576 1.517 . . . . 0.0 111.272 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.5 ' O ' ' NE2' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -67.82 -172.68 0.29 Allowed 'General case' 0 N--CA 1.509 2.477 0 C-N-CA 119.132 -1.027 . . . . 0.0 108.914 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.523 ' OD1' ' C ' ' A' ' 12' ' ' ASN . 0.1 OUTLIER 55.83 -9.22 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.54 0 N-CA-C 114.169 1.174 . . . . 0.0 114.169 175.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.786 HE22 HG11 ' A' ' 61' ' ' VAL . 5.7 pt20 -55.66 132.96 50.27 Favored 'General case' 0 N--CA 1.505 2.324 0 N-CA-C 107.089 -1.448 . . . . 0.0 107.089 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.4 -179.65 3.98 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.834 -1.166 . . . . 0.0 111.167 -175.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.602 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -54.29 171.76 0.27 Allowed Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.649 179.167 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.602 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 1.7 Cg_endo -78.71 121.13 7.76 Favored 'Cis proline' 0 N--CA 1.493 1.47 0 C-N-CA 123.793 -1.336 . . . . 0.0 114.012 0.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.518 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 20.4 m-85 -110.62 170.49 5.24 Favored Pre-proline 0 C--N 1.297 -1.697 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 175.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 13.9 Cg_exo -69.7 167.63 70.15 Favored 'Cis proline' 0 N--CA 1.507 2.323 0 CA-C-N 120.172 1.097 . . . . 0.0 112.798 0.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.4 mtp180 -148.94 142.16 25.04 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD1' ' NZ ' ' A' ' 23' ' ' LYS . 9.3 t0 -67.77 136.03 53.57 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.532 HG21 HD11 ' A' ' 9' ' ' ILE . 36.0 m -126.84 6.06 3.67 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 176.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.11 -175.0 45.48 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.809 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.579 ' HZ2' ' CB ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -145.17 121.72 11.07 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.925 -1.338 . . . . 0.0 110.36 -178.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.492 HG23 HG22 ' A' ' 59' ' ' VAL . 33.2 t -89.88 131.45 37.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 170.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' O ' HG13 ' A' ' 3' ' ' VAL . 40.5 t -132.0 149.75 32.99 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 -177.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -105.7 138.79 41.31 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.936 -1.105 . . . . 0.0 108.704 177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -26.54 63.4 Favored 'General case' 0 C--N 1.281 -2.373 0 C-N-CA 120.489 -0.484 . . . . 0.0 111.299 -176.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.454 ' OD1' ' NH1' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -147.71 -13.77 0.38 Allowed 'General case' 0 C--N 1.307 -1.281 0 O-C-N 120.662 -1.274 . . . . 0.0 112.264 -172.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -55.27 145.76 44.91 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 120.665 -1.272 . . . . 0.0 111.307 -175.152 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_exo -35.38 133.68 0.22 Allowed 'Trans proline' 0 N--CA 1.488 1.175 0 C-N-CA 124.281 3.321 . . . . 0.0 112.732 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -55.14 -19.89 8.77 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.249 -0.907 . . . . 0.0 109.462 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.592 ' NH2' HG22 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -83.29 -16.27 46.89 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.322 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -63.0 136.06 57.63 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.111 -1.036 . . . . 0.0 110.857 -174.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 48.6 mttm -115.76 146.66 41.72 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.902 ' CE1' HG23 ' A' ' 79' ' ' THR . 89.6 m-85 -93.84 144.2 25.64 Favored 'General case' 0 C--N 1.282 -2.359 0 O-C-N 121.233 -0.917 . . . . 0.0 112.84 -172.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.34 150.99 22.43 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 172.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.61 ' HG ' HG21 ' A' ' 42' ' ' VAL . 21.0 tp -125.86 140.15 52.9 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 172.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -150.27 171.11 17.48 Favored 'General case' 0 C--N 1.268 -2.973 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA3' ' HA ' ' A' ' 75' ' ' LEU . . . 117.0 169.85 15.2 Favored Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.315 -1.422 . . . . 0.0 111.594 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 45' ' ' GLU . 6.5 mtpp -60.05 111.13 1.39 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 120.21 -18.21 9.63 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 107.8 -2.12 . . . . 0.0 107.8 -177.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.61 HG21 ' HG ' ' A' ' 37' ' ' LEU . 42.7 t -116.68 -97.33 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.625 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 3.4 t70 -93.52 -8.04 42.53 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.367 -0.833 . . . . 0.0 109.388 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.414 ' HB2' ' HA ' ' A' ' 40' ' ' LYS . 35.3 mt-30 -107.02 148.2 29.0 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 174.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.508 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . 1.5 mp0 -55.85 133.55 73.05 Favored Pre-proline 0 C--N 1.264 -3.152 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 24.8 Cg_endo -70.77 127.54 12.0 Favored 'Cis proline' 0 N--CA 1.498 1.742 0 C-N-CA 123.403 -1.499 . . . . 0.0 110.045 -0.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.625 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 15.3 mtpp -82.12 150.41 27.48 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 120.953 -1.092 . . . . 0.0 111.321 -173.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.403 ' O ' ' NH2' ' A' ' 63' ' ' ARG . . . 62.81 38.95 97.35 Favored Glycine 0 N--CA 1.493 2.454 0 O-C-N 121.894 -0.504 . . . . 0.0 111.899 173.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.496 ' HA ' ' NH1' ' A' ' 63' ' ' ARG . 5.9 mm -100.27 -48.13 11.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.532 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 88.8 m-85 -114.48 143.02 45.63 Favored 'General case' 0 C--N 1.279 -2.462 0 C-N-CA 120.309 -0.556 . . . . 0.0 109.688 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 133.78 26.19 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.446 ' CG2' ' HB2' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -95.85 150.78 4.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.554 ' OD1' HG23 ' A' ' 56' ' ' THR . 14.5 t-20 -79.82 105.71 11.31 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 35' ' ' PHE . 2.0 mt-10 -42.81 -36.81 1.59 Allowed 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.454 -175.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -92.76 -43.73 8.89 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.206 -0.933 . . . . 0.0 111.562 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.554 HG23 ' OD1' ' A' ' 53' ' ' ASN . 4.5 p -85.07 -25.35 27.64 Favored 'General case' 0 C--N 1.282 -2.361 0 O-C-N 121.027 -1.045 . . . . 0.0 108.7 -176.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.06 9.51 86.1 Favored Glycine 0 C--N 1.287 -2.154 0 N-CA-C 108.008 -2.037 . . . . 0.0 108.008 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.579 ' CB ' ' HZ2' ' A' ' 23' ' ' LYS . 70.0 m -65.8 120.55 13.23 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.395 -1.062 . . . . 0.0 109.472 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 24' ' ' VAL . 2.0 t -83.99 121.78 36.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 176.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.25 148.95 43.59 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.482 -0.761 . . . . 0.0 110.139 -177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.786 HG11 HE22 ' A' ' 13' ' ' GLN . 11.9 p -98.41 149.09 5.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 177.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.576 ' OG1' ' NH1' ' A' ' 63' ' ' ARG . 4.3 p -105.02 -15.52 15.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.481 -0.762 . . . . 0.0 112.002 -174.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.686 HH11 ' HG2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -157.41 -159.33 0.83 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.871 -1.143 . . . . 0.0 108.506 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.468 ' N ' ' HG3' ' A' ' 63' ' ' ARG . 4.8 t -80.8 179.42 7.82 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.168 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 13.4 mt -142.21 167.64 21.62 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -147.76 139.19 23.72 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 176.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.558 ' NH1' ' O ' ' A' ' 104' ' ' ARG . 16.7 ttm105 -76.06 -10.72 59.64 Favored 'General case' 0 C--N 1.282 -2.329 0 O-C-N 122.105 -0.372 . . . . 0.0 111.645 -174.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -90.12 -20.08 23.54 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.703 -1.248 . . . . 0.0 108.964 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 95.0 t -79.04 -53.26 13.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.297 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.452 ' O ' HG21 ' A' ' 97' ' ' VAL . 1.1 mt -148.36 134.21 11.77 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.034 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 176.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.423 ' O ' HG23 ' A' ' 97' ' ' VAL . . . -89.09 -28.29 20.19 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.43 115.08 3.64 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.506 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 62.3 m-85 -81.78 111.91 18.45 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 174.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.439 ' CD ' ' H ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -92.39 95.53 9.72 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 106.916 -1.512 . . . . 0.0 106.916 -178.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.484 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.4 OUTLIER -90.26 170.6 10.14 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 122.25 1.024 . . . . 0.0 108.424 -178.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 85.1 m-85 -134.44 131.96 38.75 Favored 'General case' 0 C--N 1.262 -3.211 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.514 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.26 150.14 14.6 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -176.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.458 ' HB3' ' CG2' ' A' ' 86' ' ' THR . 2.2 mt-10 -142.12 142.13 32.74 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.902 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -88.72 129.35 35.56 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 175.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.617 ' C ' HD21 ' A' ' 87' ' ' LEU . 11.3 p -123.19 150.37 43.44 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.642 ' N ' HD21 ' A' ' 87' ' ' LEU . 26.0 t70 -92.59 170.09 10.01 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 119.22 -0.992 . . . . 0.0 108.564 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.592 HG22 ' NH2' ' A' ' 32' ' ' ARG . 0.8 OUTLIER -58.54 -14.98 4.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 174.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.19 -5.08 53.41 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.98 -4.91 60.12 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.4 OUTLIER -75.19 150.6 38.64 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.332 -1.099 . . . . 0.0 108.615 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 88' ' ' GLU . 0.7 OUTLIER -90.55 119.64 30.98 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 176.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.958 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.41 -30.62 14.37 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.57 ' O ' HG22 ' A' ' 86' ' ' THR . 1.5 tp10 -135.28 170.13 16.4 Favored 'General case' 0 N--CA 1.504 2.247 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.99 -179.17 51.72 Favored Glycine 0 N--CA 1.48 1.633 0 N-CA-C 108.495 -1.842 . . . . 0.0 108.495 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.56 127.03 7.7 Favored 'Cis proline' 0 C--N 1.306 -1.707 0 C-N-CA 123.158 -1.601 . . . . 0.0 112.609 0.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.72 HG21 HG21 ' A' ' 2' ' ' ILE . 2.1 m -105.5 161.92 21.3 Favored Pre-proline 0 C--N 1.28 -2.424 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 174.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -94.44 151.17 1.96 Allowed 'Trans proline' 0 C--N 1.288 -2.637 0 C-N-CA 122.238 1.959 . . . . 0.0 112.527 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.46 HD13 HG23 ' A' ' 4' ' ' VAL . 10.2 tp -141.79 129.76 21.93 Favored 'General case' 0 C--N 1.279 -2.468 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 176.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -110.88 130.18 55.65 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 120.926 -1.109 . . . . 0.0 110.04 -177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.532 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 46.7 t -111.42 111.66 37.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 174.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.6 mp -95.54 142.44 13.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 O-C-N 121.236 -0.915 . . . . 0.0 109.073 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.498 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 1.5 t -91.91 96.08 5.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.611 HG21 ' HB3' ' A' ' 8' ' ' LEU . 5.7 pt -82.21 172.01 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 O-C-N 120.893 -1.13 . . . . 0.0 110.125 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.417 ' CG ' ' NH2' ' A' ' 67' ' ' ARG . 3.1 m-20 -97.59 174.97 6.38 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.512 ' NE2' ' HB2' ' A' ' 10' ' ' PRO . 0.2 OUTLIER -135.75 105.91 6.33 Favored 'General case' 0 C--N 1.275 -2.658 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 175.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.438 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 0.4 OUTLIER 53.63 47.08 24.65 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -173.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 50.27 77.89 0.11 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.79 -176.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.454 ' CG ' HD22 ' A' ' 12' ' ' ASN . 4.4 t30 -68.53 -51.8 38.97 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.558 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 1.2 mtp85 -157.69 82.88 2.92 Favored Pre-proline 0 C--N 1.281 -2.377 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo . . . . . 0 C--O 1.192 -1.798 0 C-N-CA 123.411 2.741 . . . . 0.0 113.239 -178.626 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.429 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.4 OUTLIER . . . . . 0 CA--C 1.517 -0.322 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.769 HG21 HG21 ' A' ' 91' ' ' VAL . 11.4 mt -68.77 113.86 4.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 O-C-N 121.162 -0.961 . . . . 0.0 110.363 -178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.21 111.2 29.15 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.805 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 174.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.625 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -127.84 164.21 29.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 -179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.479 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -142.63 152.29 59.39 Favored Pre-proline 0 C--N 1.275 -2.652 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 175.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.686 ' HB3' HD11 ' A' ' 96' ' ' ILE . 48.9 Cg_exo -49.51 136.67 33.05 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.681 1.588 . . . . 0.0 111.108 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.644 HD11 HG21 ' A' ' 59' ' ' VAL . 21.9 mt -102.55 110.08 28.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.723 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.4 mp -98.83 96.87 8.17 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 -177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.519 HD11 HG21 ' A' ' 21' ' ' VAL . 15.6 mt -103.75 133.56 20.2 Favored Pre-proline 0 C--N 1.275 -2.673 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -176.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.6 Cg_endo -70.65 120.65 7.26 Favored 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.318 1.345 . . . . 0.0 109.683 175.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 13' ' ' GLN . 0.0 OUTLIER -43.1 -71.9 0.07 Allowed 'General case' 0 N--CA 1.522 3.155 0 O-C-N 121.241 -0.912 . . . . 0.0 111.943 -174.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.513 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 34.2 p30 -62.47 42.92 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -173.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.519 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 22.3 mt-30 -77.61 140.77 39.7 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 169.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.513 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -117.77 177.35 4.8 Favored 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.416 -0.803 . . . . 0.0 110.038 -176.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.62 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -49.02 167.88 0.2 Allowed Pre-proline 0 C--N 1.292 -1.895 0 C-N-CA 123.461 0.704 . . . . 0.0 109.882 178.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 4.8 Cg_exo -77.16 121.64 8.01 Favored 'Cis proline' 0 C--N 1.311 -1.417 0 C-N-CA 123.714 -1.369 . . . . 0.0 113.158 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.404 ' CE2' HG13 ' A' ' 61' ' ' VAL . 26.4 m-85 -102.76 165.88 12.92 Favored Pre-proline 0 C--N 1.287 -2.152 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 175.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.22 154.48 85.23 Favored 'Cis proline' 0 N--CA 1.496 1.638 0 C-N-CA 124.184 -1.174 . . . . 0.0 110.516 -1.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.594 ' NH2' ' O ' ' A' ' 20' ' ' ASP . 0.3 OUTLIER -136.56 145.21 44.73 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.205 -0.935 . . . . 0.0 110.136 -178.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.594 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 5.5 t70 -65.87 142.3 57.96 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.519 HG21 HD11 ' A' ' 9' ' ' ILE . 32.8 m -137.44 1.77 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.412 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 170.2 176.35 39.7 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.8 ttpm? -146.27 125.74 13.21 Favored 'General case' 0 C--N 1.293 -1.863 0 O-C-N 120.669 -1.489 . . . . 0.0 110.185 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' A' ' 4' ' ' VAL . 18.4 t -87.6 143.48 11.21 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 172.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.6 t -136.73 160.98 36.98 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.587 ' HB3' ' HG3' ' A' ' 29' ' ' ARG . 10.2 t70 -120.54 137.73 54.23 Favored 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 118.945 -1.102 . . . . 0.0 108.081 175.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -51.06 -25.46 4.97 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.341 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.451 ' O ' ' HD3' ' A' ' 30' ' ' PRO . 39.5 t0 -148.94 89.95 1.72 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.341 -0.85 . . . . 0.0 108.766 177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.587 ' HG3' ' HB3' ' A' ' 26' ' ' ASP . 1.0 OUTLIER -77.78 111.44 17.83 Favored Pre-proline 0 N--CA 1.5 2.054 0 O-C-N 121.346 -0.846 . . . . 0.0 108.781 178.019 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.499 ' HG2' ' HG ' ' A' ' 87' ' ' LEU . 62.3 Cg_exo -44.16 146.26 1.9 Allowed 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.707 1.604 . . . . 0.0 111.621 178.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 30' ' ' PRO . 1.2 mp0 -25.0 -56.6 0.05 Allowed 'General case' 0 N--CA 1.504 2.26 0 C-N-CA 124.243 1.017 . . . . 0.0 112.505 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.447 ' HB2' HG12 ' A' ' 82' ' ' VAL . 5.3 mtm180 -118.32 32.74 5.98 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.212 -0.93 . . . . 0.0 108.993 -177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p -64.35 148.8 49.55 Favored 'General case' 0 C--N 1.286 -2.155 0 O-C-N 121.1 -1.0 . . . . 0.0 110.337 -176.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 54' ' ' GLU . 4.4 mmtp -113.86 169.39 9.03 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 174.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.509 ' CB ' HD13 ' A' ' 52' ' ' ILE . 10.3 m-85 -115.42 126.3 54.2 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 174.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HG3' HG21 ' A' ' 80' ' ' THR . 13.8 mmt-85 -98.68 119.11 36.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.725 ' HG ' HG21 ' A' ' 42' ' ' VAL . 42.4 tp -103.73 139.71 38.6 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 176.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.466 HG22 ' CG ' ' A' ' 43' ' ' ASP . 0.2 OUTLIER -152.89 170.29 20.72 Favored 'General case' 0 C--N 1.279 -2.47 0 O-C-N 121.262 -0.899 . . . . 0.0 108.613 -176.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.438 ' N ' ' OD1' ' A' ' 43' ' ' ASP . . . 116.88 169.99 15.3 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.43 ' NZ ' ' HG3' ' A' ' 45' ' ' GLU . 11.1 mtpp -54.82 115.31 2.11 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 120.8 -21.64 8.36 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.725 HG21 ' HG ' ' A' ' 37' ' ' LEU . 34.9 t -119.78 -88.07 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.39 -1.065 . . . . 0.0 109.122 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.476 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 15.8 p-10 -93.14 -14.17 27.54 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.451 HE21 ' CG ' ' A' ' 43' ' ' ASP . 11.1 mt-30 -113.9 160.76 18.43 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.43 ' HG3' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -61.69 133.84 93.67 Favored Pre-proline 0 C--N 1.286 -2.184 0 O-C-N 122.152 -0.343 . . . . 0.0 110.722 -174.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HB2' HD11 ' A' ' 49' ' ' ILE . 3.2 Cg_exo -76.13 123.76 9.68 Favored 'Cis proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.173 -1.595 . . . . 0.0 109.296 -1.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 27.2 mttp -71.01 154.0 42.16 Favored 'General case' 0 C--N 1.282 -2.346 0 O-C-N 120.923 -1.11 . . . . 0.0 110.894 -174.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 59.19 21.31 53.11 Favored Glycine 0 N--CA 1.489 2.215 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.201 172.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.739 HD12 ' NE ' ' A' ' 63' ' ' ARG . 26.6 mm -73.55 -43.59 54.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 174.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.542 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 87.9 m-85 -116.7 141.38 48.28 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.428 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -139.83 129.16 24.0 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.509 HD13 ' CB ' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -96.38 149.84 4.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 O-C-N 121.643 -0.661 . . . . 0.0 110.05 -174.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.451 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 14.1 t-20 -79.76 112.6 17.18 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' OE2' ' NH1' ' A' ' 36' ' ' ARG . 1.4 mt-10 -53.28 -31.11 42.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.847 -0.533 . . . . 0.0 111.541 -176.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.402 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -97.22 -23.39 16.19 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.279 -0.888 . . . . 0.0 112.601 -174.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 19.5 p -112.29 -27.5 8.29 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 84.82 5.43 86.38 Favored Glycine 0 C--N 1.283 -2.389 0 N-CA-C 108.345 -1.902 . . . . 0.0 108.345 -177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 t -60.67 125.7 24.69 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.644 HG21 HD11 ' A' ' 7' ' ' ILE . 2.6 t -86.5 118.76 33.39 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 176.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -110.84 140.65 45.11 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.411 -178.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.492 ' CG2' HD21 ' A' ' 65' ' ' LEU . 7.7 p -99.77 145.17 11.1 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 70.4 p -97.51 -14.99 20.77 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.511 -0.743 . . . . 0.0 111.46 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.739 ' NE ' HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -153.03 170.6 20.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.847 -1.158 . . . . 0.0 110.938 -177.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 t -66.32 140.25 58.09 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 175.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.492 HD21 ' CG2' ' A' ' 61' ' ' VAL . 49.6 mt -92.44 170.04 10.08 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.63 -1.294 . . . . 0.0 111.106 -173.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.454 ' HB2' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -127.18 102.55 6.99 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 67' ' ' ARG . 4.3 ttm105 -66.35 -18.74 65.54 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' A' ' 68' ' ' GLU . 1.2 mp0 -76.94 -26.18 53.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.858 -1.151 . . . . 0.0 108.378 -178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.454 HG23 ' HB2' ' A' ' 66' ' ' ASP . 6.8 t -97.18 -52.99 8.52 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.577 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.408 HG21 ' CG ' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -125.97 112.15 29.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.45 -33.66 54.7 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.4 p -149.42 131.89 6.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.532 ' OH ' ' NH2' ' A' ' 63' ' ' ARG . 61.0 m-85 -87.8 120.27 28.95 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 32.0 tp60 -88.48 81.23 7.21 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.19 170.46 16.09 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 122.128 0.966 . . . . 0.0 109.015 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.9 m-85 -137.13 130.05 30.6 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 175.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.539 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -113.56 160.52 13.01 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 CA-C-O 121.277 0.56 . . . . 0.0 110.143 -175.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.761 ' HB3' HG23 ' A' ' 86' ' ' THR . 47.8 mt-10 -147.4 143.01 27.65 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.646 ' N ' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -88.72 123.09 32.82 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 104.447 -2.427 . . . . 0.0 104.447 173.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.555 HG21 ' HG3' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -109.0 153.38 23.68 Favored 'General case' 0 C--N 1.268 -2.968 0 CA-C-O 121.582 0.706 . . . . 0.0 111.677 -172.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.501 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 3.0 t70 -96.48 170.1 9.45 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 174.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.501 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -52.79 -27.16 11.96 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.573 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 176.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -79.69 2.05 24.14 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.484 -0.76 . . . . 0.0 109.511 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.82 19.41 75.1 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -91.3 154.92 18.91 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.761 HG23 ' HB3' ' A' ' 78' ' ' GLU . 8.2 m -84.13 124.35 31.05 Favored 'General case' 0 C--N 1.277 -2.558 0 CA-C-O 121.854 0.835 . . . . 0.0 111.012 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -86.11 -45.63 11.2 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 175.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -142.41 151.53 41.91 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.51 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 105.39 177.34 24.18 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 107.929 -2.068 . . . . 0.0 107.929 -176.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -63.32 109.97 0.48 Allowed 'Cis proline' 0 N--CA 1.495 1.605 0 CA-C-N 118.949 1.374 . . . . 0.0 113.065 0.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.769 HG21 HG21 ' A' ' 2' ' ' ILE . 2.5 m -91.47 161.44 34.46 Favored Pre-proline 0 C--N 1.281 -2.374 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 175.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -90.99 155.37 3.92 Favored 'Trans proline' 0 C--N 1.281 -3.0 0 C-N-CA 121.762 1.641 . . . . 0.0 111.726 177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.63 HD23 HD11 ' A' ' 37' ' ' LEU . 8.8 tp -142.85 125.64 16.03 Favored 'General case' 0 C--N 1.276 -2.599 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -109.38 112.09 24.01 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 121.772 -0.58 . . . . 0.0 110.033 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.542 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 56.7 t -102.39 97.74 5.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.792 ' H ' HD12 ' A' ' 96' ' ' ILE . 2.8 mp -81.13 132.94 30.39 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 O-C-N 121.653 -0.654 . . . . 0.0 109.456 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 31.8 t -88.22 92.67 3.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.649 HG21 ' HB3' ' A' ' 8' ' ' LEU . 4.9 pt -80.35 171.04 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 O-C-N 121.248 -0.908 . . . . 0.0 109.112 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -104.79 168.09 9.29 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.478 ' HB3' ' HB3' ' A' ' 10' ' ' PRO . 15.9 pt20 -148.4 154.16 39.53 Favored 'General case' 0 C--N 1.273 -2.751 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -74.82 63.47 1.18 Allowed 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.554 ' C ' ' H ' ' A' ' 104' ' ' ARG . 57.5 t0 -60.12 165.55 3.34 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 174.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.446 ' O ' ' C ' ' A' ' 104' ' ' ARG . 1.1 m-80 -68.84 31.55 0.03 OUTLIER 'General case' 0 C--N 1.244 -3.99 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.554 ' H ' ' C ' ' A' ' 102' ' ' ASP . 2.9 mtm105 29.58 58.02 0.77 Allowed Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 122.956 0.502 . . . . 0.0 110.7 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 104' ' ' ARG . 6.2 Cg_exo . . . . . 0 N--CA 1.492 1.428 0 C-N-CA 122.993 2.462 . . . . 0.0 111.397 -178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.484 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.192 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.721 HG21 HG21 ' A' ' 91' ' ' VAL . 4.7 mt -62.57 142.15 17.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 121.449 0.643 . . . . 0.0 109.771 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.38 106.15 15.87 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.723 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -127.8 158.7 39.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.434 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -124.42 151.05 66.16 Favored Pre-proline 0 C--N 1.281 -2.409 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -57.18 141.72 94.43 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 121.475 1.45 . . . . 0.0 109.155 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.422 HD13 ' HA3' ' A' ' 22' ' ' GLY . 24.5 mt -107.96 113.04 42.74 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 O-C-N 121.412 -0.805 . . . . 0.0 109.865 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.886 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.94 94.2 9.54 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.507 HD11 HG21 ' A' ' 21' ' ' VAL . 23.4 mt -101.25 127.42 31.83 Favored Pre-proline 0 C--N 1.29 -1.988 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.8 Cg_endo -70.55 128.11 14.86 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 N-CA-C 109.493 -1.003 . . . . 0.0 109.493 174.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.551 ' CD ' ' HE ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -59.75 -178.78 0.08 Allowed 'General case' 0 C--N 1.288 -2.107 0 C-N-CA 119.501 -0.879 . . . . 0.0 109.995 -176.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 65.12 14.86 9.66 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.65 -0.657 . . . . 0.0 111.724 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.441 ' O ' ' OG1' ' A' ' 64' ' ' THR . 26.8 mt-30 -67.05 137.06 56.15 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 104.963 -2.236 . . . . 0.0 104.963 173.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.54 ' N ' ' CD ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -114.4 -178.58 3.4 Favored 'General case' 0 C--N 1.281 -2.376 0 O-C-N 120.881 -1.137 . . . . 0.0 110.676 -175.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.628 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 13.8 mp0 -59.3 169.0 1.39 Allowed Pre-proline 0 C--N 1.294 -1.828 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.628 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 30.5 Cg_endo -70.91 114.84 2.48 Favored 'Cis proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.621 -1.408 . . . . 0.0 114.475 0.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.439 ' N ' ' HA ' ' A' ' 15' ' ' GLN . 13.7 m-85 -102.92 164.33 15.77 Favored Pre-proline 0 C--N 1.303 -1.455 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 175.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.431 ' CB ' ' HD3' ' A' ' 51' ' ' ARG . 30.9 Cg_endo -68.3 156.03 88.49 Favored 'Cis proline' 0 N--CA 1.495 1.581 0 C-N-CA 123.864 -1.307 . . . . 0.0 111.092 -0.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 60' ' ' SER . 1.4 tmt_? -134.26 144.7 48.53 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -70.57 137.73 50.3 Favored 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 9' ' ' ILE . 30.6 m -133.93 2.7 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.516 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.422 ' HA3' HD13 ' A' ' 7' ' ' ILE . . . 178.57 179.2 48.36 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 17.3 mttp -146.52 133.69 20.49 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.007 -1.29 . . . . 0.0 110.762 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.595 HG11 HG11 ' A' ' 77' ' ' VAL . 20.0 t -108.23 131.0 59.84 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 171.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 t -133.96 170.05 20.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.751 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 1' ' ' SER . 0.9 OUTLIER -119.68 154.62 33.79 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.8 -1.188 . . . . 0.0 109.184 177.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.453 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 8.2 m -58.33 -48.21 81.28 Favored 'General case' 0 C--N 1.267 -3.011 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.026 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.1 t0 -126.0 56.78 1.4 Allowed 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.265 -0.897 . . . . 0.0 110.591 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.624 ' H ' ' NE ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -44.89 113.77 1.88 Allowed Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.584 -0.698 . . . . 0.0 110.472 -177.541 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.51 ' O ' ' C ' ' A' ' 31' ' ' GLU . 79.0 Cg_exo -43.56 144.82 1.94 Allowed 'Trans proline' 0 N--CA 1.492 1.399 0 C-N-CA 122.261 1.974 . . . . 0.0 109.821 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.51 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -24.35 -70.84 0.03 OUTLIER 'General case' 0 N--CA 1.516 2.87 0 CA-C-N 118.241 0.473 . . . . 0.0 110.825 -176.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.559 ' NH2' ' O ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -114.58 63.88 0.67 Allowed 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.938 177.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.559 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -76.86 157.87 31.16 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -121.4 138.56 54.22 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.786 ' CE1' HG23 ' A' ' 79' ' ' THR . 36.7 m-85 -93.19 124.34 37.09 Favored 'General case' 0 C--N 1.287 -2.139 0 O-C-N 121.03 -1.044 . . . . 0.0 109.131 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.572 ' NH1' HG21 ' A' ' 80' ' ' THR . 25.4 mtm-85 -99.29 148.07 24.53 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 175.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.691 ' O ' HG11 ' A' ' 42' ' ' VAL . 18.1 tp -131.38 128.82 40.39 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -140.47 170.36 15.94 Favored 'General case' 0 C--N 1.269 -2.921 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.488 ' C ' ' HB2' ' A' ' 44' ' ' GLN . . . 120.87 166.18 12.95 Favored Glycine 0 C--N 1.282 -2.465 0 O-C-N 120.815 -1.178 . . . . 0.0 110.259 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.33 111.48 0.54 Allowed 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 124.08 -19.14 7.35 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 -177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.691 HG11 ' O ' ' A' ' 37' ' ' LEU . 23.0 t -120.59 -92.29 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.289 -1.124 . . . . 0.0 108.976 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.489 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 2.0 t0 -94.13 -10.78 32.15 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.516 ' N ' ' OE1' ' A' ' 44' ' ' GLN . 17.4 mp0 -109.33 159.19 17.18 Favored 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 177.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.53 ' H ' ' CD ' ' A' ' 45' ' ' GLU . 2.0 pm0 -66.59 132.67 94.16 Favored Pre-proline 0 C--N 1.263 -3.172 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.091 -177.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.441 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -74.12 120.12 6.18 Favored 'Cis proline' 0 N--CA 1.498 1.74 0 C-N-CA 123.39 -1.504 . . . . 0.0 110.759 -0.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.489 ' HE2' ' O ' ' A' ' 43' ' ' ASP . 8.7 mttm -70.86 154.37 41.89 Favored 'General case' 0 C--N 1.289 -2.057 0 O-C-N 121.106 -0.996 . . . . 0.0 111.023 -175.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.78 30.13 74.15 Favored Glycine 0 N--CA 1.495 2.633 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.467 171.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.463 ' N ' ' O ' ' A' ' 41' ' ' GLY . 9.4 mm -90.6 -45.95 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 CA-C-N 119.007 1.404 . . . . 0.0 107.647 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.531 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 69.4 m-85 -114.34 151.91 32.26 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.271 0.558 . . . . 0.0 110.198 -178.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.431 ' HD3' ' CB ' ' A' ' 18' ' ' PRO . 2.7 ptm85 -144.29 137.13 27.02 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 35' ' ' PHE . 13.6 tt -105.44 159.73 5.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.407 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 17.6 t-20 -90.45 132.72 35.49 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 177.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HA ' ' H ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -66.15 -31.21 71.92 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.832 -176.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -97.5 -51.88 3.98 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.676 0.75 . . . . 0.0 110.541 -174.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.416 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 7.8 p -80.43 -21.39 42.21 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -176.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 68.75 14.06 66.99 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -177.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.496 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 37.0 m -64.07 120.91 12.95 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.173 -1.192 . . . . 0.0 108.849 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.502 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.3 t -83.95 122.01 37.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 176.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -122.03 154.91 36.65 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.645 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.507 ' CG2' HD21 ' A' ' 65' ' ' LEU . 7.4 p -102.05 149.8 6.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 N-CA-C 107.003 -1.481 . . . . 0.0 107.003 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 63.5 p -98.29 -16.51 19.35 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.613 -0.68 . . . . 0.0 110.226 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -144.63 178.49 7.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.416 -0.802 . . . . 0.0 109.973 -174.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 5.7 t -76.62 139.41 40.61 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 174.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.507 HD21 ' CG2' ' A' ' 61' ' ' VAL . 53.0 mt -98.96 156.23 17.01 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.393 -0.817 . . . . 0.0 109.516 -178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -135.67 128.47 31.09 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 177.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.551 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 12.9 mtm180 -64.64 -5.84 6.49 Favored 'General case' 0 N--CA 1.504 2.231 0 C-N-CA 119.06 -1.056 . . . . 0.0 109.19 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.57 -21.61 52.24 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.105 -0.997 . . . . 0.0 108.516 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.3 t -96.25 -55.79 5.78 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.403 HD12 ' CE1' ' A' ' 73' ' ' TYR . 1.2 mt -141.84 136.63 30.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 O-C-N 121.416 -0.803 . . . . 0.0 108.935 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.28 -26.25 25.06 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.3 p -156.35 137.8 5.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.463 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 71.8 m-85 -99.25 116.86 32.41 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.511 HE22 ' CG ' ' A' ' 94' ' ' GLU . 15.1 tp60 -85.86 79.6 9.2 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.65 170.78 16.04 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 34.4 m-85 -137.35 141.15 41.81 Favored 'General case' 0 C--N 1.256 -3.457 0 N-CA-C 105.931 -1.878 . . . . 0.0 105.931 177.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.595 HG11 HG11 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -115.37 148.51 18.05 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.505 0 O-C-N 121.687 -0.633 . . . . 0.0 109.399 -176.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.499 ' HB3' ' CG2' ' A' ' 86' ' ' THR . 0.5 OUTLIER -134.39 135.27 42.51 Favored 'General case' 0 C--N 1.28 -2.455 0 O-C-N 121.195 -0.94 . . . . 0.0 108.859 176.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.786 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -87.51 132.14 34.13 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.607 -1.997 . . . . 0.0 105.607 174.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.584 ' C ' HD21 ' A' ' 87' ' ' LEU . 17.7 p -127.0 164.26 21.89 Favored 'General case' 0 C--N 1.279 -2.494 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.986 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.497 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 2.1 t70 -97.54 170.22 9.19 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.497 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 0.9 OUTLIER -46.43 -33.67 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.409 0 CA-C-O 121.457 0.646 . . . . 0.0 109.874 178.848 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.53 2.63 21.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.558 -0.714 . . . . 0.0 109.742 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.61 15.23 81.39 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.324 -1.91 . . . . 0.0 108.324 -178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.552 ' O ' ' HA ' ' A' ' 80' ' ' THR . 8.3 mtpp -74.49 150.11 40.0 Favored 'General case' 0 CA--C 1.474 -1.943 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.589 ' C ' HD13 ' A' ' 87' ' ' LEU . 1.2 m -99.6 118.01 35.22 Favored 'General case' 0 C--N 1.272 -2.768 0 C-N-CA 120.409 -0.516 . . . . 0.0 110.132 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.869 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.68 -24.11 17.3 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 179.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.38 158.62 44.21 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.465 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 75.09 -175.19 51.06 Favored Glycine 0 C--N 1.293 -1.846 0 N-CA-C 108.613 -1.795 . . . . 0.0 108.613 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -57.94 108.74 0.2 OUTLIER 'Cis proline' 0 N--CA 1.498 1.78 0 C-N-CA 123.707 -1.372 . . . . 0.0 113.795 0.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.721 HG21 HG21 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -84.85 167.48 26.23 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 172.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -94.47 156.43 2.0 Favored 'Trans proline' 0 C--N 1.286 -2.763 0 C-N-CA 121.959 1.773 . . . . 0.0 112.791 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.723 HD13 ' CG2' ' A' ' 4' ' ' VAL . 4.5 tp -142.89 131.28 22.22 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.511 ' CG ' HE22 ' A' ' 74' ' ' GLN . 13.8 mt-10 -106.11 109.76 21.8 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.508 -0.745 . . . . 0.0 109.432 -177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.531 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 89.8 t -98.06 96.67 5.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 176.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.58 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.7 mp -79.79 128.29 38.68 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.26 105.09 15.6 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 1.9 pt -93.3 171.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.503 ' OD2' ' NH1' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -95.51 158.63 15.37 Favored 'General case' 0 C--N 1.282 -2.337 0 O-C-N 120.984 -1.072 . . . . 0.0 108.467 -177.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' OE1' ' NH1' ' A' ' 14' ' ' ARG . 13.8 mt-30 -74.89 68.63 1.79 Allowed 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 174.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 4.9 p30 -72.0 -71.72 0.26 Allowed 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -96.65 -46.29 6.36 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 175.144 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.11 23.95 13.34 Favored 'General case' 0 N--CA 1.508 2.451 0 CA-C-O 121.26 0.552 . . . . 0.0 110.046 178.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.528 ' H ' ' CG ' ' A' ' 102' ' ' ASP . 13.6 mmm180 39.43 71.29 1.19 Allowed Pre-proline 0 N--CA 1.497 1.92 0 CA-C-O 121.374 0.607 . . . . 0.0 110.993 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 0 C--O 1.187 -2.042 0 C-N-CA 123.474 2.783 . . . . 0.0 110.68 178.077 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.459 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.505 -0.774 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 1.023 HG21 HG21 ' A' ' 91' ' ' VAL . 11.2 mt -65.24 131.21 31.04 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 C-N-CA 119.221 -0.991 . . . . 0.0 109.214 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.95 128.64 73.17 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.909 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.482 HG23 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -141.45 159.1 22.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -139.59 144.26 38.71 Favored Pre-proline 0 C--N 1.281 -2.37 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.435 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 36.8 Cg_exo -51.08 135.2 44.44 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.446 1.431 . . . . 0.0 109.88 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.421 HD13 ' HA3' ' A' ' 22' ' ' GLY . 22.7 mt -103.67 115.56 45.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.858 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -90.42 105.59 17.92 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.656 HD11 HG21 ' A' ' 21' ' ' VAL . 34.1 mt -114.02 123.28 33.0 Favored Pre-proline 0 C--N 1.287 -2.115 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.538 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 27.2 Cg_endo -66.83 142.8 64.44 Favored 'Trans proline' 0 C--N 1.314 -1.274 0 C-N-CA 120.748 0.965 . . . . 0.0 112.434 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 0.6 OUTLIER -67.16 -178.55 0.82 Allowed 'General case' 0 C--N 1.283 -2.325 0 CA-C-O 122.278 1.037 . . . . 0.0 112.307 -176.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LEU . 5.9 m-20 47.25 18.01 0.08 Allowed 'General case' 0 N--CA 1.514 2.762 0 C-N-CA 124.177 0.991 . . . . 0.0 113.341 174.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -76.64 122.84 25.23 Favored 'General case' 0 C--N 1.283 -2.298 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 174.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.28 -163.48 1.02 Allowed 'General case' 0 C--N 1.293 -1.858 0 O-C-N 121.354 -0.841 . . . . 0.0 110.428 -175.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.568 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -46.66 165.57 0.19 Allowed Pre-proline 0 N--CA 1.5 2.062 0 CA-C-O 121.377 0.608 . . . . 0.0 111.409 -177.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.568 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 55.3 Cg_endo -86.92 120.9 5.78 Favored 'Cis proline' 0 C--N 1.32 -0.963 0 C-N-CA 123.442 -1.483 . . . . 0.0 113.613 0.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 19' ' ' ARG . 27.4 m-85 -115.27 163.61 19.64 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 19.7 Cg_exo -67.07 162.63 74.65 Favored 'Cis proline' 0 N--CA 1.504 2.136 0 C-N-CA 124.553 -1.019 . . . . 0.0 113.077 -0.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -153.1 149.23 27.87 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.772 -0.58 . . . . 0.0 109.517 -178.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.476 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -71.39 139.68 49.86 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 176.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.656 HG21 HD11 ' A' ' 9' ' ' ILE . 33.5 m -132.75 -3.48 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA3' HD13 ' A' ' 7' ' ' ILE . . . -178.98 170.72 42.63 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.997 -1.641 . . . . 0.0 108.997 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.3 tttm -131.24 121.11 24.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.293 -1.122 . . . . 0.0 109.906 -178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.577 HG23 ' CG2' ' A' ' 59' ' ' VAL . 41.9 t -91.85 147.63 5.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 171.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.456 HG12 ' N ' ' A' ' 26' ' ' ASP . 17.6 t -142.41 170.07 12.24 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.542 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.602 ' O ' ' NE ' ' A' ' 29' ' ' ARG . 34.5 t0 -143.27 78.18 1.59 Allowed 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 104.097 -2.557 . . . . 0.0 104.097 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -33.31 -46.6 0.18 Allowed 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.035 -172.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.01 66.32 4.97 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.731 0.777 . . . . 0.0 110.152 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.602 ' NE ' ' O ' ' A' ' 26' ' ' ASP . 1.3 mtm180 -77.69 133.15 66.99 Favored Pre-proline 0 C--N 1.291 -1.948 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 31' ' ' GLU . 19.1 Cg_exo -59.39 170.46 3.17 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 N-CA-C 108.917 -1.224 . . . . 0.0 108.917 171.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -23.77 -90.54 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.886 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -175.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.566 ' CZ ' HG11 ' A' ' 82' ' ' VAL . 15.1 mtm180 -109.86 27.56 9.46 Favored 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.712 -1.242 . . . . 0.0 110.016 -175.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -54.45 146.38 16.15 Favored 'General case' 0 C--N 1.283 -2.303 0 O-C-N 121.683 -0.636 . . . . 0.0 111.128 -178.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -127.15 167.37 16.12 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 54' ' ' GLU . 87.9 m-85 -98.41 142.63 29.8 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 120.944 -1.098 . . . . 0.0 112.123 -175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.599 ' NH2' ' O ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER -110.05 126.56 54.12 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 172.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.633 ' HG ' HG21 ' A' ' 42' ' ' VAL . 37.5 tp -107.83 142.1 38.41 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.9 p -151.73 171.58 17.46 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 75' ' ' LEU . . . 121.3 172.73 14.47 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 120.843 -1.161 . . . . 0.0 111.418 178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.438 ' HA ' ' HB2' ' A' ' 44' ' ' GLN . 24.9 mtpp -61.19 111.69 1.82 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 177.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.462 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 121.49 -22.05 7.92 Favored Glycine 0 C--N 1.279 -2.632 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 -175.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.633 HG21 ' HG ' ' A' ' 37' ' ' LEU . 20.1 t -118.91 -85.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.417 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 6.5 p-10 -101.14 -14.58 17.69 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.458 ' CD ' ' HA2' ' A' ' 39' ' ' GLY . 27.7 mt-30 -104.16 152.75 21.76 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 173.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.542 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 7.2 mm-40 -66.77 139.5 95.83 Favored Pre-proline 0 C--N 1.285 -2.206 0 O-C-N 121.85 -0.531 . . . . 0.0 110.373 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 37.7 Cg_endo -68.94 119.62 3.77 Favored 'Cis proline' 0 N--CA 1.509 2.41 0 C-N-CA 123.592 -1.42 . . . . 0.0 111.327 -1.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.542 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 11.2 mtpp -76.96 162.92 27.19 Favored 'General case' 0 C--N 1.288 -2.104 0 O-C-N 120.768 -1.207 . . . . 0.0 110.696 -175.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 60.04 19.11 50.19 Favored Glycine 0 N--CA 1.496 2.674 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.939 173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.725 HD12 ' HD2' ' A' ' 63' ' ' ARG . 11.7 mm -83.09 -48.38 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 CA-C-N 119.487 1.643 . . . . 0.0 107.591 176.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.74 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 52.1 m-85 -111.88 145.74 38.97 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 121.275 0.56 . . . . 0.0 110.646 -178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -148.35 135.49 20.26 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 174.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 37' ' ' LEU . 1.9 tt -102.96 157.01 4.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -176.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.455 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 11.6 t-20 -80.91 115.13 20.23 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 175.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 35' ' ' PHE . 1.7 mp0 -50.5 -40.84 52.46 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 122.061 -0.399 . . . . 0.0 111.496 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -90.43 -44.58 9.53 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.604 -1.31 . . . . 0.0 111.512 -174.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.455 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 8.8 p -80.78 -28.48 36.36 Favored 'General case' 0 C--N 1.288 -2.089 0 O-C-N 121.226 -0.921 . . . . 0.0 109.417 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.6 10.49 84.29 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.6 m -67.38 123.44 20.39 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.388 -1.066 . . . . 0.0 108.224 178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.577 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.1 t -86.58 124.48 40.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -121.09 150.9 40.51 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.622 HG21 HD21 ' A' ' 65' ' ' LEU . 9.8 p -110.49 148.27 14.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 39.9 p -97.29 -28.12 14.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.495 -0.753 . . . . 0.0 110.926 -175.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.725 ' HD2' HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -135.26 167.54 20.83 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.094 -1.004 . . . . 0.0 110.232 -177.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.502 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 13.3 t -57.37 156.5 7.67 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.622 HD21 HG21 ' A' ' 61' ' ' VAL . 21.6 mt -110.88 140.94 44.91 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 120.951 -1.093 . . . . 0.0 108.683 178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.448 ' C ' ' H ' ' A' ' 68' ' ' GLU . 2.7 p-10 -131.4 122.97 27.22 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' NH1' ' O ' ' A' ' 97' ' ' VAL . 1.4 mtp85 -75.12 10.05 1.7 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' H ' ' C ' ' A' ' 66' ' ' ASP . 52.1 mt-10 -74.11 -24.19 59.42 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.1 t -126.18 -82.55 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -175.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -91.16 127.67 43.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 O-C-N 121.12 -0.988 . . . . 0.0 108.987 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.59 -25.74 19.05 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.5 p -152.84 121.03 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.353 -0.842 . . . . 0.0 108.9 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.443 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 79.7 m-85 -80.11 120.66 24.55 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.463 HE22 ' HG3' ' A' ' 94' ' ' GLU . 26.2 tp60 -86.79 94.19 9.47 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.478 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.2 OUTLIER -92.57 170.65 9.57 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.913 0.863 . . . . 0.0 109.198 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.0 m-85 -140.78 131.24 25.3 Favored 'General case' 0 C--N 1.27 -2.853 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.746 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.37 146.41 18.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 O-C-N 122.055 -0.403 . . . . 0.0 110.517 -174.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.623 ' HB3' HG23 ' A' ' 86' ' ' THR . 45.3 mt-10 -132.14 141.65 49.21 Favored 'General case' 0 C--N 1.287 -2.13 0 O-C-N 120.939 -1.101 . . . . 0.0 109.143 176.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.609 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -86.38 135.43 33.51 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 105.029 -2.212 . . . . 0.0 105.029 171.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.665 ' C ' HD21 ' A' ' 87' ' ' LEU . 1.1 p -127.14 152.36 47.44 Favored 'General case' 0 C--N 1.286 -2.179 0 O-C-N 121.481 -0.762 . . . . 0.0 111.251 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.581 ' N ' HD21 ' A' ' 87' ' ' LEU . 46.1 p-10 -89.28 171.99 9.37 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 122.104 0.954 . . . . 0.0 109.614 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.566 HG11 ' CZ ' ' A' ' 32' ' ' ARG . 4.1 m -54.02 -9.59 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.264 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.101 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -100.57 -34.96 9.69 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.122 . . . . 0.0 108.423 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.599 ' O ' ' NH2' ' A' ' 36' ' ' ARG . . . 118.57 23.44 3.41 Favored Glycine 0 C--N 1.287 -2.156 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -95.6 141.09 29.52 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.623 HG23 ' HB3' ' A' ' 78' ' ' GLU . 89.0 m -79.96 119.56 22.98 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.442 -0.786 . . . . 0.0 110.611 -177.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.905 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.1 OUTLIER -89.02 -25.72 21.84 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.96 -1.087 . . . . 0.0 108.393 176.287 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.409 ' OE2' ' N ' ' A' ' 2' ' ' ILE . 26.5 tt0 -151.88 160.02 43.66 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 175.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.522 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 94.64 -173.85 32.72 Favored Glycine 0 C--N 1.289 -2.046 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 -177.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -67.82 105.91 0.43 Allowed 'Cis proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.162 -1.599 . . . . 0.0 111.595 -0.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.023 HG21 HG21 ' A' ' 2' ' ' ILE . 5.0 m -73.93 164.47 60.92 Favored Pre-proline 0 C--N 1.286 -2.161 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 177.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -92.44 153.71 3.01 Favored 'Trans proline' 0 C--N 1.286 -2.736 0 C-N-CA 121.315 1.343 . . . . 0.0 112.064 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.482 HD13 HG23 ' A' ' 4' ' ' VAL . 11.5 tp -142.12 128.64 20.19 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.463 ' HG3' HE22 ' A' ' 74' ' ' GLN . 17.2 mt-10 -108.69 108.45 19.3 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.649 -0.657 . . . . 0.0 109.335 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.74 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 84.7 t -96.72 99.56 9.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 176.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 2.4 mp -80.95 132.02 32.55 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.572 ' O ' ' NH1' ' A' ' 67' ' ' ARG . 19.8 t -89.09 111.47 22.83 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.576 HG21 ' HB3' ' A' ' 8' ' ' LEU . 13.6 pt -97.08 170.96 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 O-C-N 121.452 -0.78 . . . . 0.0 109.394 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 101' ' ' ASN . 7.0 m-20 -84.21 -167.46 1.77 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.148 -0.97 . . . . 0.0 108.459 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.473 ' O ' ' NH1' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -62.85 70.05 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.765 0.793 . . . . 0.0 110.895 -176.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.615 ' O ' ' N ' ' A' ' 103' ' ' ASN . 0.2 OUTLIER -52.1 -46.0 65.1 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.471 ' CG ' ' H ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER 42.02 -6.63 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.876 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 176.856 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 101' ' ' ASN . 54.8 t30 67.74 1.91 2.82 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 120.686 -1.258 . . . . 0.0 109.896 -177.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.473 ' NH1' ' O ' ' A' ' 100' ' ' GLN . 3.9 mpt_? 61.07 162.27 0.11 Allowed Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo . . . . . 0 C--O 1.19 -1.906 0 C-N-CA 122.186 1.924 . . . . 0.0 111.751 -177.257 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.463 ' HG ' ' CB ' ' A' ' 27' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.407 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.84 HG21 HG21 ' A' ' 91' ' ' VAL . 7.2 mt -79.49 122.27 34.38 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -104.59 142.6 17.62 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 177.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.415 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -150.05 160.43 4.71 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.415 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -132.24 130.77 22.08 Favored Pre-proline 0 C--N 1.276 -2.592 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.612 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HB3' HD11 ' A' ' 96' ' ' ILE . 54.0 Cg_exo -41.15 129.14 3.11 Favored 'Trans proline' 0 N--CA 1.486 1.043 0 C-N-CA 122.213 1.942 . . . . 0.0 110.189 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.419 HG22 HG12 ' A' ' 9' ' ' ILE . 28.8 mt -95.79 109.41 22.59 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.509 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.05 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.933 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -90.41 107.08 18.92 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 177.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.419 HG12 HG22 ' A' ' 7' ' ' ILE . 15.9 mt -107.22 125.19 33.05 Favored Pre-proline 0 C--N 1.286 -2.191 0 O-C-N 121.433 -0.792 . . . . 0.0 109.11 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.3 Cg_endo -64.96 120.11 7.29 Favored 'Trans proline' 0 C--N 1.32 -0.945 0 C-N-CA 121.125 1.216 . . . . 0.0 109.43 175.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.483 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.5 OUTLIER -70.8 -171.97 0.59 Allowed 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.532 0.682 . . . . 0.0 110.767 -174.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 59.99 -2.9 0.13 Allowed 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -56.96 137.82 54.95 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.41 175.43 5.51 Favored 'General case' 0 C--N 1.287 -2.135 0 O-C-N 121.272 -0.892 . . . . 0.0 110.707 -174.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 1.0 OUTLIER -49.68 166.56 0.26 Allowed Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 123.045 0.538 . . . . 0.0 109.935 178.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.583 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 1.9 Cg_endo -78.71 143.22 71.28 Favored 'Cis proline' 0 C--N 1.307 -1.638 0 C-N-CA 123.18 -1.592 . . . . 0.0 112.926 -0.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.501 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 30.0 m-85 -115.41 160.98 32.3 Favored Pre-proline 0 C--N 1.275 -2.663 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 3.9 Cg_endo -70.94 160.64 91.22 Favored 'Cis proline' 0 N--CA 1.487 1.142 0 C-N-CA 124.04 -1.233 . . . . 0.0 112.877 0.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 16' ' ' PRO . 4.9 mtp85 -131.14 136.33 48.25 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -66.84 137.57 56.69 Favored 'General case' 0 N--CA 1.512 2.637 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.03 5.33 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.49 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 164.53 177.42 37.15 Favored Glycine 0 N--CA 1.5 2.911 0 C-N-CA 117.707 -2.187 . . . . 0.0 110.462 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.564 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 16.1 tttm -139.2 123.21 17.83 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.118 -1.225 . . . . 0.0 110.955 -176.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.564 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 14.3 t -82.0 155.99 4.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 172.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.437 ' O ' HG13 ' A' ' 3' ' ' VAL . 22.0 t -144.89 148.4 17.98 Favored 'Isoleucine or valine' 0 C--O 1.192 -1.941 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.486 ' HB2' HG21 ' A' ' 79' ' ' THR . 11.4 t0 -112.79 131.69 55.58 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 173.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.463 ' CB ' ' HG ' ' A' ' 1' ' ' SER . 0.1 OUTLIER -59.25 -18.97 41.84 Favored 'General case' 0 C--N 1.286 -2.152 0 O-C-N 121.748 -0.595 . . . . 0.0 110.121 -178.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -143.99 83.19 1.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.565 -0.71 . . . . 0.0 109.381 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.543 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 3.4 mtp85 -85.9 115.1 60.43 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.416 -0.803 . . . . 0.0 109.76 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.479 ' HG2' ' HG ' ' A' ' 87' ' ' LEU . 69.9 Cg_exo -49.04 132.76 28.03 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 C-N-CA 121.39 1.394 . . . . 0.0 109.541 174.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -29.52 -45.62 0.05 OUTLIER 'General case' 0 N--CA 1.509 2.501 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -176.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.7 mtm180 -113.19 20.84 15.88 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.98 -1.075 . . . . 0.0 110.418 -177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.479 ' O ' ' NZ ' ' A' ' 34' ' ' LYS . 2.6 p -62.47 173.11 1.31 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.819 -1.176 . . . . 0.0 111.166 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 33' ' ' SER . 5.3 mmtm -137.74 170.99 15.1 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.486 ' HB3' HD13 ' A' ' 52' ' ' ILE . 14.5 m-85 -117.58 121.28 40.51 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.406 -0.809 . . . . 0.0 109.14 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.478 ' HG3' ' CG2' ' A' ' 80' ' ' THR . 0.0 OUTLIER -100.96 144.28 30.09 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 173.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 22.9 tp -127.94 142.55 51.22 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 174.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.46 171.38 16.17 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 124.86 166.42 12.38 Favored Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.51 -1.329 . . . . 0.0 111.318 177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.58 119.05 4.72 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 109.39 -24.81 19.53 Favored Glycine 0 C--N 1.281 -2.491 0 N-CA-C 107.661 -2.175 . . . . 0.0 107.661 -176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.6 t -105.89 -100.42 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.553 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -90.25 -0.51 57.65 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.393 -0.817 . . . . 0.0 109.351 178.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -123.36 157.66 32.82 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.997 178.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -47.94 127.21 11.52 Favored Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.847 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.443 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 4.4 Cg_exo -76.38 113.16 2.71 Favored 'Cis proline' 0 C--O 1.203 -1.25 0 C-N-CA 123.694 -1.378 . . . . 0.0 109.188 -1.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.553 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 11.4 mtpp -64.9 139.98 58.82 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 121.024 -1.048 . . . . 0.0 111.438 -173.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 77.67 35.68 35.46 Favored Glycine 0 N--CA 1.502 3.076 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.104 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.492 ' N ' ' O ' ' A' ' 41' ' ' GLY . 5.1 mm -104.33 -46.12 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 118.717 1.259 . . . . 0.0 107.944 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.468 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 67.1 m-85 -114.11 137.76 51.31 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 121.65 0.738 . . . . 0.0 110.318 -177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.24 143.33 31.69 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.486 HD13 ' HB3' ' A' ' 35' ' ' PHE . 8.3 tt -106.58 166.39 3.76 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.601 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.475 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 9.8 t-20 -86.95 120.49 28.27 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 176.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -56.27 -13.98 2.52 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -175.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.543 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 52.7 m-80 -119.93 -46.83 2.42 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.844 -1.16 . . . . 0.0 111.382 -177.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.475 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 22.0 p -79.39 -40.99 28.74 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-O 121.742 0.782 . . . . 0.0 108.991 -176.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.42 6.15 56.67 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 -175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 6.6 m -61.77 125.58 24.31 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.4 -1.059 . . . . 0.0 108.169 177.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.484 HG22 HG23 ' A' ' 24' ' ' VAL . 2.1 t -93.56 129.48 43.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.4 155.78 44.19 Favored 'General case' 0 C--N 1.291 -1.97 0 O-C-N 121.541 -0.724 . . . . 0.0 109.174 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.525 HG22 ' H ' ' A' ' 63' ' ' ARG . 8.5 p -106.81 139.87 26.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 49' ' ' ILE . 0.7 OUTLIER -94.34 6.28 49.19 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.479 -0.763 . . . . 0.0 112.796 -176.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.669 ' NH1' ' O ' ' A' ' 64' ' ' THR . 15.6 ptt85 -156.18 172.38 18.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.441 -1.412 . . . . 0.0 110.759 175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.669 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 5.9 t -65.42 138.17 57.95 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 174.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 11' ' ' GLU . 47.3 mt -96.28 163.89 12.89 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.943 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.567 ' CG ' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -152.07 121.73 6.94 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.415 ' HG2' ' HB ' ' A' ' 97' ' ' VAL . 24.0 mtm-85 -67.1 1.99 1.75 Allowed 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.411 -0.806 . . . . 0.0 109.352 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -71.73 -22.01 61.68 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 53.8 t -101.34 -70.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.9 mt -130.49 145.86 34.93 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.53 -23.53 15.98 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.4 p -151.38 139.13 13.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.67 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -110.88 143.87 40.81 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.16 95.6 5.69 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.407 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.5 OUTLIER -88.58 170.33 10.94 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.302 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 68.6 m-85 -129.93 121.19 26.13 Favored 'General case' 0 C--N 1.279 -2.494 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.606 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -107.38 152.86 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 120.93 0.395 . . . . 0.0 110.106 -176.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.761 ' HB3' HG23 ' A' ' 86' ' ' THR . 48.0 mt-10 -138.88 140.39 38.4 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 121.701 -0.625 . . . . 0.0 109.401 175.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.573 ' N ' HD11 ' A' ' 2' ' ' ILE . 0.0 OUTLIER -91.07 124.65 35.46 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 104.895 -2.261 . . . . 0.0 104.895 172.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -110.0 158.82 17.86 Favored 'General case' 0 C--N 1.268 -2.936 0 CA-C-O 121.817 0.818 . . . . 0.0 111.523 -171.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.616 ' HB2' HD21 ' A' ' 87' ' ' LEU . 14.2 t0 -99.58 169.38 9.33 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 175.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.451 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 2.4 m -59.33 -19.86 17.05 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.981 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -80.61 -1.28 41.58 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.42 24.76 74.39 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 80' ' ' THR . 6.5 pttp -107.5 159.46 16.41 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.645 -0.915 . . . . 0.0 108.843 178.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.761 HG23 ' HB3' ' A' ' 78' ' ' GLU . 4.2 m -83.23 120.83 26.31 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.358 0.599 . . . . 0.0 112.415 -174.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.616 HD21 ' HB2' ' A' ' 81' ' ' ASP . 1.2 mm? -79.81 -46.91 16.07 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 172.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.456 ' HG2' ' HA ' ' A' ' 1' ' ' SER . 0.5 OUTLIER -142.71 155.05 44.83 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.24 179.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.596 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 105.08 177.7 24.4 Favored Glycine 0 C--N 1.291 -1.928 0 N-CA-C 107.73 -2.148 . . . . 0.0 107.73 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 77' ' ' VAL . 36.1 Cg_endo -68.34 102.59 0.29 Allowed 'Cis proline' 0 N--CA 1.5 1.888 0 C-N-CA 123.835 -1.319 . . . . 0.0 112.403 0.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.84 HG21 HG21 ' A' ' 2' ' ' ILE . 6.8 m -79.17 160.41 70.92 Favored Pre-proline 0 C--N 1.29 -1.989 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 176.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -94.03 148.2 2.05 Favored 'Trans proline' 0 C--N 1.284 -2.838 0 C-N-CA 121.673 1.582 . . . . 0.0 111.775 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.467 HD12 ' N ' ' A' ' 94' ' ' GLU . 3.9 tp -131.57 128.4 39.14 Favored 'General case' 0 C--N 1.277 -2.552 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 176.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.467 ' N ' HD12 ' A' ' 93' ' ' LEU . 23.3 mt-10 -102.64 119.74 39.35 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 97.7 t -109.18 111.05 34.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 176.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.634 HD13 ' CD1' ' A' ' 8' ' ' LEU . 5.2 mp -94.82 134.41 32.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.483 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 21.4 t -91.22 119.57 38.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.565 HG21 ' HB3' ' A' ' 8' ' ' LEU . 12.2 pt -119.17 171.33 7.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -90.61 -176.1 4.63 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 177.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.644 ' H ' ' NE2' ' A' ' 100' ' ' GLN . 2.0 mp0 -52.85 136.25 34.47 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' A' ' 103' ' ' ASN . 4.5 p-10 -74.87 -145.72 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 174.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 101' ' ' ASN . 1.5 m-20 -63.21 4.05 0.23 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.36 -1.463 . . . . 0.0 109.113 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.555 ' H ' ' C ' ' A' ' 101' ' ' ASN . 0.9 OUTLIER 72.68 13.59 5.21 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -173.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.486 ' NE ' ' O ' ' A' ' 103' ' ' ASN . 5.1 mmp_? -124.27 81.85 58.0 Favored Pre-proline 0 C--N 1.292 -1.91 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo . . . . . 0 C--O 1.195 -1.646 0 C-N-CA 122.771 2.314 . . . . 0.0 111.596 -174.013 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.492 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.949 HG21 HG21 ' A' ' 91' ' ' VAL . 10.0 mt -78.38 139.99 17.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 O-C-N 121.071 -1.018 . . . . 0.0 111.168 -178.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.513 HG13 ' HB ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -122.83 123.84 69.11 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 172.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.517 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -126.47 162.93 29.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 O-C-N 121.15 -0.969 . . . . 0.0 110.003 -175.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.457 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -142.95 133.76 12.51 Favored Pre-proline 0 C--N 1.289 -2.054 0 N-CA-C 107.185 -1.413 . . . . 0.0 107.185 178.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -47.35 152.72 2.19 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 122.497 2.131 . . . . 0.0 111.517 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.433 HG13 HD11 ' A' ' 93' ' ' LEU . 4.4 mt -115.66 114.34 45.99 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 121.345 -0.847 . . . . 0.0 109.312 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.884 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -89.35 108.39 19.61 Favored 'General case' 0 C--N 1.274 -2.7 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.287 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.463 ' C ' HG12 ' A' ' 98' ' ' ILE . 12.7 mt -118.0 130.05 24.97 Favored Pre-proline 0 C--N 1.286 -2.153 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 28.1 Cg_endo -67.53 132.06 26.19 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 121.143 1.228 . . . . 0.0 111.514 -179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.63 ' CD ' HH21 ' A' ' 67' ' ' ARG . 21.0 pt-20 -54.86 164.75 0.74 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.437 -0.79 . . . . 0.0 109.495 -178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 60.48 29.64 19.16 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.774 -0.579 . . . . 0.0 111.453 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.421 ' O ' ' OG1' ' A' ' 64' ' ' THR . 2.8 mt-30 -60.47 140.48 57.25 Favored 'General case' 0 N--CA 1.504 2.243 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.583 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 48.7 mtm-85 -114.62 169.09 9.32 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.008 -1.057 . . . . 0.0 111.685 -178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.614 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 22.6 mt-30 -49.71 169.55 0.18 Allowed Pre-proline 0 C--N 1.297 -1.687 0 C-N-CA 123.387 0.675 . . . . 0.0 109.529 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.614 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 5.9 Cg_exo -76.32 125.45 11.72 Favored 'Cis proline' 0 N--CA 1.49 1.291 0 C-N-CA 123.978 -1.259 . . . . 0.0 113.268 -0.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.533 ' CE1' ' HD3' ' A' ' 19' ' ' ARG . 35.3 m-85 -100.26 159.3 30.14 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.42 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 15.4 Cg_exo -68.42 149.27 84.81 Favored 'Cis proline' 0 N--CA 1.505 2.167 0 C-N-CA 124.594 -1.003 . . . . 0.0 112.629 -0.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 13.9 mtp180 -118.89 122.77 43.07 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.458 -0.776 . . . . 0.0 110.081 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 1.7 t70 -66.22 135.03 53.91 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 5.2 m -130.1 0.16 2.48 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.778 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.54 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 172.14 174.32 39.48 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.645 ' CE ' HG22 ' A' ' 25' ' ' VAL . 3.5 tttp -134.91 126.66 29.12 Favored 'General case' 0 C--N 1.288 -2.098 0 O-C-N 121.305 -1.115 . . . . 0.0 109.587 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.585 HG23 ' CG2' ' A' ' 59' ' ' VAL . 62.0 t -89.06 153.12 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.645 HG22 ' CE ' ' A' ' 23' ' ' LYS . 2.7 t -137.16 170.19 18.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 118.212 -1.395 . . . . 0.0 109.433 -174.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 1' ' ' SER . 16.3 t0 -143.9 123.37 13.16 Favored 'General case' 0 C--N 1.284 -2.258 0 N-CA-C 105.751 -1.944 . . . . 0.0 105.751 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.32 -63.1 1.36 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.381 -0.824 . . . . 0.0 109.377 -177.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -75.82 64.81 1.85 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 175.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.596 ' NE ' ' OG ' ' A' ' 33' ' ' SER . 9.5 mtp180 -64.94 160.79 52.78 Favored Pre-proline 0 C--N 1.282 -2.358 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.11 -174.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.629 ' HG2' HD23 ' A' ' 87' ' ' LEU . 31.2 Cg_exo -65.04 -141.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 123.134 2.556 . . . . 0.0 108.291 165.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.599 ' HB2' ' NH1' ' A' ' 32' ' ' ARG . 33.3 mt-10 -89.08 -84.74 0.21 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.238 -1.538 . . . . 0.0 107.613 174.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.599 ' NH1' ' HB2' ' A' ' 31' ' ' GLU . 2.6 mtt85 -90.94 79.55 5.87 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.596 ' OG ' ' NE ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -60.32 102.79 0.19 Allowed 'General case' 0 C--N 1.277 -2.576 0 CA-C-O 121.4 0.619 . . . . 0.0 111.579 -175.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -100.07 126.74 46.33 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 173.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.749 ' HB3' HD13 ' A' ' 52' ' ' ILE . 61.8 m-85 -86.65 130.12 34.61 Favored 'General case' 0 C--N 1.28 -2.439 0 O-C-N 121.563 -0.711 . . . . 0.0 110.059 -177.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.555 ' HG3' HG21 ' A' ' 80' ' ' THR . 0.3 OUTLIER -103.7 135.58 45.0 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.378 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' ' NH2' ' A' ' 36' ' ' ARG . 20.2 tp -114.57 145.94 41.35 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 176.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.515 HG23 ' NH2' ' A' ' 36' ' ' ARG . 1.2 p -148.01 170.98 16.56 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -176.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.14 171.86 16.94 Favored Glycine 0 N--CA 1.501 3.007 0 C-N-CA 120.043 -1.075 . . . . 0.0 111.463 175.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -60.78 117.44 5.39 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 117.44 -24.44 9.15 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 107.017 -2.433 . . . . 0.0 107.017 -175.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.487 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 15.2 t -126.51 -104.04 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.02 -22.75 66.46 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 121.223 -0.923 . . . . 0.0 110.22 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.0 mm-40 -116.73 159.35 22.4 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.615 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 6.6 mm-40 -74.46 150.15 86.86 Favored Pre-proline 0 C--N 1.287 -2.115 0 O-C-N 121.971 -0.456 . . . . 0.0 110.336 -177.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 31.2 Cg_endo -67.13 115.91 1.8 Allowed 'Cis proline' 0 N--CA 1.511 2.554 0 C-N-CA 123.835 -1.319 . . . . 0.0 110.631 -0.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.615 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 2.1 mtpm? -78.22 165.75 23.53 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 120.657 -1.277 . . . . 0.0 110.946 -173.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.19 31.47 69.09 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 111.036 -0.825 . . . . 0.0 111.036 174.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.6 mm -105.69 -45.29 8.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-N 118.645 1.222 . . . . 0.0 107.936 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.621 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 97.0 m-85 -124.42 156.25 37.47 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.611 0.72 . . . . 0.0 110.633 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -156.78 150.96 25.11 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.749 HD13 ' HB3' ' A' ' 35' ' ' PHE . 15.1 tt -108.81 157.48 9.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 118.61 -1.236 . . . . 0.0 108.962 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.486 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 10.2 t-20 -83.34 119.38 24.53 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -75.56 10.72 1.56 Allowed 'General case' 0 C--N 1.287 -2.128 0 CA-C-O 120.865 0.364 . . . . 0.0 111.496 -175.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.486 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 19.5 t-20 -124.14 -43.18 2.1 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.837 -1.165 . . . . 0.0 109.276 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.417 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 43.7 p -95.74 -38.6 10.26 Favored 'General case' 0 C--N 1.278 -2.53 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.59 6.06 55.07 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.0 m -66.54 124.56 23.14 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.568 -0.96 . . . . 0.0 109.512 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.585 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.7 t -87.61 124.62 41.01 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -124.17 155.66 38.08 Favored 'General case' 0 C--N 1.288 -2.067 0 O-C-N 121.325 -0.859 . . . . 0.0 109.641 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.427 HG13 ' CE1' ' A' ' 17' ' ' PHE . 7.4 p -102.17 137.55 29.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.2 -12.99 39.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.454 -0.779 . . . . 0.0 111.548 -174.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.559 ' NE ' ' O ' ' A' ' 64' ' ' THR . 2.0 ptm180 -153.08 -176.4 5.76 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.841 -1.162 . . . . 0.0 110.208 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.559 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 12.6 t -70.51 156.06 39.9 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 119.154 -1.018 . . . . 0.0 109.686 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 81.1 mt -113.09 123.01 49.28 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.243 -0.911 . . . . 0.0 109.407 -178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -109.07 113.77 26.92 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.63 HH21 ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -58.65 -7.29 0.92 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.518 0.675 . . . . 0.0 109.229 179.327 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -70.67 -19.79 62.76 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 66' ' ' ASP . 2.3 t -101.7 -58.57 3.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -176.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.8 mt -136.21 134.85 50.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.197 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.63 -28.13 24.97 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.3 p -152.79 128.0 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.508 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 29.7 m-85 -91.21 125.44 35.99 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -90.68 85.08 5.97 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.57 170.45 13.39 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 70.3 m-85 -135.96 133.99 38.16 Favored 'General case' 0 C--N 1.267 -3.014 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.744 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -111.24 155.56 12.61 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 O-C-N 121.826 -0.546 . . . . 0.0 109.595 -176.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.41 ' C ' HD11 ' A' ' 2' ' ' ILE . 2.1 mt-10 -144.76 147.85 33.42 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.702 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -94.21 133.64 37.51 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 175.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.555 HG21 ' HG3' ' A' ' 36' ' ' ARG . 17.1 p -128.14 153.93 46.32 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' OD1' ' NH1' ' A' ' 32' ' ' ARG . 1.2 t70 -109.69 170.7 7.9 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.416 HG13 ' HB2' ' A' ' 32' ' ' ARG . 29.7 m -56.99 -3.67 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.357 0 O-C-N 121.306 -0.871 . . . . 0.0 111.003 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 81' ' ' ASP . 1.0 OUTLIER -79.71 -19.68 48.32 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.34 28.96 31.75 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 107.978 -2.049 . . . . 0.0 107.978 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -116.34 168.21 10.34 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 88' ' ' GLU . 1.3 m -109.8 118.87 37.66 Favored 'General case' 0 C--N 1.294 -1.813 0 O-C-N 121.453 -0.78 . . . . 0.0 110.015 -177.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.91 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.6 -20.31 21.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.537 ' O ' HG22 ' A' ' 86' ' ' THR . 12.7 tt0 -157.2 164.08 38.13 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.46 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 114.92 166.5 15.21 Favored Glycine 0 C--N 1.288 -2.132 0 N-CA-C 107.045 -2.422 . . . . 0.0 107.045 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -82.63 107.2 1.02 Allowed 'Cis proline' 0 C--N 1.3 -2.003 0 C-N-CA 123.127 -1.614 . . . . 0.0 110.801 0.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.949 HG21 HG21 ' A' ' 2' ' ' ILE . 18.9 m -78.58 159.46 74.37 Favored Pre-proline 0 C--N 1.285 -2.214 0 N-CA-C 105.682 -1.969 . . . . 0.0 105.682 176.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -91.5 148.18 3.47 Favored 'Trans proline' 0 C--N 1.285 -2.77 0 C-N-CA 121.419 1.412 . . . . 0.0 112.675 -178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.487 HD21 HG11 ' A' ' 59' ' ' VAL . 11.2 tp -138.65 113.28 9.0 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 174.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -95.47 113.79 25.48 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.621 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 15.8 t -95.28 107.76 19.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 176.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.407 HD13 ' CD1' ' A' ' 8' ' ' LEU . 2.4 mp -90.89 127.7 43.17 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.6 t -84.62 104.86 13.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 7.4 pt -94.67 172.08 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 O-C-N 121.517 -0.739 . . . . 0.0 109.365 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.582 ' HB3' ' CB ' ' A' ' 103' ' ' ASN . 1.1 m-20 -82.72 179.88 7.64 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -65.02 83.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.46 ' OD1' ' N ' ' A' ' 102' ' ' ASP . 21.2 t-20 64.25 -139.98 0.28 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.46 ' N ' ' OD1' ' A' ' 101' ' ' ASN . 0.4 OUTLIER -64.7 -30.35 71.36 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.683 -1.261 . . . . 0.0 108.451 179.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.582 ' CB ' ' HB3' ' A' ' 99' ' ' ASP . 60.9 t30 51.42 37.1 18.28 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.824 0.821 . . . . 0.0 109.636 -177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.418 HH12 ' CG ' ' A' ' 102' ' ' ASP . 9.9 mtm-85 -116.89 79.55 10.26 Favored Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo . . . . . 0 C--N 1.312 -1.39 0 C-N-CA 122.498 2.132 . . . . 0.0 112.04 -178.4 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 1.02 HG21 HG21 ' A' ' 91' ' ' VAL . 11.7 mt -59.01 120.18 4.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 119.283 -0.967 . . . . 0.0 109.187 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -112.0 113.94 45.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.496 HG23 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -136.74 158.96 37.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -178.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.413 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -148.69 139.73 13.79 Favored Pre-proline 0 C--N 1.273 -2.73 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 178.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -41.48 132.65 3.58 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.216 1.944 . . . . 0.0 111.451 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.52 HG13 HD11 ' A' ' 93' ' ' LEU . 34.7 mt -98.42 110.91 26.86 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.881 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -87.71 108.44 19.11 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.638 HD11 HG21 ' A' ' 21' ' ' VAL . 20.5 mt -117.09 136.1 23.25 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.58 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 30.0 Cg_endo -70.54 132.37 21.95 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 121.299 1.333 . . . . 0.0 110.968 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.548 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 13.1 pt-20 -63.78 176.75 0.85 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.018 -178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.549 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 20.4 t-20 58.56 23.51 10.94 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.587 -0.696 . . . . 0.0 111.757 176.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 10' ' ' PRO . 2.8 mt-30 -70.22 115.79 9.82 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 175.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.549 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -89.57 176.1 7.02 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 120.928 -1.108 . . . . 0.0 109.932 -177.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.573 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 11.6 mm-40 -42.92 167.62 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.61 0 C-N-CA 124.063 0.945 . . . . 0.0 110.61 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 2.2 Cg_endo -82.7 146.34 60.09 Favored 'Cis proline' 0 N--CA 1.495 1.567 0 C-N-CA 124.186 -1.172 . . . . 0.0 114.027 -0.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.487 ' N ' ' OE1' ' A' ' 15' ' ' GLN . 42.3 m-85 -133.62 160.35 68.94 Favored Pre-proline 0 C--N 1.282 -2.369 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 18.4 Cg_exo -66.46 163.49 69.81 Favored 'Cis proline' 0 N--CA 1.499 1.807 0 C-N-CA 124.079 -1.217 . . . . 0.0 112.162 -0.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.521 ' NE ' ' O ' ' A' ' 16' ' ' PRO . 9.9 ttm180 -146.13 143.55 29.4 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.667 -0.646 . . . . 0.0 109.455 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 9.0 t0 -74.73 137.51 42.12 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.638 HG21 HD11 ' A' ' 9' ' ' ILE . 35.0 m -132.64 6.03 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 174.82 179.47 45.42 Favored Glycine 0 N--CA 1.506 3.322 0 C-N-CA 118.896 -1.621 . . . . 0.0 109.702 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.7 ttpm? -145.37 122.98 11.78 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.787 -1.419 . . . . 0.0 110.118 -177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.567 HG11 HG11 ' A' ' 77' ' ' VAL . 45.4 t -93.49 143.57 11.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 104.982 -2.229 . . . . 0.0 104.982 171.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' HE2' ' A' ' 23' ' ' LYS . 11.9 t -139.18 170.08 16.45 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.793 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 1' ' ' SER . 10.1 t0 -132.67 120.5 21.81 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.419 ' HG ' ' H3 ' ' A' ' 1' ' ' SER . 0.2 OUTLIER -73.79 2.62 7.96 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.823 -176.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.45 ' C ' ' HD3' ' A' ' 29' ' ' ARG . 11.6 m-20 -142.46 0.25 1.29 Allowed 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.507 -1.371 . . . . 0.0 111.758 -174.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.658 ' N ' ' HD3' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -97.76 150.16 36.48 Favored Pre-proline 0 N--CA 1.503 2.2 0 O-C-N 120.554 -1.341 . . . . 0.0 111.729 -171.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -37.63 142.4 0.2 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 123.99 3.127 . . . . 0.0 112.88 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -19.33 28.11 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 176.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.448 ' O ' ' NZ ' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -101.39 5.23 42.07 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.909 -0.494 . . . . 0.0 110.0 -177.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.63 147.9 50.33 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.079 -1.048 . . . . 0.0 109.505 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' NZ ' ' O ' ' A' ' 32' ' ' ARG . 4.1 mttm -113.66 123.96 51.16 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.911 ' CE2' HG23 ' A' ' 79' ' ' THR . 53.0 m-85 -83.33 139.42 33.05 Favored 'General case' 0 C--N 1.287 -2.121 0 O-C-N 120.967 -1.083 . . . . 0.0 109.695 -178.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.569 HH22 ' CD ' ' A' ' 54' ' ' GLU . 41.2 mmt-85 -120.38 155.61 33.06 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.47 HD11 HD23 ' A' ' 93' ' ' LEU . 16.1 tp -133.27 142.07 48.32 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 p -147.97 171.52 15.66 Favored 'General case' 0 C--N 1.275 -2.64 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 -178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.72 179.4 16.91 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.531 -1.355 . . . . 0.0 111.154 178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 15.0 mtmm -63.13 106.98 0.94 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.489 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 129.64 -18.13 5.45 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.327 -1.909 . . . . 0.0 108.327 -177.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 t -130.46 -90.29 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.988 -0.713 . . . . 0.0 109.324 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.41 -20.03 32.52 Favored 'General case' 0 C--N 1.309 -1.152 0 O-C-N 120.923 -1.111 . . . . 0.0 108.777 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -112.35 161.26 16.85 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.365 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.425 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 6.5 mt-10 -69.33 143.41 93.5 Favored Pre-proline 0 C--N 1.281 -2.401 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.573 -176.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.489 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 40.8 Cg_endo -72.87 123.65 8.56 Favored 'Cis proline' 0 N--CA 1.501 1.934 0 C-N-CA 123.179 -1.592 . . . . 0.0 110.271 -2.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.425 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 2.3 mtpm? -80.35 166.06 21.67 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 120.716 -1.24 . . . . 0.0 109.674 -177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 69.09 34.02 75.27 Favored Glycine 0 C--N 1.284 -2.355 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.471 HD13 ' NE ' ' A' ' 63' ' ' ARG . 4.5 mm -110.85 -50.27 6.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.008 -1.29 . . . . 0.0 108.4 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.654 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 97.3 m-85 -121.59 161.12 22.96 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.405 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.66 ' HG2' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -160.07 134.26 7.4 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.453 HD13 ' HB3' ' A' ' 35' ' ' PHE . 19.3 tt -100.13 167.23 2.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 O-C-N 120.793 -1.192 . . . . 0.0 109.04 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.417 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 7.1 t-20 -100.59 122.86 43.98 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 176.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.569 ' CD ' HH22 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -49.1 -49.75 40.32 Favored 'General case' 0 C--N 1.284 -2.244 0 O-C-N 121.965 -0.46 . . . . 0.0 112.005 -176.445 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 34.6 t30 -90.08 -40.78 12.07 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.292 -0.88 . . . . 0.0 111.936 -173.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.417 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 9.3 p -84.14 -22.79 30.92 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -177.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.0 9.19 62.72 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.0 m -64.4 123.72 19.93 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.263 -1.139 . . . . 0.0 108.714 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.473 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.3 t -83.15 120.75 35.02 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -116.88 153.85 31.8 Favored 'General case' 0 C--N 1.282 -2.344 0 O-C-N 121.577 -0.702 . . . . 0.0 109.97 -177.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.472 HG23 HD21 ' A' ' 65' ' ' LEU . 7.2 p -105.67 140.83 22.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.66 HG23 ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -93.06 -15.17 26.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.429 -0.795 . . . . 0.0 111.209 -176.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.471 ' NE ' HD13 ' A' ' 49' ' ' ILE . 6.0 ptp180 -154.34 -167.64 2.69 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.747 -1.22 . . . . 0.0 110.004 -178.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 1.7 t -74.78 148.57 40.25 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 12' ' ' ASN . 67.0 mt -106.63 129.95 54.46 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.18 126.77 55.43 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.413 HH12 ' CG ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER -67.62 -9.58 44.38 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.19 -28.57 62.27 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.1 t -88.32 -52.9 10.6 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 -177.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.425 ' O ' HG21 ' A' ' 97' ' ' VAL . 1.1 mt -148.43 136.76 14.85 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.12 -22.37 27.13 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.591 -1.262 . . . . 0.0 107.591 176.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -155.33 123.09 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.503 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 65.0 m-85 -88.21 121.65 30.85 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 120.915 -1.115 . . . . 0.0 108.509 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.2 98.47 11.79 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.63 170.42 9.35 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.2 m-85 -135.46 124.27 23.96 Favored 'General case' 0 C--N 1.262 -3.198 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 178.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -104.88 152.18 6.96 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.084 0.469 . . . . 0.0 110.293 -174.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.55 ' HB3' HG23 ' A' ' 86' ' ' THR . 42.7 mt-10 -139.71 140.12 36.73 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 176.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.911 HG23 ' CE2' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -93.26 130.91 38.81 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 170.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.517 ' C ' HD21 ' A' ' 87' ' ' LEU . 70.5 p -124.5 164.82 18.95 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 118.517 -1.273 . . . . 0.0 111.744 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.476 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 25.5 t70 -88.23 167.66 13.39 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.2 m -53.65 -27.07 14.58 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.685 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -79.87 -11.18 59.83 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.582 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.8 56.98 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.1 OUTLIER -76.46 146.97 38.2 Favored 'General case' 0 C--O 1.194 -1.824 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 175.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 78' ' ' GLU . 85.2 m -93.4 115.17 27.72 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 118.76 0.709 . . . . 0.0 109.199 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.881 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.05 -31.71 27.22 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.54 ' HG3' ' NH2' ' A' ' 29' ' ' ARG . 1.6 tt0 -144.84 160.65 40.94 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.475 -0.766 . . . . 0.0 109.201 175.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.422 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 94.65 178.27 38.16 Favored Glycine 0 C--N 1.287 -2.187 0 N-CA-C 106.544 -2.622 . . . . 0.0 106.544 -174.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -67.94 121.36 4.34 Favored 'Cis proline' 0 C--N 1.299 -2.058 0 C-N-CA 123.026 -1.656 . . . . 0.0 111.433 0.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.02 HG21 HG21 ' A' ' 2' ' ' ILE . 3.0 m -101.86 163.27 18.12 Favored Pre-proline 0 C--N 1.287 -2.114 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -91.01 150.07 3.84 Favored 'Trans proline' 0 C--N 1.287 -2.673 0 C-N-CA 121.53 1.487 . . . . 0.0 112.372 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.52 HD11 HG13 ' A' ' 7' ' ' ILE . 10.5 tp -137.46 128.3 27.22 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.06 109.94 21.5 Favored 'General case' 0 C--N 1.285 -2.204 0 O-C-N 121.629 -0.669 . . . . 0.0 109.886 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.654 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 61.3 t -91.75 97.08 6.82 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 174.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.447 ' HB ' HD12 ' A' ' 8' ' ' LEU . 2.1 mt -79.63 132.24 32.41 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.063 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 -177.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 21.7 t -91.15 116.79 33.09 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 11.5 pt -105.85 171.82 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.413 ' CG ' HH12 ' A' ' 67' ' ' ARG . 11.6 m-20 -83.17 172.41 12.66 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 120.907 -1.12 . . . . 0.0 109.356 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -91.36 158.75 16.36 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.941 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.463 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 0.2 OUTLIER -110.35 30.15 7.04 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 174.089 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 102' ' ' ASP . 14.9 p-10 -76.14 -26.49 56.37 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 61.21 24.06 14.2 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -174.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 104' ' ' ARG . 0.1 OUTLIER -117.49 90.16 34.22 Favored Pre-proline 0 C--N 1.312 -1.027 0 O-C-N 121.671 -0.643 . . . . 0.0 110.293 -179.833 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 C--N 1.314 -1.276 0 C-N-CA 122.223 1.949 . . . . 0.0 110.194 176.657 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.511 -0.545 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 1.09 HG21 HG21 ' A' ' 91' ' ' VAL . 31.7 mt -65.7 132.13 31.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-O 121.734 0.778 . . . . 0.0 110.74 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -119.44 122.84 69.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.069 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 175.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.603 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -137.87 169.13 19.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -177.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.522 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 1.5 m -159.81 169.76 9.81 Favored Pre-proline 0 C--N 1.274 -2.695 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 25.1 Cg_exo -61.85 134.87 52.5 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 121.35 1.367 . . . . 0.0 110.745 -176.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.613 HD13 ' HA3' ' A' ' 22' ' ' GLY . 24.4 mt -106.11 111.83 36.79 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.868 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.42 98.56 11.85 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.459 ' CD1' HG21 ' A' ' 21' ' ' VAL . 20.3 mt -101.19 129.0 28.01 Favored Pre-proline 0 N--CA 1.497 1.923 0 O-C-N 120.97 -1.081 . . . . 0.0 109.0 -178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 5.0 Cg_endo -63.38 124.91 14.61 Favored 'Trans proline' 0 C--N 1.325 -0.676 0 C-N-CA 121.091 1.194 . . . . 0.0 110.046 175.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.52 ' HB3' HG12 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -67.04 171.43 5.53 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-O 122.717 1.246 . . . . 0.0 113.929 -170.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.512 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 6.4 m-80 47.71 24.15 0.51 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.486 172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.458 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 73.0 mt-30 -67.0 146.79 54.0 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 173.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.541 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 0.0 OUTLIER -104.9 179.26 4.32 Favored 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.174 -0.954 . . . . 0.0 110.031 -177.037 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.639 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -54.2 176.74 0.12 Allowed Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.639 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 5.7 Cg_exo -72.79 117.99 4.4 Favored 'Cis proline' 0 N--CA 1.491 1.359 0 C-N-CA 123.942 -1.274 . . . . 0.0 113.986 0.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.409 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 31.8 m-85 -100.15 165.08 15.16 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 174.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 55.2 Cg_endo -73.12 162.25 92.14 Favored 'Cis proline' 0 N--CA 1.497 1.681 0 C-N-CA 124.242 -1.149 . . . . 0.0 111.84 -0.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.458 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 11.3 mtp180 -138.19 145.5 41.56 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 5.0 t0 -73.75 134.53 43.48 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.459 HG21 ' CD1' ' A' ' 9' ' ' ILE . 31.1 m -129.91 3.24 2.42 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.431 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.609 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.613 ' HA3' HD13 ' A' ' 7' ' ' ILE . . . -172.83 -171.32 37.48 Favored Glycine 0 N--CA 1.499 2.899 0 C-N-CA 117.347 -2.358 . . . . 0.0 111.146 -178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' NZ ' ' O ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -150.29 113.68 4.92 Favored 'General case' 0 C--N 1.292 -1.892 0 O-C-N 120.998 -1.295 . . . . 0.0 110.851 -178.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.603 HG13 ' HB ' ' A' ' 4' ' ' VAL . 11.4 t -100.91 112.06 32.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.302 0 N-CA-C 103.41 -2.811 . . . . 0.0 103.41 169.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.545 ' O ' HG13 ' A' ' 3' ' ' VAL . 58.5 t -120.66 154.46 24.0 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.008 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.7 t70 -104.23 135.41 45.74 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.58 -32.23 7.79 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -137.02 75.31 1.52 Allowed 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 37.7 mtm180 -55.61 121.13 36.93 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 121.181 -0.949 . . . . 0.0 109.641 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 31' ' ' GLU . 54.6 Cg_exo -48.64 141.05 21.14 Favored 'Trans proline' 0 N--CA 1.501 1.955 0 C-N-CA 122.243 1.962 . . . . 0.0 110.328 176.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -24.88 -59.12 0.06 Allowed 'General case' 0 N--CA 1.51 2.537 0 C-N-CA 123.617 0.767 . . . . 0.0 112.076 -175.376 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' HA ' ' CZ ' ' A' ' 32' ' ' ARG . 0.2 OUTLIER -126.23 52.94 1.66 Allowed 'General case' 0 C--N 1.289 -2.023 0 O-C-N 121.313 -0.867 . . . . 0.0 108.915 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -75.31 160.56 30.18 Favored 'General case' 0 C--N 1.285 -2.232 0 O-C-N 121.343 -0.848 . . . . 0.0 110.887 -177.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.3 mtmm -126.61 133.01 51.13 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 174.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.614 ' HB3' HD13 ' A' ' 52' ' ' ILE . 12.1 m-85 -79.9 137.73 36.97 Favored 'General case' 0 C--N 1.273 -2.755 0 O-C-N 121.137 -0.977 . . . . 0.0 108.543 176.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.413 ' NH2' HG23 ' A' ' 38' ' ' THR . 0.0 OUTLIER -114.97 126.52 54.86 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 175.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.584 ' HG ' HG21 ' A' ' 42' ' ' VAL . 19.5 tp -105.8 148.98 26.9 Favored 'General case' 0 C--N 1.274 -2.698 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.413 HG23 ' NH2' ' A' ' 36' ' ' ARG . 0.3 OUTLIER -152.03 170.39 20.02 Favored 'General case' 0 C--N 1.267 -2.996 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -177.154 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.5 ' C ' ' HB2' ' A' ' 44' ' ' GLN . . . 110.43 172.41 20.05 Favored Glycine 0 N--CA 1.497 2.765 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.954 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.48 ' N ' ' HB2' ' A' ' 44' ' ' GLN . 9.6 mtpp -53.25 114.75 1.59 Allowed 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.44 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 115.18 -20.66 13.94 Favored Glycine 0 C--N 1.28 -2.564 0 N-CA-C 108.296 -1.921 . . . . 0.0 108.296 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.584 HG21 ' HG ' ' A' ' 37' ' ' LEU . 9.2 t -113.06 -89.49 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.45 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 31.7 t70 -100.17 -13.02 19.11 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.243 -0.91 . . . . 0.0 109.501 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.533 ' N ' ' CD ' ' A' ' 44' ' ' GLN . 0.4 OUTLIER -100.13 158.42 15.86 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 176.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 137.24 96.17 Favored Pre-proline 0 C--N 1.271 -2.808 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.492 -177.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.44 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.2 Cg_exo -76.88 119.47 6.39 Favored 'Cis proline' 0 N--CA 1.5 1.874 0 C-N-CA 123.442 -1.483 . . . . 0.0 110.624 -0.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.45 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 2.2 mttm -69.27 144.49 53.6 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.708 -1.245 . . . . 0.0 110.353 -176.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.49 37.83 34.59 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 120.243 -0.979 . . . . 0.0 112.344 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.432 HG13 ' HA2' ' A' ' 41' ' ' GLY . 5.0 mm -106.11 -43.0 7.04 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 174.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.499 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 84.8 m-85 -118.71 149.93 40.61 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.793 0.806 . . . . 0.0 110.264 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.485 ' HG2' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -148.13 142.94 26.75 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 176.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.614 HD13 ' HB3' ' A' ' 35' ' ' PHE . 12.2 tt -100.09 158.46 3.83 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.4 0 O-C-N 120.505 -1.372 . . . . 0.0 109.845 -178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 58' ' ' SER . 6.2 m-80 -84.76 84.71 7.6 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.732 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 2.0 pm0 -24.78 -54.52 0.04 OUTLIER 'General case' 0 C--N 1.287 -2.139 0 C-N-CA 124.18 0.992 . . . . 0.0 113.554 -174.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.506 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 40.1 t30 -80.95 -33.94 33.59 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.168 -0.958 . . . . 0.0 111.939 -175.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.8 p -94.94 -25.84 16.38 Favored 'General case' 0 C--N 1.287 -2.126 0 O-C-N 121.161 -0.962 . . . . 0.0 109.073 -175.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 82.91 10.52 82.89 Favored Glycine 0 C--N 1.285 -2.273 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -66.8 128.73 37.42 Favored 'General case' 0 C--N 1.312 -1.043 0 O-C-N 120.859 -1.377 . . . . 0.0 108.608 178.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.554 HG21 HD11 ' A' ' 7' ' ' ILE . 4.6 t -79.91 119.2 28.87 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.433 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.477 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.8 OUTLIER -113.29 151.6 30.93 Favored 'General case' 0 C--N 1.282 -2.335 0 O-C-N 121.699 -0.626 . . . . 0.0 109.561 -179.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.534 HG21 HD11 ' A' ' 65' ' ' LEU . 12.8 p -112.63 143.17 22.88 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.927 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.485 HG23 ' HG2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -96.43 -15.36 21.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.695 -0.628 . . . . 0.0 111.54 -176.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -146.95 178.54 8.27 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.464 -1.397 . . . . 0.0 111.783 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.541 ' OG1' ' NH2' ' A' ' 14' ' ' ARG . 4.9 t -70.05 122.51 19.52 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.534 HD11 HG21 ' A' ' 61' ' ' VAL . 28.3 mt -90.81 127.2 36.26 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.161 -0.962 . . . . 0.0 108.926 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -111.25 139.28 46.77 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 176.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.442 ' CG ' ' HB3' ' A' ' 11' ' ' GLU . 7.4 mtp180 -81.88 -11.24 59.02 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.803 -0.56 . . . . 0.0 111.29 -176.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -77.85 -22.76 49.43 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.0 t -83.83 -63.46 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.41 ' O ' HG21 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -130.44 127.41 62.47 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.25 -25.86 31.27 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -156.69 135.97 3.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.419 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 67.1 m-85 -98.75 124.7 43.78 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -90.74 90.86 8.13 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.87 170.47 11.15 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-O 122.132 0.968 . . . . 0.0 109.458 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 53.5 m-85 -134.08 127.6 32.51 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.755 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.29 142.89 23.25 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 121.24 0.543 . . . . 0.0 110.452 -175.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HB3' HG23 ' A' ' 86' ' ' THR . 45.2 mt-10 -133.7 145.19 49.66 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 175.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.698 ' HB ' HD23 ' A' ' 87' ' ' LEU . 0.1 OUTLIER -92.24 142.38 27.53 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 171.302 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.574 ' C ' HD21 ' A' ' 87' ' ' LEU . 24.1 p -127.6 155.3 44.08 Favored 'General case' 0 C--N 1.279 -2.492 0 C-N-CA 118.947 -1.101 . . . . 0.0 109.441 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.659 ' HB2' HD11 ' A' ' 87' ' ' LEU . 37.3 t0 -97.1 170.01 9.42 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.59 -0.844 . . . . 0.0 108.806 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.441 ' N ' ' OD2' ' A' ' 81' ' ' ASP . 13.5 m -56.42 -16.15 3.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 174.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -85.75 -13.08 49.41 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.22 22.65 58.61 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 109.081 -1.608 . . . . 0.0 109.081 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -98.97 150.46 21.93 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 176.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 78' ' ' GLU . 57.7 m -84.49 129.01 34.9 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.971 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -99.16 -30.24 12.4 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 177.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.502 ' HG2' ' H ' ' A' ' 2' ' ' ILE . 3.9 tp10 -149.47 153.66 37.62 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.602 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 97.96 -176.35 30.64 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 107.968 -2.053 . . . . 0.0 107.968 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -67.26 104.97 0.36 Allowed 'Cis proline' 0 N--CA 1.496 1.641 0 CA-C-N 118.861 1.33 . . . . 0.0 112.089 -0.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.09 HG21 HG21 ' A' ' 2' ' ' ILE . 16.1 m -79.79 161.94 64.49 Favored Pre-proline 0 C--N 1.284 -2.247 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 176.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -93.3 155.76 2.54 Favored 'Trans proline' 0 C--N 1.291 -2.478 0 C-N-CA 121.6 1.533 . . . . 0.0 111.016 178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.462 HD13 HG23 ' A' ' 4' ' ' VAL . 12.9 tp -142.18 128.08 19.46 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -108.97 104.14 13.31 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.526 -0.734 . . . . 0.0 109.496 -177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.499 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 70.7 t -94.4 107.95 20.06 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.9 mp -90.64 129.95 40.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 11' ' ' GLU . 1.5 t -86.97 109.72 19.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.662 HG21 ' HB3' ' A' ' 8' ' ' LEU . 20.6 pt -109.15 171.54 2.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 CA-C-O 121.425 0.631 . . . . 0.0 109.407 -176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -108.33 148.33 30.21 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -133.32 69.01 1.48 Allowed 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 173.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 43.3 24.64 0.05 Allowed 'General case' 0 N--CA 1.515 2.792 0 O-C-N 121.713 -0.617 . . . . 0.0 110.12 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.31 -44.04 84.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.049 -1.032 . . . . 0.0 108.695 -176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.4 ' O ' ' HB2' ' A' ' 104' ' ' ARG . 0.0 OUTLIER 56.86 15.09 2.1 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -176.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.409 ' NH1' ' OE1' ' A' ' 11' ' ' GLU . 0.0 OUTLIER 67.8 110.62 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.498 1.761 0 C-N-CA 122.603 2.202 . . . . 0.0 112.158 -177.882 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.476 ' HA ' ' HG3' ' A' ' 88' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.754 HG21 HG21 ' A' ' 91' ' ' VAL . 7.9 mt -72.16 139.89 18.96 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.676 0 CA-C-O 121.583 0.706 . . . . 0.0 110.599 -177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.85 128.04 75.59 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 174.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.522 HG23 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -140.68 162.23 23.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 O-C-N 121.4 -0.813 . . . . 0.0 109.728 -175.158 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.443 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.3 OUTLIER -145.59 156.01 52.87 Favored Pre-proline 0 C--N 1.284 -2.268 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 172.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 96' ' ' ILE . 52.8 Cg_exo -49.76 149.42 10.74 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.63 1.553 . . . . 0.0 111.164 -178.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.935 HG13 HD11 ' A' ' 93' ' ' LEU . 8.1 mt -112.27 111.88 38.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 177.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.914 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -92.64 105.06 17.28 Favored 'General case' 0 C--N 1.274 -2.701 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 8.6 mt -110.25 128.36 25.5 Favored Pre-proline 0 C--N 1.286 -2.157 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.604 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 31.7 Cg_endo -69.91 125.23 11.83 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 120.969 1.113 . . . . 0.0 110.872 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.504 ' HB3' HG12 ' A' ' 97' ' ' VAL . 11.1 pt-20 -61.37 170.86 1.6 Allowed 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.822 -175.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.535 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 81.33 -19.17 0.44 Allowed 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 172.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.421 ' O ' ' OG1' ' A' ' 64' ' ' THR . 2.3 mt-30 -52.27 134.31 33.74 Favored 'General case' 0 N--CA 1.518 2.974 0 O-C-N 120.687 -1.258 . . . . 0.0 108.128 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.535 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -111.28 -170.85 1.72 Allowed 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.773 0.797 . . . . 0.0 111.163 -177.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.513 ' H ' ' CD ' ' A' ' 15' ' ' GLN . 2.5 mp0 -45.88 163.44 0.22 Allowed Pre-proline 0 C--N 1.305 -1.329 0 C-N-CA 124.547 1.139 . . . . 0.0 109.943 178.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 39.9 Cg_endo -79.33 141.77 62.93 Favored 'Cis proline' 0 C--N 1.314 -1.275 0 C-N-CA 123.146 -1.606 . . . . 0.0 112.103 -0.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 37.3 m-85 -112.83 158.88 36.4 Favored Pre-proline 0 C--N 1.28 -2.454 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 59.5 Cg_endo -75.95 153.37 97.65 Favored 'Cis proline' 0 N--CA 1.498 1.747 0 C-N-CA 123.942 -1.274 . . . . 0.0 112.909 0.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.499 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 7.1 mtp180 -120.33 135.99 54.84 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.92 147.75 52.88 Favored 'General case' 0 N--CA 1.511 2.592 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.3 m -140.9 6.09 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.873 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 163.26 -177.19 39.33 Favored Glycine 0 N--CA 1.498 2.816 0 C-N-CA 117.98 -2.057 . . . . 0.0 110.157 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -141.51 117.66 10.65 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.139 -1.212 . . . . 0.0 110.445 -176.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.631 HG23 HG22 ' A' ' 59' ' ' VAL . 21.9 t -87.38 135.84 24.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 103.539 -2.763 . . . . 0.0 103.539 169.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.38 150.64 34.83 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.622 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -178.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 1' ' ' SER . 24.0 t0 -127.83 112.72 15.06 Favored 'General case' 0 C--N 1.276 -2.592 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.1 -8.98 58.93 Favored 'General case' 0 C--N 1.272 -2.768 0 O-C-N 121.682 -0.636 . . . . 0.0 110.433 -173.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -125.67 81.36 1.97 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.461 HH11 ' HD2' ' A' ' 29' ' ' ARG . 18.9 mtm180 -115.92 142.29 28.9 Favored Pre-proline 0 C--N 1.288 -2.072 0 O-C-N 121.211 -0.93 . . . . 0.0 110.379 -177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -66.65 161.37 41.88 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 121.551 1.501 . . . . 0.0 110.865 173.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -25.05 -60.77 0.06 Allowed 'General case' 0 N--CA 1.513 2.681 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -176.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.63 ' O ' ' NZ ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -129.31 36.53 4.14 Favored 'General case' 0 N--CA 1.508 2.462 0 O-C-N 120.72 -1.238 . . . . 0.0 110.914 -173.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.436 ' OG ' ' HB3' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -57.14 148.7 21.28 Favored 'General case' 0 C--N 1.276 -2.609 0 O-C-N 121.825 -0.547 . . . . 0.0 110.811 -178.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.63 ' NZ ' ' O ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -117.23 147.99 42.03 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 174.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.763 ' HB3' HD13 ' A' ' 52' ' ' ILE . 57.4 m-85 -83.89 150.63 25.58 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 121.27 -0.894 . . . . 0.0 109.311 178.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.669 ' HG3' HG21 ' A' ' 80' ' ' THR . 6.1 mmp_? -123.73 135.0 53.59 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 173.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.722 ' HG ' HG21 ' A' ' 42' ' ' VAL . 36.8 tp -112.93 144.27 42.78 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.84 171.02 18.91 Favored 'General case' 0 C--N 1.271 -2.823 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -175.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.472 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 119.22 166.36 13.39 Favored Glycine 0 C--N 1.29 -1.99 0 N-CA-C 110.104 -1.198 . . . . 0.0 110.104 177.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.421 ' HB2' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -59.09 109.92 0.94 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.418 ' HA2' HG13 ' A' ' 49' ' ' ILE . . . 124.21 -20.37 7.08 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -174.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.722 HG21 ' HG ' ' A' ' 37' ' ' LEU . 22.4 t -118.19 -86.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.991 -1.299 . . . . 0.0 108.788 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.49 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 27.3 t70 -99.5 -12.63 19.99 Favored 'General case' 0 C--O 1.206 -1.198 0 O-C-N 121.598 -0.689 . . . . 0.0 109.412 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.472 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 13.1 mp0 -109.76 160.34 16.41 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.84 135.81 92.92 Favored Pre-proline 0 C--N 1.273 -2.747 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.303 -174.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.579 ' HB2' HD11 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -77.21 124.18 10.35 Favored 'Cis proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.824 -1.74 . . . . 0.0 109.97 -1.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.49 ' NZ ' ' OD1' ' A' ' 43' ' ' ASP . 6.0 mttm -72.4 154.23 41.01 Favored 'General case' 0 C--N 1.29 -2.019 0 O-C-N 121.327 -0.858 . . . . 0.0 109.128 -178.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.41 34.95 63.45 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 120.145 -1.026 . . . . 0.0 112.148 173.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.756 HD13 HH11 ' A' ' 63' ' ' ARG . 4.0 mm -106.64 -49.08 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.658 -1.496 . . . . 0.0 107.854 176.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.49 ' HB2' HG22 ' A' ' 42' ' ' VAL . 94.7 m-85 -118.96 152.73 35.82 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.481 -0.762 . . . . 0.0 110.691 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.639 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 6.9 ptm180 -143.43 169.92 16.76 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.763 HD13 ' HB3' ' A' ' 35' ' ' PHE . 8.6 tt -129.2 159.73 40.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.318 0 C-N-CA 119.231 -0.987 . . . . 0.0 108.758 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.516 ' N ' ' O ' ' A' ' 58' ' ' SER . 37.6 t-20 -79.94 96.92 6.53 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.588 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 2.1 mp0 -33.91 -50.07 0.36 Allowed 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 122.588 0.355 . . . . 0.0 110.942 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.49 ' OD1' ' NH2' ' A' ' 32' ' ' ARG . 0.3 OUTLIER -83.03 -42.78 17.09 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.211 -0.931 . . . . 0.0 112.354 -175.68 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 p -94.74 -29.76 14.62 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.108 -0.995 . . . . 0.0 111.041 -171.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 24' ' ' VAL . . . 95.33 -1.38 64.44 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -56.05 129.33 39.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.043 -1.269 . . . . 0.0 108.185 176.419 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 24' ' ' VAL . 1.9 t -94.02 134.36 31.9 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.267 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.639 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -131.73 159.67 37.73 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 121.455 -0.778 . . . . 0.0 109.663 178.369 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 63' ' ' ARG . 12.3 p -103.79 139.99 23.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.1 p -94.74 -2.99 50.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.412 -0.805 . . . . 0.0 111.303 -175.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.756 HH11 HD13 ' A' ' 49' ' ' ILE . 2.8 ptp85 -157.21 -179.84 8.58 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 177.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 3.1 t -69.4 170.42 10.47 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 177.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 43.8 mt -131.41 136.28 47.88 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -126.87 122.79 35.68 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.532 HH22 ' CG ' ' A' ' 99' ' ' ASP . 5.3 mtm180 -57.12 -15.61 5.87 Favored 'General case' 0 N--CA 1.509 2.475 0 O-C-N 121.059 -1.026 . . . . 0.0 111.43 -175.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -69.28 -19.65 63.91 Favored 'General case' 0 C--N 1.281 -2.408 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.2 t -90.9 -60.02 2.61 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.108 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.482 HD12 ' CE1' ' A' ' 73' ' ' TYR . 1.9 mt -143.68 145.17 22.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.7 -24.92 16.31 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.1 p -154.72 139.01 9.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 121.784 -0.572 . . . . 0.0 109.647 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.482 ' CE1' HD12 ' A' ' 70' ' ' ILE . 33.5 m-85 -106.39 127.09 53.02 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.4 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 8.6 tp-100 -91.79 86.88 6.06 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 176.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.419 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -83.76 170.67 13.94 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 179.565 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 78.5 m-85 -135.55 133.37 38.3 Favored 'General case' 0 C--N 1.265 -3.104 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.617 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.85 145.42 18.85 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 -175.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.612 ' HB3' HG23 ' A' ' 86' ' ' THR . 50.8 mt-10 -135.23 143.88 46.59 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 176.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.561 ' C ' HD22 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -90.36 133.02 35.26 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 171.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.669 HG21 ' HG3' ' A' ' 36' ' ' ARG . 39.1 p -129.55 170.5 13.66 Favored 'General case' 0 C--N 1.278 -2.512 0 O-C-N 121.344 -0.848 . . . . 0.0 109.262 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.569 ' O ' ' N ' ' A' ' 83' ' ' ASN . 6.1 t0 -149.78 171.62 16.45 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.409 -0.807 . . . . 0.0 110.328 176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.47 HG13 ' OD1' ' A' ' 81' ' ' ASP . 8.3 m -13.9 -41.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 126.276 1.83 . . . . 0.0 114.724 -178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 81' ' ' ASP . 8.0 t-20 -79.43 -7.51 58.45 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 120.722 -1.236 . . . . 0.0 109.732 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 72.18 19.18 78.45 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 108.099 -2.0 . . . . 0.0 108.099 -178.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.5 OUTLIER -99.78 167.61 10.43 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 78' ' ' GLU . 91.3 m -94.07 119.68 33.26 Favored 'General case' 0 C--N 1.277 -2.563 0 O-C-N 122.154 -0.341 . . . . 0.0 111.292 -176.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.839 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.71 -34.79 24.84 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 174.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 1' ' ' SER . 0.3 OUTLIER -142.09 163.32 33.19 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.792 -0.568 . . . . 0.0 109.743 179.242 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.467 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 89.87 -172.18 38.42 Favored Glycine 0 N--CA 1.481 1.699 0 N-CA-C 108.067 -2.013 . . . . 0.0 108.067 -177.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.77 102.95 0.34 Allowed 'Cis proline' 0 N--CA 1.496 1.661 0 C-N-CA 123.732 -1.362 . . . . 0.0 112.225 -0.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.754 HG21 HG21 ' A' ' 2' ' ' ILE . 5.8 m -74.05 164.19 62.95 Favored Pre-proline 0 C--N 1.285 -2.199 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 175.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -94.48 154.61 1.99 Allowed 'Trans proline' 0 C--N 1.291 -2.491 0 C-N-CA 121.694 1.596 . . . . 0.0 111.295 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.935 HD11 HG13 ' A' ' 7' ' ' ILE . 16.6 tp -144.36 119.95 10.41 Favored 'General case' 0 C--N 1.275 -2.666 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 177.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.4 ' HG2' ' NE2' ' A' ' 74' ' ' GLN . 59.6 mt-10 -99.85 110.48 22.84 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.762 -0.586 . . . . 0.0 110.046 -177.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 50.9 t -94.25 107.3 19.16 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.7 mp -90.82 135.06 27.67 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.504 HG12 ' HB3' ' A' ' 11' ' ' GLU . 18.7 t -91.33 114.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.895 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.65 HG21 ' HB3' ' A' ' 8' ' ' LEU . 22.4 pt -111.42 172.34 2.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 O-C-N 121.58 -0.7 . . . . 0.0 110.498 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.532 ' CG ' HH22 ' A' ' 67' ' ' ARG . 5.6 m-20 -78.51 165.45 23.73 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -69.7 84.35 0.45 Allowed 'General case' 0 C--N 1.285 -2.197 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.2 t30 -57.77 -46.63 84.28 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.438 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 36.1 t0 47.36 -97.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 0.4 OUTLIER -146.81 30.76 0.97 Allowed 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 173.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.438 ' HG3' ' HB3' ' A' ' 102' ' ' ASP . 48.3 mtm180 -84.92 130.22 53.36 Favored Pre-proline 0 C--N 1.304 -1.409 0 O-C-N 121.702 -0.624 . . . . 0.0 111.238 -172.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo . . . . . 0 C--O 1.202 -1.29 0 C-N-CA 122.859 2.373 . . . . 0.0 110.557 175.398 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.406 ' N ' ' OE2' ' A' ' 88' ' ' GLU . 0.9 OUTLIER . . . . . 0 CA--C 1.502 -0.868 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.781 HG21 HG21 ' A' ' 91' ' ' VAL . 3.6 mt -78.08 117.77 23.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.341 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -85.0 120.41 35.41 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.489 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 174.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.47 HG23 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -139.75 159.14 27.34 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 -179.238 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.427 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -143.14 145.81 34.21 Favored Pre-proline 0 C--N 1.269 -2.925 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -53.83 134.52 59.4 Favored 'Trans proline' 0 C--N 1.314 -1.241 0 C-N-CA 121.586 1.524 . . . . 0.0 109.928 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.9 mt -106.79 116.66 51.02 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.281 0 C-N-CA 119.356 -0.938 . . . . 0.0 109.137 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.873 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -89.61 104.34 16.91 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.508 HD12 ' CG1' ' A' ' 95' ' ' VAL . 38.3 mt -110.32 127.28 27.28 Favored Pre-proline 0 C--N 1.281 -2.389 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -68.83 130.83 21.24 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 120.787 0.991 . . . . 0.0 111.034 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -74.46 -170.53 1.03 Allowed 'General case' 0 C--N 1.29 -1.988 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.305 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.605 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 0.0 OUTLIER 61.05 -26.97 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 175.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 11' ' ' GLU . 71.9 mt-30 -37.19 139.25 0.24 Allowed 'General case' 0 N--CA 1.521 3.098 0 O-C-N 121.007 -1.058 . . . . 0.0 108.529 179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.605 ' NH1' ' OD1' ' A' ' 12' ' ' ASN . 0.1 OUTLIER -91.24 -175.32 4.23 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 175.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.623 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 1.4 mt-30 -67.16 -168.58 0.05 OUTLIER Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.623 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 20.0 Cg_exo -66.96 127.44 8.53 Favored 'Cis proline' 0 N--CA 1.492 1.42 0 CA-C-N 120.499 1.214 . . . . 0.0 112.222 -0.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.516 ' CD2' ' HA ' ' A' ' 15' ' ' GLN . 32.9 m-85 -115.61 163.54 20.38 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 177.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 17.2 Cg_exo -68.1 163.35 76.79 Favored 'Cis proline' 0 N--CA 1.499 1.827 0 C-N-CA 123.959 -1.267 . . . . 0.0 111.207 -0.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.425 ' NH2' ' OE1' ' A' ' 13' ' ' GLN . 2.3 mtp85 -136.75 139.81 42.13 Favored 'General case' 0 C--N 1.293 -1.852 0 O-C-N 121.384 -0.823 . . . . 0.0 109.404 178.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.49 146.18 55.19 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.466 HG21 HD11 ' A' ' 9' ' ' ILE . 33.6 m -138.83 -1.18 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.486 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.456 176.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.45 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 167.04 178.35 39.37 Favored Glycine 0 N--CA 1.495 2.628 0 C-N-CA 118.968 -1.587 . . . . 0.0 109.344 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 3.1 tttp -135.36 130.63 35.25 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.306 -1.114 . . . . 0.0 110.625 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.573 HG11 HG11 ' A' ' 77' ' ' VAL . 41.8 t -99.78 145.54 10.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 171.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 26' ' ' ASP . 20.6 t -144.33 170.62 7.95 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.39 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.445 ' N ' HG12 ' A' ' 25' ' ' VAL . 7.6 t0 -129.58 148.97 51.53 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.9 p -105.17 -7.73 18.85 Favored 'General case' 0 C--N 1.278 -2.538 0 O-C-N 121.96 -0.462 . . . . 0.0 110.163 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.515 ' O ' ' NE ' ' A' ' 29' ' ' ARG . 3.1 m-20 -133.06 25.01 4.25 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.109 -1.036 . . . . 0.0 111.755 -172.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.515 ' NE ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -126.08 158.2 67.01 Favored Pre-proline 0 N--CA 1.506 2.338 0 CA-C-N 119.263 0.938 . . . . 0.0 110.961 -178.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' O ' ' OG ' ' A' ' 33' ' ' SER . 82.4 Cg_exo -37.34 129.42 0.66 Allowed 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 123.438 2.759 . . . . 0.0 112.311 178.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' A' ' 31' ' ' GLU . 8.5 mp0 -42.12 -30.85 0.32 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.985 -0.447 . . . . 0.0 111.097 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 32' ' ' ARG . 17.4 mtp180 -103.56 10.45 37.03 Favored 'General case' 0 C--N 1.291 -1.941 0 O-C-N 121.19 -0.944 . . . . 0.0 110.681 -175.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.535 ' HB2' HG22 ' A' ' 79' ' ' THR . 0.3 OUTLIER -55.48 133.27 49.96 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 118.485 -1.286 . . . . 0.0 108.358 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 33.8 mttm -96.89 156.33 16.39 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.725 ' CE1' HG23 ' A' ' 79' ' ' THR . 70.1 m-85 -105.4 142.24 35.51 Favored 'General case' 0 C--N 1.285 -2.23 0 O-C-N 121.476 -0.765 . . . . 0.0 111.657 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.527 ' NH1' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -103.1 149.0 25.03 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 174.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.529 ' HG ' HG21 ' A' ' 42' ' ' VAL . 26.4 tp -125.6 140.26 52.89 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 174.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 p -148.29 170.78 17.16 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -174.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.72 174.9 18.96 Favored Glycine 0 N--CA 1.499 2.88 0 O-C-N 121.019 -1.05 . . . . 0.0 111.817 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.7 mtmm -59.8 116.34 4.01 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 115.75 -19.33 14.19 Favored Glycine 0 C--N 1.28 -2.543 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 -177.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.529 HG21 ' HG ' ' A' ' 37' ' ' LEU . 27.1 t -122.56 -95.46 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.588 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 23.0 t70 -83.7 -15.85 47.2 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.046 -1.034 . . . . 0.0 109.765 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 62.6 mm-40 -113.26 155.07 25.75 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.257 -0.902 . . . . 0.0 109.226 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 4.9 mt-10 -54.43 133.31 62.56 Favored Pre-proline 0 C--N 1.29 -2.014 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.523 -177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HG2' HG13 ' A' ' 49' ' ' ILE . 28.2 Cg_endo -73.62 118.11 4.72 Favored 'Cis proline' 0 N--CA 1.499 1.819 0 C-N-CA 123.526 -1.448 . . . . 0.0 110.305 -1.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.588 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 3.7 mtpp -68.27 145.41 54.27 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 120.902 -1.124 . . . . 0.0 112.242 -172.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 61.88 28.11 69.69 Favored Glycine 0 N--CA 1.498 2.816 0 CA-C-N 115.881 -0.6 . . . . 0.0 113.389 171.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.436 HG13 ' HG2' ' A' ' 46' ' ' PRO . 17.8 mm -85.26 -46.42 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 CA-C-N 119.254 1.527 . . . . 0.0 107.053 175.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -107.66 147.39 30.76 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.686 0.755 . . . . 0.0 109.18 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.66 170.09 16.35 Favored 'General case' 0 C--N 1.262 -3.222 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.411 HD11 ' HA2' ' A' ' 57' ' ' GLY . 1.2 tt -134.19 150.38 31.02 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.016 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.413 ' OD1' HG23 ' A' ' 56' ' ' THR . 19.0 t-20 -84.81 83.2 8.12 Favored 'General case' 0 C--N 1.271 -2.819 0 N-CA-C 106.314 -1.735 . . . . 0.0 106.314 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' CD ' HH21 ' A' ' 36' ' ' ARG . 5.8 mt-10 -37.44 -33.47 0.07 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.557 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -79.72 -15.56 57.28 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.156 -0.965 . . . . 0.0 110.985 -174.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.413 HG23 ' OD1' ' A' ' 53' ' ' ASN . 74.8 p -127.27 -36.85 2.09 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 52' ' ' ILE . . . 100.93 6.23 52.4 Favored Glycine 0 C--N 1.277 -2.699 0 N-CA-C 108.301 -1.919 . . . . 0.0 108.301 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 2.4 m -66.16 119.87 12.23 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.41 -1.053 . . . . 0.0 108.745 178.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.542 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.2 t -87.11 134.95 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.27 158.21 44.95 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.358 -0.838 . . . . 0.0 108.756 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 13.6 p -106.81 141.49 21.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 44.1 p -89.58 -13.93 36.15 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.546 -0.722 . . . . 0.0 110.571 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.617 ' NE ' ' O ' ' A' ' 64' ' ' THR . 1.8 ptm180 -157.18 -173.53 4.48 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.187 -0.945 . . . . 0.0 109.593 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.617 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 14.6 t -70.06 178.65 2.65 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 11' ' ' GLU . 35.2 mt -131.22 162.28 30.33 Favored 'General case' 0 C--N 1.291 -1.964 0 O-C-N 120.541 -1.349 . . . . 0.0 108.504 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.401 ' OD1' ' NH2' ' A' ' 63' ' ' ARG . 14.1 m-20 -140.0 113.71 8.7 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 5.2 ttp180 -60.45 -11.18 6.14 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -69.21 -22.8 63.85 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 177.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.5 t -105.05 -55.95 5.35 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.469 HD12 ' CE1' ' A' ' 73' ' ' TYR . 1.4 mt -141.53 142.3 29.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 121.569 -0.707 . . . . 0.0 110.06 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.22 -23.16 16.3 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 7.2 p -152.9 135.15 6.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 O-C-N 121.638 -0.664 . . . . 0.0 109.733 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.469 ' CE1' HD12 ' A' ' 70' ' ' ILE . 84.3 m-85 -100.86 117.28 34.63 Favored 'General case' 0 C--N 1.29 -2.019 0 N-CA-C 106.768 -1.568 . . . . 0.0 106.768 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -85.91 87.03 7.35 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.431 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -81.62 170.72 15.48 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 73.1 m-85 -134.08 132.31 39.82 Favored 'General case' 0 C--N 1.264 -3.149 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.671 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -112.2 152.66 13.99 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.106 0 O-C-N 121.983 -0.448 . . . . 0.0 109.864 -177.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.716 ' HB3' HG23 ' A' ' 86' ' ' THR . 50.4 mt-10 -138.47 139.51 38.84 Favored 'General case' 0 C--N 1.289 -2.059 0 O-C-N 121.779 -0.575 . . . . 0.0 109.565 177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.725 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -88.69 134.21 33.97 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 105.293 -2.114 . . . . 0.0 105.293 173.233 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.529 ' HA ' ' O ' ' A' ' 85' ' ' LYS . 7.9 p -137.14 163.04 31.77 Favored 'General case' 0 C--N 1.279 -2.472 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.545 -176.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -105.8 171.15 7.49 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.2 m -46.29 -27.72 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-O 121.369 0.604 . . . . 0.0 110.5 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -79.59 0.52 29.69 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.507 -0.745 . . . . 0.0 110.385 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.21 20.46 76.61 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 80' ' ' THR . 25.5 mttp -85.11 146.89 26.91 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 176.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.716 HG23 ' HB3' ' A' ' 78' ' ' GLU . 31.8 m -99.26 117.04 32.83 Favored 'General case' 0 C--N 1.28 -2.439 0 CA-C-O 121.145 0.498 . . . . 0.0 110.816 -177.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.842 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.58 -28.78 17.31 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.459 ' CD ' ' NH1' ' A' ' 29' ' ' ARG . 1.1 tp10 -140.81 151.37 44.33 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 94.73 -177.58 35.84 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -62.74 102.75 0.16 OUTLIER 'Cis proline' 0 N--CA 1.5 1.899 0 C-N-CA 123.821 -1.325 . . . . 0.0 113.469 -0.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.781 HG21 HG21 ' A' ' 2' ' ' ILE . 3.3 m -74.8 164.19 63.05 Favored Pre-proline 0 C--N 1.294 -1.831 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 173.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -92.35 151.06 3.03 Favored 'Trans proline' 0 C--N 1.283 -2.912 0 C-N-CA 121.395 1.397 . . . . 0.0 111.905 177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.47 HD13 HG23 ' A' ' 4' ' ' VAL . 12.1 tp -135.76 126.74 27.76 Favored 'General case' 0 C--N 1.278 -2.526 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 175.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -103.57 105.52 15.79 Favored 'General case' 0 C--N 1.284 -2.248 0 O-C-N 121.831 -0.543 . . . . 0.0 109.715 -176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.508 ' CG1' HD12 ' A' ' 9' ' ' ILE . 24.7 t -95.7 104.6 16.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 175.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.8 mp -87.57 134.0 28.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.446 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 16.1 t -89.67 108.94 19.86 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 108.21 -1.034 . . . . 0.0 108.21 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.604 HG21 ' HB3' ' A' ' 8' ' ' LEU . 15.3 pt -102.85 171.21 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 101' ' ' ASN . 4.8 m-20 -80.39 174.47 11.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.424 ' OE1' ' NH2' ' A' ' 14' ' ' ARG . 4.3 mt-30 -66.67 68.76 0.06 Allowed 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.545 ' N ' ' O ' ' A' ' 99' ' ' ASP . 1.9 t-20 -75.5 53.53 0.69 Allowed 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.542 ' O ' ' N ' ' A' ' 104' ' ' ARG . 0.8 OUTLIER -57.12 -45.72 83.24 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -178.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 64.09 -61.12 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' A' ' 102' ' ' ASP . 77.6 mtp180 -153.97 121.6 2.96 Favored Pre-proline 0 C--N 1.296 -1.742 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 177.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.187 -2.051 0 C-N-CA 122.753 2.302 . . . . 0.0 111.489 176.884 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.581 ' H2 ' ' CG ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.217 -0.636 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.884 HG21 HG21 ' A' ' 91' ' ' VAL . 5.2 mt -73.73 120.49 22.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.811 0 O-C-N 121.075 -1.016 . . . . 0.0 110.611 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.66 119.98 50.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.54 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -142.42 163.76 18.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.468 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -149.53 159.44 36.38 Favored Pre-proline 0 C--N 1.278 -2.517 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.34 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.752 ' HB3' HD11 ' A' ' 96' ' ' ILE . 27.3 Cg_exo -44.73 131.03 10.02 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.855 1.703 . . . . 0.0 111.893 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.57 HG13 HD11 ' A' ' 93' ' ' LEU . 19.5 mt -101.4 122.5 53.6 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.226 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 175.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.3 mp -106.88 115.8 30.82 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.919 HD11 HG21 ' A' ' 21' ' ' VAL . 23.0 mt -122.21 128.04 25.66 Favored Pre-proline 0 C--N 1.26 -3.314 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 21.5 Cg_endo -70.98 141.78 41.06 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 CA-C-N 120.038 1.049 . . . . 0.0 110.064 178.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.438 ' OE1' ' NH1' ' A' ' 67' ' ' ARG . 3.4 pt-20 -55.69 173.76 0.12 Allowed 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 121.988 0.899 . . . . 0.0 110.104 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.431 ' ND2' ' OE1' ' A' ' 100' ' ' GLN . 4.1 p30 52.74 19.15 1.18 Allowed 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 176.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.513 ' HG3' HG22 ' A' ' 9' ' ' ILE . 1.6 mm-40 -57.49 131.35 49.9 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 173.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.474 ' O ' ' NH1' ' A' ' 19' ' ' ARG . 3.3 mtt180 -101.84 -174.37 2.57 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 119.546 1.066 . . . . 0.0 110.434 -176.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.636 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 16.8 mt-30 -54.16 168.14 0.47 Allowed Pre-proline 0 C--N 1.298 -1.664 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.636 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 4.1 Cg_exo -77.02 131.71 25.12 Favored 'Cis proline' 0 C--N 1.308 -1.593 0 C-N-CA 123.503 -1.457 . . . . 0.0 112.831 0.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -119.61 159.55 45.71 Favored Pre-proline 0 C--N 1.29 -1.997 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 13.0 Cg_exo -69.74 155.29 93.28 Favored 'Cis proline' 0 N--CA 1.493 1.497 0 C-N-CA 123.878 -1.301 . . . . 0.0 110.426 -0.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.474 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -129.54 131.34 46.56 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.25 -179.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.21 116.01 9.16 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.919 HG21 HD11 ' A' ' 9' ' ' ILE . 19.5 m -118.42 7.61 6.85 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.592 -178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . -179.53 163.5 30.91 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -135.58 116.33 14.0 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.27 -1.135 . . . . 0.0 109.641 179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.577 HG23 ' CG2' ' A' ' 59' ' ' VAL . 21.8 t -80.97 146.9 6.77 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.947 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 176.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.3 t -139.3 166.72 21.19 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.581 ' CG ' ' H2 ' ' A' ' 1' ' ' SER . 11.9 t70 -112.98 140.14 48.04 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 173.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 1' ' ' SER . 0.0 OUTLIER -45.15 -35.49 3.21 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.301 0.572 . . . . 0.0 109.53 -177.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -150.93 84.72 1.34 Allowed 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.624 ' NH2' ' O ' ' A' ' 55' ' ' ASN . 23.3 mtp180 -64.73 121.25 72.3 Favored Pre-proline 0 C--N 1.288 -2.076 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -177.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -57.33 -163.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 122.601 2.201 . . . . 0.0 113.235 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -58.82 -78.71 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.225 -0.922 . . . . 0.0 111.882 -174.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.624 ' HB2' HG13 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -107.77 31.26 5.61 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.322 -0.862 . . . . 0.0 110.239 -173.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.8 OUTLIER -65.0 143.17 58.13 Favored 'General case' 0 C--N 1.275 -2.654 0 O-C-N 120.927 -1.108 . . . . 0.0 110.876 -178.068 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.454 ' NZ ' ' O ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -124.18 138.88 54.36 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.487 ' CE2' HG23 ' A' ' 79' ' ' THR . 71.6 m-85 -82.43 144.11 30.71 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.747 -0.596 . . . . 0.0 110.598 -178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.454 HH12 ' CD ' ' A' ' 54' ' ' GLU . 4.2 mmp_? -120.86 145.02 48.06 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 38' ' ' THR . 23.4 tp -120.79 153.45 37.05 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 37' ' ' LEU . 3.0 p -158.13 171.26 20.53 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -176.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.51 175.63 18.77 Favored Glycine 0 N--CA 1.502 3.083 0 C-N-CA 119.796 -1.192 . . . . 0.0 111.444 175.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.2 mtpp -59.24 119.54 7.56 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 113.07 -19.12 20.92 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -177.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.462 HG21 ' HG ' ' A' ' 37' ' ' LEU . 47.5 t -118.07 -98.21 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.619 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.7 OUTLIER -85.77 -12.46 50.92 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.253 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -113.12 148.89 34.39 Favored 'General case' 0 C--N 1.286 -2.195 0 O-C-N 121.06 -1.025 . . . . 0.0 108.363 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.509 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.1 pt-20 -51.85 136.02 36.49 Favored Pre-proline 0 C--N 1.284 -2.282 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.359 -176.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.503 ' HB2' ' CG1' ' A' ' 49' ' ' ILE . 2.9 Cg_exo -72.83 118.07 4.46 Favored 'Cis proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.475 -1.469 . . . . 0.0 109.161 -1.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.619 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 8.9 mtpp -68.56 145.62 53.82 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 120.856 -1.153 . . . . 0.0 111.251 -172.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 65.76 34.1 87.83 Favored Glycine 0 N--CA 1.492 2.401 0 O-C-N 121.806 -0.559 . . . . 0.0 112.383 172.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.586 HG23 ' HD2' ' A' ' 63' ' ' ARG . 8.8 mm -89.47 -45.58 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 174.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.743 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 26.3 m-85 -111.49 139.22 47.09 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.591 0.71 . . . . 0.0 110.041 -178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.419 ' HE ' ' HG ' ' A' ' 60' ' ' SER . 0.6 OUTLIER -137.22 128.96 28.78 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 58' ' ' SER . 7.7 tt -98.9 161.93 2.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.523 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 13.2 t-20 -96.03 106.73 18.94 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' CD ' HH12 ' A' ' 36' ' ' ARG . 0.0 OUTLIER -40.82 -39.15 1.06 Allowed 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.108 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.624 ' O ' ' NH2' ' A' ' 29' ' ' ARG . 8.0 t-20 -96.36 -30.95 13.11 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.35 -0.844 . . . . 0.0 112.704 -173.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.523 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 18.1 p -98.16 -26.92 14.4 Favored 'General case' 0 C--N 1.283 -2.295 0 O-C-N 120.757 -1.215 . . . . 0.0 108.611 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.01 5.1 88.02 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -178.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 4.4 m -63.63 125.22 23.57 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.263 -1.139 . . . . 0.0 109.409 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.577 ' CG2' HG23 ' A' ' 24' ' ' VAL . 2.0 t -90.66 121.91 41.49 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.419 ' HG ' ' HE ' ' A' ' 51' ' ' ARG . 0.1 OUTLIER -119.11 146.93 44.71 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.343 -0.848 . . . . 0.0 110.031 -178.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 14.6 p -102.53 142.42 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 176.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.466 ' N ' ' O ' ' A' ' 49' ' ' ILE . 43.8 p -95.33 -20.05 19.46 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.524 -0.735 . . . . 0.0 112.908 -173.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.586 ' HD2' HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -139.89 176.48 8.71 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.483 -1.386 . . . . 0.0 110.253 -178.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.47 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 13.0 t -70.15 127.9 34.42 Favored 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.546 HD22 ' CE2' ' A' ' 73' ' ' TYR . 97.3 mt -83.22 120.51 25.91 Favored 'General case' 0 C--N 1.291 -1.958 0 O-C-N 121.292 -0.88 . . . . 0.0 109.131 -177.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.436 ' OD2' ' NH2' ' A' ' 63' ' ' ARG . 0.1 OUTLIER -108.61 114.09 27.61 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 177.45 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.449 ' HG3' ' CG1' ' A' ' 97' ' ' VAL . 14.7 mtp-105 -53.66 -7.96 0.13 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.447 -0.783 . . . . 0.0 110.399 -178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -68.45 -28.68 67.27 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 177.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.4 t -91.47 -63.55 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -138.68 132.41 40.58 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.53 -23.7 24.29 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.8 p -150.22 132.07 5.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.546 ' CE2' HD22 ' A' ' 65' ' ' LEU . 82.8 m-85 -94.7 117.21 29.76 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.35 83.39 7.69 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 178.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.462 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -87.06 170.31 11.65 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.468 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 64.8 m-85 -138.31 131.14 29.61 Favored 'General case' 0 C--N 1.265 -3.082 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.7 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -110.14 155.73 11.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 CA-C-O 121.396 0.617 . . . . 0.0 109.75 -175.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.32 147.54 28.47 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.79 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -101.83 131.79 47.96 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 175.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.625 ' C ' HD21 ' A' ' 87' ' ' LEU . 80.8 p -121.22 164.85 16.29 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 83' ' ' ASN . 1.5 t0 -144.75 172.18 13.37 Favored 'General case' 0 C--N 1.292 -1.928 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.837 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.624 HG13 ' HB2' ' A' ' 32' ' ' ARG . 24.4 m -38.82 -21.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 C-N-CA 123.455 0.702 . . . . 0.0 111.61 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 81' ' ' ASP . 3.9 t-20 -79.14 -4.91 52.7 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.175 -0.953 . . . . 0.0 108.746 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 63.52 27.55 71.05 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 107.685 -2.166 . . . . 0.0 107.685 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.562 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -119.84 162.79 18.52 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 88' ' ' GLU . 1.3 m -90.18 124.08 34.54 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.843 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -93.95 -13.22 27.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.896 -1.128 . . . . 0.0 107.985 178.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.647 ' O ' HG22 ' A' ' 86' ' ' THR . 1.0 OUTLIER -156.02 162.36 40.33 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.526 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 91.95 -175.64 38.52 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -70.83 104.75 0.49 Allowed 'Cis proline' 0 N--CA 1.499 1.818 0 C-N-CA 123.58 -1.425 . . . . 0.0 111.373 0.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.884 HG21 HG21 ' A' ' 2' ' ' ILE . 18.1 m -76.81 160.62 76.3 Favored Pre-proline 0 C--N 1.284 -2.271 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -93.46 153.79 2.45 Favored 'Trans proline' 0 C--N 1.288 -2.625 0 C-N-CA 121.556 1.504 . . . . 0.0 111.455 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.57 HD11 HG13 ' A' ' 7' ' ' ILE . 8.2 tp -140.3 127.38 20.9 Favored 'General case' 0 C--N 1.271 -2.833 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -112.57 110.21 20.23 Favored 'General case' 0 C--N 1.288 -2.093 0 O-C-N 121.488 -0.758 . . . . 0.0 109.286 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.743 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 5.3 t -99.51 101.94 12.77 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.752 HD11 ' HB3' ' A' ' 6' ' ' PRO . 4.6 mp -80.59 129.37 37.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 O-C-N 121.613 -0.679 . . . . 0.0 109.234 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.449 ' CG1' ' HG3' ' A' ' 67' ' ' ARG . 16.8 t -86.29 92.14 3.51 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 174.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 13.8 pt -79.71 171.58 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 O-C-N 121.515 -0.741 . . . . 0.0 109.28 -177.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 101' ' ' ASN . 16.6 m-20 -77.94 166.9 22.29 Favored 'General case' 0 C--N 1.282 -2.349 0 O-C-N 120.983 -1.073 . . . . 0.0 108.674 -178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.431 ' OE1' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -68.54 68.62 0.15 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.531 HD21 HD12 ' A' ' 98' ' ' ILE . 4.8 p30 -108.48 24.55 12.87 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 104' ' ' ARG . 4.3 p-10 -74.98 -112.78 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 175.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -128.04 -1.98 5.82 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 173.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.458 ' CZ ' ' HD2' ' A' ' 105' ' ' PRO . 0.1 OUTLIER 60.04 109.67 0.03 OUTLIER Pre-proline 0 C--N 1.307 -1.256 0 C-N-CA 123.113 0.565 . . . . 0.0 111.669 -178.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.458 ' HD2' ' CZ ' ' A' ' 104' ' ' ARG . 34.8 Cg_endo . . . . . 0 C--O 1.206 -1.083 0 C-N-CA 122.383 2.055 . . . . 0.0 111.08 175.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.49 ' N ' ' OD2' ' A' ' 26' ' ' ASP . 0.6 OUTLIER . . . . . 0 CA--C 1.508 -0.643 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.887 HG21 HG21 ' A' ' 91' ' ' VAL . 7.1 mt -62.58 135.39 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 O-C-N 121.695 -0.628 . . . . 0.0 109.495 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.52 122.34 62.29 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.382 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 175.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.475 ' HB ' HG13 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -133.19 160.47 42.47 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.257 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.412 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.2 OUTLIER -131.89 157.34 78.46 Favored Pre-proline 0 C--N 1.275 -2.665 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.56 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -57.35 134.97 67.24 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.285 1.323 . . . . 0.0 109.815 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.7 mt -109.27 113.97 45.63 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.244 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.934 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -92.14 112.58 24.57 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 178.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.613 HD11 HG21 ' A' ' 21' ' ' VAL . 20.0 mt -117.96 133.99 23.34 Favored Pre-proline 0 C--N 1.287 -2.134 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 31.1 Cg_endo -69.74 140.39 42.63 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.09 1.193 . . . . 0.0 110.692 178.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.481 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -79.5 174.36 11.65 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.887 -1.125 . . . . 0.0 108.698 178.41 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.527 ' OD1' ' NH2' ' A' ' 104' ' ' ARG . 59.6 m-20 58.29 38.22 26.03 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.813 -0.554 . . . . 0.0 110.692 175.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.47 ' OE1' ' N ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -88.43 166.57 14.14 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 175.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -117.5 167.04 11.65 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.681 -1.262 . . . . 0.0 111.856 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.567 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -64.48 178.71 0.43 Allowed Pre-proline 0 C--N 1.285 -2.203 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 11.8 Cg_exo -66.51 140.34 48.65 Favored 'Cis proline' 0 C--N 1.307 -1.647 0 C-N-CA 123.704 -1.373 . . . . 0.0 112.786 0.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.448 ' HB3' ' O ' ' A' ' 62' ' ' THR . 35.0 m-85 -119.46 167.39 12.23 Favored Pre-proline 0 C--N 1.299 -1.607 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 176.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 38.5 Cg_endo -66.01 168.53 47.51 Favored 'Cis proline' 0 N--CA 1.5 1.9 0 CA-C-N 120.529 1.225 . . . . 0.0 111.899 -0.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.437 ' O ' ' HA ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -133.35 129.1 37.0 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 120.231 -0.587 . . . . 0.0 109.957 -179.092 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -66.45 140.44 58.03 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 174.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.613 HG21 HD11 ' A' ' 9' ' ' ILE . 35.4 m -137.68 3.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.791 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 177.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 172.75 168.39 34.0 Favored Glycine 0 N--CA 1.507 3.371 0 C-N-CA 118.933 -1.603 . . . . 0.0 110.268 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.2 OUTLIER -132.35 122.45 25.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.035 -1.274 . . . . 0.0 109.936 -178.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.546 ' CG1' HG23 ' A' ' 2' ' ' ILE . 16.5 t -90.6 135.58 26.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 172.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.8 t -131.61 157.73 43.2 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 1' ' ' SER . 8.4 t70 -111.29 122.5 48.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.253 -0.904 . . . . 0.0 109.7 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.408 ' H ' ' HG ' ' A' ' 27' ' ' SER . 2.2 p -63.51 -6.04 4.58 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.445 0.64 . . . . 0.0 109.739 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 29' ' ' ARG . 23.6 t0 -137.78 29.9 2.58 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.296 -0.877 . . . . 0.0 108.943 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.656 ' NH1' ' OG ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -29.57 97.45 0.09 OUTLIER Pre-proline 0 N--CA 1.502 2.131 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' GLU . 19.7 Cg_exo -62.24 145.1 96.21 Favored 'Trans proline' 0 CA--C 1.549 1.227 0 N-CA-C 108.5 -1.385 . . . . 0.0 108.5 172.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -25.3 -88.04 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.163 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -174.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.559 ' HB2' HG13 ' A' ' 82' ' ' VAL . 2.5 mmp_? -88.49 26.75 1.39 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.699 -1.251 . . . . 0.0 110.035 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.656 ' OG ' ' NH1' ' A' ' 29' ' ' ARG . 14.0 p -59.67 120.82 10.2 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.918 -1.114 . . . . 0.0 110.372 -177.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -104.83 148.13 26.98 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 178.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.589 ' CE2' HG23 ' A' ' 79' ' ' THR . 67.4 m-85 -88.19 126.87 35.36 Favored 'General case' 0 C--N 1.274 -2.706 0 O-C-N 121.359 -0.838 . . . . 0.0 110.35 179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.449 ' HG3' HG21 ' A' ' 80' ' ' THR . 4.7 mtp180 -106.24 141.35 37.73 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 175.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.2 tp -121.51 145.48 47.9 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -151.64 171.12 18.13 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -177.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 117.74 164.86 13.37 Favored Glycine 0 N--CA 1.499 2.839 0 O-C-N 120.951 -1.093 . . . . 0.0 110.561 178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -55.46 117.74 3.84 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.479 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 117.03 -21.05 11.23 Favored Glycine 0 N--CA 1.5 2.955 0 N-CA-C 107.766 -2.134 . . . . 0.0 107.766 -176.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.465 HG22 ' HB2' ' A' ' 50' ' ' PHE . 43.3 t -125.06 -92.58 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.7 -0.882 . . . . 0.0 108.747 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -85.39 -9.14 57.94 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.528 -0.733 . . . . 0.0 109.489 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 4.0 mp0 -125.97 161.71 26.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.447 -0.783 . . . . 0.0 109.35 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.468 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 2.5 mt-10 -60.27 131.63 90.11 Favored Pre-proline 0 C--N 1.289 -2.027 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.361 -177.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.479 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 41.1 Cg_endo -73.03 115.13 2.97 Favored 'Cis proline' 0 N--CA 1.512 2.605 0 C-N-CA 123.521 -1.449 . . . . 0.0 110.992 -1.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 4.5 mttp -66.47 150.32 49.12 Favored 'General case' 0 C--N 1.293 -1.876 0 O-C-N 120.921 -1.112 . . . . 0.0 112.744 -173.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.18 29.27 36.33 Favored Glycine 0 N--CA 1.493 2.44 0 CA-C-N 115.015 -0.993 . . . . 0.0 113.284 171.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.436 ' N ' ' O ' ' A' ' 41' ' ' GLY . 13.9 mm -80.91 -44.29 21.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 174.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.499 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 62.1 m-85 -109.16 138.46 45.48 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.656 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -139.79 138.88 36.2 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 174.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.454 HG13 HG22 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -106.49 152.5 8.08 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 O-C-N 121.825 -0.547 . . . . 0.0 109.546 -176.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -79.83 119.47 22.75 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 35' ' ' PHE . 3.1 mt-10 -51.11 -45.52 61.59 Favored 'General case' 0 C--N 1.289 -2.046 0 O-C-N 122.207 -0.308 . . . . 0.0 111.658 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.437 HD22 ' C ' ' A' ' 55' ' ' ASN . 0.1 OUTLIER -81.12 -53.02 6.75 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.081 -1.637 . . . . 0.0 111.997 -176.438 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.9 p -79.74 -27.81 40.52 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 121.2 0.524 . . . . 0.0 110.575 -172.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.81 12.9 80.73 Favored Glycine 0 C--N 1.285 -2.29 0 N-CA-C 108.847 -1.701 . . . . 0.0 108.847 -178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 14.9 m -67.9 120.14 13.71 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.275 -1.132 . . . . 0.0 108.91 178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.456 ' CG2' HG23 ' A' ' 24' ' ' VAL . 1.6 t -87.13 132.19 33.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -134.04 150.72 51.23 Favored 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.27 -0.894 . . . . 0.0 109.491 179.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -97.36 142.15 14.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' PHE . 63.0 p -88.11 -20.76 25.24 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.55 -0.719 . . . . 0.0 110.795 -175.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.59 ' NE ' ' O ' ' A' ' 64' ' ' THR . 1.6 ptm180 -148.27 -172.88 4.18 Favored 'General case' 0 C--N 1.289 -2.062 0 O-C-N 121.208 -0.933 . . . . 0.0 108.834 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.59 ' O ' ' NE ' ' A' ' 63' ' ' ARG . 13.1 t -67.38 168.41 10.75 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.47 ' N ' ' OE1' ' A' ' 13' ' ' GLN . 92.5 mt -122.58 149.34 44.1 Favored 'General case' 0 C--N 1.278 -2.521 0 O-C-N 120.629 -1.294 . . . . 0.0 108.695 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.499 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -130.49 117.6 19.87 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 -178.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.26 1.86 1.42 Allowed 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 66' ' ' ASP . 2.9 mt-10 -78.53 -29.23 46.34 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.7 t -91.79 -55.77 5.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.955 0 CA-C-O 122.209 1.004 . . . . 0.0 108.342 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.4 HG21 ' CG ' ' A' ' 73' ' ' TYR . 1.9 mt -137.85 139.27 43.03 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.54 -24.21 18.05 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 1.7 p -154.1 129.6 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.409 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 58.1 m-85 -97.21 124.1 41.19 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -98.55 88.39 4.08 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.6 170.74 15.47 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 62.8 m-85 -124.58 131.57 53.47 Favored 'General case' 0 C--N 1.274 -2.711 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 176.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.614 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -114.06 146.92 17.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 -177.285 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.65 ' HB3' HG23 ' A' ' 86' ' ' THR . 40.8 mt-10 -137.1 138.53 40.45 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 175.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.638 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -86.76 133.54 33.65 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 103.57 -2.752 . . . . 0.0 103.57 170.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.605 ' C ' HD21 ' A' ' 87' ' ' LEU . 4.6 p -129.78 146.13 51.54 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.052 -1.059 . . . . 0.0 112.476 -172.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.519 ' HB2' HD11 ' A' ' 87' ' ' LEU . 1.4 t70 -80.66 170.14 16.71 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.559 HG13 ' HB2' ' A' ' 32' ' ' ARG . 35.2 m -61.62 -24.43 33.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.15 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 174.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -79.72 2.5 22.53 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.23 16.93 78.61 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.133 -1.587 . . . . 0.0 109.133 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 80' ' ' THR . 14.0 mttp -81.02 142.15 33.68 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.65 HG23 ' HB3' ' A' ' 78' ' ' GLU . 35.5 m -88.76 116.77 27.26 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.904 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -91.98 -19.45 22.4 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.77 146.73 23.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.537 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 99.41 -176.72 29.19 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -66.86 103.99 0.31 Allowed 'Cis proline' 0 N--CA 1.5 1.873 0 C-N-CA 123.669 -1.388 . . . . 0.0 112.519 -0.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.887 HG21 HG21 ' A' ' 2' ' ' ILE . 11.7 m -79.9 162.97 60.41 Favored Pre-proline 0 C--N 1.289 -2.038 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 177.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -94.52 151.06 1.92 Allowed 'Trans proline' 0 C--N 1.296 -2.19 0 C-N-CA 121.808 1.672 . . . . 0.0 112.101 178.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.44 HD13 ' CG2' ' A' ' 4' ' ' VAL . 5.3 tp -133.88 129.8 36.92 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 177.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -107.39 114.13 27.94 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.477 -0.764 . . . . 0.0 109.907 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.499 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 57.8 t -103.81 104.1 16.21 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.552 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.8 mp -86.13 139.19 17.75 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 11' ' ' GLU . 38.5 t -95.0 124.38 47.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 10.4 pt -112.13 170.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -94.54 171.39 8.83 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.921 -1.112 . . . . 0.0 108.124 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 102' ' ' ASP . 23.2 pt20 -156.93 158.55 36.86 Favored 'General case' 0 C--N 1.286 -2.174 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -71.9 66.76 0.58 Allowed 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.527 ' CG ' ' N ' ' A' ' 103' ' ' ASN . 4.3 p-10 -56.46 -57.06 13.93 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.406 -171.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.527 ' N ' ' CG ' ' A' ' 102' ' ' ASP . 1.3 m-20 58.92 27.79 16.7 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.527 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 24.9 mtm180 -61.01 135.3 93.17 Favored Pre-proline 0 N--CA 1.492 1.663 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo . . . . . 0 C--O 1.199 -1.462 0 C-N-CA 122.044 1.829 . . . . 0.0 112.57 -179.311 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 2.7 p . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.746 HG21 HG21 ' A' ' 91' ' ' VAL . 24.8 mt -86.46 134.43 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 O-C-N 121.42 -0.8 . . . . 0.0 110.438 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -120.89 124.64 72.75 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 173.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.463 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -135.52 157.05 39.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.74 143.18 47.99 Favored Pre-proline 0 C--N 1.276 -2.596 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.33 133.86 30.92 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.017 1.811 . . . . 0.0 110.359 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.42 HG21 HG23 ' A' ' 21' ' ' VAL . 42.9 mt -105.05 112.29 38.04 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 O-C-N 121.54 -0.725 . . . . 0.0 109.653 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.873 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -93.49 110.73 22.3 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.536 HG22 ' NE2' ' A' ' 13' ' ' GLN . 1.8 mt -120.23 134.7 24.11 Favored Pre-proline 0 N--CA 1.501 2.083 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.541 ' O ' ' NE2' ' A' ' 13' ' ' GLN . 35.8 Cg_endo -74.13 154.46 47.03 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 CA-C-N 119.68 0.922 . . . . 0.0 112.742 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -77.0 174.24 10.86 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-O 122.304 1.05 . . . . 0.0 111.12 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.583 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 57.5 t30 52.38 24.69 3.05 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.541 ' NE2' ' O ' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -77.99 137.47 38.31 Favored 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 105.396 -2.076 . . . . 0.0 105.396 174.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.583 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -101.26 175.21 5.66 Favored 'General case' 0 C--N 1.267 -3.005 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.524 -177.652 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.651 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -53.49 -179.32 0.05 OUTLIER Pre-proline 0 C--N 1.296 -1.758 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.651 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 6.7 Cg_exo -70.74 128.92 14.45 Favored 'Cis proline' 0 N--CA 1.491 1.338 0 C-N-CA 124.25 -1.146 . . . . 0.0 113.422 -0.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.453 ' CD2' ' HA ' ' A' ' 63' ' ' ARG . 22.7 m-85 -113.43 165.74 12.7 Favored Pre-proline 0 C--N 1.298 -1.669 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.421 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 14.7 Cg_exo -70.66 161.43 88.82 Favored 'Cis proline' 0 N--CA 1.5 1.869 0 C-N-CA 124.412 -1.078 . . . . 0.0 112.254 -1.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.477 ' NH2' ' OE1' ' A' ' 13' ' ' GLN . 1.2 mtp-105 -131.17 128.28 39.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.477 -0.764 . . . . 0.0 109.711 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 5.3 t0 -63.06 133.2 54.14 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.42 HG23 HG21 ' A' ' 7' ' ' ILE . 29.4 m -128.86 5.57 2.77 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 175.14 168.74 36.11 Favored Glycine 0 N--CA 1.501 2.993 0 C-N-CA 119.108 -1.52 . . . . 0.0 109.635 -178.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.3 OUTLIER -131.99 117.09 17.95 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.164 -1.198 . . . . 0.0 109.699 -178.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.516 HG23 HG22 ' A' ' 59' ' ' VAL . 16.5 t -81.81 134.4 27.15 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 172.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.603 ' O ' HG13 ' A' ' 3' ' ' VAL . 24.9 t -126.64 133.26 68.99 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 -177.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.613 ' CB ' HG21 ' A' ' 79' ' ' THR . 9.1 t0 -107.4 137.46 45.4 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 176.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.34 4.0 41.06 Favored 'General case' 0 C--N 1.274 -2.692 0 O-C-N 121.104 -0.998 . . . . 0.0 110.752 -175.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -148.86 72.6 1.19 Allowed 'General case' 0 N--CA 1.505 2.307 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.452 ' HG3' ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -104.01 126.54 31.47 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.181 -0.95 . . . . 0.0 110.357 -177.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.448 ' O ' ' C ' ' A' ' 31' ' ' GLU . 74.9 Cg_exo -49.77 154.3 4.98 Favored 'Trans proline' 0 N--CA 1.499 1.818 0 C-N-CA 122.54 2.16 . . . . 0.0 111.171 174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -25.12 -63.06 0.06 Allowed 'General case' 0 N--CA 1.512 2.646 0 C-N-CA 123.541 0.736 . . . . 0.0 111.382 -179.125 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' NH2' ' O ' ' A' ' 33' ' ' SER . 1.6 mmm180 -129.99 74.24 1.58 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.964 0.888 . . . . 0.0 109.118 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.538 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -80.49 158.13 25.95 Favored 'General case' 0 C--N 1.283 -2.311 0 CA-C-O 121.545 0.688 . . . . 0.0 109.634 -179.516 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 11.3 mmtp -105.4 170.61 7.79 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.613 ' HB3' HD13 ' A' ' 52' ' ' ILE . 23.5 m-85 -120.98 131.9 54.59 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.685 ' HA ' ' NE ' ' A' ' 36' ' ' ARG . 4.3 mmp_? -108.28 139.24 43.26 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.687 ' O ' HG11 ' A' ' 42' ' ' VAL . 15.3 tp -128.54 139.28 52.38 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 178.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -145.07 170.56 15.96 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 124.31 159.1 10.31 Favored Glycine 0 N--CA 1.499 2.879 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.93 114.0 1.42 Allowed 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 124.76 -22.15 6.52 Favored Glycine 0 C--N 1.281 -2.492 0 N-CA-C 107.383 -2.287 . . . . 0.0 107.383 -173.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.687 HG11 ' O ' ' A' ' 37' ' ' LEU . 47.0 t -116.52 -97.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.451 ' OD2' ' NZ ' ' A' ' 47' ' ' LYS . 35.0 t0 -90.87 -5.53 55.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.324 -0.86 . . . . 0.0 109.759 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -114.09 156.88 23.36 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.583 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 14.0 mm-40 -67.21 136.36 93.79 Favored Pre-proline 0 C--N 1.277 -2.563 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.533 -176.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.541 ' HB2' HD11 ' A' ' 49' ' ' ILE . 29.3 Cg_endo -69.94 115.05 2.3 Favored 'Cis proline' 0 N--CA 1.51 2.449 0 C-N-CA 123.316 -1.535 . . . . 0.0 111.359 -0.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.583 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 6.3 mttm -68.35 152.17 45.82 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.915 -1.116 . . . . 0.0 111.1 -174.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.574 ' O ' ' NH1' ' A' ' 63' ' ' ARG . . . 56.44 49.08 71.32 Favored Glycine 0 N--CA 1.487 2.098 0 O-C-N 121.796 -0.565 . . . . 0.0 112.389 172.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.855 HD13 HH11 ' A' ' 63' ' ' ARG . 3.7 mm -106.42 -43.0 6.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -116.79 138.73 51.28 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.973 0.892 . . . . 0.0 110.996 -178.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 -124.16 170.32 10.84 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 175.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.613 HD13 ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -132.91 147.96 31.55 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.473 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 171.283 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 55' ' ' ASN . 21.1 t-20 -78.68 112.18 15.53 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 118.101 -1.44 . . . . 0.0 108.31 -176.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 6.6 mp0 -59.58 10.27 0.01 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 C-N-CA 124.455 1.102 . . . . 0.0 112.263 -176.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 53' ' ' ASN . 31.8 m-80 -137.86 -48.39 0.56 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.065 -1.022 . . . . 0.0 109.009 178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 17.5 p -87.33 -27.76 22.65 Favored 'General case' 0 C--N 1.291 -1.972 0 O-C-N 121.543 -0.723 . . . . 0.0 109.478 -177.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.47 5.82 74.77 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 14.6 m -66.84 123.53 20.41 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.394 -1.062 . . . . 0.0 109.379 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.552 HG11 HD21 ' A' ' 93' ' ' LEU . 2.0 t -82.57 122.42 37.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -123.42 140.89 52.54 Favored 'General case' 0 C--N 1.294 -1.84 0 O-C-N 121.404 -0.81 . . . . 0.0 110.133 -177.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 18' ' ' PRO . 10.6 p -90.93 144.04 9.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 19.9 p -96.27 -17.62 20.6 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.773 -0.58 . . . . 0.0 111.146 -176.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.855 HH11 HD13 ' A' ' 49' ' ' ILE . 5.5 ptp85 -153.52 -176.22 5.71 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 120.783 -1.198 . . . . 0.0 110.464 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 4.1 t -74.86 142.99 44.07 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 121.446 0.641 . . . . 0.0 110.127 -178.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.2 mt -104.64 158.81 16.25 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.323 -0.861 . . . . 0.0 109.164 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.406 ' HB3' HG23 ' A' ' 69' ' ' VAL . 0.4 OUTLIER -136.71 120.71 17.64 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' HG3' HG12 ' A' ' 97' ' ' VAL . 34.5 mtm105 -63.91 -12.11 33.97 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.965 -1.085 . . . . 0.0 108.342 175.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -73.03 -22.96 60.55 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.406 HG23 ' HB3' ' A' ' 66' ' ' ASP . 24.1 t -101.11 -53.23 7.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.459 HD12 ' CE2' ' A' ' 73' ' ' TYR . 1.4 mt -144.9 136.41 20.65 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.64 -24.24 20.55 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -159.74 140.52 4.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.587 -0.695 . . . . 0.0 109.511 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.459 ' CE2' HD12 ' A' ' 70' ' ' ILE . 58.6 m-85 -104.13 136.99 42.73 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.17 92.28 5.95 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 175.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -91.72 170.56 9.8 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 77.6 m-85 -135.66 140.62 44.63 Favored 'General case' 0 C--N 1.265 -3.08 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -119.23 155.18 21.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.077 0 CA-C-O 120.977 0.418 . . . . 0.0 110.079 -177.186 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.809 ' HB3' HG23 ' A' ' 86' ' ' THR . 33.1 mt-10 -140.94 141.35 34.5 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 173.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.613 HG21 ' CB ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -88.31 128.37 35.49 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 171.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.502 ' H ' ' HG1' ' A' ' 80' ' ' THR . 0.1 OUTLIER -119.86 161.2 21.22 Favored 'General case' 0 C--N 1.272 -2.766 0 O-C-N 121.543 -0.723 . . . . 0.0 110.847 -172.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.608 ' HB2' HD21 ' A' ' 87' ' ' LEU . 5.2 t0 -108.97 170.44 8.04 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 175.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.9 m -52.98 -22.85 4.64 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -79.66 2.24 23.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.423 -0.798 . . . . 0.0 109.171 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 81' ' ' ASP . . . 62.97 28.14 71.52 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 80' ' ' THR . 17.0 mttm -95.24 137.95 33.61 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.809 HG23 ' HB3' ' A' ' 78' ' ' GLU . 10.7 m -71.97 117.67 13.86 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.608 HD21 ' HB2' ' A' ' 81' ' ' ASP . 1.5 mm? -81.45 -46.37 14.67 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 175.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.448 ' OE2' ' N ' ' A' ' 1' ' ' SER . 0.6 OUTLIER -140.11 157.82 45.03 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 95.09 -177.48 35.25 Favored Glycine 0 N--CA 1.482 1.752 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 -177.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -62.76 112.92 0.61 Allowed 'Cis proline' 0 N--CA 1.499 1.808 0 C-N-CA 123.776 -1.343 . . . . 0.0 112.652 -0.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.746 HG21 HG21 ' A' ' 2' ' ' ILE . 0.9 OUTLIER -93.45 168.27 12.34 Favored Pre-proline 0 C--N 1.284 -2.274 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 175.106 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -96.23 156.67 1.35 Allowed 'Trans proline' 0 C--N 1.295 -2.287 0 C-N-CA 121.564 1.509 . . . . 0.0 112.823 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.552 HD21 HG11 ' A' ' 59' ' ' VAL . 9.6 tp -142.52 124.35 15.14 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 175.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -105.43 115.38 30.15 Favored 'General case' 0 C--N 1.283 -2.302 0 CA-C-O 121.432 0.634 . . . . 0.0 109.652 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 72' ' ' VAL . 96.0 t -102.55 108.82 24.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.624 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.8 mp -90.71 139.34 17.78 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.061 0 O-C-N 121.488 -0.758 . . . . 0.0 108.971 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.433 HG12 ' HG3' ' A' ' 67' ' ' ARG . 17.4 t -95.17 110.44 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 6.8 pt -96.7 170.9 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.711 ' CB ' HH12 ' A' ' 104' ' ' ARG . 0.2 OUTLIER -72.98 161.71 30.37 Favored 'General case' 0 C--N 1.281 -2.411 0 O-C-N 120.883 -1.136 . . . . 0.0 110.481 -175.205 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 102' ' ' ASP . 35.7 mt-30 -50.91 87.4 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.547 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 103' ' ' ASN . 5.6 t-20 61.47 -72.4 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.378 -0.826 . . . . 0.0 110.674 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.483 ' O ' ' NH1' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -66.1 77.75 0.09 Allowed 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.277 -0.889 . . . . 0.0 108.855 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 101' ' ' ASN . 0.2 OUTLIER -51.04 -27.8 8.77 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.769 -178.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.711 HH12 ' CB ' ' A' ' 99' ' ' ASP . 0.0 OUTLIER 39.58 65.96 3.29 Favored Pre-proline 0 N--CA 1.505 2.294 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -178.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 C--O 1.195 -1.64 0 C-N-CA 122.335 2.023 . . . . 0.0 111.047 -179.014 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 1.1 m . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.913 HG21 HG21 ' A' ' 91' ' ' VAL . 24.6 mt -88.98 142.79 12.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.714 0.769 . . . . 0.0 111.329 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -135.85 135.17 50.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.584 HG21 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -141.12 162.51 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.134 -0.978 . . . . 0.0 109.177 -176.758 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -128.0 149.64 71.46 Favored Pre-proline 0 C--N 1.294 -1.842 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 173.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.648 ' HB3' HD11 ' A' ' 96' ' ' ILE . 50.4 Cg_exo -51.71 137.75 50.37 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 C-N-CA 122.013 1.809 . . . . 0.0 110.464 178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.604 HG13 HD11 ' A' ' 93' ' ' LEU . 32.1 mt -99.44 110.63 27.08 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.737 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -100.24 98.39 9.07 Favored 'General case' 0 C--N 1.285 -2.239 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.4 ' CG1' HG22 ' A' ' 7' ' ' ILE . 17.8 mt -102.18 129.25 26.67 Favored Pre-proline 0 C--N 1.271 -2.837 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -176.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.562 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 19.4 Cg_endo -66.95 125.16 13.21 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 N-CA-C 109.715 -0.917 . . . . 0.0 109.715 174.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.746 ' HB3' HG12 ' A' ' 97' ' ' VAL . 4.5 pt-20 -62.6 -176.74 0.12 Allowed 'General case' 0 C--N 1.284 -2.279 0 CA-C-O 122.266 1.032 . . . . 0.0 111.746 -173.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.74 -4.54 0.07 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 68.0 mt-30 -59.68 113.86 2.46 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.43 ' HD3' ' H ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -79.5 -174.94 4.5 Favored 'General case' 0 C--N 1.287 -2.131 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.924 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.57 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 10.3 mm-40 -47.32 166.36 0.19 Allowed Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 3.4 Cg_endo -82.47 148.4 67.17 Favored 'Cis proline' 0 C--N 1.309 -1.549 0 C-N-CA 123.918 -1.284 . . . . 0.0 114.285 0.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.46 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 37.6 m-85 -134.0 170.46 11.24 Favored Pre-proline 0 C--N 1.289 -2.034 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 5.2 Cg_exo -75.07 156.69 99.83 Favored 'Cis proline' 0 N--CA 1.498 1.788 0 CA-C-N 120.812 1.326 . . . . 0.0 110.84 0.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.447 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 24.8 mtp180 -133.8 126.51 30.72 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.327 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.69 129.84 43.53 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 7' ' ' ILE . 0.3 OUTLIER -126.2 -5.18 5.21 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.905 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -171.33 141.27 6.34 Favored Glycine 0 C--N 1.285 -2.275 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 22.9 ttpp -109.9 119.91 40.81 Favored 'General case' 0 C--N 1.286 -2.184 0 O-C-N 121.487 -1.007 . . . . 0.0 109.889 -177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.592 HG23 ' CG2' ' A' ' 59' ' ' VAL . 44.0 t -80.84 142.32 14.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 171.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.2 t -126.13 126.2 69.15 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 C-N-CA 118.801 -1.16 . . . . 0.0 108.837 -177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 14.9 t0 -99.17 128.49 45.31 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 171.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.1 p -80.54 -87.55 0.08 Allowed 'General case' 0 C--N 1.283 -2.288 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.166 -172.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -73.65 53.96 0.45 Allowed 'General case' 0 C--N 1.29 -1.995 0 O-C-N 121.534 -0.729 . . . . 0.0 109.463 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' NH2' ' O ' ' A' ' 56' ' ' THR . 25.7 mtt180 -64.86 155.49 82.87 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.611 -0.681 . . . . 0.0 110.715 -176.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -64.16 121.76 9.52 Favored 'Trans proline' 0 N--CA 1.49 1.301 0 N-CA-C 107.006 -1.959 . . . . 0.0 107.006 163.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -31.01 -48.89 0.12 Allowed 'General case' 0 N--CA 1.513 2.678 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -172.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 32' ' ' ARG . 3.5 mtp180 -105.03 20.97 17.92 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.026 -1.046 . . . . 0.0 110.91 -176.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.1 p -64.48 156.26 30.17 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 120.975 -1.078 . . . . 0.0 108.586 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -120.02 170.4 9.32 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.341 -0.849 . . . . 0.0 109.169 178.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.69 ' HB3' HD13 ' A' ' 52' ' ' ILE . 47.8 m-85 -105.75 126.38 52.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.234 -0.916 . . . . 0.0 110.3 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.474 ' HG3' HG21 ' A' ' 80' ' ' THR . 0.0 OUTLIER -109.31 121.22 44.7 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 174.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.677 HD11 HD23 ' A' ' 93' ' ' LEU . 19.5 tp -99.6 156.77 16.89 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 175.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 37' ' ' LEU . 0.6 OUTLIER -160.14 171.44 19.25 Favored 'General case' 0 C--N 1.265 -3.101 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 -174.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.34 174.66 19.05 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.356 177.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.27 111.17 1.64 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 123.99 -13.51 8.03 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 107.783 -2.127 . . . . 0.0 107.783 -176.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 24.7 t -130.46 -99.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.616 -0.932 . . . . 0.0 108.568 -179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.418 ' O ' ' HE3' ' A' ' 47' ' ' LYS . 0.4 OUTLIER -84.1 -1.58 55.19 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.346 -0.846 . . . . 0.0 108.898 178.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -126.12 150.69 48.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.317 -0.864 . . . . 0.0 108.685 177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.583 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 1.7 mp0 -60.62 133.06 91.43 Favored Pre-proline 0 C--N 1.279 -2.49 0 C-N-CA 123.579 0.752 . . . . 0.0 110.463 -176.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 30.6 Cg_endo -66.24 117.46 2.06 Favored 'Cis proline' 0 N--CA 1.509 2.399 0 C-N-CA 123.634 -1.402 . . . . 0.0 110.921 -1.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.583 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 23.3 mttp -69.84 145.56 52.0 Favored 'General case' 0 C--N 1.29 -2.011 0 O-C-N 121.155 -0.966 . . . . 0.0 111.611 -173.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 55.24 41.45 79.21 Favored Glycine 0 C--N 1.283 -2.412 0 CA-C-N 115.416 -0.811 . . . . 0.0 113.416 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.5 ' N ' ' O ' ' A' ' 41' ' ' GLY . 12.6 mm -88.7 -41.41 14.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 173.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 74.2 m-85 -112.25 148.91 33.14 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.069 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -145.47 135.16 23.4 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 172.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.69 HD13 ' HB3' ' A' ' 35' ' ' PHE . 18.6 tt -94.93 161.25 2.62 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.663 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -79.4 114.4 18.31 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.486 ' HA ' ' H ' ' A' ' 35' ' ' PHE . 2.9 mt-10 -65.53 10.55 0.09 Allowed 'General case' 0 C--N 1.286 -2.189 0 O-C-N 121.838 -0.538 . . . . 0.0 112.425 -174.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.411 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 1.4 t-20 -133.05 -50.19 0.88 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.658 -1.276 . . . . 0.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.471 ' O ' ' NH2' ' A' ' 29' ' ' ARG . 55.0 p -79.4 -54.12 6.24 Favored 'General case' 0 C--N 1.271 -2.826 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -177.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.429 ' HA2' ' CD2' ' A' ' 35' ' ' PHE . . . 121.97 2.26 10.3 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 108.362 -1.895 . . . . 0.0 108.362 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -63.48 122.25 15.82 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.671 -0.899 . . . . 0.0 109.466 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.592 ' CG2' HG23 ' A' ' 24' ' ' VAL . 44.5 t -91.35 117.65 35.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -109.17 140.31 42.93 Favored 'General case' 0 C--N 1.287 -2.147 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.918 -176.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.409 ' CG2' HD21 ' A' ' 65' ' ' LEU . 8.9 p -89.43 141.89 13.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 174.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.418 ' HG1' ' C ' ' A' ' 49' ' ' ILE . 24.3 p -94.32 -19.71 20.42 Favored 'General case' 0 C--N 1.294 -1.824 0 O-C-N 121.29 -0.881 . . . . 0.0 111.034 -175.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.2 178.21 8.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.006 -1.059 . . . . 0.0 110.393 -176.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 2.0 t -68.53 143.8 54.81 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 61' ' ' VAL . 63.4 mt -106.25 142.28 36.2 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.305 -0.872 . . . . 0.0 109.115 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.484 ' HB2' HG23 ' A' ' 69' ' ' VAL . 19.4 m-20 -123.99 122.41 37.84 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.647 ' HE ' ' CD ' ' A' ' 11' ' ' GLU . 6.4 mtm105 -60.48 -9.72 4.05 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -79.15 -27.9 42.76 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.484 HG23 ' HB2' ' A' ' 66' ' ' ASP . 20.9 t -88.84 -55.56 6.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -144.74 134.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.99 -26.18 22.77 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 176.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 3.8 p -152.79 139.42 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.683 -0.636 . . . . 0.0 109.641 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -101.17 134.04 44.8 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.479 ' NE2' ' HG2' ' A' ' 94' ' ' GLU . 14.5 tp60 -96.96 96.08 8.26 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.431 HD12 ' HA ' ' A' ' 75' ' ' LEU . 0.0 OUTLIER -98.61 170.1 9.04 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-O 122.193 0.996 . . . . 0.0 108.982 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 82.9 m-85 -137.47 137.28 38.55 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 177.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.709 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -117.42 138.21 48.82 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 CA-C-O 121.128 0.489 . . . . 0.0 110.573 -176.423 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.673 ' HB3' HG23 ' A' ' 86' ' ' THR . 32.7 mt-10 -133.95 139.87 46.4 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 174.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.643 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.53 141.62 31.48 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 103.772 -2.677 . . . . 0.0 103.772 169.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.478 ' C ' HD21 ' A' ' 87' ' ' LEU . 1.2 p -129.52 162.13 28.89 Favored 'General case' 0 C--N 1.275 -2.668 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.364 -174.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 10.2 t70 -100.67 170.3 8.45 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.502 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.2 m -53.6 -27.01 14.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 176.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.457 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 14.0 t-20 -79.89 3.53 19.53 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.408 -0.807 . . . . 0.0 109.538 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 68.31 17.5 70.39 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.457 ' NZ ' ' OD1' ' A' ' 83' ' ' ASN . 18.1 mttp -82.79 146.91 28.7 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.166 -1.197 . . . . 0.0 108.057 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.673 HG23 ' HB3' ' A' ' 78' ' ' GLU . 87.7 m -91.51 116.53 28.93 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.925 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.88 -23.8 18.67 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.017 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.779 ' HG3' HD12 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -145.41 164.84 30.28 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.526 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 80.72 -166.02 48.53 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -69.65 103.88 0.38 Allowed 'Cis proline' 0 C--N 1.314 -1.288 0 C-N-CA 123.487 -1.464 . . . . 0.0 110.926 -0.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.913 HG21 HG21 ' A' ' 2' ' ' ILE . 14.6 m -72.92 158.21 87.53 Favored Pre-proline 0 C--N 1.286 -2.193 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -90.4 141.61 3.4 Favored 'Trans proline' 0 C--N 1.283 -2.901 0 C-N-CA 121.552 1.501 . . . . 0.0 112.424 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.677 HD23 HD11 ' A' ' 37' ' ' LEU . 12.6 tp -131.57 125.73 33.03 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.479 ' HG2' ' NE2' ' A' ' 74' ' ' GLN . 66.3 mt-10 -109.0 123.09 48.58 Favored 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.517 -0.739 . . . . 0.0 109.232 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 41.6 t -108.3 100.43 10.71 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.189 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.769 ' H ' HD12 ' A' ' 96' ' ' ILE . 3.4 mp -84.69 135.94 23.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 CA-C-O 121.457 0.646 . . . . 0.0 109.298 -178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.746 HG12 ' HB3' ' A' ' 11' ' ' GLU . 5.1 t -92.37 99.25 9.41 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 176.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.588 HG21 ' HB3' ' A' ' 8' ' ' LEU . 16.4 pt -90.76 171.9 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.13 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.09 170.65 15.92 Favored 'General case' 0 C--N 1.291 -1.945 0 O-C-N 120.946 -1.096 . . . . 0.0 108.295 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.457 ' OE1' ' NH1' ' A' ' 104' ' ' ARG . 4.3 mt-30 -72.2 118.88 15.63 Favored 'General case' 0 C--N 1.272 -2.804 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 100' ' ' GLN . 4.2 t-20 30.2 81.32 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.643 0 CA-C-O 121.113 0.482 . . . . 0.0 111.541 177.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.505 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 0.4 OUTLIER 53.05 25.62 4.24 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.645 -0.66 . . . . 0.0 110.013 -179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER 75.71 16.92 2.41 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.734 -0.604 . . . . 0.0 109.385 -177.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.457 ' NH1' ' OE1' ' A' ' 100' ' ' GLN . 3.2 mtm180 49.49 61.7 13.38 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.414 ' HD3' ' N ' ' A' ' 104' ' ' ARG . 1.1 Cg_endo . . . . . 0 C--O 1.195 -1.671 0 C-N-CA 121.659 1.573 . . . . 0.0 111.411 -177.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.505 ' N ' ' OE1' ' A' ' 88' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.501 -0.941 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.95 HG21 HG21 ' A' ' 91' ' ' VAL . 40.5 mt -72.34 123.13 26.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.458 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.64 124.43 72.76 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -131.44 158.78 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.253 -0.904 . . . . 0.0 109.402 -178.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.417 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -127.37 131.03 23.64 Favored Pre-proline 0 C--N 1.287 -2.135 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 173.595 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.459 ' HB2' HD11 ' A' ' 8' ' ' LEU . 53.6 Cg_exo -41.25 140.89 1.31 Allowed 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 122.205 1.936 . . . . 0.0 110.85 -178.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.52 HG13 HD11 ' A' ' 93' ' ' LEU . 12.6 mt -103.93 115.45 45.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.097 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.724 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -107.99 96.8 6.63 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.44 ' CG1' HG22 ' A' ' 7' ' ' ILE . 1.3 mt -107.79 128.13 26.42 Favored Pre-proline 0 C--N 1.279 -2.471 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -176.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 40.5 Cg_endo -72.07 135.4 25.11 Favored 'Trans proline' 0 C--N 1.32 -0.936 0 C-N-CA 120.79 0.993 . . . . 0.0 110.163 175.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.46 ' HB3' ' CG1' ' A' ' 97' ' ' VAL . 2.1 pp20? -68.26 -173.32 0.39 Allowed 'General case' 0 C--N 1.276 -2.623 0 CA-C-O 121.996 0.903 . . . . 0.0 111.388 -175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.472 ' O ' ' NH1' ' A' ' 14' ' ' ARG . 0.8 OUTLIER 60.65 -5.99 0.1 Allowed 'General case' 0 N--CA 1.513 2.697 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 174.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.536 ' OE1' ' NH1' ' A' ' 19' ' ' ARG . 57.5 mt-30 -61.87 137.0 58.2 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.472 ' NH1' ' O ' ' A' ' 12' ' ' ASN . 0.2 OUTLIER -107.14 -159.78 0.71 Allowed 'General case' 0 C--N 1.293 -1.887 0 O-C-N 121.681 -0.637 . . . . 0.0 110.158 -174.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.521 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -55.6 166.48 0.97 Allowed Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 177.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.521 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 4.0 Cg_endo -80.29 118.18 5.63 Favored 'Cis proline' 0 C--N 1.303 -1.822 0 C-N-CA 123.273 -1.553 . . . . 0.0 113.525 0.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -107.13 165.58 12.59 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 106.498 -1.668 . . . . 0.0 106.498 175.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.5 162.77 79.54 Favored 'Cis proline' 0 N--CA 1.504 2.094 0 C-N-CA 124.57 -1.012 . . . . 0.0 111.631 -1.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.536 ' NH1' ' OE1' ' A' ' 13' ' ' GLN . 39.4 mtp180 -132.26 144.57 50.7 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 33.7 t70 -77.01 139.34 40.04 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 174.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.484 HG23 HG21 ' A' ' 7' ' ' ILE . 31.0 m -127.01 -2.16 4.29 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 C-N-CA 119.34 -0.944 . . . . 0.0 109.859 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 169.77 -178.6 42.64 Favored Glycine 0 N--CA 1.511 3.693 0 C-N-CA 117.355 -2.355 . . . . 0.0 110.401 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.494 ' NZ ' ' O ' ' A' ' 56' ' ' THR . 6.8 ttmm -137.01 127.73 27.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.712 -1.464 . . . . 0.0 112.0 -176.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.667 HG11 HG11 ' A' ' 77' ' ' VAL . 15.3 t -94.91 132.57 38.53 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 104.165 -2.532 . . . . 0.0 104.165 168.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.3 t -125.3 156.51 34.47 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.852 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' A' ' 29' ' ' ARG . 8.3 t70 -132.85 146.05 51.48 Favored 'General case' 0 C--N 1.29 -1.995 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.3 -1.71 26.61 Favored 'General case' 0 C--N 1.285 -2.206 0 O-C-N 121.559 -0.713 . . . . 0.0 111.322 -176.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -140.12 86.11 2.06 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.499 ' HD2' ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -125.43 133.0 24.46 Favored Pre-proline 0 C--N 1.295 -1.77 0 O-C-N 121.397 -0.814 . . . . 0.0 109.946 -179.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 32' ' ' ARG . 69.9 Cg_exo -52.53 131.49 41.12 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 121.433 1.422 . . . . 0.0 109.146 170.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -31.85 -35.57 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.463 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 8.7 mtp85 -114.39 10.63 17.08 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.253 -0.904 . . . . 0.0 110.794 -173.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 p -71.94 152.62 42.4 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.132 -0.98 . . . . 0.0 109.512 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.539 ' HB3' ' CB ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -131.19 154.74 48.08 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 176.948 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -79.78 144.76 33.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.498 -0.751 . . . . 0.0 110.801 -177.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.468 ' NH1' ' OE1' ' A' ' 78' ' ' GLU . 1.3 mtp180 -116.5 145.08 43.57 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 105.844 -1.909 . . . . 0.0 105.844 173.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.3 tp -122.17 143.85 49.31 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 p -144.12 170.86 15.14 Favored 'General case' 0 C--N 1.276 -2.613 0 O-C-N 121.251 -0.905 . . . . 0.0 109.056 -175.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.02 164.88 13.29 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.56 106.19 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 133.75 -16.23 4.54 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 -175.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.418 HG22 ' HB2' ' A' ' 50' ' ' PHE . 38.2 t -132.73 -88.4 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.578 -0.954 . . . . 0.0 109.577 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.03 -20.51 34.87 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -118.11 157.31 27.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.844 0.831 . . . . 0.0 109.53 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 45' ' ' GLU . 1.8 mp0 -56.33 132.4 76.01 Favored Pre-proline 0 C--N 1.28 -2.414 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.756 -176.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.632 ' HB2' HD11 ' A' ' 49' ' ' ILE . 4.9 Cg_endo -75.85 115.94 3.86 Favored 'Cis proline' 0 N--CA 1.491 1.349 0 C-N-CA 123.091 -1.629 . . . . 0.0 110.126 -0.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 32.8 mtpt -69.42 153.85 42.92 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 120.721 -1.237 . . . . 0.0 111.425 -174.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 63.52 9.1 29.69 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-O 119.261 -0.744 . . . . 0.0 113.34 173.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 46' ' ' PRO . 8.1 mm -60.83 -48.76 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.509 0 CA-C-N 120.239 2.019 . . . . 0.0 106.795 176.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.418 ' HB2' HG22 ' A' ' 42' ' ' VAL . 86.4 m-85 -108.35 166.62 10.62 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-O 121.815 0.817 . . . . 0.0 110.413 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -154.84 126.6 7.53 Favored 'General case' 0 C--N 1.281 -2.378 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.432 HG13 HG22 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -93.46 146.84 5.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.251 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -178.298 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.477 HD22 ' CG2' ' A' ' 56' ' ' THR . 34.3 t30 -79.46 85.11 5.27 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.539 ' CB ' ' HB3' ' A' ' 34' ' ' LYS . 1.9 mt-10 -30.82 -34.35 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 C-N-CA 124.053 0.941 . . . . 0.0 113.431 -174.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -93.0 -50.42 5.55 Favored 'General case' 0 C--N 1.285 -2.231 0 O-C-N 121.544 -0.723 . . . . 0.0 110.373 -174.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.494 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 18.8 p -88.32 -12.32 43.8 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 122.047 0.927 . . . . 0.0 108.831 -175.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 53' ' ' ASN . . . 69.82 9.36 62.47 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.49 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 3.5 m -69.35 124.58 24.22 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.326 -1.103 . . . . 0.0 108.291 177.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.499 ' CG2' HG23 ' A' ' 24' ' ' VAL . 1.8 t -90.02 122.52 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.182 -0.949 . . . . 0.0 109.192 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.1 OUTLIER -118.26 154.15 32.75 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.198 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.602 ' CG2' HD21 ' A' ' 65' ' ' LEU . 12.1 p -107.46 149.92 10.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 24.7 p -104.32 -22.9 13.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.503 -0.748 . . . . 0.0 112.101 -175.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' HD2' HD12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -137.56 168.52 19.5 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.979 -1.075 . . . . 0.0 111.381 -175.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 13' ' ' GLN . 12.1 t -64.87 123.42 19.36 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.602 HD21 ' CG2' ' A' ' 61' ' ' VAL . 36.7 mt -82.08 163.54 21.97 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.063 -1.023 . . . . 0.0 108.497 -179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -127.92 170.42 12.86 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.546 ' NE ' ' O ' ' A' ' 97' ' ' VAL . 0.1 OUTLIER -121.68 27.39 8.22 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 121.873 0.844 . . . . 0.0 109.158 -177.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -120.32 -42.18 2.58 Favored 'General case' 0 C--N 1.262 -3.213 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.8 t -84.81 -47.78 16.96 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 70' ' ' ILE . 2.0 mt -129.85 137.25 57.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -101.44 -24.13 14.23 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 1.8 p -156.29 146.43 11.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 O-C-N 121.423 -0.798 . . . . 0.0 109.345 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.492 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 60.6 m-85 -103.96 114.48 28.76 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 174.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.503 HE22 ' CG ' ' A' ' 94' ' ' GLU . 18.2 tp60 -88.01 83.07 7.07 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.79 170.58 15.54 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.513 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 43.8 m-85 -133.69 129.74 37.2 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.698 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -105.77 144.21 15.61 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 O-C-N 121.894 -0.503 . . . . 0.0 109.859 -175.711 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.708 ' HB3' HG23 ' A' ' 86' ' ' THR . 56.0 mt-10 -131.31 140.95 49.86 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.648 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -86.3 127.63 34.81 Favored 'General case' 0 C--N 1.274 -2.708 0 N-CA-C 102.806 -3.035 . . . . 0.0 102.806 167.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.584 ' C ' HD21 ' A' ' 87' ' ' LEU . 19.5 p -123.04 146.05 48.0 Favored 'General case' 0 C--N 1.283 -2.297 0 C-N-CA 118.567 -1.253 . . . . 0.0 111.713 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.736 ' N ' HD21 ' A' ' 87' ' ' LEU . 29.0 t70 -88.72 165.76 14.51 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.017 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.463 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 1.0 OUTLIER -55.76 -27.21 21.66 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.404 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.321 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -79.5 -13.19 59.73 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 118.894 -1.122 . . . . 0.0 109.102 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.04 7.18 50.67 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -76.4 143.77 40.44 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 120.666 -1.49 . . . . 0.0 107.787 178.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.708 HG23 ' HB3' ' A' ' 78' ' ' GLU . 98.3 m -86.98 116.08 24.8 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.884 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.2 OUTLIER -87.24 -20.8 26.37 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 -178.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' OE1' ' N ' ' A' ' 1' ' ' SER . 4.7 tt0 -157.94 153.2 25.81 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.521 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 83.91 -169.5 46.53 Favored Glycine 0 C--N 1.28 -2.536 0 N-CA-C 106.698 -2.561 . . . . 0.0 106.698 -174.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.85 103.23 0.14 OUTLIER 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.644 -1.398 . . . . 0.0 112.722 -0.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.95 HG21 HG21 ' A' ' 2' ' ' ILE . 3.7 m -78.4 164.35 56.7 Favored Pre-proline 0 C--N 1.289 -2.059 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 175.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -93.71 153.14 2.32 Favored 'Trans proline' 0 C--N 1.29 -2.534 0 C-N-CA 121.498 1.465 . . . . 0.0 112.622 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.604 HD13 HG21 ' A' ' 4' ' ' VAL . 5.4 tp -141.0 129.76 22.92 Favored 'General case' 0 C--N 1.283 -2.287 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.503 ' CG ' HE22 ' A' ' 74' ' ' GLN . 31.7 mt-10 -102.92 110.57 22.54 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.492 ' HB ' ' HB2' ' A' ' 73' ' ' TYR . 60.0 t -103.69 93.08 2.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 176.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.495 ' H ' HD12 ' A' ' 96' ' ' ILE . 3.4 mp -79.76 134.3 27.9 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.22 0 O-C-N 121.507 -0.746 . . . . 0.0 109.24 -177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.546 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 55.2 t -88.38 102.49 12.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.518 HG21 ' HB3' ' A' ' 8' ' ' LEU . 9.5 pt -80.17 170.78 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 C-N-CA 118.957 -1.097 . . . . 0.0 108.244 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -95.97 178.66 5.35 Favored 'General case' 0 C--N 1.28 -2.434 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.45 ' O ' ' C ' ' A' ' 101' ' ' ASN . 34.7 mm-40 -70.94 107.64 4.15 Favored 'General case' 0 C--N 1.282 -2.336 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 175.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 100' ' ' GLN . 71.6 m-20 -38.79 -55.75 1.45 Allowed 'General case' 0 N--CA 1.51 2.544 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.503 ' O ' ' NH1' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -118.58 109.5 16.24 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 171.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.422 ' O ' ' HD3' ' A' ' 105' ' ' PRO . 8.5 t30 -59.25 129.89 44.29 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.503 ' NH1' ' O ' ' A' ' 102' ' ' ASP . 6.6 mmt-85 -104.86 97.34 12.56 Favored Pre-proline 0 C--N 1.282 -2.347 0 O-C-N 121.467 -0.77 . . . . 0.0 109.526 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 103' ' ' ASN . 38.1 Cg_endo . . . . . 0 C--N 1.317 -1.123 0 C-N-CA 122.173 1.915 . . . . 0.0 110.641 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.467 ' N ' ' OE2' ' A' ' 88' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.73 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.777 HG21 HG21 ' A' ' 91' ' ' VAL . 18.9 mt -67.82 148.54 11.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.53 0.681 . . . . 0.0 110.015 -178.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.76 114.31 24.66 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 176.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.524 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -134.32 169.63 21.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -177.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.524 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 2.1 m -159.39 165.94 17.2 Favored Pre-proline 0 C--N 1.276 -2.618 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 94' ' ' GLU . 33.1 Cg_exo -55.47 131.32 45.46 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 121.553 1.502 . . . . 0.0 111.946 -175.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.4 HG13 HD11 ' A' ' 93' ' ' LEU . 11.1 mt -106.13 115.88 48.72 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.841 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -90.25 108.01 19.49 Favored 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.421 ' CD1' HG13 ' A' ' 95' ' ' VAL . 23.2 mt -109.81 124.23 34.19 Favored Pre-proline 0 C--N 1.283 -2.323 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 -178.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 6.5 Cg_exo -66.06 124.49 12.69 Favored 'Trans proline' 0 C--N 1.319 -1.008 0 C-N-CA 121.062 1.175 . . . . 0.0 110.777 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -41.86 -72.2 0.07 Allowed 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.578 0.704 . . . . 0.0 111.797 -176.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.492 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 48.2 p-10 -66.4 40.55 0.02 OUTLIER 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 -174.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.484 ' O ' ' CZ ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -76.01 56.04 0.96 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 119.608 -1.933 . . . . 0.0 106.145 172.074 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.564 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -45.59 175.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.331 1.062 . . . . 0.0 113.599 -172.216 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 37.5 mt-30 -48.25 166.34 0.22 Allowed Pre-proline 0 C--N 1.285 -2.201 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.754 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 5.7 Cg_exo -76.1 134.89 37.7 Favored 'Cis proline' 0 N--CA 1.497 1.721 0 C-N-CA 123.725 -1.364 . . . . 0.0 113.898 0.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.484 ' CZ ' ' O ' ' A' ' 13' ' ' GLN . 24.2 m-85 -102.49 166.24 12.37 Favored Pre-proline 0 C--N 1.293 -1.875 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.422 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 12.2 Cg_exo -69.36 166.7 72.32 Favored 'Cis proline' 0 N--CA 1.499 1.799 0 C-N-CA 123.966 -1.264 . . . . 0.0 111.312 -0.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.564 ' NH2' ' O ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -125.1 135.28 52.54 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -69.98 137.16 51.19 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.2 m -128.25 4.83 3.06 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.011 0 C-N-CA 119.441 -0.903 . . . . 0.0 109.014 178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 158.37 -170.32 35.04 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 118.218 -1.944 . . . . 0.0 109.632 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' NZ ' ' OG ' ' A' ' 58' ' ' SER . 19.4 ttmm -148.13 128.56 13.97 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.23 -1.159 . . . . 0.0 109.768 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.672 HG11 HG11 ' A' ' 77' ' ' VAL . 21.7 t -89.25 147.07 5.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 172.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 26' ' ' ASP . 61.0 t -132.38 163.73 36.86 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.53 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 9.8 t70 -125.09 141.11 52.32 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.459 ' HG ' ' HB2' ' A' ' 1' ' ' SER . 0.7 OUTLIER -74.25 -21.74 59.63 Favored 'General case' 0 C--N 1.26 -3.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.362 -176.095 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -144.56 82.16 1.68 Allowed 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.48 ' CG ' ' HB3' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -87.3 115.82 64.03 Favored Pre-proline 0 C--N 1.294 -1.842 0 O-C-N 121.154 -0.966 . . . . 0.0 109.746 -176.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -42.4 138.09 3.44 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 121.909 1.739 . . . . 0.0 109.461 175.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -41.49 -35.55 0.72 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.813 -0.554 . . . . 0.0 110.937 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -120.59 40.15 3.58 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.81 -0.556 . . . . 0.0 110.2 -176.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.477 ' C ' ' HG2' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -84.62 -179.85 7.22 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 120.798 -1.189 . . . . 0.0 111.263 -177.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HG2' ' C ' ' A' ' 33' ' ' SER . 6.2 mmtm -147.71 150.51 34.44 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 178.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.491 ' N ' ' O ' ' A' ' 54' ' ' GLU . 35.5 m-85 -94.65 124.28 38.59 Favored 'General case' 0 C--N 1.28 -2.446 0 O-C-N 121.408 -0.807 . . . . 0.0 109.485 177.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.698 ' HG3' HG21 ' A' ' 80' ' ' THR . 4.4 mmp_? -107.61 125.77 51.73 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.669 ' HG ' HG21 ' A' ' 42' ' ' VAL . 44.1 tp -106.29 144.45 32.95 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 176.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -149.68 170.89 17.64 Favored 'General case' 0 C--N 1.278 -2.5 0 O-C-N 121.163 -0.96 . . . . 0.0 108.732 -175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.91 176.26 18.71 Favored Glycine 0 N--CA 1.502 3.033 0 C-N-CA 119.567 -1.302 . . . . 0.0 111.056 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 44' ' ' GLN . 36.5 mtpt -61.11 121.16 11.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 49' ' ' ILE . . . 110.16 -20.77 25.62 Favored Glycine 0 C--N 1.28 -2.552 0 N-CA-C 107.773 -2.131 . . . . 0.0 107.773 -177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.669 HG21 ' HG ' ' A' ' 37' ' ' LEU . 40.9 t -116.2 -93.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -92.98 -12.58 30.37 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.59 -0.694 . . . . 0.0 109.647 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 40' ' ' LYS . 6.0 mm-40 -109.7 157.58 18.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -57.81 132.52 82.95 Favored Pre-proline 0 C--N 1.288 -2.1 0 O-C-N 121.982 -0.449 . . . . 0.0 110.084 -177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.444 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -77.42 118.77 5.95 Favored 'Cis proline' 0 N--CA 1.501 1.959 0 C-N-CA 123.91 -1.287 . . . . 0.0 110.24 -0.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 mttp -67.14 149.69 50.17 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 120.788 -1.195 . . . . 0.0 111.947 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.22 29.3 72.61 Favored Glycine 0 N--CA 1.49 2.286 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.748 171.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.498 HG23 ' HD2' ' A' ' 63' ' ' ARG . 10.6 mm -83.77 -44.75 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 173.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.663 ' HB2' HG22 ' A' ' 42' ' ' VAL . 84.3 m-85 -106.33 147.76 28.82 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.601 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.57 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -141.94 126.25 17.59 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 177.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.424 HD13 ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.61 147.67 8.88 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -179.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.542 ' CG ' HG23 ' A' ' 56' ' ' THR . 28.5 t-20 -79.68 99.97 7.65 Favored 'General case' 0 C--N 1.285 -2.215 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 178.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -42.39 -26.64 0.12 Allowed 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.896 -177.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -106.5 -37.28 6.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.909 -1.12 . . . . 0.0 111.69 -178.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.542 HG23 ' CG ' ' A' ' 53' ' ' ASN . 5.1 p -89.8 -15.23 32.78 Favored 'General case' 0 N--CA 1.511 2.61 0 O-C-N 120.984 -1.072 . . . . 0.0 108.918 -178.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 71.24 2.62 49.14 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -178.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.518 ' OG ' ' NZ ' ' A' ' 23' ' ' LYS . 19.3 m -64.51 124.37 21.67 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.292 -1.122 . . . . 0.0 108.815 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 24' ' ' VAL . 2.1 t -88.96 131.0 37.4 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.57 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -130.87 160.53 34.17 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.009 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.6 p -117.44 149.37 19.76 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.1 p -94.71 -10.57 31.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.48 -0.763 . . . . 0.0 111.148 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.528 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -155.15 162.92 40.85 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.052 -1.03 . . . . 0.0 109.306 -178.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.528 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 5.1 t -62.18 138.2 58.37 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' A' ' 11' ' ' GLU . 65.2 mt -90.71 131.58 36.31 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.417 ' C ' ' H ' ' A' ' 68' ' ' GLU . 0.0 OUTLIER -106.06 119.34 38.96 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -57.62 -7.65 0.71 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -77.89 -26.93 49.49 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.9 t -89.87 -53.02 9.88 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.416 HD12 ' CE1' ' A' ' 73' ' ' TYR . 2.8 mt -151.66 144.02 16.19 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -95.28 -25.55 16.29 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.1 p -154.92 135.95 5.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 C-N-CA 119.878 -0.729 . . . . 0.0 109.501 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.416 ' CE1' HD12 ' A' ' 70' ' ' ILE . 37.4 m-85 -106.03 138.64 41.86 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.443 HE22 ' CG ' ' A' ' 94' ' ' GLU . 0.3 OUTLIER -100.7 87.08 3.25 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.317 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.405 ' CD1' HG23 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -81.11 170.78 15.74 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.033 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 57.0 m-85 -132.21 131.37 42.09 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.716 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -110.18 140.64 28.3 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 O-C-N 122.022 -0.424 . . . . 0.0 110.046 -177.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.619 ' HB3' HG23 ' A' ' 86' ' ' THR . 43.8 mt-10 -130.28 137.12 49.82 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 175.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.681 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -86.2 133.8 33.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 104.586 -2.375 . . . . 0.0 104.586 172.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.698 HG21 ' HG3' ' A' ' 36' ' ' ARG . 4.1 p -125.27 159.17 32.31 Favored 'General case' 0 C--N 1.282 -2.367 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.689 -174.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.488 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -101.07 170.55 8.2 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 106.951 -1.499 . . . . 0.0 106.951 177.134 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.488 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 0.9 OUTLIER -43.09 -38.0 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 CA-C-O 121.825 0.821 . . . . 0.0 109.613 179.314 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.435 ' N ' ' CG2' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -79.95 2.85 21.93 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.697 -0.627 . . . . 0.0 109.975 -177.131 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.67 15.48 80.64 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 80' ' ' THR . 2.0 mtpp -73.51 134.18 43.8 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.619 HG23 ' HB3' ' A' ' 78' ' ' GLU . 91.0 m -81.27 116.92 21.37 Favored 'General case' 0 C--N 1.289 -2.064 0 C-N-CA 120.324 -0.55 . . . . 0.0 109.803 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.914 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -92.33 -22.02 19.95 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.467 ' OE2' ' N ' ' A' ' 1' ' ' SER . 1.0 OUTLIER -151.21 149.37 29.35 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 176.265 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.556 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 105.43 -178.39 23.33 Favored Glycine 0 N--CA 1.482 1.714 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -71.63 104.43 0.49 Allowed 'Cis proline' 0 N--CA 1.491 1.354 0 C-N-CA 123.304 -1.54 . . . . 0.0 111.568 0.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.777 HG21 HG21 ' A' ' 2' ' ' ILE . 9.5 m -75.23 159.04 83.25 Favored Pre-proline 0 C--N 1.298 -1.648 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 176.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -91.78 145.16 3.08 Favored 'Trans proline' 0 C--N 1.279 -3.089 0 C-N-CA 121.529 1.486 . . . . 0.0 111.699 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.544 HD23 HD11 ' A' ' 37' ' ' LEU . 11.2 tp -128.84 126.97 40.94 Favored 'General case' 0 C--N 1.275 -2.637 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 177.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.443 ' CG ' HE22 ' A' ' 74' ' ' GLN . 4.2 mt-10 -106.81 110.29 22.42 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.63 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 24.8 t -101.8 112.22 34.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 6' ' ' PRO . 3.7 mp -97.55 136.28 28.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.57 111.76 23.48 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.674 HG21 ' HB3' ' A' ' 8' ' ' LEU . 9.7 pt -105.45 171.63 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.58 154.7 27.85 Favored 'General case' 0 C--N 1.279 -2.46 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -91.14 69.02 6.13 Favored 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -172.09 155.16 3.62 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -175.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.439 ' OD1' ' NH1' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -115.45 -36.85 4.17 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.1 t30 61.21 19.4 10.03 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.439 ' NH1' ' OD1' ' A' ' 102' ' ' ASP . 4.3 mtm-85 -57.04 117.67 19.25 Favored Pre-proline 0 N--CA 1.485 1.303 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 C--N 1.305 -1.711 0 C-N-CA 122.15 1.9 . . . . 0.0 110.603 179.702 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.411 ' H3 ' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.85 HG21 HG21 ' A' ' 91' ' ' VAL . 17.2 mt -62.01 146.02 12.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.141 0 CA-C-O 121.934 0.874 . . . . 0.0 111.065 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -134.85 115.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.553 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 174.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.528 HG23 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -127.14 161.86 33.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 121.057 -1.027 . . . . 0.0 108.9 -175.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.451 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -155.52 138.84 10.89 Favored Pre-proline 0 C--N 1.273 -2.74 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -41.9 138.91 2.55 Favored 'Trans proline' 0 N--CA 1.488 1.149 0 C-N-CA 122.351 2.034 . . . . 0.0 112.724 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.508 HG13 HD11 ' A' ' 93' ' ' LEU . 16.2 mt -104.63 119.44 53.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 175.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.718 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.8 mp -106.15 79.42 1.4 Allowed 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -177.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.486 HG13 HG22 ' A' ' 7' ' ' ILE . 4.7 mt -81.99 140.35 46.47 Favored Pre-proline 0 C--N 1.281 -2.398 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 -178.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.559 ' HB3' ' HB2' ' A' ' 100' ' ' GLN . 11.1 Cg_endo -73.69 137.13 24.44 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 C-N-CA 120.748 0.965 . . . . 0.0 111.046 177.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.696 ' HB3' HG12 ' A' ' 97' ' ' VAL . 1.5 pt-20 -66.08 170.59 5.48 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.283 -0.886 . . . . 0.0 109.198 -178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.438 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 5.3 t-20 59.8 13.5 3.58 Favored 'General case' 0 C--N 1.287 -2.114 0 O-C-N 121.752 -0.593 . . . . 0.0 112.093 174.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -57.58 127.63 32.97 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.571 ' O ' ' NH2' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -89.67 158.53 17.54 Favored 'General case' 0 C--N 1.285 -2.201 0 O-C-N 121.153 -0.967 . . . . 0.0 112.781 -170.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.59 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 12.3 mp0 -50.07 167.05 0.25 Allowed Pre-proline 0 C--N 1.296 -1.733 0 C-N-CA 124.938 1.295 . . . . 0.0 109.022 176.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 67.8 Cg_endo -79.61 154.67 88.64 Favored 'Cis proline' 0 C--N 1.31 -1.473 0 C-N-CA 123.613 -1.411 . . . . 0.0 113.641 0.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.526 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 33.9 m-85 -135.09 169.86 12.7 Favored Pre-proline 0 C--N 1.276 -2.597 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.6 Cg_exo -68.94 173.34 41.99 Favored 'Cis proline' 0 N--CA 1.493 1.469 0 C-N-CA 124.485 -1.048 . . . . 0.0 112.124 0.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.571 ' NH2' ' O ' ' A' ' 14' ' ' ARG . 7.1 ttm180 -155.88 145.2 20.81 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -65.65 132.83 49.78 Favored 'General case' 0 N--CA 1.503 2.176 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.0 m -124.01 3.74 5.14 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.173 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 163.36 179.11 37.61 Favored Glycine 0 N--CA 1.5 2.917 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.93 131.88 35.74 Favored 'General case' 0 C--N 1.293 -1.887 0 O-C-N 120.818 -1.401 . . . . 0.0 110.134 -177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 77' ' ' VAL . 24.2 t -91.69 126.62 44.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 N-CA-C 102.179 -3.267 . . . . 0.0 102.179 166.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.437 ' HB ' HG13 ' A' ' 3' ' ' VAL . 33.0 t -112.07 159.69 11.91 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 C-N-CA 118.472 -1.291 . . . . 0.0 109.068 -173.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -144.99 110.35 5.24 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 174.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -88.33 -56.45 3.31 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -175.138 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' CG ' ' O ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -71.3 62.03 0.33 Allowed 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 122.634 1.207 . . . . 0.0 107.799 178.196 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.471 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 6.9 mtm180 -95.43 126.1 47.15 Favored Pre-proline 0 C--N 1.281 -2.401 0 O-C-N 121.173 -0.954 . . . . 0.0 110.05 -177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.1 -122.44 0.0 OUTLIER 'Trans proline' 0 CA--C 1.567 2.174 0 C-N-CA 122.955 2.437 . . . . 0.0 113.059 175.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -80.44 -90.39 0.06 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.317 -1.49 . . . . 0.0 110.799 -177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 6.6 mtp85 -107.64 36.94 2.56 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.994 -1.066 . . . . 0.0 109.556 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 80' ' ' THR . 0.0 OUTLIER -41.33 114.16 0.47 Allowed 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 122.957 0.503 . . . . 0.0 111.065 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' NZ ' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -107.14 142.35 36.97 Favored 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.743 -0.598 . . . . 0.0 110.331 -176.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.418 ' CD1' ' CA ' ' A' ' 57' ' ' GLY . 78.8 m-85 -79.11 139.1 38.14 Favored 'General case' 0 C--N 1.273 -2.74 0 O-C-N 120.972 -1.08 . . . . 0.0 111.255 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.458 ' NH2' ' OG1' ' A' ' 86' ' ' THR . 7.0 mtm-85 -115.57 127.16 55.04 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 172.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.546 ' HG ' HG21 ' A' ' 42' ' ' VAL . 27.2 tp -108.71 138.97 44.17 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -147.69 170.8 16.75 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.68 163.83 13.0 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.0 ptmt -57.21 112.81 1.48 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 125.74 -18.88 6.67 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 107.934 -2.067 . . . . 0.0 107.934 -176.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.546 HG21 ' HG ' ' A' ' 37' ' ' LEU . 39.3 t -123.77 -97.01 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -177.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -86.98 -18.32 30.98 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.9 mp0 -107.13 156.88 18.33 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.625 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 15.5 mm-40 -68.54 140.93 92.59 Favored Pre-proline 0 C--N 1.269 -2.893 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.537 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.48 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 5.7 Cg_exo -70.52 113.39 1.83 Allowed 'Cis proline' 0 N--CA 1.51 2.48 0 C-N-CA 123.605 -1.415 . . . . 0.0 111.438 1.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.625 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 5.3 mtpm? -69.17 152.82 44.64 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.766 -1.209 . . . . 0.0 111.909 -173.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.441 ' O ' ' OG1' ' A' ' 62' ' ' THR . . . 69.87 5.1 50.8 Favored Glycine 0 N--CA 1.489 2.198 0 CA-C-O 119.113 -0.826 . . . . 0.0 113.474 171.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.402 ' CG1' ' HB2' ' A' ' 46' ' ' PRO . 11.7 mm -65.24 -46.66 90.07 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 120.456 2.128 . . . . 0.0 107.338 177.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.641 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 69.6 m-85 -115.75 144.67 43.64 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.296 -178.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.18 136.01 29.52 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 174.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' SER . 1.0 OUTLIER -109.23 157.54 9.49 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.602 -0.686 . . . . 0.0 109.989 -176.122 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.49 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 11.4 t-20 -85.32 126.94 34.13 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 175.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.476 ' HB3' ' HB3' ' A' ' 34' ' ' LYS . 1.8 mt-10 -59.7 -38.54 81.86 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.771 -0.581 . . . . 0.0 111.06 -177.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.471 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 10.6 t30 -88.57 -48.03 7.87 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.014 -1.054 . . . . 0.0 111.673 -176.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.1 p -80.49 -34.43 35.81 Favored 'General case' 0 C--N 1.281 -2.376 0 O-C-N 121.727 -0.608 . . . . 0.0 109.662 -174.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.418 ' CA ' ' CD1' ' A' ' 35' ' ' PHE . . . 84.08 10.38 80.68 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 108.397 -1.881 . . . . 0.0 108.397 -176.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 16.8 m -64.54 122.09 15.98 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 121.209 -1.171 . . . . 0.0 108.334 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.555 HG22 HG23 ' A' ' 24' ' ' VAL . 1.8 t -88.92 127.74 41.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.59 146.01 49.29 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.532 -0.73 . . . . 0.0 109.654 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.455 HG21 ' CG ' ' A' ' 65' ' ' LEU . 8.3 p -101.63 149.18 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 177.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 48' ' ' GLY . 28.8 p -99.86 -17.32 17.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.634 -0.666 . . . . 0.0 112.122 -175.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -145.93 167.17 23.93 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.798 -1.189 . . . . 0.0 110.567 -178.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.506 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 7.1 t -58.01 122.51 13.19 Favored 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.455 ' CG ' HG21 ' A' ' 61' ' ' VAL . 86.3 mt -79.73 140.87 36.81 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.466 -1.396 . . . . 0.0 109.904 -175.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.499 ' CG ' HH12 ' A' ' 63' ' ' ARG . 0.0 OUTLIER -124.37 117.3 24.17 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -60.17 -14.73 18.86 Favored 'General case' 0 C--N 1.29 -1.999 0 O-C-N 121.765 -0.584 . . . . 0.0 109.88 178.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.406 ' H ' ' CD ' ' A' ' 68' ' ' GLU . 1.5 mp0 -78.56 -28.3 45.94 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 120.889 -1.132 . . . . 0.0 108.694 -176.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.86 -52.75 12.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.1 mt -145.33 132.59 15.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -84.36 -25.46 29.14 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.22 136.59 5.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 42.7 m-85 -100.05 122.52 43.06 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 177.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -92.44 93.91 8.83 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.94 170.75 9.8 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 121.779 0.799 . . . . 0.0 109.028 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.423 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 93.5 m-85 -133.0 131.21 40.46 Favored 'General case' 0 C--N 1.272 -2.768 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 175.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.638 HG11 HG11 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -117.9 150.13 20.1 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.036 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -174.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.635 ' HB3' HG23 ' A' ' 86' ' ' THR . 0.3 OUTLIER -146.46 146.87 30.71 Favored 'General case' 0 C--N 1.289 -2.034 0 O-C-N 121.302 -0.874 . . . . 0.0 108.652 176.093 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.712 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -95.27 135.63 36.62 Favored 'General case' 0 C--N 1.289 -2.051 0 N-CA-C 104.711 -2.329 . . . . 0.0 104.711 170.419 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.712 ' C ' HD21 ' A' ' 87' ' ' LEU . 38.0 p -125.76 158.22 35.46 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 121.411 -0.806 . . . . 0.0 111.553 -171.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.429 ' HB2' HD11 ' A' ' 87' ' ' LEU . 28.1 t70 -79.64 170.96 15.79 Favored 'General case' 0 C--N 1.279 -2.482 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 174.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.428 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 2.1 m -58.41 -27.71 33.9 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.548 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -79.61 2.01 23.99 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.736 0.779 . . . . 0.0 108.997 177.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' HA2' ' HZ1' ' A' ' 34' ' ' LYS . . . 77.36 11.65 85.31 Favored Glycine 0 N--CA 1.486 2.007 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 80' ' ' THR . 0.2 OUTLIER -77.51 140.05 39.7 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.635 HG23 ' HB3' ' A' ' 78' ' ' GLU . 39.0 m -81.51 118.98 23.18 Favored 'General case' 0 C--N 1.287 -2.141 0 CA-C-O 120.777 0.322 . . . . 0.0 110.187 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.927 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -94.21 -31.29 14.18 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.468 ' HB3' ' OG1' ' A' ' 79' ' ' THR . 5.1 tp10 -138.04 153.18 49.37 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.56 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 89.12 -171.5 38.86 Favored Glycine 0 C--N 1.288 -2.119 0 N-CA-C 106.931 -2.467 . . . . 0.0 106.931 -174.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -68.37 111.54 1.03 Allowed 'Cis proline' 0 C--N 1.308 -1.594 0 C-N-CA 123.364 -1.515 . . . . 0.0 111.037 -0.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.85 HG21 HG21 ' A' ' 2' ' ' ILE . 4.2 m -86.9 163.56 40.28 Favored Pre-proline 0 C--N 1.28 -2.432 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -93.85 159.84 2.26 Favored 'Trans proline' 0 C--N 1.289 -2.561 0 C-N-CA 121.933 1.756 . . . . 0.0 110.868 177.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.528 HD13 HG23 ' A' ' 4' ' ' VAL . 15.4 tp -144.88 124.48 13.24 Favored 'General case' 0 C--N 1.277 -2.562 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 177.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.81 113.14 25.12 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.641 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 78.1 t -105.16 91.39 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.6 mp -80.82 138.04 20.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.978 0 O-C-N 121.506 -0.746 . . . . 0.0 109.179 -177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.696 HG12 ' HB3' ' A' ' 11' ' ' GLU . 4.0 t -97.1 106.72 18.87 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 23.2 pt -97.12 170.92 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 O-C-N 121.081 -1.012 . . . . 0.0 110.307 -177.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.406 ' O ' ' CG ' ' A' ' 100' ' ' GLN . 0.2 OUTLIER -97.77 139.04 34.23 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.726 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.559 ' HB2' ' HB3' ' A' ' 10' ' ' PRO . 34.3 mt-30 -163.99 69.88 0.2 Allowed 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 175.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 103' ' ' ASN . 40.0 t-20 -130.19 120.6 24.78 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.421 ' O ' ' CG ' ' A' ' 103' ' ' ASN . 7.4 m-20 -75.93 18.15 0.28 Allowed 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.507 ' O ' ' ND2' ' A' ' 103' ' ' ASN . 0.0 OUTLIER 76.64 23.02 1.11 Allowed 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 123.799 0.84 . . . . 0.0 109.42 -175.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.34 63.3 9.15 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.495 1.61 0 C-N-CA 123.036 2.491 . . . . 0.0 111.968 -177.011 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.247 0.934 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.856 HG21 HG21 ' A' ' 91' ' ' VAL . 7.2 mt -74.96 146.85 8.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.361 0.6 . . . . 0.0 109.621 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.465 HG13 ' HB ' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -125.25 137.89 56.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 176.379 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' A' ' 5' ' ' SER . 0.2 OUTLIER -150.61 167.43 2.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -178.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.494 ' N ' ' CG2' ' A' ' 4' ' ' VAL . 0.1 OUTLIER -140.87 145.73 40.88 Favored Pre-proline 0 C--N 1.289 -2.055 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 174.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -50.28 133.11 35.78 Favored 'Trans proline' 0 C--N 1.318 -1.027 0 C-N-CA 122.093 1.862 . . . . 0.0 110.323 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.2 mt -103.93 112.1 36.14 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.392 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.167 -179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.898 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -90.22 105.33 17.74 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.634 HD11 HG21 ' A' ' 21' ' ' VAL . 19.3 mt -111.93 128.4 25.51 Favored Pre-proline 0 C--N 1.291 -1.939 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 33.9 Cg_endo -69.27 130.16 19.45 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 C-N-CA 121.172 1.248 . . . . 0.0 110.727 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 66' ' ' ASP . 10.9 pt-20 -64.35 173.88 1.88 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 120.131 -0.628 . . . . 0.0 110.104 -177.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 57.39 61.75 2.4 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.688 0.756 . . . . 0.0 111.418 174.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.423 ' O ' ' OG1' ' A' ' 64' ' ' THR . 73.8 mt-30 -119.88 131.98 55.42 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 174.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -96.97 177.82 5.49 Favored 'General case' 0 C--N 1.285 -2.221 0 O-C-N 121.062 -1.024 . . . . 0.0 111.673 -172.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.567 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 18.2 mp0 -54.76 166.94 0.67 Allowed Pre-proline 0 C--N 1.3 -1.559 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 175.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 70.5 Cg_endo -78.12 122.13 8.44 Favored 'Cis proline' 0 C--N 1.315 -1.203 0 C-N-CA 123.785 -1.34 . . . . 0.0 114.459 0.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.506 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 29.6 m-85 -97.86 170.2 7.45 Favored Pre-proline 0 C--N 1.279 -2.49 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 173.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.506 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 16.7 Cg_exo -68.05 163.27 76.82 Favored 'Cis proline' 0 N--CA 1.493 1.483 0 C-N-CA 124.194 -1.169 . . . . 0.0 111.224 -1.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 19' ' ' ARG . 1.1 mtp180 -124.47 126.93 46.71 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 24.6 t70 -76.66 132.64 39.5 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.634 HG21 HD11 ' A' ' 9' ' ' ILE . 15.6 m -127.46 5.67 3.4 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.513 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.643 179.141 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 166.7 179.55 39.96 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 117.707 -2.187 . . . . 0.0 109.756 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 29.5 tttp -143.03 139.57 30.61 Favored 'General case' 0 C--N 1.291 -1.967 0 O-C-N 120.852 -1.381 . . . . 0.0 109.678 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.485 HG11 HG11 ' A' ' 77' ' ' VAL . 6.6 t -94.34 152.48 3.58 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.258 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 172.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.465 ' HB ' HG13 ' A' ' 3' ' ' VAL . 3.5 t -144.14 151.4 16.18 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 -177.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.515 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 9.2 t0 -112.25 135.08 53.37 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 173.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.08 -4.64 58.75 Favored 'General case' 0 C--N 1.269 -2.9 0 O-C-N 122.141 -0.349 . . . . 0.0 111.501 -177.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -141.21 -21.37 0.77 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.695 -1.253 . . . . 0.0 111.935 -175.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.608 ' NH1' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -72.51 146.26 88.56 Favored Pre-proline 0 C--N 1.286 -2.191 0 O-C-N 120.66 -1.275 . . . . 0.0 111.398 -171.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -41.86 143.91 1.05 Allowed 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 123.178 2.586 . . . . 0.0 111.048 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -57.92 -29.1 64.85 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.0 mtm180 -74.9 52.91 0.56 Allowed 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.656 ' HB2' HG22 ' A' ' 79' ' ' THR . 1.4 p -122.68 134.66 54.47 Favored 'General case' 0 C--N 1.282 -2.356 0 O-C-N 121.241 -0.912 . . . . 0.0 108.766 -178.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 54' ' ' GLU . 40.8 mttm -113.52 139.17 49.19 Favored 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 173.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.846 ' CE1' HG23 ' A' ' 79' ' ' THR . 61.9 m-85 -89.77 135.5 33.59 Favored 'General case' 0 C--N 1.271 -2.818 0 O-C-N 121.24 -0.912 . . . . 0.0 110.991 -174.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.509 ' NH2' ' OG1' ' A' ' 80' ' ' THR . 0.0 OUTLIER -100.0 139.27 35.92 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 106.514 -1.662 . . . . 0.0 106.514 174.23 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.463 HD11 HD23 ' A' ' 93' ' ' LEU . 19.2 tp -121.01 135.45 55.21 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.2 p -144.91 170.52 15.99 Favored 'General case' 0 C--N 1.274 -2.692 0 O-C-N 121.472 -0.768 . . . . 0.0 109.019 -174.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.15 173.39 17.69 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -58.16 111.5 1.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 124.52 -15.3 7.62 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 -179.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 50' ' ' PHE . 21.2 t -129.36 -81.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.294 -1.121 . . . . 0.0 109.154 -178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.459 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -96.53 -14.46 22.28 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.3 mp0 -118.85 158.51 25.51 Favored 'General case' 0 C--N 1.294 -1.82 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.521 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -51.9 127.85 36.08 Favored Pre-proline 0 C--N 1.281 -2.389 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.779 -176.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.445 ' HB2' HD11 ' A' ' 49' ' ' ILE . 4.3 Cg_endo -80.36 120.66 7.32 Favored 'Cis proline' 0 C--O 1.202 -1.311 0 C-N-CA 123.5 -1.458 . . . . 0.0 110.517 -1.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.459 ' NZ ' ' O ' ' A' ' 43' ' ' ASP . 28.0 mttp -63.47 155.51 29.0 Favored 'General case' 0 C--N 1.284 -2.25 0 O-C-N 120.872 -1.143 . . . . 0.0 111.268 -175.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 53.75 32.73 48.01 Favored Glycine 0 N--CA 1.49 2.285 0 CA-C-N 115.435 -0.802 . . . . 0.0 113.149 171.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.488 HD12 ' HD2' ' A' ' 63' ' ' ARG . 8.7 mm -87.89 -43.44 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 174.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.521 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 67.1 m-85 -110.39 141.44 43.46 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.813 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.586 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -132.6 120.61 22.02 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 176.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 0.0 OUTLIER -89.09 141.87 13.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 176.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.513 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 46.6 t30 -79.09 84.79 5.04 Favored 'General case' 0 C--N 1.269 -2.931 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 1.3 mp0 -24.22 -53.43 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.95 0 C-N-CA 125.327 1.451 . . . . 0.0 113.54 -174.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -79.75 -39.49 30.92 Favored 'General case' 0 C--N 1.294 -1.833 0 O-C-N 121.161 -0.962 . . . . 0.0 111.325 -174.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 29.2 p -94.32 -26.28 16.64 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-O 121.735 0.779 . . . . 0.0 109.313 -174.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 89.33 2.6 76.67 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -65.07 121.35 14.52 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.313 -1.11 . . . . 0.0 109.482 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.479 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.1 t -86.83 120.87 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.586 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.2 OUTLIER -123.73 155.42 37.9 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.418 178.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.568 ' CG2' HD21 ' A' ' 65' ' ' LEU . 7.4 p -102.19 143.54 14.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.111 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 59.9 p -90.48 -20.51 22.62 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.446 -0.784 . . . . 0.0 111.037 -175.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.49 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -151.81 175.66 12.22 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.115 -0.99 . . . . 0.0 110.033 -175.535 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.49 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 2.7 t -66.62 136.69 55.95 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-O 121.83 0.824 . . . . 0.0 110.793 -178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.568 HD21 ' CG2' ' A' ' 61' ' ' VAL . 22.0 mt -98.78 150.61 21.67 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.65 ' HB2' HG23 ' A' ' 69' ' ' VAL . 8.7 m-20 -132.9 122.66 24.67 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 106.613 -1.625 . . . . 0.0 106.613 177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 8.0 mtp-105 -57.26 -13.33 3.11 Favored 'General case' 0 N--CA 1.504 2.241 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -77.79 -22.94 49.37 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 66' ' ' ASP . 25.1 t -85.37 -55.87 6.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.448 ' O ' HG21 ' A' ' 97' ' ' VAL . 1.1 mt -144.74 136.39 21.07 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.11 -25.46 36.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 4.1 p -160.02 132.83 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.456 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 70.6 m-85 -94.42 115.23 27.38 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.447 ' HA ' HE21 ' A' ' 74' ' ' GLN . 0.0 OUTLIER -97.21 93.1 6.35 Favored 'General case' 0 C--N 1.281 -2.394 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.008 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.41 170.62 10.39 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-O 121.956 0.884 . . . . 0.0 108.994 -177.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.44 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 78.4 m-85 -128.15 122.23 31.44 Favored 'General case' 0 C--N 1.266 -3.023 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.565 ' O ' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -103.37 146.15 11.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -177.389 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.75 ' HB3' HG23 ' A' ' 86' ' ' THR . 91.3 mt-10 -136.5 140.02 42.71 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.846 HG23 ' CE1' ' A' ' 35' ' ' PHE . 0.3 OUTLIER -83.49 127.35 33.64 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 170.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.509 ' OG1' ' NH2' ' A' ' 36' ' ' ARG . 1.0 OUTLIER -125.46 159.67 31.36 Favored 'General case' 0 C--N 1.267 -3.007 0 C-N-CA 119.265 -0.974 . . . . 0.0 109.895 -178.092 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.532 ' CG ' ' N ' ' A' ' 82' ' ' VAL . 14.8 t70 -97.31 170.3 9.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.532 ' N ' ' CG ' ' A' ' 81' ' ' ASP . 1.5 m -54.43 -22.6 9.14 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 175.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -80.27 -2.86 46.91 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.426 -0.796 . . . . 0.0 109.058 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.12 8.62 86.95 Favored Glycine 0 N--CA 1.501 2.984 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 80' ' ' THR . 4.2 mttp -81.1 150.21 28.86 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.75 HG23 ' HB3' ' A' ' 78' ' ' GLU . 94.0 m -94.48 118.21 31.3 Favored 'General case' 0 C--N 1.279 -2.484 0 CA-C-O 121.219 0.533 . . . . 0.0 110.302 -177.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.908 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -89.15 -32.5 17.45 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 89' ' ' GLY . 0.3 OUTLIER -137.83 170.41 16.11 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.593 -0.692 . . . . 0.0 109.758 -178.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.511 ' HA2' HG13 ' A' ' 91' ' ' VAL . . . 83.5 -165.91 43.1 Favored Glycine 0 C--N 1.289 -2.039 0 N-CA-C 107.718 -2.153 . . . . 0.0 107.718 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -69.63 101.31 0.27 Allowed 'Cis proline' 0 N--CA 1.495 1.579 0 C-N-CA 123.564 -1.432 . . . . 0.0 110.79 -0.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.856 HG21 HG21 ' A' ' 2' ' ' ILE . 10.6 m -74.15 160.37 81.75 Favored Pre-proline 0 C--N 1.291 -1.954 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -92.49 147.07 2.8 Favored 'Trans proline' 0 C--N 1.285 -2.8 0 C-N-CA 121.868 1.712 . . . . 0.0 112.03 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.463 HD23 HD11 ' A' ' 37' ' ' LEU . 8.8 tp -130.51 125.85 35.36 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 175.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -108.27 106.91 17.28 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 121.651 -0.656 . . . . 0.0 109.677 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.521 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 38.9 t -98.45 100.5 10.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.64 HD13 ' CD1' ' A' ' 8' ' ' LEU . 4.8 mp -79.93 131.69 33.59 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.276 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 70' ' ' ILE . 3.1 t -90.05 111.24 22.97 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 10' ' ' PRO . 11.3 pt -105.25 171.39 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 O-C-N 121.688 -0.632 . . . . 0.0 109.537 -177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 101' ' ' ASN . 3.2 m-20 -83.37 176.2 9.28 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 178.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -70.83 68.98 0.44 Allowed 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.447 ' N ' ' O ' ' A' ' 99' ' ' ASP . 48.0 t-20 -83.1 176.97 8.81 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 104' ' ' ARG . 24.3 t70 -58.67 116.79 3.94 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.441 ' ND2' ' C ' ' A' ' 103' ' ' ASN . 0.4 OUTLIER -69.29 14.72 0.08 Allowed 'General case' 0 C--N 1.283 -2.302 0 O-C-N 121.781 -0.574 . . . . 0.0 110.644 -179.142 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.445 ' H ' ' C ' ' A' ' 102' ' ' ASP . 16.3 mtp180 49.5 64.19 8.98 Favored Pre-proline 0 N--CA 1.485 1.317 0 O-C-N 121.202 -0.936 . . . . 0.0 109.229 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 104' ' ' ARG . 2.9 Cg_endo . . . . . 0 C--O 1.192 -1.809 0 C-N-CA 122.337 2.025 . . . . 0.0 111.137 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.492 ' N ' ' OG ' ' A' ' 27' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 91' ' ' VAL . 7.0 mt -69.22 138.1 22.94 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.903 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.56 133.4 69.3 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 177.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.525 ' CG2' HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -146.69 157.9 10.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-O 121.637 0.732 . . . . 0.0 109.462 -177.36 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.3 t -128.36 141.84 42.73 Favored Pre-proline 0 C--N 1.281 -2.384 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.502 ' HB3' HD11 ' A' ' 96' ' ' ILE . 53.4 Cg_exo -45.67 132.92 13.41 Favored 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 121.531 1.487 . . . . 0.0 109.811 179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.519 ' HB ' HG22 ' A' ' 95' ' ' VAL . 40.7 mt -98.08 111.89 28.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.764 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -100.3 103.12 14.53 Favored 'General case' 0 C--N 1.282 -2.354 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.623 HG22 HE21 ' A' ' 13' ' ' GLN . 4.1 mt -108.11 127.8 26.92 Favored Pre-proline 0 C--N 1.27 -2.877 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.609 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . 18.5 Cg_endo -74.4 135.98 21.1 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 CA-C-N 119.444 0.837 . . . . 0.0 111.945 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.401 ' CG ' ' HA ' ' A' ' 66' ' ' ASP . 2.9 tt0 -39.38 147.08 0.08 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.502 0.668 . . . . 0.0 111.848 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.522 ' HA ' ' OG1' ' A' ' 64' ' ' THR . 2.3 t-20 59.87 66.54 0.97 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 174.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.623 HE21 HG22 ' A' ' 9' ' ' ILE . 18.9 mp0 -92.17 54.59 2.39 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 175.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.54 ' N ' ' HD2' ' A' ' 14' ' ' ARG . 0.1 OUTLIER -26.11 162.34 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.954 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -174.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.558 ' CB ' ' HA ' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -46.14 169.18 0.09 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 CA-C-N 113.044 -1.889 . . . . 0.0 110.753 175.996 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.558 ' HA ' ' CB ' ' A' ' 15' ' ' GLN . 1.2 Cg_endo -77.47 131.47 24.07 Favored 'Cis proline' 0 N--CA 1.492 1.392 0 C-N-CA 123.321 -1.533 . . . . 0.0 112.37 -0.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.529 ' CZ ' ' N ' ' A' ' 64' ' ' THR . 55.1 m-85 -97.74 163.95 18.5 Favored Pre-proline 0 C--N 1.293 -1.86 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -72.19 156.27 98.19 Favored 'Cis proline' 0 N--CA 1.502 1.977 0 C-N-CA 124.12 -1.2 . . . . 0.0 110.841 -1.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.418 ' NH1' ' O ' ' A' ' 14' ' ' ARG . 38.2 mtp180 -124.77 135.29 52.85 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.435 -0.791 . . . . 0.0 110.101 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 0.1 OUTLIER -62.17 140.27 58.44 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 175.756 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.1 m -139.33 -4.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . -176.07 170.44 43.33 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 118.75 -1.69 . . . . 0.0 109.313 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.571 ' NZ ' ' O ' ' A' ' 24' ' ' VAL . 5.1 tttm -141.62 114.1 8.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.163 -1.198 . . . . 0.0 109.687 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.694 HG11 HG11 ' A' ' 77' ' ' VAL . 22.0 t -79.65 158.92 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 175.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' CE ' ' A' ' 23' ' ' LYS . 6.3 t -141.81 170.1 13.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.1 t70 -131.13 143.93 51.01 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 172.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.492 ' OG ' ' N ' ' A' ' 1' ' ' SER . 0.2 OUTLIER -58.84 -39.12 80.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -178.657 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -163.17 79.95 0.46 Allowed 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.161 -0.615 . . . . 0.0 110.364 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.564 ' HG2' HG21 ' A' ' 79' ' ' THR . 0.8 OUTLIER -64.26 152.03 89.37 Favored Pre-proline 0 C--N 1.289 -2.061 0 O-C-N 120.907 -1.121 . . . . 0.0 108.634 175.907 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' ' O ' ' A' ' 29' ' ' ARG . 73.1 Cg_exo -46.28 -121.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.515 2.741 0 C-N-CA 123.661 2.907 . . . . 0.0 112.1 173.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HB2' ' NH1' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -105.55 -57.91 1.97 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 119.855 -1.778 . . . . 0.0 110.065 179.311 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.471 ' NH1' ' HB2' ' A' ' 31' ' ' GLU . 11.9 mtm-85 -125.99 45.61 2.59 Favored 'General case' 0 N--CA 1.511 2.593 0 O-C-N 120.932 -1.105 . . . . 0.0 109.764 -178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.425 ' OG ' ' HD2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -68.61 155.58 39.74 Favored 'General case' 0 C--N 1.286 -2.169 0 O-C-N 121.352 -0.843 . . . . 0.0 110.734 -178.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HB2' HH22 ' A' ' 36' ' ' ARG . 2.4 mmtp -111.02 135.41 51.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.709 -0.619 . . . . 0.0 109.712 -178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.468 ' CE1' ' NH1' ' A' ' 29' ' ' ARG . 9.0 m-85 -84.58 116.08 22.96 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 174.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.597 ' NH1' HG21 ' A' ' 80' ' ' THR . 0.0 OUTLIER -95.31 133.73 38.89 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.633 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.706 ' HG ' HG21 ' A' ' 42' ' ' VAL . 61.0 tp -106.93 136.91 45.99 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 176.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.22 170.45 16.72 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.538 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . 117.35 167.3 14.32 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 110.25 -1.14 . . . . 0.0 110.25 179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -53.92 116.07 2.35 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' CA ' ' O ' ' A' ' 46' ' ' PRO . . . 119.33 -22.12 9.03 Favored Glycine 0 C--N 1.28 -2.566 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.872 HG22 ' HB2' ' A' ' 50' ' ' PHE . 11.1 t -117.82 -83.89 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 121.428 -1.043 . . . . 0.0 109.12 -178.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.35 -23.26 16.72 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.538 ' OE1' ' N ' ' A' ' 39' ' ' GLY . 20.4 mp0 -103.34 161.22 14.02 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.447 ' HA ' ' C ' ' A' ' 46' ' ' PRO . 2.5 mp0 -68.73 134.69 90.26 Favored Pre-proline 0 C--N 1.27 -2.855 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 -176.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.457 ' O ' ' CA ' ' A' ' 41' ' ' GLY . 35.1 Cg_endo -68.73 126.42 8.76 Favored 'Cis proline' 0 N--CA 1.514 2.705 0 C-N-CA 123.615 -1.411 . . . . 0.0 110.942 -0.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -87.23 152.51 22.25 Favored 'General case' 0 C--N 1.289 -2.056 0 O-C-N 120.82 -1.175 . . . . 0.0 111.649 -173.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.01 15.26 71.67 Favored Glycine 0 N--CA 1.492 2.376 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.314 174.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 23.0 mm -78.37 -48.86 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 CA-C-N 119.561 1.68 . . . . 0.0 107.653 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.872 ' HB2' HG22 ' A' ' 42' ' ' VAL . 91.8 m-85 -108.42 155.71 20.27 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 121.708 0.766 . . . . 0.0 109.673 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.553 ' NH1' ' OG ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -146.75 160.0 42.78 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 176.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.426 HG12 ' N ' ' A' ' 53' ' ' ASN . 10.9 tt -132.08 164.13 35.61 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.023 0 O-C-N 120.81 -1.181 . . . . 0.0 109.941 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.471 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 21.9 t-20 -91.94 108.71 20.12 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.464 ' OE2' ' NZ ' ' A' ' 34' ' ' LYS . 32.1 mt-10 -46.98 -33.45 4.69 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.154 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 2.3 t-20 -95.9 -48.84 5.56 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.415 -0.803 . . . . 0.0 110.961 -176.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 10.0 p -84.91 -21.58 29.61 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 121.491 -0.756 . . . . 0.0 110.083 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.8 7.82 86.28 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.034 -1.627 . . . . 0.0 109.034 -178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 12.0 m -64.15 123.4 18.99 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.547 HG13 HD22 ' A' ' 37' ' ' LEU . 3.3 t -92.78 122.78 44.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.553 ' OG ' ' NH1' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -117.25 149.42 40.46 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.412 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.516 ' CG2' HD21 ' A' ' 65' ' ' LEU . 8.6 p -104.11 143.63 15.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.0 p -91.96 -13.88 30.38 Favored 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.547 -0.72 . . . . 0.0 110.852 -175.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.573 ' NH1' ' O ' ' A' ' 64' ' ' THR . 0.1 OUTLIER -148.17 160.25 43.12 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.605 -1.309 . . . . 0.0 109.905 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.573 ' O ' ' NH1' ' A' ' 63' ' ' ARG . 0.7 OUTLIER -63.21 127.55 31.79 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 -179.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.596 ' HB2' HE22 ' A' ' 13' ' ' GLN . 34.5 mt -84.68 151.89 24.14 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.242 -1.536 . . . . 0.0 111.604 -172.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.717 ' HB2' HG23 ' A' ' 69' ' ' VAL . 4.8 m-20 -123.91 131.05 53.51 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 175.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.558 HH11 ' CB ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -72.14 -6.0 39.53 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 176.017 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -85.44 -19.56 31.12 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -175.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.717 HG23 ' HB2' ' A' ' 66' ' ' ASP . 34.1 t -90.25 -62.96 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 105.146 -2.168 . . . . 0.0 105.146 176.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.516 HG21 ' CD1' ' A' ' 73' ' ' TYR . 0.9 OUTLIER -140.49 127.98 23.41 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 175.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.79 -24.63 24.97 Favored 'General case' 0 C--N 1.288 -2.094 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.5 p -146.17 121.79 3.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.516 ' CD1' HG21 ' A' ' 70' ' ' ILE . 65.5 m-85 -92.36 119.7 32.17 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -89.76 81.93 6.33 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.468 HD23 HG23 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -80.46 170.2 16.68 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-O 122.301 1.048 . . . . 0.0 109.974 -177.5 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 90.4 m-85 -135.2 136.68 41.98 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 175.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.694 HG11 HG11 ' A' ' 24' ' ' VAL . 0.2 OUTLIER -114.07 147.33 17.66 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 -178.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.566 ' HB3' HG23 ' A' ' 86' ' ' THR . 49.0 mt-10 -138.18 141.8 40.05 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 176.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.564 HG21 ' HG2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -96.86 131.78 43.27 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 172.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.597 HG21 ' NH1' ' A' ' 36' ' ' ARG . 18.0 p -122.78 162.32 22.31 Favored 'General case' 0 C--N 1.278 -2.528 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.935 -175.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.439 ' HB2' HD11 ' A' ' 87' ' ' LEU . 0.7 OUTLIER -107.97 171.09 7.6 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 177.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 27.5 m -47.62 -22.74 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 O-C-N 121.81 -0.556 . . . . 0.0 111.818 -177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.48 -17.17 54.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.744 -1.222 . . . . 0.0 109.856 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.91 11.61 57.55 Favored Glycine 0 N--CA 1.498 2.806 0 N-CA-C 108.628 -1.789 . . . . 0.0 108.628 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 80' ' ' THR . 14.2 mttm -90.27 160.54 16.12 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.628 ' C ' HD13 ' A' ' 87' ' ' LEU . 90.3 m -101.2 120.29 40.01 Favored 'General case' 0 C--N 1.278 -2.538 0 CA-C-O 120.841 0.353 . . . . 0.0 110.085 -178.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.901 HD13 ' N ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -96.22 -11.23 26.36 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -178.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.473 ' O ' ' CG2' ' A' ' 86' ' ' THR . 11.3 tp10 -152.2 167.54 28.24 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 72.59 -168.75 52.73 Favored Glycine 0 N--CA 1.486 2.0 0 N-CA-C 108.398 -1.881 . . . . 0.0 108.398 -178.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -67.03 112.56 1.05 Allowed 'Cis proline' 0 N--CA 1.493 1.463 0 C-N-CA 123.25 -1.563 . . . . 0.0 112.356 0.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.791 HG21 HG21 ' A' ' 2' ' ' ILE . 5.3 m -83.2 165.28 41.73 Favored Pre-proline 0 C--N 1.284 -2.269 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -94.27 152.54 2.06 Favored 'Trans proline' 0 C--N 1.297 -2.151 0 C-N-CA 121.948 1.766 . . . . 0.0 112.329 177.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.525 HD13 ' CG2' ' A' ' 4' ' ' VAL . 6.5 tp -141.49 126.68 18.51 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -108.45 116.64 32.34 Favored 'General case' 0 C--N 1.285 -2.239 0 O-C-N 121.354 -0.841 . . . . 0.0 109.173 -178.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG22 ' HB ' ' A' ' 7' ' ' ILE . 79.1 t -104.15 104.47 16.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.113 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.633 ' H ' HD12 ' A' ' 96' ' ' ILE . 3.0 mp -92.52 134.52 30.29 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 -178.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 9' ' ' ILE . 15.0 t -89.73 104.0 14.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.534 HG21 ' HB3' ' A' ' 8' ' ' LEU . 15.1 pt -85.46 170.85 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.503 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.422 ' OD2' ' NH2' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -91.87 -177.94 4.88 Favored 'General case' 0 C--N 1.284 -2.252 0 O-C-N 120.746 -1.221 . . . . 0.0 109.256 -176.667 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.609 ' HG2' ' HB2' ' A' ' 10' ' ' PRO . 4.7 mm-40 -136.17 122.37 20.39 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.462 ' O ' ' ND2' ' A' ' 101' ' ' ASN . 1.6 t30 -83.9 50.99 1.93 Allowed 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 104.679 -2.341 . . . . 0.0 104.679 171.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 36.72 82.48 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.75 -173.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -47.45 -35.69 8.95 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.7 mtp85 -140.96 94.23 8.0 Favored Pre-proline 0 C--N 1.293 -1.872 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo . . . . . 0 N--CA 1.499 1.799 0 C-N-CA 122.659 2.239 . . . . 0.0 111.913 -178.113 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 26' ' ' ASP . 0.7 OUTLIER . . . . . 0 C--O 1.217 -0.626 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.765 ' CG2' HG21 ' A' ' 91' ' ' VAL . 2.7 mt -77.69 123.28 34.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 CA-C-O 121.873 0.844 . . . . 0.0 110.511 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.64 134.17 44.29 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.821 HG21 HD13 ' A' ' 93' ' ' LEU . 0.1 OUTLIER -155.0 154.86 6.42 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -179.816 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.15 141.71 33.5 Favored Pre-proline 0 C--N 1.28 -2.445 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 176.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -47.63 132.36 20.62 Favored 'Trans proline' 0 N--CA 1.485 1.007 0 C-N-CA 121.34 1.36 . . . . 0.0 108.93 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.568 HG13 HD11 ' A' ' 93' ' ' LEU . 3.0 mt -99.4 112.41 31.61 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.468 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.896 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -89.5 98.57 11.84 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.49 ' CD1' HG13 ' A' ' 95' ' ' VAL . 12.5 mt -106.42 121.29 45.79 Favored Pre-proline 0 C--N 1.279 -2.493 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 18.5 Cg_endo -66.07 137.46 48.45 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 120.629 0.886 . . . . 0.0 111.275 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -72.13 179.5 3.29 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.675 -178.137 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.543 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 2.2 m-20 58.69 17.51 5.16 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 172.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.41 ' O ' ' OG1' ' A' ' 64' ' ' THR . 58.3 mt-30 -77.21 129.45 35.95 Favored 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 174.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.543 ' NH2' ' OD1' ' A' ' 12' ' ' ASN . 0.3 OUTLIER -97.81 -175.39 3.15 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.095 -1.003 . . . . 0.0 110.884 -173.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.502 ' HB3' ' HA ' ' A' ' 16' ' ' PRO . 4.3 mt-30 -49.2 160.78 0.49 Allowed Pre-proline 0 C--N 1.307 -1.252 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 177.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HA ' ' HB3' ' A' ' 15' ' ' GLN . 0.9 OUTLIER -80.53 148.56 76.89 Favored 'Cis proline' 0 C--N 1.301 -1.935 0 C-N-CA 123.195 -1.585 . . . . 0.0 113.901 -0.145 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -129.13 166.49 24.88 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 105.404 -2.072 . . . . 0.0 105.404 175.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.501 ' O ' ' NE ' ' A' ' 19' ' ' ARG . 16.9 Cg_exo -67.26 169.6 49.78 Favored 'Cis proline' 0 N--CA 1.496 1.647 0 C-N-CA 124.354 -1.103 . . . . 0.0 112.157 -0.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.501 ' NE ' ' O ' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -137.04 137.67 39.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.622 -0.674 . . . . 0.0 109.583 178.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 60' ' ' SER . 12.4 t70 -75.87 140.11 42.03 Favored 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.0 m -131.94 5.2 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . 162.41 173.89 31.64 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.197 -1.954 . . . . 0.0 109.919 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 58' ' ' SER . 0.0 OUTLIER -136.86 124.88 22.83 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.355 -1.085 . . . . 0.0 109.764 -178.412 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.812 HG11 HG11 ' A' ' 77' ' ' VAL . 8.1 t -82.94 157.7 3.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 174.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.8 t -144.32 169.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 2' ' ' ILE . 10.0 t70 -125.73 141.42 52.01 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -27.83 65.16 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -162.97 91.7 0.74 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.533 ' NH2' ' O ' ' A' ' 33' ' ' SER . 12.2 mtp-105 -65.67 120.85 71.93 Favored Pre-proline 0 C--N 1.294 -1.834 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.431 ' HB2' ' H ' ' A' ' 31' ' ' GLU . 5.0 Cg_exo -39.77 -102.25 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 123.451 2.767 . . . . 0.0 115.327 -176.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.431 ' H ' ' HB2' ' A' ' 30' ' ' PRO . 6.2 mt-10 -105.21 -67.75 0.9 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.759 -1.213 . . . . 0.0 110.075 -175.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.35 58.88 1.7 Allowed 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.537 ' HA ' ' HA ' ' A' ' 81' ' ' ASP . 0.3 OUTLIER -85.1 138.76 32.21 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.025 -169.571 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 154.94 29.12 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 54' ' ' GLU . 65.9 m-85 -86.63 137.51 32.42 Favored 'General case' 0 C--N 1.285 -2.227 0 O-C-N 121.973 -0.455 . . . . 0.0 110.003 -179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' NH2' ' OG1' ' A' ' 80' ' ' THR . 0.7 OUTLIER -110.08 130.28 55.56 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 173.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.666 ' HG ' HG21 ' A' ' 42' ' ' VAL . 46.4 tp -111.02 138.01 47.96 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.2 p -146.69 171.26 15.41 Favored 'General case' 0 C--N 1.271 -2.814 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.478 ' H ' ' HG3' ' A' ' 44' ' ' GLN . . . 113.32 173.88 18.8 Favored Glycine 0 N--CA 1.51 3.608 0 C-N-CA 120.0 -1.095 . . . . 0.0 110.78 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.7 ptmt -62.32 119.46 9.1 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 46' ' ' PRO . . . 117.32 -22.81 10.09 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 108.112 -1.995 . . . . 0.0 108.112 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.666 HG21 ' HG ' ' A' ' 37' ' ' LEU . 21.3 t -115.86 -95.32 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -178.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.602 ' O ' ' NZ ' ' A' ' 47' ' ' LYS . 0.9 OUTLIER -92.55 -6.39 49.72 Favored 'General case' 0 C--O 1.204 -1.327 0 O-C-N 121.22 -0.925 . . . . 0.0 109.171 178.081 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.478 ' HG3' ' H ' ' A' ' 39' ' ' GLY . 20.0 mt-30 -116.8 148.65 41.01 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.627 ' HA ' ' N ' ' A' ' 47' ' ' LYS . 5.2 mm-40 -58.94 140.08 86.84 Favored Pre-proline 0 C--N 1.271 -2.82 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.204 -174.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 45' ' ' GLU . 37.2 Cg_endo -68.64 116.02 2.29 Favored 'Cis proline' 0 N--CA 1.511 2.507 0 C-N-CA 123.299 -1.542 . . . . 0.0 110.456 -1.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.627 ' N ' ' HA ' ' A' ' 45' ' ' GLU . 7.8 mtpp -73.4 147.1 44.6 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.657 -1.277 . . . . 0.0 111.305 -172.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 71.38 21.5 78.6 Favored Glycine 0 N--CA 1.497 2.753 0 O-C-N 121.515 -0.741 . . . . 0.0 112.914 172.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.553 HD12 ' HD2' ' A' ' 63' ' ' ARG . 17.2 mm -86.15 -47.27 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.689 ' CZ ' HG11 ' A' ' 95' ' ' VAL . 74.8 m-85 -110.04 138.63 46.15 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.163 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -136.59 142.82 43.35 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 tt -111.45 162.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' HB3' ' OG1' ' A' ' 56' ' ' THR . 19.4 t-20 -97.18 109.89 22.55 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 176.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -36.56 -41.89 0.32 Allowed 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 122.804 0.442 . . . . 0.0 111.784 -177.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -92.86 -48.04 6.74 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.032 -1.043 . . . . 0.0 111.61 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.494 ' OG1' ' HB3' ' A' ' 53' ' ' ASN . 4.1 p -79.98 -27.97 39.58 Favored 'General case' 0 C--N 1.281 -2.401 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 -173.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 2.85 90.35 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 108.535 -1.826 . . . . 0.0 108.535 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 12.3 m -63.06 122.95 17.33 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.67 -0.9 . . . . 0.0 109.278 178.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 24' ' ' VAL . 1.6 t -94.88 123.49 47.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 20' ' ' ASP . 0.0 OUTLIER -126.7 153.35 45.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.211 -0.931 . . . . 0.0 109.792 177.814 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.612 HG22 ' H ' ' A' ' 63' ' ' ARG . 2.5 p -104.68 146.12 12.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 13.0 p -96.25 -7.39 35.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.667 -0.646 . . . . 0.0 112.061 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.612 ' H ' HG22 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -154.5 172.06 18.4 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.462 -1.399 . . . . 0.0 110.685 -175.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.462 ' O ' ' HD3' ' A' ' 63' ' ' ARG . 13.9 t -65.16 137.89 57.91 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 48.1 mt -98.85 149.76 22.58 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' OD1' HG23 ' A' ' 69' ' ' VAL . 0.8 OUTLIER -126.3 142.36 51.56 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 12.5 mtp180 -91.93 9.24 33.84 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.81 -30.53 20.15 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.559 HG23 ' OD1' ' A' ' 66' ' ' ASP . 26.5 t -101.18 -47.08 11.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.0 mt -134.22 139.96 47.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.293 -0.879 . . . . 0.0 109.121 -178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.49 -23.98 15.33 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 95' ' ' VAL . 2.8 p -156.12 138.1 6.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.26 -0.9 . . . . 0.0 109.084 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.452 ' HB2' ' HB ' ' A' ' 95' ' ' VAL . 36.4 m-85 -99.0 128.09 45.06 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 17.4 tp60 -90.79 97.56 11.25 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.71 170.34 9.65 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.523 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 86.2 m-85 -138.88 128.78 25.07 Favored 'General case' 0 C--N 1.268 -2.946 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.812 HG11 HG11 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -110.4 139.52 33.52 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 O-C-N 122.043 -0.411 . . . . 0.0 110.045 -176.063 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.697 ' HB3' HG23 ' A' ' 86' ' ' THR . 41.2 mt-10 -129.33 137.5 51.03 Favored 'General case' 0 C--N 1.287 -2.141 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.616 ' O ' HD22 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -85.17 134.37 34.17 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 104.311 -2.477 . . . . 0.0 104.311 170.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 33' ' ' SER . 15.6 p -128.06 151.21 49.45 Favored 'General case' 0 C--N 1.267 -2.983 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -176.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.545 ' N ' HD21 ' A' ' 87' ' ' LEU . 0.3 OUTLIER -116.15 172.2 7.33 Favored 'General case' 0 N--CA 1.508 2.446 0 CA-C-N 118.808 0.731 . . . . 0.0 109.815 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' A' ' 81' ' ' ASP . 34.8 m -29.3 -40.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -176.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.446 ' OD1' ' NZ ' ' A' ' 85' ' ' LYS . 28.7 t-20 -80.46 -8.6 59.61 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.72 -1.237 . . . . 0.0 110.195 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.61 13.14 78.9 Favored Glycine 0 C--N 1.287 -2.169 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' THR . 5.2 mttp -74.96 160.2 30.87 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 78' ' ' GLU . 16.6 m -96.01 116.53 29.08 Favored 'General case' 0 C--N 1.275 -2.662 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.926 HD22 ' H ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -96.02 -11.07 27.01 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.539 ' HG3' HD12 ' A' ' 2' ' ' ILE . 1.1 tp10 -154.54 154.56 33.3 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.412 ' HA2' ' N ' ' A' ' 91' ' ' VAL . . . 78.41 -162.24 49.23 Favored Glycine 0 C--N 1.284 -2.316 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 177.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.35 105.58 0.24 Allowed 'Cis proline' 0 N--CA 1.495 1.586 0 C-N-CA 123.305 -1.54 . . . . 0.0 111.458 -0.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 77' ' ' VAL . 20.4 m -73.48 159.09 85.54 Favored Pre-proline 0 C--N 1.286 -2.18 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 177.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -91.37 152.01 3.65 Favored 'Trans proline' 0 C--N 1.283 -2.895 0 C-N-CA 121.359 1.373 . . . . 0.0 111.438 177.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.821 HD13 HG21 ' A' ' 4' ' ' VAL . 4.2 tp -139.02 128.51 24.41 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' N ' HD12 ' A' ' 93' ' ' LEU . 9.3 mt-10 -102.41 111.57 23.92 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.636 -0.665 . . . . 0.0 109.525 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.689 HG11 ' CZ ' ' A' ' 50' ' ' PHE . 4.9 t -93.43 95.34 5.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 105.234 -2.136 . . . . 0.0 105.234 174.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 1.1 mt -79.96 130.66 35.66 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.495 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 5.7 t -92.06 122.14 43.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.68 HG21 ' HB3' ' A' ' 8' ' ' LEU . 12.5 pt -112.49 171.52 3.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 121.345 -0.847 . . . . 0.0 110.661 -178.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -84.37 158.35 21.15 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.151 -0.968 . . . . 0.0 108.545 -178.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.478 ' NE2' ' O ' ' A' ' 11' ' ' GLU . 3.9 pt20 -111.09 131.39 55.12 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.459 ' O ' ' C ' ' A' ' 102' ' ' ASP . 48.0 t30 -69.57 -25.26 63.9 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.648 -1.283 . . . . 0.0 107.595 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' C ' ' O ' ' A' ' 101' ' ' ASN . 6.8 t70 -13.19 -84.51 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.745 0 C-N-CA 125.025 1.33 . . . . 0.0 111.403 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 172.35 -35.61 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.558 ' HB3' ' CD ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER 61.8 -177.95 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -177.125 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 104' ' ' ARG . 2.5 Cg_endo . . . . . 0 C--O 1.201 -1.33 0 C-N-CA 121.783 1.655 . . . . 0.0 109.386 177.064 . . . . . . . . 1 1 . 1 stop_ save_